Legalize / Česká republika / Vyhláška o úhradách léčiv a potravin pro zvláštní lékařské účely / Historie

Historie novel

Vyhláška o úhradách léčiv a potravin pro zvláštní lékařské účely

4 verzí · 2005-12-29

2006-12-31

Vyhláška č. 532/2005 Sb.

Zobrazit změny Text k tomuto datu

2006-07-31

Vyhláška č. 532/2005 Sb.

Zobrazit změny Text k tomuto datu

2006-02-28

Vyhláška č. 532/2005 Sb.

Zobrazit změny Text k tomuto datu

Změny ze dne 2006-02-28

@@ -42,384 +42,422 @@

| 1 | Stomatologika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 1.1 | A01AA01 | fluorid sodný | p.o. | 1.10 | MG | 0.88 | |

| 46265 | ZYMAFLUOR 1/4 MG | portblnob 200x0.25mg | FAJ | I |

| --- | --- | --- | --- | --- |

| 1.2 | A01AB10 | natamycin | lok. | 20.00 | MG | 7.48 | |

| | | | | | | | |

| 1.3 | A01AB03 | chlorhexidin | lok. | 1 000.00 | ML | 178.70 | H |

| | | | | | | | |

| 1.4 | A01AC01 | triamcinolon | lok. | 1.00 | GM | 13.69 | L/DER,STO, ORL |

| | | | | | | | |

| 1.5 | A01AC02 | dexametason | lok. | 1.00 | GM | 11.68 | L/DER,STO, ORL |

| 1.1 | A01AA01 | fluorid sodný | p.o. | 1.10 | MG | 0,86 | |

| 46265 | ZYMAFLUOR 1/4 MG | por tbl nob 200×0.25mg | FAJ | I |

| --- | --- | --- | --- | --- |

| 1.2 | A01AB10 | natamycin | lok. | 20.00 | MG | 7,31 | |

| | | | | | | | |

| 1.3 | A01AB03 | chlorhexidin | lok. | 1 000.00 | ML | 174,64 | H |

| | | | | | | | |

| 1.4 | A01AC01 | triamcinolon | lok. | 1.00 | GM | 13,38 | L/DER,STO, ORL |

| | | | | | | | |

| 1.5 | A01AC02 | dexametason | lok. | 1.00 | GM | 11,41 | L/DER,STO, ORL |

| | | | | | | | |

| 2 | adsobční anatacida a protivředová léčiva ze skupiny H2-blokátorů, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 2.1 | A02AD | kombinace hliníku, vápníku a hořčíku (pevné lékové formy) | p.o. | 10.00 | DF | 3.10 | |

| | | | | | | | |

| 2.2 | A02AD | kombinace hliníku, vápníku a hořčíku (tekuté lékové formy) | p.o. | 50.00 | ML | 3.10 | |

| | | | | | | | |

| 2.3 | A02AD01 | kombinace hliníku, vápníku a hořčíku (obvyklé kombinace solí – pevné lékové formy) | p.o. | 10.00 | DF | 3.10 | |

| | | | | | | | |

| 2.4 | A02AD01 | kombinace hliníku, vápníku a hořčíku (obvyklé kombinace solí – tekuté lékové formy) | p.o. | 50.00 | ML | 3.10 | |

| | | | | | | | |

| 2.5 | A02AD04 | hydrotalcit (pevné lékové formy) | p.o. | 10.00 | DF | 3.10 | |

| | | | | | | | |

| 2.6 | A02AD04 | hydrotalcit (tekuté lékové formy) | p.o. | 50.00 | ML | 3.10 | |

| | | | | | | | |

| 2.7 | A02BA01 | cimetidin | p.o. | 0.80 | GM | 3.10 | |

| | | | | | | | |

| 2.8 | A02BA02 | ranitidin nad 75 mg v 1tbl | p.o. | 0.30 | GM | 3.10 | |

| 12346 | HISTAC 150 | tbl obd 20x150mg | RXY | IND |

| --- | --- | --- | --- | --- |

| 14664 | HISTAC 150 | por tbl flm 20x150mg | IRI | IRL |

| 2.9 | A02BA03 | famotidin 20 mg a výše v 1 tabletě | p.o. | 40.00 | MG | 3.10 | |

| | | | | | | | |

| 2.10 | A02BA04 | nizatidin | p.o. | 0.30 | GM | 3.10 | |

| 2.11 | A02BA06 | roxatidin | p.o. | 0.15 | GM | 3.10 | |

| | | | | | | | |

| 2.12 | A02BA07 | ranitidin bismut citrát | p.o. | 0.80 | GM | 28.50 | |

| | | | | | | | |

| 3 | protivředová léčiva ze skupiny inhibitorů protonové pumpy a ostatní protivředová léčiva | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 3.1 | A02BA01 | cimetidin | parent. | 0.80 | GM | 32.06 | H |

| | | | | | | | |

| 3.2 | A02BA02 | ranitidin | parent. | 0.30 | GM | 68.43 | H |

| | | | | | | | |

| 3.3 | A02BA03 | famotidin | parent. | 40.00 | MG | 68.43 | H |

| | | | | | | | |

| 3.4 | A02BB01 | misoprostol | p.o. | 0.80 | MG | 47.36 | Z |

| | | | | | | | |

| 3.5 | A02BC01 | omeprazol | parent. | 20.00 | MG | 170.00 | H |

| | | | | | | | |

| 3.6 | A02BC01 | omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20.00 | MG | 13.95 | |

| | | | | | | | |

| 3.7 | A02BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20.00 | MG | 8.35 | |

| 60160 | ULTOP | cps 14x20mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 3.8 | A02BC02 | pantoprazol | p.o. | 40.00 | MG | 8.35 | |

| | | | | | | | |

| 3.9 | A02BC02 | pantoprazol | parent. | 40.00 | MG | 170.00 | H |

| | | | | | | | |

| 3.10 | A02BC03 | lansoprazol | p.o. | 30.00 | MG | 8.35 | |

| | | | | | | | |

| 3.11 | A02BC05 | esomeprazol (do 20mg v jedné dávce včetně) | p.o. | 30.00 | MG | 18.00 | L/GIT,INT,GER |

| | | | | | | | |

| 3.12 | A02BC05 | esomeprazol (nad 20mg v jedné dávce) | p.o. | 30.00 | MG | 10.00 | L/GIT,INT,GER |

| | | | | | | | |

| 3.13 | A02BX | ostatní léčiva peptického vředu (bismut subsalicylat) | p.o. | 3.00 | DF | 22.29 | |

| | | | | | | | |

| 3.14 | A02BX02 | sukralfát | p.o. | 4.00 | GM | 8.35 | |

| | | | | | | | |

| 3.15 | A02BX03 | pirenzepin | p.o. | 0.10 | GM | 8.55 | |

| | | | | | | | |

| 3.16 | A02BX03 | pirenzepin | parent. | 20.00 | MG | 105.58 | H |

| | | | | | | | |

| 3.17 | A02BX05 | zásaditý citronan bismutitý | p.o. | 0.48 | GM | 23.07 | |

| 2.1 | A02AD | kombinace hliníku, vápníku a hořčíku (pevné lékové formy) | p.o. | 10.00 | DF | 3,03 | |

| | | | | | | | |

| 2.2 | A02AD | kombinace hliníku, vápníku a hořčíku (tekuté lékové formy) | p.o. | 50.00 | ML | 3,03 | |

| | | | | | | | |

| 2.3 | A02AD01 | kombinace hliníku, vápníku a hořčíku (obvyklé kombinace solí – pevné lékové formy) | p.o. | 10.00 | DF | 3,03 | |

| | | | | | | | |

| 2.4 | A02AD01 | kombinace hliníku, vápníku a hořčíku (obvyklé kombinace solí – tekuté lékové formy) | p.o. | 50.00 | ML | 3,03 | |

| | | | | | | | |

| 2.5 | A02AD04 | hydrotalcit (pevné lékové formy) | p.o. | 10.00 | DF | 3,03 | |

| | | | | | | | |

| 2.6 | A02AD04 | hydrotalcit (tekuté lékové formy) | p.o. | 50.00 | ML | 3,03 | |

| | | | | | | | |

| 2.7 | A02BA01 | cimetidin | p.o. | 0.80 | GM | 3,03 | |

| | | | | | | | |

| 2.8 | A02BA02 | ranitidin nad 75 mg v 1tbl | p.o. | 0.30 | GM | 3,03 | |

| 12346 | HISTAC 150 | tbl obd 20×150mg | RXY | IND |

| --- | --- | --- | --- | --- |

| 14664 | HISTAC 150 | por tbl flm 20×150mg | IRI | IRL |

| 2.9 | A02BA03 | famotidin 20 mg a výše v 1 tabletě | p.o. | 40.00 | MG | 3,03 | | |

| | | | | | | | | |

| 2.10 | A02BA04 | nizatidin | p.o. | 0.30 | GM | 3,03 | | |

| | | | | | | | | |

| 2.11 | A02BA06 | roxatidin | p.o. | 0.15 | GM | 3,03 | | |

| | | | | | | | | |

| 2.12 | A02BA07 | ranitidin bismut citrát | p.o. | 0.80 | GM | 27,85 | | |

| | | | | | | | | |

| 3 | protivředová léčiva ze skupiny inhibitorů protonové pumpy a ostatní protivředová léčiva | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | | |

| 3.1 | A02BA01 | cimetidin | parent. | 0.80 | GM | 31,33 | H | |

| | | | | | | | | |

| 3.2 | A02BA02 | ranitidin | parent. | 0.30 | GM | 66,88 | H | |

| | | | | | | | | |

| 3.3 | A02BA03 | famotidin | parent. | 40.00 | MG | 66,88 | H | |

| | | | | | | | | |

| 3.4 | A02BB01 | misoprostol | p.o. | 0.80 | MG | 46,28 | Z | |

| | | | | | | | | |

| 3.5 | A02BC01 | omeprazol | parent. | 20.00 | MG | 166,14 | H | |

| | | | | | | | | |

| 3.6 | A02BC01 | omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20.00 | MG | 13,63 | | |

| | | | | | | | | |

| 3.7 | A02 | BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20.00 | MG | 8,16 | |

| 60160 | ULTOP | cps 14×20mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 3.8 | A02BC02 | pantoprazol | p.o. | 40.00 | MG | 8,16 | |

| | | | | | | | |

| 3.9 | A02BC02 | pantoprazol | parent. | 40.00 | MG | 166,14 | H |

| | | | | | | | |

| 3.10 | A02BC03 | lansoprazol | p.o. | 30.00 | MG | 8,16 | |

| | | | | | | | |

| 3.11 | A02BC05 | esomeprazol (do 20mg v jedné dávce včetně) | p.o. | 30.00 | MG | 17,59 | L/GIT,INT,GER |

| | | | | | | | |

| 3.12 | A02BC05 | esomeprazol (nad 20mg v jedné dávce) | p.o. | 30.00 | MG | 9,77 | L/GIT,INT,GER |

| | | | | | | | |

| 3.13 | A02BX | ostatní léčiva peptického vředu (bismut subsalicylat) | p.o. | 3.00 | DF | 21,78 | |

| | | | | | | | |

| 3.14 | A02BX02 | sukralfát | p.o. | 4.00 | GM | 8,16 | |

| | | | | | | | |

| 3.15 | A02BX03 | pirenzepin | p.o. | 0.10 | GM | 8,36 | |

| | | | | | | | |

| 3.16 | A02BX03 | pirenzepin | parent. | 20.00 | MG | 103,18 | H |

| | | | | | | | |

| 3.17 | A02BX05 | zásaditý citronan bismutitý | p.o. | 0.48 | GM | 22,55 | |

| | | | | | | | |

| 4 | spasmolytika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 4.1 | A03AA04 | mebeverin | p.o. | 0.30 | GM | 4.94 | |

| | | | | | | | |

| 4.2 | A03AA05 | trimebutin | p.o. | 0.30 | GM | 4.94 | |

| | | | | | | | |

| 4.3 | A03AB03 | oxyfenon | p.o. | 25.00 | MG | 2.30 | |

| | | | | | | | |

| 4.4 | A03AB06 | otilonium bromid | p.o. | 0.12 | GM | 12.42 | |

| | | | | | | | |

| 4.5 | A03AB11 | poldin | p.o. | 12.00 | MG | 2.30 | |

| | | | | | | | |

| 4.6 | A03AD01 | papaverin | p.o. | 0.10 | GM | 0.68 | |

| | | | | | | | |

| 4.7 | A03AD02 | drotaverin | p.o. | 0.10 | GM | 4.88 | |

| 17933 | NO-SPA FORTE | tbl 10x80mg | CPW | H |

| --- | --- | --- | --- | --- |

| 4.8 | A03BA01 | atropin | p.o. | 1.50 | MG | 0.49 | |

| | | | | | | | |

| 4.9 | A03BB01 | butylskopolamin | p.o. | 60.00 | MG | 14.21 | |

| 4.1 | A03AA04 | mebeverin | p.o. | 0.30 | GM | 4,83 | |

| | | | | | | | |

| 4.2 | A03AA05 | trimebutin | p.o. | 0.30 | GM | 4,83 | |

| | | | | | | | |

| 4.3 | A03AB03 | oxyfenon | p.o. | 25.00 | MG | 2,25 | |

| | | | | | | | |

| 4.4 | A03AB06 | otilonium bromid | p.o. | 0.12 | GM | 12,14 | |

| | | | | | | | |

| 4.5 | A03AB11 | poldin | p.o. | 12.00 | MG | 2,25 | |

| | | | | | | | |

| 4.6 | A03AD01 | papaverin | p.o. | 0.10 | GM | 0,66 | |

| | | | | | | | |

| 4.7 | A03AD02 | drotaverin | p.o. | 0.10 | GM | 4,77 | |

| 17933 | NO-SPA FORTE | tbl 10×80mg | CPW | H |

| --- | --- | --- | --- | --- |

| 4.8 | A03BA01 | atropin | p.o. | 1.50 | MG | 0,48 | |

| | | | | | | | |

| 4.9 | A03BB01 | butylskopolamin | p.o. | 60.00 | MG | 13,89 | |

| | | | | | | | |

| 5 | spasmolytika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 5.1 | A03AD01 | papaverin | parent. | 0.10 | GM | 17.94 | |

| | | | | | | | |

| 5.2 | A03AD02 | drotaverin | parent. | 0.10 | GM | 25.55 | |

| 02552 | NO-SPA | inj 5x2ml/40mg | CHN | H |

| --- | --- | --- | --- | --- |

| 5.3 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.50 | MG | 8.11 | |

| | | | | | | | |

| 5.4 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.50 | MG | 15.15 | |

| | | | | | | | |

| 5.5 | A03BB01 | butylskopolamin | p.rect. | 60.00 | MG | 14.66 | |

| | | | | | | | |

| 5.6 | A03BB01 | butylskopolamin | parent. | 60.00 | MG | 37.62 | |

| 5.1 | A03AD01 | papaverin | parent. | 0.10 | GM | 17,53 | |

| | | | | | | | |

| 5.2 | A03AD02 | drotaverin | parent. | 0.10 | GM | 24,97 | |

| 02552 | NO-SPA | inj 5×2ml/40mg | CHN | H |

| --- | --- | --- | --- | --- |

| 5.3 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.50 | MG | 7,93 | |

| | | | | | | | |

| 5.4 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.50 | MG | 14,81 | |

| | | | | | | | |

| 5.5 | A03BB01 | butylskopolamin | p.rect. | 60.00 | MG | 14,33 | |

| | | | | | | | |

| 5.6 | A03BB01 | butylskopolamin | parent. | 60.00 | MG | 36,77 | |

| | | | | | | | |

| 6 | anticholinergika a spasmolytika v kombinaci s analgetiky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 6.1 | A03DA | syntetická anticholinergika v komb. s analgetiky | p.o. | 2.00 | DF | 3.96 | |

| | | | | | | | |

| 6.2 | A03DA02 | pitofenon kombinace s analgetiky | p.rect. | 2.00 | DF | 13.60 | |

| 6.1 | A03DA | syntetická anticholinergika v komb. s analgetiky | p.o. | 2.00 | DF | 3,87 | |

| | | | | | | | |

| 6.2 | A03DA02 | pitofenon kombinace s analgetiky | p.rect. | 2.00 | DF | 13,29 | |

| 91517 | ALGIFEN SUP | rct sup 5 | LEX | CZ |

| --- | --- | --- | --- | --- |

| 6.3 | A03DA02 | pitofenon kombinace s analgetiky | parent. | 2.00 | DF | 44.25 | |

| | | | | | | | |

| 6.4 | A03DA02 | pitofenon kombinace s analgetiky (pevné lékové formy) | p.o. | 2.00 | DF | 4.11 | |

| | | | | | | | |

| 6.5 | A03DA02 | pitofenon kombinace s analgetiky (tekuté lékové formy) | p.o. | 2.00 | ML | 5.82 | |

| | | | | | | | |

| 6.6 | A03EA | antispasmodika, psycholeptika, analgetika v komb. | p.rect. | 2.00 | DF | 12.72 | |

| 6.3 | A03DA02 | pitofenon kombinace s analgetiky | parent. | 2.00 | DF | 43,25 | |

| | | | | | | | |

| 6.4 | A03DA02 | pitofenon kombinace s analgetiky (pevné lékové formy) | p.o. | 2.00 | DF | 4,02 | |

| | | | | | | | |

| 6.5 | A03DA02 | pitofenon kombinace s analgetiky (tekuté lékové formy) | p.o. | 2.00 | ML | 5,69 | |

| | | | | | | | |

| 6.6 | A03EA | antispasmodika, psycholeptika, analgetika v komb. | p.rect. | 2.00 | DF | 12,43 | |

| | | | | | | | |

| 7 | prokinetika, antiflatulencia, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 7.1 | A03AE02 | tegaserod | p.o. | 12.00 | MG | 30.00 | |

| | | | | | | | |

| 7.2 | A03AX13 | silikony (pevné lékové formy) | p.o. | 0.50 | GM | 10.91 | |

| | | | | | | | |

| 7.3 | A03AX13 | silikony (tekuté lékové formy) | p.o. | 0.50 | GM | 18.57 | |

| 93500 | SAB SIMPLEX | sus 1x30ml | PDA | D |

| --- | --- | --- | --- | --- |

| 7.4 | A03AX58 | alverin (kombinace se silikony) | p.o. | 0.18 | GM | 7.90 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 7.5 | A03FA | itoprid | p.o. | 0.15 | GM | 26.60 | L/GIT,INT,PED |

| | | | | | | | |

| 7.6 | A03FA01 | metoclopramid hydrochlorid | p.o. | 30.00 | MG | 3.96 | |

| 56695 | MCP HEXAL 10 | tbl 50x10mg | SFS | D |

| --- | --- | --- | --- | --- |

| 56696 | MCP HEXAL 10 | tbl 100x10mg | SFS | D |

| 7.7 | A03FA02 | cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě) | p.o. | 30.00 | MG | 22.50 | L/GIT,INT,PED, PSY, GER |

| | | | | | | | |

| 7.8 | A03FA02 | cisaprid (pevné lékové formy, nad 5 mg do 10 mg včetně v 1 tabletě) | p.o. | 30.00 | MG | 26.00 | L/GIT,INT,PED, PSY, GER |

| | | | | | | | |

| 7.9 | A03FA02 | cisaprid (tekuté lékové formy dělené -sáčky) | p.o. | 30.00 | MG | 26.00 | L/GIT,INT,PED, PSY, GER |

| | | | | | | | |

| 7.10 | A03FA02 | cisaprid (tekuté lékové formy) s obsahem 1 mg v 1 ml | p.o. | 30.00 | MG | 57.18 | L/GIT,INT,PED, PSY, GER |

| | | | | | | | |

| 7.11 | A03FA03 | domperidon | p.o. | 30.00 | MG | 3.96 | |

| | | | | | | | |

| 7.12 | A03FA05 | alizaprid | p.o. | 0.15 | GM | 3.96 | |

| 7.1 | A03AE02 | tegaserod | p.o. | 12.00 | MG | 29,32 | |

| | | | | | | | |

| 7.2 | A03AX13 | silikony (pevné lékové formy) | p.o. | 0.50 | GM | 10,66 | |

| | | | | | | | |

| 7.3 | A03AX13 | silikony (tekuté lékové formy) | p.o. | 0.50 | GM | 18,15 | |

| 93500 | SAB SIMPLEX | sus 1×30ml | PDA | D |

| --- | --- | --- | --- | --- |

| 7.4 | A03AX58 | alverin (kombinace se silikony) | p.o. | 0.18 | GM | 7,72 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 7.5 | A03FA | itoprid | p.o. | 0.15 | GM | 26,00 | L/GIT,INT,PED |

| | | | | | | | |

| 7.6 | A03FA01 | metoclopramid hydrochlorid | p.o. | 30.00 | MG | 3,87 | |

| 56695 | MCP HEXAL 10 | tbl 50×10mg | SFS | D |

| --- | --- | --- | --- | --- |

| 56696 | MCP HEXAL 10 | tbl 100×10mg | SFS | D |

| 7.7 | A03FA02 | cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě) | p.o. | 30.00 | MG | 21,99 | L/GIT,INT,PED PSY, GER |

| | | | | | | | |

| 7.8 | A03FA02 | cisaprid (pevné lékové formy, nad 5 mg do 10 mg včetně v 1 tabletě) | p.o. | 30.00 | MG | 25,41 | L/GIT,INT,PED PSY, GER |

| | | | | | | | |

| 7.9 | A03FA02 | cisaprid (tekuté lékové formy dělené -sáčky) | p.o. | 30.00 | MG | 25,41 | L/GIT,INT,PED PSY, GER |

| | | | | | | | |

| 7.10 | A03FA02 | cisaprid (tekuté lékové formy) s obsahem 1 mg v 1 ml | p.o. | 30.00 | MG | 55,88 | L/GIT,INT,PED PSY, GER |

| | | | | | | | |

| 7.11 | A03FA03 | domperidon | p.o. | 30.00 | MG | 3,87 | |

| | | | | | | | |

| 7.12 | A03FA05 | alizaprid | p.o. | 0.15 | GM | 3,87 | |

| | | | | | | | |

| 8 | prokinetika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 8.1 | A03FA01 | metoclopramid | p.rect. | 30.00 | MG | 41.50 | |

| | | | | | | | |

| 8.2 | A03FA01 | metoclopramid | parent. | 30.00 | MG | 21.28 | O |

| 93105 | DEGAN | inj 50x2ml/10mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 8.3 | A03FA02 | cisaprid | p.rect. | 30.00 | MG | 47.57 | |

| | | | | | | | |

| 8.4 | A03FA03 | domperidon | p.rect. | 0.12 | GM | 41.50 | |

| | | | | | | | |

| 8.5 | A03FA05 | alizaprid | parent. | 0.15 | GM | 16.47 | O |

| 8.1 | A03FA01 | metoclopramid | p.rect. | 30.00 | MG | 40,56 | |

| | | | | | | | |

| 8.2 | A03FA01 | metoclopramid | parent. | 30.00 | MG | 20,80 | O |

| 93105 | DEGAN | inj 50×2ml/10mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 8.3 | A03FA02 | cisaprid | p.rect. | 30.00 | MG | 46,49 | |

| | | | | | | | |

| 8.4 | A03FA03 | domperidon | p.rect. | 0.12 | GM | 40,56 | |

| | | | | | | | |

| 8.5 | A03FA05 | alizaprid | parent. | 0.15 | GM | 16,10 | O |

| | | | | | | | |

| 9 | antiemetika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 9.1 | A04AA01 | ondansetron (pevné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16.00 | MG | 481.95 | P |

| 15829 | EMESET- 4 | por tbl flm 6x4mg | SDD | CZ |

| --- | --- | --- | --- | --- |

| 15830 | EMESET- 4 | por tbl flm 60x4mg | SDD | CZ |

| 84744 | EMESET- 4 | tbl obd 6x4mg | CIA | IND |

| 9.2 | A04AA01 | ondansetron (pevné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16.00 | MG | 357.20 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15831 | EMESET- 8 | por tbl flm 6x8mg | SDD | CZ |

| --- | --- | --- | --- | --- |

| 9.3 | A04AA01 | ondansetron (tekuté lékové formy) | p.o. | 16.00 | MG | 754.65 | P |

| | | | | | | | |

| 9.4 | A04AA02 | granisetron | p.o. | 2.00 | MG | 357.20 | P |

| | | | | | | | |

| 9.5 | A04AA03 | tropisetron | p.o. | 5.00 | MG | 357.20 | P |

| | | | | | | | |

| 9.6 | A04AA04 | dolasetron | p.o. | 200.00 | MG | 357.20 | P |

| Ondansetron, granisetron, tropisetron a dolasetron jsou hrazeny u pacientů s nauzeou a zvracením v důsledku silného uvolnění serotoninu, tj. navozeného cytotoxickou chemoterapií a radioterapií. | | | | | | | |

| 9.7 | A04AD | různá antiemetika (meklozin) | p.o. | 50.00 | MG | 3.31 | |

| | | | | | | | |

| 9.8 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50.00 | MG | 3.31 | |

| | | | | | | | |

| 9.9 | A04AD | různá antiemetika (theoklát moxastinu) | p.o. | 0.10 | GM | 3.31 | |

| 9.1 | A04AA01 | ondansetron (pevné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16.00 | MG | 471,01 | P |

| 15829 | EMESET- 4 | por tbl flm 6×4mg | SDD | CZ |

| --- | --- | --- | --- | --- |

| 15830 | EMESET- 4 | por tbl flm 60×4mg | SDD | CZ |

| 84744 | EMESET- 4 | tbl obd 6×4mg | CIA | IND |

| 9.2 | A04AA01 | ondansetron (pevné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16.00 | MG | 349,09 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15831 | EMESET- 8 | por tbl flm 6×8mg | SDD | CZ |

| --- | --- | --- | --- | --- |

| 9.3 | A04AA01 | ondansetron (tekuté lékové formy) | p.o. | 16.00 | MG | 737,52 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 9.4 | A04AA02 | granisetron | p.o. | 2.00 | MG | 349,09 | P |

| | | | | | | | |

| 9.5 | A04AA03 | tropisetron | p.o. | 5.00 | MG | 349,09 | P |

| | | | | | | | |

| 9.6 | A04AA04 | dolasetron | p.o. | 200.00 | MG | 349,09 | P |

Ondansetron, granisetron, tropisetron a dolasetron jsou hrazeny u pacientů s nauzeou a zvracením v důsledku silného uvolnění serotoninu, tj. navozeného cytotoxickou chemoterapií a radioterapií.

| 9.7 | A04AD | různá antiemetika (meklozin) | p.o. | 50.00 | MG | 3,23 | |

| | | | | | | | |

| 9.8 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50.00 | MG | 3,23 | |

| | | | | | | | |

| 9.9 | A04AD | různá antiemetika (theoklát moxastinu) | p.o. | 0.10 | GM | 3,23 | |

| | | | | | | | |

| 10 | antiemetika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 10.1 | A04AA | palonosetron | parent. | 1 | DF | 2900.00 | P |

| | | | | | | | |

| 10.2 | A04AA01 | ondansetron (léková forma čípků) | p.rect. | 16.00 | MG | 584.00 | P |

| | | | | | | | |

| 10.3 | A04AA01 | ondansetron (do 4 mg v jedné ampuli včetně) | parent. | 16.00 | MG | 806.13 | P |

| 15827 | EMESET | inj sol 5x2ml/4mg | SDD | CZ |

| --- | --- | --- | --- | --- |

| 84441 | EMESET | inj 5x2ml/4mg | CIA | IND |

| 10.4 | A04AA01 | ondansetron (nad 4 mg v jedné ampuli) | parent. | 16.00 | MG | 650.16 | P |

| 10.1 | A04AA | palonosetron | parent. | 1 | DF | 2 834,17 | P |

| | | | | | | | |

| 10.2 | A04AA01 | ondansetron (léková forma čípků) | p.rect. | 16.00 | MG | 570,74 | P |

| | | | | | | | |

| 10.3 | A04AA01 | ondansetron (do 4 mg v jedné ampuli včetně) | parent. | 16.00 | MG | 787,83 | P |

| 15827 | EMESET | inj sol 5×2ml/4mg | SDD | CZ |

| --- | --- | --- | --- | --- |

| 84441 | EMESET | inj 5×2ml/4mg | CIA | IND |

| 10.4 | A04AA01 | ondansetron (nad 4 mg v jedné ampuli) | parent. | 16.00 | MG | 635,40 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15828 | EMESET | inj sol 5×4ml/8mg | SDD | CZ |

| --- | --- | --- | --- | --- |

| 10.5 | A04AA02 | granisetron | parent. | 3.00 | MG | 426.80 | P |

| | | | | | | | |

| 10.6 | A04AA03 | tropisetron (do 2,5 mg včetně v jedné ampuli) | parent. | 5.00 | MG | 734.58 | P |

| | | | | | | | |

| 10.7 | A04AA03 | tropisetron (nad 2,5 mg v jedné ampuli) | parent. | 5.00 | MG | 426.80 | P |

| | | | | | | | |

| 10.8 | A04AA04 | dolasetron | parent. | 100.00 | MG | 426.80 | P |

| Ondansetron, granisetron, tropisetron, dolasetron a palonosetron jsou hrazeny u pacientů s nauzeou a zvracením v důsledku silného uvolnění serotoninu, tj. navozeného cytotoxickou chemoterapií a radioterapií. | | | | | | | |

| 10.9 | A04AD01 | různá antiemetika (theoklát moxastinu) | p.rect. | 0.10 | GM | 9.38 | |

| 10.5 | A04AA02 | granisetron | parent. | 3.00 | MG | 417,11 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 10.6 | A04AA03 | tropisetron (do 2,5 mg včetně v jedné ampuli) | parent. | 5.00 | MG | 717,91 | P |

| | | | | | | | |

| 10.7 | A04AA03 | tropisetron (nad 2,5 mg v jedné ampuli) | parent. | 5.00 | MG | 417,11 | P |

| | | | | | | | |

| 10.8 | A04AA04 | dolasetron | parent. | 100.00 | MG | 417,11 | P |

Ondansetron, granisetron, tropisetron, dolasetron a palonosetron jsou hrazeny u pacientů s nauzeou a zvracením v důsledku silného uvolnění serotoninu, tj. navozeného cytotoxickou chemoterapií a radioterapií.

| 10.9 | A04AD01 | různá antiemetika (theoklát moxastinu) | p.rect. | 0.10 | GM | 9,17 | |

| | | | | | | | |

| 11 | hepatika a hepatoprotektiva a další léčiva působící na žlučové cesty nebo játra | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 11.1 | A05AA01 | kyselina chenodeoxycholová | p.o. | 1.00 | GM | 21.46 | L/GIT,INF |

| | | | | | | | |

| 11.2 | A05AA02 | kyselina ursodeoxycholová | p.o. | 0.75 | GM | 23.74 | L/GIT,INF |

| 13808 | URSOSAN | por cpsdur 100x250mg | PMP | CZ |

| --- | --- | --- | --- | --- |

| 11.3 | A05AX | jiná léčiva onemocnění žlučníku (fenipentol) | p.o. | 3.00 | DF | 1.62 | |

| | | | | | | | |

| 11.4 | A05AX02 | hymekromon | p.o. | 1.20 | GM | 5.96 | |

| | | | | | | | |

| 11.5 | A05BA | léčiva onemocnění jater (fosfolipidy) | p.o. | 4.00 | DF | 11.73 | |

| | | | | | | | |

| 11.6 | A05BA | léčiva onemocnění jater (fosfolipidy) | parent. | 1.00 | DF | 42.72 | H |

| | | | | | | | |

| 11.7 | A05BA | léčiva onemocnění jater (silymarin v kombinaci) | p.o. | 0.21 | GM | 5.51 | |

| | | | | | | | |

| 11.8 | A05BA03 | silymarin | parent. | 0.35 | GM | 2 345.13 | H |

| | | | | | | | |

| 11.9 | A05BA03 | silymarin (do 70 mg včetně v jedné tabletě) | p.o. | 0.21 | GM | 5.51 | |

| | | | | | | | |

| 11.10 | A05BA03 | silymarin (nad 70 mg v jedné tabletě) | p.o. | 0.21 | GM | 4.40 | |

| 11.1 | A05AA01 | kyselina chenodeoxycholová | p.o. | 1.00 | GM | 20,97 | L/GIT, INF |

| | | | | | | | |

| 11.2 | A05AA02 | kyselina ursodeoxycholová | p.o. | 0.75 | GM | 23,20 | L/GIT,INF |

| 13808 | URSOSAN | por cps dur 100×250mg | PMP | CZ |

| --- | --- | --- | --- | --- |

| 11.3 | A05AX | jiná léčiva onemocnění žlučníku (fenipentol) | p.o. | 3.00 | DF | 1,58 | |

| | | | | | | | |

| 11.4 | A05AX02 | hymekromon | p.o. | 1.20 | GM | 5,82 | |

| | | | | | | | |

| 11.5 | A05BA | léčiva onemocnění jater (fosfolipidy) | p.o. | 4.00 | DF | 11,46 | |

| | | | | | | | |

| 11.6 | A05BA | léčiva onemocnění jater (fosfolipidy) | parent. | 1.00 | DF | 41,75 | H |

| | | | | | | | |

| 11.7 | A05BA | léčiva onemocnění jater (silymarin v kombinaci) | p.o. | 0.21 | GM | 5,38 | |

| | | | | | | | |

| 11.8 | A05BA03 | silymarin | parent. | 0.35 | GM | 2 291,90 | H |

| | | | | | | | |

| 11.9 | A05BA03 | silymarin (do 70 mg včetně v jedné tabletě) | p.o. | 0.21 | GM | 5,38 | |

| | | | | | | | |

| 11.10 | A05BA03 | silymarin (nad 70 mg v jedné tabletě) | p.o. | 0.21 | GM | 4,30 | |

| | | | | | | | |

| 12 | laxativa a další léčiva k očištění střeva | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12.1 | A06AD10 | kombinace minerálních solí (k přípravě Golytelyho roztoku) | p.o. | 4.00 | DF | 242.70 | |

| | | | | | | | |

| 12.2 | A06AD11 | laktulóza | p.o. | 6.70 | GM | 4.50 | L/GIT,INT,GER, PED,CHI, ONK |

| 42547 | LACTULOSE AL SIRUP | por sir 1x500ml | APA | D |

| --- | --- | --- | --- | --- |

| 81456 | DUPHALAC | por sir 1x500ml-hdp | SOO | NL |

| 12.3 | A06AD12 | laktitol | p.o. | 10.00 | GM | 3.71 | L/GIT,INT,GER, CHI |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 12.4 | A06AD15 | macrogol | p.o. | 4.00 | DF | 242.70 | |

| | | | | | | | |

| 12.5 | A06AG10 | sorbitol v kombinaci s kont. laxativem | p.rect. | 2.00 | DF | 174.01 | |

| 92489 | YAL | sol 10x67.5ml | TRM | D |

| | | | | | | | |

| 12.1 | A06AD10 | kombinace minerálních solí (k přípravě Golytelyho roztoku) | p.o. | 4.00 | DF | 237,19 | |

| | | | | | | | |

| 12.2 | A06AD11 | laktulóza | p.o. | 6.70 | GM | 4,40 | L/GIT,INT,GER, PED,CHI,ONK |

| 42547 | LACTULOSE AL SIRUP | por sir 1×500ml | APA | D |

| --- | --- | --- | --- | --- |

| 81456 | DUPHALAC | por sir 1×500ml-hdp | SOO | NL |

| 12.3 | A06AD12 | laktitol | p.o. | 10.00 | GM | 3,63 | L/GIT,INT,GER, CHI |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 12.4 | A06AD15 | macrogol | p.o. | 4.00 | DF | 237,19 | |

| | | | | | | | |

| 12.5 | A06AG10 | sorbitol v kombinaci s kont. laxativem | p.rect. | 2.00 | DF | 170,06 | |

| 92489 | YAL | sol 10×67.5ml | TRM | D |

| --- | --- | --- | --- | --- |

| 13 | antidiarhoika, antiinfekční a protizánětlivá léčiva gastrointestinálního traktu, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 13.1 | A07AA01 | neomycin | p.o. | 5.00 | GM | 609.91 | H |

| | | | | | | | |

| 13.2 | A07AA02 | nystatin | p.o. | 1.50 | MU | 5.96 | |

| | | | | | | | |

| 13.3 | A07AA03 | natamycin | p.o. | 0.30 | GM | 41.01 | |

| | | | | | | | |

| 13.4 | A07AA11 | rifaximin | p.o. | 0.80 | GM | 85.00 | P |

| Rifaximin je indikován v těchto případech: 1) hepatální encefalopatie, 2) profylaxe v kolorektální chirurgii, 3) pseudomembranosní kolitida, 4) bakteriální infekce provázejících nespecifická zánětlivá onemocnění střev (Crohnovy choroby a ulcerosní colitidy) citlivých na rifaximin, 5) prokázaná divertikulitida tračníku citlivá na rifaximin. | | | | | | | |

| 13.5 | A07BC05 | diosmectit (plv. susp.) | p.o. | 1.00 | DF | 3.86 | L/PED, INF |

| | | | | | | | |

| 13.6 | A07EA06 | budesonid | p.o. | 9.00 | MG | 103.80 | P |

| Léčbu perorálním budesonidem předepisuje gastroenterolog nebo internista v akutní atace, popřípadě v chronické fázi Crohnovy choroby, zejména tam, kde vzniká potřeba léčby steroidy a současně nutnost minimalizovat jejich systémové účinky. | | | | | | | |

| 64786 | BUDENOFALK | cps ent 50x3mg | FAK | D |

| --- | --- | --- | --- | --- |

| 13.7 | A07EB01 | natrium kromoglykát | p.o. | 800.00 | MG | 73.58 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| Léčbu natrium kromoglykátem předepisuje alergolog a klinický imunolog na základě alergologického vyšetření kožním eventuálně expozičním testem nebo průkazem specifických IgE protilátek a při prokázané potravinové alergii se závažnými místními či celkovými příznaky, které nelze eliminací alergenů z potravy plně upravit. | | | | | | | |

| 13.8 | A07EC01 | sulfasalazin | p.o. | 2.00 | GM | 15.14 | L/GIT,INT,REV, GER |

| | | | | | | | |

| 13.9 | A07EC02 | mesalazin (léková forma - sáčky) | p.o. | 1.50 | GM | 44.12 | P |

| Mesalazin per os – léková forma-sáčky: je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé části tlustého střeva (ileokolitida) u dětí do 3 let a u pacientů s poruchou polykání. Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku; zde je indikován až po selhání ostatních aminosalicylátů. | | | | | | | |

| 13.10 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.50 | GM | 23.08 | L/GIT,INT,GER |

| 15533 | ASACOL 400 | por tblflm 100x400mg | MBO | CZ |

| --- | --- | --- | --- | --- |

| 13.11 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.50 | GM | 41.90 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| Mesalazin per os – tablety s řízeným uvolňováním: je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé části tlustého střeva (ileokolitida). Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku, zde je indikován až po selhání ostatních aminosalicylátů. | | | | | | | |

| 13.12 | A07FA | protiprůjmové mikroorganismy (Escherichia coli), lékové formy tobolek | p.o. | 2.00 | DF | 25.14 | P |

| Přípravek je hrazen v udržovací léčbě u nespecifických střevních zánětů. | | | | | | | |

| 66065 | MUTAFLOR 20MG | cps ent 20x20mg | ARP | D |

| --- | --- | --- | --- | --- |

| 13.13 | A07FA | protiprůjmové mikroorganismy (Escherichia coli), tekuté lékové formy | p.o. | 1.00 | DF | 43.99 | L/PED, INF |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 13.14 | A07FA01 | organismy produkující kyselinu mléčnou, pevné lékové formy | p.o. | 4.00 | DF | 3.86 | L/PED,GIT,GER, INF |

| | | | | | | | |

| 13.15 | A07FA01 | organismy produkující kyselinu mléčnou, tekuté lékové formy | p.o. | 2.00 | ML | 3.55 | L/PED,GIT,GER, INF |

| 09159 | HYLAK FORTE | sol 1x100ml | MCK | D |

| --- | --- | --- | --- | --- |

| 13.16 | A07FA02 | saccharomyces boulardii sicatus | p.o. | 1.00 | DF | 5.50 | P |

| Přípravky s obsahem saccharomyces boulardii sic. jsou indikovány u infekčních průjmů, k profylaxi a léčbě průjmů u pacientů živených gastrickou nebo enterální výživou pomocí sondy. | | | | | | | |

| 13.1 | A07AA01 | neomycin | p.o. | 5.00 | GM | 596,07 | H |

| | | | | | | | |

| 13.2 | A07AA02 | nystatin | p.o. | 1.50 | MU | 5,82 | |

| | | | | | | | |

| 13.3 | A07AA03 | natamycin | p.o. | 0.30 | GM | 40,08 | |

| | | | | | | | |

| 13.4 | A07AA11 | rifaximin | p.o. | 0.80 | GM | 83,07 | P |

Rifaximin je indikován v těchto případech:

1) hepatální encefalopatie,

2) profylaxe v kolorektální chirurgii,

3) pseudomembranosní kolitida,

4) bakteriální infekce provázejících nespecifická zánětlivá onemocnění střev (Crohnovy choroby a ulcerosní colitidy) citlivých na rifaximin,

5) prokázaná divertikulitida tračníku citlivá na rifaximin.

| 13.5 | A07BC05 | diosmectit (plv. susp.) | p.o. | 1.00 | DF | 3,77 | L/PED, INF |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 13.6 | A07EA06 | budesonid | p.o. | 9.00 | MG | 101,44 | P |

Léčbu perorálním budesonidem předepisuje gastroenterolog nebo internista v akutní atace, popřípadě v chronické fázi Crohnovy choroby, zejména tam, kde vzniká potřeba léčby steroidy a současně nutnost minimalizovat jejich systémové účinky.

| 64786 | BUDENOFALK | cps ent 50×3mg | FAK | D |

| --- | --- | --- | --- | --- |

| 13.7 | A07EB01 | natrium kromoglykát | p.o. | 800.00 | MG | 71,91 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu natrium kromoglykátem předepisuje alergolog a klinický imunolog na základě alergologického vyšetření kožním eventuálně expozičním testem nebo průkazem specifických IgE protilátek a při prokázané potravinové alergii se závažnými místními či celkovými příznaky, které nelze eliminací alergenů z potravy plně upravit.

| 13.8 | A07EC01 | sulfasalazin | p.o. | 2.00 | GM | 14,80 | L/GIT,INT,REV, GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 13.9 | A07EC02 | mesalazin (léková forma - sáčky) | p.o. | 1.50 | GM | 43,12 | P |

Mesalazin per os – léková forma-sáčky: je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé části tlustého střeva (ileokolitida) u dětí do 3 let a u pacientů s poruchou polykání. Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku; zde je indikován až po selhání ostatních aminosalicylátů.

| 13.10 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.50 | GM | 22,56 | L/GIT,INT,GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15533 | ASACOL 400 | por tbl flm100×400mg | MBO | CZ |

| --- | --- | --- | --- | --- |

| 13.11 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.50 | GM | 40,95 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Mesalazin per os – tablety s řízeným uvolňováním: je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé části tlustého střeva (ileokolitida). Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku, zde je indikován až po selhání ostatních aminosalicylátů.

| 13.12 | A07FA | protiprůjmové mikroorganismy (Escherichia coli), lékové formy tobolek | p.o. | 2.00 | DF | 24,57 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Přípravek je hrazen v udržovací léčbě u nespecifických střevních zánětů.

| 66065 | MUTAFLOR 20MG | cps ent 20×20mg | ARP | D |

| --- | --- | --- | --- | --- |

| 13.13 | A07FA | protiprůjmové mikroorganismy (Escherichia coli), tekuté lékové formy | p.o. | 1.00 | DF | 42.99 | L/PED, INF |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 13.14 | A07FA01 | organismy produkující kyselinu mléčnou, pevné lékové formy | p.o. | 4.00 | DF | 3,77 | L/PED,GIT,GER, INF |

| | | | | | | | |

| 13.15 | A07FA01 | organismy produkující kyselinu mléčnou, tekuté lékové formy | p.o. | 2.00 | ML | 3,47 | L/PED,GIT,GER, INF |

| 09159 | HYLAK FORTE | sol 1×100ml | MCK | D |

| --- | --- | --- | --- | --- |

| 13.16 | A07FA02 | saccharomyces boulardii sicatus | p.o. | 1.00 | DF | 5,38 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Přípravky s obsahem saccharomyces boulardii sic. jsou indikovány u infekčních průjmů, k profylaxi a léčbě průjmů u pacientů živených gastrickou nebo enterální výživou pomocí sondy.

| 14 | antidiarhoika, antiinfekční a protizánětlivá léčiva gastrointestinálního traktu, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 14.1 | A07EA06 | budesonid | p.rect. | 2.00 | MG | 250.00 | L/GIT,INT,GER |

| | | | | | | | |

| 14.2 | A07EC | paraaminosalicylát sodný | p.rect. | 2.00 | GM | 46.20 | L/GIT |

| | | | | | | | |

| 14.3 | A07EC02 | mesalazin (čípky do 250 mg včetně) | p.rect. | 1.50 | GM | 111.30 | L/GIT |

| | | | | | | | |

| 14.4 | A07EC02 | mesalazin (čípky nad 250 mg) | p.rect. | 1.50 | GM | 96.05 | L/GIT |

| | | | | | | | |

| 14.5 | A07EC02 | mesalazin (enm.) | p.rect. | 1.50 | GM | 68.28 | L/GIT |

| 15535 | ASACOL ENEMA 4 G | sus rec 1x100ml/4gm | MBO | CZ |

| --- | --- | --- | --- | --- |

| 15536 | ASACOL ENEMA 4 G | sus rec 7x100ml/4gm | MBO | CZ |

| 14.1 | A07EA06 | budesonid | p.rect. | 2.00 | MG | 244,33 | L/GIT,INT,GER |

| | | | | | | | |

| 14.2 | A07EC | paraaminosalicylát sodný | p.rect. | 2.00 | GM | 45,15 | L/GIT |

| | | | | | | | |

| 14.3 | A07EC02 | mesalazin (čípky do 250 mg včetně) | p.rect. | 1.50 | GM | 108,77 | L/GIT |

| | | | | | | | |

| 14.4 | A07EC02 | mesalazin (čípky nad 250 mg) | p.rect. | 1.50 | GM | 93,87 | L/GIT |

| | | | | | | | |

| 14.5 | A07EC02 | mesalazin (enm.) | p.rect. | 1.50 | GM | 66,73 | L/GIT |

| 15535 | ASACOL ENEMA 4 G | sus rec 1×100ml/4gm | MBO | CZ |

| --- | --- | --- | --- | --- |

| 15536 | ASACOL ENEMA 4 G | sus rec 7×100ml/4gm | MBO | CZ |

| 15 | digestiva včetně enzymových přípravků | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 15.1 | A09AA | enzymové přípravky (s pankreatinem, dle obsahu lipázy) | p.o. | 5 000.00 | U | 0.10 | |

| | | | | | | | |

| 15.2 | A09AA02 | multienzymy (dle obsahu lipázy: do 10 000 U včetně v jedné tabletě nebo kapsli) | p.o. | 5 000.00 | U | 1.47 | P |

| Multienzymy s obsahem lipázy do 10 000 U v jedné tabletě jsou indikovány pro dětské pacienty do 10-ti kg jejich tělesné hmotnosti s diagnózou cystická fibróza. | | | | | | | |

| 15.3 | A09AA02 | multienzymy (dle obsahu lipázy: nad 10 000 do 19 999 U v jedné tabletě) | p.o. | 5 000.00 | U | 0.10 | |

| | | | | | | | |

| 15.4 | A09AA02 | multienzymy (dle obsahu lipázy: 20 000U v jedné tabletě) | p.o. | 5 000.00 | U | 1.41 | P |

| 15.1 | A09AA | enzymové přípravky (s pankreatinem, dle obsahu lipázy) | p.o. | 5 000.00 | U | 0,10 | |

| | | | | | | | |

| 15.2 | A09AA02 | multienzymy (dle obsahu lipázy: do 10 000U včetně v jedné tabletě nebo kapsli) | p.o. | 5 000.00 | U | 1,44 | P |

Multienzymy s obsahem lipázy do 10 000 U v jedné tabletě jsou indikovány pro dětské pacienty do 10-ti kg jejich tělesné hmotnosti s diagnózou cystická fibróza.

| 15.3 | A09AA02 | multienzymy (dle obsahu lipázy: nad 10 000 do 19 999 U v jedné tabletě) | p.o. | 5 000.00 | U | 0,10 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 15.4 | A09AA02 | multienzymy (dle obsahu lipázy: 20 000U v jedné tabletě) | p.o. | 5 000.00 | U | 1,38 | P |

Multienzymy ve formě enterosolventních tablet s obsahem lipázy 20 000U v jedné tabletě jsou indikovány u pacientů s prokázanou algickou formou chronické pankreatitidy pomocí alespoň jedné z následujících metod: ERCP, EUS, CT, MRCP, peroperačně, dále u pacientů s karcinomem pankreatu a po resekcích pankreatu.

@@ -427,333 +465,405 @@

| --- | --- | --- | --- | --- |

| 40379 | PANZYNORM FORTE-N | por tbl flm 100 | KRK | SLO |

| 15.5 | A09AA02 | multienzymy (dle obsahu lipázy: nad 20000U v jedné tabletě) – formy mikropelet | p.o. | 5 000.00 | U | 1.95 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| Multienzymy ve formě mikropelet jsou indikovány u pacientů s cystickou fibrózou a prokázanou chronickou pankreatitidou pomocí alespoň jedné z následujících metod: ERCP, EUS, CT, MRCP, dále u pacientů s karcinomem pankreatu a po resekcích pankreatu.. | | | | | | | |

| 15.5 | A09AA02 | multienzymy (dle obsahu lipázy: nad 20000U v jedné tabletě) – formy mikropelet | p.o. | 5 000.00 | U | 1,91 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Multienzymy ve formě mikropelet jsou indikovány u pacientů s cystickou fibrózou a prokázanou chronickou pankreatitidou pomocí alespoň jedné z následujících metod: ERCP, EUS, CT, MRCP, dále u pacientů s karcinomem pankreatu a po resekcích pankreatu..

| 14811 | KREON 25 000 | por cps dur 50 | SVP | D |

| --- | --- | --- | --- | --- |

| 15.6 | A09AA02 | multienzymy (dle lipázy, nad 20.000 U v jedné tabletě) | p.o. | 5 000.00 | U | 0.10 | |

| | | | | | | | |

| 15.7 | A09AC01 | pepsin a kyselinotvorné látky | p.o. | 2.00 | DF | 0.10 | |

| 15.6 | A09AA02 | multienzymy (dle lipázy, nad 20.000 U v jedné tabletě) | p.o. | 5 000.00 | U | 0,10 | |

| | | | | | | | |

| 15.7 | A09AC01 | pepsin a kyselinotvorné látky | p.o. | 2.00 | DF | 0,10 | |

| | | | | | | | |

| 16 | insuliny krátkodobě působící | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 16.1 | A10AB01 | insulin lidský rychle účinkující 100 U/ml, cartridge | parent. | 40.00 | U | 22.00 | L/DIA |

| | | | | | | | |

| 16.2 | A10AB01 | insulin lidský rychle účinkující 100 U/ml, cartridge v jednorázovém aplikátoru | parent. | 40.00 | U | 26.60 | P |

| Diabetes mellitus léčený insulinem u osob s definovanou poruchou zraku stanovenou na základě vyšetření oftalmologem pokles zrakové ostrosti pod 0,4 na lepším oku s optimální korekcí a při hodnotě zrakové ostrosti do blízka více než 10 Jg s optimální korekcí a prokazatelně nemůže v důsledku zrakového postižení používat jiné aplikátory. | | | | | | | |

| 16.3 | A10AB01 | insulin lidský rychle účinkující, lahv. | parent. | 40.00 | U | 16.67 | |

| 40876 | INSULIN-HM R | inj 1x10ml/1ku | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 16.4 | A10AB03 | insulin vepřový rychle účinkující - cartridge | parent. | 40.00 | U | 22.00 | L/DIA |

| | | | | | | | |

| 16.5 | A10AB03 | insulin vepřový rychle účinkující - lahv. | parent. | 40.00 | U | 16.48 | |

| 16.1 | A10AB01 | insulin lidský rychle účinkující 100 U/ml, cartridge | parent. | 40.00 | U | 21,50 | L/DIA |

| | | | | | | | |

| 16.2 | A10AB01 | insulin lidský rychle účinkující 100 U/ml, cartridge v jednorázovém aplikátoru | parent. | 40.00 | U | 26,00 | P |

Diabetes mellitus léčený insulinem u osob s definovanou poruchou zraku stanovenou na základě vyšetření oftalmologem – pokles zrakové ostrosti pod 0,4 na lepším oku s optimální korekcí a při hodnotě zrakové ostrosti do blízka více než 10 Jg s optimální korekcí a prokazatelně nemůže v důsledku zrakového postižení používat jiné aplikátory.

| 16.3 | A10AB01 | insulin lidský rychle účinkující, lahv. | parent. | 40.00 | U | 16,29 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 40876 | INSULIN-HM R | inj 1×10ml/1ku | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 16.4 | A10AB03 | insulin vepřový rychle účinkující – cartridge | parent. | 40.00 | U | 21,50 | L/DIA |

| | | | | | | | |

| 16.5 | A10AB03 | insulin vepřový rychle účinkující - lahv. | parent. | 40.00 | U | 16,11 | |

| | | | | | | | |

| 17 | insuliny střednědobě působící včetně kombinací | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 17.1 | A10AC02 | insulin hovězí středně dlouze účinkující - cartridge | parent. | 40.00 | U | 21.60 | L/DIA |

| | | | | | | | |

| 17.2 | A10AC02 | insulin hovězí středně dlouze účinkující - lahv. | parent. | 40.00 | U | 11.99 | |

| | | | | | | | |

| 17.3 | A10AC03 | insulin vepřový středně dlouze účinkující | parent. | 40.00 | U | 12.64 | |

| | | | | | | | |

| 17.4 | A10AC30 | insulin kombinace zvířecí středně dlouze účinkující | parent. | 40.00 | U | 12.64 | |

| | | | | | | | |

| 17.5 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge | parent. | 40.00 | U | 22.00 | L/DIA |

| | | | | | | | |

| 17.6 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge v jednorázovém aplikátoru | parent. | 40.00 | U | 26.60 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17.7 | A10AD01 | insulin lidský kombinace středně a rychle účinného, lahv. | parent. | 40.00 | U | 16.67 | |

| 40878 | INSULIN-HM MIX 30 | inj 1x10ml/1ku | ZEH | CZ |

| 17.1 | A10AC02 | insulin hovězí středně dlouze účinkující -cartridge | parent. | 40.00 | U | 21,11 | L/DIA |

| | | | | | | | |

| 17.2 | A10AC02 | insulin hovězí středně dlouze účinkující -lahv. | parent. | 40.00 | U | 11,72 | |

| | | | | | | | |

| 17.3 | A10AC03 | insulin vepřový středně dlouze účinkující | parent. | 40.00 | U | 12,35 | |

| | | | | | | | |

| 17.4 | A10AC30 | insulin kombinace zvířecí středně dlouze účinkující | parent. | 40.00 | U | 12,35 | |

| | | | | | | | |

| 17.5 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge | parent. | 40.00 | U | 21,50 | L/DIA |

| | | | | | | | |

| 17.6 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge v jednorázovém aplikátoru | parent. | 40.00 | U | 26,00 | P |

| 17.7 | A10AD01 | insulin lidský kombinace středně a rychle účinného, lahv. | parent. | 40.00 | U | 16,29 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 40878 | INSULIN-HM MIX 30 | inj 1×10ml/1ku | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 18 | insuliny dlouhodobě působící | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 18.1 | A10AC01 | insulin lidský středně dlouze účinkující 100U/ml, cartridge | parent. | 40.00 | U | 22.00 | L/DIA |

| | | | | | | | |

| 18.2 | A10AC01 | insulin lidský středně dlouze účinkující 100U/ml, cartridge v jednorázovém aplikátoru | parent. | 40.00 | U | 26.60 | P |

| 18.3 | A10AC01 | insulin lidský středně dlouze účinkující, lahv. | parent. | 40.00 | U | 16.67 | |

| 40875 | INSULIN-HM NPH | inj 1x10ml/1ku | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 18.4 | A10AE01 | insulin lidský dlouhodobě účinkující | parent. | 40.00 | U | 16.67 | |

| | | | | | | | |

| 18.5 | A10AE02 | insulin hovězí dlouhodobě účinkující -lahv. | parent. | 40.00 | U | 11.99 | |

| | | | | | | | |

| 18.6 | A10AE30 | insulin kombinace zvířecí dlouhodobě účinkující | parent. | 40.00 | U | 12.64 | |

| 18.1 | A10AC01 | insulin lidský středně dlouze účinkující 100U/ml, cartridge | parent. | 40.00 | U | 21,50 | L/DIA |

| | | | | | | | |

| 18.2 | A10AC01 | insulin lidský středně dlouze účinkující 100U/ml, cartridge v jednorázovém aplikátoru | parent. | 40.00 | U | 26,00 | P |

| 18.3 | A10AC01 | insulin lidský středně dlouze účinkující, lahv. | parent. | 40.00 | U | 16,29 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 40875 | INSULIN-HM NPH | inj 1×10ml/1ku | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 18.4 | A10AE01 | insulin lidský dlouhodobě účinkující | parent. | 40.00 | U | 16,29 | |

| | | | | | | | |

| 18.5 | A10AE02 | insulin hovězí dlouhodobě účinkující -lahv. | parent. | 40.00 | U | 11,72 | |

| | | | | | | | |

| 18.6 | A10AE30 | insulin kombinace zvířecí dlouhodobě účinkující | parent. | 40.00 | U | 12,35 | |

| | | | | | | | |

| 19 | analoga insulinů a insuliny používané k aplikaci pomocí insulinové pumpy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 19.1 | A10AB04 | insulin-lispro krátce působící, cartridge 100U/ML | parent. | 40.00 | U | 28.96 | P |

| | | | | | | | |

| 19.2 | A10AB04 | insulin-lispro krátce působící, lahv. | parent. | 40.00 | U | 28.28 | |

| | | | | | | | |

| 19.3 | A10AB05 | insulin-aspart krátce působící, cartridge 100U/ML | parent. | 40.00 | U | 28.96 | P |

| | | | | | | | |

| 19.4 | A10AB05 | insulin-aspart krátce působící, lahv. | parent. | 40.00 | U | 28.28 | |

| | | | | | | | |

| 19.5 | A10AB06 | insulin glulisin, cartridge 100U/ML | parent. | 40.00 | U | 28.96 | P |

| Insulinová analoga (insulin aspart, insulin lispro, insulin glulisin) jsou indikována u pacientů, kde vedou k prokazatelnému zlepšení kompenzace diabetu v porovnání s klasickými humánními insuliny, tj. kde podmiňují pokles průměrné hodnoty HbA1c aspoň o 10 % a vedou tudíž i ke zlepšení glykemických profilů včetně snížení frekvence hypoglykémie. | | | | | | | |

| 19.6 | A10AB01 | insulin lidský rychle účinkující pro aplikaci do insulinových pump | parent. | 40.00 | U | 28.24 | L/DIA |

| 28001 | VELOSULIN 100 IU/ML | inj sol 1x10ml/1ku | NOO | DK |

| --- | --- | --- | --- | --- |

| 19.7 | A10AD05 | insulin aspart, kombinace středně a rychle účinného, cartridge | parent. | 40.00 | U | 28.96 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 19.8 | A10AE04 | insulin glargin, dlouhodobě účinný, lahv. | parent. | 40.00 | U | 22.00 | L/DIA |

| 19.9 | A10AE04 | insulin glargin, dlouhodobě účinný, cartridge | parent. | 40.00 | U | 46.55 | P |

| | | | | | | | |

| 19.10 | A10AE05 | insulin detemir, dlouhodobě účinný, cartridge | parent. | 40.00 | U | 46.55 | P |

| Analoga inzulínů s dlouhodobým účinkem jsou předepisována jen u nemocných léčených v diabetologických centrech nebo ambulantními diabetology na doporučení diabetologického centra, u nichž je indikována léčba inzulínovou pumpou (opakované hypoglykémie, rozkolísaný diabetes s neuspokojivou kompenzací, nutnost podávat dlouhodobě účinný inzulín vícekrát denně). | | | | | | | |

| 19.1 | A10AB04 | insulin-lispro krátce působící, cartridge 100U/ML | parent. | 40.00 | U | 28,30 | P |

| | | | | | | | |

| 19.2 | A10AB04 | insulin-lispro krátce působící, lahv. | parent. | 40.00 | U | 27,64 | |

| | | | | | | | |

| 19.3 | A10AB05 | insulin-aspart krátce působící, cartridge 100U/ML | parent. | 40.00 | U | 28,30 | P |

| | | | | | | | |

| 19.4 | A10AB05 | insulin-aspart krátce působící, lahv. | parent. | 40.00 | U | 27,64 | |

| | | | | | | | |

| 19.5 | A10AB06 | insulin glulisin, cartridge 100U/ML | parent. | 40.00 | U | 28,30 | P |

Insulinová analoga (insulin aspart, insulin lispro, insulin glulisin) jsou indikována u pacientů, kde vedou k prokazatelnému zlepšení kompenzace diabetu v porovnání s klasickými humánními insuliny, tj. kde podmiňují pokles průměrné hodnoty HbA1c aspoň o 10 % a vedou tudíž i ke zlepšení glykemických profilů včetně snížení frekvence hypoglykémie.

| 19.6 | A10AB01 | insulin lidský rychle účinkující pro aplikaci do insulinových pump | parent. | 40.00 | U | 27,60 | L/DIA |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 28001 | VELOSULIN 100 IU/ML | inj sol 1×10ml/1ku | NOO | DK |

| --- | --- | --- | --- | --- |

| 19.7 | A10AD05 | insulin aspart, kombinace středně a rychle účinného, cartridge | parent. | 40.00 | U | 28,30 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 19.8 | A10AE04 | insulin glargin, dlouhodobě účinný, lahv. | parent. | 40.00 | U | 21,50 | L/DIA |

| | | | | | | | |

| 19.9 | A10AE04 | insulin glargin, dlouhodobě účinný, cartridge | parent. | 40.00 | U | 45,49 | P |

| | | | | | | | |

| 19.10 | A10AE05 | insulin detemir, dlouhodobě účinný, cartridge | parent. | 40.00 | U | 45,49 | P |

Analoga inzulinů s dlouhodobým účinkem jsou předepisována jen u nemocných léčených v diabetologických centrech nebo ambulantními diabetology na doporučení diabetologického centra, u nichž je indikována léčba inzulínovou pumpou (opakované hypoglykémie, rozkolísaný diabetes s neuspokojivou kompenzací, nutnost podávat dlouhodobě účinný inzulín vícekrát denně).

| 20 | perorální antidiabetika ze skupiny biguanidů a glitazonů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 20.1 | A10BA02 | metformin hydrochlorid | p.o. | 2.00 | GM | 6.12 | |

| 06668 | METFIREX 500 MG | por tbl flm60x500mg | CHN | H |

| --- | --- | --- | --- | --- |

| 23228 | METFIREX 1 G | por tblflm60x1000mg | CPW | H |

| 30294 | ADIMET | tbl obd 60x850mg | MCK | D |

| 30343 | METFORMIN AL 500 | por tbl flm30x500mg | APA | D |

| 30356 | METFORMIN AL 500 | por tbl flm60x500mg | APA | D |

| 30361 | METFORMIN AL 500 | por tblflm120x500mg | APA | D |

| 40001 | METFORMIN AL 850 | por tbl flm 30x850mg | APA | D |

| 40155 | METFORMIN AL 850 | por tbl flm60x850mg | APA | D |

| 40174 | METFORMIN AL 850 | por tblflm120x850mg | APA | D |

| 41506 | METFIREX 850 MG | por tblflm120x850mg | CHN | H |

| 41507 | METFIREX 500 MG | por tblflm120x500mg | CHN | H |

| 58122 | DIAPHAGE 850 | por tbl flm50x850mg | SVS | CZ |

| 58123 | DIAPHAGE 850 | por tblflm100x850mg | SVS | CZ |

| 58124 | DIAPHAGE 500 | por tblflm100x500mg | SVS | CZ |

| 58125 | DIAPHAGE 500 | por tbl flm50x500mg | SVS | CZ |

| 64641 | ADIMET | tbl obd 30x850mg | MCK | D |

| 64642 | ADIMET | tbl obd 120x850mg | MCK | D |

| 20.2 | A10BA03 | buformin | p.o. | 0.20 | GM | 3.47 | |

| | | | | | | | |

| 20.3 | A10BD02 | metformin a glibenklamid - kombinace | p.o. | 3.00 | DF | 4.95 | |

| | | | | | | | |

| 20.4 | A10BD03 | metformin a roziglitazon v kombinaci 500 mg a 1 mg | p.o. | 1.00 | DF | 10.25 | P |

| | | | | | | | |

| 20.5 | A10BD03 | metformin a roziglitazon v kombinaci 500 mg a 2 mg | p.o. | 1.00 | DF | 19.00 | P |

| | | | | | | | |

| 20.6 | A10BD03 | metformin a roziglitazon v kombinaci 1000 mg a 2 mg | p.o. | 1.00 | DF | 20.50 | P |

| Metformin a rosiglitazon v kombinaci je indikován pro léčbu pacientů s diabetem 2. typu a nadváhou (BMI vyšší než 25 kg/m2) a nedostatečnou kompenzací dosavadní léčbou metforminem v dávce alespoň 2g denně ( HbA1c vyšší než 6,0 %/dle IFCC). | | | | | | | |

| 20.7 | A10BF01 | akarboza | p.o. | 0.30 | GM | 10.26 | |

| | | | | | | | |

| 20.8 | A10BG02 | rosiglitason s obsahem 4 mg vjedné tabletě | p.o. | 1.00 | DF | 35.00 | P |

| | | | | | | | |

| 20.9 | A10BG03 | pioglitazon s obsahem 15 mg vjedné tabletě | p.o. | 1.00 | DF | 35.00 | P |

| | | | | | | | |

| 20.10 | A10BG03 | pioglitazon s obsahem 30 mg vjedné tabletě | p.o. | 1.00 | DF | 41.60 | P |

| Deriváty thiazolidindionů předepisuje diabetolog pro léčbu pacientů s diabetem 2. typu a nadváhou či obezitou (BMI vyšší než 25 kg/m2) s vyjádřenou inzulínovou rezistencí za podmínek opakovaně prokázané nedostatečné kompenzace dosavadní léčbou (HbA1c vyšší než 6,0% /dle IFCC). Indikovaná denní dávka je 1tbl s obsahem 4 mg rosiglitazonu, nebo 1 tbl s obsahem 15 mg nebo 1 tableta s obsahem 30mg pioglitazonu. | | | | | | | |

| 20.1 | A10BA02 | metformin hydrochlorid | p.o. | 2.00 | GM | 5,98 | |

| 06668 | METFIREX 500 MG | por tbl flm 60×500mg | CHN | H |

| --- | --- | --- | --- | --- |

| 23228 | METFIREX 1 G | por tbl flm 60×1000mg | CPW | H |

| 30294 | ADIMET | tbl obd 60×850mg | MCK | D |

| 30343 | METFORMIN AL 500 | por tbl flm 30×500mg | APA | D |

| 30356 | METFORMIN AL 500 | por tbl flm 60×500mg | APA | D |

| 30361 | METFORMIN AL 500 | por tbl flm 120×500mg | APA | D |

| 40001 | METFORMIN AL 850 | por tbl flm 30×850mg | APA | D |

| 40155 | METFORMIN AL 850 | por tbl flm 60×850mg | APA | D |

| 40174 | METFORMIN AL 850 | por tbl flm 120×850mg | APA | D |

| 41506 | METFIREX 850 MG | por tbl flm 120×850mg | CHN | H |

| 41507 | METFIREX 500 MG | por tbl flm 120×500mg | CHN | H |

| 58122 | DIAPHAGE 850 | por tbl flm 50×850mg | SVS | CZ |

| 58123 | DIAPHAGE 850 | por tbl flm 100×850mg | SVS | CZ |

| 58124 | DIAPHAGE 500 | por tbl flm 100×500mg | SVS | CZ |

| 58125 | DIAPHAGE 500 | por tbl flm 50×500mg | SVS | CZ |

| 64641 | ADIMET | tbl obd 30×850mg | MCK | D |

| 64642 | ADIMET | tbl obd 120×850mg | MCK | D |

| 20.2 | A10BA03 | buformin | p.o. | 0.20 | GM | 3,39 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 20.3 | A10BD02 | metformin a glibenklamid - kombinace | p.o. | 3.00 | DF | 4,84 | |

| | | | | | | | |

| 20.4 | A10BD03 | metformin a roziglitazon v kombinaci 500 mg a 1 mg | p.o. | 1.00 | DF | 10,02 | P |

| | | | | | | | |

| 20.5 | A10BD03 | metformin a roziglitazon v kombinaci 500 mg a 2 mg | p.o. | 1.00 | DF | 18,57 | P |

| | | | | | | | |

| 20.6 | A10BD03 | metformin a roziglitazon v kombinaci 1000 mg a 2 mg | p.o. | 1.00 | DF | 20,03 | P |

Metformin a rosiglitazon v kombinaci je indikován pro léčbu pacientů s diabetem 2. typu a nadváhou (BMI vyšší než 25 kg/m^2) a nedostatečnou kompenzací dosavadní léčbou metforminem v dávce alespoň 2g denně ( HbA1c vyšší než 6,0 %/dle IFCC).

| 20.7 | A10BF01 | akarboza | p.o. | 0.30 | GM | 10,03 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 20.8 | A10BG02 | rosiglitason s obsahem 4 mg v jedné tabletě | p.o. | 1.00 | DF | 34,21 | P |

| | | | | | | | |

| 20.9 | A10BG03 | pioglitazon s obsahem 15 mg v jedné tabletě | p.o. | 1.00 | DF | 34,21 | P |

| | | | | | | | |

| 20.10 | A10BG03 | pioglitazon s obsahem 30 mg v jedné tabletě | p.o. | 1.00 | DF | 40,66 | P |

Deriváty thiazolidindionů předepisuje diabetolog pro léčbu pacientů s diabetem 2. typu a nadváhou či obezitou (BMI vyšší než 25 kg/m^2) s vyjádřenou inzulínovou rezistencí za podmínek opakovaně prokázané nedostatečné kompenzace dosavadní léčbou (HbA1c vyšší než 6,0% /dle IFCC). Indikovaná denní dávka je 1 tbl s obsahem 4 mg rosiglitazonu, nebo 1 tbl s obsahem 15 mg nebo 1tableta s obsahem 30mg pioglitazonu.

| 21 | perorální antidiabetika ze skupiny sulfonylurey a meglitinidů, případně další antidiabetika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 21.1 | A10BB01 | glibenklamid (do 1 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 2.30 | |

| | | | | | | | |

| 21.2 | A10BB01 | glibenklamid (nad 1 mg v jedné tabletě) | p.o. | 10.00 | MG | 0.86 | |

| | | | | | | | |

| 21.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg včetně v jedné tabletě) | p.o. | 7.00 | MG | 1.37 | |

| 94523 | GLUCOBENE 1.75 MG | tbl 120x1.75mg | MCK | D |

| --- | --- | --- | --- | --- |

| 21.4 | A10BB01 | glibenklamid (mikronizované formy, nad 1,75 mg v jedné tabletě) | p.o. | 7.00 | MG | 0.86 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 94525 | GLUCOBENE 3.5 MG | tbl 120x3.5mg | MCK | D |

| --- | --- | --- | --- | --- |

| 21.5 | A10BB02 | chlorpropamid | p.o. | 0.37 | GM | 0.78 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 21.6 | A10BB03 | tolbutamid | p.o. | 1.50 | GM | 2.32 | |

| | | | | | | | |

| 21.7 | A10BB04 | glibornurid | p.o. | 38.00 | MG | 4.79 | |

| | | | | | | | |

| 21.8 | A10BB05 | tolazamid | p.o. | 1.00 | GM | 2.49 | |

| | | | | | | | |

| 21.9 | A10BB07 | glipizid | p.o. | 10.00 | MG | 3.80 | |

| | | | | | | | |

| 21.10 | A10BB08 | gliquidon | p.o. | 60.00 | MG | 5.65 | |

| | | | | | | | |

| 21.11 | A10BB09 | gliklazid | p.o. | 0.16 | GM | 5.90 | |

| 31897 | GLICIREX | por tbl nob 60x80mg | RTT | D |

| --- | --- | --- | --- | --- |

| 21.12 | A10BB09 | gliklazid, retardované lékové formy | p.o. | 2.00 | DF | 5.90 | |

| | | | | | | | |

| 21.13 | A10BB12 | glymepirid do 2 mg vjedné tabletě včetně | p.o. | 2.00 | MG | 5.90 | |

| | | | | | | | |

| 21.14 | A10BB12 | glymepirid nad 2 mg vjedné tabletě | p.o. | 2.00 | MG | 4.90 | |

| | | | | | | | |

| 21.15 | A10BX02 | repaglinid | p.o. | 1.00 | DF | 5.00 | L/DIA |

| | | | | | | | |

| 21.16 | A10BX03 | nateglinid | p.o. | 1.00 | DF | 5.00 | L/DIA |

| 21.1 | A10BB01 | glibenklamid (do 1 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 2,25 | |

| | | | | | | | |

| 21.2 | A10BB01 | glibenklamid (nad 1 mg v jedné tabletě) | p.o. | 10.00 | MG | 0,84 | |

| | | | | | | | |

| 21.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg včetně v jedné tabletě) | p.o. | 7.00 | MG | 1,34 | |

| 94523 | GLUCOBENE 1.75 MG | tbl 120×1.75mg | MCK | D |

| --- | --- | --- | --- | --- |

| 21.4 | A10BB01 | glibenklamid (mikronizované formy, nad 1,75 mg v jedné tabletě) | p.o. | 7.00 | MG | 0,84 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 94525 | GLUCOBENE 3.5 MG | tbl 120×3.5mg | MCK | D |

| --- | --- | --- | --- | --- |

| 21.5 | A10BB02 | chlorpropamid | p.o. | 0.37 | GM | 0,76 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 21.6 | A10BB03 | tolbutamid | p.o. | 1.50 | GM | 2,27 | |

| | | | | | | | |

| 21.7 | A10BB04 | glibornurid | p.o. | 38.00 | MG | 4,68 | |

| | | | | | | | |

| 21.8 | A10BB05 | tolazamid | p.o. | 1.00 | GM | 2,43 | |

| | | | | | | | |

| 21.9 | A10BB07 | glipizid | p.o. | 10.00 | MG | 3,71 | |

| | | | | | | | |

| 21.10 | A10BB08 | gliquidon | p.o. | 60.00 | MG | 5,52 | |

| | | | | | | | |

| 21.11 | A10BB09 | gliklazid | p.o. | 0.16 | GM | 5,77 | |

| 31897 | GLICIREX | por tbl nob 60×80mg | RTT | D |

| --- | --- | --- | --- | --- |

| 21.12 | A10BB09 | gliklazid, retardované lékové formy | p.o. | 2.00 | DF | 5,77 | |

| | | | | | | | |

| 21.13 | A10BB12 | glymepirid do 2 mg v jedné tabletě včetně | p.o. | 2.00 | MG | 5,77 | |

| | | | | | | | |

| 21.14 | A10BB12 | glymepirid nad 2 mg v jedné tabletě | p.o. | 2.00 | MG | 4,79 | |

| | | | | | | | |

| 21.15 | A10BX02 | repaglinid | p.o. | 1.00 | DF | 4,89 | L/DIA |

| | | | | | | | |

| 21.16 | A10BX03 | nateglinid | p.o. | 1.00 | DF | 4,89 | L/DIA |

| | | | | | | | |

| 22 | vitamin A nebo D včetně jejich kombinací, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 22.1 | A11CA01 | retinol (vitamin A) | p.o. | 50.00 | KU | 1.12 | |

| | | | | | | | |

| 22.2 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6.00 | KU | 0.54 | |

| 00353 | VITAMIN D SLOVAKOFARMA | cps1x300ku | SLO | SK |

| --- | --- | --- | --- | --- |

| 22.3 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6.00 | KU | 13.10 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 22.4 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6.00 | KU | 0.78 | |

| 00716 | INFADIN | gtt 1x10ml /100mg | SLO | SK |

| --- | --- | --- | --- | --- |

| 22.5 | A11CC02 | dihydrotachysterol | p.o. | 1.00 | MG | 17.13 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 22.6 | A11CC03 | alfakalcidol do 0,50 rg včetně | p.o. | 1.00 | RG | 15.80 | P |

| | | | | | | | |

| 22.7 | A11CC03 | alfakalcidol nad 0,50 rg | p.o. | 1.00 | RG | 14.90 | P |

| | | | | | | | |

| 22.8 | A11CC04 | kalcitriol | p.o. | 1.00 | RG | 29.83 | P |

| Léčbu p.o. alfakalcidolem a kalcitriolem předepisuje internista, endokrinolog, urolog, pediatr a lékař na dialyzační jednotce u pacientů: 1. S osteoporózou: a) senilní nebo osteoporotickou zlomeninou, která se vyvinula během terapie prostým vitaminem D a vápníkem, b) indukovanou léčbou glukokortikoidy, c) při vysoké dávce kortikoidů (7,5 mg prednisonu denně a větší) se zvýšenou hladinou PTH rezistentní na terapii vitaminem D a vápníkem. 2. K léčbě renální osteodystrofie s chronickou renální insuficiencí (především u dialyzovaných nemocných). 3. S křivicí rezistentní na vitamin D. 4. S osteomalacií rezistentní na vitamin D. 5. S hypoparathyreózou nebo pseudohypoparathyreózou rezistentní na léčbu vitaminem D a vápníkem. | | | | | | | |

| 22.9 | A11CC05 | cholekalciferol - pevné lékové formy | p.o. | 0.50 | MG | 1.04 | |

| | | | | | | | |

| 22.10 | A11CC05 | cholekalciferol – tekuté lékové formy | p.o. | 0.50 | MG | 3.84 | |

| 12023 | VIGANTOL | por gtt sol 1x10ml | MEC | D |

| 22.1 | A11CA01 | retinol (vitamin A) | p.o. | 50.00 | KU | 1,09 | |

| | | | | | | | |

| 22.2 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6.00 | KU | 0,53 | |

| 00353 | VITAMIN D SLOVAKOFARMA | cps 1×300ku | SLO | SK |

| --- | --- | --- | --- | --- |

| 22.3 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6.00 | KU | 12,80 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 22.4 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6.00 | KU | 0,76 | |

| 00716 | INFADIN | gtt 1×10ml/100mg | SLO | SK |

| --- | --- | --- | --- | --- |

| 22.5 | A11CC02 | dihydrotachysterol | p.o. | 1.00 | MG | 16,74 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 22.6 | A11CC03 | alfakalcidol do 0,50 rg včetně | p.o. | 1.00 | RG | 15,44 | P |

| | | | | | | | |

| 22.7 | A11CC03 | alfakalcidol nad 0,50 rg | p.o. | 1.00 | RG | 14,56 | P |

| | | | | | | | |

| 22.8 | A11CC04 | kalcitriol | p.o. | 1.00 | RG | 29,15 | P |

Léčbu p.o. alfakalcidolem a kalcitriolem předepisuje internista, endokrinolog, urolog, pediatr a lékař na dialyzační jednotce u pacientů:

- 1. S osteoporózou:

- a) senilní nebo osteoporotickou zlomeninou, která se vyvinula během terapie prostým vitaminem D a vápníkem,

- b) indukovanou léčbou glukokortikoidy,

- c) při vysoké dávce kortikoidů (7,5 mg prednisonu denně a větší) se zvýšenou hladinou PTH rezistentní na terapii vitaminem D a vápníkem.

- 2. K léčbě renální osteodystrofie s chronickou renální insuficiencí (především u dialyzovaných nemocných).

- 3. S křivicí rezistentní na vitamin D.

- 4. S osteomalacií rezistentní na vitamin D.

- 5. S hypoparathyreózou nebo pseudohypoparathyreózou rezistentní na léčbu vitaminem D a vápníkem.

| 22.9 | A11CC05 | cholekalciferol - pevné lékové formy | p.o. | 0.50 | MG | 1,02 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 22.10 | A11CC05 | cholekalciferol - tekuté lékové formy | p.o. | 0.50 | MG | 3,75 | |

| 12023 | VIGANTOL | por gtt sol 1×10ml | MEC | D |

| --- | --- | --- | --- | --- |

| 23 | vitamin A nebo D včetně jejich kombinací, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 23.1 | A11CA01 | retinol (vitamin A) | parent. | 50.00 | KU | 10.40 | |

| | | | | | | | |

| 23.2 | A11CC | paricalcitolum | parent. | 2.50 | RG | 385.00 | O/P |

| Léčba parikalcitolem je indikována pokud: a) je koncentrace PHT v séru vyšší než 400pg/ml i přes léčbu kalcitriolem, trvající 3 měsíce, b) selhává léčba kalcitriolem (hyperkalcémie při léčbě kalcitriolem - vyšší než 2,7 mmol/l a hyperfosfatémie vyšší než 2,5 mmol/l; fosfokalciový součin je vyšší než 6,5), c) extraoseální kalcifikace při pokročilé hyperparathyreóze). Podmínkou léčby je: a) sonograficky prokázaná zvětšená příštítná tělíska, b) ověřená účinnost hemodialýzy (Kt/V vyšší než 1,2), c) compliance pacienta s opatřeními regulujícími koncentraci fosforu v séru (dietoterapie, účinná dialýza, preskripce vazačů fosfátů v GIT. | | | | | | | |

| 16881 | ZEMPLAR 5 MCG/ML | inj sol 5x2ml | ABB | I |

| --- | --- | --- | --- | --- |

| 23.3 | A11CC01 | ergokalciferol | parent. | 6.00 | KU | 0.72 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 23.4 | A11CC04 | kalcitriol | parent. | 1.00 | RG | 174.20 | P |

| Léčbu parenterálním kalcitriolem předepisuje internista, endokrinolog, urolog, pediatr a lékař na dialyzační jednotce u pacientů: 1. S osteoporózou: a) senilní nebo osteoporotickou zlomeninou, která se vyvinula během terapie prostým vitaminem D a vápníkem, b) indukovanou léčbou glukokortikoidy, c) při vysoké dávce kortikoidů (7,5 mg prednisonu denně a větší) se zvýšenou hladinou PTH rezistentní na terapii vitaminem D a vápníkem. 2. K léčbě renální osteodystrofie s chronickou renální insuficiencí (především u dialyzovaných nemocných). 3. S křivicí rezistentní na vitamin D. 4. S osteomalacií rezistentní na vitamin D. 5. S hypoparathyreózou rezistentní na léčbu vitaminem D a vápníkem. | | | | | | | |

| 23.5 | A11CC05 | cholekalciferol | parent. | 1.00 | KU | 0.94 | |

| 11093 | VIGANTOL 50000 | inj 5x1 ml/1.25mg | MEC | D |

| 23.1 | A11CA01 | retinol (vitamin A) | parent. | 50.00 | KU | 10,16 | |

| | | | | | | | |

| 23.2 | A11CC | paricalcitolum | parent. | 2.50 | RG | 376,26 | O/P |

Léčba parikalcitolem je indikována pokud:

- a) je koncentrace PHT v séru vyšší než 400pg/ml i přes léčbu kalcitriolem, trvající 3 měsíce,

- b) selhává léčba kalcitriolem (hyperkalcémie při léčbě kalcitriolem – vyšší než 2,7 mmol/l a hyperfosfatémie vyšší než 2,5 mmol/l; fosfokalciový součin je vyšší než 6,5),

- c) extraoseální kalcifikace při pokročilé hyperparathyreóze).

Podmínkou léčby je:

- a) sonograficky prokázaná zvětšená příštítná tělíska,

- b) ověřená účinnost hemodialýzy (Kt/V vyšší než 1,2),

- c) compliance pacienta s opatřeními regulujícími koncentraci fosforu v séru (dietoterapie, účinná dialýza, preskripce vazačů fosfátů v GIT.

| 16881 | ZEMPLAR 5 MCG/ML | inj sol 5×2ml | ABB | I |

| --- | --- | --- | --- | --- |

| 23.3 | A11CC01 | ergokalciferol | parent. | 6.00 | KU | 0,70 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 23.4 | A11CC04 | kalcitriol | parent. | 1.00 | RG | 170,25 | P |

Léčbu parenterálním kalcitriolem předepisuje internista, endokrinolog, urolog, pediatr a lékař na dialyzační jednotce u pacientů:

- 1. S osteoporózou:

- a) senilní nebo osteoporotickou zlomeninou, která se vyvinula během terapie prostým vitaminem D a vápníkem,

- b) indukovanou léčbou glukokortikoidy,

- c) při vysoké dávce kortikoidů (7,5 mg prednisonu denně a větší) se zvýšenou hladinou PTH rezistentní na terapii vitaminem D a vápníkem.

- 2. K léčbě renální osteodystrofie s chronickou renální insuficiencí (především u dialyzovaných nemocných).

- 3. S křivicí rezistentní na vitamin D.

- 4. S osteomalacií rezistentní na vitamin D.

- 5. S hypoparathyreózou rezistentní na léčbu vitaminem D a vápníkem.

| 23.5 | A11CC05 | cholekalciferol | parent. | 1.00 | KU | 0,92 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11093 | VIGANTOL 50000 | inj 5×1ml/1.25mg | MEC | D |

| --- | --- | --- | --- | --- |

| 24 | soli vápníku, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 24.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | p.o. | 0.50 | GM | 0.59 | |

| | | | | | | | |

| 24.2 | A12AA04 | uhličitan vápenatý (na obsah vápníku) tablety | p.o. | 0.50 | GM | 2.34 | |

| 70536 | TBL.CALCII CARBON.PRAEC.0.5 MVM | por tbl nob 1000x0.5gm | MVM | CZ |

| --- | --- | --- | --- | --- |

| 24.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku), léková forma šumivé tablety | p.o. | 0.50 | GM | 2.34 | |

| | | | | | | | |

| 24.4 | A12AA04 | uhličitan vápenatý(na obsah vápníku), léková forma prášky | p.o. | 0.50 | GM | 2.34 | |

| | | | | | | | |

| 24.5 | A12AA07 | chlorid vápenatý (na obsah vápníku), tekuté lékové formy, | p.o. | 0.20 | GM | 0.64 | |

| | | | | | | | |

| 24.6 | A12AA12 | octan vápenatý (na obsah vápníku) | p.o. | 0.50 | GM | 10.00 | |

| 24.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | p.o. | 0.50 | GM | 0,58 | |

| | | | | | | | |

| 24.2 | A12AA04 | uhličitan vápenatý (na obsah vápníku) tablety | p.o. | 0.50 | GM | 2,29 | |

| 70536 | TBL.CALCII CARBON.PRAEC.0.5 MVM | portblnob 1000×0.5gm | MVM | CZ |

| --- | --- | --- | --- | --- |

| 24.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku), léková forma šumivé tablety | p.o. | 0.50 | GM | 2,29 | |

| | | | | | | | |

| 24.4 | A12AA04 | uhličitan vápenatý(na obsah vápníku), léková forma prášky | p.o. | 0.50 | GM | 2,29 | |

| | | | | | | | |

| 24.5 | A12AA07 | chlorid vápenatý (na obsah vápníku), tekuté lékové formy, | p.o. | 0.20 | GM | 0,63 | |

| | | | | | | | |

| 24.6 | A12AA12 | octan vápenatý (na obsah vápníku) | p.o. | 0.50 | GM | 9,77 | |

| | | | | | | | |

| 25 | kombinace solí vápníku, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 25.1 | A12AA20 | vápník (kombinace různých solí, na obsah vápníku) | p.o. | 0.50 | GM | 2.54 | |

| | | | | | | | |

| 25.2 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) do 600 mg vápníku v 1 dávce včetně a do 5 mg cholekalciferolu v 1 dávce včetně | p.o. | 1.00 | DF | 3.26 | |

| | | | | | | | |

| 25.3 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) do 600 mg vápníku v 1 dávce včetně a nad 5 mg cholekalciferolu v 1 dávce | p.o. | 1.00 | DF | 4.00 | |

| | | | | | | | |

| 25.4 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) nad 600 mg vápníku v 1 dávce | p.o. | 1.00 | DF | 6.51 | |

| | | | | | | | |

| 25.5 | A12AX | vápník v kombinaci s fluorem (fluorofosfat sodný) | p.o. | 1.00 | DF | 5.38 | L/INT,GYN,ORT, REV,GER |

| | | | | | | | |

| 25.6 | A12AX | vápník v kombinaci s fluorem (levoglutamid fluorofosfat) | p.o. | 1.00 | DF | 4.01 | L/INT,GYN,ORT, REV,GER |

| | | | | | | | |

| 25.7 | A12CX | jiné minerální produkty (na obsah vápníku) | p.o. | 0.50 | GM | 1.19 | |

| 99808 | BIOMIN H | plv 60x3gm(sáčky) | BMN | SK |

| 25.1 | A12AA20 | vápník (kombinace různých solí, na obsah vápníku) | p.o. | 0.50 | GM | 2,48 | |

| | | | | | | | |

| 25.3 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) do 600 mg vápníku v 1 dávce včetně a nad 5 mg cholekalciferolu v 1 dávce | p.o. | 1.00 | DF | 3,91 | |

| | | | | | | | |

| 25.4 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) nad 600 mg vápníku v 1 dávce | p.o. | 1.00 | DF | 6,36 | |

| | | | | | | | |

| 25.5 | A12AX | vápník v kombinaci s fluorem (fluorofosfat sodný) | p.o. | 1.00 | DF | 5,26 | L/INT,GYN,ORT, REV,GER |

| | | | | | | | |

| 25.6 | A12AX | vápník v kombinaci s fluorem (levoglutamid fluorofosfat) | p.o. | 1.00 | DF | 3,92 | L/INT,GYN,ORT, REV,GER |

| | | | | | | | |

| 25.7 | A12CX | jiné minerální produkty (na obsah vápníku) | p.o. | 0.50 | GM | 1,16 | |

| 99808 | BIOMIN H | plv 60×3gm(sáčky) | BMN | SK |

| --- | --- | --- | --- | --- |

| 26 | soli vápníku, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 26.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | parent. | 3.00 | GM | 59.16 | |

| | | | | | | | |

| 26.2 | A12AA07 | chlorid vápenatý (na obsah vápníku) | parent. | 0.20 | GM | 2.98 | |

| 00409 | CALCIUM CHLORATUM BIOTIKA | inj 5x10ml 10% | HBS | SK |

| --- | --- | --- | --- | --- |

| 27 | soli draslíku, perorální podání |

| --- | --- |

| 27.1 | A12BA | draslík (na obsah draslíku) | p.o. | 1.50 | GM | 2.44 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 27.2 | A12BA | draslík v kombinaci s hořčíkem (na obsah draslíku) | p.o. | 1.00 | GM | 9.78 | |

| | | | | | | | |

| 27.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3.00 | GM | 2.37 | |

| 13715 | KALNORMIN | por tbl pro 30x1gm | ICN | H |

| 26.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | parent. | 3.00 | GM | 57,82 | |

| | | | | | | | |

| 26.2 | A12AA07 | chlorid vápenatý (na obsah vápníku) | parent. | 0.20 | GM | 2,91 | |

| 00409 | CALCIUM CHLORATUM BIOTIKA | inj 5×10ml 10% | HBS | SK |

| --- | --- | --- | --- | --- |

| 27 | soli draslíku, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 27.1 | A12BA | draslík (na obsah draslíku) | p.o. | 1.50 | GM | 2,38 | |

| | | | | | | | |

| 27.2 | A12BA | draslík v kombinaci s hořčíkem (na obsah draslíku) | p.o. | 1.00 | GM | 9,56 | |

| | | | | | | | |

| 27.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3.00 | GM | 2,32 | |

| 13715 | KALNORMIN | por tbl pro 30×1gm | ICN | H |

| --- | --- | --- | --- | --- |

| 28 | soli draslíku, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 28.1 | A12BA | draslík v kombinaci s hořčíkem | parent. | 1.00 | DF | 13.20 | O |

| 02132 | CARDILAN inj 10x10ml | HBS | SK |

| --- | --- | --- | --- |

| 28.2 | A12BA | draslík v kombinaci s hořčíkem, léková forma infuzí | parent. | 250.00 | ML | 86.00 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 28.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3.00 | GM | 53.45 | O |

| 02486 | KALIUM CHLORATUM LÉČIVA 7.5% | inj 5x10ml 7.5% | ZEH | CZ |

| 28.1 | A12BA | draslík v kombinaci s hořčíkem | parent. | 1.00 | DF | 12,90 | O |

| 02132 | CARDILAN | inj 10×10ml | HBS | SK |

| --- | --- | --- | --- | --- |

| 28.2 | A12BA | draslík v kombinaci s hořčíkem, léková forma infuzí | parent. | 250.00 | ML | 84,05 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 28.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3.00 | GM | 52,24 | O |

| 02486 | KALIUM CHLORATUM LÉČIVA 7.5% | inj 5×10ml 7.5% | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 29 | soli hořčíku a jiné minerální produkty, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 29.1 | A12CC03 | glukonat hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11.38 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.2 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11.38 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.3 | A12CC05 | aspartat hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11.38 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.4 | A12CC06 | mléčnan hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11.38 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.5 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11.38 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.6 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1.00 | GM | 11.38 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.1 | A12CC03 | glukonát hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11,12 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.2 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11,12 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.3 | A12CC05 | aspartat hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11,12 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.4 | A12CC06 | mléčnan hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11,12 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.5 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1.00 | GM | 11,12 | L/INT,NEU,PSY, GYN,GER |

| | | | | | | | |

| 29.6 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1.00 | GM | 11,12 | L/INT,NEU,PSY, GYN,GER |

| 18774 | MAGNESIUM 250 MG PHARMAVIT | por tbl eff 20 | BSQ | F |

| --- | --- | --- | --- | --- |

@@ -762,147 +872,148 @@

| 30 | soli hořčíku, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 30.1 | A12CC02 | síran hořečnatý (koncentrace do 10 % včetně) | parent. | 1.00 | GM | 19.72 | O |

| | | | | | | | |

| 30.2 | A12CC02 | síran hořečnatý (koncentrace nad 10%) | parent. | 1.00 | GM | 9.28 | O |

| 00499 | MAGNESIUM SULFURICUM BIOT.20% | inj 5x10ml 20% | HBS | SK |

| 30.1 | A12CC02 | síran hořečnatý (koncentrace do 10 % včetně) | parent. | 1.00 | GM | 19,27 | O |

| | | | | | | | |

| 30.2 | A12CC02 | síran hořečnatý (koncentrace nad 10%) | parent. | 1.00 | GM | 9,07 | O |

| 00499 | MAGNESIUM SULFURICUM BIOT.20% | inj 5×10ml 20% | HBS | SK |

| --- | --- | --- | --- | --- |

| 31 | soli fluoru, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 31.1 | A12CD01 | fluorid sodný | p.o. | 88.00 | MG | 5.28 | |

| 91080 | FLUOSSEN | por tbl ent 30x15mg | ICN | PL |

| 31.1 | A12CD01 | fluorid sodný | p.o. | 88.00 | MG | 5,16 | |

| 91080 | FLUOSSEN | por tbl ent 30×15mg | ICN | PL |

| --- | --- | --- | --- | --- |

| 32 | ostatní léčiva ovlivňující trávicí systém | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 32.1 | A08AA10 | sibutramin s obsahem 10 mg v jedné tabletě | p.o. | 15.00 | MG | 50.00 | P |

| | | | | | | | |

| 32.2 | A08AA10 | sibutramin s obsahem 15 mg v jedné tabletě | p.o. | 15.00 | MG | 37.70 | P |

Sibutramin předepisuje diabetolog pacientům s nedostatečně kompenzovaným diabetes mellitus 2. typu (glykohemoglobin vyšší než 6% /dle IFCC) a současně s BMI vyšším než 35 kg/m^2, u nichž je diagnostikována diabetická dyslipidémie vyžadující farmakologickou léčbu. Kontraindikací je ICHS nebo krevní tlak vyšší než 145/90. Sibutramin lze předepsat pouze těm pacientům, kteří sníží svou hmotnost o 3 kg v průběhu 6 týdnů za použití pouze režimových (dietních a pohybových) opatření. Tolerance musí být vyhodnocena každých 14 dnů od zahájení léčby (krevní tlak a tepová frekvence) po dobu 3 měsíců, účinnost po 3 měsících léčby sibutraminem. Kritériem účinnosti léčby sibutraminem je pokles hmotnosti nejméně o 5% původní tělesné hmotnosti a současně zlepšení kompenzace diabetu (glykémie nalačno nebo pokles HbA1c o alespoň 0,5%). Není - li léčba účinná, je podávání sibutraminu po 3 měsících ukončeno. Léčba sibutraminem je indikována nejdéle na dobu 12 měsíců.

| 32.3 | A08AB01 | orlistat | p.o. | 360.00 | MG | 37.70 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Diabetolog předepisuje orlistat k léčbě obézních pacientů s diabetem 2. typu a BMI nad 35 kg/m2 se současně diagnostikovanou arteriální hypertenzí a/nebo dyslipidémií a/nebo ischemickou chorobou srdeční, u nichž není diabetes uspokojivě kompenzován (HbA1c vyšší než 6,0% /IFCC) při stávající antidiabetické medikaci. Orlistat lze předepsat pouze těm pacientům, kteří sníží svou hmotnost o 3 kg v průběhu 6 týdnů za použití pouze režimových (dietních a pohybových) opatření. Účinnost terapie orlistatem je kontrolována po 3 měsících, kritériem je zlepšení kompenzace diabetu (glykémie nalačno anebo pokles HbA1c o alespoň 0,5% v absolutním vyjádření) a pokles hmotnosti nejméně o 5% původní tělesné hmotnosti. Není - li léčba účinná, je podávání orlistatu po 3 měsících ukončeno. Léčba je indikována nejdéle na dobu 12 měsíců.

| 32.4 | A11GA01 | kyselina askorbová (vitamin C) | parent. | 0.20 | GM | 3.32 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 32.5 | A14AB01 | nandrolon phenpropionát | parent. | 2.00 | MG | 3.11 | |

| | | | | | | | |

| 32.6 | A16AA01 | levokarnitin | parent. | 2.00 | GM | 356.82 | O |

| | | | | | | | |

| 32.7 | A16AA02 | ademetionin | p.o. | 1.00 | GM | 59.83 | Z |

| | | | | | | | |

| 32.8 | A16AA02 | ademetionin | parent. | 0.50 | GM | 94.66 | Z |

| 12319 | TRANSMETIL 500 MG INJEKCE | inj pso Iqf 5x500mg | HOL | I |

| --- | --- | --- | --- | --- |

| 32.9 | A16AB02 | imiglucerasa | parent. | 200.00 | U | 40 341.80 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 28018 | CEREZYME | inf plv sol 1x200ut | GZE | NL |

| --- | --- | --- | --- | --- |

| 28020 | CEREZYME | inf plv sol 1x400ut | GZE | NL |

| 32.10 | A16AB03 | agalsidáza alfa | parent. | 1.00 | MG | 17 700.00 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 32.11 | A16AB04 | agalsidáza beta | parent. | 5.00 | MG | 17 700.00 | Z |

| | | | | | | | |

| 32.12 | A16AB05 | laronidáza | parent. | 1.00 | DF | 33 264.00 | Z |

| 13206 | ALDURAZYME | inf cnc sol 1x5ml | GBZ | GB |

| --- | --- | --- | --- | --- |

| 13207 | ALDURAZYME | inf cnc sol 10x5ml | GBZ | GB |

| 13208 | ALDURAZYME | inf cnc sol 25x5ml | GBZ | GB |

| 26354 | ALDURAZYME | inf cnc sol 1x5ml | GZE | NL |

| 32.13 | A16AX01 | kyselina tioktová | parent. | 0.20 | GM | 81.09 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 55381 | THIOGAMMA 600 INJECT | inj 500x20ml/600mg | SLH | D |

| --- | --- | --- | --- | --- |

| 84380 | THIOGAMMA 600 INJECT | inj 50x20ml/600mg | SLH | D |

| 84381 | THIOGAMMA 600 INJECT | inj 100x20ml/600mg | SLH | D |

| 84382 | THIOGAMMA 600 INJECT | inj 1000x20ml/600mg | SLH | D |

| 32.14 | A16AX06 | miglustat | p.o. | 0.30 | GM | 9 734.00 | Z |

| 32.1 | A08AA10 | sibutramin s obsahem 10 mg v jedné tabletě | p.o. | 15.00 | MG | 48,87 | P |

| | | | | | | | |

| 32.2 | A08AA10 | sibutramin s obsahem 15 mg v jedné tabletě | p.o. | 15.00 | MG | 36,84 | P |

Sibutramin předepisuje diabetolog pacientům s nedostatečně kompenzovaným diabetes mellitus 2. typu (glykohemoglobin vyšší než 6% /dle IFCC) a současně s BMI vyšším než 35 kg/m^2, u nichž je diagnostikována diabetická dyslipidémie vyžadující farmakologickou léčbu. Kontraindikací je ICHS nebo krevní tlak vyšší než 145/90. Sibutramin lze předepsat pouze těm pacientům, kteří sníží svou hmotnost o 3 kg v průběhu 6 týdnů za použití pouze režimových (dietních a pohybových) opatření. Tolerance musí být vyhodnocena každých 14 dnů od zahájení léčby (krevní tlak a tepová frekvence) po dobu 3 měsíců, účinnost po 3 měsících léčby sibutraminem. Kritériem účinnosti léčby sibutraminem je pokles hmotnosti nejméně o 5% původní tělesné hmotnosti a současně zlepšení kompenzace diabetu (glykémie nalačno nebo pokles HbA1c o alespoň 0,5%). Není – li léčba účinná, je podávání sibutraminu po 3 měsících ukončeno. Léčba sibutraminem je indikována nejdéle na dobu 12 měsíců.

| 32.3 | A08AB01 | orlistat | p.o. | 360.00 | MG | 36,84 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Diabetolog předepisuje orlistat k léčbě obézních pacientů s diabetem 2. typu a BMI nad 35 kg/m2 se současně diagnostikovanou arteriální hypertenzí a/nebo dyslipidémií a/nebo ischemickou chorobou srdeční, u nichž není diabetes uspokojivě kompenzován (HbA1c vyšší než 6,0% /IFCC) při stávající antidiabetické medikaci. Orlistat lze předepsat pouze těm pacientům, kteří sníží svou hmotnost o 3 kg v průběhu 6 týdnů za použití pouze režimových (dietních a pohybových) opatření. Účinnost terapie orlistatem je kontrolována po 3 měsících, kritériem je zlepšení kompenzace diabetu (glykémie nalačno anebo pokles HbA1c o alespoň 0,5% v absolutním vyjádření) a pokles hmotnosti nejméně o 5% původní tělesné hmotnosti. Není – li léčba účinná, je podávání orlistatu po 3 měsících ukončeno. Léčba je indikována nejdéle na dobu 12 měsíců.

| 32.4 | A11GA01 | kyselina askorbová (vitamin C) | parent. | 0.20 | GM | 3,24 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 32.5 | A14AB01 | nandrolon phenpropionát | parent. | 2.00 | MG | 3,04 | |

| | | | | | | | |

| 32.6 | A16AA01 | levokarnitin | parent. | 2.00 | GM | 348,72 | O |

| | | | | | | | |

| 32.7 | A16AA02 | ademetionin | p.o. | 1.00 | GM | 58,47 | Z |

| | | | | | | | |

| 32.8 | A16AA02 | ademetionin | parent. | 0.50 | GM | 92,51 | Z |

| 12319 | TRANSMETIL 500 MG INJEKCE | inj pso Iqf 5×500mg | HOL | I |

| --- | --- | --- | --- | --- |

| 32.9 | A16AB02 | imiglucerasa | parent. | 200.00 | U | 39 426,04 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 28018 | CEREZYME | inf plv sol 1×200ut | GZE | NL |

| --- | --- | --- | --- | --- |

| 28020 | CEREZYME | inf plv sol 1×400ut | GZE | NL |

| 32.10 | A16AB03 | agalsidáza alfa | parent. | 1.00 | MG | 17 298,21 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 32.11 | A16AB04 | agalsidáza beta | parent. | 5.00 | MG | 17 298,21 | Z |

| | | | | | | | |

| 32.12 | A16AB05 | laronidáza | parent. | 1.00 | DF | 32 508,91 | Z |

| 13206 | ALDURAZYME | inf cnc sol 1×5ml | GBZ | GB |

| --- | --- | --- | --- | --- |

| 13207 | ALDURAZYME | inf cnc sol 10×5ml | GBZ | GB |

| 13208 | ALDURAZYME | inf cnc sol 25×5ml | GBZ | GB |

| 26354 | ALDURAZYME | inf cnc sol 1×5ml | GZE | NL |

| 32.13 | A16AX01 | kyselina tioktová | parent. | 0.20 | GM | 79,25 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 55381 | THIOGAMMA 600 INJECT | inj 500×20ml/600mg | SLH | D |

| --- | --- | --- | --- | --- |

| 84380 | THIOGAMMA 600 INJECT | inj 50×20ml/600mg | SLH | D |

| 84381 | THIOGAMMA 600 INJECT | inj 100×20ml/600mg | SLH | D |

| 84382 | THIOGAMMA 600 INJECT | inj 1000×20ml/600mg | SLH | D |

| 32.14 | A16AX06 | miglustat | p.o. | 0.30 | GM | 9 513,04 | Z |

| | | | | | | | |

| 33 | antithrombotika ze skupiny antagonistů vitaminu K | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 33.1 | B01AA03 | warfarin | p.o. | 7.50 | MG | 3.22 | |

| 58161 | LAWARIN 2 | tbl 50x2mg | PVL | CZ |

| --- | --- | --- | --- | --- |

| 58162 | LAWARIN 5 | tbl 50x5mg | PVL | CZ |

| 94114 | WARFARIN ORION 5 MG | tbl 100x5mg | ORN | SF |

| 33.2 | B01AA08 | ethylbiskumacetát (do 75 mg v jedné tabletě včetně) | p.o. | 0.60 | GM | 3.60 | |

| | | | | | | | |

| 33.3 | B01AA08 | ethylbiskumacetát (nad 75 mg v jedné tabletě) | p.o. | 0.60 | GM | 4.30 | |

| 33.1 | B01AA03 | warfarin | p.o. | 7.50 | MG | 3,15 | |

| 58161 | LAWARIN 2 | tbl 50×2mg | PVL | CZ |

| --- | --- | --- | --- | --- |

| 58162 | LAWARIN 5 | tbl 50×5mg | PVL | CZ |

| 94114 | WARFARIN ORION 5 MG | tbl 100×5mg | ORN | SF |

| 33.2 | B01AA08 | ethylbiskumacetát (do 75 mg v jedné tabletě včetně) | p.o. | 0.60 | GM | 3,52 | |

| | | | | | | | |

| 33.3 | B01AA08 | ethylbiskumacetát (nad 75 mg v jedné tabletě) | p.o. | 0.60 | GM | 4,20 | |

| | | | | | | | |

| 34 | antithrombotika ze skupiny heparinu a antithrombinu III | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 34.1 | B01AB01 | heparin | parent. | 10.00 | KU | 13.32 | O |

| | | | | | | | |

| 34.2 | B01AB02 | antithrombin | parent. | 2.10 | KU | 24 250.00 | U |

| 93174 | ANTITHROMBIN III IMMUNO | inj pso Iqf 1x1ku | BXG | A |

| --- | --- | --- | --- | --- |

| 35 | antithrombotika ze skupiny nízkomolekulárních heparinů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 35.1 | B01AB | certoparin | parent. | 3.00 | KU | 76.79 | P |

| 31316 | TROPARIN AMPOULE | inj 10x0.5ml/32mg | BCA | A |

| --- | --- | --- | --- | --- |

| 35.2 | B01AB04 | dalteparin do 2,5 KU včetně v jedné ampuli | parent. | 3.00 | KU | 64.45 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 35.3 | B01AB04 | dalteparin nad 2,5 KU do 5 KU včetně v jedné ampuli | parent. | 3.00 | KU | 64.40 | P |

| | | | | | | | |

| 35.4 | B01AB04 | dalteparin nad 5 KU v jedné ampuli | parent. | 3.00 | KU | 49.60 | P |

| | | | | | | | |

| 35.5 | B01AB05 | enoxaparin do 20 mg včetně v jedné ampuli | parent. | 3.00 | KU | 64.45 | P |

| | | | | | | | |

| 35.6 | B01AB05 | enoxaparin nad 20 mg do 40 mg včetně v jedné ampuli | parent. | 3.00 | KU | 64.40 | P |

| | | | | | | | |

| 35.7 | B01AB05 | enoxaparin nad 40 mg do 80 mg včetně v jedné ampuli | parent. | 3.00 | KU | 59.74 | P |

| | | | | | | | |

| 35.8 | B01AB05 | enoxaparin nad 80 mg do 100 mg v jedné ampuli včetně | parent. | 3.00 | KU | 49.60 | P |

| | | | | | | | |

| 35.9 | B01AB05 | enoxaparin nad 100 mg v jedné ampuli | parent. | 3.00 | KU | 39.60 | P |

| | | | | | | | |

| 35.10 | B01AB06 | nadroparin do 2,85 KU včetně v jedné ampuli | parent. | 3.00 | KU | 64.45 | P |

| | | | | | | | |

| 35.11 | B01AB06 | nadroparin nad 2,85 do 3,8 KU včetně v jedné ampuli | parent. | 3.00 | KU | 64.40 | P |

| 35.12 | B01AB06 | nadroparin nad 3,8 do 7,6 KU včetně v jedné ampuli | parent. | 3.00 | KU | 59.74 | P |

| | | | | | | | |

| 35.13 | B01AB06 | nadroparin nad 7,6 KU do 10 KU v jedné ampuli včetně | parent. | 3.00 | KU | 49.60 | P |

| | | | | | | | |

| 35.14 | B01AB06 | nadroparin nad 10 KU v jedné ampuli | parent. | 3.00 | KU | 39.60 | P |

| | | | | | | | |

| 35.15 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3.00 | KU | 64.45 | P |

| | | | | | | | |

| 35.16 | B01AB07 | parnaparin nad 3,2 do 4,250 KU včetně v jedné ampuli | parent. | 3.00 | KU | 64.40 | P |

| | | | | | | | |

| 35.17 | B01AB07 | parnaparin nad 4,250 KU v jedné ampuli | parent. | 3.00 | KU | 59.74 | P |

| | | | | | | | |

| 35.18 | B01AB08 | reviparin do 1,432 KU včetně v jedné ampuli | parent. | 3.00 | KU | 64.45 | P |

| | | | | | | | |

| 35.19 | B01AB08 | reviparin nad 1,432 KU v jedné ampuli | parent. | 3.00 | KU | 64.40 | P |

| 34.1 | B01AB01 | heparin | parent. | 10.00 | KU | 13,02 | O |

| | | | | | | | |

| 34.2 | B01AB02 | antithrombin | parent. | 2.10 | KU | 23 699,53 | U |

| 93174 | ANTITHROMBIN III IMMUNO | inj pso Iqf 1×1ku | BXG | A |

| --- | --- | --- | --- | --- |

| 35 | antithrombotika ze skupiny nízkomolekulárních heparinů | |

| --- | --- | --- |

| | | |

| 35.1 IB01A | B certoparin parent. 3.00 | \|KU \|75,05 \|P |

| 31316 | TROPARIN AMPOULE | inj 10×0.5ml/32mg | BCA | A |

| --- | --- | --- | --- | --- |

| 35.2 | B01AB04 | dalteparin do 2,5 KU včetně v jedné ampuli | parent. | 3.00 | KU | 62,99 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 35.3 | B01AB04 | dalteparin nad 2,5 KU do 5 KU včetně v jedné ampuli | parent. | 3.00 | KU | 62,94 | P |

| | | | | | | | |

| 35.4 | B01AB04 | dalteparin nad 5 KU v jedné ampuli | parent. | 3.00 | KU | 48,47 | P |

| | | | | | | | |

| 35.5 | B01AB05 | enoxaparin do 20 mg včetně v jedné ampuli | parent. | 3.00 | KU | 62,99 | P |

| | | | | | | | |

| 35.6 | B01AB05 | enoxaparin nad 20 mg do 40 mg včetně v jedné ampuli | parent. | 3.00 | KU | 62,94 | P |

| | | | | | | | |

| 35.7 | B01AB05 | enoxaparin nad 40 mg do 80 mg včetně v jedné ampuli | parent. | 3.00 | KU | 58,38 | P |

| | | | | | | | |

| 35.8 | B01AB05 | enoxaparin nad 80 mg do 100 mg v jedné ampuli včetně | parent. | 3.00 | KU | 48,47 | P |

| | | | | | | | |

| 35.9 | B01AB05 | enoxaparin nad 100 mg v jedné ampuli | parent. | 3.00 | KU | 38,70 | P |

| | | | | | | | |

| 35.10 | B01AB06 | nadroparin do 2,85 KU včetně v jedné ampuli | parent. | 3.00 | KU | 62,99 | P |

| | | | | | | | |

| 35.11 | B01AB06 | nadroparin nad 2,85 do 3,8 KU včetně v jedné ampuli | parent. | 3.00 | KU | 62,94 | P |

| | | | | | | | |

| 35.12 | B01AB06 | nadroparin nad 3,8 do 7,6 KU včetně v jedné ampuli | parent. | 3.00 | KU | 58,38 | P |

| | | | | | | | |

| 35.13 | B01AB06 | nadroparin nad 7,6 KU do 10 KU v jedné ampuli včetně | parent. | 3.00 | KU | 48,47 | P |

| | | | | | | | |

| 35.14 | B01AB06 | nadroparin nad 10 KU v jedné ampuli | parent. | 3.00 | KU | 38,70 | P |

| | | | | | | | |

| 35.15 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3.00 | KU | 62,99 | P |

| | | | | | | | |

| 35.16 | B01AB07 | parnaparin nad 3,2 do 4,250 KU včetně v jedné ampuli | parent. | 3.00 | KU | 62,94 | P |

| | | | | | | | |

| 35.17 | B01AB07 | parnaparin nad 4,250 KU v jedné ampuli | parent. | 3.00 | KU | 58,38 | P |

| | | | | | | | |

| 35.18 | B01AB08 | reviparin do 1,432 KU včetně v jedné ampuli | parent. | 3.00 | KU | 62,99 | P |

| | | | | | | | |

| 35.19 | B01AB08 | reviparin nad 1,432 KU v jedné ampuli | parent. | 3.00 | KU | 62,94 | P |

Nízkomolekulární hepariny pro ambulatní péči lze předepisovat na recept pouze:

@@ -916,18 +1027,18 @@

5) prevenci a léčbu hluboké žilní trombosy u nemocných s prokázaným vrozenýcm či získaným hyperkoagulačním stavem, u nichž nelze stabilizovat požadované snížení koagulačních faktorů perorálními antikoagulancii či při nemožnosti tato antikoagulancia podat (dalteparin, enoxaparin, nadroparin)

| 35.20 | B01AB11 | sulodexid | parent. | 600.00 | U | 63.44 | O |

| | | | | | | | |

| 35.21 | B01AB11 | sulodexid | p.o. | 250.00 | U | 10.60 | L/OPH,INT,NEU, DIA, GER |

| 35.20 | B01AB11 | sulodexid | parent. | 600.00 | U | 62,00 | O |

| | | | | | | | |

| 35.21 | B01AB11 | sulodexid | p.o. | 250.00 | U | 10,36 | L/OPH,INT,NEU, DIA,GER |

| | | | | | | | |

| 36 | antiagregancia kromě heparinu | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 36.1 | B01AC | lysin acetylosalicylát (do 160 mg ekvivalentu kys. acetylosalicylové včetně v jedné dávce) | p.o. | 1.00 | DF | 0.68 | |

| | | | | | | | |

| 36.2 | B01AC | lysin acetylosalicylát (nad 160 mg ekvivalentu kys. acetylosalicylové v jedné dávce) | p.o. | 1.00 | DF | 0.64 | |

| | | | | | | | |

| 36.3 | B01AC04 | klopidogrel | p.o. | 75.00 | MG | 49.00 | P |

| 36.1 | B01AC | lysin acetylosalicylát (do 160 mg ekvivalentu kys. acetylosalicylové včetně v jedné dávce) | p.o. | 1.00 | DF | 0,66 | |

| | | | | | | | |

| 36.2 | B01AC | lysin acetylosalicylát (nad 160 mg ekvivalentu kys. acetylosalicylové v jedné dávce) | p.o. | 1.00 | DF | 0,63 | |

| | | | | | | | |

| 36.3 | B01AC04 | klopidogrel | p.o. | 75.00 | MG | 47,89 | P |

Léčbu klopidogrelem předepisuje internista nebo kardiolog:

@@ -935,7 +1046,7 @@

- b) po intravaskulárních intervencích s vysokým rizikem trombózy (implantace stentu, rotablace, aterektomie, přímá koronární angioplastika) obvykle v kombinaci s k. acetylsalicylovou po dobu jednoho měsíce či u tzv. „potahovaných“ stentů uvolňujících sirolimus či paclitaxel po dobu 3 měsíců.

| 36.4 | B01AC05 | ticlopidin | p.o. | 0.50 | GM | 20.70 | P |

| 36.4 | B01AC05 | ticlopidin | p.o. | 0.50 | GM | 20,23 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ticlopidinem předepisuje internista, kardiolog nebo neurolog:

@@ -946,85 +1057,85 @@

- c) v prevenci opakující se trombózy v arterio-venózní spojce u hemodialyzovaných nemocných při léčbě k.acetylsalicylovou

| 02973 | TICLOPIDIN-RATIOPHARM 250 MG | tbl obd 30x250mg | MCK | D |

| --- | --- | --- | --- | --- |

| 02974 | TICLOPIDIN-RATIOPHARM 250 MG | tbl obd 90x250mg | MCK | D |

| 02984 | APO-TIC | por tbl obd 30x250mg | APT | CND |

| 02985 | APO-TIC | por tbl obd 100x250mg | APT | CND |

| 15320 | APO-TIC | por tbl flm 30x250mg | CMG | IRL |

| 15321 | APO-TIC | por tbl flm 100x250mg | CMG | IRL |

| 16584 | APO-TIC | por tbl flm 30x250mg | KAT | NL |

| 16585 | APO-TIC | por tbl flm 100x250mg | KAT | NL |

| 21023 | IPATON 250 MG | por tbl flm 60x250mg | EGI | H |

| 66938 | TAGREN | tbl 30x250mg | KRK | SLO |

| 36.5 | B01AC06 | kyselina acetylsalicylová | parent. | 3.00 | GM | 36.30 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 36.6 | B01AC06 | kyselina acetylsalicylová (do 30 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 0.51 | |

| | | | | | | | |

| 36.7 | B01AC06 | kyselina acetylsalicylová (nad 100 do 150 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 0.98 | |

| | | | | | | | |

| 36.8 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 0.51 | |

| | | | | | | | |

| 36.9 | B01AC07 | dipyridamol | p.o. | 400.00 | MG | 8.65 | P |

| 02973 | TICLOPIDIN-RATIOPHARM 250 MG | tbl obd 30×250mg | MCK | D |

| --- | --- | --- | --- | --- |

| 02974 | TICLOPIDIN-RATIOPHARM 250 MG | tbl obd 90×250mg | MCK | D |

| 02984 | APO-TIC | por tbl obd 30×250mg | APT | CND |

| 02985 | APO-TIC | por tbl obd 100×250mg | APT | CND |

| 15320 | APO-TIC | por tbl flm 30×250mg | CMG | IRL |

| 15321 | APO-TIC | por tbl flm100×250mg | CMG | IRL |

| 16584 | APO-TIC | por tbl flm 30×250mg | KAT | NL |

| 16585 | APO-TIC | por tbl flm 100×250mg | KAT | NL |

| 21023 | IPATON 250 MG | por tbl flm 60×250mg | EGI | H |

| 66938 | TAGREN | tbl 30×250mg | KRK | SLO |

| 36.5 | B01AC06 | kyselina acetylsalicylová | parent. | 3.00 | GM | 35,48 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 36.6 | B01AC06 | kyselina acetylsalicylová (do 30 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 0,50 | |

| | | | | | | | |

| 36.7 | B01AC06 | kyselina acetylsalicylová (nad 100 do 150 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 0,96 | |

| | | | | | | | |

| 36.8 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 0,50 | |

| | | | | | | | |

| 36.9 | B01AC07 | dipyridamol | p.o. | 400.00 | MG | 8,45 | P |

Léčbu dipyridamolem včetně kombinací předepisuje neurolog nebo internista k sekundární prevenci ischemických mozkových příhod u pacientů, kteří netolerují vyšší dávky kyseliny acetylosalicylové nebo při selhání antiagregační léčby, které se projeví cévní mozkovou příhodou.

| 36.10 | B01AC07 | dipyridamol | parent. | 0.20 | GM | 224.45 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 36.11 | B01AC09 | epoprostenol | parent. | 0.50 | MG | 3 595.00 | X |

| | | | | | | | |

| 36.12 | B01AC10 | indobufen | p.o. | 0.30 | GM | 8.40 | P |

| 36.10 | B01AC07 | dipyridamol | parent. | 0.20 | GM | 219,35 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 36.11 | B01AC09 | epoprostenol | parent. | 0.50 | MG | 3 513,39 | X |

| | | | | | | | |

| 36.12 | B01AC10 | indobufen | p.o. | 0.30 | GM | 8,21 | P |

Léčbu indobufenem předepisuje internista, kardiolog nebo neurolog u pacientů, u kterých je potřebné zajistit pouze krátkodobě antiagregační účinek (např. před chirurgickým výkonem).

| 36.13 | B01AC10 | indobufen | parent. | 0.30 | GM | 89.35 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 36.14 | B01AC11 | iloprost | parent. | 50.00 | RG | 660.60 | X |

| | | | | | | | |

| 36.15 | B01AC11 | iloprost | inhal. | 50.00 | RG | 1765.00 | X |

| | | | | | | | |

| 36.16 | B01AC21 | treprostinil | parent. | 1.00 | MG | 7 190.00 | X |

| | | | | | | | |

| 36.17 | B01AC30 | dipyridamol a kyselina acetylosalicylová v kombinaci | p.o. | 2.00 | DF | 12.00 | P |

| 36.13 | B01AC10 | indobufen | parent. | 0.30 | GM | 87,32 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 36.14 | B01AC11 | iloprost | parent. | 50.00 | RG | 645,60 | X |

| | | | | | | | |

| 36.15 | B01AC11 | iloprost | inhal. | 50.00 | RG | 1 765,00 | X |

| | | | | | | | |

| 36.16 | B01AC21 | treprostinil | parent. | 1.00 | MG | 7 190,00 | X |

| | | | | | | | |

| 36.17 | B01AC30 | dipyridamol a kyselina acetylosalicylová v kombinaci | p.o. | 2.00 | DF | 11,73 | P |

Léčbu dipyridamolem včetně kombinací předepisuje neurolog nebo internista k sekundární prevenci ischemických mozkových příhod u pacientů, kteří netolerují vyšší dávky k. acetylosalicylové nebo při selhání antiagregační léčby, které se projeví cévní mozkovou příhodou.

| 37 | fibrinolytické enzymy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 37.1 | B01AC13 | abciximab | parent. | 1.00 | DF | 10 018.00 | H |

| | | | | | | | |

| 37.2 | B01AC14 | anagrelid | parent. | 1.00 | DF | 140.00 | X |

| | | | | | | | |

| 37.3 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.50 | MU | 3 384.60 | U |

| 10937 | STREPTASE | inj sic 1x750ku | AVN | D |

| --- | --- | --- | --- | --- |

| 37.4 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.50 | MU | 3 314.67 | U |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 62461 | STREPTASE inj sic 1x1.5mu | AVN | D |

| --- | --- | --- | --- |

| 37.5 | B01AD02 | altepláza | parent. | 0.10 | GM | 34 897.44 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 37.6 | B01AD04 | urokináza (do 100 KU v jedné dávce včetně) | parent. | 3.00 | MU | 53 928.40 | U/P |

| | | | | | | | |

| 37.7 | B01AD04 | urokináza (nad 100 do 500 KU v jedné dávce včetně) | parent. | 3.00 | MU | 45 346.56 | U/P |

| 07411 | RHEOTROMB 500.000 | inj plv sol 1x500ku | BGD | D |

| --- | --- | --- | --- | --- |

| 37.8 | B01AD04 | urokináza (nad 500 KU v jedné dávce) | parent. | 3.00 | MU | 42 565.93 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 37.9 | B01AD07 | retepláza | parent. | 20.00 | U | 43 265.44 | U/P |

| 37.1 | B01AC13 | abciximab | parent. | 1.00 | DF | 9 790,59 | H |

| | | | | | | | |

| 37.2 | B01AC14 | anagrelid | parent. | 1.00 | DF | 140,00 | X |

| | | | | | | | |

| 37.3 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.50 | MU | 3 307,77 | U |

| 10937 | STREPTASE | inj sic 1×750ku | AVN | D |

| --- | --- | --- | --- | --- |

| 37.4 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.50 | MU | 3 239,43 | U |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 62461 | STREPTASE | inj sic 1×1.5mu | AVN | D |

| --- | --- | --- | --- | --- |

| 37.5 | B01AD02 | altepláza | parent. | 0.10 | GM | 34 105,27 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 37.6 | B01AD04 | urokináza (do 100 KU v jedné dávce včetně) | parent. | 3.00 | MU | 52 704,23 | U/P |

| | | | | | | | |

| 37.7 | B01AD04 | urokináza (nad 100 do 500 KU v jedné dávce včetně) | parent. | 3.00 | MU | 44 317,19 | U/P |

| 07411 | RHEOTROMB 500.000 | inj plv sol 1×500ku | BGD | D |

| --- | --- | --- | --- | --- |

| 37.8 | B01AD04 | urokináza (nad 500 KU v jedné dávce) | parent. | 3.00 | MU | 41 599,68 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 37.9 | B01AD07 | retepláza | parent. | 20.00 | U | 42 283,31 | U/P |

Altepláza, urokináza, tenektepláza a retepláza jsou indikovány v těchto indikacích:

@@ -1038,134 +1149,127 @@

- b) trombolýzu akutních a subakutních uzávěrů periferních cév.

| 37.10 | B01AD10 | drotrecogin alfa (aktivovaný) | parent. | 5.00 | MG | 6 882.00 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 37.11 | B01AD11 | tenekteplaza do 40 mg včetně | parent. | 40.00 | MG | 42 757.20 | U/P |

| | | | | | | | |

| 37.12 | B01AD11 | tenekteplaza nad 40 mg | parent. | 40.00 | MG | 35 914.50 | U/P |

| | | | | | | | |

| 37.13 | B01AD12 | protein C | parent. | 1.00 | IU | 65.38 | U/P |

| 37.10 | B01AD10 | drotrecogin alfa (aktivovaný) | parent. | 5.00 | MG | 6 725,78 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 37.11 | B01AD11 | tenekteplaza do 40 mg včetně | parent. | 40.00 | MG | 41 786,61 | U/P |

| | | | | | | | |

| 37.12 | B01AD11 | tenekteplaza nad 40 mg | parent. | 40.00 | MG | 35 099,24 | U/P |

| | | | | | | | |

| 37.13 | B01AD12 | protein C | parent. | 1.00 | IU | 63,90 | U/P |

Léčbu proteinem C předepisuje hematolog v centru pro vrozené a získané poruchy hemostázy u nemocných s prokázaným vrozeným deficitem proteinu C.

| 28023 | CEPROTIN | inj pso Iqf 1x500ut | BXG | A |

| --- | --- | --- | --- | --- |

| 28024 | CEPROTIN | inj pso Iqf 1x1000ut | BXG | A |

| 37.14 | B01AX03 | lepirudin | parent. | 1.00 | DF | 2 300.00 | H |

| | | | | | | | |

| 37.15 | B01AX05 | fondaparinux | parent. | 1.00 | DF | 95.00 | H |

| 28023 | CEPROTIN | inj pso Iqf 1×500ut | BXG | A |

| --- | --- | --- | --- | --- |

| 28024 | CEPROTIN | inj pso Iqf 1×1000ut | BXG | A |

| 37.14 | B01AX03 | lepirudin | parent. | 1.00 | DF | 2 247,79 | H |

| | | | | | | | |

| 37.15 | B01AX05 | fondaparinux | parent. | 1.00 | DF | 92,84 | H |

| | | | | | | | |

| 38 | antifibrinolytika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 38.1 | B02AA01 | kyselina aminokaproová | p.o. | 16.00 | GM | 38.86 | |

| | | | | | | | |

| 38.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2.00 | GM | 40.72 | |

| | | | | | | | |

| 38.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2.00 | GM | 29.69 | |

| 42613 | EXACYL | por tbl flm 20x500mg | SXQ | P |

| --- | --- | --- | --- | --- |

| 38.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 19.13 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 38.1 | B02AA01 | kyselina aminokaproová | p.o. | 16.00 | GM | 37,98 | |

| | | | | | | | |

| 38.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2.00 | GM | 39,80 | |

| | | | | | | | |

| 38.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2.00 | GM | 29,02 | |

| 42613 | EXACYL | por tbl flm20×500mg | SXQ | P |

| --- | --- | --- | --- | --- |

| 38.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 18,70 | |

| | | | | | | | |

| 39 | antifibrinolytika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 39.1 | B01AC16 | eptifibatide infuze | parent. | 1.00 | DF | 2 637.30 | H |

| | | | | | | | |

| 39.2 | B01AC16 | eptifibatide injekce | parent. | 1.00 | DF | 837.24 | H |

| | | | | | | | |

| 39.3 | B01AC17 | tirofiban | parent. | 1.00 | DF | 4 893.30 | H |

| | | | | | | | |

| 39.4 | B02AA01 | kyselina aminokaproo vá | parent. | 16.00 | GM | 65.01 | |

| | | | | | | | |

| 39.5 | B02AA02 | kyselina tranexámová | parent. | 2.00 | GM | 64.32 | |

| | | | | | | | |

| 39.6 | B02AA03 | kyselina aminomethyl benzoová | parent. | 0.25 | GM | 186.61 | |

| 42630 | PAMBA | inj sol 5x5ml/50mg | AKZ | D |

| --- | --- | --- | --- | --- |

| 39.7 | B02AB01 | aprotinin | parent. | 500.00 | KU | 664.66 | H |

| | | | | | | | |

| 39.8 | B02AB02 | Alfa1 antitrypsin | parent. | 1.00 | GM | 11 200.00 | Z |

| | | | | | | | |

| 40 | vitamin K a jiná hemostatika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 40.1 | B02BA | menadiolfosfat sodná sůl | parent. | 10.00 | MG | 14.27 | |

| | | | | | | | |

| 40.2 | B02BA01 | fytomenadion | p.o. | 20.00 | MG | 10.38 | |

| | | | | | | | |

| 40.3 | B02BA01 | fytomenadion | parent. | 20.00 | MG | 15.68 | |

| | | | | | | | |

| 40.4 | B02BB01 | lidský fibrinogen | parent. | 5.00 | GM | 24 234,20 | U |

| --- | --- | --- | --- |

| 40.5 | B02BC | lokální hemostatika – karboxycelulosa (zásyp) | lok. | 1.00 | GM | 15.40 | |

| | | | | | | | |

| 40.6 | B02BC | lokální hemostatika (pěna) | lok. | 1.00 | C2 | 1.47 | |

| | | | | | | | |

| 40.7 | B02BC | lokální hemostatika (rektální lékové formy) | lok. | 1.00 | DF | 7.19 | |

| | | | | | | | |

| 40.8 | B02BC | lidský thrombin a fibrimogen (houba) | lok. | 1.00 | DF | 56.80 | H |

| | | | | | | | |

| 40.9 | B02BC01 | absorbovatelná želatinová houba | lok. | 1.00 | C2 | 2.69 | |

| | | | | | | | |

| 40.10 | B02BC06 | thrombin (houba) | lok. | 1.00 | DF | 56.80 | |

| | | | | | | | |

| 40.11 | B02BX01 | etamsylat | p.o. | 0.75 | GM | 11.30 | L/OPH,HEM, ORL |

| | | | | | | | |

| 40.12 | B02BX01 | etamsylat | parent. | 0.75 | GM | 72.45 | O |

| 39.1 | B01AC16 | eptifibatide infuze | parent. | 1.00 | DF | 2 577,43 | H |

| | | | | | | | |

| 39.2 | B01AC16 | eptifibatide injekce | parent. | 1.00 | DF | 818,23 | H |

| | | | | | | | |

| 39.3 | B01AC17 | tirofiban | parent. | 1.00 | DF | 4 782,22 | H |

| | | | | | | | |

| 39.4 | B02AA01 | kyselina aminokaproová | parent. | 16.00 | GM | 63,53 | |

| | | | | | | | |

| 39.5 | B02AA02 | kyselina tranexámová | parent. | 2.00 | GM | 62,86 | |

| | | | | | | | |

| 39.6 | B02AA03 | kyselina aminomethylbenzoová | parent. | 0.25 | GM | 182,37 | |

| 42630 | PAMBA | inj sol 5×5ml/50mg | AKZ | D |

| --- | --- | --- | --- | --- |

| 39.7 | B02 | AB01 | aprotinin | parent. | 500.00 | KU | 649,57 | H |

| | | | | | | | | |

| 39.8 | B02AB02 | Alfa1 antitrypsin | parent. | 1.00 | GM | 10 945,76 | Z | |

| | | | | | | | | |

| 40 | vitamin K a jiná hemostatika | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | | |

| 40.1 | B02BA | menadiolfosfat sodná sůl | parent. | 10.00 | MG | 13,95 | | |

| | | | | | | | | |

| 40.2 | B02BA01 | fytomenadion | p.o. | 20.00 | MG | 10,14 | | |

| | | | | | | | | |

| 40.3 | B02BA01 | fytomenadion | parent. | 20.00 | MG | 15,32 | | |

| | | | | | | | | |

| 40.4 | B02BB01 | lidský fibrinogen | parent. | 5.00 | GM | 23 684,08 | U | |

| 62464 | HAEMOCOMPLETTAN P | inf plv sol 1×1000mg | AVN | D |

| --- | --- | --- | --- | --- |

| 62465 | HAEMOCOMPLETTAN P | inf plv sol 1×2000mg | AVN | D |

| 40.5 | B02BC | lokální hemostatika – karboxycelulosa (zásyp) | lok. | 1.00 | GM | 15,05 | |

| | | | | | | | |

| 40.6 | B02BC | lokální hemostatika (pěna) | lok. | 1.00 | C2 | 1,44 | |

| | | | | | | | |

| 40.7 | B02BC | lokální hemostatika (rektální lékové formy) | lok. | 1.00 | DF | 7,03 | |

| | | | | | | | |

| 40.8 | B02BC | lidský thrombin a fibrimogen (houba) | lok. | 1.00 | DF | 55,51 | H |

| | | | | | | | |

| 40.9 | B02BC01 | absorbovatelná želatinová houba | lok. | 1.00 | C2 | 2,63 | |

| | | | | | | | |

| 40.10 | B02BC06 | thrombin (houba) | lok. | 1.00 | DF | 55,51 | |

| | | | | | | | |

| 40.11 | B02BX01 | etamsylat | p.o. | 0.75 | GM | 11,04 | L/OPH,HEM, ORL |

| | | | | | | | |

| 40.12 | B02BX01 | etamsylat | parent. | 0.75 | GM | 70,81 | O |

| | | | | | | | |

| 41 | koagulační faktory (koagulační faktor VIII) | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 41.1 | B02BD02 | koagulační faktor VIII (středně čištěný) | parent. | 500.00 | U | 5 083.42 | B/P |

| | | | | | | | |

| 41.2 | B02BD02 | koagulační faktor VIII (vysoce čištěný) | parent. | 500.00 | U | 5 818.70 | B/P |

| | | | | | | | |

| 41.3 | B02BD02 | koagulační faktor VIII (rekombinantní) | parent. | 500.00 | U | 5 818.70 | B/P |

| 41.4 | B02BD02 | koagulační faktor VIII středně čištěný s von Willebrandovým faktorem | parent. | 500.00 | U | 7 820.64 | B/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 41.5 | B02BD02 | koagulační faktor VIII vysoce čištěný s von Wilebrandovým faktorem | parent. | 500.00 | U | 9 263.30 | B/P |

| 41.1 | B02BD02 | koagulační faktor VIII (středně čištěný) | parent. | 500.00 | U | 4 968,03 | B/P |

| | | | | | | | |

| 41.2 | B02BD02 | koagulační faktor VIII (vysoce čištěný) | parent. | 500.00 | U | 5 686,62 | B/P |

| | | | | | | | |

| 41.3 | B02BD02 | koagulační faktor VIII (rekombinantní) | parent. | 500.00 | U | 5 686,62 | B/P |

| 41.4 | B02BD02 | koagulační faktor VIII středně čištěný s von Willebrandovým faktorem | parent. | 500.00 | U | 7 643,11 | B/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 41.5 | B02BD02 | koagulační faktor VIII vysoce čištěný s von Wilebrandovým faktorem | parent. | 500.00 | U | 9 053,02 | B/P |

Léčbu koagulačním faktorem VIII předepisuje hematolog pro:

- a) prevenci a léčbu krvácivých stavů u nemocných s vrozeným či získaným nedostatkem faktoru VIII,

- b) u nemocných s výskytem inhibitoru proti faktoru VIII v nízkém titru (do 5 Bethesda jednotek),

- c) vepřový faktor VIII je hrazen u nemocných s vysokým titrem protilátek proti lidskému faktoru VIII a s nízkým titrem protilátek proti vepřovému faktoru VIII,

- d) u nemocných s prokázanými opakovanými těžkými alergickými reakcemi na vysoce čištěné přípravky s obsahem faktoru VIII či při absolutní nesnášenlivosti těchto přípravků je hrazen koagulační faktor VIII rekombinantní.

| 88335 | HAEMATE P | inj sic 1x250ut+sol | AVN | D |

| --- | --- | --- | --- | --- |

| 88336 | HAEMATE P | inj sic 1x500ut+sol | AVN | D |

| 88337 | HAEMATE P | inj sic 1x1ku+solv. | AVN | D |

- a) prevenci a léčbu krvácivých stavů u nemocných s vrozeným či získaným nedostatkem faktoru VIII, b) u nemocných s výskytem inhibitoru proti faktoru VIII v nízkém titru (do 5 Bethesda jednotek), c) vepřový faktor VIII je hrazen u nemocných s vysokým titrem protilátek proti lidskému faktoru VIII a s nízkým titrem protilátek proti vepřovému faktoru VIII, d) u nemocných s prokázanými opakovanými těžkými alergickými reakcemi na vysoce čištěné přípravky s obsahem faktoru VIII či při absolutní nesnášenlivosti těchto přípravků je hrazen koagulační faktor VIII rekombinantní.

| 88335 | HAEMATE P | inj sic 1×250ut+sol | AVN | D |

| --- | --- | --- | --- | --- |

| 88336 | HAEMATE P | inj sic 1×500ut+sol | AVN | D |

| 88337 | HAEMATE P | inj sic 1×1ku+solv. | AVN | D |

| 42 | koagulační faktory (koagulační faktor IX) | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 42.1 | B02BD04 | koagulační faktor IX (středně čištěný) | parent. | 350.00 | U | 3 284.67 | B/P |

| | | | | | | | |

| 42.2 | B02BD04 | koagulační faktor IX (vysoce čištěný) | parent. | 350.00 | U | 4 285.96 | B/P |

| 75079 | IMMUNINE 600 I.E. | inj sic 1x600ut+5ml | BXG | A |

| 42.1 | B02BD04 | koagulační faktor IX (středně čištěný) | parent. | 350.00 | U | 3 210,11 | B/P |

| | | | | | | | |

| 42.2 | B02BD04 | koagulační faktor IX (vysoce čištěný) | parent. | 350.00 | U | 4 188,67 | B/P |

| 75079 | IMMUNINE 600 I.E. | inj sic 1×600ut+5ml | BXG | A |

| --- | --- | --- | --- | --- |

| 75080 | IMMUNINE 1200 I.E. | inj sic 1.2ku+10ml | BXG | A |

| 42.3 | B02BD04 | koagulační faktor IX (rekombinantní) | parent. | 350 | U | 4 285.96 | B/P |

| 42.3 | B02BD04 | koagulační faktor IX (rekombinantní) | parent. | 350 | U | 4 188,67 | B/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu koagulačním faktorem IX předepisuje hematolog k prevenci a léčbě krvácivých stavů u nemocných s prokázaným deficitem faktoru IX, anebo u nemocných s přítomností inhibitoru faktoru VIII; u nemocných s prokázanými opakovanými těžkými alergickými reakcemi na vysoce čištěné přípravky s obsahem faktoru IX, je indikován koagulační faktor IX rekombinantní.

@@ -1173,58 +1277,58 @@

| 43 | ostatní koagulační faktory | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 43.1 | B02BD | srážecí faktory | parent. | 350.00 | U | 2 975.02 | X |

| | | | | | | | |

| 43.2 | B02BD01 | kombinace koagulačních faktorů IX,II,VII a X | parent. | 350.00 | U | 3 091.66 | B/P |

| 86657 | PROTHROMPLEX TOTAL TIM 4 200I.U | injpsolqf 1x200ut+s | BXG | A |

| --- | --- | --- | --- | --- |

| 43.3 | B02BD03 | aktivita obcházející inhibitor faktoru VIII parent. | 10.00 | KU | 274 092.00 | B/P |

| --- | --- | --- | --- | --- | --- | --- |

| 43.1 | B02BD | srážecí faktory | parent. | 350.00 | U | 2 907,49 | X |

| | | | | | | | |

| 43.2 | B02BD01 | kombinace koagulačních faktorů IX,II,VII a X | parent. | 350.00 | U | 3 021,48 | B/P |

| 86657 | PROTHROMPLEX TOTAL TIM 4 200I.U | inj pso lqf 1×200ut+s | BXG | A |

| --- | --- | --- | --- | --- |

| 43.3 | B02BD03 | aktivita obcházející inhibitor faktoru VIII | parent. | 10.00 | KU | 267 870,11 | B/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu aktivitou obcházející inhibitor faktoru VIII předepisuje hematolog k léčbě krvácivých stavů způsobených prokázaným inhibitorem faktorů koagulačního systému.

| 85676 | FEIBA TIM 4 500 J. | inf pso Iqf 1x500ut | BXG | A |

| --- | --- | --- | --- | --- |

| 43.4 | B02BD05 | koagulační faktor VII | parent. | 6.00 | KU | 87 982.20 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 43.5 | B02BD07 | koagulační faktor XIII | parent. | 350.00 | U | 2 975.02 | X |

| | | | | | | | |

| 43.6 | B02BD08 | eptakog alfa (aktivovaný) | parent. | 2.50 | MU | 1 357 785.42 | B/P |

| 85676 | FEIBA TIM 4 500 J. | inf pso Iqf 1×500ut | BXG | A |

| --- | --- | --- | --- | --- |

| 43.4 | B02BD05 | koagulační faktor VII | parent. | 6.00 | KU | 85 985,00 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 43.5 | B02BD07 | koagulační faktor XIII | parent. | 350.00 | U | 2 907,49 | X |

| | | | | | | | |

| 43.6 | B02BD08 | eptakog alfa (aktivovaný) | parent. | 2.50 | MU | 1 326 963,69 | B/P |

Léčbu eptakogem alfa předepisuje hematolog k léčbě akutního život ohrožujícího krvácení, které není prokazatelně zvládnutelné jiným léčivým přípravkem jakož i u nemocných s prokázaným inhibitorem faktorů koagulačního systému.

| 44 | soli železa, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 44.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.10 | GM | 1.12 | |

| | | | | | | | |

| 44.2 | B03AA02 | fumarát železnatý (tekuté lékové formy) | p.o. | 0.10 | GM | 2.98 | |

| 00677 | FERRONAT | sus 1x100ml/3gm | IXP | CZ |

| --- | --- | --- | --- | --- |

| 44.3 | B03AA03 | glukonát železnatý (pevné lékové formy) | p.o. | 0.10 | GM | 1.12 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 44.4 | B03AA03 | glukonát železnatý (tekuté lékové formy) | p.o. | 0.10 | GM | 3.20 | |

| | | | | | | | |

| 44.5 | B03AA05 | chlorid železnatý (pevné lékové formy) | p.o. | 0.10 | GM | 1.12 | |

| | | | | | | | |

| 44.6 | B03AA05 | chlorid železnatý (tekuté lékové formy) | p.o. | 0.10 | GM | 3.20 | |

| | | | | | | | |

| 44.7 | B03AA07 | síran železnatý (pevné lékové formy) | p.o. | 0.10 | GM | 1.12 | |

| | | | | | | | |

| 44.8 | B03AA07 | síran železnatý (tekuté lékové formy) | p.o. | 0.10 | GM | 3.20 | |

| | | | | | | | |

| 44.9 | B03AB | soli trojmocného železa (tekuté lékové formy) | p.o. | 0.10 | GM | 3.20 | |

| | | | | | | | |

| 44.10 | B03AB02 | polymaltosum ferricum (pevné lékové formy) | p.o. | 0.10 | GM | 2,28 | |

| | | | | | | | |

| 44.11 | B03AB02 | polymaltosum ferricum (tekuté lékové formy) | p.o. | 0.10 | GM | 10.80 | |

| 44.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.10 | GM | 1,09 | |

| | | | | | | | |

| 44.2 | B03AA02 | fumarát železnatý (tekuté lékové formy) | p.o. | 0.10 | GM | 2,91 | |

| 00677 | FERRONAT | sus 1×100ml/3gm | IXP | CZ |

| --- | --- | --- | --- | --- |

| 44.3 | B03AA03 | glukonát železnatý (pevné lékové formy) | p.o. | 0.10 | GM | 1,09 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 44.4 | B03AA03 | glukonát železnatý (tekuté lékové formy) | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 44.5 | B03AA05 | chlorid železnatý (pevné lékové formy) | p.o. | 0.10 | GM | 1,09 | |

| | | | | | | | |

| 44.6 | B03AA05 | chlorid železnatý (tekuté lékové formy) | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 44.7 | B03AA07 | síran železnatý (pevné lékové formy) | p.o. | 0.10 | GM | 1,09 | |

| | | | | | | | |

| 44.8 | B03AA07 | síran železnatý (tekuté lékové formy) | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 44.9 | B03AB | soli trojmocného železa (tekuté lékové formy) | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 44.10 | B03AB02 | polymaltosum ferricum (pevné lékové formy) | p.o. | 0.10 | GM | 2,23 | |

| | | | | | | | |

| 44.11 | B03AB02 | polymaltosum ferricum (tekuté lékové formy) | p.o. | 0.10 | GM | 10,55 | |

| 02946 | MALTOFER | por gtt sol 30 ml | VII | CH |

| --- | --- | --- | --- | --- |

@@ -1233,84 +1337,85 @@

| 45 | soli železa v kombinaci s kyselinou listovou a jiné kombinace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 45.1 | B03AD | glukonát železnatý/kys elina listová | p.o. | 0.10 | GM | 3.90 | L/GYN,HEM, INT, GER |

| | | | | | | | |

| 45.2 | B03AD | chlorid železnatý/kys elina listová | p.o. | 0.10 | GM | 3.90 | L/GYN,HEM, INT, GER |

| | | | | | | | |

| 45.3 | B03AD02 | fumarat železnatý/kys elina listová | p.o. | 0.10 | GM | 3.90 | L/GYN,HEM, INT, GER |

| 45.1 | B03AD | glukonat železnatý/kyselina listová | p.o. | 0.10 | GM | 3,81 | L/GYN,HEM,INT, GER |

| | | | | | | | |

| 45.2 | B03AD | chlorid železnatý/kyselina listová | p.o. | 0.10 | GM | 3,81 | L/GYN,HEM,INT, GER |

| | | | | | | | |

| 45.3 | B03AD02 | fumarat železnatý/kyselina listová | p.o. | 0.10 | GM | 3,81 | L/GYN,HEM,INT, GER |

| 89140 | FERRETAB COMP. | cps 30 | LAR | A |

| --- | --- | --- | --- | --- |

| 45.4 | B03AD03 | síran železnatý/kyselina listová | p.o. | 0.10 | GM | 3.90 | L/GYN,HEM,INT, GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 45.5 | B03AD04 | polymaltosum ferricum /kyselina listová | p.o. | 0.10 | GM | 3.90 | L/GYN,HEM,INT, GER |

| | | | | | | | |

| 45.6 | B03AE01 | dvojmocné soli železa/kyselina listová/vitamin B12 | p.o. | 0.10 | GM | 3.20 | |

| | | | | | | | |

| 45.7 | B03AE02 | dvojmocné soli železa/kyselina listová/vitaminy | p.o. | 0.10 | GM | 3.20 | |

| | | | | | | | |

| 45.8 | B03AE10 | fumarat železnatý/kyselina listová | p.o. | 0.10 | GM | 3.20 | |

| | | | | | | | |

| 45.9 | B03AE10 | glukonat železnatý/kyselina listová | p.o. | 0.10 | GM | 3.20 | |

| | | | | | | | |

| 45.10 | B03AE10 | chlorid železnatý/kyselina listová | p.o. | 0.10 | GM | 3.20 | |

| | | | | | | | |

| 45.11 | B03AE10 | různé kombinace bez kyseliny listové | p.o. | 0.10 | GM | 2.30 | |

| 45.4 | B03AD03 | síran železnatý/kyselina listová | p.o. | 0.10 | GM | 3,81 | L/GYN,HEM,INT, GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 45.5 | B03AD04 | polymaltosum ferricum /kyselina listová | p.o. | 0.10 | GM | 3,81 | L/GYN,HEM,INT, GER |

| | | | | | | | |

| 45.6 | B03AE01 | dvojmocné soli železa/kyselina listová/vitamin B12 | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 45.7 | B03AE02 | dvojmocné soli železa/kyselina listová/vitaminy | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 45.8 | B03AE10 | fumarat železnatý/kyselina listová | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 45.9 | B03AE10 | glukonat železnatý/kyselina listová | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 45.10 | B03AE10 | chlorid železnatý/kyselina listová | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 45.11 | B03AE10 | různé kombinace bez kyseliny listové | p.o. | 0.10 | GM | 2,25 | |

| 97402 | SORBIFER DURULES | tbl obd 50×100mg | EGI | H |

| --- | --- | --- | --- | --- |

| 45.12 | B03AE10 | síran železnatý/kyselina listová | p.o. | 0.10 | GM | 3.20 | |

| 45.13 | B03AE10 | síran železnatý/serin - pevné lékové formy | p.o. | 0.10 | GM | 2.30 | |

| | | | | | | | |

| 45.14 | B03AE10 | síran železnatý/serin - tekuté lékové formy | p.o. | 0.10 | GM | 10.80 | |

| 145.12 | B03AE10 | síran železnatý/kyselina listová | p.o. | 0.10 | GM | 3,13 | |

| | | | | | | | |

| 45.13 | B03AE10 | síran železnatý/serin -pevné lékové formy | p.o. | 0.10 | GM | 2,25 | |

| | | | | | | | |

| 45.14 | B03AE10 | síran železnatý/serin -tekuté lékové formy | p.o. | 0.10 | GM | 10,55 | |

| | | | | | | | |

| 46 | soli železa, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 46.1 | B03AC02 | hydroxid železitý se sacharózou | parent. | 0.10 | GM | 31.47 | O |

| 04084 | FERRUM LEK I.M. | inj sol 50x2ml/100mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 46.2 | B03AC03 | komplex železo-sorbitol-citronová kyselina | parent. | 0.10 | GM | 25.56 | O |

| | | | | | | | |

| 46.3 | B03AC07 | glukonát železito-sodný | parent. | 0.10 | GM | 41.25 | O |

| 46.1 | B03AC02 | hydroxid železitý se sacharózou | parent. | 0.10 | GM | 30,76 | O |

| 04084 | FERRUM LEK I.M. | inj sol 50×2ml/100mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 46.2 | B03AC03 | komplex železo-sorbitol-citronová kyselina | parent. | 0.10 | GM | 24,98 | O |

| | | | | | | | |

| 46.3 | B03AC07 | glukonát železito-sodný | parent. | 0.10 | GM | 40,31 | O |

| | | | | | | | |

| 47 | vitamin B12, kyselina listová a jiná antianemika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 47.1 | B03BA01 | cyanokobalamin (do 0,3 mg v jedné ampuli včetně) | parent. | 0.02 | MG | 0.51 | |

| | | | | | | | |

| 47.2 | B03BA01 | cyanokobalamin (nad 0,3 mg v jedné ampuli) | parent. | 0.02 | MG | 0.20 | |

| 92503 | NEUROBENE | inj 6x1ml/1000rg | MCK | D |

| --- | --- | --- | --- | --- |

| 47.3 | B03BB01 | kyselina listová | p.o. | 10.00 | MG | 1.39 | |

| 47.1 | B03BA01 | cyanokobalamin (do 0,3 mg v jedné ampuli včetně) | parent. | 0.02 | MG | 0,50 | |

| | | | | | | | |

| 47.2 | B03BA01 | cyanokobalamin (nad 0,3 mg v jedné ampuli) | parent. | 0.02 | MG | 0,20 | |

| 92503 | NEUROBENE | inj 6×1ml/1000rg | MCK | D |

| --- | --- | --- | --- | --- |

| 47.3 | B03BB01 | kyselina listová | p.o. | 10.00 | MG | 1,36 | |

| | | | | | | | |

| 48 | erytropoetin a ostatní léčiva krve a krvetvorných orgánů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 48.1 | B03XA01 | erythropoetin do 500 IU v jedné ampuli včetně | parent. | 1.00 | KU | 493.27 | K/P |

| 26700 | NEORECORMON 500 IU | inj sol 6x0.3ml | RRG | GB |

| --- | --- | --- | --- | --- |

| 48.2 | B03XA01 | erythropoetin více než 500 IU do 10 KU v jedné ampuli včetně | parent. | 1.00 | KU | 376.75 | K/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 48.3 | B03XA01 | erythropoetin více než 10 KU v jedné ampuli | parent. | 1.00 | KU | 356.00 | K/P |

| 26714 | NEORECORMON 60 000 IU | inj pso Iqf 3x1mldv | RRG | GB |

| --- | --- | --- | --- | --- |

| 48.4 | B03XA02 | darbepoetin do 50 mikrogramů v ampuli včetně | parent. | 5.00 | RG | 376.75 | K/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 48.5 | B03XA02 | darbepoetin nad 50 mikrogramů v ampuli | parent. | 5.00 | RG | 356.00 | K/P |

| 48.1 | B03XA01 | erythropoetin do 500 IU v jedné ampuli včetně | parent. | 1.00 | KU | 482,07 | K/P |

| 26700 | NEORECORMON 500 IU | inj sol 6×0.3ml | RRG | GB |

| --- | --- | --- | --- | --- |

| 48.2 | B03XA01 | erythropoetin více než 500 IU do 10 KU v jedné ampuli včetně | parent. | 1.00 | KU | 368,20 | K/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 48.3 | B03XA01 | erythropoetin více než 10 KU v jedné ampuli | parent. | 1.00 | KU | 347,92 | K/P |

| 26714 | NEORECORMON 60 000 IU | inj pso Iqf 3×1mldv | RRG | GB |

| --- | --- | --- | --- | --- |

| 48.4 | B03XA02 | darbepoetin do 50 mikrogramů v ampuli včetně | parent. | 5.00 | RG | 368,20 | K/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 48.5 | B03XA02 | darbepoetin nad 50 mikrogramů v ampuli | parent. | 5.00 | RG | 347,92 | K/P |

Léčbu erythropoetinem a darbepoetinem předepisuje onkolog, hematolog, internista, nefrolog nebo pediatr:

@@ -1323,1094 +1428,1096 @@

| 49 | substituenty plazmy a plazmatické proteiny (albumin) | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 49.1 | B05AA01 | albumin | parent. | 20.00 | GM | 1 883.29 | B |

| 62471 | HUMAN ALBUMIN 20% IMMUNO | inf sol 1x100ml 20% | BXG | A |

| 49.1 | B05AA01 | albumin | parent. | 20.00 | GM | 1 840,54 | B |

| 62471 | HUMAN ALBUMIN 20% IMMUNO | inf sol 1×100ml 20% | BXG | A |

| --- | --- | --- | --- | --- |

| 50 | substituenty plazmy a plazmatické proteiny (ostatní) | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 50.1 | B05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100.00 | ML | 952.16 | B |

| | | | | | | | |

| 50.2 | B05AA05 | dextran (koncentrace 10%) | parent. | 500.00 | ML | 185.84 | O |

| | | | | | | | |

| 50.3 | B05AA05 | dextran (koncentrace 6%) | parent. | 500.00 | ML | 108.80 | O |

| | | | | | | | |

| 50.4 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500.00 | ML | 123.86 | O |

| | | | | | | | |

| 50.5 | B05AA06 | želatinové přípravky | parent. | 500.00 | ML | 168.71 | O |

| 56412 | GELOFUSINE | inf 1x500ml | BME | CH |

| --- | --- | --- | --- | --- |

| 83274 | GELOFUSINE | inf sol 1x500ml v | BMM | D |

| 50.6 | B05AA07 | hydroxyethyl škrob | parent. | 500.00 | ML | 286.90 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01798 | SERAG-HAES 6% | inf sol 1x500ml/30gm | SWS | D |

| --- | --- | --- | --- | --- |

| 01894 | SERAG-HAES 10% | inf sol 1x500ml/50gm | SWS | D |

| 44431 | HEMOHES 6% | inf sol 1x500ml-pe | BMM | D |

| 55897 | HEMOHES 6% | inf sol 10x500ml-pe | BMM | D |

| 50.1 | B05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100.00 | ML | 930,55 | B |

| | | | | | | | |

| 50.2 | B05AA05 | dextran (koncentrace 10%) | parent. | 500.00 | ML | 181,62 | O |

| | | | | | | | |

| 50.3 | B05AA05 | dextran (koncentrace 6%) | parent. | 500.00 | ML | 106,33 | O |

| | | | | | | | |

| 50.4 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500.00 | ML | 121,05 | O |

| | | | | | | | |

| 50.5 | B05AA06 | želatinové přípravky | parent. | 500.00 | ML | 164,88 | O |

| 56412 | GELOFUSINE | inf 1×500ml | BME | CH |

| --- | --- | --- | --- | --- |

| 83274 | GELOFUSINE | inf sol 1×500ml v | BMM | D |

| 50.6 | B05AA07 | hydroxyethyl škrob | parent. | 500.00 | ML | 280,39 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01798 | SERAG-HAES 6% | inf sol 1×500ml/30gm | SWS | D |

| --- | --- | --- | --- | --- |

| 01894 | SERAG-HAES 10% | inf sol 1×500ml/50gm | SWS | D |

| 44431 | HEMOHES 6% | inf sol 1×500ml-pe | BMM | D |

| 55897 | HEMOHES 6% | inf sol 10×500ml-pe | BMM | D |

| 51 | parenterální výživa | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 51.1 | B05BA01 | aminokyseliny (koncentrace do 6% včetně) | parent. | 100.00 | ML | 38.76 | H |

| 31989 | CLINIMIX N9G20E | inf sol 4x2000ml | BXF | GB |

| --- | --- | --- | --- | --- |

| 98240 | AMINOPLASMAL 5% E | inf 1x500ml | BME | D |

| 51.2 | B05BA01 | aminokyseliny (koncentrace nad 6% do 10% včetně) | parent. | 100.00 | ML | 47.42 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11626 | AMINOPLASMAL 10% | inf 1x500ml | BME | D |

| --- | --- | --- | --- | --- |

| 31985 | CLINIMIX N14G30E | inf sol 4x2000ml | BXF | GB |

| 31987 | CLINIMIX N17G35E | inf sol 4x2000ml | BXF | GB |

| 51.3 | B05BA01 | aminokyseliny (koncentrace nad 10% do 14% včetně) | parent. | 100.00 | ML | 70.48 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 51.4 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100.00 | ML | 63.44 | H |

| 75521 | AMINOPLASMAL 15% E | inf 1x1000ml | BME | D |

| --- | --- | --- | --- | --- |

| 51.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 173.20 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31526 | SOYACAL 10% | inf eml 20x100ml | GFL | E |

| --- | --- | --- | --- | --- |

| 49956 | INTRALIPID 10% | inf 12x100ml-sklo | FRK | A |

| 49959 | INTRALIPID 10% | inf 1x100ml-vak | FRK | A |

| 49960 | INTRALIPID 10% | inf 10x100ml-vak | FRK | A |

| 49970 | INTRALIPID 10% | inf 1x100ml-sklo | FRK | A |

| 51.6 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml v jednom balení) | parent. | 100.00 | ML | 53.83 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49962 | INTRALIPID 10% | inf 12x500ml-vak | FRK | A |

| --- | --- | --- | --- | --- |

| 49973 | INTRALIPID 10% | inf 12x500ml-sklo | FRK | A |

| 51.7 | B05BA02 | tukové emulze (nad 10% do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 196.40 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31529 | SOYACAL 20% | inf eml 20x100ml | GFL | E |

| --- | --- | --- | --- | --- |

| 51.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml v jednom balení) | parent. | 100.00 | ML | 67.58 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49971 | INTRALIPID 20% | inf 1x1000ml-sklo | FRK | A |

| --- | --- | --- | --- | --- |

| 49972 | INTRALIPID 20% | inf 6x1000ml-sklo | FRK | A |

| 57247 | INTRALIPID 20% | inf 6x1000ml-sklo | FRK | S |

| 51.9 | B05BA03 | fruktóza (koncentrace do 5% včetně) | parent. | 100.00 | ML | 14.47 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 51.10 | B05BA03 | fruktóza (koncentrace nad 5% do 10% včetně) | parent. | 100.00 | ML | 15.54 | H |

| | | | | | | | |

| 51.11 | B05BA03 | fruktóza (koncentrace nad 10%) | parent. | 100.00 | ML | 17.74 | H |

| | | | | | | | |

| 51.12 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 28.00 | O |

| 03433 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 20x100ml-sk | FKI | I |

| --- | --- | --- | --- | --- |

| 31430 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-skl | FKI | I |

| 59432 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFF | I |

| 59436 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E |

| 51.13 | B05BA03 | glukóza 10% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 12.71 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31432 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-skl | FKI | I |

| --- | --- | --- | --- | --- |

| 31433 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 16x250ml-sk | FKI | I |

| 59433 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFF | I |

| 59437 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E |

| 62376 | INFUSIO GLUCOSI 10 IMUNA | inf 1x250ml(sklo) | IMA | SK |

| 97735 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I |

| 51.14 | B05BA03 | glukóza 10% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100.00 | ML | 6.04 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31437 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-pp | FKI | I |

| --- | --- | --- | --- | --- |

| 47000 | GLUKÓZA 10 BRAUN | inf 1x500ml-pe | BME | E |

| 47017 | GLUKÓZA 10 BRAUN | inf 1x500ml-pe | BME | CH |

| 59419 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E |

| 71735 | INFUSIO GLUCOSI 100 G/L MVM G10 | inf sol 1x500ml | MVM | CZ |

| 96877 | GLUKÓZA 10 BRAUN | inf 1x500ml-pe | BMM | D |

| 97736 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I |

| 97737 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFF | I |

| 51.15 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100.00 | ML | 5.82 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31436 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-sk | FKI | I |

| --- | --- | --- | --- | --- |

| 31439 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-pp | FKI | I |

| 31440 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 12x1000ml-pp | FKI | I |

| 31447 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-va | FKI | I |

| 31449 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x2000ml-va | FKI | I |

| 31450 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 4x2000ml-va | FKI | I |

| 47001 | GLUKÓZA 10 BRAUN | inf 1x1000ml-pe | BME | E |

| 47018 | GLUKÓZA 10 BRAUN | inf 1x1000ml-pe | BME | CH |

| 59434 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFF | I |

| 59438 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E |

| 92772 | INFUSIO GLUCOSI 10 MEDIEKOS G10 | inf 1x2000ml(vak) | INK | CZ |

| 96878 | GLUKÓZA 10 BRAUN | inf 1x1000ml-pe | BMM | D |

| 51.16 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 29.10 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 57750 | GLUCOSE 20% INFUSION-HUMAN | inf 1x100ml | HUA | H |

| --- | --- | --- | --- | --- |

| 51.17 | B05BA03 | glukóza 20% (nad 100 ml v jednom balení) | parent. | 100.00 | ML | 6.46 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 59421 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E |

| --- | --- | --- | --- | --- |

| 59422 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E |

| 86054 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFF | I |

| 97738 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I |

| 51.18 | B05BA03 | glukóza 5% (do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 27.76 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03432 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x100ml-sk | FKI | I |

| --- | --- | --- | --- | --- |

| 31451 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-skl | FKI | I |

| 31462 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-vak | FKI | I |

| 31463 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 40x100ml-va | FKI | I |

| 46994 | GLUKÓZA 5 BRAUN | inf 1x100ml-sklo | BME | E |

| 47011 | GLUKÓZA 5 BRAUN | inf 1x100ml-sklo | BME | CH |

| 47252 | GLUKÓZA 5 BRAUN | inf 1x100ml-pe | BMM | D |

| 47253 | GLUKÓZA 5 BRAUN | inf 1x100ml-pe | BME | E |

| 47254 | GLUKÓZA 5 BRAUN | inf 1x100ml-pe | BME | CH |

| 47255 | GLUKÓZA 5 BRAUN | inf 20x100ml-pe | BME | CH |

| 47256 | GLUKÓZA 5 BRAUN | inf 20x100ml-pe | BMM | D |

| 47257 | GLUKÓZA 5 BRAUN | inf 20x100ml-pe | BME | E |

| 59413 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E |

| 62370 | INFUSIO GLUCOSI 5 IMUNA | inf 1x100ml(sklo) | IMA | SK |

| 96871 | GLUKÓZA 5 BRAUN | inf 1x100ml-sklo | BMM | D |

| 97728 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(sklo) | BFF | I |

| 97731 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFF | I |

| 98886 | GLUKÓZA 5% VIAFLO | inf sol 50x100ml | BFH | E |

| 51.19 | B05BA03 | glukóza 5% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 12.90 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31453 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-skl | FKI | I |

| --- | --- | --- | --- | --- |

| 31454 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 16x250ml-sk | FKI | I |

| 31464 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-vak | FKI | I |

| 31465 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 30x250ml-va | FKI | I |

| 51.1 | B05BA01 | aminokyseliny (koncentrace do 6% včetně) | parent. | 100.00 | ML | 37,88 | H |

| 31989 | CLINIMIX N9G20E | inf sol 4×2000ml | BXF | GB |

| --- | --- | --- | --- | --- |

| 98240 | AMINOPLASMAL 5% E | inf 1×500ml | BME | D |

| 51.2 | B05BA01 | aminokyseliny (koncentrace nad 6% do 10 % včetně) | parent. | 100.00 | ML | 46,34 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11626 | AMINOPLASMAL 10% | inf 1×500ml | BME | D |

| --- | --- | --- | --- | --- |

| 31985 | CLINIMIX N14G30E | inf sol 4×2000ml | BXF | GB |

| 31987 | CLINIMIX N17G35E | inf sol 4×2000ml | BXF | GB |

| 51.3 | B05BA01 | aminokyseliny (koncentrace nad 10% do 14% včetně) | parent. | 100.00 | ML | 68,88 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 51.4 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100.00 | ML | 62,00 | H |

| 75521 | AMINOPLASMAL 15% E | inf 1×1000ml | BME | D |

| --- | --- | --- | --- | --- |

| 51.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 169,27 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31526 | SOYACAL 10% | inf eml 20×100ml | GFL | E |

| --- | --- | --- | --- | --- |

| 49956 | INTRALIPID 10% | inf 12×100ml-sklo | FRK | A |

| 49959 | INTRALIPID 10% | inf 1×100ml-vak | FRK | A |

| 49960 | INTRALIPID 10% | inf 10×100ml-vak | FRK | A |

| 49970 | INTRALIPID 10% | inf 1×100ml-sklo | FRK | A |

| 51.6 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml v jednom balerní) | parent. | 100.00 | ML | 52,61 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49962 | INTRALIPID 10% | inf 12×500ml-vak | FRK | A |

| --- | --- | --- | --- | --- |

| 49973 | INTRALIPID 10% | inf 12×500ml-sklo | FRK | A |

| 51.7 | B05BA02 | tukové emulze (nad 10% do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 191,94 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31529 | SOYACAL 20% | inf eml 20×100ml | GFL | E |

| --- | --- | --- | --- | --- |

| 51.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml v jednom balení) | parent. | 100.00 | ML | 66,05 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49971 | INTRALIPID 20 % | inf 1×1000ml-sklo | FRK | A |

| --- | --- | --- | --- | --- |

| 49972 | INTRALIPID 20% | inf 6×1000ml-sklo | FRK | A |

| 57247 | INTRALIPID 20 % | inf 6×1000ml-sklo | FRK | S |

| 51.9 | B05BA03 | fruktóza (koncentrace do 5% včetně) | parent. | 100.00 | ML | 14,14 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 51.10 | B05BA03 | fruktóza (koncentrace nad 5% do 10% včetně) | parent. | 100.00 | ML | 15,19 | H |

| | | | | | | | |

| 51.11 | B05BA03 | fruktóza (koncentrace nad 10%) | parent. | 100.00 | ML | 17,34 | H |

| | | | | | | | |

| 51.12 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 27,36 | O |

| 03433 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 20×100ml-sk | FKI | I |

| --- | --- | --- | --- | --- |

| 31430 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1×100ml-skl | FKI | I |

| 59432 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×100ml(vak) | BFF | I |

| 59436 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×100ml(vak) | BFH | E |

| 51.13 | B05BA03 | glukóza 10% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 12,42 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31432 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1×250ml-skl | FKI | I |

| --- | --- | --- | --- | --- |

| 31433 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 16×250ml-sk | FKI | I |

| 59433 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×250ml(vak) | BFF | I |

| 59437 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×250ml(vak) | BFH | E |

| 62376 | INFUSIO GLUCOSI 10 IMUNA | inf 1×250ml(sklo) | IMA | SK |

| 97735 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×250ml(sklo) | BFF | I |

| 51.14 | B05BA03 | glukóza 10% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100.00 | ML | 5,90 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31437 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1×500ml-pp | FKI | I |

| --- | --- | --- | --- | --- |

| 47000 | GLUKÓZA 10 BRAUN | inf 1×500ml-pe | BME | E |

| 47017 | GLUKÓZA 10 BRAUN | inf 1×500ml-pe | BME | CH |

| 59419 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×500ml(vak) | BFH | E |

| 71735 | INFUSIO GLUCOSI 100 G/L MVM G10 | inf sol 1×500ml | MVM | CZ |

| 96877 | GLUKÓZA 10 BRAUN | inf 1×500ml-pe | BMM | D |

| 97736 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×500ml(sklo) | BFF | I |

| 97737 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×500ml(vak) | BFF | I |

| 51.15 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100.00 | ML | 5,69 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31436 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1×1000ml-sk | FKI | I |

| --- | --- | --- | --- | --- |

| 31439 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1×1000ml-pp | FKI | I |

| 31440 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 12×1000ml-pp | FKI | I |

| 31447 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1×1000ml-va | FKI | I |

| 31449 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1×2000ml-va | FKI | I |

| 31450 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 4×2000ml-va | FKI | I |

| 47001 | GLUKÓZA 10 BRAUN | inf 1×1000ml-pe | BME | E |

| 47018 | GLUKÓZA 10 BRAUN | inf 1×1000ml-pe | BME | CH |

| 59434 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×1000ml(vak) | BFF | I |

| 59438 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1×1000ml(vak) | BFH | E |

| 92772 | INFUSIO GLUCOSI 10 MEDIEKOS G10 | inf 1×2000ml(vak) | INK | CZ |

| 96878 | GLUKÓZA 10 BRAUN | inf 1×1000ml-pe | BMM | D |

| 51.16 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 28,44 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 57750 | GLUCOSE 20% INFUSION-HUMAN | inf 1×100ml | HUA | H |

| --- | --- | --- | --- | --- |

| 51.17 | B05BA03 | glukóza 20% (nad 100 ml v jednom balení) | parent. | 100.00 | ML | 6,31 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 59421 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1×500ml(vak) | BFH | E |

| --- | --- | --- | --- | --- |

| 59422 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1×1000ml(vak) | BFH | E |

| 86054 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1×500ml(vak) | BFF | I |

| 97738 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1×500ml(sklo) | BFF | I |

| 51.18 | B05BA03 | glukóza 5% (do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 27,13 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03432 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20×100ml-sk | FKI | I |

| --- | --- | --- | --- | --- |

| 31451 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1×100ml-skl | FKI | I |

| 31462 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1×100ml-vak | FKI | I |

| 31463 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 40×100ml-va | FKI | I |

| 46994 | GLUKÓZA 5 BRAUN | inf 1×100ml-sklo | BME | E |

| 47011 | GLUKÓZA 5 BRAUN | inf 1×100ml-sklo | BME | CH |

| 47252 | GLUKÓZA 5 BRAUN | inf 1×100ml-pe | BMM | D |

| 47253 | GLUKÓZA 5 BRAUN | inf 1×100ml-pe | BME | E |

| 47254 | GLUKÓZA 5 BRAUN | inf 1×100ml-pe | BME | CH |

| 47255 | GLUKÓZA 5 BRAUN | inf 20×100ml-pe | BME | CH |

| 47256 | GLUKÓZA 5 BRAUN | inf 20×100ml-pe | BMM | D |

| 47257 | GLUKÓZA 5 BRAUN | inf 20×100ml-pe | BME | E |

| 59413 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×100ml(vak) | BFH | E |

| 62370 | INFUSIO GLUCOSI 5 IMUNA | inf 1×100ml(sklo) | IMA | SK |

| 96871 | GLUKÓZA 5 BRAUN | inf 1×100ml-sklo | BMM | D |

| 97728 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×100ml(sklo) | BFF | I |

| 97731 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×100ml(vak) | BFF | I |

| 98886 | GLUKÓZA 5% VIAFLO | inf sol 50×100ml | BFH | E |

| 51.19 | B05BA03 | glukóza 5% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 12,61 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31453 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-skl | FKI | l |

| --- | --- | --- | --- | --- |

| 31454 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 16x250ml-sk | FKI | l |

| 31464 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-vak | FKI | l |

| 31465 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 30x250ml-va | FKI | l |

| 46995 | GLUKÓZA 5 BRAUN | inf 1x250ml-pe | BME | E |

| 47012 | GLUKÓZA 5 BRAUN | inf 1x250ml-pe | BME | CH |

| 59414 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E |

| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml(sklo) | IMA | SK |

| 66866 | INFUSIO GLUCOSI 5% INFUSIA | inf sol 1x250ml-skl | IHO | CZ |

| 96872 | GLUKÓZA 5 BRAUN | inf 1x250ml-pe | BMM | D |

| 97729 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I |

| 97732 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFF | I |

| 98893 | GLUKÓZA 5% VIAFLO | inf sol 35x150ml | BFH | E |

| 98894 | GLUKÓZA 5% VIAFLO | inf sol 30x250ml | BFH | E |

| 51.20 | B05BA03 | glukóza 5% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100.00 | ML | 6.89 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31455 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-skl | FKI | I |

| --- | --- | --- | --- | --- |

| 31456 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 12x500ml-sk | FKI | I |

| 31458 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-pp | FKI | I |

| 31459 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x500ml-pp | FKI | I |

| 31466 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-vak | FKI | I |

| 31467 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x500ml-va | FKI | I |

| 46996 | GLUKÓZA 5 BRAUN | inf 1x500ml-pe | BME | E |

| 47013 | GLUKÓZA 5 BRAUN | inf 1x500ml-pe | BME | CH |

| 59415 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E |

| 71734 | INFUSIO GLUCOSI 50 G/L MVM G5 | inf sol 1x500ml | MVM | CZ |

| 96873 | GLUKÓZA 5 BRAUN | inf 1x500ml-pe | BMM | D |

| 97730 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I |

| 97733 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFF | I |

| 98901 | GLUKÓZA 5% VIAFLO | inf sol 20x500ml | BFH | E |

| 51.21 | B05BA03 | glukóza 5% (nad 500 ml v jednom balení) | parent. | 100.00 | ML | 3.96 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31468 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-va | FKI | I |

| --- | --- | --- | --- | --- |

| 31469 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 10x1000ml-va | FKI | I |

| 31470 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x2000ml-va | FKI | I |

| 31471 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 4x2000ml-va | FKI | I |

| 59416 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E |

| 97734 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFF | I |

| 98902 | GLUKÓZA 5% VIAFLO | inf sol 10x1000ml | BFH | E |

| 51.22 | B05BA03 | glukóza do 10% včetně (do 10 ml v jedné ampuli včetně) | parent. | 100.00 | ML | 23.90 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 47241 | GLUKÓZA 5 BRAUN | inf 20x10ml-pla.amp | BMM | D |

| --- | --- | --- | --- | --- |

| 51.23 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli) | parent. | 100.00 | ML | 83.15 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02587 | GLUKÓZA 40 BRAUN | inf 20x10ml-pla.amp | BMM | D |

| --- | --- | --- | --- | --- |

| 02588 | GLUKÓZA 40 BRAUN | inf 20x10ml-pla.amp | BME | E |

| 02589 | GLUKÓZA 40 BRAUN | inf 20x10ml-pla.amp | BME | CH |

| 51.24 | B05BA03 | glukóza nad 10% do 39 % (do 10 ml v jedné ampuli včetně) | parent. | 100.00 | ML | 98.74 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 51.25 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 31.97 | O |

| 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1x100ml | IMA | SK |

| --- | --- | --- | --- | --- |

| 51.26 | B05BA03 | glukóza nad 20% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 18.18 | O |

| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1×250ml(sklo) | IMA | SK |

| 66866 | INFUSIO GLUCOSI 5% INFUSIA | inf sol 1×250ml-skl | IHO | CZ |

| 96872 | GLUKÓZA 5 BRAUN | inf 1×250ml-pe | BMM | D |

| 97729 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×250ml(sklo) | BFF | I |

| 97732 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×250ml(vak) | BFF | I |

| 98893 | GLUKÓZA 5% VIAFLO | inf sol 35×150ml | BFH | E |

| 98894 | GLUKÓZA 5% VIAFLO | inf sol 30×250ml | BFH | E |

| 51.20 | B05BA03 | glukóza 5% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100.00 | ML | 6,73 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31455 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1×500ml-skl | FKI | I |

| --- | --- | --- | --- | --- |

| 31456 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 12×500ml-sk | FKI | I |

| 31458 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1×500ml-pp | FKI | I |

| 31459 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20×500ml-pp | FKI | I |

| 31466 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1×500ml-vak | FKI | I |

| 31467 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20×500ml-va | FKI | I |

| 46996 | GLUKÓZA 5 BRAUN | inf 1×500ml-pe | BME | E |

| 47013 | GLUKÓZA 5 BRAUN | inf 1×500ml-pe | BME | CH |

| 59415 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×500ml(vak) | BFH | E |

| 71734 | INFUSIO GLUCOSI 50 G/L MVM G5 | inf sol 1×500ml | MVM | CZ |

| 96873 | GLUKÓZA 5 BRAUN | inf 1×500ml-pe | BMM | D |

| 97730 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×500ml(sklo) | BFF | I |

| 97733 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×500ml(vak) | BFF | I |

| 98901 | GLUKÓZA 5% VIAFLO | inf sol 20×500ml | BFH | E |

| 51.21 | B05BA03 | glukóza 5% (nad 500 ml v jednom balení) | parent. | 100.00 | ML | 3,87 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31468 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1×1000ml-va | FKI | I |

| --- | --- | --- | --- | --- |

| 31469 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 10×1000ml-va | FKI | I |

| 31470 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1×2000ml-va | FKI | I |

| 31471 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 4×2000ml-va | FKI | I |

| 59416 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×1000ml(vak) | BFH | E |

| 97734 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1×1000ml(vak) | BFF | I |

| 98902 | GLUKÓZA 5% VIAFLO | inf sol 10×1000ml | BFH | E |

| 51.22 | B05BA03 | glukóza do 10% včetně (do 10 ml v jedné ampuli včetně) | parent. | 100.00 | ML | 23,36 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 47241 | GLUKÓZA 5 BRAUN | inf 20×10ml-pla.amp | BMM | D |

| --- | --- | --- | --- | --- |

| 51.23 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli) | parent. | 100.00 | ML | 81,26 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02587 | GLUKÓZA 40 BRAUN | inf 20×10ml-pla.amp | BMM | D |

| --- | --- | --- | --- | --- |

| 02588 | GLUKÓZA 40 BRAUN | inf 20×10ml-pla.amp | BME | E |

| 02589 | GLUKÓZA 40 BRAUN | inf 20×10ml-pla.amp | BME | CH |

| 51.24 | B05BA03 | glukóza nad 10% do 39 % (do 10 ml v jedné ampuli včetně) | parent. | 100.00 | ML | 96,50 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 51.25 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100.00 | ML | 31,24 | O |

| 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1×100ml | IMA | SK |

| --- | --- | --- | --- | --- |

| 51.26 | B05BA03 | glukóza nad 20% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 17,77 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 55630 | INFUSIO GLUCOSI 40 IMUNA | inf 1×250ml | IMA | SK |

| --- | --- | --- | --- | --- |

| 51.27 | B05BA03 | glukóza nad 20% (nad 250 ml v jednom balení) | parent. | 100.00 | ML | 8.26 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 51.28 | B05BA03 | sorbitol (koncentrace do 5% včetně) | parent. | 100.00 | ML | 7.66 | H |

| | | | | | | | |

| 51.29 | B05BA03 | sorbitol (koncentrace nad 10%) | parent. | 100.00 | ML | 11.10 | H |

| | | | | | | | |

| 51.30 | B05BA03 | sorbitol (koncentrace nad 5% do 10% včetně) | parent. | 100.00 | ML | 8.14 | H |

| | | | | | | | |

| 51.31 | B05BA03 | xylitol (koncentrace do 5% včetně) | parent. | 100.00 | ML | 16.62 | H |

| | | | | | | | |

| 51.32 | B05BA03 | xylitol (koncentrace nad 5%) | parent. | 100.00 | ML | 22.83 | H |

| | | | | | | | |

| 51.33 | B05BA10 | kombinace bez obsahu aminokyselin | parent. | 100.00 | ML | 13.20 | H |

| | | | | | | | |

| 51.34 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100.00 | ML | 55.76 | H |

| 02452 | NUTRIFLEX SPECIAL | inf 5x1000ml | BMB | CH |

| --- | --- | --- | --- | --- |

| 02453 | NUTRIFLEX SPECIAL | inf 5x1500ml | BMB | CH |

| 02454 | NUTRIFLEX PERI | inf 5x1000ml | BMB | CH |

| 02455 | NUTRIFLEX PERI | inf 5x2000ml | BMB | CH |

| 02458 | NUTRIFLEX PLUS | inf 5x1000ml | BMB | CH |

| 02459 | NUTRIFLEX PLUS | inf 5x2000ml | BMB | CH |

| 02460 | NUTRIFLEX BASAL | inf 5x1000ml | BMB | CH |

| 02461 | NUTRIFLEX BASAL | inf 5x2000ml | BMB | CH |

| 32599 | OLICLINOMEL N4-550E | inf eml 4x2000ml | BXI | B |

| 32782 | NEONUTRIMIX P | inf sol (1.5+0.5)It | IHO | CZ |

| 40178 | AMINOPLASMAL 10% E | inf 1x1000ml | BME | D |

| 42557 | OLICLINOMEL N5-800E | inf eml 6x1000ml | BXI | B |

| 42603 | OLICLINOMEL N6-900E | inf eml 4x2000ml | BXI | B |

| 46235 | NEONUTRIMIX C | inf sol (1+0.875)It | IHO | CZ |

| 95637 | NUTRIFLEX LIPID PLUS | inf eml 5x1875ml | BMM | D |

| 95638 | NUTRIFLEX LIPID PLUS | inf eml 5x2500ml | BMM | D |

| 95640 | NUTRIFLEX LIPID PERI | inf eml 5x1875ml | BMM | D |

| 95641 | NUTRIFLEX LIPID PERI | inf eml 5x2500ml | BMM | D |

| 98053 | OLICLINOMEL N4-550E | inf eml 4x2000ml | CTT | F |

| 98055 | OLICLINOMEL N5-800E | inf eml 6x1000ml | CTT | F |

| 98086 | OLICLINOMEL N6-900E | inf eml 4x2000ml | CTT | F |

| 51.27 | B05BA03 | glukóza nad 20% (nad 250 ml v jednom balení) | parent. | 100.00 | ML | 8,07 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 51.28 | B05BA03 | sorbitol (koncentrace do 5% včetně) | parent. | 100.00 | ML | 7,49 | H |

| | | | | | | | |

| 51.29 | B05BA03 | sorbitol (koncentrace nad 10%) | parent. | 100.00 | ML | 10,85 | H |

| | | | | | | | |

| 51.30 | B05BA03 | sorbitol (koncentrace nad 5% do 10% včetně) | parent. | 100.00 | ML | 7,96 | H |

| | | | | | | | |

| 51.31 | B05BA03 | xylitol (koncentrace do 5% včetně) | parent. | 100.00 | ML | 16,24 | H |

| | | | | | | | |

| 51.32 | B05BA03 | xylitol (koncentrace nad 5%) | parent. | 100.00 | ML | 22,31 | H |

| | | | | | | | |

| 51.33 | B05BA10 | kombinace bez obsahu aminokyselin | parent. | 100.00 | ML | 12,90 | H |

| | | | | | | | |

| 51.34 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100.00 | ML | 54,49 | H |

| 02452 | NUTRIFLEX SPECIAL | inf 5×1000ml | BMB | CH |

| --- | --- | --- | --- | --- |

| 02453 | NUTRIFLEX SPECIAL | inf 5×1500ml | BMB | CH |

| 02454 | NUTRIFLEX PERI | inf 5×1000ml | BMB | CH |

| 02455 | NUTRIFLEX PERI | inf 5×2000ml | BMB | CH |

| 02458 | NUTRIFLEX PLUS | inf 5×1000ml | BMB | CH |

| 02459 | NUTRIFLEX PLUS | inf 5×2000ml | BMB | CH |

| 02460 | NUTRIFLEX BASAL | inf 5×1000ml | BMB | CH |

| 02461 | NUTRIFLEX BASAL | inf 5×2000ml | BMB | CH |

| 32599 | OLICLINOMEL N4-550E | inf eml 4×2000ml | BXI | B |

| 32782 | NEONUTRIMIX P | inf sol (1.5+0.5)lt | IHO | CZ |

| 40178 | AMINOPLASMAL 10% E | inf 1×1000ml | BME | D |

| 42557 | OLICLINOMEL N5-800E | inf eml 6×1000ml | BXI | B |

| 42603 | OLICLINOMEL N6-900E | inf eml 4×2000ml | BXI | B |

| 46235 | NEONUTRIMIX C | inf sol (1+0.875)lt | IHO | CZ |

| 95637 | NUTRIFLEX LIPID PLUS | inf eml 5×1875ml | BMM | D |

| 95638 | NUTRIFLEX LIPID PLUS | inf eml 5×2500ml | BMM | D |

| 95640 | NUTRIFLEX LIPID PERI | inf eml 5×1875ml | BMM | D |

| 95641 | NUTRIFLEX LIPID PERI | inf eml 5×2500ml | BMM | D |

| 98053 | OLICLINOMEL N4-550E | inf eml 4×2000ml | CTT | F |

| 98055 | OLICLINOMEL N5-800E | inf eml 6×1000ml | CTT | F |

| 98086 | OLICLINOMEL N6-900E | inf eml 4×2000ml | CTT | F |

| 52 | intravenozní roztoky fysiologického roztoku | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 52.1 | B05BB | roztoky ovlivňující rovnováhu elektrolytů | parent. | 100.00 | ML | 10.46 | H |

| | | | | | | | |

| 52.2 | B05BB01 | elektrolyty | parent. | 100.00 | ML | 8.07 | H |

| 05860 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x3000ml(vak) | INK | CZ |

| --- | --- | --- | --- | --- |

| 05869 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x5000ml(vak) | INK | CZ |

| 05870 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x5000ml(vak) | INK | CZ |

| 11222 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-vak | FKI | I |

| 11305 | RINGER'S INJECTION FRESENIUS | inf 10x1000ml-vak | FKI | I |

| 11323 | RINGER'S INJECTION FRESENIUS | inf 1x500ml-sklo | FKI | I |

| 11328 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-sklo | FKI | I |

| 11376 | RINGER'S INJECTION FRESENIUS | inf 12x500ml-sklo | FKI | I |

| 11380 | RINGER'S INJECTION FRESENIUS | inf 12x1000ml-sklo | FKI | I |

| 18304 | RINGERFUNDIN B.BRAUN | inf sol 10x500ml pe | BMM | D |

| 18305 | RINGERFUNDIN B.BRAUN | inf sol 10x1000ml pe | BMM | D |

| 21291 | INFUSIO DARROWI INFUSIA | inf 1x1000ml-vak | IHO | CZ |

| 21329 | INFUSIO HARTMANNI INFUSIA | inf 1x1000ml-vak | IHO | CZ |

| 44100 | HARTMANNUV ROZTOK BRAUN BP | inf 1x500ml-plast | BMM | D |

| 44101 | HARTMANNUV ROZTOK BRAUN BP | inf 1x1000ml-plast | BMM | D |

| 44102 | HARTMANNUV ROZTOK BRAUN BP | inf 10x500ml-plast | BMM | D |

| 44103 | HARTMANNUV ROZTOK BRAUN BP | inf 10x1000ml-plast | BMM | D |

| 49995 | HARTMANN'S SOL. BP FRESENIUS | infsol 10x1000ml | FRE | D |

| 49996 | HARTMANN'S SOL. BP FRESENIUS | inf sol 10x1000 ml | FRE | D |

| 55616 | INFUSIO RINGERI IMUNA | inf 1x2000ml(vak) | IMA | SK |

| 55617 | INFUSIO RINGERI IMUNA | inf 1x3000ml(vak) | IMA | SK |

| 59357 | RINGERUV ROZTOK BRAUN | inf 10x500ml(Idpe) | BMM | D |

| 59358 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(Idpe) | BMM | D |

| 59361 | RINGERUV ROZTOK BRAUN | inf 10x500ml(Idpe) | BME | E |

| 59362 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(Idpe) | BME | E |

| 59365 | RINGERUV ROZTOK BRAUN | inf 10x500ml(Idpe) | BME | CH |

| 59366 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(Idpe) | BME | CH |

| 59374 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x500ml(vak) | BFH | E |

| 66833 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 1x1000ml | BxF | GB |

| 69235 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x500ml(sklo) | BFF | I |

| 70524 | INFUSIO HARTMANNI MEDICAM.H1/1 | inf sol 1x500ml | MVM | CZ |

| 70527 | INFUSIO DARROWI MEDICAMEN.D1/1 | inf sol 1x500ml | MVM | CZ |

| 70529 | INFUSIO RINGERI MEDICAMENTAR1/1 | inf sol 1x500ml | MVM | CZ |

| 70530 | INFUSIO RINGERI C.NATR.LACT.MVM | inf sol 1x500ml | MVM | CZ |

| 72793 | INFUSIO RINGERI IMUNA | inf 1x500ml(sklo) | IMA | SK |

| 83946 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x500ml(vak) | INK | CZ |

| 85578 | INFUSIO RINGERI IMUNA | inf 1x1000ml(vak) | IMA | SK |

| 85887 | INFUSIO HARTMANNI IMUNA | inf 1x1000ml(vak) | IMA | SK |

| 89861 | INFUSIO RINGERI INFUSIA | inf 1x500ml-sklo | IHO | CZ |

| 89864 | INFUSIO RINGERI INFUSIA | inf 1x1000ml-vak | IHO | CZ |

| 92580 | INFUSIO HARTMANNI IMUNA | inf 1x2000ml(vak) | IMA | SK |

| 92581 | INFUSIO HARTMANNI IMUNA | inf 1x3000ml(vak) | IMA | SK |

| 92775 | INFUSIO DARROWI MEDIEKOS D1/1 | inf 1x2000ml(vak) | INK | CZ |

| 92777 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x1000ml(vak) | INK | CZ |

| 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x2000ml(vak) | INK | CZ |

| 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x1000ml (vak) | INK | CZ |

| 92802 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x2000ml(vak) | INK | CZ |

| 93527 | ARDEAELYTOSOL R 1/1 | inf 1x500ml | ARD | CZ |

| 95569 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-pe | FKI | I |

| 95571 | RINGER'S INJECTION FRESENIUS | inf 12x1000ml-pe | FKI | I |

| 95579 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-f | FKI | I |

| 95758 | HARTMANN'S SOL. BP FRESENIUS | inf sol 6x1000ml | FRF | F |

| 95782 | HARTMANN'S SOL. BP FRESENIUS | inf sol 20x500ml | FRE | D |

| 95787 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1x1000ml | FRE | D |

| 95788 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1x1000ml | FRE | D |

| 95789 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1x1000ml | FRE | D |

| 95790 | HARTMANN´S SOL. BP FRESENIUS | inf sol 1x1000ml | FRE | D |

| 95791 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1x1000ml | FRF | F |

| 95792 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1x1000ml | FRF | F |

| 95793 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1x1000ml | FKI | I |

| 95794 | HARTMANN'S SOL. BP FRESENIUS | inf sol 6x1000ml | FKI | I |

| 95795 | HARTMANN'S SOL. BP FRESENIUS | inf sol 10x1000ml | FRF | F |

| 95796 | HARTMANN'S SOL. BP FRESENIUS | inf sol 10x1000ml | FRE | D |

| 95797 | HARTMANN'S SOL. BP FRESENIUS | inf sol 10x1000ml | FRE | D |

| 95798 | HARTMANN'S SOL. BP FRESENIUS | inf sol 8x1000ml | FRE | D |

| 95799 | HARTMANN'S SOL. BP FRESENIUS | inf sol 8x1000ml | FRE | D |

| 97014 | INFUSIO HARTMANNI BP-HUMAN | inf 1x500ml | HUA | H |

| 97015 | RINGER INFUSION-HUMAN | inf 1x500ml | HUA | H |

| 99168 | INFUSIO HARTMANNI IMUNA | inf 1x500ml(sklo) | IMA | SK |

| 52.3 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. | 100.00 | ML | 39.65 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46068 | CHLORID SODNÝ 0.9% BRAUN | inf sol 20x10ml-plamp | BMR | E |

| --- | --- | --- | --- | --- |

| 46078 | CHLORID SODNÝ 0.9% BRAUN | inf sol 20x10ml-plamp | BME | CH |

| 96886 | CHLORID SODNÝ 0.9% BRAUN | inf sol 20x10ml-plamp | BMM | D |

| 52.4 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100.00 | ML | 21.08 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46065 | CHLORID SODNÝ 0.9% BRAUN | inf sol 1x100ml-sk | BMR | E |

| --- | --- | --- | --- | --- |

| 46069 | CHLORID SODNÝ 0.9% BRAUN | inf sol 20x20ml-plamp | BMR | E |

| 46075 | CHLORID SODNÝ 0.9% BRAUN | inf sol 1x100ml-skl | BME | CH |

| 46079 | CHLORID SODNÝ 0.9% BRAUN | inf sol 20x20ml-plamp | BME | CH |

| 50973 | CHLORID SODNÝ 0.9% BRAUN | inf sol 1x100mlpelah | BMR | E |

| 51246 | CHLORID SODNÝ 0.9% BRAUN | inf sol 1x100ml-pelah | BME | CH |

| 51365 | CHLORID SODNÝ 0.9% BRAUN | inf sol 1x100ml-pelah | BMM | D |

| 57681 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(vak ii) | BFH | E |

| 96882 | CHLORID SODNY 0.9% BRAUN | inf sol 1x100ml-sk | BMM | D |

| 52.1 | B05BB | roztoky ovlivňující rovnováhu elektrolytů | parent. | 100.00 | ML | 10,22 | H |

| | | | | | | | |

| 52.2 | B05BB01 | elektrolyty | parent. | 100.00 | ML | 7,89 | H |

| 05860 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1×3000ml(vak) | INK | CZ |

| --- | --- | --- | --- | --- |

| 05869 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1×5000ml(vak) | INK | CZ |

| 05870 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1×5000ml(vak) | INK | CZ |

| 11222 | RINGER'S INJECTION FRESENIUS | inf 1×1000ml-vak | FKI | I |

| 11305 | RINGER'S INJECTION FRESENIUS | inf 10×1000ml-vak | FKI | I |

| 11323 | RINGER'S INJECTION FRESENIUS | inf 1×500ml-sklo | FKI | I |

| 11328 | RINGER'S INJECTION FRESENIUS | inf 1×1000ml-sklo | FKI | I |

| 11376 | RINGER'S INJECTION FRESENIUS | inf 12×500ml-sklo | FKI | I |

| 11380 | RINGER'S INJECTION FRESENIUS | inf 12×1000ml-sklo | FKI | I |

| 18304 | RINGERFUNDIN B.BRAUN | inf sol 10×500ml pe | BMM | D |

| 18305 | RINGERFUNDIN B.BRAUN | inf sol 10×1000ml pe | BMM | D |

| 21291 | INFUSIO DARROWI INFUSIA | inf 1×1000ml-vak | IHO | CZ |

| 21329 | INFUSIO HARTMANNI INFUSIA | inf 1×1000ml-vak | IHO | CZ |

| 44100 | HARTMANNUV ROZTOK BRAUN BP | inf 1×500ml-plast | BMM | D |

| 44101 | HARTMANNUV ROZTOK BRAUN BP | inf 1×1000ml-plast | BMM | D |

| 44102 | HARTMANNUV ROZTOK BRAUN BP | inf 10×500ml-plast | BMM | D |

| 44103 | HARTMANNUV ROZTOK BRAUN BP | inf 10×1000ml-plast | BMM | D |

| 49995 | HARTMANN'S SOL. BP FRESENIUS | inf sol 10×1000ml | FRE | D |

| 49996 | HARTMANN'S SOL. BP FRESENIUS | inf sol 10×1000 ml | FRE | D |

| 55616 | INFUSIO RINGERI IMUNA | inf 1×2000ml(vak) | IMA | SK |

| 55617 | INFUSIO RINGERI IMUNA | inf 1×3000ml(vak) | IMA | SK |

| 59357 | RINGERUV ROZTOK BRAUN | inf 10×500ml(ldpe) | BMM | D |

| 59358 | RINGERUV ROZTOK BRAUN | inf 10×1000ml(ldpe) | BMM | D |

| 59361 | RINGERUV ROZTOK BRAUN | inf 10×500ml(ldpe) | BME | E |

| 59362 | RINGERUV ROZTOK BRAUN | inf 10×1000ml(ldpe) | BME | E |

| 59365 | RINGERUV ROZTOK BRAUN | inf 10×500ml(ldpe) | BME | CH |

| 59366 | RINGERUV ROZTOK BRAUN | inf 10×1000ml(ldpe) | BME | CH |

| 59374 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1×500ml(vak) | BFH | E |

| 66833 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 1×1000ml | BXF | GB |

| 69235 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1×500ml(sklo) | BFF | I |

| 70524 | INFUSIO HARTMANNI MEDICAM.H1/1 | inf sol 1×500ml | MVM | CZ |

| 70527 | INFUSIO DARROWI MEDICAMEN.D1/1 | inf sol 1×500ml | MVM | CZ |

| 70529 | INFUSIO RINGERI MEDICAMENTAR1/1 | inf sol 1×500ml | MVM | CZ |

| 70530 | INFUSIO RINGERI C.NATR.LACT.MVM | inf sol 1×500ml | MVM | CZ |

| 72793 | INFUSIO RINGERI IMUNA | inf 1×500ml(sklo) | IMA | SK |

| 83946 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1×500ml(vak) | INK | CZ |

| 85578 | INFUSIO RINGERI IMUNA | inf 1×1000ml(vak) | IMA | SK |

| 85887 | INFUSIO HARTMANNI IMUNA | inf 1×1000ml(vak) | IMA | SK |

| 89861 | INFUSIO RINGERI INFUSIA | inf 1×500ml-sklo | IHO | CZ |

| 89864 | INFUSIO RINGERI INFUSIA | inf 1×1000ml-vak | IHO | CZ |

| 92580 | INFUSIO HARTMANNI IMUNA | inf 1×2000ml(vak) | IMA | SK |

| 92581 | INFUSIO HARTMANNI IMUNA | inf 1×3000ml(vak) | IMA | SK |

| 92775 | INFUSIO DARROWI MEDIEKOS D1/1 | inf 1×2000ml(vak) | INK | CZ |

| 92777 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1×1000ml(vak) | INK | CZ |

| 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1×2000ml(vak) | INK | CZ |

| 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1×1000ml (vak) | INK | CZ |

| 92802 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1×2000ml(vak) | INK | CZ |

| 93527 | ARDEAELYTOSOL R 1/1 | inf 1×500ml | ARD | CZ |

| 95569 | RINGER'S INJECTION FRESENIUS | inf 1×1000ml-pe | FKI | I |

| 95571 | RINGER'S INJECTION FRESENIUS | inf 12×1000ml-pe | FKI | I |

| 95579 | RINGER'S INJECTION FRESENIUS | inf 1×1000ml-f | FKI | I |

| 95758 | HARTMANN'S SOL. BP FRESENIUS | inf sol 6×1000ml | FRF | F |

| 95782 | HARTMANN'S SOL. BP FRESENIUS | inf sol 20×500ml | FRE | D |

| 95787 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1×1000ml | FRE | D |

| 95788 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1×1000ml | FRE | D |

| 95789 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1×1000ml | FRE | D |

| 95790 | HARTMANNT´S SOL. BP FRESENIUS | inf sol 1×1000ml | FRE | D |

| 95791 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1×1000ml | FRF | F |

| 95792 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1×1000ml | FRF | F |

| 95793 | HARTMANN'S SOL. BP FRESENIUS | inf sol 1×1000ml | FKI | I |

| 95794 | HARTMANN'S SOL. BP FRESENIUS | inf sol 6×1000ml | FKI | I |

| 95795 | HARTMANN'S SOL. BP FRESENIUS | inf sol 10×1000ml | FRF | F |

| 95796 | HARTMANN'S SOL. BP FRESENIUS | inf sol 10×1000ml | FRE | D |

| 95797 | HARTMANN'S SOL. BP FRESENIUS | inf sol 10×1000ml | FRE | D |

| 95798 | HARTMANN'S SOL. BP FRESENIUS | inf sol 8×1000ml | FRE | D |

| 95799 | HARTMANN'S SOL. BP FRESENIUS | inf sol 8×1000ml | FRE | D |

| 97014 | INFUSIO HARTMANNI BP-HUMAN | inf 1×500ml | HUA | H |

| 97015 | RINGER INFUSION-HUMAN | inf 1×500ml | HUA | H |

| 99168 | INFUSIO HARTMANNI IMUNA | inf 1×500ml(sklo) | IMA | SK |

| 52.3 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. | 100.00 | ML | 38,75 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46068 | CHLORID SODNY 0.9% BRAUN | infsol20×10ml-plamp | BMR | E |

| --- | --- | --- | --- | --- |

| 46078 | CHLORID SODNY 0.9% BRAUN | infsol20×10ml-plamp | BME | CH |

| 96886 | CHLORID SODNY 0.9% BRAUN | infsol20×10ml-plamp | BMM | D |

| 52.4 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100.00 | ML | 20,60 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46065 | CHLORID SODNY 0.9% BRAUN | inf sol 1×100ml-sk | BMR | E |

| --- | --- | --- | --- | --- |

| 46069 | CHLORID SODNY 0.9% BRAUN | inf sol 20×20ml-plamp | BMR | E |

| 46075 | CHLORID SODNY 0.9% BRAUN | inf sol 1×100ml-skl | BME | CH |

| 46079 | CHLORID SODNY 0.9% BRAUN | inf sol 20×20ml-plamp | BME | CH |

| 50973 | CHLORID SODNÝ 0.9% BRAUN | inf sol 1×100mlpelah | BMR | E |

| 51246 | CHLORID SODNÝ 0.9% BRAUN | inf sol 1×100ml-pelah | BME | CH |

| 51365 | CHLORID SODNÝ 0.9% BRAUN | inf sol 1×100ml-pelah | BMM | D |

| 57681 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×100ml(vak ii) | BFH | E |

| 96882 | CHLORID SODNY 0.9% BRAUN | inf sol 1×100ml-sk | BMM | D |

| 96887 | CHLORID SODNY 0.9% BRAUN | inf sol 20×20mlpl.amp | BMM | D |

| 97748 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(sklo) | BFF | I |

| 97751 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(vak ii) | BFF | I |

| 98864 | FYZIOLOGICKÝ ROZTOK VIAFLO | inf sol 50x100ml | BFH | E |

| 52.5 | B05BB01 | chlorid sodný 0.9% (nad 100 ml do 250 ml včetně) | parent. | 100.00 | ML | 7.40 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46070 | CHLORID SODNY 0.9% BRAUN | inf sol 1x250ml-pelah | BMR | E |

| --- | --- | --- | --- | --- |

| 46080 | CHLORID SODNY 0.9% BRAUN | inf sol 1x250ml-pelah | BME | CH |

| 57683 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(vak ii) | BFH | E |

| 97682 | CHLORID SODNY 0.9% BRAUN | inf sol 1x250ml-pelah | BMM | D |

| 97749 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(sklo) | BFF | I |

| 97752 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(vak ii) | BFF | I |

| 98872 | FYZIOLOGICKÝ ROZTOK VIAFLO | inf sol 30x250ml | BFH | E |

| 52.6 | B05BB01 | chlorid sodný 0.9% (nad 250 ml v balení) | parent. | 100.00 | ML | 3.77 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03122 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(vak i) | BFH | E |

| --- | --- | --- | --- | --- |

| 03124 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1500ml(vak i) | BFF | I |

| 03126 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak i) | BFH | E |

| 03127 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak i) | BFF | I |

| 31487 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol 1x1000ml-skl | FKI | I |

| 31490 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol 1x1000ml-pp | FKI | I |

| 31500 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol 1x2000ml-vak | FKI | I |

| 31501 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol 4x2000ml-vak | FKI | I |

| 46067 | CHLORID SODNY 0.9% BRAUN | inf sol 1x1000mlpelah | BMR | E |

| 46077 | CHLORID SODNY 0.9% BRAUN | inf sol 1x1000mlpelah | BME | CH |

| 57672 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1500ml(vak ii) | BFH | E |

| 57673 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak ii) | BFH | E |

| 57685 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x500ml(vak ii) | BFH | E |

| 57687 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(vak ii) | BFH | E |

| 69180 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1500ml(vak ii) | BFF | I |

| 69181 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak ii) | BFF | I |

| 75611 | 0.9% SODIUM CHLOR.I.V.BP BAXTER | inf 1x1000ml(vak) | BXF | GB |

| 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x3000ml(vak) | IMA | SK |

| 96885 | CHLORID SODNY 0.9% BRAUN | inf sol 1x1000mlpelah | BMM | D |

| 97753 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x500ml(vak ii) | BFF | I |

| 97754 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(vak ii) | BFF | I |

| 98880 | FYZIOLOGICKÝ ROZTOK VIAFLO | inf sol 10x1000ml | BFH | E |

| 52.7 | B05BB02 | elektrolyty se sacharidy | parent. | 100.00 | ML | 9.04 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 56702 | INFUSIO F 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ |

| --- | --- | --- | --- | --- |

| 56706 | INFUSIO R 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ |

| 62369 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1x500ml(sklo) | IMA | SK |

| 69660 | ARDEAELYTOSOL F 1/2 | inf 1x500ml | ARD | CZ |

| 71732 | INFUSIO NATR.CHL.+GLUC.F 1/2 MVM | inf sol 1x500ml | MVM | CZ |

| 71733 | INFUSIO NATR.CHL.+GLUC.F1/3 MVM | inf sol 1x500ml | MVM | CZ |

| 85566 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1x1000ml(vak) | IMA | SK |

| 92624 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1x2000ml(vak) | IMA | SK |

| 92625 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1x3000ml(vak) | IMA | SK |

| 52.8 | B05BB03 | trometamol | parent. | 100.00 | ML | 23.02 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 52.9 | B05BC01 | mannitol (koncentrace do 10% včetně, do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 19.31 | H |

| 46026 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E |

| --- | --- | --- | --- | --- |

| 74983 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I |

| 80494 | INFUSIO MANNITOLI 100 G/L MVM | inf sol 1x250ml | MVM | CZ |

| 52.10 | B05BC01 | mannitol (koncentrace do 10% včetně, nad 250 ml v jednom balení) | parent. | 100.00 | ML | 12.17 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46027 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E |

| --- | --- | --- | --- | --- |

| 71727 | INFUSIO MANNITOLI 100 G/L MVM | inf sol 1x500ml | MVM | CZ |

| 74984 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I |

| 75517 | INFUSIO MANNITOLI 10 IMUNA | inf 1x500ml(sklo) | IMA | SK |

| 52.11 | B05BC01 | mannitol (koncentrace nad 10%, do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 21.70 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21383 | MANITOL 20% VIAFLO | inf sol 30x250ml | BFH | E |

| --- | --- | --- | --- | --- |

| 31475 | 20% MANNITOL IN WATER FRESENIUS | inf 1x250ml-sklo | FKI | I |

| 31476 | 20% MANNITOL IN WATER FRESENIUS | inf 16x250ml-sklo | FKI | I |

| 59741 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E |

| 59742 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I |

| 80497 | INFUSIO MANNITOLI 200 G/L MVM | inf sol 1x250ml | MVM | CZ |

| 97745 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I |

| 52.12 | B05BC01 | mannitol (koncentrace nad 10%, nad 250 ml v jednom balení) | parent. | 100.00 | ML | 13.78 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31477 | 20% MANNITOL IN WATER FRESENIUS | inf 1x500ml-sklo | FKI | I |

| --- | --- | --- | --- | --- |

| 31478 | 20% MANNITOL IN WATER FRESENIUS | inf 12x500ml-sklo | FKI | I |

| 31479 | 20% MANNITOL IN WATER FRESENIUS | inf 1x1000ml-sklo | FKI | I |

| 31480 | 20% MANNITOL IN WATER FRESENIUS | inf 6x1000ml-sklo | FKI | I |

| 46025 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E |

| 59743 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x1000ml (vak) | BFH | E |

| 71728 | INFUSIO MANNITOLI 200 G/L MVM | inf sol 1x500ml | MVM | CZ |

| 97746 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I |

| 97747 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I |

| 52.13 | B05BC02 | karbamid | parent. | 90.00 | GM | 1 133.11 | H |

| 97748 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×100ml(sklo) | BFF | I |

| 97751 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×100ml(vak ii) | BFF | I |

| 98864 | FYZIOLOGICKÝ ROZTOK VIAFLO | inf sol 50×100ml | BFH | E |

| 52.5 | B05BB01 | chlorid sodný 0.9% (nad 100 ml do 250 ml včetně) | parent. | 100.00 | ML | 7,23 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46070 | CHLORID SODNY 0.9% BRAUN | inf sol 1×250ml-pelah | BMR | E |

| --- | --- | --- | --- | --- |

| 46080 | CHLORID SODNY 0.9% BRAUN | inf sol 1×250ml-pelah | BME | CH |

| 57683 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×250ml(vak ii) | BFH | E |

| 97682 | CHLORID SODNY 0.9% BRAUN | inf sol 1×250ml-pelah | BMM | D |

| 97749 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×250ml(sklo) | BFF | I |

| 97752 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×250ml(vak ii) | BFF | I |

| 98872 | FYZIOLOGICKÝ ROZTOK VIAFLO | inf sol 30×250ml | BFH | E |

| 52.6 | B05BB01 | chlorid sodný 0.9% (nad 250 ml v balení) | parent. | 100.00 | ML | 3,68 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03122 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×1000ml(vak i) | BFH | E |

| --- | --- | --- | --- | --- |

| 03124 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×1500ml(vaki) | BFF | I |

| 03126 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×2000ml(vak i) | BFH | E |

| 03127 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×2000ml(vak i) | BFF | I |

| 31487 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol 1×1000ml-skl | FKI | I |

| 31490 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol 1×1000ml-pp | FKI | I |

| 31500 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol 1×2000ml-vak | FKI | I |

| 31501 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol 4×2000ml-vak | FKI | I |

| 46067 | CHLORID SODNY 0.9% BRAUN | inf sol 1×1000mlpelah | BMR | E |

| 46077 | CHLORID SODNY 0.9% BRAUN | inf sol 1×1000mlpelah | BME | CH |

| 57672 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×1500ml(vak ii) | BFH | E |

| 57673 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×2000ml(vak ii) | BFH | E |

| 57685 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×500ml(vak ii) | BFH | E |

| 57687 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×1000ml(vak ii) | BFH | E |

| 69180 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×1500ml(vak ii) | BFF | I |

| 69181 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×2000ml(vak ii) | BFF | I |

| 75611 | 0.9% SODIUM CHLOR.I.V.BP BAXTER | inf 1×1000ml(vak) | BXF | GB |

| 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1×3000ml(vak) | IMA | SK |

| 96885 | CHLORID SODNY 0.9% BRAUN | inf sol 1×1000mlpelah | BMM | D |

| 97753 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×500ml(vak ii) | BFF | I |

| 97754 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1×1000ml(vak ii) | BFF | I |

| 98880 | FYZIOLOGICKÝ ROZTOK VIAFLO | inf sol 10×1000ml | BFH | E |

| 52.7 | B05BB02 | elektrolyty se sacharidy | parent. | 100.00 | ML | 8,83 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 56702 | INFUSIO F 1/2 INFUSIA | inf 1×500ml(sklo) | IHO | CZ |

| --- | --- | --- | --- | --- |

| 56706 | INFUSIO R 1/2 INFUSIA | inf 1×500ml(sklo) | IHO | CZ |

| 62369 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1×500ml(sklo) | IMA | SK |

| 69660 | ARDEAELYTOSOL F 1/2 | inf 1×500ml | ARD | CZ |

| 71732 | INFUSIO NATR.CHL.+GLUC.F1/2 MVM | inf sol 1×500ml | MVM | CZ |

| 71733 | INFUSIO NATR.CHL.+GLUC.F1/3 MVM | inf sol 1×500ml | MVM | CZ |

| 85566 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1×1000ml(vak) | IMA | SK |

| 92624 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1×2000ml(vak) | IMA | SK |

| 92625 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1×3000ml(vak) | IMA | SK |

| 52.8 | B05BB03 | trometamol | parent. | 100.00 | ML | 22,50 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 52.9 | B05BC01 | mannitol (koncentrace do 10% včetně, do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 18,87 | H |

| --- | --- | --- | --- |

| 52.10 | B05BC01 | mannitol (koncentrace do 10% včetně, nad 250 ml v jednom balení) | parent. | 100.00 | ML | 11,89 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46027 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1×500ml(vak) | BFH | E |

| --- | --- | --- | --- | --- |

| 71727 | INFUSIO MANNITOLI 100 G/L MVM | inf sol 1×500ml | MVM | CZ |

| 74984 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1×500ml(vak) | BFF | I |

| 75517 | INFUSIO MANNITOLI 10 IMUNA | inf 1×500ml(sklo) | IMA | SK |

| 52.11 | B05BC01 | mannitol (koncentrace nad 10%, do 250 ml v jednom balení včetně) | parent. | 100.00 | ML | 21,21 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21383 | MANITOL 20% VIAFLO | inf sol 30×250ml | BFH | E |

| --- | --- | --- | --- | --- |

| 31475 | 20% MANNITOL IN WATER FRESENIUS | inf 1×250ml-sklo | FKI | I |

| 31476 | 20% MANNITOL IN WATER FRESENIUS | inf 16×250ml-sklo | FKI | I |

| 59741 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1×250ml(vak) | BFH | E |

| 59742 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1×250ml(vak) | BFF | I |

| 80497 | INFUSIO MANNITOLI 200 G/L MVM | inf sol 1×250ml | MVM | CZ |

| 97745 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1×250ml(sklo) | BFF | I |

| 52.12 | B05BC01 | mannitol (koncentrace nad 10%, nad 250 ml v jednom balení) | parent. | 100.00 | ML | 13,47 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 31477 | 20% MANNITOL IN WATER FRESENIUS | inf 1×500ml-sklo | FKI | I |

| --- | --- | --- | --- | --- |

| 31478 | 20% MANNITOL IN WATER FRESENIUS | inf 12×500ml-sklo | FKI | I |

| 31479 | 20% MANNITOL IN WATER FRESENIUS | inf 1×1000ml-sklo | FKI | I |

| 31480 | 20% MANNITOL IN WATER FRESENIUS | inf 6×1000ml-sklo | FKI | I |

| 46025 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1×500ml(vak) | BFH | E |

| 59743 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1×1000ml(vak) | BFH | E |

| 71728 | INFUSIO MANNITOLI 200 G/L MVM | inf sol 1×500ml | MVM | CZ |

| 97746 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1×500ml(sklo) | BFF | I |

| 97747 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1×500ml(vak) | BFF | I |

| 52.13 | B05BC02 | karbamid | parent. | 90.00 | GM | 1 107,39 | H |

| | | | | | | | |

| 53 | ostatní intravenozní roztoky k peritoneální dialýze a k hemodialýze | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 53.1 | B05CB01 | chlorid sodný | lok. | 1 000.00 | ML | 37.29 | H |

| | | | | | | | |

| 53.2 | B05CX02 | sorbitol | lok. | 1 000.00 | ML | 37.29 | H |

| | | | | | | | |

| 53.3 | B05CX03 | glycin | lok. | 1 000.00 | ML | 54.04 | H |

| | | | | | | | |

| 53.4 | B05CX10 | kombinované roztoky k irigaci | lok. | 1 000.00 | ML | 54.04 | H |

| | | | | | | | |

| 53.5 | B05DA | přípravky pro peritoneální dialýzu isotonické | parent. | 1 000.00 | ML | 138.04 | H |

| | | | | | | | |

| 53.6 | B05DB | přípravky pro peritoneální dialýzu hypertonické | parent. | 1 000.00 | ML | 138.04 | H |

| 01184 | GAMBROSOL TRIO 10 | sol 4x2500ml(sy10) | BJS | I |

| --- | --- | --- | --- | --- |

| 01186 | GAMBROSOL TRIO 10 | sol 2x5000ml(sy10) | BJS | I |

| 01215 | GAMBROSOL TRIO 40 | sol 4x2500ml(sy10) | BJS | I |

| 01218 | GAMBROSOL TRIO 40 | sol 2x5000ml(sy10) | BJS | I |

| 14856 | BALANCE 4.25%GLU.,1.75MMOL/L CA | dlp prn sol 4x2500mlst | FMC | D |

| 14858 | BALANCE 4.25%GLU.,1.75MMOL/L CA | dlp prn sol 4x3000mlsl | FMC | D |

| 14861 | BALANCE 2.3%GL.,1.75MMOL/L CA | dlp prn sol 4x2500mlst | FMC | D |

| 14863 | BALANCE 2.3%GL.,1.75MMOL/L CA | dlp prn sol 4x3000mlsl | FMC | D |

| 14866 | BALANCE 1.5%GL.,1.75MMOL/L CA | dlp prn sol 4x2500mlst | FMC | D |

| 14868 | BALANCE 1.5%GL.,1.75MMOL/L CA | dlp prn sol 4x3000mlsl | FMC | D |

| 15037 | BALANCE 1.5%GL.,1.25MMOL/L CA | sol 4x3000ml(sleep) | FMC | D |

| 15042 | BALANCE 4.25%GL.,1.25MMOL/L CA | sol 4x3000ml(sleep) | FMC | D |

| 15047 | BALANCE 2.3%GL.,1.25MMOL/L CA | sol 4x3000ml(sleep) | FMC | D |

| 15256 | CAPD/DPCA 18 | sol 4x2000ml-stay | FMC | D |

| 15257 | CAPD/DPCA 18 | sol 4x2500ml-stay | FMC | D |

| 15259 | CAPD/DPCA 18 | sol 2x5000ml-sleep | FMC | D |

| 15261 | CAPD/DPCA 19 | sol 4x2000ml-stay | FMC | D |

| 15262 | CAPD/DPCA 19 | sol 4x2500ml-stay | FMC | D |

| 15264 | CAPD/DPCA 19 | sol 2x5000ml-sleep | FMC | D |

| 15266 | CAPD/DPCA 17 | sol 4x2000ml-stay | FMC | D |

| 15267 | CAPD/DPCA 17 | sol 4x2500ml-stay | FMC | D |

| 15269 | CAPD/DPCA 17 | sol 2x5000ml-sleep | FMC | D |

| 19229 | DIANEAL PD1 GL.1.36%/13.6MG/ML | dlp prn sol 5x2000ml-1 | B×I | IRL |

| 19231 | DIANEAL PD1 GL.2.27%/22.7MG/ML | dlp prn sol 5x2000ml-1 | B×I | IRL |

| 19236 | DIANEAL PD1 GL.1.36%/13.6MG/ML | dlp prn sol 4x2500ml-2 | B×I | IRL |

| 19238 | DIANEAL PD1 GL.2.27%/22.7MG/ML | dlp prn sol 4x2500ml-2 | B×I | IRL |

| 19240 | DIANEAL PD1 GL.3.86%/38.6MG/ML | dlp prn sol 4x2500ml-2 | B×I | IRL |

| 19247 | DIANEAL PD1 GL.1.36%/13.6MG/ML | dlp prn sol 2x5000ml-1 | B×I | IRL |

| 19249 | DIANEAL PD1 GL.2.27%/22.7MG/ML | dlp prn sol 2x5000ml-1 | B×I | IRL |

| 19251 | DIANEAL PD1 GL.3.86%/38.6MG/ML | dlp prn sol 2x5000ml-1 | B×I | IRL |

| 19271 | DIANEAL PD4 GL.1.36%/13.6MG/ML | dlp prn sol 5x2000ml-1 | B×I | IRL |

| 19273 | DIANEAL PD4 GL.2.27%/22.7MG/ML | dlp prn sol 5x2000ml-1 | B×I | IRL |

| 19278 | DIANEAL PD4 GL.1.36%/13.6MG/ML | dlp prn sol 4x2500ml-2 | B×I | IRL |

| 19280 | DIANEAL PD4 GL.2.27%/22.7MG/ML | dlp prn sol 4x2500ml-2 | B×I | IRL |

| 19282 | DIANEAL PD4 GL.3.86%/38.6MG/ML | dlp prn sol 4x2500ml-2 | B×I | IRL |

| 19289 | DIANEAL PD4 GL.1.36%/13.6MG/ML | dlp prn sol 2x5000ml-1 | B×I | IRL |

| 19291 | DIANEAL PD4 GL.2.27%/22.7MG/ML | dlp prn sol 2x5000ml-1 | B×I | IRL |

| 19293 | DIANEAL PD4 GL.3.86%/38.6MG/ML | dlp prn sol 2x5000ml-1 | B×I | IRL |

| 21574 | CAPD/DPCA 2 | sol 6x1500ml-stay | FMC | D |

| 21577 | CAPD/DPCA 3 | sol 6x1500ml-stay | FMC | D |

| 21582 | CAPD/DPCA 4 | sol 6x1500ml-stay | FMC | D |

| 30828 | CAPD/DPCA 2 BALANCE | sol 4x2500ml-stay | FMC | D |

| 30848 | CAPD/DPCA 3 BALANCE | sol 4x2500ml-stay | FMC | D |

| 30852 | CAPD/DPCA 4 BALANCE | sol 4x2500ml-stay | FMC | D |

| 31627 | PHYSIONEAL 40 GLUCOSE 2.27% | dlp prn sol 4x2.5lt1kl | B×I | IRL |

| 31675 | PHYSIONEAL 40 GLUCOSE 3.86% | dlp prn sol 4x2.5lt1kl | B×I | IRL |

| 31724 | PHYSIONEAL 40 GLUCOSE 1.36% | dlp prn sol 4x2.5lt1kl | B×I | IRL |

| 45632 | GAMBROSOL 10 H | sol 6x1500ml(sy10) | BJS | I |

| 45638 | GAMBROSOL 10 H | sol 4x2500ml(sy10) | BJS | I |

| 45640 | GAMBROSOL 10 H | sol 2x4500ml(sy10) | BJS | I |

| 45645 | GAMBROSOL 10 H | sol 4x2500ml(ge10) | BJS | I |

| 45668 | GAMBROSOL 10 M | sol 6x1500ml(sy10) | BJS | I |

| 45672 | GAMBROSOL 10 M | sol 4x2500ml(sy10) | BJS | I |

| 45674 | GAMBROSOL 10 M | sol 2x4500ml(sy10) | BJS | I |

| 45677 | GAMBROSOL 10 M | sol 4x2500ml(ge10) | BJS | I |

| 45700 | GAMBROSOL 10 L | sol 6x1500ml(sy10) | BJS | I |

| 45704 | GAMBROSOL 10 L | sol 4x2500ml(sy10) | BJS | I |

| 45706 | GAMBROSOL 10 L | sol 2x4500ml(sy10) | BJS | I |

| 45711 | GAMBROSOL 10 L | sol 4x2500ml(ge10) | BJS | I |

| 46906 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x2000ml(vak) | B×I | IRL |

| 46907 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x2500ml(vak) | B×I | IRL |

| 46909 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x5000ml(vak) | B×I | IRL |

| 46914 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x2000ml(vak) | B×I | IRL |

| 46916 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x2500ml(vak) | B×I | IRL |

| 46918 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x5000ml(vak) | B×I | IRL |

| 46924 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x2000ml(vak) | B×I | IRL |

| 46925 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x2500ml(vak) | B×I | IRL |

| 46927 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x5000ml(vak) | B×I | IRL |

| 47900 | CAPD/DPCA 19 BALANCE | sol 4x3000ml-sleep | FMC | D |

| 47908 | CAPD/DPCA 18 BALANCE | sol 4x3000ml-sleep | FMC | D |

| 47941 | CAPD/DPCA 17 BALANCE | sol 4x3000ml-sleep | FMC | D |

| 59059 | NUTRINEAL PD4WITH 1.1%AMINOAC. | dlp prn sol 4x2500ml | B×I | IRL |

| 65936 | GAMBROSOL 10 M | sol 3x3000ml(ge10) | BJS | I |

| 65937 | GAMBROSOL 10 M | sol 5x2000ml(ge10) | BJS | I |

| 65946 | GAMBROSOL 10 M | sol 3x3000ml(sy10) | BJS | I |

| 65949 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | BJS | I |

| 65950 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | BJS | I |

| 65956 | GAMBROSOL 10 L | sol 3x3000ml(sy10) | BJS | I |

| 65959 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | BJS | I |

| 65962 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | BJS | I |

| 65963 | GAMBROSOL 10 L | sol 5x2000ml(ge10) | BJS | I |

| 65967 | GAMBROSOL 10 L | sol 3x3000ml(ge10) | BJS | I |

| 68321 | GAMBROSOL 10 H | sol 3x3000ml(sy10) | BJS | I |

| 68460 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | BJS | I |

| 68515 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | BJS | I |

| 69304 | GAMBROSOL 10 H | sol 5x2000ml(ge10) | BJS | I |

| 69318 | GAMBROSOL 10 H | sol 3x3000ml(ge10) | BJS | I |

| 76613 | DIANEAL PD4 GL.1.36%/13.6MG/ML | sol 1x2000ml(vak) | B×I | IRL |

| 76614 | DIANEAL PD4 GL.1.36%/13.6MG/ML | sol 1x2500ml(vak) | B×I | IRL |

| 76616 | DIANEAL PD4 GL.1.36%/13.6MG/ML | sol 1x5000ml(vak) | B×I | IRL |

| 76622 | DIANEAL PD4 GL.2.27%/22.7MG/ML | sol 1x2000ml(vak) | B×I | IRL |

| 76623 | DIANEAL PD4 GL.2.27%/22.7MG/ML | sol 1x2500ml(vak) | B×I | IRL |

| 76625 | DIANEAL PD4 GL.2.27%/22.7MG/ML | sol 1x5000ml(vak) | B×I | IRL |

| 76631 | DIANEAL PD4 GL.3.86%/38.6MG/ML | sol 1x2000ml(vak) | B×I | IRL |

| 76632 | DIANEAL PD4 GL.3.86%/38.6MG/ML | sol 1x2500ml(vak) | B×I | IRL |

| 76634 | DIANEAL PD4 GL.3.86%/38.6MG/ML | sol 1x5000ml(vak) | B×I | IRL |

| 81204 | CAPD/DPCA 2 BALANCE | sol 4x3000ml-sleep | FMC | D |

| 81337 | CAPD/DPCA 4 BALANCE | sol 4x3000ml-sleep | FMC | D |

| 95424 | CAPD/DPCA 2 | sol 4x2000ml-stay | FMC | D |

| 95425 | CAPD/DPCA 2 | sol 4x2500ml-stay | FMC | D |

| 95427 | CAPD/DPCA 2 | sol 2x5000ml-sleep | FMC | D |

| 95432 | CAPD/DPCA 3 | sol 2x5000ml-stand | FMC | D |

| 95433 | CAPD/DPCA 3 | sol 4x2000ml-stand | FMC | D |

| 95435 | CAPD/DPCA 3 | sol 6x1500ml-stand | FMC | D |

| 95442 | CAPD/DPCA 3 | sol 4x2000ml-andy | FMC | D |

| 95443 | CAPD/DPCA 3 | sol 4x2500ml-andy | FMC | D |

| 95489 | CAPD/DPCA 3 | sol 4x2000ml-stay | FMC | D |

| 95490 | CAPD/DPCA 3 | sol 4x2500ml-stay | FMC | D |

| 95492 | CAPD/DPCA 3 | sol 2x5000ml-sleep | FMC | D |

| 95497 | CAPD/DPCA 4 | sol 2x5000ml-stand | FMC | D |

| 95498 | CAPD/DPCA 4 | sol 4x2000ml-stand | FMC | D |

| 95499 | CAPD/DPCA 4 | sol 6x1500ml-stand | FMC | D |

| 95506 | CAPD/DPCA 4 | sol 4x2000ml-andy | FMC | D |

| 95507 | CAPD/DPCA 4 | sol 4x2500ml-andy | FMC | D |

| 95514 | CAPD/DPCA 4 | sol 4x2000ml-stay | FMC | D |

| 95515 | CAPD/DPCA 4 | sol 4x2500ml-stay | FMC | D |

| 95517 | CAPD/DPCA 4 | sol 2x5000ml-sleep | FMC | D |

| 96072 | CAPD/DPCA 3 BALANCE | sol 4x3000ml-sleep | FMC | D |

| 97356 | CAPD/DPCA 2 | sol 2x5000ml-stand | FMC | D |

| 97357 | CAPD/DPCA 2 | sol 4x2000ml-stand | FMC | D |

| 97359 | CAPD/DPCA 2 | sol 6x1500ml-stand | FMC | D |

| 97366 | CAPD/DPCA 2 | sol 4x2000ml-andy | FMC | D |

| 97367 | CAPD/DPCA 2 | sol 4x2500ml-andy | FMC | D |

| 53.1 | B05CB01 | chlorid sodný | lok. | 1 000.00 | ML | 36,44 | H |

| | | | | | | | |

| 53.2 | B05CX02 | sorbitol | lok. | 1 000.00 | ML | 36,44 | H |

| | | | | | | | |

| 53.3 | B05CX03 | glycin | lok. | 1 000.00 | ML | 52,81 | H |

| | | | | | | | |

| 53.4 | B05CX10 | kombinované roztoky k irigaci | lok. | 1 000.00 | ML | 52,81 | H |

| | | | | | | | |

| 53.5 | B05DA | přípravky pro peritoneální dialýzu isotonické | parent. | 1 000.00 | ML | 134,91 | H |

| | | | | | | | |

| 53.6 | B05DB | přípravky pro peritoneální dialýzu hypertonické | parent. | 1 000.00 | ML | 134,91 | H |

| 01184 | GAMBROSOL TRIO 10 | sol 4×2500ml(sy10) | BJS | I |

| --- | --- | --- | --- | --- |

| 01186 | GAMBROSOL TRIO 10 | sol 2×5000ml(sy10) | BJS | I |

| 01215 | GAMBROSOL TRIO 40 | sol 4×2500ml(sy10) | BJS | I |

| 01218 | GAMBROSOL TRIO 40 | sol 2×5000ml(sy10) | BJS | I |

| 14856 | BALANCE 4.25%GLU.,1.75MMOL/L CA | dlp prn sol 4×2500mlst | FMC | D |

| 14858 | BALANCE 4.25%GLU.,1.75MMOL/L CA | dlp prn sol 4×3000mlsl | FMC | D |

| 14861 | BALANCE 2.3%GL.,1.75MMOL/L CA | dlp prn sol 4×2500mlst | FMC | D |

| 14863 | BALANCE 2.3%GL.,1.75MMOL/L CA | dlp prn sol 4×3000mlsl | FMC | D |

| 14866 | BALANCE 1.5%GL.,1.75MMOL/L CA | dlp prn sol 4×2500mlst | FMC | D |

| 14868 | BALANCE 1.5%GL.,1.75MMOL/L CA | dlp prn sol 4×3000mlsl | FMC | D |

| 15037 | BALANCE 1.5%GL.,1.25MMOL/L CA | sol 4×3000ml(sleep) | FMC | D |

| 15042 | BALANCE 4.25%GL.,1.25MMOL/L CA | sol 4×3000ml(sleep) | FMC | D |

| 15047 | BALANCE 2.3%GL.,1.25MMOL/L CA | sol 4×3000ml(sleep) | FMC | D |

| 15256 | CAPD/DPCA 18 | sol 4×2000ml-stay | FMC | D |

| 15257 | CAPD/DPCA 18 | sol 4×2500ml-stay | FMC | D |

| 15259 | CAPD/DPCA 18 | sol 2×5000ml-sleep | FMC | D |

| 15261 | CAPD/DPCA 19 | sol 4×2000ml-stay | FMC | D |

| 15262 | CAPD/DPCA 19 | sol 4×2500ml-stay | FMC | D |

| 15264 | CAPD/DPCA 19 | sol 2×5000ml-sleep | FMC | D |

| 15266 | CAPD/DPCA 17 | sol 4×2000ml-stay | FMC | D |

| 15267 | CAPD/DPCA 17 | sol 4×2500ml-stay | FMC | D |

| 15269 | CAPD/DPCA 17 | sol 2×5000ml-sleep | FMC | D |

| 19229 | DIANEAL PD1 GL.1.36%/13.6MG/ML | dlp prn sol 5×2000ml-1 | BXI | IRL |

| 19231 | DIANEAL PD1 GL.2.27%/22.7MG/ML | dlp prn sol 5×2000ml-1 | BXI | IRL |

| 19236 | DIANEAL PD1 GL.1.36%/13.6MG/ML | dlp prn sol 4×2500ml-2 | BXI | IRL |

| 19238 | DIANEAL PD1 GL.2.27%/22.7MG/ML | dlp prn sol 4×2500ml-2 | BXI | IRL |

| 19240 | DIANEAL PD1 GL.3.86%/38.6MG/ML | dlp prn sol 4×2500ml-2 | BXI | IRL |

| 19247 | DIANEAL PD1 GL.1.36%/13.6MG/ML | dlp prn sol 2×5000ml-1 | BXI | IRL |

| 19249 | DIANEAL PD1 GL.2.27%/22.7MG/ML | dlp prn sol 2×5000ml-1 | BXI | IRL |

| 19251 | DIANEAL PD1 GL.3.86%/38.6MG/ML | dlp prn sol 2×5000ml-1 | BXI | IRL |

| 19271 | DIANEAL PD4 GL.1.36%/13.6MG/ML | dlp prn sol 5×2000ml-1 | BXI | IRL |

| 19273 | DIANEAL PD4 GL.2.27%/22.7MG/ML | dlp prn sol 5×2000ml-1 | BXI | IRL |

| 19278 | DIANEAL PD4 GL.1.36%/13.6MG/ML | dlp prn sol 4×2500ml-2 | BXI | IRL |

| 19280 | DIANEAL PD4 GL.2.27%/22.7MG/ML | dlp prn sol 4×2500ml-2 | BXI | IRL |

| 19282 | DIANEAL PD4 GL.3.86%/38.6MG/ML | dlp prn sol 4×2500ml-2 | BXI | IRL |

| 19289 | DIANEAL PD4 GL.1.36%/13.6MG/ML | dlp prn sol 2×5000ml-1 | BXI | IRL |

| 19291 | DIANEAL PD4 GL.2.27%/22.7MG/ML | dlp prn sol 2×5000ml-1 | BXI | IRL |

| 19293 | DIANEAL PD4 GL.3.86%/38.6MG/ML | dlp prn sol 2×5000ml-1 | BXI | IRL |

| 21574 | CAPD/DPCA 2 | sol 6×1500ml-stay | FMC | D |

| 21577 | CAPD/DPCA 3 | sol 6×1500ml-stay | FMC | D |

| 21582 | CAPD/DPCA 4 | sol 6×1500ml-stay | FMC | D |

| 30828 | CAPD/DPCA 2 BALANCE | sol 4×2500ml-stay | FMC | D |

| 30848 | CAPD/DPCA 3 BALANCE | sol 4×2500ml-stay | FMC | D |

| 30852 | CAPD/DPCA 4 BALANCE | sol 4×2500ml-stay | FMC | D |

| 31627 | PHYSIONEAL 40 GLUCOSE 2.27% | dlp prn sol 4×2.5lt1kl | BXI | IRL |

| 31675 | PHYSIONEAL 40 GLUCOSE 3.86% | dlp prn sol 4×2.5lt1kl | BXI | IRL |

| 31724 | PHYSIONEAL 40 GLUCOSE 1.36% | dlp prn sol 4×2.5lt1kl | BXI | IRL |

| 45632 | GAMBROSOL 10 H | sol 6×1500ml(sy10) | BJS | I |

| 45638 | GAMBROSOL 10 H | sol 4×2500ml(sy10) | BJS | I |

| 45640 | GAMBROSOL 10 H | sol 2×4500ml(sy10) | BJS | I |

| 45645 | GAMBROSOL 10 H | sol 4×2500ml(ge10) | BJS | I |

| 45668 | GAMBROSOL 10 M | sol 6×1500ml(sy10) | BJS | I |

| 45672 | GAMBROSOL 10 M | sol 4×2500ml(sy10) | BJS | I |

| 45674 | GAMBROSOL 10 M | sol 2×4500ml(sy10) | BJS | I |

| 45677 | GAMBROSOL 10 M | sol 4×2500ml(ge10) | BJS | I |

| 45700 | GAMBROSOL 10 L | sol 6×1500ml(sy10) | BJS | I |

| 45704 | GAMBROSOL 10 L | sol 4×2500ml(sy10) | BJS | I |

| 45706 | GAMBROSOL 10 L | sol 2×4500ml(sy10) | BJS | I |

| 45711 | GAMBROSOL 10 L | sol 4×2500ml(ge10) | BJS | I |

| 46906 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1×2000ml(vak) | BXI | IRL |

| 46907 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1×2500ml(vak) | BXI | IRL |

| 46909 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1×5000ml(vak) | BXI | IRL |

| 46914 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1×2000ml(vak) | BXI | IRL |

| 46916 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1×2500ml(vak) | BXI | IRL |

| 46918 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1×5000ml(vak) | BXI | IRL |

| 46924 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1×2000ml(vak) | BXI | IRL |

| 46925 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1×2500ml(vak) | BXI | IRL |

| 46927 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1×5000ml(vak) | BXI | IRL |

| 47900 | CAPD/DPCA 19 BALANCE | sol 4×3000ml-sleep | FMC | D |

| 47908 | CAPD/DPCA 18 BALANCE | sol 4×3000ml-sleep | FMC | D |

| 47941 | CAPD/DPCA 17 BALANCE | sol 4×3000ml-sleep | FMC | D |

| --- | --- | --- | --- | --- |

| 59059 | NUTRINEAL PD4WITH 1.1%AMINOAC. | dlp prn sol 4×2500ml | BXI | IRL |

| 65936 | GAMBROSOL 10 M | sol 3×3000ml(ge10) | BJS | I |

| 65937 | GAMBROSOL 10 M | sol 5×2000ml(ge10) | BJS | I |

| 65946 | GAMBROSOL 10 M | sol 3×3000ml(sy10) | BJS | I |

| 65949 | GAMBROSOL 10 M | sol 5×2000ml(sy10) | BJS | I |

| 65950 | GAMBROSOL 10 M | sol 2×5000ml(sy10) | BJS | I |

| 65956 | GAMBROSOL 10 L | sol 3×3000ml(sy10) | BJS | I |

| 65959 | GAMBROSOL 10 L | sol 2×5000ml(sy10) | BJS | I |

| 65962 | GAMBROSOL 10 L | sol 5×2000ml(sy10) | BJS | I |

| 65963 | GAMBROSOL 10 L | sol 5×2000ml(ge10) | BJS | I |

| 65967 | GAMBROSOL 10 L | sol 3×3000ml(ge10) | BJS | I |

| 68321 | GAMBROSOL 10 H | sol 3×3000ml(sy10) | BJS | I |

| 68460 | GAMBROSOL 10 H | sol 5×2000ml(sy10) | BJS | I |

| 68515 | GAMBROSOL 10 H | sol 2×5000ml(sy10) | BJS | I |

| 69304 | GAMBROSOL 10 H | sol 5×2000ml(ge10) | BJS | I |

| 69318 | GAMBROSOL 10 H | sol 3×3000ml(ge10) | BJS | I |

| 76613 | DIANEAL PD4 GL.1.36%/13.6MG/ML | sol 1×2000ml(vak) | BXI | IRL |

| 76614 | DIANEAL PD4 GL.1.36%/13.6MG/ML | sol 1×2500ml(vak) | BXI | IRL |

| 76616 | DIANEAL PD4 GL.1.36%/13.6MG/ML | sol 1×5000ml(vak) | BXI | IRL |

| 76622 | DIANEAL PD4 GL.2.27%/22.7MG/ML | sol 1×2000ml(vak) | BXI | IRL |

| 76623 | DIANEAL PD4 GL.2.27%/22.7MG/ML | sol 1×2500ml(vak) | BXI | IRL |

| 76625 | DIANEAL PD4 GL.2.27%/22.7MG/ML | sol 1×5000ml(vak) | BXI | IRL |

| 76631 | DIANEAL PD4 GL.3.86%/38.6MG/ML | sol 1×2000ml(vak) | BXI | IRL |

| 76632 | DIANEAL PD4 GL.3.86%/38.6MG/ML | sol 1×2500ml(vak) | BXI | IRL |

| 76634 | DIANEAL PD4 GL.3.86%/38.6MG/ML | sol 1×5000ml(vak) | BXI | IRL |

| 81204 | CAPD/DPCA 2 BALANCE | sol 4×3000ml-sleep | FMC | D |

| 81337 | CAPD/DPCA 4 BALANCE | sol 4×3000ml-sleep | FMC | D |

| 95424 | CAPD/DPCA 2 | sol 4×2000ml-stay | FMC | D |

| 95425 | CAPD/DPCA 2 | sol 4×2500ml-stay | FMC | D |

| 95427 | CAPD/DPCA 2 | sol 2×5000ml-sleep | FMC | D |

| 95432 | CAPD/DPCA 3 | sol 2×5000ml-stand | FMC | D |

| 95433 | CAPD/DPCA 3 | sol 4×2000ml-stand | FMC | D |

| 95435 | CAPD/DPCA 3 | sol 6×1500ml-stand | FMC | D |

| 95442 | CAPD/DPCA 3 | sol 4×2000ml-andy | FMC | D |

| 95443 | CAPD/DPCA 3 | sol 4×2500ml-andy | FMC | D |

| 95489 | CAPD/DPCA 3 | sol 4×2000ml-stay | FMC | D |

| 95490 | CAPD/DPCA 3 | sol 4×2500ml-stay | FMC | D |

| 95492 | CAPD/DPCA 3 | sol 2×5000ml-sleep | FMC | D |

| 95497 | CAPD/DPCA 4 | sol 2×5000ml-stand | FMC | D |

| 95498 | CAPD/DPCA 4 | sol 4×2000ml-stand | FMC | D |

| 95499 | CAPD/DPCA 4 | sol 6×1500ml-stand | FMC | D |

| 95506 | CAPD/DPCA 4 | sol 4×2000ml-andy | FMC | D |

| 95507 | CAPD/DPCA 4 | sol 4×2500ml-andy | FMC | D |

| 95514 | CAPD/DPCA 4 | sol 4×2000ml-stay | FMC | D |

| 95515 | CAPD/DPCA 4 | sol 4×2500ml-stay | FMC | D |

| 95517 | CAPD/DPCA 4 | sol 2×5000ml-sleep | FMC | D |

| 96072 | CAPD/DPCA 3 BALANCE | sol 4×3000ml-sleep | FMC | D |

| 97356 | CAPD/DPCA 2 | sol 2×5000ml-stand | FMC | D |

| 97357 | CAPD/DPCA 2 | sol 4×2000ml-stand | FMC | D |

| 97359 | CAPD/DPCA 2 | sol 6×1500ml-stand | FMC | D |

| 97366 | CAPD/DPCA 2 | sol 4×2000ml-andy | FMC | D |

| 97367 | CAPD/DPCA 2 | sol 4×2500ml-andy | FMC | D |

| 54 | aditiva k intravenozním roztokům | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 54.1 | B05XA01 | chlorid draselný (koncentrace 7,45%) | parent. | 100.00 | ML | 17.40 | H |

| | | | | | | | |

| 54.2 | B05XA02 | hydrogenuhličitan sodný (do 20 ml v jedné ampuli včetně) | parent. | 100.00 | ML | 124.74 | O |

| | | | | | | | |

| 54.3 | B05XA02 | hydrogenuhličitan sodný (nad 20 ml v jedné ampuli) | parent. | 100.00 | ML | 10.65 | O |

| | | | | | | | |

| 54.4 | B05XA03 | chlorid sodný (koncentrace do 5,85% včetně) | parent | 100.00 | ML | 20.30 | H |

| 44171 | CHLORID SODNÝ 5.85% BRAUN | inf 1x100ml | BME | D |

| --- | --- | --- | --- | --- |

| 54.5 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100.00 | ML | 18.55 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 54.6 | B05XA04 | chlorid amonný | parent. | 100.00 | ML | 11.68 | H |

| | | | | | | | |

| 54.7 | B05XA06 | fosforečnan draselný, vč. kombinací | parent. | 100.00 | ML | 52.35 | H |

| | | | | | | | |

| 54.8 | B05XA30 | kombinace elektrolytů (stopové prvky) | parent. | 10.00 | ML | 12.46 | H |

| 54.1 | B05XA01 | chlorid draselný (koncentrace 7,45%) | parent. | 100.00 | ML | 17,01 | H |

| | | | | | | | |

| 54.2 | B05XA02 | hydrogenuhličitan sodný (do 20 ml v jedné ampuli včetně) | parent. | 100.00 | ML | 121,91 | O |

| | | | | | | | |

| 54.3 | B05XA02 | hydrogenuhličitan sodný (nad 20 ml v jedné ampuli) | parent. | 100.00 | ML | 10,41 | O |

| | | | | | | | |

| 54.4 | B05XA03 | chlorid sodný (koncentrace do 5,85% včetně) | parent | 100.00 | ML | 19,84 | H |

| 44171 | CHLORID SODNY 5.85% BRAUN | inf 1×100ml | BME | D |

| --- | --- | --- | --- | --- |

| 54.5 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100.00 | ML | 18,13 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 54.6 | B05XA04 | chlorid amonný | parent. | 100.00 | ML | 11,41 | H |

| | | | | | | | |

| 54.7 | B05XA06 | fosforečnan draselný, vč. kombinací | parent. | 100.00 | ML | 51,16 | H |

| | | | | | | | |

| 54.8 | B05XA30 | kombinace elektrolytů (stopové prvky) | parent. | 10.00 | ML | 12,18 | H |

| 10285 | UNIEL INFUSIA | inf sol 100ml | IHO | CZ | B05XA30 |

| --- | --- | --- | --- | --- | --- |

| 10286 | UNIEL INFUSIA | inf sol 250ml | IHO | CZ | B05XA30 |

| 54.9 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100.00 | ML | 33.26 | H |

| | | | | | | | |

| 54.10 | B05XB01 | chlorid argininu (koncentrace 21%) | parent. | 100.00 | ML | 233.08 | H |

| | | | | | | | |

| 54.11 | B05XB02 | alanylglutamin | parent. | 1.00 | ML | 4.39 | H |

| | | | | | | | |

| 54.12 | B05XC | vitamíny | parent. | 1.00 | DF | 43.99 | H |

| | | | | | | | |

| 54.13 | B05XX | ostatní i.v. roztoky | parent. | 100.00 | ML | 7.63 | H |

| 54.9 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100.00 | ML | 32,50 | H |

| | | | | | | | |

| 54.10 | B05XB01 | chlorid argininu (koncentrace 21%) | parent. | 100.00 | ML | 227,79 | H |

| | | | | | | | |

| 54.11 | B05XB02 | alanylglutamin | parent. | 1.00 | ML | 4,29 | H |

| | | | | | | | |

| 54.12 | B05XC | vitamíny | parent. | 1.00 | DF | 42,99 | H |

| | | | | | | | |

| 54.13 | B05XX | ostatní i.v. roztoky | parent. | 100.00 | ML | 7,46 | H |

| | | | | | | | |

| 55 | ostatní léčiva používaná u nemocí krvetvorného systému | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 55.1 | B05Z | hemodialytika a hemofiltráty | lok. | 1 000.00 | ML | 94.50 | H |

| | | | | | | | |

| 55.2 | B05ZA | hemodialytika, koncentráty | lok. | 1 000.00 | ML | 125.72 | H |

| | | | | | | | |

| 55.3 | B05ZB | hemofiltráty | lok. | 1 000.00 | ML | 94.50 | H |

| 89174 | SOLUTION FOR HAEMOFILTRATION E2 | sol 1x5000ml | BFF | I | B05ZB |

| 55.1 | B05Z | hemodialytika a hemofiltráty | lok. | 1 000.00 | ML | 92,35 | H |

| | | | | | | | |

| 55.2 | B05ZA | hemodialytika, koncentráty | lok. | 1 000.00 | ML | 122,87 | H |

| | | | | | | | |

| 55.3 | B05ZB | hemofiltráty | lok. | 1 000.00 | ML | 92,35 | H |

| 89174 | SOLUTION FOR HAEMOFILTRATION E2 | sol 1×5000ml | BFF | I | B05ZB |

| --- | --- | --- | --- | --- | --- |

| 56 | srdeční glykosidy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 56.1 | C01AA02 | acetyldigoxin | p.o. | 0.50 | MG | 1.03 | |

| | | | | | | | |

| 56.2 | C01AA04 | digitoxin | p.o. | 0.10 | MG | 1.03 | |

| | | | | | | | |

| 56.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1.27 | |

| 03542 | DIGOXIN 0.250 LÉČIVA | tbl 30x0.25mg | ZEH | CZ | C01AA05 |

| 56.1 | C01AA02 | acetyldigoxin | p.o. | 0.50 | MG | 1,01 | |

| | | | | | | | |

| 56.2 | C01AA04 | digitoxin | p.o. | 0.10 | MG | 1,01 | |

| | | | | | | | |

| 56.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1,24 | |

| 03542 | DIGOXIN 0.250 LÉČIVA | tbl 30×0.25mg | ZEH | CZ | C01AA05 |

| --- | --- | --- | --- | --- | --- |

| 18000 | DIGOXIN-GALENA | porgttsol 1x10ml/5mg | IVX | CZ | C01AA05 |

| 56.4 | C01AA05 | digoxin | parent. | 0.25 | MG | 7.32 | |

| | | | | | | | |

| 56.5 | C01AA08 | metildigoxin | p.o. | 0.20 | MG | 1.03 | |

| | | | | | | | |

| 56.6 | C01AA08 | metildigoxin | parent. | 0.20 | MG | 6.99 | |

| | | | | | | | |

| 56.7 | C01AC01 | g-strofantin | parent. | 0.25 | MG | 23.46 | |

| 18000 | DIGOXIN-GALENA | por gtt sol 1×10ml/5mg | IVX | CZ | C01AA05 |

| 56.4 | C01AA05 | digoxin | parent. | 0.25 | MG | 7,15 | |

| | | | | | | | |

| 56.5 | C01AA08 | metildigoxin | p.o. | 0.20 | MG | 1,01 | |

| | | | | | | | |

| 56.6 | C01AA08 | metildigoxin | parent. | 0.20 | MG | 6,83 | |

| | | | | | | | |

| 56.7 | C01AC01 | g-strofantin | parent. | 0.25 | MG | 22,93 | |

| | | | | | | | |

| 57 | antiarytmika třída I a III, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 57.1 | C01BA | detajmii bitartras | p.o. | 75.00 | MG | 13.64 | |

| | | | | | | | |

| 57.2 | C01BA01 | chinidin (neretardované lékové formy) | p.o. | 1.20 | GM | 10.80 | |

| | | | | | | | |

| 57.3 | C01BA01 | chinidin (retardované lékové formy) | p.o. | 1.20 | GM | 17.40 | |

| | | | | | | | |

| 57.4 | C01BA02 | prokainamid | p.o. | 3.00 | GM | 38.61 | |

| | | | | | | | |

| 57.5 | C01BA03 | disopyramid | p.o. | 0.40 | GM | 12.37 | |

| | | | | | | | |

| 57.6 | C01BA08 | prajmalin | p.o. | 30.00 | MG | 10.80 | |

| | | | | | | | |

| 57.7 | C01BB02 | mexiletin | p.o. | 0.80 | GM | 9.41 | |

| | | | | | | | |

| 57.8 | C01BB03 | tocainid | p.o. | 1.20 | GM | 10.22 | |

| | | | | | | | |

| 57.9 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.30 | GM | 17.16 | |

| | | | | | | | |

| 57.10 | C01BC03 | propafenon (nad 150 mg v jedné tabletě) | p.o. | 0.30 | GM | 5.40 | |

| | | | | | | | |

| 57.11 | C01BC03 | propafenon (od 100 mg do 150 mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 6.40 | |

| 53535 | PROPAFENON AL 150 | tbl obd 50x150mg | APA | D | C01BC03 |

| 57.1 | C01BA | detajmii bitartras | p.o. | 75.00 | MG | 13,33 | |

| | | | | | | | |

| 57.2 | C01BA01 | chinidin (neretardované lékové formy) | p.o. | 1.20 | GM | 10,55 | |

| | | | | | | | |

| 57.3 | C01BA01 | chinidin (retardované lékové formy) | p.o. | 1.20 | GM | 17,01 | |

| | | | | | | | |

| 57.4 | C01BA02 | prokainamid | p.o. | 3.00 | GM | 37,73 | |

| | | | | | | | |

| 57.5 | C01BA03 | disopyramid | p.o. | 0.40 | GM | 12,09 | |

| | | | | | | | |

| 57.6 | C01BA08 | prajmalin | p.o. | 30.00 | MG | 10,55 | |

| | | | | | | | |

| 57.7 | C01BB02 | mexiletin | p.o. | 0.80 | GM | 9,20 | |

| | | | | | | | |

| 57.8 | C01BB03 | tocainid | p.o. | 1.20 | GM | 9,99 | |

| | | | | | | | |

| 57.9 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.30 | GM | 16,77 | |

| | | | | | | | |

| 57.10 | C01BC03 | propafenon (nad 150 mg v jedné tabletě) | p.o. | 0.30 | GM | 5,28 | |

| | | | | | | | |

| 57.11 | C01BC03 | propafenon (od 100 mg do 150 mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 6,25 | |

| 53535 | PROPAFENON AL 150 | tbl obd 50×150mg | APA | D | C01BC03 |

| --- | --- | --- | --- | --- | --- |

| 91276 | PROLEKOFEN 150 MG | tbl obd 50x150mg | LEK | SLO | C01BC03 |

| 57.12 | C01BD01 | amiodaron | p.o. | 0.20 | GM | 4.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17850 | AMIOHEXAL 200 | tbl 20x200mg | HPZ | PL | C01BD01 |

| 91276 | PROLEKOFEN 150 MG | tbl obd 50×150mg | LEK | SLO | C01BC03 |

| 57.12 | C01BD01 | amiodaron | p.o. | 0.20 | GM | 3,91 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17850 | AMIOHEXAL 200 | tbl 20×200mg | HPZ | PL | C01BD01 |

| --- | --- | --- | --- | --- | --- |

| 17851 | AMIOHEXAL 200 | tbl 50x200mg | HPZ | PL | C01BD01 |

| 17852 | AMIOHEXAL 200 | tbl 100x200mg | HPZ | PL | C01BD01 |

| 59284 | AMIOHEXAL 200 | tbl 20x200mg | SFS | D | C01BD01 |

| 59285 | AMIOHEXAL 200 | tbl 50x200mg | SFS | D | C01BD01 |

| 59286 | AMIOHEXAL 200 | tbl 100x200mg | SFS | D | C01BD01 |

| 59655 | AMIOKORDIN | por tbl nob 60x200mg | KRK | SLO | C01BD01 |

| 17851 | AMIOHEXAL 200 | tbl 50×200mg | HPZ | PL | C01BD01 |

| 17852 | AMIOHEXAL 200 | tbl 100×200mg | HPZ | PL | C01BD01 |

| 59284 | AMIOHEXAL 200 | tbl 20×200mg | SFS | D | C01BD01 |

| 59285 | AMIOHEXAL 200 | tbl 50×200mg | SFS | D | C01BD01 |

| 59286 | AMIOHEXAL 200 | tbl 100×200mg | SFS | D | C01BD01 |

| 59655 | AMIOKORDIN | por tbl nob 60×200mg | KRK | SLO | C01BD01 |

| 58 | antiarytmika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 58.1 | C01B | ipratropium | parent. | 3.00 | MG | 782.94 | O |

| | | | | | | | |

| 58.2 | C01BA02 | prokainamid | parent. | 3.00 | GM | 251.87 | O |

| | | | | | | | |

| 58.3 | C01BA03 | disopyramid | parent. | 0.40 | GM | 251.87 | O |

| | | | | | | | |

| 58.4 | C01BA05 | ajmalin | parent. | 0.30 | GM | 251.87 | O |

| | | | | | | | |

| 58.5 | C01BB01 | lidokain | parent. | 1.00 | ML | 1.22 | O/INT,KAR, GER |

| | | | | | | | |

| 58.6 | C01BB02 | mexiletin | parent. | 0.80 | GM | 351.64 | O/INT,KAR, GER |

| | | | | | | | |

| 58.7 | C01BB03 | tocainid | parent. | 1.20 | GM | 351.64 | O/INT,KAR, GER |

| | | | | | | | |

| 58.8 | C01BC03 | propafenon | parent. | 0.30 | GM | 174.0 | O/INT,KAR, GER |

| | | | | | | | |

| 58.9 | C01BC07 | lorcainid | parent. | 0.20 | GM | 139.01 | O/INT,KAR, GER |

| | | | | | | | |

| 58.10 | C01BD01 | amiodaron | parent. | 0.20 | GM | 18.58 | O/INT,KAR, GER |

| 58.1 | C01B | ipratropium | parent. | 3.00 | MG | 765,17 | O |

| | | | | | | | |

| 58.2 | C01BA02 | prokainamid | parent. | 3.00 | GM | 246,15 | O |

| | | | | | | | |

| 58.3 | C01BA03 | disopyramid | parent. | 0.40 | GM | 246,15 | O |

| | | | | | | | |

| 58.4 | C01BA05 | ajmalin | parent. | 0.30 | GM | 246,15 | O |

| | | | | | | | |

| 58.5 | C01BB01 | lidokain | parent. | 1.00 | ML | 1,19 | O/INT,KAR,GER |

| | | | | | | | |

| 58.6 | C01BB02 | mexiletin | parent. | 0.80 | GM | 343,66 | O/INT,KAR,GER |

| | | | | | | | |

| 58.7 | C01BB03 | tocainid | parent. | 1.20 | GM | 343,66 | O/INT,KAR,GER |

| | | | | | | | |

| 58.8 | C01BC03 | propafenon | parent. | 0.30 | GM | 170,05 | O/INT,KAR,GER |

| | | | | | | | |

| 58.9 | C01BC07 | lorcainid | parent. | 0.20 | GM | 135,85 | O/INT,KAR,GER |

| | | | | | | | |

| 58.10 | C01BD01 | amiodaron | parent. | 0.20 | GM | 18,16 | O/INT,KAR,GER |

| 96600 | SEDACORON | inj sol 5×3ml/150mg | EBP | A |

| --- | --- | --- | --- | --- |

| 58.11 | C01BD02 | bretylium tosilát | parent. | 100.00 | MG | 139.01 | O/INT,KAR,GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 58.11 | C01BD02 | bretylium tosilát | parent. | 100.00 | MG | 135,85 | O/INT,KAR,GER |

| | | | | | | | |

| 59 | adrenergní a dopaminergní léčiva a jiná kardiaka | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 59.1 | C01CA | ipratropium | p.o. | 30.00 | MG | 53.77 | |

| | | | | | | | |

| 59.2 | C01CA02 | isoprenalin | parent. | 90.00 | MG | 15 620.16 | H |

| | | | | | | | |

| 59.3 | C01CA03 | norepinefrin | parent. | 6.00 | MG | 80.34 | O |

| | | | | | | | |

| 59.4 | C01CA04 | dopamin | parent. | 0.50 | GM | 114.50 | O |

| | | | | | | | |

| 59.5 | C01CA05 | norfenefrin | parent. | 25.00 | MG | 23.76 | H |

| | | | | | | | |

| 59.6 | C01CA07 | dobutamin | parent. | 0.50 | GM | 324.00 | H |

| | | | | | | | |

| 59.7 | C01CA09 | metaraminol | parent. | 50.00 | MG | 191.26 | H |

| | | | | | | | |

| 59.8 | C01CA10 | metoxamin | parent. | 30.00 | MG | 40.91 | H |

| | | | | | | | |

| 59.9 | C01CA11 | mepentermin | parent. | 30.00 | MG | 101.67 | H |

| | | | | | | | |

| 59.10 | C01CA14 | dopexamin | parent. | 500.00 | MG | 109.39 | H |

| | | | | | | | |

| 59.11 | C01CA17 | midodrin | parent. | 7.50 | MG | 83.44 | H |

| | | | | | | | |

| 59.12 | C01CA24 | epinefrin | parent. | 0.50 | MG | 4.75 | O |

| 59.1 | C01CA | ipratropium | p.o. | 30.00 | MG | 52,55 | |

| | | | | | | | |

| 59.2 | C01CA02 | isoprenalin | parent. | 90.00 | MG | 15 265,58 | H |

| | | | | | | | |

| 59.3 | C01CA03 | norepinefrin | parent. | 6.00 | MG | 78,52 | O |

| | | | | | | | |

| 59.4 | C01CA04 | dopamin | parent. | 0.50 | GM | 111,90 | O |

| | | | | | | | |

| 59.5 | C01CA05 | norfenefrin | parent. | 25.00 | MG | 23,22 | H |

| | | | | | | | |

| 59.6 | C01CA07 | dobutamin | parent. | 0.50 | GM | 316,65 | H |

| | | | | | | | |

| 59.7 | C01CA09 | metaraminol | parent. | 50.00 | MG | 186,92 | H |

| | | | | | | | |

| 59.8 | C01CA10 | metoxamin | parent. | 30.00 | MG | 39,98 | H |

| | | | | | | | |

| 59.9 | C01CA11 | mepentermin | parent. | 30.00 | MG | 99,36 | H |

| | | | | | | | |

| 59.10 | C01CA14 | dopexamin | parent. | 500.00 | MG | 106,91 | H |

| | | | | | | | |

| 59.11 | C01CA17 | midodrin | parent. | 7.50 | MG | 81,55 | H |

| | | | | | | | |

| 59.12 | C01CA24 | epinefrin | parent. | 0.50 | MG | 4,64 | O |

| 00362 | ADRENALIN LÉČIVA | inj 5×1ml/1mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 59.13 | C01CA24 | epinefrin (lékové formy autoinjektoru) | parent. | 1.00 | DF | 1 300.00 | P |

| 59.13 | C01CA24 | epinefrin (lékové formy autoinjektoru) | parent. | 1.00 | DF | 1 270,49 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčivý přípravek obsahující epinefrin v lékových formách autoinjektoru předepisuje alergolog, klinický imunolog a pediatr u pacientů s anamnézou anafylaktického šoku vyvolaného alergií na hmyzí bodnutí.

| 59.14 | C01CE01 | amrinon | parent. | 0.50 | GM | 4 059.95 | H |

| | | | | | | | |

| 59.15 | C01CE02 | milrinon | parent. | 50.00 | MG | 3 980.00 | H |

| 59.14 | C01CE01 | amrinon | parent. | 0.50 | GM | 3 967,79 | H |

| | | | | | | | |

| 59.15 | C01CE02 | milrinon | parent. | 50.00 | MG | 3 889,65 | H |

| | | | | | | | |

| 60 | vazodilatační látky pro srdeční onemocnění, perorální podání pro chronickou léčbu | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 60.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5.00 | MG | 2.00 | |

| | | | | | | | |

| 60.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5.00 | MG | 3.00 | |

| 13467 | NITROPELET 2.5 | por cps pro 30x2.5mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 13468 | NITROPELET 2.5 | por cps pro 30x2.5mg | ZEH | SK |

| 60.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5.00 | MG | 2.12 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 60.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60.00 | MG | 3.50 | |

| 47758 | ISOPELET 20 | por cps pro 30x20mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 60.5 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60.00 | MG | 1.25 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 60.6 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60.00 | MG | 2.50 | |

| 47762 | ISOPELET 40 | por cps pro 30x40mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 47765 | ISOPELET 60 | por cps pro 20x60mg | ZEH | SK |

| 60.7 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60.00 | MG | 4.20 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21453 | CARDIKET RETARD 120 | por cps pro 30x120mg | SWP | D |

| --- | --- | --- | --- | --- |

| 91591 | CARDIKET RETARD 120 | cps ret 20x120mg | SWP | D |

| 60.8 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40.00 | MG | 2.44 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 20159 | MONOTAB 20 | por tbl nob 20x20mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 23305 | MONOSAN 20 MG | por tbl nob 100x20mg | PMP | CZ |

| 47686 | ISMIN AL 20 | por tbl nob 60x20mg | APA | D |

| 47687 | ISMIN AL 20 | por tbl nob 100x20mg | APA | D |

| 61467 | ISMN AL 20 | por tbl nob 100x20mg | APA | D |

| 76401 | SORBIMON 20 MG | tbl 50x20mg | MCK | D |

| 76402 | SORBIMON 20 MG | tbl 100x20mg | MCK | D |

| 96187 | MONOSAN 20 MG | por tbl nob 50x20mg | PMP | CZ |

| 60.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40.00 | MG | 1.77 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 20301 | MONOTAB 40 | por tbl nob 20x40mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 21793 | MONOTAB SR | por tbl pro 20x100mg | ZEH | SK |

| 21794 | MONOTAB SR | por tbl pro 50x100mg | ZEH | SK |

| 21795 | MONOTAB SR | por tbl pro 100x100mg | ZEH | SK |

| 23306 | MONOSAN 40 MG | por tbl nob 100x40mg | PMP | CZ |

| 47690 | ISMIN AL 40 | por tbl nob 100x40mg | APA | D |

| 76403 | SORBIMON 40 MG | tbl 20x40mg | MCK | D |

| 76404 | SORBIMON 40 MG | tbl 50x40mg | MCK | D |

| 76405 | SORBIMON 40 MG | tbl 100x40mg | MCK | D |

| 60.10 | C01DX03 | oxifedrin | p.o. | 40.00 | MG | 4.79 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 60.11 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6.00 | MG | 4.25 | |

| 49553 | MOLSIHEXAL 2 MG | tbl 100x2mg | SFS | D |

| --- | --- | --- | --- | --- |

| 60.12 | C01DX12 | molsidomin (nad 2 do 4 mg v jedné tabletě včetně) | p.o. | 6.00 | MG | 2.59 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49554 | MOLSIHEXAL 4 MG | tbl 100x4mg | SFS | D |

| --- | --- | --- | --- | --- |

| 60.13 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6.00 | MG | 1.48 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | SFS | D |

| --- | --- | --- | --- | --- |

| 49560 | MOLSIHEXAL RETARD | tbl ret 30x8mg | SFS | D |

| 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | SFS | D |

| 60.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5.00 | MG | 1,95 | |

| | | | | | | | |

| 60.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5.00 | MG | 2,93 | |

| 13467 | NITROPELET 2.5 | por cps pro 30×2.5mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 13468 | NITROPELET 2.5 | por cps pro 30×2.5mg | ZEH | SK |

| 60.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5.00 | MG | 2,07 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 60.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60.00 | MG | 3,42 | |

| 47758 | ISOPELET 20 | por cps pro 30×20mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 60.5 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60.00 | MG | 1,22 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 60.6 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60.00 | MG | 2,44 | |

| 47762 ISOPELET 40 | por cps pro 30×40mg | ZEH | SK |

| --- | --- | --- | --- |

| 47765 ISOPELET 60 | por cps pro 20×60mg | ZEH | SK |

| 60.7 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60.00 | MG | 4,10 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21453 | CARDIKET RETARD 120 | por cps pro 30×120mg | SWP | D |

| --- | --- | --- | --- | --- |

| 91591 | CARDIKET RETARD 120 | cps ret 20×120mg | SWP | D |

| 60.8 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40.00 | MG | 2,38 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 20159 | MONOTAB 20 | por tbl nob 20×20mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 23305 | MONOSAN 20 MG | por tbl nob 100×20mg | PMP | CZ |

| 47686 | ISMIN AL 20 | por tbl nob 60×20mg | APA | D |

| 47687 | ISMIN AL 20 | por tbl nob 100×20mg | APA | D |

| 61467 | ISMN AL 20 | por tbl nob 100×20mg | APA | D |

| 76401 | SORBIMON 20 MG | tbl 50×20mg | MCK | D |

| 76402 | SORBIMON 20 MG | tbl 100×20mg | MCK | D |

| 96187 | MONOSAN 20 MG | por tbl nob 50×20mg | PMP | CZ |

| 60.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40.00 | MG | 1,73 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 20301 | MONOTAB 40 | por tbl nob 20×40mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 21793 | MONOTAB SR | por tbl pro 20×100mg | ZEH | SK |

| 21794 | MONOTAB SR | por tbl pro 50×100mg | ZEH | SK |

| 21795 | MONOTAB SR | por tbl pro 100×100mg | ZEH | SK |

| 23306 | MONOSAN 40 MG | por tbl nob 100×40mg | PMP | CZ |

| 47690 | ISMIN AL 40 | por tbl nob 100×40mg | APA | D |

| 76403 | SORBIMON 40 MG | tbl 20×40mg | MCK | D |

| 76404 | SORBIMON 40 MG | tbl 50×40mg | MCK | D |

| 76405 | SORBIMON 40 MG | tbl 100×40mg | MCK | D |

| 60.10 | C01DX03 | oxifedrin | p.o. | 40.00 | MG | 4,68 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 60.11 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6.00 | MG | 4,15 | |

| 49553 | MOLSIHEXAL 2 MG | tbl 100×2mg | SFS | D |

| --- | --- | --- | --- | --- |

| 60.12 | C01DX12 | molsidomin (nad 2 do 4 mg v jedné tabletě včetně) | p.o. | 6.00 | MG | 2,53 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49554 | MOLSIHEXAL 4 MG | tbl 100×4mg | SFS | D |

| --- | --- | --- | --- | --- |

| 60.13 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6.00 | MG | 1,45 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49559 | MOLSIHEXAL RETARD | tbl ret 100×8mg | SFS | D |

| --- | --- | --- | --- | --- |

| 49560 | MOLSIHEXAL RETARD | tbl ret 30×8mg | SFS | D |

| 49561 | MOLSIHEXAL RETARD | tbl ret 60×8mg | SFS | D |

| 61 | vazodilatační látky pro srdeční onemocnění, perorální podání pro akutní léčbu | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 61.1 | C01DA02 | glycerol trinitrát | spr. | 5.00 | DF | 2.44 | |

| | | | | | | | |

| 61.2 | C01DA02 | glycerol trinitrát | sublng. | 2.50 | MG | 5.93 | |

| 00231 | NITROGLYCERIN-SLOVAKOFARMA | tbl 20x0.5mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 61.3 | C01DA08 | isosorbid dinitrát | sublng. | 20.00 | MG | 3.03 | |

| | | | | | | | |

| 61.4 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20.00 | MG | 8.80 | |

| 61.1 | C01DA02 | glycerol trinitrát | spr. | 5.00 | DF | 2,38 | |

| | | | | | | | |

| 61.2 | C01DA02 | glycerol trinitrát | sublng. | 2.50 | MG | 5,80 | |

| 00231 | NITROGLYCERIN-SLOVAKOFARMA | tbl 20×0.5mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 61.3 | C01DA08 | isosorbid dinitrát | sublng. | 20.00 | MG | 2,96 | |

| | | | | | | | |

| 61.4 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20.00 | MG | 8,60 | |

| | | | | | | | |

| 62 | prostaglandiny a jiná kardiaka | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 62.1 | C01EA01 | alprostadil | parent. | 0.50 | MG | 2 800.00 | X |

| 44169 | ALPROSTAPINT 500 MCG/ML | inf cnc sol 5x1ml | BGD | D |

| --- | --- | --- | --- | --- |

| 62.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20.00 | RG | 570.85 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 62.3 | C01EB10 | adenosin | parent. | 15.00 | MG | 679.10 | O/INT,KAR,GER |

| | | | | | | | |

| 62.4 | C01EB15 | trimetazidin | p.o. | 40.00 | MG | 5.80 | P |

Léčba trimetazidinem je indikována u nemocných s anginou pectoris, u kterých nevedla monoterapie nebo kombinace β-blokátorů s blokátory kalciového kanálu či s nitráty k uspokojivé kontrole výskytu stenokardií nebo u nemocných, u kterých nelze β-blokátory nebo vazodilatancia použít.

| 62.1 | C01EA01 | alprostadil | parent. | 0.50 | MG | 2 736,44 | X |

| 44169 | ALPROSTAPINT 500 MCG/ML | inf cnc sol 5×1ml | BGD | D |

| --- | --- | --- | --- | --- |

| 62.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20.00 | RG | 557,89 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 62.3 | C01EB10 | adenosin | parent. | 15.00 | MG | 663,68 | O/INT,KAR,GER |

| | | | | | | | |

| 62.4 | C01EB15 | trimetazidin | p.o. | 40.00 | MG | 5,67 | P |

Léčba trimetazidinem je indikována u nemocných s anginou pectoris, u kterých nevedla monoterapie nebo kombinace ᵝ-blokátorů s blokátory kalciového kanálu či s nitráty k uspokojivé kontrole výskytu stenokardií nebo u nemocných, u kterých nelze ᵝ-blokátory nebo vazodilatancia použít.

| 63 | antihypertenziva – antiadrenergní látky a látky působící na hladké svalstvo arteriol, vč. Kombinací s diuretiky, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 63.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1.00 | GM | 5.80 | |

| | | | | | | | |

| 63.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 5.53 | |

| | | | | | | | |

| 63.3 | C02AC02 | guanfacin | p.o. | 3.00 | MG | 5.53 | |

| | | | | | | | |

| 63.4 | C02AC05 | moxonidin do 0,2 mg v 1 tabletě včetně | p.o. | 0.30 | MG | 6.13 | |

| | | | | | | | |

| 63.5 | C02AC05 | moxonidin nad 0,2 mg v 1 tabletě | p.o. | 0.30 | MG | 5.53 | |

| | | | | | | | |

| 63.6 | C02AC06 | rilmenidin | p.o. | 1.00 | MG | 5.53 | |

| | | | | | | | |

| 63.7 | C02CA | metazosin | p.o. | 20.00 | MG | 5.53 | |

| | | | | | | | |

| 63.8 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5.00 | MG | 12.59 | |

| | | | | | | | |

| 63.9 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5.00 | MG | 3.35 | |

| 88173 | DEPRAZOLIN | tbl 30x2mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 63.10 | C02CA06 | urapidil | p.o. | 50.00 | MG | 6.89 | |

| | | | | | | | |

| 63.11 | C02DB01 | dihydralazin | p.o. | 75.00 | MG | 2.00 | |

| | | | | | | | |

| 63.12 | C02DB03 | endralazin | p.o. | 10.00 | MG | 9.43 | |

| | | | | | | | |

| 63.13 | C02DC01 | minoxidil | p.o. | 20.00 | MG | 20.14 | L/INT,KAR, GER |

| | | | | | | | |

| 63.14 | C02LA51 | reserpin a diuretika | p.o. | 1.00 | DF | 1.63 | |

| | | | | | | | |

| 63.15 | C02LB01 | methyldopa/hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3.00 | DF | 4.94 | |

| | | | | | | | |

| 63.16 | C02LB01 | methyldopa/hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2.00 | DF | 3.42 | |

| | | | | | | | |

| 63.17 | C02KX01 | bosentan | p.o. | 250.00 | MG | 3 278.00 | X |

| 63.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1.00 | GM | 5,67 | |

| | | | | | | | |

| 63.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 5,40 | |

| | | | | | | | |

| 63.3 | C02AC02 | guanfacin | p.o. | 3.00 | MG | 5,40 | |

| | | | | | | | |

| 63.4 | C02AC05 | moxonidin do 0,2 mg v 1 tabletě včetně | p.o. | 0.30 | MG | 5,99 | |

| | | | | | | | |

| 63.5 | C02AC05 | moxonidin nad 0,2 mg v 1 tabletě | p.o. | 0.30 | MG | 5,40 | |

| | | | | | | | |

| 63.6 | C02AC06 | rilmenidin | p.o. | 1.00 | MG | 5,40 | |

| | | | | | | | |

| 63.7 | C02CA | metazosin | p.o. | 20.00 | MG | 5,40 | |

| | | | | | | | |

| 63.8 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5.00 | MG | 12,30 | |

| | | | | | | | |

| 63.9 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5.00 | MG | 3,27 | |

| 88173 | DEPRAZOLIN | tbl 30×2mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 63.10 | C02CA06 | urapidil | p.o. | 50.00 | MG | 6,73 | |

| | | | | | | | |

| 63.11 | C02DB01 | dihydralazin | p.o. | 75.00 | MG | 1,95 | |

| | | | | | | | |

| 63.12 | C02DB03 | endralazin | p.o. | 10.00 | MG | 9,22 | |

| | | | | | | | |

| 63.13 | C02DC01 | minoxidil | p.o. | 20.00 | MG | 19,68 | L/INT,KAR,GER |

| | | | | | | | |

| 63.14 | C02LA51 | reserpin a diuretika | p.o. | 1.00 | DF | 1,59 | |

| | | | | | | | |

| 63.15 | C02LB01 | methyldopa/hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3.00 | DF | 4,83 | |

| | | | | | | | |

| 63.16 | C02LB01 | methyldopa/hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2.00 | DF | 3,34 | |

| | | | | | | | |

| 63.17 | C02KX01 | bosentan | p.o. | 250.00 | MG | 3 278,00 | X |

| | | | | | | | |

| 64 | antihypertenziva, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 64.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 70.66 | H |

| | | | | | | | |

| 64.2 | C02CA06 | urapidil | parent. | 50.00 | MG | 217.84 | O |

| 90763 | EBRANTIL I.V. 25 | inj sol 5x5ml/25mg | AKZ | D |

| --- | --- | --- | --- | --- |

| 90765 | EBRANTIL I.V. 50 | inj sol 5x10ml/50mg | AKZ | D |

| 64.3 | C02DA01 | diazoxid | parent. | 300.00 | MG | 214.62 | H |

| | | | | | | | |

| 64.4 | C02DB01 | dihydralazin | parent. | 25.00 | MG | 29.88 | H |

| | | | | | | | |

| 64.5 | C02DD01 | nitroprusid sodný | parent. | 50.00 | MG | 263.31 | H |

| 64.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 69,06 | H |

| | | | | | | | |

| 64.2 | C02CA06 | urapidil | parent. | 50.00 | MG | 212,90 | O |

| 90763 | EBRANTIL I.V. 25 | inj sol 5×5ml/25mg | AKZ | D |

| --- | --- | --- | --- | --- |

| 90765 | EBRANTIL I.V. 50 | inj sol 5×10ml/50mg | AKZ | D |

| 64.3 | C02DA01 | diazoxid | parent. | 300.00 | MG | 209,75 | H |

| | | | | | | | |

| 64.4 | C02DB01 | dihydralazin | parent. | 25.00 | MG | 29,20 | H |

| | | | | | | | |

| 64.5 | C02DD01 | nitroprusid sodný | parent. | 50.00 | MG | 257,33 | H |

| | | | | | | | |

| 65 | diuretika s nižším diuretickým účinkem | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 65.1 | C03AA03 | hydrochlorothiazid | p.o. | 25.00 | MG | 0.94 | |

| | | | | | | | |

| 65.2 | C03B | cikletanin | p.o. | 50.00 | MG | 1.03 | |

| | | | | | | | |

| 65.3 | C03BA | metipamid | p.o. | 2.50 | MG | 1.03 | |

| | | | | | | | |

| 65.4 | C03BA04 | chlortalidon | p.o. | 25.00 | MG | 0.61 | |

| | | | | | | | |

| 65.5 | C03BA10 | xipamid | p.o. | 20.00 | MG | 1.03 | |

| | | | | | | | |

| 65.6 | C03BA11 | indapamid | p.o. | 2.50 | MG | 1.12 | |

| 46635 | INDAPAMID HF | tbl obd 30x2.5mg | HMF | YU |

| --- | --- | --- | --- | --- |

| 65.7 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1.50 | MG | 1.12 | |

| 65.1 | C03AA03 | hydrochlorothiazid | p.o. | 25.00 | MG | 0,92 | |

| | | | | | | | |

| 65.2 | C03B | cikletanin | p.o. | 50.00 | MG | 1,01 | |

| | | | | | | | |

| 65.3 | C03BA | metipamid | p.o. | 2.50 | MG | 1,01 | |

| | | | | | | | |

| 65.4 | C03BA04 | chlortalidon | p.o. | 25.00 | MG | 0,60 | |

| | | | | | | | |

| 65.5 | C03BA10 | xipamid | p.o. | 20.00 | MG | 1,01 | |

| | | | | | | | |

| 65.6 | C03BA11 | indapamid | p.o. | 2.50 | MG | 1,09 | |

| 46635 | INDAPAMID HF | tbl obd 30×2.5mg | HMF | YU |

| --- | --- | --- | --- | --- |

| 65.7 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1.50 | MG | 1,09 | |

| | | | | | | | |

| 66 | diuretika s vysokým účinkem, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 66.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40.00 | MG | 0.86 | |

| 02079 | FUROSEMID-SLOVAKOFARMA | tbl 20x40mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 15332 | APO-FUROSEMIDE 80 MG | tbl 100x80mg | CMG | IRL |

| 15335 | APO-FUROSEMIDE 40 MG | tbl 100x40mg | CMG | IRL |

| 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND |

| 56804 | FURORESE 40 | tbl 50x40mg | SFS | D |

| 56805 | FURORESE 40 | tbl 100x40mg | SFS | D |

| 96738 | APO-FUROSEMIDE 80MG | tbl 100x80mg | APT | CND |

| 98219 | FURON 40 MG | por tbl nob 50x40mg | MCK | D |

| 66.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40.00 | MG | 0.68 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17854 | FURORESE 125 | por tbl nob 30x125mg | HPZ | PL |

| --- | --- | --- | --- | --- |

| 17855 | FURORESE 125 | por tbl nob 50x125mg | HPZ | PL |

| 17856 | FURORESE 125 | por tbl nob 100x125mg | HPZ | PL |

| 56807 | FURORESE 125 | tbl 30x125mg | SFS | D |

| 56808 | FURORESE 125 | tbl 50x125mg | SFS | D |

| 56810 | FURORESE 250 | por tbl nob 20x250mg | SFS | D |

| 56811 | FURORESE 250 | por tbl nob 50x250mg | SFS | D |

| 56812 | FURORESE 250 | por tbl nob 100x250mg | SFS | D |

| 56814 | FURORESE 500 | tbl 50x500mg | SFS | D |

| 56815 | FURORESE 500 | tbl 100x500mg | SFS | D |

| 68632 | FURORESE 500 | tbl 20x500mg | SFS | D |

| 81498 | FUROSEMID AL 500 | por tbl nob 50x500mg | APA | D |

| 81499 | FUROSEMID AL 500 | por tbl nob 100x500mg | APA | D |

| 98937 | FURORESE 250 | por tbl nob 10x250mg | SFS | D |

| 66.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15.00 | MG | 0.88 | |

| | | | | | | | |

| 66.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15.00 | MG | 0.68 | |

| 66.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40.00 | MG | 0,84 | |

| 02079 | FUROSEMID-SLOVAKOFARMA | tbl 20×40mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 15332 | APO-FUROSEMIDE 80 MG | tbl 100×80mg | CMG | IRL |

| 15335 | APO-FUROSEMIDE 40 MG | tbl 100×40mg | CMG | IRL |

| 56347 | APO-FUROSEMIDE 40MG | tbl 100×40mg | APT | CND |

| 56804 | FURORESE 40 | tbl 50×40mg | SFS | D |

| 56805 | FURORESE 40 | tbl 100×40mg | SFS | D |

| 96738 | APO-FUROSEMIDE 80MG | tbl 100×80mg | APT | CND |

| 98219 | FURON 40 MG | por tbl nob 50×40mg | MCK | D |

| 66.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40.00 | MG | 0,66 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17854 | FURORESE 125 | por tbl nob 30×125mg | HPZ | PL |

| --- | --- | --- | --- | --- |

| 17855 | FURORESE 125 | por tbl nob 50×125mg | HPZ | PL |

| 17856 | FURORESE 125 | por tbl nob 100×125mg | HPZ | PL |

| 56807 | FURORESE 125 | tbl 30×125mg | SFS | D |

| 56808 | FURORESE 125 | tbl 50×125mg | SFS | D |

| 56810 | FURORESE 250 | por tbl nob 20×250mg | SFS | D |

| 56811 | FURORESE 250 | por tbl nob 50×250mg | SFS | D |

| 56812 | FURORESE 250 | por tbl nob 100×250mg | SFS | D |

| 56814 | FURORESE 500 | tbl 50×500mg | SFS | D |

| 56815 | FURORESE 500 | tbl 100×500mg | SFS | D |

| 68632 | FURORESE 500 | tbl 20×500mg | SFS | D |

| 81498 | FUROSEMID AL 500 | por tbl nob 50×500mg | APA | D |

| 81499 | FUROSEMID AL 500 | por tbl nob 100×500mg | APA | D |

| 98937 | FURORESE 250 | por tbl nob 10×250mg | SFS | D |

| 66.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15.00 | MG | 0,86 | |

| | | | | | | | |

| 66.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15.00 | MG | 0,66 | |

| | | | | | | | |

| 67 | diuretika s vysokým účinkem, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 67.1 | C03C | kyselina etakrynová | parent. | 50.00 | MG | 543.63 | O |

| | | | | | | | |

| 67.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40.00 | MG | 7.36 | O |

| 56819 | FURORESE ROZTOK | inf 5x25ml/250mg | PHH | D |

| --- | --- | --- | --- | --- |

| 56820 | FURORESE ROZTOK | inf 25x25ml/250mg | PHH | D |

| 67.3 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40.00 | MG | 15.04 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 56818 | FURORESE 20 INJEKT | inj 25x2ml/20mg | PHH | D |

| --- | --- | --- | --- | --- |

| 67.4 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15.00 | MG | 16.03 | O |

| | | | | | | | |

| 67.5 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15.00 | MG | 7.72 | O |

| 67.1 | C03C | kyselina etakrynová | parent. | 50.00 | MG | 531,29 | O |

| | | | | | | | |

| 67.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40.00 | MG | 7,19 | O |

| 56819 FURORESE ROZTOK | inf 5×25ml/250mg | PHH D |

| --- | --- | --- |

| 56820 FURORESE ROZTOK | inf 25×25ml/250mg | PHH D |

| 67.3 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40.00 | MG 14,70 | O |

| --- | --- | --- | --- | --- | --- | --- |

| 56818 | FURORESE 20 INJEKT | inj 25×2ml/20mg | PHH | D |

| --- | --- | --- | --- | --- |

| 67.4 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15.00 | MG | 15,67 | O |

| | | | | | | | |

| 67.5 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15.00 | MG | 7,54 | O |

| | | | | | | | |

| 68 | diuretika šetřící draslík | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 68.1 | C03DA01 | spironolakton | p.o. | 75.00 | MG | 4.60 | |

| | | | | | | | |

| 68.2 | C03DB01 | amilorid | p.o. | 10.00 | MG | 1.57 | |

| 87662 | AMICLARAN | tbl 50x5mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 68.3 | C03DB02 | triamteren | p.o. | 100.00 | MG | 1.22 | |

| 68.1 | C03DA01 | spironolakton | p.o. | 75.00 | MG | 4,50 | |

| | | | | | | | |

| 68.2 | C03DB01 | amilorid | p.o. | 10.00 | MG | 1,53 | |

| 87662 | AMICLARAN | tbl 50×5mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 68.3 | C03DB02 | triamteren | p.o. | 100.00 | MG | 1,19 | |

| | | | | | | | |

| 69 | kombinace diuretik | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 69.1 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.50 | DF | 0.50 | |

| 69.1 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.50 | DF | 0,49 | |

| 47476 | LORADUR | por tbl nob 50 | MCK | D |

| --- | --- | --- | --- | --- |

@@ -2418,744 +2525,745 @@

| 83717 | AMILORID/HCT AL | tbl 50 | APA | D |

| 83718 | AMILORID/HCT AL | tbl 100 | APA | D |

| 69.2 | C03EA06 | chlorthalidon a kalium šetřící látky | p.o. | 1.00 | DF | 1.10 | |

| | | | | | | | |

| 69.3 | C03EA14 | spironolakton/butizid | p.o. | 1.00 | DF | 9.78 | |

| 69.2 | C03EA06 | chlorthalidon a kalium šetřící látky | p.o. | 1.00 | DF | 1,08 | |

| | | | | | | | |

| 69.3 | C03EA14 | spironolakton/butizid | p.o. | 1.00 | DF | 9,56 | |

| | | | | | | | |

| 70 | periferní vazodilatancia, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 70.1 | C04AC01 | kyselina nikotinová | p.o. | 0.20 | GM | 0.44 | |

| | | | | | | | |

| 70.2 | C04AD02 | xantinol nikotinát | p.o. | 0.90 | GM | 3.87 | |

| | | | | | | | |

| 70.3 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1.00 | GM | 3.87 | |

| | | | | | | | |

| 70.4 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1.00 | GM | 4.77 | |

| | | | | | | | |

| 70.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1.00 | GM | 5.40 | |

| | | | | | | | |

| 70.6 | C04AD04 | etophyllin nikotinát | p.o. | 0.30 | GM | 1.65 | |

| | | | | | | | |

| 70.7 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3.00 | MG | 2.13 | |

| 91032 | SECATOXIN FORTE | por gtt sol 1x25ml | IXP | CZ |

| --- | --- | --- | --- | --- |

| 70.8 | C04AE02 | nicergolin | p.o. | 30.00 | MG | 8.50 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 05742 | ERGOTOP 30 | por tbl flm 28x30mg | IVX | CZ |

| --- | --- | --- | --- | --- |

| 70.9 | C04AE54 | dihydroergokristin, kombinace | p.o. | 2.00 | ML | 1.87 | |

| | | | | | | | |

| 70.10 | C04AX | jiná periferní vasodilatancia | p.o. | 3.00 | DF | 4.77 | |

| | | | | | | | |

| 70.11 | C04AX02 | fenoxybenzamin | p.o. | 30.00 | MG | 4.77 | |

| | | | | | | | |

| 70.12 | C04AX19 | sulkotidil | p.o. | 0.30 | GM | 4.77 | |

| | | | | | | | |

| 70.13 | C04AX20 | buflomedil | p.o. | 0.60 | GM | 4.77 | |

| | | | | | | | |

| 70.14 | C04AX21 | naftidrofuryl | p.o. | 0.20 | GM | 4.25 | |

| 70.1 | C04AC01 | kyselina nikotinová | p.o. | 0.20 | GM | 0,43 | |

| | | | | | | | |

| 70.2 | C04AD02 | xantinol nikotinát | p.o. | 0.90 | GM | 3,78 | |

| | | | | | | | |

| 70.3 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1.00 | GM | 3,78 | |

| | | | | | | | |

| 70.4 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1.00 | GM | 4,66 | |

| | | | | | | | |

| 70.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1.00 | GM | 5,28 | |

| | | | | | | | |

| 70.6 | C04AD04 | etophyllin nikotinát | p.o. | 0.30 | GM | 1,61 | |

| | | | | | | | |

| 70.7 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3.00 | MG | 2,08 | |

| 91032 | SECATOXIN FORTE | por gtt sol 1×25ml | IXP | CZ |

| --- | --- | --- | --- | --- |

| 70.8 | C04AE02 | nicergolin | p.o. | 30.00 | MG | 8,31 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 05742 | ERGOTOP 30 | por tbl flm 28×30mg | IVX | CZ |

| --- | --- | --- | --- | --- |

| 70.9 | C04AE54 | dihydroergokristin, kombinace | p.o. | 2.00 | ML | 1,83 | |

| | | | | | | | |

| 70.10 | C04AX | jiná periferní vasodilatancia | p.o. | 3.00 | DF | 4,66 | |

| | | | | | | | |

| 70.11 | C04AX02 | fenoxybenzamin | p.o. | 30.00 | MG | 4,66 | |

| | | | | | | | |

| 70.12 | C04AX19 | sulkotidil | p.o. | 0.30 | GM | 4,66 | |

| | | | | | | | |

| 70.13 | C04AX20 | buflomedil | p.o. | 0.60 | GM | 4,66 | |

| | | | | | | | |

| 70.14 | C04AX21 | naftidrofuryl | p.o. | 0.20 | GM | 4,15 | |

| | | | | | | | |

| 71 | periferní vazodilatancia a vasoprotektiva, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 71.1 | C04AC | olamin nikotinát | parent. | 0.90 | GM | 20.04 | |

| | | | | | | | |

| 71.2 | C04AB01 | fentolamin | parent. | 10.00 | MG | 20.82 | O |

| | | | | | | | |

| 71.3 | C04AB02 | tolazolin | parent. | 75.00 | MG | 87.00 | O |

| | | | | | | | |

| 71.4 | C04AD | etophyllin/theophyllin | parent. | 0.30 | GM | 11.11 | |

| | | | | | | | |

| 71.5 | C04AD02 | xantinol nikotinát | parent. | 0.90 | GM | 4.25 | |

| | | | | | | | |

| 71.6 | C04AD03 | pentoxifylin | parent. | 0.30 | GM | 25.33 | |

| 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 69241 | PENTILIN INJEKCE 100MG/5ML | inj 5x5ml/100mg | KRK | SLO |

| 71.7 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3.00 | MG | 69.21 | |

| | | | | | | | |

| 71.8 | C04AX | jiná periferní vasodilatancia | parent. | 2.00 | DF | 14.86 | |

| | | | | | | | |

| 71.9 | C04AX11 | bencyklan | parent. | 0.60 | GM | 51.52 | |

| | | | | | | | |

| 71.10 | C04AX21 | naftidrofuryl | parent. | 0.20 | GM | 53.95 | |

| 71.1 | C04AC | olamin nikotinát | parent. | 0.90 | GM | 19,59 | |

| | | | | | | | |

| 71.2 | C04AB01 | fentolamin | parent. | 10.00 | MG | 20,35 | O |

| | | | | | | | |

| 71.3 | C04AB02 | tolazolin | parent. | 75.00 | MG | 85,03 | O |

| | | | | | | | |

| 71.4 | C04AD | etophyllin/theophyllin | parent. | 0.30 | GM | 10,86 | |

| | | | | | | | |

| 71.5 | C04AD02 | xantinol nikotinát | parent. | 0.90 | GM | 4,15 | |

| | | | | | | | |

| 71.6 | C04AD03 | pentoxifylin | parent. | 0.30 | GM | 24,76 | |

| 43709 | TRENTAL | inf 10×15ml/300mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 69241 | PENTILIN INJEKCE 100MG/5ML | inj 5×5ml/100mg | KRK | SLO |

| 71.7 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3.00 | MG | 67,64 | |

| | | | | | | | |

| 71.8 | C04AX | jiná periferní vasodilatancia | parent. | 2.00 | DF | 14,52 | |

| | | | | | | | |

| 71.9 | C04AX11 | bencyklan | parent. | 0.60 | GM | 50,35 | |

| | | | | | | | |

| 71.10 | C04AX21 | naftidrofuryl | parent. | 0.20 | GM | 52,73 | |

| | | | | | | | |

| 72 | vazoprotektiva a venofarmaka | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 72.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1.00 | DF | 0.98 | |

| | | | | | | | |

| 72.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1.00 | GM | 0.81 | |

| | | | | | | | |

| 72.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1.00 | DF | 0.98 | |

| | | | | | | | |

| 72.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1.00 | GM | 0.81 | |

| | | | | | | | |

| 72.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1.00 | DF | 0.98 | |

| | | | | | | | |

| 72.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1.00 | GM | 0.84 | |

| | | | | | | | |

| 72.7 | C05AX02 | bismutové přípravky, kombinace (lékové formy čípků) | lok. | 1.00 | DF | 0.98 | |

| | | | | | | | |

| 72.8 | C05AX02 | bismutové přípravky, kombinace (lékové formy mastí) | lok. | 1.00 | GM | 0.78 | |

| | | | | | | | |

| 72.9 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy čípků) | lok. | 1.00 | DF | 0.98 | |

| | | | | | | | |

| 72.10 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1.00 | GM | 0.78 | |

| | | | | | | | |

| 72.11 | C05BA01 | organo-heparinoidy | lok. | 1.00 | GM | 0.87 | |

| | | | | | | | |

| 72.12 | C05BA03 | heparin k zevnímu použití | lok. | 1.00 | GM | 0.87 | |

| 86042 | HEPARIN AL MAST 30000 | ung 1x100gm | APA | D |

| --- | --- | --- | --- | --- |

| 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D |

| 72.13 | C05BA53 | heparin, kombinace k zevnímu použití | lok. | 1.00 | GM | 0.87 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 72.14 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1.00 | ML | 13.96 | O |

| 08510 | AETHOXYSKLEROL 0.5% | inj 5x2ml | KRS | D |

| --- | --- | --- | --- | --- |

| 08512 | AETHOXYSKLEROL 0.5% | inj 1x30ml | KRS | D |

| 72.15 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1.00 | ML | 16.06 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 20033 | AETHOXYSKLEROL 1% | inj 5x2ml | KRS | D |

| --- | --- | --- | --- | --- |

| 20034 | AETHOXYSKLEROL 1% | inj 1x30ml | KRS | D |

| 72.16 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1.00 | ML | 17.89 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02529 | AETHOXYSKLEROL 3% | inj 5x2ml | KRS | D |

| --- | --- | --- | --- | --- |

| 08511 | AETHOXYSKLEROL 2% | inj 5x2ml | KRS | D |

| 72.17 | C05BB02 | polidokanol (více než 3 %) | parent. | 1.00 | ML | 19.35 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 90799 | AETHOXYSKLEROL 4% | inj 5x2ml | KRS | D |

| --- | --- | --- | --- | --- |

| 72.18 | C05BB04 | natrium tetradecyl sulfat (koncentrace do 1 % včetně) | parent. | 1.00 | ML | 13.96 | O |

| | | | | | | | |

| 72.19 | C05BB04 | natrium tetradecyl sulfat (koncentrace nad 1%) | parent. | 1.00 | ML | 19.64 | O |

| | | | | | | | |

| 72.20 | C05BX01 | dobesilat vápenatý | p.o. | 0.75 | GM | 4.05 | |

| | | | | | | | |

| 72.21 | C05CA04 | troxerutin | p.o. | 3.00 | DF | 4.05 | |

| | | | | | | | |

| 72.22 | C05CA51 | rutosidy (kombinace, pevné lékové formy) | p.o. | 3.00 | DF | 1.30 | |

| | | | | | | | |

| 72.23 | C05CA51 | rutosidy (kombinace, tekuté lékové formy) | p.o. | 2.00 | ML | 3.03 | |

| | | | | | | | |

| 72.24 | C05CA53 | diosmin, kombinace | p.o. | 2.00 | DF | 4.05 | |

| | | | | | | | |

| 72.25 | C05CA54 | troxerutin, kombinace | p.o. | 2.00 | DF | 4.05 | |

| | | | | | | | |

| 72.26 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60.00 | MG | 4.05 | |

| | | | | | | | |

| 72.27 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5.00 | MG | 54.26 | H |

| | | | | | | | |

| 72.28 | C05CX01 | tribenosid | p.o. | 0.80 | GM | 4.05 | |

| 72.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |

| | | | | | | | |

| 72.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1.00 | GM | 0,79 | |

| | | | | | | | |

| 72.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |

| | | | | | | | |

| 72.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1.00 | GM | 0,79 | |

| | | | | | | | |

| 72.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |

| | | | | | | | |

| 72.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1.00 | GM | 0,82 | |

| | | | | | | | |

| 72.7 | C05AX02 | bismutové přípravky, kombinace (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |

| | | | | | | | |

| 72.8 | C05AX02 | bismutové přípravky, kombinace (lékové formy mastí) | lok. | 1.00 | GM | 0,76 | |

| | | | | | | | |

| 72.9 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |

| | | | | | | | |

| 72.10 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1.00 | GM | 0,76 | |

| | | | | | | | |

| 72.11 | C05BA01 | organo-heparinoidy | lok. | 1.00 | GM | 0,85 | |

| | | | | | | | |

| 72.12 | C05BA03 | heparin k zevnímu použití | ok. | 1.00 | GM | 0,85 | |

| 86042 | HEPARIN AL MAST 30000 | ung 1×100gm | APA | D |

| --- | --- | --- | --- | --- |

| 86044 | HEPARIN AL GEL 30000 | gel 1×100gm | APA | D |

| 72.13 | C05BA53 | heparin, kombinace k zevnímu použití | lok. | 1.00 | GM | 0,85 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 72.14 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1.00 | ML | 13,64 | O |

| 08510 | AETHOXYSKLEROL 0.5% | inj 5×2ml | KRS | D |

| --- | --- | --- | --- | --- |

| 08512 | AETHOXYSKLEROL 0.5% | inj 1×30ml | KRS | D |

| 72.15 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1.00 | ML | 15,70 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 20033 | AETHOXYSKLEROL 1% | inj 5×2ml | KRS | D |

| --- | --- | --- | --- | --- |

| 20034 | AETHOXYSKLEROL 1% | inj 1×30ml | KRS | D |

| 72.16 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1.00 | ML | 17,48 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02529 | AETHOXYSKLEROL 3% | inj 5×2ml | KRS | D |

| --- | --- | --- | --- | --- |

| 08511 | AETHOXYSKLEROL 2% | inj 5×2ml | KRS | D |

| 72.17 | C05BB02 | polidokanol (více než 3 %) | parent. | 1.00 | ML | 18,91 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 90799 | AETHOXYSKLEROL 4% | inj 5×2ml | KRS | D |

| --- | --- | --- | --- | --- |

| 72.18 | C05BB04 | natrium tetradecyl sulfat (koncentrace do 1 % včetně) | parent. | 1.00 | ML | 13,64 | O |

| | | | | | | | |

| 72.19 | C05BB04 | natrium tetradecyl sulfat (koncentrace nad 1%) | parent. | 1.00 | ML | 19,19 | O |

| | | | | | | | |

| 72.20 | C05BX01 | dobesilat vápenatý | p.o. | 0.75 | GM | 3,96 | |

| | | | | | | | |

| 72.21 | C05CA04 | troxerutin | p.o. | 3.00 | DF | 3,96 | |

| | | | | | | | |

| 72.22 | C05CA51 | rutosidy (kombinace, pevné lékové formy) | p.o. | 3.00 | DF | 1,27 | |

| | | | | | | | |

| 72.23 | C05CA51 | rutosidy (kombinace, tekuté lékové formy) | p.o. | 2.00 | ML | 2,96 | |

| | | | | | | | |

| 72.24 | C05CA53 | diosmin, kombinace | p.o. | 2.00 | DF | 3,96 | |

| | | | | | | | |

| 72.25 | C05CA54 | troxerutin, kombinace | p.o. | 2.00 | DF | 3,96 | |

| | | | | | | | |

| 72.26 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60.00 | MG | 3,96 | |

| | | | | | | | |

| 72.27 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5.00 | MG | 53,03 | H |

| | | | | | | | |

| 72.28 | C05CX01 | tribenosid | p.o. | 0.80 | GM | 3,96 | |

| | | | | | | | |

| 73 | neselektivní beta-blokátory, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 73.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10.00 | MG | 0.78 | |

| | | | | | | | |

| 73.2 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10.00 | MG | 0.29 | |

| | | | | | | | |

| 73.3 | C07AA | metipranolol (nad 5 do 10 mg včetně v 1 tabletě) | p.o. | 10.00 | MG | 0.66 | |

| | | | | | | | |

| 73.4 | C07AA02 | oxprenolol | p.o. | 0.10 | GM | 2.74 | |

| | | | | | | | |

| 73.5 | C07AA03 | pindolol | p.o. | 15.00 | MG | 2.74 | |

| | | | | | | | |

| 73.6 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2.74 | |

| | | | | | | | |

| 73.7 | C07AA07 | sotalol | p.o. | 0.16 | GM | 4.75 | L/KAR,INT, GER |

| 17847 | SOTAHEXAL 160 | por tbl nob 20x160mg | HPZ | PL |

| --- | --- | --- | --- | --- |

| 17848 | SOTAHEXAL 160 | por tbl nob 50x160mg | HPZ | PL |

| 49012 | SOTAHEXAL 80 | por tbl nob 20x80mg | SFS | D |

| 49019 | SOTAHEXAL 160 | por tbl nob 20x160mg | SFS | D |

| 49020 | SOTAHEXAL 160 | por tbl nob 50x160mg | SFS | D |

| 83480 | SOTAHEXAL 80 | tbl 20x80mg | HEX | D |

| 83481 | SOTAHEXAL 160 | tbl 20x160mg | HEX | D |

| 83670 | SOTAHEXAL 160 | tbl 50x160mg | HEX | D |

| 85476 | SOTAHEXAL 80 | por tbl nob 20x80mg | HPZ | PL |

| 73.8 | C07AA12 | nadolol | p.o. | 0.16 | GM | 2.74 | |

| | | | | | | | |

| 73.9 | C07AA16 | tertatolol | p.o. | 5.00 | MG | 2.74 | |

| | | | | | | | |

| 73.10 | C07AA17 | bopindolol | p.o. | 1.00 | MG | 2.74 | |

| | | | | | | | |

| 73.11 | C07AA23 | penbutolol | p.o. | 40.00 | MG | 2.74 | |

| | | | | | | | |

| 73.12 | C07AA27 | kloranolol | p.o. | 20.00 | MG | 2.74 | |

| 73.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10.00 | MG | 0,76 | |

| | | | | | | | |

| 73.2 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10.00 | MG | 0,28 | |

| | | | | | | | |

| 73.3 | C07AA | metipranolol (nad 5 do 10 mg včetně v 1 tabletě) | p.o. | 10.00 | MG | 0,65 | |

| | | | | | | | |

| 73.4 | C07AA02 | oxprenolol | p.o. | 0.10 | GM | 2,68 | |

| | | | | | | | |

| 73.5 | C07AA03 | pindolol | p.o. | 15.00 | MG | 2,68 | |

| | | | | | | | |

| 73.6 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2,68 | |

| | | | | | | | |

| 73.7 | C07AA07 | sotalol | p.o. | 0.16 | GM | 4,64 | L/KAR,INT, GER |

| 17847 | SOTAHEXAL 160 | por tbl nob 20×160mg | HPZ | PL |

| --- | --- | --- | --- | --- |

| 17848 | SOTAHEXAL 160 | por tbl nob 50×160mg | HPZ | PL |

| 49012 | SOTAHEXAL 80 | por tbl nob 20×80mg | SFS | D |

| 49019 | SOTAHEXAL 160 | por tbl nob 20×160mg | SFS | D |

| 49020 | SOTAHEXAL 160 | por tbl nob 50×160mg | SFS | D |

| 83480 | SOTAHEXAL 80 | tbl 20×80mg | HEX | D |

| 83481 | SOTAHEXAL 160 | tbl 20×160mg | HEX | D |

| 83670 | SOTAHEXAL 160 | tbl 50×160mg | HEX | D |

| 85476 | SOTAHEXAL 80 | por tbl nob 20×80mg | HPZ | PL |

| 73.8 | C07AA12 | nadolol | p.o. | 0.16 | GM | 2,68 | |

| | | | | | | | |

| 73.9 | C07AA16 | tertatolol | p.o. | 5.00 | MG | 2,68 | |

| | | | | | | | |

| 73.10 | C07AA17 | bopindolol | p.o. | 1.00 | MG | 2,68 | |

| | | | | | | | |

| 73.11 | C07AA23 | penbutolol | p.o. | 40.00 | MG | 2,68 | |

| | | | | | | | |

| 73.12 | C07AA27 | kloranolol | p.o. | 20.00 | MG | 2,68 | |

| | | | | | | | |

| 74 | selektivní beta-blokátory a kombinace alfa a beta aktivity, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 74.1 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 2.63 | |

| 32673 | METOPROLOL AL 200 RETARD | por tbl pro 50x200mg | APA | D |

| --- | --- | --- | --- | --- |

| 47501 | METOPROLOL AL 200 RETARD | por tbl pro 100x200mg | APA | D |

| 74.2 | C07AB02 | metoprolol (do 50 mg včetně v jedné tabletě) | p.o. | 0.15 | GM | 2.56 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 74.3 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) do 25 mg v jedné tabletě včetně | p.o. | 0.15 | GM | 12.90 | P |

| 74.1 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 2,57 | |

| 32673 | METOPROLOL AL 200 RETARD | por tbl pro 50×200mg | APA | D |

| --- | --- | --- | --- | --- |

| 47501 | METOPROLOL AL 200 RETARD | por tbl pro 100×200mg | APA | D |

| 74.2 | C07AB02 | metoprolol (do 50 mg včetně v jedné tabletě) | p.o. | 0.15 | GM | 2,50 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 74.3 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) do 25 mg v jedné tabletě včetně | p.o. | 0.15 | GM | 12,61 | P |

Metoprolol v lékové formě tablet s řízeným uvolňováním je indikován v léčbě srdečního selhání; v dávce 25 mg je určen k zahájení léčby. Pouze v případech, kdy není pacientem tolerována dávka vyšší, je možné podávat v dávce 25 mg dlouhodobě. Cílová dávka metoprololu v lékové formě tablet s řízeným uvolňováním v indikaci srdečního selhání je 200 mg denně, k této udržovací dávce jsou indikovány tablety s obsahem 100 mg.

| 74.4 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) nad 25 mg v jedné tabletě | p.o. | 0.15 | GM | 8.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 74.5 | C07AB02 | metoprolol (nad 50 mg v jedné tabletě) | p.o. | 0.15 | GM | 2.47 | |

| 47675 | METOPROLOL AL 100 | por tbl nob 100x100mg | APA | D |

| --- | --- | --- | --- | --- |

| 74.6 | C07AB03 | atenolol do 50 mg v jedné tabletě včetně | p.o. | 75.00 | MG | 2.65 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02951 | ATENOLOL AL 50 | por tbl nob 100x50mg | APA | D |

| --- | --- | --- | --- | --- |

| 42457 | ATEHEXAL 50 | por tbl flm 50x50mg | SFS | D |

| 42458 | ATEHEXAL 50 | por tbl flm 100x50mg | SFS | D |

| 74.7 | C07AB03 | atenolol nad 50 mg v jedné tabletě | p.o. | 75.00 | MG | 1.93 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 42461 | ATEHEXAL 100 | por tbl flm 100x100mg | SFS | D |

| --- | --- | --- | --- | --- |

| 74.8 | C07AB04 | acebutolol | p.o. | 0.40 | GM | 3.52 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46301 | ACEBIREX 200 MG | por tbl flm 30x200mg | BTT | F |

| --- | --- | --- | --- | --- |

| 46303 | ACEBIREX 400 MG | por tbl flm 30x400mg | BTT | F |

| 74.9 | C07AB05 | betaxolol | p.o. | 20.00 | MG | 3.52 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 95400 | BETAXA 20 | por tbl flm 30x20mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 95401 | BETAXA 20 | por tbl flm 60x20mg | ZEH | SK |

| 95402 | BETAXA 20 | por tbl flm 100x20mg | ZEH | SK |

| 74.10 | C07AB07 | bisoprolol | p.o. | 10.00 | MG | 3.52 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32963 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 30x5mg | MCK | D |

| --- | --- | --- | --- | --- |

| 32967 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D |

| 32970 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D |

| 32974 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob 100x10mg | MCK | D |

| 42870 | KORDOBIS 5 MG TBL. | por tbl flm 30x5mg | PVL | CZ |

| 42871 | KORDOBIS 10 MG TBL. | por tbl flm 30x10mg | PVL | CZ |

| 74.11 | C07AB07 | bisoprolol hemifumarát do 2,5 mg v jedné tabletě včetně | p.o. | 10.00 | MG | 13.17 | P |

| 74.4 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) nad 25 mg v jedné tabletě | p.o. | 0.15 | GM | 7,82 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 74.5 | C07AB02 | metoprolol (nad 50 mg v jedné tabletě) | p.o. | 0.15 | GM | 2,41 | |

| 47675 | METOPROLOL AL 100 | por tbl nob 100×100mg | APA | D |

| --- | --- | --- | --- | --- |

| 74.6 | C07AB03 | atenolol do 50 mg v jedné tabletě včetně | p.o. | 75.00 | MG | 2,59 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02951 | ATENOLOL AL 50 | por tbl nob 100×50mg | APA | D |

| --- | --- | --- | --- | --- |

| 42457 | ATEHEXAL 50 | por tbl flm 50×50mg | SFS | D |

| 42458 | ATEHEXAL 50 | por tbl flm 100×50mg | SFS | D |

| 74.7 | C07AB03 | atenolol nad 50 mg v jedné tabletě | p.o. | 75.00 | MG | 1,89 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 42461 | ATEHEXAL 100 | por tbl flm 100×100mg | SFS | D |

| --- | --- | --- | --- | --- |

| 74.8 | C07AB04 | acebutolol | p.o. | 0.40 | GM | 3,44 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 46301 | ACEBIREX 200 MG | por tbl flm 30×200mg | BTT | F |

| --- | --- | --- | --- | --- |

| 46303 | ACEBIREX 400 MG | por tbl flm 30×400mg | BTT | F |

| 74.9 | C07AB05 | betaxolol | p.o. | 20.00 | MG | 3,44 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 95400 | BETAXA 20 | por tbl flm 30×20mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 95401 | BETAXA 20 | por tbl flm 60×20mg | ZEH | SK |

| 95402 | BETAXA 20 | por tbl flm 100×20mg | ZEH | SK |

| 74.10 | C07AB07 | bisoprolol | p.o. | 10.00 | MG | 3,44 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32963 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 30×5mg | MCK | D |

| --- | --- | --- | --- | --- |

| 32967 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 100×5mg | MCK | D |

| 32970 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob 30×10mg | MCK | D |

| 32974 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob 100×10mg | MCK | D |

| 42870 | KORDOBIS 5 MG TBL. | por tbl flm 30×5mg | PVL | CZ |

| 42871 | KORDOBIS 10 MG TBL. | por tbl flm 30×10mg | PVL | CZ |

| 74.11 | C07AB07 | bisoprolol hemifumarát do 2,5 mg v jedné tabletě včetně | p.o. | 10.00 | MG | 12,87 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Bisoprolol je indikován v léčbě srdečního selhání; v dávce 2,5 mg je určen k zahájení léčby. Pouze v případech, kdy není pacientem tolerována dávka vyšší, je možné podávat v dávce 2,5 mg dlouhodobě. Cílová dávka bisoprololu v této indikaci je 10 mg denně a k udržovací léčbě je bisoprolol indikován v tabletách s obsahem 10 mg.

| 74.12 | C07AB07 | bisoprolol hemifumarát nad 2,5 mg v jedné tabletě | p.o. | 10.00 | MG | 8.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03824 | CONCOR COR 10 MG | tbl obd 28x10mg | MEC | D |

| --- | --- | --- | --- | --- |

| 74.13 | C07AB08 | celiprolol | p.o. | 0.20 | GM | 3.52 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 74.14 | C07AB12 | nebivolol | p.o. | 5.00 | MG | 6.00 | P |

| 74.12 | C07AB07 | bisoprolol hemifumarát nad 2,5 mg v jedné tabletě | p.o. | 10.00 | MG | 7,82 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03824 | CONCOR COR 10 MG | tbl obd 28×10mg | MEC | D |

| --- | --- | --- | --- | --- |

| 74.13 | C07AB08 | celiprolol | p.o. | 0.20 | GM | 3,44 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 74.14 | C07AB12 | nebivolol | p.o. | 5.00 | MG | 5,86 | P |

Nebivolol je indikován v léčbě srdečního selhání. Nebivolol v dávce 5mg je určen k zahájení léčby. Cílová dávka nebivololu v této indikaci je 10 mg denně.

| 74.15 | C07AG01 | labetalol | p.o. | 0.60 | GM | 19.50 | L/KAR,INT,GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 74.16 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.50 | MG | 13.17 | P |

| | | | | | | | |

| 74.17 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.50 | MG | 8.00 | P |

| 74.15 | C07AG01 | labetalol | p.o. | 0.60 | GM | 19,06 | L/KAR,INT,GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 74.16 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.50 | MG | 12,87 | P |

| | | | | | | | |

| 74.17 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.50 | MG | 7,82 | P |

Karvedilol je indikován v léčbě srdečního selhání. Karvedilol v dávce 6,25 mg je určen k zahájení léčby. Pouze v případech, že není vyšší dávka tolerována, je možno podávat dávku 6,25 mg dlouhodobě. Cílová dávka karvedilolu v této indikaci je 25 – 50 mg denně, k udržovací léčbě je karvedilol indikován v tabletách s obsahem 12,5 a 25 mg.

| 75 | beta-blokátory, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 75.1 | C07AA | metipranolol | parent. | 10.00 | MG | 62.97 | O |

| 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 75.2 | C07AG01 | labetalol | parent. | 0.60 | GM | 1 027.60 | H |

| | | | | | | | |

| 75.3 | C07AA | talinolol | parent. | 50.00 | MG | 93.65 | O |

| | | | | | | | |

| 75.4 | C07AA02 | oxprenolol | parent. | 0.10 | GM | 99.13 | O |

| | | | | | | | |

| 75.5 | C07AA03 | pindolol | parent. | 15.00 | MG | 99.13 | O |

| | | | | | | | |

| 75.6 | C07AA07 | sotalol | parent. | 0.16 | GM | 900.64 | O |

| | | | | | | | |

| 75.7 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1 398.18 | O |

| | | | | | | | |

| 75.8 | C07AB03 | atenolol | parent. | 75.00 | MG | 1 840.83 | O |

| | | | | | | | |

| 75.9 | C07AB04 | acebutolol | parent. | 0.40 | GM | 1 398.18 | O |

| | | | | | | | |

| 75.10 | C07AB09 | esmolol | parent. | 2.50 | GM | 4 205.00 | O |

| 75.1 | C07AA | metipranolol | parent. | 10.00 | MG | 61,54 | O |

| 85886 | TRIMEPRANOL | inj 10×1ml/1mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 75.2 | C07AG01 | labetalol | parent. | 0.60 | GM | 1 004,27 | H |

| | | | | | | | |

| 75.3 | C07AA | talinolol | parent. | 50.00 | MG | 91,52 | O |

| | | | | | | | |

| 75.4 | C07AA02 | oxprenolol | parent. | 0.10 | GM | 96,88 | O |

| | | | | | | | |

| 75.5 | C07AA03 | pindolol | parent. | 15.00 | MG | 96,88 | O |

| | | | | | | | |

| 75.6 | C07AA07 | sotalol | parent. | 0.16 | GM | 880,20 | O |

| | | | | | | | |

| 75.7 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1 366,44 | O |

| | | | | | | | |

| 75.8 | C07AB03 | atenolol | parent. | 75.00 | MG | 1 799,04 | O |

| | | | | | | | |

| 75.9 | C07AB04 | acebutolol | parent. | 0.40 | GM | 1 366,44 | O |

| | | | | | | | |

| 75.10 | C07AB09 | esmolol | parent. | 2.50 | GM | 4 109,55 | O |

| | | | | | | | |

| 76 | kombinace beta-blokátorů s jinými antihypertenzivy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 76.1 | C07BB03 | atenolol a thiazidy | p.o. | 1.00 | DF | 4.41 | |

| 76.1 | C07BB03 | atenolol a thiazidy | p.o. | 1.00 | DF | 4,31 | |

| 76715 | TENORETIC | por tbl flm 28 | AZC | GB |

| --- | --- | --- | --- | --- |

| 76.2 | C07BB07 | bisoprolol a thiazidy | p.o. | 1.00 | DF | 3.71 | |

| | | | | | | | |

| 76.3 | C07CA17 | bopindolol a thiazidy | p.o. | 1.00 | DF | 4.41 | |

| | | | | | | | |

| 76.4 | C07FA | beta-blokátory, neselektivní, a jiná antihypertensiva | p.o. | 0.50 | DF | 0.73 | |

| 76.2 | C07BB07 | bisoprolol a thiazidy | p.o. | 1.00 | DF | 3,63 | |

| | | | | | | | |

| 76.3 | C07CA17 | bopindolol a thiazidy | p.o. | 1.00 | DF | 4,31 | |

| | | | | | | | |

| 76.4 | C07FA | beta-blokátory, neselektivní, a jiná antihypertensiva | p.o. | 0.50 | DF | 0,71 | |

| | | | | | | | |

| 77 | blokátory vápníkového kanálu ze skupiny dihydropyridinů, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 77.1 | C08CA01 | amlodipin do 5 mg v 1 tbl včetně | p.o. | 5.00 | MG | 5.00 | |

| 02945 | AGEN 5 | por tbl nob 30x5mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 03936 | AMLOPP-5 | por tbl nob 30x5mg | SDD | CZ |

| 03993 | NORMODIPINE 5 MG | por tbl nob 30x5mg | GED | H |

| 03998 | CARDILOPIN 5 MG | por tbl nob 30x5mg | EGI | H |

| 13464 | ORCAL 5 MG | por tbl nob 90x5mg | LEK | SLO |

| 15378 | AGEN 5 | por tbl nob 90x5mg | ZEH | CZ |

| 19440 | ORCAL 5 MG TABLETY | por tbl nob 30x5mg | LSW | PL |

| 19444 | ORCAL 5 MG TABLETY | por tbl nob 90x5mg | LSW | PL |

| 32924 | ZOREM 5 MG | por tbl nob 30x5mg | PVL | CZ |

| 42833 | AMLODIPIN-RATIOPHARM 5 MG | por tbl nob 30x5mg | MCK | D |

| 42837 | AMLODIPIN-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D |

| 42848 | HIPRES 5 | por tbl nob 30x5mg | KRK | SLO |

| 58415 | ORCAL 5MG | tbl 30x5mg | LEK | SLO |

| 58874 | AMLOZEK 5 | por tbl nob 30x5mg | ADD | PL |

| 95582 | ZOREM 5 MG | por tbl nob 100x5mg | PVL | CZ |

| 77.2 | C08CA01 | amlodipin nad 5 mg v 1 tbl | p.o. | 5.00 | MG | 4.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02954 | AGEN 10 | por tbl nob 30x10mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 03944 | AMLOPP-10 | por tbl nob 30x10mg | SDD | CZ |

| 03999 | CARDILOPIN 10 MG | por tbl nob 30x10mg | EGI | H |

| 13466 | ORCAL 10 MG | por tbl nob 90x10mg | LEK | SLO |

| 13851 | AMLODIPIN-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D |

| 13852 | AMLODIPIN-RATIOPHARM 10 MG | por tbl nob 100x10mg | MCK | D |

| 15379 | AGEN 10 | por tbl nob 90x10mg | ZEH | CZ |

| 19442 | ORCAL 10 MG TABLETY | por tbl nob 30x10mg | LSW | PL |

| 19446 | ORCAL 10 MG TABLETY | por tbl nob 90x10mg | LSW | PL |

| 42849 | HIPRES 10 | por tbl nob 30x10mg | KRK | SLO |

| 58417 | ORCAL 10MG | tbl 30x10mg | LEK | SLO |

| 58876 | AMLOZEK 10 | por tbl nob 30x10mg | ADD | PL |

| 77.3 | C08CA02 | felodipin do 5 mg v 1 tbl včetně | p.o. | 5.00 | MG | 5.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02957 | PRESID 5 MG | por tbl ret 30x5mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 02961 | PRESID 2.5 MG | por tbl ret 30x2.5mg | IXP | CZ |

| 20394 | FELODIPIN-RATIOPHARM 5 MG | por tbl pro 30x5mg | MCK | D |

| 20397 | FELODIPIN-RATIOPHARM 5 MG | por tbl pro 100x5mg | MCK | D |

| 21534 | FELOCOR 5 | por tbl pro 30x5mg | SFS | D |

| 21548 | FELOCOR 5 | por tbl pro 30x5mg | HED | DK |

| 42942 | FELODIPIN AL 5 RETARD | por tbl ret 30x5mg | APA | D |

| 48584 | FELOCOR 5 | por tbl pro 30x5mg | SFS | D |

| 48595 | FELOCOR 5 | por tbl pro 30x5mg | HED | DK |

| 77.4 | C08CA02 | felodipin nad 5 mg v 1 tbl | p.o. | 5.00 | MG | 4.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02959 | PRESID 10 MG | por tbl ret 30x10mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 20317 | FELODIPIN-RATIOPHARM 10 MG | por tbl pro 30x10mg | MCK | D |

| 20320 | FELODIPIN-RATIOPHARM 10 MG | por tbl pro 100x10mg | MCK | D |

| 21504 | FELOCOR 10 | por tbl pro 30x10mg | SFS | D |

| 21519 | FELOCOR 10 | por tbl pro 30x10mg | HED | DK |

| 42946 | FELODIPIN AL 10 RETARD | por tbl ret 30x10mg | APA | D |

| 48608 | FELOCOR 10 | por tbl pro 30x10mg | SFS | D |

| 48619 | FELOCOR 10 | por tbl pro 30x10mg | HED | DK |

| 77.5 | C08CA03 | Isradipin | p.o. | 5.00 | MG | 4.75 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 77.6 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5.00 | MG | 5.00 | |

| | | | | | | | |

| 77.7 | C08CA05 | nifedipin | p.o. | 30.00 | MG | 1.45 | |

| | | | | | | | |

| 77.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1.00 | DF | 5.00 | |

| 03033 | CORDIPIN XL | tbl ret 30x40mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 53372 | NIFECARD XL 30MG | tbl ret 30x30mg | LEK | SLO |

| 77.9 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30.00 | MG | 2.03 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 47490 | CORINFAR 20 RETARD | por tbl pro 30x20mg | AWD | D |

| --- | --- | --- | --- | --- |

| 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO |

| 77.10 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30.00 | MG | 1.37 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 77.11 | C08CA06 | nimodipin | p.o. | 0.30 | GM | 136.08 | X |

| 94189 | DILCEREN | tbl obd 50x30mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 77.12 | C08CA07 | nisoldipin | p.o. | 20.00 | MG | 5.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 77.13 | C08CA08 | nitrendipin | p.o. | 20.00 | MG | 5.00 | |

| 03078 | UNIPRES 20 | tbl 30x20mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 03079 | UNIPRES 10 | tbl 30x10mg | KRK | SLO |

| 30965 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob 100x20mg | MCK | D |

| 66469 | NITREPRESS 10 | por tbl nob 20x10mg | HHO | D |

| 66495 | NITREPRESS 10 | por tbl nob 50x10mg | HHO | D |

| 66498 | NITREPRESS 20 | por tbl nob 50x20mg | HHO | D |

| 66499 | NITREPRESS 20 | por tbl nob 20x20mg | HHO | D |

| 94688 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob 30x20mg | MCK | D |

| 95584 | NITREPRESS 10 | por tbl nob 28x10mg | HHO | D |

| 95586 | NITREPRESS 20 | por tbl nob 28x20mg | HHO | D |

| 77.14 | C08CA09 | lacidipin | p.o. | 4.00 | MG | 5.00 | |

| | | | | | | | |

| 77.15 | C08CA10 | nilvadipin do 8 mg v 1 tbl včetně | p.o. | 8.00 | MG | 5.00 | |

| | | | | | | | |

| 77.16 | C08CA10 | nilvadipin nad 8 mg v 1 tbl | p.o. | 8.00 | MG | 4.00 | |

| | | | | | | | |

| 77.17 | C08CA12 | barnidipin do 10 mg v 1 tbl včetně | p.o. | 10.00 | MG | 5.00 | |

| | | | | | | | |

| 77.18 | C08CA12 | barnidipin nad 10 mg v 1 tbl | p.o. | 10.00 | MG | 4.00 | |

| | | | | | | | |

| 77.19 | C08CA13 | lercanidipin | p.o. | 10.00 | MG | 5.00 | |

| 77.1 | C08CA01 | amlodipin do 5 mg v 1 tbl včetně | p.o. | 5.00 | MG | 4,89 | |

| 02945 | AGEN 5 | por tbl nob 30×5mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 03936 | AMLOPP-5 | por tbl nob 30×5mg | SDD | CZ |

| 03993 | NORMODIPINE 5 MG | por tbl nob 30×5mg | GED | H |

| 03998 | CARDILOPIN 5 MG | por tbl nob 30×5mg | EGI | H |

| 13464 | ORCAL 5 MG | por tbl nob 90×5mg | LEK | SLO |

| 15378 | AGEN 5 | por tbl nob 90×5mg | ZEH | CZ |

| 19440 | ORCAL 5 MG TABLETY | por tbl nob 30×5mg | LSW | PL |

| 19444 | ORCAL 5 MG TABLETY | por tbl nob 90×5mg | LSW | PL |

| 32924 | ZOREM 5 MG | por tbl nob 30×5mg | PVL | CZ |

| 42833 | AMLODIPIN-RATIOPHARM 5 MG | por tbl nob 30×5mg | MCK | D |

| 42837 | AMLODIPIN-RATIOPHARM 5 MG | por tbl nob 100×5mg | MCK | D |

| 42848 | HIPRES 5 | por tbl nob 30×5mg | KRK | SLO |

| 58415 | ORCAL 5MG | tbl 30×5mg | LEK | SLO |

| 58874 | AMLOZEK 5 | por tbl nob 30×5mg | ADD | PL |

| 95582 | ZOREM 5 MG | por tbl nob 100×5mg | PVL | CZ |

| 77.2 | C08CA01 | amlodipin nad 5 mg v 1 tbl | p.o. | 5.00 | MG | 3,91 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02954 | AGEN 10 | por tbl nob 30×10mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 03944 | AMLOPP-10 | por tbl nob 30×10mg | SDD | CZ |

| 03999 | CARDILOPIN 10 MG | por tbl nob 30×10mg | EGI | H |

| 13466 | ORCAL 10 MG | por tbl nob 90×10mg | LEK | SLO |

| 13851 | AMLODIPIN-RATIOPHARM 10 MG | por tbl nob 30×10mg | MCK | D |

| 13852 | AMLODIPIN-RATIOPHARM 10 MG | por tbl nob 100×10mg | MCK | D |

| 15379 | AGEN 10 | por tbl nob 90×10mg | ZEH | CZ |

| 19442 | ORCAL 10 MG TABLETY | por tbl nob 30×10mg | LSW | PL |

| 19446 | ORCAL 10 MG TABLETY | por tbl nob 90×10mg | LSW | PL |

| 42849 | HIPRES 10 | por tbl nob 30×10mg | KRK | SLO |

| 58417 | ORCAL 10MG | tbl 30×10mg | LEK | SLO |

| 58876 | AMLOZEK 10 | por tbl nob 30×10mg | ADD | PL |

| 77.3 | C08CA02 | felodipin do 5 mg v 1 tbl včetně | p.o. | 5.00 | MG | 4,89 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02957 | PRESID 5 MG | por tbl ret 30×5mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 02961 | PRESID 2.5 MG | por tbl ret 30×2.5mg | IXP | CZ |

| 20394 | FELODIPIN-RATIOPHARM 5 MG | por tbl pro 30×5mg | MCK | D |

| 20397 | FELODIPIN-RATIOPHARM 5 MG | por tbl pro 100×5mg | MCK | D |

| 21534 | FELOCOR 5 | por tbl pro 30×5mg | SFS | D |

| 21548 | FELOCOR 5 | por tbl pro 30×5mg | HED | DK |

| 42942 | FELODIPIN AL 5 RETARD | por tbl ret 30×5mg | APA | D |

| 48584 | FELOCOR 5 | por tbl pro 30×5mg | SFS | D |

| 48595 | FELOCOR 5 | por tbl pro 30×5mg | HED | DK |

| 77.4 | C08CA02 | felodipin nad 5 mg v 1 tbl | p.o. | 5.00 | MG | 3,91 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02959 | PRESID 10 MG | por tbl ret 30×10mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 20317 | FELODIPIN-RATIOPHARM 10 MG | por tbl pro 30×10mg | MCK | D |

| 20320 | FELODIPIN-RATIOPHARM 10 MG | por tbl pro 100×10mg | MCK | D |

| 21504 | FELOCOR 10 | por tbl pro 30×10mg | SFS | D |

| 21519 | FELOCOR 10 | por tbl pro 30×10mg | HED | DK |

| 42946 | FELODIPIN AL 10 RETARD | por tbl ret 30×10mg | APA | D |

| 48608 | FELOCOR 10 | por tbl pro 30×10mg | SFS | D |

| 48619 | FELOCOR 10 | por tbl pro 30×10mg | HED | DK |

| 77.5 | C08CA03 | Isradipin | p.o. | 5.00 | MG | 4,64 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 77.6 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5.00 | MG | 4,89 | |

| | | | | | | | |

| 77.7 | C08CA05 | nifedipin | p.o. | 30.00 | MG | 1,42 | |

| | | | | | | | |

| 77.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1.00 | DF | 4,89 | |

| 03033 | CORDIPIN XL | tbl ret 30×40mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 53372 | NIFECARD XL 30MG | tbl ret 30×30mg | LEK | SLO |

| 77.9 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30.00 | MG | 1,98 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 47490 | CORINFAR 20 RETARD | por tbl pro 30×20mg | AWD | D |

| --- | --- | --- | --- | --- |

| 93460 | CORDIPIN RETARD | tbl ret 30×20mg | KRK | SLO |

| 77.10 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30.00 | MG | 1,34 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 77.11 | C08CA06 | nimodipin | p.o. | 0.30 | GM | 132,99 | X |

| 94189 | DILCEREN | tbl obd 50×30mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 77.12 | C08CA07 | nisoldipin | p.o. | 20.00 | MG | 4,89 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 77.13 | C08CA08 | nitrendipin | p.o. | 20.00 | MG | 4,89 | |

| 03078 | UNIPRES 20 | tbl 30×20mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 03079 | UNIPRES 10 | tbl 30×10mg | KRK | SLO |

| 30965 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob 100×20mg | MCK | D |

| 66469 | NITREPRESS 10 | por tbl nob 20×10mg | HHO | D |

| 66495 | NITREPRESS 10 | por tbl nob 50×10mg | HHO | D |

| 66498 | NITREPRESS 20 | por tbl nob 50×20mg | HHO | D |

| 66499 | NITREPRESS 20 | por tbl nob 20×20mg | HHO | D |

| 94688 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob 30×20mg | MCK | D |

| 95584 | NITREPRESS 10 | por tbl nob 28×10mg | HHO | D |

| 95586 | NITREPRESS 20 | por tbl nob 28×20mg | HHO | D |

| 77.14 | C08CA09 | lacidipin | p.o. | 4.00 | MG | 4,89 | |

| | | | | | | | |

| 77.15 | C08CA10 | nilvadipin do 8 mg v 1 tbl včetně | p.o. | 8.00 | MG | 4,89 | |

| | | | | | | | |

| 77.16 | C08CA10 | nilvadipin nad 8 mg v 1 tbl | p.o. | 8.00 | MG | 3,91 | |

| | | | | | | | |

| 77.17 | C08CA12 | barnidipin do 10 mg v 1 tbl včetně | p.o. | 10.00 | MG | 4,89 | |

| | | | | | | | |

| 77.18 | C08CA12 | barnidipin nad 10 mg v 1 tbl | p.o. | 10.00 | MG | 3,91 | |

| | | | | | | | |

| 77.19 | C08CA13 | lercanidipin | p.o. | 10.00 | MG | 4,89 | |

| | | | | | | | |

| 78 | blokátory vápníkových kanálů ostatních skupin, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 78.1 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 5.00 | |

| 43879 | VEROGALID ER 240 MG | portblpro 100x240mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 54032 | VERAPAMIL AL 240 RETARD | por tbl ret50x240mg | APA | D |

| 54034 | VERAPAMIL AL 240 RETARD | por tblret100x240mg | APA | D |

| 56164 | VERAHEXAL RR | tbl ret 30x240mg | FST | D |

| 56165 | VERAHEXAL RR | tbl ret 50x240mg | FST | D |

| 56166 | VERAHEXAL RR | tbl ret 100x240mg | FST | D |

| 93679 | LEKOPTIN RETARD | tbl ret 20x240mg | LEK | SLO |

| 99575 | VEROGALID ER 240 MG | por tblpro30x240mg | IXP | CZ |

| 78.2 | C08DA01 | verapamil neretardované lékové formy do 240 mg v jedné tabletě včetně | p.o. | 0.24 | GM | 4.50 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17841 | VERAHEXAL 120 | portblflm30x120mg | HPZ | PL |

| --- | --- | --- | --- | --- |

| 17842 | VERAHEXAL 120 | portblflm 50x120mg | HPZ | PL |

| 17843 | VERAHEXAL 120 | portblflm100x120mg | HPZ | PL |

| 17844 | VERAHEXAL 80 | portblflm 30x80mg | HPZ | PL |

| 56152 | VERAHEXAL 40 | tbl obd 30x40mg | FST | D |

| 56155 | VERAHEXAL 80 | tbl obd 30x80mg | FST | D |

| 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D |

| 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D |

| 56160 | VERAHEXAL 120 | tbl obd 100x120mg | FST | D |

| 56161 | VERAHEXAL KHK RETARD | tbl ret 30x120mg | FST | D |

| 56162 | VERAHEXAL KHK RETARD | tbl ret 50x120mg | FST | D |

| 56163 | VERAHEXAL KHK RETARD | tbl ret 100x120mg | FST | D |

| 77037 | VERAPAMIL AL 80 | por tblflm100x80mg | APA | D |

| 86046 | VERAPAMIL AL 120 | por tblflm100x120mg | APA | D |

| 78.3 | C08DA02 | gallopamil | p.o. | 0.10 | GM | 4.50 | |

| | | | | | | | |

| 78.4 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 4.75 | |

| | | | | | | | |

| 78.5 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5.00 | |

| 78.1 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 4,89 | |

| 43879 | VEROGALID ER 240 MG | por tbl pro 100×240mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 54032 | VERAPAMIL AL 240 RETARD | por tbl ret 50×240mg | APA | D |

| 54034 | VERAPAMIL AL 240 RETARD | por tbl ret 100×240mg | APA | D |

| 56164 | VERAHEXAL RR | tbl ret 30×240mg | FST | D |

| 56165 | VERAHEXAL RR | tbl ret 50×240mg | FST | D |

| 56166 | VERAHEXAL RR | tbl ret 100×240mg | FST | D |

| 93679 | LEKOPTIN RETARD | tbl ret 20×240mg | LEK | SLO |

| 99575 | VEROGALID ER 240 MG | por tbl pro 30×240mg | IXP | CZ |

| 78.2 | C08DA01 | verapamil neretardované lékové formy do 240 mg v jedné tabletě včetně | p.o. | 0.24 | GM | 4,40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17841 | VERAHEXAL 120 | por tbl flm30×120mg | HPZ | PL |

| --- | --- | --- | --- | --- |

| 17842 | VERAHEXAL 120 | por tbl flm 50×120mg | HPZ | PL |

| 17843 | VERAHEXAL 120 | por tbl flm 100×120mg | HPZ | PL |

| 17844 | VERAHEXAL 80 | por tbl flm 30×80mg | HPZ | PL |

| 56152 | VERAHEXAL 40 | tbl obd 30×40mg | FST | D |

| 56155 | VERAHEXAL 80 | tbl obd 30×80mg | FST | D |

| 56158 | VERAHEXAL 120 | tbl obd 30×120mg | FST | D |

| 56159 | VERAHEXAL 120 | tbl obd 50×120mg | FST | D |

| 56160 | VERAHEXAL 120 | tbl obd 100×120mg | FST | D |

| 56161 | VERAHEXAL KHK RETARD | tbl ret 30×120mg | FST | D |

| 56162 | VERAHEXAL KHK RETARD | tbl ret 50×120mg | FST | D |

| 56163 | VERAHEXAL KHK RETARD | tbl ret 100×120mg | FST | D |

| 77037 | VERAPAMIL AL 80 | por tbl flm100×80mg | APA | D |

| 86046 | VERAPAMIL AL 120 | por tbl flm 100×120mg | APA | D |

| 78.3 | C08DA02 | gallopamil | p.o. | 0.10 | GM | 4,40 | |

| | | | | | | | |

| 78.4 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 4,64 | |

| | | | | | | | |

| 78.5 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 4,89 | |

| | | | | | | | |

| 79 | blokátory vápníkových kanálů, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 79.1 | C08CA03 | isradipin | parent. | 5.00 | MG | 3 074.59 | H |

| | | | | | | | |

| 79.2 | C08CA05 | nifedipin | parent. | 30.00 | MG | 3 074.59 | H |

| | | | | | | | |

| 79.3 | C08CA06 | nimodipin | parent. | 50.00 | MG | 3 019.19 | X |

| 94535 | NIMOTOP S | inf sol 5x50ml/10mg | BAY | D |

| --- | --- | --- | --- | --- |

| 79.4 | C08DA01 | verapamil | parent. | 0.24 | GM | 355.24 | H |

| | | | | | | | |

| 79.5 | C08DB01 | diltiazem | parent. | 25.00 | MG | 332.07 | H |

| 79.1 | C08CA03 | isradipin | parent. | 5.00 | MG | 3 004,80 | H |

| | | | | | | | |

| 79.2 | C08CA05 | nifedipin | parent. | 30.00 | MG | 3 004,80 | H |

| | | | | | | | |

| 79.3 | C08CA06 | nimodipin | parent. | 50.00 | MG | 2 950,65 | X |

| 94535 | NIMOTOP S | inf sol 5×50ml/10mg | BAY | D |

| --- | --- | --- | --- | --- |

| 79.4 | C08DA01 | verapamil | parent. | 0.24 | GM | 347,18 | H |

| | | | | | | | |

| 79.5 | C08DB01 | diltiazem | parent. | 25.00 | MG | 324,53 | H |

| | | | | | | | |

| 80 | ACE inhibitory působící méně než 24 hodin | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 80.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50.00 | MG | 3.90 | |

| 15327 | APO-CAPTO 12.5 MG | tbl 100x12.5mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 16564 | APO-CAPTO 12.5 MG | tbl 100x12.5mg | KAT | NL |

| 96903 | APO-CAPTO 12.5 MG | tbl 100x12.5mg | APT | CND |

| 80.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50.00 | MG | 3.60 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15326 | APO-CAPTO 25 MG | tbl 100x25mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 16563 | APO-CAPTO 25 MG | tbl 100x25mg | KAT | NL |

| 68839 | APO-CAPTO 25 MG | tbl 100x25mg | APT | CND |

| 80.3 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50.00 | MG | 3.40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 80.4 | C09AA02 | enalapril hydrogenmaleát (do 5 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 4.00 | |

| 20419 | ENALAPRIL AL 5 | por tbl nob 100x5mg | APA | D |

| --- | --- | --- | --- | --- |

| 32758 | ENALEK 5 MG | por tbl nob 30x5mg | LEK | SLO |

| 59879 | ENAPRIL 5 | tbl 100x5mg | SFS | D |

| 80.5 | C09AA02 | enalapril hydrogenmaleát (nad 10 mg v jedné tabletě) | p.o. | 10.00 | MG | 2.30 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32760 | ENALEK 20 MG | por tbl nob 30x20mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 80.6 | C09AA02 | enalapril hydrogenmaleát (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 3.30 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 20422 | ENALAPRIL AL 10 | por tbl nob100x10mg | APA | D |

| --- | --- | --- | --- | --- |

| 32759 | ENALEK 10 MG | por tbl nob 30x10mg | LEK | SLO |

| 80.7 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 24.39 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 62597 | ENAP I.V. | inj 5x1ml/1.25mg | KRK | SLO |

| 80.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50.00 | MG | 3,81 | |

| 15327 | APO-CAPTO 12.5 MG | tbl 100×12.5mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 16564 | APO-CAPTO 12.5 MG | tbl 100×12.5mg | KAT | NL |

| 96903 | APO-CAPTO 12.5 MG | tbl 100×12.5mg | APT | CND |

| 80.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50.00 | MG | 3,52 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15326 | APO-CAPTO 25 MG | tbl 100×25mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 16563 | APO-CAPTO 25 MG | tbl 100×25mg | KAT | NL |

| 68839 | APO-CAPTO 25 MG | tbl 100×25mg | APT | CND |

| 80.3 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50.00 | MG | 3,32 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 80.4 | C09AA02 | enalapril hydrogenmaleát (do 5 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 3,91 | |

| 20419 | ENALAPRIL AL 5 | por tbl nob 100×5mg | APA | D |

| --- | --- | --- | --- | --- |

| 32758 | ENALEK 5 MG | por tbl nob 30×5mg | LEK | SLO |

| 59879 | ENAPRIL 5 | tbl 100×5mg | SFS | D |

| 80.5 | C09AA02 | enalapril hydrogenmaleát (nad 10 mg v jedné tabletě) | p.o. | 10.00 | MG | 2,25 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32760 | ENALEK 20 MG | por tbl nob 30×20mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 80.6 | C09AA02 | enalapril hydrogenmaleát (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 3,23 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 20422 | ENALAPRIL AL 10 | por tbl nob100×10mg | APA | D |

| --- | --- | --- | --- | --- |

| 32759 | ENALEK 10 MG | por tbl nob 30×10mg | LEK | SLO |

| 80.7 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 23,84 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 62597 | ENAP I.V. | inj 5×1ml/1.25mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 81 | ostatní ACE-inhibitory | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 81.1 | C09AA03 | lisinopril | p.o. | 10.00 | MG | 4.50 | |

| 10625 | LISINOPRIL-RATIOPHARM 5 MG | por tbl nob 30x5mg | MCK | D |

| --- | --- | --- | --- | --- |

| 10629 | LISINOPRIL-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D |

| 10683 | LISINOPRIL-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D |

| 10685 | LISINOPRIL-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D |

| 10884 | LISINOPRIL-RATIOPHARM 20 MG | por tbl nob30x20mg | MCK | D |

| 11006 | DIROTON 10 MG | tbl 100x10mg | GED | H |

| 32501 | DAPRIL 5 | por tbl nob 100x5mg | MOE | CY |

| 32503 | DAPRIL 10 | por tbl nob 100x10mg | MOE | CY |

| 32505 | DAPRIL 20 | por tbl nob 60x20mg | MOE | CY |

| 95657 | LISIPRIL 5 | por tbl nob 30x5mg | SFS | D |

| 95665 | LISIPRIL 10 | por tbl nob 30x10mg | SFS | D |

| 95673 | LISIPRIL 20 | por tbl nob 30x20mg | SFS | D |

| 81.2 | C09AA04 | perindopril do 4 mg v 1 tbl včetně | p.o. | 4.00 | MG | 5.53 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 81.3 | C09AA04 | perindopril nad 4 mg v 1 tbl | p.o. | 4.00 | MG | 3.87 | |

| | | | | | | | |

| 81.4 | C09AA05 | ramipril do 2,5 mg v jedné tabletě včetně | p.o. | 2.50 | MG | 5.53 | |

| 01436 | PIRAMIL 1.25 MG | por tblnob30x1.25mg | LSW | PL |

| --- | --- | --- | --- | --- |

| 01444 | PIRAMIL 1.25 MG | portblnob100x1.25mg | LSW | PL |

| 01544 | PIRAMIL 2.5 MG | por tbl nob30x2.5mg | LSW | PL |

| 01564 | PIRAMIL 2.5 MG | por tblnob100x2.5mg | LSW | PL |

| 13469 | RAMIL 1.25 | por tblnob30x1.25mg | ZEH | CZ |

| 13470 | RAMIL 1.25 | por tblnob90x1.25mg | ZEH | CZ |

| 13472 | RAMIL 2.5 | por tblnob 30x2.5mg | ZEH | CZ |

| 13473 | RAMIL 2.5 | por tblnob 90x2.5mg | ZEH | CZ |

| 16405 | PIRAMIL 1.25 MG | por tblnob30x1.25mg | SZP | D |

| 16407 | PIRAMIL 1.25 MG | portblnob100x1.25mg | SZP | D |

| 16420 | PIRAMIL 2.5 MG | por tbl nob30x2.5mg | SZP | D |

| 16422 | PIRAMIL 2.5 MG | por tblnob100x2.5mg | SZP | D |

| 18668 | RAMILIFE 2.5 MG | por tbl nob30x2.5mg | AHJ | IS |

| 23954 | AMPRILAN 1.25 | portblnob 30x1.25mg | KRK | SLO |

| 23956 | AMPRILAN 1.25 | portblnob 60x1.25mg | KRK | SLO |

| 23957 | AMPRILAN 1.25 | portblnob 90x1.25mg | KRK | SLO |

| 23958 | AMPRILAN 2.5 | portbl nob 30x2.5mg | KRK | SLO |

| 23960 | AMPRILAN 2.5 | portbl nob 60x2.5mg | KRK | SLO |

| 23961 | AMPRILAN 2.5 | portbl nob 90x2.5mg | KRK | SLO |

| 48752 | HARTIL 1.25 MG | portblnob 28x1.25mg | EGI | H |

| 48753 | HARTIL 2.5 MG | portblnob 28x2.5mg | EGI | H |

| 81.5 | C09AA05 | ramipril nad 2,5 mg do 5 mg v jedné tabletě včetně | p.o. | 2.50 | MG | 3.87 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01874 | PIRAMIL 5 MG | por tbl nob 30x5mg | LSW | PL |

| --- | --- | --- | --- | --- |

| 01893 | PIRAMIL 5 MG | por tbl nob100x5mg | LSW | PL |

| 13475 | RAMIL 5 | por tblnob 30x5mg | ZEH | CZ |

| 13476 | RAMIL 5 | por tblnob 90x5mg | ZEH | CZ |

| 16367 | PIRAMIL 5 MG | por tbl nob 30x5mg | SZP | D |

| 16369 | PIRAMIL 5 MG | por tbl nob100x5mg | SZP | D |

| 23962 | AMPRILAN 5 | por tbl nob 30x5mg | KRK | SLO |

| 23964 | AMPRILAN 5 | por tbl nob 60x5mg | KRK | SLO |

| 23965 | AMPRILAN 5 | por tbl nob 90x5mg | KRK | SLO |

| 48754 | HARTIL 5 MG | portblnob 28x5mg | EGI | H |

| 81.6 | C09AA05 | ramipril nad 5 mg v jedné tabletě | p.o. | 2.50 | MG | 2.70 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02023 | PIRAMIL 10 MG | por tbl nob 30x10mg | LSW | PL |

| --- | --- | --- | --- | --- |

| 02058 | PIRAMIL 10 MG | por tbl nob100x10mg | LSW | PL |

| 13477 | RAMIL 10 | por tblnob 30x10mg | ZEH | CZ |

| 13478 | RAMIL 10 | por tblnob 90x10mg | ZEH | CZ |

| 16383 | PIRAMIL 10 MG | por tbl nob 30x10mg | SZP | D |

| 16385 | PIRAMIL 10 MG | por tbl nob100x10mg | SZP | D |

| 23966 | AMPRILAN 10 | por tbl nob 30x10mg | KRK | SLO |

| 23968 | AMPRILAN 10 | por tbl nob 60x10mg | KRK | SLO |

| 23969 | AMPRILAN 10 | por tbl nob 90x10mg | KRK | SLO |

| 48755 | HARTIL 10 MG | portblnob 28x10mg | EGI | H |

| 81.7 | C09AA06 | quinapril do 15 mg v jedné tabletě včetně | p.o. | 15.00 | MG | 5.53 | |

| | | | | | | | |

| 81.8 | C09AA06 | quinapril nad 15 mg v jedné tabletě | p.o. | 15.00 | MG | 3.87 | |

| | | | | | | | |

| 81.9 | C09AA07 | benazepril | p.o. | 7.50 | MG | 5.53 | |

| | | | | | | | |

| 81.10 | C09AA08 | cilazapril do 2,5 mg v 1 tbl včetně | p.o. | 2.50 | MG | 5.53 | |

| | | | | | | | |

| 81.11 | C09AA08 | cilazapril nad 2,5 mg v 1 tbl | p.o. | 2.50 | MG | 3.87 | |

| | | | | | | | |

| 81.12 | C09AA09 | fosinopril | p.o. | 15.00 | MG | 3.87 | |

| | | | | | | | |

| 81.13 | C09AA10 | trandolapril | p.o. | 2.00 | MG | 5.53 | |

| | | | | | | | |

| 81.14 | C09AA11 | spirapril | p.o. | 6.00 | MG | 5.53 | |

| | | | | | | | |

| 81.15 | C09AA12 | delapril | p.o. | 30.00 | MG | 5.53 | |

| | | | | | | | |

| 81.16 | C09AA13 | moexipril | p.o. | 15.00 | MG | 5.53 | |

| | | | | | | | |

| 81.17 | C09AA16 | imidapril do 5 mg v jedné tabletě včetně | p.o. | 5.00 | MG | 5.53 | |

| | | | | | | | |

| 81.18 | C09AA16 | imidapril nad 5 mg v jedné tabletě | p.o. | 5.00 | MG | 3.87 | |

| 81.1 | C09AA03 | lisinopril | p.o. | 10.00 | MG | 4,40 | |

| 10625 | LISINOPRIL-RATIOPHARM 5 MG | por tbl nob 30×5mg | MCK | D |

| --- | --- | --- | --- | --- |

| 10629 | LISINOPRIL-RATIOPHARM 5 MG | por tbl nob 100×5mg | MCK | D |

| 10683 | LISINOPRIL-RATIOPHARM 10 MG | por tbl nob 30×10mg | MCK | D |

| 10685 | LISINOPRIL-RATIOPHARM 10 MG | por tbl nob 100×10mg | MCK | D |

| 10884 | LISINOPRIL-RATIOPHARM 20 MG | por tbl nob 30×20mg | MCK | D |

| 11006 | DIROTON 10 MG | tbl 100×10mg | GED | H |

| 32501 | DAPRIL 5 | por tbl nob 100×5mg | MOE | CY |

| 32503 | DAPRIL 10 | por tbl nob 100×10mg | MOE | CY |

| 32505 | DAPRIL 20 | por tbl nob 60×20mg | MOE | CY |

| 95657 | LISIPRIL 5 | por tbl nob 30×5mg | SFS | D |

| 95665 | LISIPRIL 10 | por tbl nob 30×10mg | SFS | D |

| 95673 | LISIPRIL 20 | por tbl nob 30×20mg | SFS | D |

| 81.2 | C09AA04 | perindopril do 4 mg v 1 tbl včetně | p.o. | 4.00 | MG | 5,40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 81.3 | C09AA04 | perindopril nad 4 mg v 1 tbl | p.o. | 4.00 | MG | 3,78 | |

| | | | | | | | |

| 81.4 | C09AA05 | ramipril do 2,5 mg v jedné tabletě včetně | p.o. | 2.50 | MG | 5,40 | |

| 01436 | PIRAMIL 1.25 MG | por tbl nob 30×1.25mg | LSW | PL |

| --- | --- | --- | --- | --- |

| 01444 | PIRAMIL 1.25 MG | por tbl nob 100×1.25mg | LSW | PL |

| 01544 | PIRAMIL 2.5 MG | por tbl nob 30×2.5mg | LSW | PL |

| 01564 | PIRAMIL 2.5 MG | por tbl nob 100×2.5mg | LSW | PL |

| 13469 | RAMIL 1.25 | por tbl nob 30×1.25mg | ZEH | CZ |

| 13470 | RAMIL 1.25 | por tbl nob 90×1.25mg | ZEH | CZ |

| 13472 | RAMIL 2.5 | por tbl nob 30×2.5mg | ZEH | CZ |

| 13473 | RAMIL 2.5 | por tbl nob 90×2.5mg | ZEH | CZ |

| 16405 | PIRAMIL 1.25 MG | por tbl nob 30×1.25mg | SZP | D |

| 16407 | PIRAMIL 1.25 MG | por tbl nob 100×1.25mg | SZP | D |

| 16420 | PIRAMIL 2.5 MG | por tbl nob 30×2.5mg | SZP | D |

| 16422 | PIRAMIL 2.5 MG | por tbl nob 100×2.5mg | SZP | D |

| 18668 | RAMILIFE 2.5 MG | por tbl nob 30×2.5mg | AHJ | IS |

| 23954 | AMPRILAN 1.25 | por tbl nob 30×1.25mg | KRK | SLO |

| 23956 | AMPRILAN 1.25 | por tbl nob 60×1.25mg | KRK | SLO |

| 23957 | AMPRILAN 1.25 | por tbl nob 90×1.25mg | KRK | SLO |

| 23958 | AMPRILAN 2.5 | por tbl nob 30×2.5mg | KRK | SLO |

| 23960 | AMPRILAN 2.5 | por tbl nob 60×2.5mg | KRK | SLO |

| 23961 | AMPRILAN 2.5 | por tbl nob 90×2.5mg | KRK | SLO |

| 48752 | HARTIL 1.25 MG | por tbl nob 28×1.25mg | EGI | H |

| 48753 | HARTIL 2.5 MG | por tbl nob 28×2.5mg | EGI | H |

| 81.5 | C09AA05 | ramipril nad 2,5 mg do 5 mg v jedné tabletě včetně | p.o. | 2.50 | MG | 3,78 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01874 | PIRAMIL 5 MG | por tbl nob 30×5mg | LSW | PL |

| --- | --- | --- | --- | --- |

| 01893 | PIRAMIL 5 MG | por tbl nob 100×5mg | LSW | PL |

| 13475 | RAMIL 5 | por tbl nob 30×5mg | ZEH | CZ |

| 13476 | RAMIL 5 | por tbl nob 90×5mg | ZEH | CZ |

| 16367 | PIRAMIL 5 MG | por tbl nob 30×5mg | SZP | D |

| 16369 | PIRAMIL 5 MG | por tbl nob 100×5mg | SZP | D |

| 23962 | AMPRILAN 5 | por tbl nob 30×5mg | KRK | SLO |

| 23964 | AMPRILAN 5 | por tbl nob 60×5mg | KRK | SLO |

| 23965 | AMPRILAN 5 | por tbl nob 90×5mg | KRK | SLO |

| 48754 | HARTIL 5 MG | por tbl nob 28×5mg | EGI | H |

| 81.6 | C09AA05 | ramipril nad 5 mg v jedné tabletě | p.o. | 2.50 | MG | 2,64 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02023 | PIRAMIL 10 MG | por tbl nob 30×10mg | LSW | PL |

| --- | --- | --- | --- | --- |

| 02058 | PIRAMIL 10 MG | por tbl nob 100×10mg | LSW | PL |

| 13477 | RAMIL 10 | por tbl nob 30×10mg | ZEH | CZ |

| 13478 | RAMIL 10 | por tbl nob 90×10mg | ZEH | CZ |

| 16383 | PIRAMIL 10 MG | por tbl nob 30×10mg | SZP | D |

| 16385 | PIRAMIL 10 MG | por tbl nob 100×10mg | SZP | D |

| 23966 | AMPRILAN 10 | por tbl nob 30×10mg | KRK | SLO |

| 23968 | AMPRILAN 10 | por tbl nob 60×10mg | KRK | SLO |

| 23969 | AMPRILAN 10 | por tbl nob 90×10mg | KRK | SLO |

| 48755 | HARTIL 10 MG | por tbl nob 28×10mg | EGI | H |

| 81.7 | C09AA06 | quinapril do 15 mg v jedné tabletě včetně | p.o. | 15.00 | MG | 5,40 | |

| | | | | | | | |

| 81.8 | C09AA06 | quinapril nad 15 mg v jedné tabletě | p.o. | 15.00 | MG | 3,78 | |

| | | | | | | | |

| 81.9 | C09AA07 | benazepril | p.o. | 7.50 | MG | 5,40 | |

| | | | | | | | |

| 81.10 | C09AA08 | cilazapril do 2,5 mg v 1 tbl včetně | p.o. | 2.50 | MG | 5,40 | |

| | | | | | | | |

| 81.11 | C09AA08 | cilazapril nad 2,5 mg v 1 tbl | p.o. | 2.50 | MG | 3,78 | |

| | | | | | | | |

| 81.12 | C09AA09 | fosinopril | p.o. | 15.00 | MG | 3,78 | |

| | | | | | | | |

| 81.13 | C09AA10 | trandolapril | p.o. | 2.00 | MG | 5,40 | |

| | | | | | | | |

| 81.14 | C09AA11 | spirapril | p.o. | 6.00 | MG | 5,40 | |

| | | | | | | | |

| 81.15 | C09AA12 | delapril | p.o. | 30.00 | MG | 5,40 | |

| | | | | | | | |

| 81.16 | C09AA13 | moexipril | p.o. | 15.00 | MG | 5,40 | |

| | | | | | | | |

| 81.17 | C09AA16 | imidapril do 5 mg v jedné tabletě včetně | p.o. | 5.00 | MG | 5,40 | |

| | | | | | | | |

| 81.18 | C09AA16 | imidapril nad 5 mg v jedné tabletě | p.o. | 5.00 | MG | 3,78 | |

| | | | | | | | |

| 82 | kombinace léčiv působících na renin-angiotenzinový systém s dalšími antihypertenzivy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 82.1 | C09BA01 | kaptopril a diuretika | p.o. | 1.00 | DF | 4.34 | |

| | | | | | | | |

| 82.2 | C09BA02 | enalapril a diuretika | p.o. | 1.00 | DF | 3.97 | |

| 82.1 | C09BA01 | kaptopril a diuretika | p.o. | 1.00 | DF | 4,24 | |

| | | | | | | | |

| 82.2 | C09BA02 | enalapril a diuretika | p.o. | 1.00 | DF | 3,88 | |

| 55429 | ENAP-HL | por tbl nob 30 | KRK | SLO |

| --- | --- | --- | --- | --- |

| 66506 | ENAP-H | por tbl nob 30 | KRK | SLO |

| 82.3 | C09BA04 | perindopril a indapamid 2mg/0,625 mg | p.o. | 1.00 | DF | 3.05 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 82.4 | C09BA04 | perindopril a indapamid 4 mg/1,25 mg | p.o. | 1.00 | DF | 6.09 | |

| | | | | | | | |

| 82.5 | C09BA05 | ramipril s obsahem 2,5 mg a diuretikum s obsahem 12,5 mg v jedné tabletě | p.o. | 1.00 | DF | 6.00 | |

| 82.3 | C09BA04 | perindopril a indapamid 2mg/0,625 mg | p.o. | 1.00 | DF | 2,98 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 82.4 | C09BA04 | perindopril a indapamid 4 mg/1,25 mg | p.o. | 1.00 | DF | 5,95 | |

| | | | | | | | |

| 82.5 | C09BA05 | ramipril s obsahem 2,5 mg a diuretikum s obsahem 12,5 mg v jedné tabletě | p.o. | 1.00 | DF | 5,86 | |

| 95275 | RAMIL H | por tbl nob 30 | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 82.6 | C09BA05 | ramipril s obsahem 5 mg a diuretikum s obsahem 25 mg v jedné tabletě | p.o. | 1.00 | DF | 8.68 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 82.7 | C09BA06 | quinapril s obsahem 10 mg v jedné tabletě a diuretikum | p.o. | 1.00 | DF | 4.16 | |

| | | | | | | | |

| 82.8 | C09BA06 | quinapril s obsahem 20 mg v jedné tabletě a diuretikum s obsahem 12,5 mg | p.o. | 1.00 | DF | 5.63 | |

| 82.9 | C09BA06 | quinapril s obsahem 20 mg v jedné tabletě a diuretikum s obsahem 25 mg | p.o. | 1.00 | DF | 6.10 | |

| | | | | | | | |

| 82.10 | C09BA07 | benazepril a diuretika | p.o. | 1.00 | DF | 5.06 | |

| | | | | | | | |

| 82.11 | C09BA08 | cilazapril a diuretika | p.o. | 1.00 | DF | 8.21 | |

| | | | | | | | |

| 82.12 | C09BB05 | ramipril s obsahem 2,5 mg a felodipin s obsahem 2,5 mg v jedné tabletě | p.o. | 1.00 | DF | 8.03 | |

| | | | | | | | |

| 82.13 | C09BB05 | ramipril s obsahem 5 mg a felodipin s obsahem 5 mg v jedné tabletě | p.o. | 1.00 | DF | 12.74 | |

| | | | | | | | |

| 82.14 | C09BB10 | trandolapril a verapamil | p.o. | 1.00 | DF | 9.28 | |

| | | | | | | | |

| 82.15 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1.00 | DF | 6.00 | |

| 82.6 | C09BA05 | ramipril s obsahem 5 mg a diuretikum s obsahem 25 mg v jedné tabletě | p.o. | 1.00 | DF | 8,48 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 82.7 | C09BA06 | quinapril s obsahem 10 mg v jedné tabletě a diuretikum | p.o. | 1.00 | DF | 4,07 | |

| | | | | | | | |

| 82.8 | C09BA06 | quinapril s obsahem 20 mg v jedné tabletě a diuretikum s obsahem 12,5 mg | p.o. | 1.00 | DF | 5,50 | |

| | | | | | | | |

| 82.9 | C09BA06 | quinapril s obsahem 20 mg v jedné tabletě a diuretikum s obsahem 25 mg | p.o. | 1.00 | DF | 5,96 | |

| | | | | | | | |

| 82.10 | C09BA07 | benazepril a diuretika | p.o. | 1.00 | DF | 4,95 | |

| | | | | | | | |

| 82.11 | C09BA08 | cilazapril a diuretika | p.o. | 1.00 | DF | 8,02 | |

| | | | | | | | |

| 82.12 | C09BB05 | ramipril s obsahem 2,5 mg a felodipin s obsahem 2,5 mg v jedné tabletě | p.o. | 1.00 | DF | 7,85 | |

| | | | | | | | |

| 82.13 | C09BB05 | ramipril s obsahem 5 mg a felodipin s obsahem 5 mg v jedné tabletě | p.o. | 1.00 | DF | 12,45 | |

| | | | | | | | |

| 82.14 | C09BB10 | trandolapril a verapamil | p.o. | 1.00 | DF | 9,07 | |

| | | | | | | | |

| 82.15 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1.00 | DF | 5,86 | |

| 97027 | LORISTA H | por tbl flm 28 | KRK | SLO |

| --- | --- | --- | --- | --- |

| 82.16 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 12,5 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1.00 | DF | 8.21 | |

| | | | | | | | |

| 82.17 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 25 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1.00 | DF | 8.68 | |

| | | | | | | | |

| 82.18 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 80 mg valsartanu v jedné tabletě včetně | p.o. | 1.00 | DF | 6.00 | |

| | | | | | | | |

| 82.19 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 16 mg kandesartanu v jedné tabletě | p.o. | 1.00 | DF | 8.21 | |

| | | | | | | | |

| 82.20 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 8 mg kandesartanu v jedné tabletě | p.o. | 1.00 | DF | 6.00 | |

| | | | | | | | |

| 82.21 | C09DA07 | telmisartan v kombinaci s thiazidy s obsahem 40 mg telmisartanu v jedné tabletě | p.o. | 1.00 | DF | 6.00 | |

| | | | | | | | |

| 82.22 | C09DA07 | telmisartan v kombinaci s thiazidy s obsahem 80 mg telmisartanu v jedné tabletě | p.o. | 1.00 | DF | 8.21 | |

| 82.16 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 12,5 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1.00 | DF | 8,02 | |

| | | | | | | | |

| 82.17 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 25 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1.00 | DF | 8,48 | |

| | | | | | | | |

| 82.18 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 80 mg valsartanu v jedné tabletě včetně | p.o. | 1.00 | DF | 5,86 | |

| | | | | | | | |

| 82.19 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 16 mg kandesartanu v jedné tabletě | p.o. | 1.00 | DF | 8,02 | |

| | | | | | | | |

| 82.20 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 8 mg kandesartanu v jedné tabletě | p.o. | 1.00 | DF | 5,86 | |

| | | | | | | | |

| 82.21 | C09DA07 | telmisartan v kombinaci s thiazidy s obsahem 40 mg telmisartanu v jedné tabletě | p.o. | 1.00 | DF | 5,86 | |

| | | | | | | | |

| 82.22 | C09DA07 | telmisartan v kombinaci s thiazidy s obsahem 80 mg telmisartanu v jedné tabletě | p.o. | 1.00 | DF | 8,02 | |

| | | | | | | | |

| 83 | léčiva ovlivňující systém renin-angiotenzin s výjimkou ACE-inhibitorů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 83.1 | C09CA01 | losartan do 50 mg v jedné tabletě včetně | p.o. | 50.00 | MG | 5.53 | |

| 10604 | LORISTA | por tblflm 28x50mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 10618 | LOZAP 12.5 | portblflm 30x12.5mg | ZEH | CZ |

| 10620 | LOZAP 50 | por tbl flm 30x50mg | ZEH | CZ |

| 13886 | LOZAP 12.5 ZENTIVA | portblflm 30x12.5mg | ZEH | SK |

| 13888 | LOZAP 12.5 ZENTIVA | portblflm 90x12.5mg | ZEH | SK |

| 13892 | LOZAP 50 ZENTIVA | por tbl flm 30x50mg | ZEH | SK |

| 13894 | LOZAP 50 ZENTIVA | por tbl flm 90x50mg | ZEH | SK |

| 15403 | LORISTA | por tblflm 56x50mg | KRK | SLO |

| 17963 | LOZAP 50 | por tbl flm 90x50mg | ZEH | CZ |

| 47610 | LORISTA | por tblflm 84x50mg | KRK | SLO |

| 95461 | LAKEA 50 MG | por tbl flm 30x50mg | LEK | SLO |

| 97062 | LOZAP 50 | por tbl flm 30x50mg | ZEH | CZ |

| 83.2 | C09CA01 | losartan nad 50 mg v jedné tabletě včetně | p.o. | 50.00 | MG | 3.87 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 83.3 | C09CA02 | eprosartan | p.o. | 600.00 | MG | 5.53 | |

| | | | | | | | |

| 83.4 | C09CA03 | valsartan do 80 mg v jedné tabletě včetně | p.o. | 80.00 | MG | 5.53 | |

| | | | | | | | |

| 83.5 | C09CA03 | valsartan nad 80 mg v jedné tabletě | p.o. | 80.00 | MG | 3.87 | |

| | | | | | | | |

| 83.6 | C09CA04 | irbesartan do 150 mg v jedné tabletě včetně | p.o. | 150.00 | MG | 7.68 | P |

| | | | | | | | |

| 83.7 | C09CA04 | irbesartan nad 150 mg v jedné tabletě | p.o. | 150.00 | MG | 6.12 | P |

| 83.1 | C09CA01 | losartan do 50 mg v jedné tabletě včetně | p.o. | 50.00 | MG | 5,40 | |

| 10604 | LORISTA | por tbl flm 28×50mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 10618 | LOZAP 12.5 | por tbl flm 30×12.5mg | ZEH | CZ |

| 10620 | LOZAP 50 | por tbl flm 30×50mg | ZEH | CZ |

| 13886 | LOZAP 12.5 ZENTIVA | por tbl flm 30×12.5mg | ZEH | SK |

| 13888 | LOZAP 12.5 ZENTIVA | por tbl flm 90×12.5mg | ZEH | SK |

| 13892 | LOZAP 50 ZENTIVA | por tbl flm 30×50mg | ZEH | SK |

| 13894 | LOZAP 50 ZENTIVA | por tbl flm 90×50mg | ZEH | SK |

| 15403 | LORISTA | por tbl flm 56×50mg | KRK | SLO |

| 17963 | LOZAP 50 | por tbl flm 90×50mg | ZEH | CZ |

| 47610 | LORISTA | por tbl flm 84×50mg | KRK | SLO |

| 95461 | LAKEA 50 MG | por tbl flm 30×50mg | LEK | SLO |

| 97062 | LOZAP 50 | por tbl flm 30×50mg | ZEH | CZ |

| 83.2 | C09CA01 | losartan nad 50 mg v jedné tabletě včetně | p.o. | 50.00 | MG | 3,78 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 83.3 | C09CA02 | eprosartan | p.o. | 600.00 | MG | 5,40 | |

| | | | | | | | |

| 83.4 | C09CA03 | valsartan do 80 mg v jedné tabletě včetně | p.o. | 80.00 | MG | 5,40 | |

| | | | | | | | |

| 83.5 | C09CA03 | valsartan nad 80 mg v jedné tabletě | p.o. | 80.00 | MG | 3,78 | |

| | | | | | | | |

| 83.6 | C09CA04 | irbesartan do 150 mg v jedné tabletě včetně | p.o. | 150.00 | MG | 7,51 | P |

| | | | | | | | |

| 83.7 | C09CA04 | irbesartan nad 150 mg v jedné tabletě | p.o. | 150.00 | MG | 5,98 | P |

Irbesartan je indikován v těchto případech:

@@ -3163,216 +3271,216 @@

- b) nediabetická nefropatie s proteinurií vyšší než 1 g/24 hodin u nemocných netolerujících ACE inhibitory.

| 83.8 | C09CA06 | kandesartan do 8 mg v jedné tabletě včetně | p.o. | 8.00 | MG | 5.53 | |

| | | | | | | | |

| 83.9 | C09CA06 | kandesartan nad 8 mg v jedné tabletě | p.o. | 8.00 | MG | 3.87 | |

| | | | | | | | |

| 83.10 | C09CA07 | telmisartan do 40 mg v jedné tabletě včetně | p.o. | 40.00 | MG | 5.53 | |

| | | | | | | | |

| 83.11 | C09CA07 | telmisartan nad 40 mg v jedné tabletě | p.o. | 40.00 | MG | 3.87 | |

| | | | | | | | |

| 83.12 | C09CA08 | olmesartan medoxomil do 20 mg v jedné tabletě včetně | p.o. | 20.00 | MG | 5.53 | |

| | | | | | | | |

| 83.13 | C09CA08 | olmesartan medoxomil nad 20 mg do 40 mg v jedné tabletě včetně | p.o. | 20.00 | MG | 3.87 | |

| 83.8 | C09CA06 | kandesartan do 8 mg v jedné tabletě včetně | p.o. | 8.00 | MG | 5,40 | |

| | | | | | | | |

| 83.9 | C09CA06 | kandesartan nad 8 mg v jedné tabletě | p.o. | 8.00 | MG | 3,78 | |

| | | | | | | | |

| 83.10 | C09CA07 | telmisartan do 40 mg v jedné tabletě včetně | p.o. | 40.00 | MG | 5,40 | |

| | | | | | | | |

| 83.11 | C09CA07 | telmisartan nad 40 mg v jedné tabletě | p.o. | 40.00 | MG | 3,78 | |

| | | | | | | | |

| 83.12 | C09CA08 | olmesartan medoxomil do 20 mg v jedné tabletě včetně | p.o. | 20.00 | MG | 5,40 | |

| | | | | | | | |

| 83.13 | C09CA08 | olmesartan medoxomil nad 20 mg do 40 mg v jedné tabletě včetně | p.o. | 20.00 | MG | 3,78 | |

| | | | | | | | |

| 84 | hypolipidemika ze skupiny statinů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 84.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 5.00 | P |

| 10390 | SIMIREX 10 MG | por tbl flm 30x10mg | SYH | E |

| --- | --- | --- | --- | --- |

| 13499 | SIMGAL 10 MG | por tbl flm 84x10mg | IXP | CZ |

| 13827 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30x10mg | SBV | NL |

| 13830 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm100x10mg | SBV | NL |

| 14733 | SIMVOR 10 MG | por tbl flm 30x10mg | IRI | IRL |

| 15697 | SIMIREX 10 MG | por tbl flm 60x10mg | SYH | E |

| 31844 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30x10mg | SYH | E |

| 31847 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm100x10mg | SYH | E |

| 32578 | SIMGAL 10 MG | por tbl flm 28x10mg | IXP | CZ |

| 45336 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30x10mg | MCK | D |

| 45359 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm100x10mg | MCK | D |

| 49919 | SIMVAX 10 | por tbl flm 28x10mg | SFS | D |

| 49923 | SIMVAX 10 | por tbl flm 28x10mg | SFS | D |

| 58136 | VASILIP 10 | tbl obd 28x10mg | KRK | SLO |

| 58773 | SIMVACARD 10 | tbl obd 28x10mg | ZEH | CZ |

| 66024 | SIMVOR 10MG | tbl obd 30x10mg | RXY | IND |

| 81479 | SIMVAX 10 | por tbl flm 28x10mg | GEA | DK |

| 95250 | VASILIP 10 | tbl obd 84x10mg | KRK | SLO |

| 97067 | SIMVAX 10 | por tbl flm 28x10mg | GEA | DK |

| 84.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 8.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10422 | SIMIREX 20 MG | por tbl flm 30x20mg | SYH | E |

| --- | --- | --- | --- | --- |

| 13701 | SIMGAL 20 MG | por tbl flm 84x20mg | IXP | CZ |

| 13843 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30x20mg | SBV | NL |

| 13848 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm100x20mg | SBV | NL |

| 14734 | SIMVOR 20 MG | por tbl flm 30x20mg | IRI | IRL |

| 15073 | SIMIREX 20 MG | por tbl flm 60x20mg | SYH | E |

| 21719 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm100x20mg | MCK | D |

| 31851 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30x20mg | SYH | E |

| 31856 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm100x20mg | SYH | E |

| 32579 | SIMGAL 20 MG | por tbl flm 28x20mg | IXP | CZ |

| 45752 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30x20mg | MCK | D |

| 47731 | SIMVACARD 20 | tbl obd 84x20mg | ZEH | CZ |

| 49911 | SIMVAX 20 | por tbl flm 28x20mg | SFS | D |

| 49912 | SIMVAX 20 | por tbl flm 30x20mg | SFS | D |

| 49915 | SIMVAX 20 | por tbl flm 28x20mg | SFS | D |

| 49916 | SIMVAX 20 | por tbl flm 30x20mg | SFS | D |

| 58064 | VASILIP 20 | tbl obd 28x20mg | KRK | SLO |

| 58775 | SIMVACARD 20 | tbl obd 28x20mg | ZEH | CZ |

| 66026 | SIMVOR 20MG | tbl obd 30x20mg | RXY | IND |

| 81483 | SIMVAX 20 | por tbl flm 28x20mg | GEA | DK |

| 81484 | SIMVAX 20 | por tbl flm 30x20mg | GEA | DK |

| 95251 | VASILIP 20 | tbl obd 84x20mg | KRK | SLO |

| 97071 | SIMVAX 20 | por tbl flm 28x20mg | GEA | DK |

| 97072 | SIMVAX 20 | por tbl flm 30x20mg | GEA | DK |

| 84.3 | C10AA01 | simvastatin (nad 20 mg do 40mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 11.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10459 | SIMIREX 40 MG | por tbl flm 30x40mg | SYH | E |

| --- | --- | --- | --- | --- |

| 13702 | SIMGAL 40 MG | por tbl flm 84x40mg | IXP | CZ |

| 13833 | SIMVASTATIN-RATIOPHARM 40 MG | por tbl flm 30x40mg | SBV | NL |

| 14735 | SIMVOR 40 MG | por tbl flm 30x40mg | IRI | IRL |

| 15070 | SIMIREX 40 MG | por tbl flm 60x40mg | SYH | E |

| 17915 | SIMVACARD 40 | tbl obd 84x40mg | ZEH | CZ |

| 31859 | SIMVASTATIN-RATIOPHARM 40 MG | por tbl flm 30x40mg | SYH | E |

| 32580 | SIMGAL 40 MG | por tbl flm 28x40mg | IXP | CZ |

| 42929 | VASILIP 40 | por tbl obd 28x40mg | KRK | SLO |

| 45535 | SIMVASTATIN-RATIOPHARM 40 MG | por tbl flm 30x40mg | MCK | D |

| 49901 | SIMVAX 40 | por tbl flm 28x40mg | SFS | D |

| 49902 | SIMVAX 40 | por tbl flm 30x40mg | SFS | D |

| 49905 | SIMVAX 40 | por tbl flm 28x40mg | SFS | D |

| 58777 | SIMVACARD 40 | tbl obd 28x40mg | ZEH | CZ |

| 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND |

| 81487 | SIMVAX 40 | por tbl flm 28x40mg | GEA | DK |

| 81488 | SIMVAX 40 | por tbl flm 30x40mg | GEA | DK |

| 97075 | SIMVAX 40 | por tbl flm 28x40mg | GEA | DK |

| 84.4 | C10AA01 | simvastatin (nad 40 mg v jedné tabletě) | p.o. | 1.00 | DF | 15.40 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 84.5 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně | p.o. | 1.00 | DF | 4.50 | P |

| 01300 | APO-LOVASTATIN 20 | tbl 30x20mg | APT | CND |

| --- | --- | --- | --- | --- |

| 15397 | APO-LOVASTATIN 20 | tbl 100x20mg | CMG | IRL |

| 15398 | APO-LOVASTATIN 20 | tbl 30x20mg | CMG | IRL |

| 16572 | APO-LOVASTATIN 20 | tbl 100x20mg | KAT | NL |

| 16573 | APO-LOVASTATIN 20 | tbl 30x20mg | KAT | NL |

| 53286 | APO-LOVASTATIN 20 | tbl 100x20mg | APT | CND |

| 53506 | MEDOSTATIN 20MG | tbl 30x20mg | MOE | CY |

| 53507 | MEDOSTATIN 20MG | tbl 100x20mg | MOE | CY |

| 58799 | HOLETAR 20 | tbl 30x20mg | KRK | SLO |

| 84.6 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě do 40 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 6.75 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01254 | APO-LOVASTATIN 40 | tbl 30x40mg | APT | CND |

| --- | --- | --- | --- | --- |

| 15394 | APO-LOVASTATIN 40 | tbl 100x40mg | CMG | IRL |

| 15396 | APO-LOVASTATIN 40 | tbl 30x40mg | CMG | IRL |

| 16575 | APO-LOVASTATIN 40 | tbl 100x40mg | KAT | NL |

| 16577 | APO-LOVASTATIN 40 | tbl 30x40mg | KAT | NL |

| 53287 | APO-LOVASTATIN 40 | tbl 100x40mg | APT | CND |

| 84.7 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 4.80 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 84.8 | C10AA03 | pravastatin (nad 10 mg do 20 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 7.20 | P |

| | | | | | | | |

| 84.9 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě) | p.o. | 1.00 | DF | 10.80 | P |

| | | | | | | | |

| 84.10 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 4.80 | P |

| | | | | | | | |

| 84.11 | C10AA04 | fluvastatin (nad 20 mg do 40 mgv jedné tabletě včetně) | p.o. | 1.00 | DF | 7.20 | P |

| | | | | | | | |

| 84.12 | C10AA04 | fluvastatin (nad 40 MG v jedné tabletě) | p.o. | 1.00 | DF | 16.85 | P |

| | | | | | | | |

| 84.13 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 1.00 | DF | 8.50 | P |

| 19590 | TORVACARD 10 | por tbl flm 30x10mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 19591 | TORVACARD 10 | por tbl flm 90x10mg | ZEH | CZ |

| 20165 | TULIP 10 MG | por tbl flm 30x10mg | LEK | SLO |

| 42051 | TULIP LEK 10 MG POTAHOVANÉ TBL | por tblflm30x10mg | LEK | SLO |

| 49004 | ATORIS 10 | por tbl flm 30x10mg | KRK | SLO |

| 49005 | ATORIS 10 | por tbl flm 60x10mg | KRK | SLO |

| 49006 | ATORIS 10 | por tbl flm 90x10mg | KRK | SLO |

| 84.14 | C10AA05 | atorvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 11.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 19592 | TORVACARD 20 | por tbl flm 30x20mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 19593 | TORVACARD 20 | por tbl flm 90x20mg | ZEH | CZ |

| 20166 | TULIP 20 MG | por tbl flm 30x20mg | LEK | SLO |

| 42056 | TULIP LEK 20 MG POTAHOVANÉ TBL | por tblflm30x20mg | LEK | SLO |

| 49007 | ATORIS 20 | por tbl flm 30x20mg | KRK | SLO |

| 49008 | ATORIS 20 | por tbl flm 60x20mg | KRK | SLO |

| 49009 | ATORIS 20 | por tbl flm 90x20mg | KRK | SLO |

| 84.15 | C10AA05 | atorvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 14.50 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 84.16 | C10AA05 | atorvastatin (nad 40 MG v jedné tabletě) | p.o. | 1.00 | DF | 29.00 | P |

| | | | | | | | |

| 84.17 | C10AA07 | rosuvastatin (do 10 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 19.26 | P |

| | | | | | | | |

| 84.18 | C10AA07 | rosuvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 28.89 | P |

| | | | | | | | |

| 84.19 | C10AA07 | rosuvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 43.34 | P |

- A) Léčba atorvastatinem (10 a 20mg), simvastatinem (10,20 a 40mg), fluvastatinem (20 a 40mg) a lovastatinem (20,40 a 80mg) a pravastatinem (20 a 40mg) je indikována u nemocných s hypercholesterolémií a manifestní aterosklerózou či diabetem nebo v případě, že celkové desetileté kardiovaskulární riziko úmrtí nemocného dle systému SCORE (platného pro ČR) je větší než 5% (toto riziko musí být při iniciaci léčby uvedeno ve zdravotnické dokumentaci). Pro účinnost léčby je nejvýznamnějším ukazatelem hodnota LDL-cholesterolu, jejíž cílová hodnota je stanovena na 3,0mmol/l. Kombinaci hypolipidemik může indikovat a předepisovat pouze kardiolog, internista, lékař lipidologické poradny a diabetolog.

| 84.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 4,89 | P |

| 10390 | SIMIREX 10 MG | por tbl flm 30×10mg | SYH | E |

| --- | --- | --- | --- | --- |

| 13499 | SIMGAL 10 MG | por tbl flm 84×10mg | IXP | CZ |

| 13827 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30×10mg | SBV | NL |

| 13830 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 100×10mg | SBV | NL |

| 14733 | SIMVOR 10 MG | por tbl flm 30×10mg | IRI | IRL |

| 15697 | SIMIREX 10 MG | por tbl flm 60×10mg | SYH | E |

| 31844 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30×10mg | SYH | E |

| 31847 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 100×10mg | SYH | E |

| 32578 | SIMGAL 10 MG | por tbl flm 28×10mg | IXP | CZ |

| 45336 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30×10mg | MCK | D |

| 45359 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 100×10mg | MCK | D |

| 49919 | SIMVAX 10 | por tbl flm 28×10mg | SFS | D |

| 49923 | SIMVAX 10 | por tbl flm 28×10mg | SFS | D |

| 58136 | VASILIP 10 | tbl obd 28×10mg | KRK | SLO |

| 58773 | SIMVACARD 10 | tbl obd 28×10mg | ZEH | CZ |

| 66024 | SIMVOR 10MG | tbl obd 30×10mg | RXY | IND |

| 81479 | SIMVAX 10 | por tbl flm 28×10mg | GEA | DK |

| 95250 | VASILIP 10 | tbl obd 84×10mg | KRK | SLO |

| 97067 | SIMVAX 10 | por tbl flm 28×10mg | GEA | DK |

| 84.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 7,82 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10422 | SIMIREX 20 MG | por tbl flm 30×20mg | SYH | E |

| --- | --- | --- | --- | --- |

| 13701 | SIMGAL 20 MG | por tbl flm 84×20mg | IXP | CZ |

| 13843 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30×20mg | SBV | NL |

| 13848 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 100×20mg | SBV | NL |

| 14734 | SIMVOR 20 MG | por tbl flm 30×20mg | IRI | IRL |

| 15073 | SIMIREX 20 MG | por tbl flm 60×20mg | SYH | E |

| 21719 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 100×20mg | MCK | D |

| 31851 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30×20mg | SYH | E |

| 31856 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 100×20mg | SYH | E |

| 32579 | SIMGAL 20 MG | por tbl flm 28×20mg | IXP | CZ |

| 45752 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30×20mg | MCK | D |

| 47731 | SIMVACARD 20 | tbl obd 84×20mg | ZEH | CZ |

| 49911 | SIMVAX 20 | por tbl flm 28×20mg | SFS | D |

| 49912 | SIMVAX 20 | por tbl flm 30×20mg | SFS | D |

| 49915 | SIMVAX 20 | por tbl flm 28×20mg | SFS | D |

| 49916 | SIMVAX 20 | por tbl flm 30×20mg | SFS | D |

| 58064 | VASILIP 20 | tbl obd 28×20mg | KRK | SLO |

| 58775 | SIMVACARD 20 | tbl obd 28×20mg | ZEH | CZ |

| 66026 | SIMVOR 20MG | tbl obd 30×20mg | RXY | IND |

| 81483 | SIMVAX 20 | por tbl flm 28×20mg | GEA | DK |

| 81484 | SIMVAX 20 | por tbl flm 30×20mg | GEA | DK |

| 95251 | VASILIP 20 | tbl obd 84×20mg | KRK | SLO |

| 97071 | SIMVAX 20 | por tbl flm 28×20mg | GEA | DK |

| 97072 | SIMVAX 20 | por tbl flm 30×20mg | GEA | DK |

| 84.3 | C10AA01 | simvastatin (nad 20 mg do 40mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 10,75 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10459 | SIMIREX 40 MG | por tbl flm 30×40mg | SYH | E |

| --- | --- | --- | --- | --- |

| 13702 | SIMGAL 40 MG | por tbl flm 84×40mg | IXP | CZ |

| 13833 | SIMVASTATIN-RATIOPHARM 40 MG | por tbl flm 30×40mg | SBV | NL |

| 14735 | SIMVOR 40 MG | por tbl flm 30×40mg | IRI | IRL |

| 15070 | SIMREX 40 MG | por tbl flm 60×40mg | SYH | E |

| 17915 | SIMVACARD 40 | tbl obd 84×40mg | ZEH | CZ |

| 31859 | SIMVASTIN-RATIOPHARM 40 MG | por tbl flm 30×40mg | SYH | E |

| 32580 | SIMVAX 40 | por tbl flm 28×40mg | IXP | CZ |

| 42929 | VASILIP 40 | por tbl obd 28×40mg | KRK | SLO |

| 45535 | SIMVASTATIN-RATIOPHARM 40 MG | por tbl flm 30×40mg | MCK | D |

| 49901 | SIMVAX 40 | por tbl flm 28×40mg | SFS | D |

| 49902 | SIMVAX 40 | por tbl flm 30×40mg | SFS | D |

| 49905 | SIMVAX 40 | por tbl flm 28×40mg | SFS | D |

| 58777 | SIMVACARD 40 | tbl obd 28×40mg | ZEH | CZ |

| 66028 | SIMVOR 40MG | tbl obd 30×40mg | RXY | IND |

| 81487 | SIMVAX 40 | por tbl flm 28×40mg | GEA | DK |

| 81488 | SIMVAX 40 | por tbl flm 30×40mg | GEA | DK |

| 97075 | SIMVAX 40 | por tbl flm 28×40mg | GEA | DK |

| 84.4 | C10AA01 | simvastatin (nad 40 mg v jedné tabletě) | p.o. | 1.00 | DF | 15,05 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 84.5 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně | p.o. | 1.00 | DF | 4,40 | P |

| 01300 | APO-LOVASTATIN 20 | tbl 30×20mg | APT | CND |

| --- | --- | --- | --- | --- |

| 15397 | APO-LOVASTATIN 20 | tbl 100×20mg | CMG | IRL |

| 15398 | APO-LOVASTATIN 20 | tbl 30×20mg | CMG | IRL |

| 16572 | APO-LOVASTATIN 20 | tbl 100×20mg | KAT | NL |

| 16573 | APO-LOVASTATIN 20 | tbl 30×20mg | KAT | NL |

| 53286 | APO-LOVASTATIN 20 | tbl 100×20mg | APT | CND |

| 53506 | MEDOSTATIN 20MG | tbl 30×20mg | MOE | CY |

| 53507 | MEDOSTATIN 20MG | tbl 100×20mg | MOE | CY |

| 58799 | HOLETAR 20 | tbl 30×20mg | KRK | SLO |

| 84.6 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě do 40 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 6,60 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01254 | APO-LOVASTATIN 40 | tbl 30×40mg | APT | CND |

| --- | --- | --- | --- | --- |

| 15394 | APO-LOVASTATIN 40 | tbl 100×40mg | CMG | IRL |

| 15396 | APO-LOVASTATIN 40 | tbl 30×40mg | CMG | IRL |

| 16575 | APO-LOVASTATIN 40 | tbl 100×40mg | KAT | NL |

| 16577 | APO-LOVASTATIN 40 | tbl 30×40mg | KAT | NL |

| 53287 | APO-LOVASTATIN 40 | tbl 100×40mg | APT | CND |

| 84.7 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 4,69 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 84.8 | C10AA03 | pravastatin (nad 10 mg do 20 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 7,04 | P |

| | | | | | | | |

| 84.9 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě) | p.o. | 1.00 | DF | 10,55 | P |

| | | | | | | | |

| 84.10 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 4,69 | P |

| | | | | | | | |

| 84.11 | C10AA04 | fluvastatin (nad 20 mg do 40 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 7,04 | P |

| | | | | | | | |

| 84.12 | C10AA04 | fluvastatin (nad 40 MG v jedné tabletě) | p.o. | 1.00 | DF | 16,47 | P |

| | | | | | | | |

| 84.13 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 1.00 | DF | 8,31 | P |

| 19590 | TORVACARD 10 | por tbl flm 30×10mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 19591 | TORVACARD 10 | por tbl flm 90×10mg | ZEH | CZ |

| 20165 | TULIP 10 MG | por tbl flm 30×10mg | LEK | SLO |

| 42051 | TULIP LEK 10 MG POTAHOVANÉ TBL | por tbl flm 30×10mg | LEK | SLO |

| 49004 | ATORIS 10 | por tbl flm 30×10mg | KRK | SLO |

| 49005 | ATORIS 10 | por tbl flm 60×10mg | KRK | SLO |

| 49006 | ATORIS 10 | por tbl flm 90×10mg | KRK | SLO |

| 84.14 | C10AA05 | atorvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 10,75 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 19592 | TORVACARD 20 | por tbl flm 30×20mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 19593 | TORVACARD 20 | por tbl flm 90×20mg | ZEH | CZ |

| 20166 | TULIP 20 MG | por tbl flm 30×20mg | LEK | SLO |

| 42056 | TULIP LEK 20 MG POTAHOVANÉ TBL | por tbl flm 30×20mg | LEK | SLO |

| 49007 | ATORIS 20 | por tbl flm 30×20mg | KRK | SLO |

| 49008 | ATORIS 20 | por tbl flm 60×20mg | KRK | SLO |

| 49009 | ATORIS 20 | por tbl flm 90×20mg | KRK | SLO |

| 84.15 | C10AA05 | atorvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 14,17 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 84.16 | C10AA05 | atorvastatin (nad 40 MG v jedné tabletě) | p.o. | 1.00 | DF | 28,34 | P |

| | | | | | | | |

| 84.17 | C10AA07 | rosuvastatin (do 10 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 18,82 | P |

| | | | | | | | |

| 84.18 | C10AA07 | rosuvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 28,23 | P |

| | | | | | | | |

| 84.19 | C10AA07 | rosuvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1.00 | DF | 42,36 | P |

- A) Léčba atorvastatinem (10 a 20mg), simvastatinem (10,20 a 40mg), fluvastatinem (20 a 40mg) a lovastatinem (20,40 a80mg) a pravastatinem (20 a 40mg) je indikována u nemocných s hypercholesterolémií a manifestní aterosklerózou či diabetem nebo v případě, že celkové desetileté kardiovaskulární riziko úmrtí nemocného dle systému SCORE (platného pro ČR) je větší než 5% (toto riziko musí být při iniciaci léčby uvedeno ve zdravotnické dokumentaci). Pro účinnost léčby je nejvýznamnějším ukazatelem hodnota LDL-cholesterolu, jejíž cílová hodnota je stanovena na 3,0mmol/l. Kombinaci hypolipidemik může indikovat a předepisovat pouze kardiolog, internista, lékař lipidologické poradny a diabetolog.

- B) Léčba atorvastatinem (v dávce vyšší než 20mg), fluvastatinem (v dávce vyšší než 40mg) či rosuvastatinem je předepisována kardiologem, internistou, diabetologem,angiologem nebo lékařem lipidologické poradny u nemocných s hypercholesterolémií a manifestní aterosklerózou či diabetem nebo v případě, že celkové desetileté kardiovaskulární riziko úmrtí nemocného dle systému SCORE (platného pro ČR) je větší než 5% a kdy nelze dosáhnout cílových hodnot (LDL ≤ 3,0mmol/l) statiny uvedenými v A) nebo kdy statiny uvedené v bodě A) nelze použít.

| 85 | hypolipidemika ze skupiny fibrátů a ostatních skupin | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 85.1 | C10AB | klofibrát (etofylin) | p.o. | 0.50 | GM | 4.32 | |

| | | | | | | | |

| 85.2 | C10AB02 | bezafibrát | p.o. | 0.60 | GM | 6.17 | |

| | | | | | | | |

| 85.3 | C10AB04 | gemfibrozil | p.o. | 1.20 | GM | 6.17 | |

| | | | | | | | |

| 85.4 | C10AB05 | fenofibrát | p.o. | 0.30 | GM | 6.17 | |

| | | | | | | | |

| 85.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1.00 | DF | 6.82 | |

| 04143 | APO-FENO | por cpsdur 30x200mg | APT | CND |

| --- | --- | --- | --- | --- |

| 04145 | APO-FENO | por cpsdur100x200mg | APT | CND |

| 13337 | LIPOHEXAL 250 RETARD | por cps ret60x250mg | SFS | D |

| 13338 | LIPOHEXAL 250 RETARD | por cps ret90x250mg | SFS | D |

| 13596 | LIPIREX 267 MG | por cps dur30x267mg | SGY | B |

| 13598 | LIPIREX 267 MG | por cps dur60x267mg | SGY | B |

| 14316 | FENOFIX 200 | por cps dur90x200mg | IXP | CZ |

| 15501 | APO-FENO | por cps dur30x200mg | CMG | IRL |

| 15503 | APO-FENO | por cpsdur100x200mg | CMG | IRL |

| 16597 | APO-FENO | por cps dur30x200mg | KAT | NL |

| 16599 | APO-FENO | por cpsdur100x200mg | KAT | NL |

| 32652 | FEBIRA 200 | por cps dur30x200mg | ZEH | SK |

| 32653 | FEBIRA 200 | por cps dur60x200mg | ZEH | SK |

| 32654 | FEBIRA 200 | por cps dur90x200mg | ZEH | SK |

| 32722 | FENOFIX 200 | por cps dur30x200mg | IXP | CZ |

| 41797 | LIPIREX 200MG | por cps dur60x200mg | SGY | B |

| 56460 | LIPIREX 200MG | por cps dur30x200mg | SGY | B |

| 58769 | LIPOHEXAL 250 RETARD | por cps ret30x250mg | SFS | D |

| 58770 | LIPOHEXAL 250 RETARD | por cpsret100x250mg | SFS | D |

| 99839 | LIPIREXS 160 MG | por cps dur60x160mg | SGY | B |

| 85.6 | C10AB05 | fenofibrát (supramikronisované lékové formy) | p.o. | 1.00 | DF | 8.55 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 85.7 | C10AB08 | ciprofibrát | p.o. | 0.10 | GM | 6.82 | |

| | | | | | | | |

| 85.8 | C10AC01 | cholestyramin | p.o. | 14.00 | GM | 31.09 | P |

| | | | | | | | |

| 85.9 | C10AC02 | colestipol | p.o. | 20.00 | GM | 31.09 | P |

| 85 | hypolipidemika ze skupiny fibratů a ostatních skupin | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 85.1 | C10AB | klofibrát (etofylin) | p.o. | 0.50 | GM | 4,22 | |

| | | | | | | | |

| 85.2 | C10AB02 | bezafibrát | p.o. | 0.60 | GM | 6,03 | |

| | | | | | | | |

| 85.3 | C10AB04 | gemfibrozil | p.o. | 1.20 | GM | 6,03 | |

| | | | | | | | |

| 85.4 | C10AB05 | fenofibrát | p.o. | 0.30 | GM | 6,03 | |

| | | | | | | | |

| 85.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1.00 | DF | 6,67 | |

| 04143 | APO-FENO | por cps dur 30×200mg | APT | CND |

| --- | --- | --- | --- | --- |

| 04145 | APO-FENO | por cp sdur 100×200mg | APT | CND |

| 13337 | LIPOHEXAL 250 RETARD | por cps ret 60×250mg | SFS | D |

| 13338 | LIPOHEXAL 250 RETARD | por cps ret 90×250mg | SFS | D |

| 13596 | LIPIREX 267 MG | por cps dur 30×267mg | SGY | B |

| 13598 | LIPIREX 267 MG | por cps dur 60×267mg | SGY | B |

| 14316 | FENOFIX 200 | por cps dur 90×200mg | IXP | CZ |

| 15501 | APO-FENO | por cps dur 30×200mg | CMG | IRL |

| 15503 | APO-FENO | por cps dur 100×200mg | CMG | IRL |

| 16597 | APO-FENO | por cps dur 30×200mg | KAT | NL |

| 16599 | APO-FENO | por cps dur 100×200mg | KAT | NL |

| 32652 | FEBIRA 200 | por cps dur 30×200mg | ZEH | SK |

| 32653 | FEBIRA 200 | por cps dur 60×200mg | ZEH | SK |

| 32654 | FEBIRA 200 | por cps dur 90×200mg | ZEH | SK |

| 32722 | FENOFIX 200 | por cps dur 30×200mg | IXP | CZ |

| 41797 | LIPIREX 200MG | por cps dur 60×200mg | SGY | B |

| 56460 | LIPIREX 200MG | por cps dur 30×200mg | SGY | B |

| 58769 | LIPOHEXAL 250 RETARD | por cps ret 30×250mg | SFS | D |

| 58770 | LIPOHEXAL 250 RETARD | por cps ret 100×250mg | SFS | D |

| 99839 | LIPIREX S 160 MG | por cps dur 60×160mg | SGY | B |

| 85.6 | C10AB05 | fenofibrát (supramikronisované lékové formy) | p.o. | 1.00 | DF | 8,36 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 85.7 | C10AB08 | ciprofibrát | p.o. | 0.10 | GM | 6,67 | |

| | | | | | | | |

| 85.8 | C10AC01 | cholestyramin | p.o. | 14.00 | GM | 30,38 | P |

| | | | | | | | |

| 85.9 | C10AC02 | colestipol | p.o. | 20.00 | GM | 30,38 | P |

Léčbu cholestyraminem a colestipolem předepisuje gastroenterolog, kardiolog, internista, nebo lékař pracující v poradnách pro léčbu poruch metabolismu lipidů:

@@ -3380,10 +3488,10 @@

- b) u pacientů s pruritem při biliární cirhóze.

| 85.10 | C10AD06 | acipimox | p.o. | 500.00 | MG | 10.59 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 85.11 | C10AX09 | ezetimib | p.o. | 10.00 | MG | 46.00 | P |

| 85.10 | C10AD06 | acipimox | p.o. | 500.00 | MG | 10,35 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 85.11 | C10AX09 | ezetimib | p.o. | 10.00 | MG | 44,96 | P |

Ezetimib je určen pro kombinační léčbu se statiny (tj. je indikován v případě použití ve druhé volbě). Léčbu ezetimibem předepisuje specialista (kardiolog, internista, diabetolog nebo lékař lipidologické poradny) u nemocných s těžkou rezistentní hyperlipoproteinémií (familiární hypercholesterolémie), u kterých nevedla léčba vyššími dávkami statinů, trvající alespoň 6 měsíců k dosažení cílových hodnot LDLcholesterolu (LDL ≤ 3,0mmol/l). Za vyšší dávku statinů je považováno 40 mg simvastatinu, 40 mg atorvastatinu, 80 mg fluvastatinu a lovastatinu, 20 mg rosuvastatinu. V kombinaci s ezetimibem jsou indikovány základní dávky statinů (tj. do 40 mg simvastatinu a atorvastatinu, do 80 mg fluvastatinu a lovastatinu a do 20 mg rosuvastatinu). Pokud kombinační léčba není účinná (nebylo dosaženo výše uvedených cílových hodnot LDL cholesterolu) po 3 měsících léčby, je ezetimib vysazen.

@@ -3392,153 +3500,152 @@

| 86 | Ostatní léčiva používaná u nemocí kardiovaskulárního systému | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 86.1 | C01CX08 | levosimendan | parent. | 11.00 | MG | 20 280.00 | H |

| | | | | | | | |

| 86.2 | C01DA02 | glycerol trinitrát | parent. | 2.50 | MG | 12.98 | H |

| 04307 | NITRO POHL INFUS. | inf 10x10ml/10mg | PLB | D |

| --- | --- | --- | --- | --- |

| 86.3 | C01DA08 | isosorbid dinitrát | parent. | 20.00 | MG | 123.96 | H |

| | | | | | | | |

| 86.4 | C01DX03 | oxifedrin | parent. | 40.00 | MG | 13.78 | H |

| | | | | | | | |

| 86.5 | C01DX12 | molsidomin | parent. | 6.00 | MG | 105.38 | H |

| 86.1 | C01CX08 | levosimendan | parent. | 11.00 | MG | 19 819,64 | H |

| | | | | | | | |

| 86.2 | C01DA02 | glycerol trinitrát | parent. | 2.50 | MG | 12,69 | H |

| 04307 | NITRO POHL INFUS. | inf 10×10ml/10mg | PLB | D |

| --- | --- | --- | --- | --- |

| 86.3 | C01DA08 | isosorbid dinitrát | parent. | 20.00 | MG | 121,15 | H |

| | | | | | | | |

| 86.4 | C01DX03 | oxifedrin | parent. | 40.00 | MG | 13,47 | H |

| | | | | | | | |

| 86.5 | C01DX12 | molsidomin | parent. | 6.00 | MG | 102,99 | H |

| | | | | | | | |

| 87 | antimykotika k lokálnímu použití ze skupiny antibiotik, imidazolových a triazolových derivátů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 87.1 | D01AA01 | nystatin | lok. | 1.00 | GM | 2.68 | |

| | | | | | | | |

| 87.2 | D01AA02 | natamycin | lok. | 1.00 | GM | 1.96 | |

| | | | | | | | |

| 87.3 | D01AC01 | klotrimazol do 20 g včetně | lok. | 1.00 | GM | 1.77 | |

| 65484 | CLOTRIMAZOL AL 1% | crm 1x20gm 1% | APA | D |

| --- | --- | --- | --- | --- |

| 87.4 | D01AC01 | klotrimazol nad 20 g | lok. | 1.00 | GM | 1.52 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 86397 | CLOTRIMAZOL AL 1% | crm 1x50gm 1% | APA | D |

| --- | --- | --- | --- | --- |

| 87.5 | D01AC01 | klotrimazol tekuté lékové formy | lok. | 1.00 | GM | 2.54 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 87.6 | D01AC02 | mikonazol | lok. | 1.00 | GM | 1.77 | |

| | | | | | | | |

| 87.7 | D01AC03 | ekonazol (lékové formy tekuté, lipogelu a pasty) | lok. | 1.00 | GM | 3.16 | |

| | | | | | | | |

| 87.8 | D01AC03 | ekonazol lékové formy krému | lok. | 1.00 | GM | 1.77 | |

| | | | | | | | |

| 87.9 | D01AC05 | isokonazol | lok. | 1.00 | ML | 1.77 | |

| | | | | | | | |

| 87.10 | D01AC08 | ketokonazol | lok. | 1.00 | GM | 1.77 | |

| | | | | | | | |

| 87.11 | D01AC10 | bifonazol | lok. | 1.00 | GM | 2.49 | |

| | | | | | | | |

| 87.12 | D01AC11 | oxikonazol | lok. | 1.00 | GM | 2.49 | |

| | | | | | | | |

| 87.13 | D01AC12 | fenticonazol | lok. | 1.00 | GM | 1.77 | |

| | | | | | | | |

| 87.14 | D01AC14 | sertakonazol | lok. | 1.00 | GM | 2.49 | |

| | | | | | | | |

| 87.15 | G01AF18 | flutrimazol, lékové forma gelu | lok. | 1.00 | GM | 3.06 | |

| | | | | | | | |

| 87.16 | G01AF18 | flutrimazol, lékové forma krém a spray | lok. | 1.00 | GM | 4.70 | |

| | | | | | | | |

| 87.17 | D01AC20 | kombinace | lok. | 1.00 | GM | 1.77 | |

| | | | | | | | |

| 87.18 | D01AC51 | clotrimazol/urea | lok. | 1.00 | GM | 1.77 | |

| | | | | | | | |

| 87.19 | D01AC60 | bifonazol, kombinace | lok. | 1.00 | GM | 13.41 | P |

| 87.1 | D01AA01 | nystatin | lok. | 1.00 | GM | 2,62 | |

| | | | | | | | |

| 87.2 | D01AA02 | natamycin | lok. | 1.00 | GM | 1,92 | |

| | | | | | | | |

| 87.3 | D01AC01 | klotrimazol do 20 g včetně | lok. | 1.00 | GM | 1,73 | |

| 65484 | CLOTRIMAZOL AL 1% | crm 1×20gm 1% | APA | D |

| --- | --- | --- | --- | --- |

| 87.4 | D01AC01 | klotrimazol nad 20 g | lok. | 1.00 | GM | 1,49 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 86397 | CLOTRIMAZOL AL 1% | crm 1×50gm 1% | APA | D |

| --- | --- | --- | --- | --- |

| 87.5 | D01AC01 | klotrimazol tekuté lékové formy | lok. | 1.00 | GM | 2,48 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 87.6 | D01AC02 | mikonazol | lok. | 1.00 | GM | 1,73 | |

| | | | | | | | |

| 87.7 | D01AC03 | ekonazol (lékové formy tekuté, lipogelu a pasty) | lok. | 1.00 | GM | 3,09 | |

| | | | | | | | |

| 87.8 | D01AC03 | ekonazol lékové formy krému | lok. | 1.00 | GM | 1,73 | |

| | | | | | | | |

| 87.9 | D01AC05 | isokonazol | lok. | 1.00 | ML | 1,73 | |

| | | | | | | | |

| 87.10 | D01AC08 | ketokonazol | lok. | 1.00 | GM | 1,73 | |

| | | | | | | | |

| 87.11 | D01AC10 | bifonazol | lok. | 1.00 | GM | 2,43 | |

| | | | | | | | |

| 87.12 | D01AC11 | oxikonazol | lok. | 1.00 | GM | 2,43 | |

| | | | | | | | |

| 87.13 | D01AC12 | fenticonazol | lok. | 1.00 | GM | 1,73 | |

| | | | | | | | |

| 87.14 | D01AC14 | sertakonazol | lok. | 1.00 | GM | 2,43 | |

| | | | | | | | |

| 87.15 | G01AF18 | flutrimazol, lékové forma gelu | lok. | 1.00 | GM | 2,99 | |

| | | | | | | | |

| 87.16 | G01AF18 | flutrimazol, lékové forma krém a spray | lok. | 1.00 | GM | 4,59 | |

| | | | | | | | |

| 87.17 | D01AC20 | kombinace | lok. | 1.00 | GM | 1,73 | |

| | | | | | | | |

| 87.18 | D01AC51 | clotrimazol/urea | lok. | 1.00 | GM | 1,73 | |

| | | | | | | | |

| 87.19 | D01AC60 | bifonazol, kombinace | lok. | 1.00 | GM | 13,11 | P |

Léčbu předepisuje dermatolog u onychomykóz, doložených kultivačním vyšetřením.

| 88 | Ostatní antimykotika k lokálnímu použití | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 88.1 | D01AE | jiná antimykotika k zevnímu použití | lok. | 1.00 | ML | 0.78 | |

| | | | | | | | |

| 88.2 | D01AE | naftini hydrochlorid | lok. | 1.00 | GM | 2.93 | |

| | | | | | | | |

| 88.3 | D01AE04 | kyselina undecylenová | lok. | 1.00 | GM | 0.97 | |

| 00871 | MYKOSEPTIN | ung 1x30gm | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 88.4 | D01AE14 | ciclopirox | lok. | 1.00 | GM | 3.79 | |

| | | | | | | | |

| 88.5 | D01AE15 | terbinafin | lok. | 1.00 | GM | 3.79 | |

| | | | | | | | |

| 88.6 | D01AE16 | amorolfin | lok. | 1.00 | MG | 3.35 | |

| | | | | | | | |

| 88.7 | D01AE18 | tolnaftat | lok. | 1.00 | GM | 1.83 | |

| | | | | | | | |

| 88.8 | D01AE19 | tolciklát | lok. | 1.00 | GM | 1.83 | |

| | | | | | | | |

| 88.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | 1.00 | GM | 0.64 | |

| | | | | | | | |

| 88.10 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1.00 | GM | 1.83 | |

| 88.1 | D01AE | jiná antimykotika k zevnímu použití | lok. | 1.00 | ML | 0,76 | |

| | | | | | | | |

| 88.2 | D01AE | naftini hydrochlorid | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 88.3 | D01AE04 | kyselina undecylenová | lok. | 1.00 | GM | 0,95 | |

| 00871 | MYKOSEPTIN | ung 1×30gm | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 88.4 | D01AE14 | ciclopirox | lok. | 1.00 | GM | 3,70 | |

| | | | | | | | |

| 88.5 | D01AE15 | terbinafin | lok. | 1.00 | GM | 3,70 | |

| | | | | | | | |

| 88.6 | D01AE16 | amorolfin | lok. | 1.00 | MG | 3,27 | |

| | | | | | | | |

| 88.7 | D01AE18 | tolnaftat | lok. | 1.00 | GM | 1,79 | |

| | | | | | | | |

| 88.8 | D01AE19 | tolciklát | lok. | 1.00 | GM | 1,79 | |

| | | | | | | | |

| 88.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | 1.00 | GM | 0,63 | |

| | | | | | | | |

| 88.10 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1.00 | GM | 1,79 | |

| | | | | | | | |

| 89 | emolliencia a protektiva | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 89.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1.00 | GM | 0.51 | |

| 54249 | SUSPENSIO ZINCI OXYDATI HERBAC. | sus 1x100gm | HEO | CZ |

| --- | --- | --- | --- | --- |

| 89.2 | D02AC | měkký parafin a tukové produkty (do 250 gm v 1 balení včetně) | lok. | 1.00 | GM | 0.59 | L/DER,PED |

| | | | | | | | |

| 89.3 | D02AC | měkký parafin a tukové produkty (do 250 ml v 1 balení včetně) - tekuté lékové formy | lok. | 1.00 | ML | 0.59 | L/DER,PED |

| | | | | | | | |

| 89.4 | D02AC | měkký parafin a tukové produkty (nad 250 gm v 1 balení) | lok. | 1.00 | GM | 0.43 | L/DER,PED |

| | | | | | | | |

| 89.5 | D02AC | měkký parafin a tukové produkty (nad 250 ml v 1 balení) - tekuté lékové formy | lok. | 1.00 | ML | 0.43 | L/DER,PED |

| | | | | | | | |

| 89.6 | D02AC | měkký parafin s polydekanolem (do 250 ml v 1 balení včetně) | lok. | 1.00 | ML | 0.65 | L/DER,PED |

| | | | | | | | |

| 89.7 | D02AC | měkký parafin s polydekanolem (nad 250 ml v 1 balení) | lok. | 1.00 | ML | 0.47 | L/DER,PED |

| | | | | | | | |

| 89.8 | D02AE01 | měkký parafin a tukové produkty s obsahem močoviny - tekuté lékové formy | lok. | 1.00 | ML | 0.46 | L/DER,PED |

| | | | | | | | |

| 89.9 | D02AE01 | urea | lok. | 1.00 | GM | 0.46 | L/DER,PED |

| | | | | | | | |

| 89.10 | D02AE51 | kombinace kyseliny salicylové s ureou | lok. | 1.00 | GM | 1.00 | |

| | | | | | | | |

| 89.11 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | 1.00 | GM | 1.71 | |

| | | | | | | | |

| 89.12 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | 1.00 | GM | 0.64 | |

| 89.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1.00 | GM | 0,50 | |

| 54249 | SUSPENSIO ZINCI OXYDATI HERBAC. | sus 1×100gm | HEO | CZ |

| --- | --- | --- | --- | --- |

| 89.2 | D02AC | měkký parafin a tukové produkty (do 250 gm v 1 balení včetně) | lok. | 1.00 | GM | 0,58 | L/DER,PED |

| | | | | | | | |

| 89.3 | D02AC | měkký parafin a tukové produkty (do 250 ml v 1 balení včetně) - tekuté lékové formy | lok. | 1.00 | ML | 0,58 | L/DER,PED |

| | | | | | | | |

| 89.4 | D02AC | měkký parafin a tukové produkty (nad 250 gm v 1 balení) | lok. | 1.00 | GM | 0,42 | L/DER,PED |

| | | | | | | | |

| 89.5 | D02AC | měkký parafin a tukové produkty (nad 250 ml v 1 balení) - tekuté lékové formy | lok. | 1.00 | ML | 0,42 | L/DER,PED |

| | | | | | | | |

| 89.6 | D02AC | měkký parafin s polydekanolem (do 250 ml v 1 balení včetně) | lok. | 1.00 | ML | 0,64 | L/DER,PED |

| | | | | | | | |

| 89.7 | D02AC | měkký parafin s polydekanolem (nad 250 ml v 1 balení) | lok. | 1.00 | ML | 0,46 | L/DER,PED |

| | | | | | | | |

| 89.8 | D02AE01 | měkký parafin a tukové produkty s obsahem močoviny - tekuté lékové formy | lok. | 1.00 | ML | 0,45 | L/DER,PED |

| | | | | | | | |

| 89.9 | D02AE01 | urea | lok. | 1.00 | GM | 0,45 | L/DER,PED |

| | | | | | | | |

| 89.10 | D02AE51 | kombinace kyseliny salicylové s ureou | lok. | 1.00 | GM | 0,98 | |

| | | | | | | | |

| 89.11 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | 1.00 | GM | 1,67 | |

| | | | | | | | |

| 89.12 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | 1.00 | GM | 0,63 | |

| | | | | | | | |

| 90 | léčiva pro léčbu ran a vředů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 90.1 | D03AX | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | 1.00 | ML | 0.49 | |

| | | | | | | | |

| 90.2 | D03AX | jiná léčiva podporující zajizvení (kombinace celulosa + karboxycelulosa, na obsah karboxycelulosy) | lok. | 1.00 | GM | 15.40 | |

| | | | | | | | |

| 90.3 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas-lékové formy gelu) | lok. | 1.00 | GM | 1.42 | |

| | | | | | | | |

| 90.4 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas-lékové formy roztoku) | lok. | 1.00 | ML | 3.91 | |

| | | | | | | | |

| 90.5 | D03AX02 | dextranomer | lok. | 1.00 | GM | 3.91 | |

| | | | | | | | |

| 90.6 | D03BA | proteolytické enzymy (chymotrypsin) | lok. | 1.00 | GM | 79.28 | P |

| | | | | | | | |

| 90.7 | D03BA | proteolytické enzymy (plasmin/deoxiribonukleáza) | lok. | 1.00 | GM | 14.02 | P |

| 02594 | FIBROLAN MAST | ung 1x25gm | PDA | F |

| --- | --- | --- | --- | --- |

| 48200 | FIBROLAN MAST | ung 1x25gm | PPO | F |

| 90.8 | D03BA | proteolytické enzymy (trypsin/chymotrypsin) | lok. | 1.00 | GM | 28.84 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 90.9 | D03BA52 | proteolytické enzymy (kolagenáza - do 10 GM v jednom balení včetně) | lok. | 1.00 | GM | 18.57 | P |

| | | | | | | | |

| 90.10 | D03BA52 | proteolytické enzymy (kolagenáza - nad 10 GM v jednom balení) | lok. | 1.00 | GM | 16.62 | P |

| 90.1 | D03AX | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | 1.00 | ML | 0,48 | |

| | | | | | | | |

| 90.2 | D03AX | jiná léčiva podporující zajizvení (kombinace celulosa + karboxycelulosa, na obsah karboxycelulosy) | lok. | 1.00 | GM | 15,05 | |

| | | | | | | | |

| 90.3 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy gelu) | lok. | 1.00 | GM | 1,39 | |

| | | | | | | | |

| 90.4 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy roztoku) | lok. | 1.00 | ML | 3,82 | |

| | | | | | | | |

| 90.5 | D03AX02 | dextranomer | lok. | 1.00 | GM | 3,82 | |

| | | | | | | | |

| 90.6 | D03BA | proteolytické enzymy (chymotrypsin) | lok. | 1.00 | GM | 77,48 | P |

| | | | | | | | |

| 90.7 | D03BA | proteolytické enzymy (plasmin/deoxiribonukleáza) | lok. | 1.00 | GM | 13,70 | P |

| 02594 | FIBROLAN MAST | ung 1×25gm | PDA | F |

| --- | --- | --- | --- | --- |

| 48200 | FIBROLAN MAST | ung 1×25gm | PPO | F |

| 90.8 | D03BA | proteolytické enzymy (trypsin/chymotrypsin) | lok. | 1.00 | GM | 28,19 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 90.9 | D03BA52 | proteolytické enzymy (kolagenáza - do 10 GM v jednom balení včetně) | lok. | 1.00 | GM | 18,15 | P |

| | | | | | | | |

| 90.10 | D03BA52 | proteolytické enzymy (kolagenáza - nad 10 GM v jednom balení) | lok. | 1.00 | GM | 16,24 | P |

Léčbu proteolytickými enzymy předepisuje chirurg, ortoped, gynekolog, otorhinolaryngolog nebo dermatolog k:

@@ -3551,48 +3658,46 @@

| 91 | Antipsoriatika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 91.1 | D05AA | dehty | lok. | 1.00 | GM | 0.73 | |

| 55290 | UNGUENTUM ICHTHAMOLI 10% MVM | drm ung 1x100gm | MVM | CZ |

| --- | --- | --- | --- | --- |

| 83870 | UNGUENTUM ICHTHAMOLI 10% MVM | drm ung 1x1kg | MVM | CZ |

| 85950 | SUSPENSIO VIŠNĚVSKI+PICE LIQUID | sus 1x1000gm | HEO | CZ |

| 91.2 | D05AA | dehty (odbarvený dehet) | lok. | 1.00 | GM | 1.17 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 91.3 | D05AC01 | dithranol | lok. | 1.00 | GM | 3.91 | |

| | | | | | | | |

| 91.4 | D05AD02 | methoxalen (0,15 % koncentrace) | lok. | 1.00 | ML | 4.05 | |

| 90618 | OXSORALEN | liq 1x50ml 0.15% | GER | A |

| --- | --- | --- | --- | --- |

| 91.5 | D05AX02 | calcipotriol | lok. | 1.00 | GM | 9.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 91.6 | D05AX03 | calcitriol | lok. | 1.00 | GM | 9.00 | P |

| | | | | | | | |

| 91.7 | D05AX04 | tacalcitol | lok. | 1.00 | GM | 18.00 | P |

| | | | | | | | |

| 91.8 | D05AX05 | tazaroten | lok. | 1.00 | GM | 18.00 | P |

| | | | | | | | |

| 91.9 | D05AX52 | kalcipotriol, kombinace | lok. | 1.00 | GM | 9.90 | P |

Léčbu deriváty vitaminu D včetně kombinací v lokálních lékových formách předepisuje dermatolog k:

léčbě torpidních lokalizovaných forem psoriázy nereagující na standardní léčbu v množství maximálně 100 g týdně.

| 91.10 | D05BA02 | methoxalen | p.o. | 10.00 | MG | 3.81 | L/DER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03733 | OXSORALEN | cps 50x10mg | GER | A |

| --- | --- | --- | --- | --- |

| 91.11 | D05BB01 | etretinát | p.o. | 35.00 | MG | 73.02 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 91.12 | D05BB02 | acitretin | p.o. | 35.00 | MG | 73.02 | P |

| 91.1 | D05AA | dehty | lok. | 1.00 | GM | 0,71 | |

| 55290 | UNGUENTUM ICHTHAMOLI 10% MVM | drm ung 1×100gm | MVM | CZ |

| --- | --- | --- | --- | --- |

| 83870 | UNGUENTUM ICHTHAMOLI 10% MVM | drm ung 1×1kg | MVM | CZ |

| 85950 | SUSPENSIO VIŠNĚVSKI+PICE LIQUID | sus 1×1000gm | HEO | CZ |

| 91.2 | D05AA | dehty (odbarvený dehet) | lok. | 1.00 | GM | 1,14 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 91.3 | D05AC01 | dithranol | lok. | 1.00 | GM | 3,82 | |

| | | | | | | | |

| 91.4 | D05AD02 | methoxalen (0,15 % koncentrace) | lok. | 1.00 | ML | 3,96 | |

| 90618 | OXSORALEN | liq 1×50ml 0.15% | GER | A |

| --- | --- | --- | --- | --- |

| 91.5 | D05AX02 | calcipotriol | lok. | 1.00 | GM | 8,80 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 91.6 | D05AX03 | calcitriol | lok. | 1.00 | GM | 8,80 | P |

| | | | | | | | |

| 91.7 | D05AX04 | tacalcitol | lok. | 1.00 | GM | 17,59 | P |

| | | | | | | | |

| 91.8 | D05AX05 | tazaroten | lok. | 1.00 | GM | 17,59 | P |

| | | | | | | | |

| 91.9 | D05AX52 | kalcipotriol, kombinace | lok. | 1.00 | GM | 9,68 | P |

Léčbu deriváty vitaminu D včetně kombinací v lokálních lékových formách předepisuje dermatolog k: léčbě torpidních lokalizovaných forem psoriázy nereagující na standardní léčbu v množství maximálně 100 g týdně.

| 91.10 | D05BA02 | methoxalen | p.o. | 10.00 | MG | 3,72 | L/DER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03733 | OXSORALEN | cps 50×10mg | GER | A |

| --- | --- | --- | --- | --- |

| 91.11 | D05BB01 | etretinát | p.o. | 35.00 | MG | 71,36 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 91.12 | D05BB02 | acitretin | p.o. | 35.00 | MG | 71,36 | P |

Léčbu etretinátem a acitretinem předepisuje dermatolog

@@ -3605,364 +3710,363 @@

| 92 | antibiotika k zevnímu použití | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 92.1 | D06AA | tetracyklin a deriváty | lok. | 1.00 | GM | 2.93 | |

| | | | | | | | |

| 92.2 | D06AX | neomycin/bacitracin (k přípravě roztoku) | lok. | 1.00 | ML | 3.83 | |

| | | | | | | | |

| 92.3 | D06AX | neomycin/bacitracin (mast) | lok. | GM | GM | 2.93 | |

| | | | | | | | |

| 92.4 | D06AX | neomycin/bacitracin (zásyp do 2 g včetně) | lok. | 1.00 | GM | 13.69 | |

| | | | | | | | |

| 92.5 | D06AX | neomycin/bacitracin (zásyp nad 2 do 5 g v jednom balení včetně) | lok. | 1.00 | GM | 7.63 | |

| | | | | | | | |

| 92.6 | D06AX | neomycin/bacitracin (zásyp nad 5 g v jednom balení) | lok. | 1.00 | GM | 2.70 | |

| 01063 | FRAMYKOIN | plv ads 1x20gm | IHO | CZ |

| --- | --- | --- | --- | --- |

| 48261 | FRAMYKOIN | plv ads 1x20gm | BHN | CZ |

| 92.7 | D06AX | primycin | lok. | 1.00 | GM | 2.44 | |

| | | | | | | | |

| 92.8 | D06AX01 | acidum fusidicum | lok. | 1.00 | GM | 4,00 | |

| | | | | | | | |

| 92.9 | D06AX02 | chloramfenikol | lok. | 1.00 | GM | 2.88 | |

| | | | | | | | |

| 92.10 | D06AX09 | mupirocin (do 5 g v jednom balení včetně) | lok. | 1.00 | GM | 6.65 | |

| | | | | | | | |

| 92.11 | D06AX09 | mupirocin (nad 5 g v jednom balení) | lok. | 1.00 | GM | 4.00 | |

| 92.1 | D06AA | tetracyklin a deriváty | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 92.2 | D06AX | neomycin/bacitracin (k přípravě roztoku) | lok. | 1.00 | ML | 3,74 | |

| | | | | | | | |

| 92.3 | D06AX | neomycin/bacitracin (mast) | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 92.4 | D06AX | neomycin/bacitracin (zásyp do 2 g včetně) | lok. | 1.00 | GM | 13,38 | |

| | | | | | | | |

| 92.5 | D06AX | neomycin/bacitracin (zásyp nad 2 do 5 g v jednom balení včetně) | lok. | 1.00 | GM | 7,46 | |

| | | | | | | | |

| 92.6 | D06AX | neomycin/bacitracin (zásyp nad 5 g v jednom balení) | lok. | 1.00 | GM | 2,64 | |

| 01063 | FRAMYKOIN | plv ads 1×20gm | IHO | CZ |

| --- | --- | --- | --- | --- |

| 48261 | FRAMYKOIN | plv ads 1×20gm | BHN | CZ |

| 92.7 | D06AX | primycin | lok. | 1.00 | GM | 2,38 | |

| | | | | | | | |

| 92.8 | D06AX01 | acidum fusidicum | lok. | 1.00 | GM | 3,91 | |

| | | | | | | | |

| 92.9 | D06AX02 | chloramfenikol | lok. | 1.00 | GM | 2,81 | |

| | | | | | | | |

| 92.10 | D06AX09 | mupirocin (do 5 g v jednom balení včetně) | lok. | 1.00 | GM | 6,50 | |

| | | | | | | | |

| 92.11 | D06AX09 | mupirocin (nad 5 g v jednom balení) | lok. | 1.00 | GM | 3,91 | |

| | | | | | | | |

| 93 | antibiotika a chemoterapeutika k zevnímu užití a virostatika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 93.1 | D06BA | sulfathiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1.00 | GM | 1.08 | L/DER,CHI |

| | | | | | | | |

| 93.2 | D06BA | sulfathiazin stříbrný (nad 50 g v jednom balení) | lok. | 1.00 | GM | 0.98 | L/DER,CHI |

| | | | | | | | |

| 93.3 | D06BA01 | sulfadiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1.00 | GM | 1.40 | L/DER,CHI |

| | | | | | | | |

| 93.4 | D06BA01 | sulfadiazin stříbrný (nad 50 g v jednom balení) | lok. | 1.00 | GM | 1.12 | L/DER,CHI |

| | | | | | | | |

| 93.5 | D06BA02 | sulfathiazol | lok. | 1.00 | GM | 0.98 | |

| | | | | | | | |

| 93.6 | D06BA03 | matenic | lok. | 1.00 | GM | 0.98 | L/DER,CHI |

| | | | | | | | |

| 93.7 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma krému) | lok. | 1.00 | GM | 5.73 | L/DER,CHI |

| 14877 | IALUGEN PLUS | crm 1x60gm | ISR | CZ |

| --- | --- | --- | --- | --- |

| 93.8 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma náplasti) | lok. | 100.00 | CM2 | 13.49 | L/DER,CHI |

| | | | | | | | |

| 93.9 | D06BB04 | podophylotoxin | lok. | 1.00 | GM | 15.00 | L/DER |

| | | | | | | | |

| 93.10 | D06BX01 | metronidazol | lok. | 1.00 | GM | 2.25 | L/DER,CHI |

| 93.1 | D06BA | sulfathiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1.00 | GM | 1,06 | L/DER,CHI |

| | | | | | | | |

| 93.2 | D06BA | sulfathiazin stříbrný (nad 50 g v jednom balení) | lok. | 1.00 | GM | 0,96 | L/DER,CHI |

| | | | | | | | |

| 93.3 | D06BA01 | sulfadiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1.00 | GM | 1,37 | L/DER,CHI |

| | | | | | | | |

| 93.4 | D06BA01 | sulfadiazin stříbrný (nad 50 g v jednom balení) | lok. | 1.00 | GM | 1,09 | L/DER,CHI |

| | | | | | | | |

| 93.5 | D06BA02 | sulfathiazol | lok. | 1.00 | GM | 0,96 | |

| | | | | | | | |

| 93.6 | D06BA03 | matenic | lok. | 1.00 | GM | 0,96 | L/DER,CHI |

| | | | | | | | |

| 93.7 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma krému) | lok. | 1.00 | GM | 5,60 | L/DER,CHI |

| 14877 | IALUGEN PLUS | crm 1×60gm | ISR | CZ |

| --- | --- | --- | --- | --- |

| 93.8 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma náplasti) | lok. | 100.00 | CM2 | 13,18 | L/DER,CHI |

| | | | | | | | |

| 93.9 | D06BB04 | podophylotoxin | lok. | 1.00 | GM | 14,66 | L/DER |

| | | | | | | | |

| 93.10 | D06BX01 | metronidazol | lok. | 1.00 | GM | 2,20 | L/DER,CHI |

| | | | | | | | |

| 94 | středně silně účinné a slabě účinné kortikosteroidy k lokálnímu použití a jejich kombinace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 94.1 | D07AA02 | hydrokortison | lok. | 1.00 | GM | 3.31 | |

| | | | | | | | |

| 94.2 | D07AA03 | prednisolon | lok. | 1.00 | GM | 3.18 | |

| | | | | | | | |

| 94.3 | D07AB01 | klobetazon | lok. | 1.00 | GM | 3.08 | |

| | | | | | | | |

| 94.4 | D07AB02 | hydrokortison butyrát | lok. | 1.00 | GM | 3.08 | |

| 09305 | LOCOID 0.1% | crm 1x30gm | YEU | NL |

| --- | --- | --- | --- | --- |

| 09307 | LOCOID 0.1% LOTION | lot 1x30ml | YEU | NL |

| 09310 | LOCOID 0.1% | ung 1x30gm | YEU | NL |

| 62047 | LOCOID LIPOCREAM 0.1% | crm 1x30gm | YEU | NL |

| 94.5 | D07AB03 | flumetason | lok. | 1.00 | GM | 3.08 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 94.6 | D07AB07 | flupredniden | lok. | 1.00 | GM | 3.08 | |

| | | | | | | | |

| 94.7 | D07AB09 | triamcinolon (lékové formy lotia) | lok. | 1.00 | ML | 2.83 | |

| 16441 | TRIAMCINOLON-IVAX | drm sol 1x30gm | IXP | CZ |

| --- | --- | --- | --- | --- |

| 66167 | TRIAMCINOLON-GALENA | drm sol 1x30gm | IXP | CZ |

| 94.8 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1.00 | GM | 2.55 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 41040 | TRIAMCINOLON HBF | drm crm 1x30gm | HEO | CZ |

| --- | --- | --- | --- | --- |

| 94.9 | D07AB09 | triamcinolon (lékové formy spreje) | lok. | 1.00 | GM | 0.73 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 94.10 | D07AB09 | triamcinolon (lékové formy tinktury) | lok. | 1.00 | ML | 0.98 | |

| | | | | | | | |

| 94.11 | D07AB10 | alclomethason | lok. | 1.00 | GM | 3.08 | |

| | | | | | | | |

| 94.12 | D07AB19 | dexamethason acetát | lok. | 1.00 | GM | 3.09 | |

| 02415 | DEXAMETHAZON LÉČIVA CRM | drm crm 1x10gm | ZEH | CZ |

| 94.1 | D07AA02 | hydrokortison | lok. | 1.00 | GM | 3,23 | |

| | | | | | | | |

| 94.2 | D07AA03 | prednisolon | lok. | 1.00 | GM | 3,11 | |

| | | | | | | | |

| 94.3 | D07AB01 | klobetazon | lok. | 1.00 | GM | 3,01 | |

| | | | | | | | |

| 94.4 | D07AB02 | hydrokortison butyrát | lok. | 1.00 | GM | 3,01 | |

| 09305 | LOCOID 0.1% | crm 1×30gm | YEU | NL |

| --- | --- | --- | --- | --- |

| 09307 | LOCOID 0.1% LOTION | lot 1×30ml | YEU | NL |

| 09310 | LOCOID 0.1% | ung 1×30gm | YEU | NL |

| 62047 | LOCOID LIPOCREAM 0.1% | crm 1×30gm | YEU | NL |

| 94.5 | D07AB03 | flumetason | lok. | 1.00 | GM | 3,01 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 94.6 | D07AB07 | flupredniden | lok. | 1.00 | GM | 3,01 | |

| | | | | | | | |

| 94.7 | D07AB09 | triamcinolon (lékové formy lotia) | lok. | 1.00 | ML | 2,77 | |

| 16441 | TRIAMCINOLON-IVAX | drm sol 1×30gm | IXP | CZ |

| --- | --- | --- | --- | --- |

| 66167 | TRIAMCINOLON-GALENA | drm sol 1×30gm | IXP | CZ |

| 94.8 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1.00 | GM | 2,49 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 41040 | TRIAMCINOLON HBF | drm crm 1×30gm | HEO | CZ |

| --- | --- | --- | --- | --- |

| 94.9 | D07AB09 | triamcinolon (lékové formy spreje) | lok. | 1.00 | GM | 0,71 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 94.10 | D07AB09 | triamcinolon (lékové formy tinktury) | lok. | 1.00 | ML | 0,96 | |

| | | | | | | | |

| 94.11 | D07AB10 | alclomethason | lok. | 1.00 | GM | 3,01 | |

| | | | | | | | |

| 94.12 | D07AB19 | dexamethason acetát | lok. | 1.00 | GM | 3,02 | |

| 02415 | DEXAMETHAZON LÉČIVA CRM | drm crm 1×10gm | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 95 | velmi silné a silně účinné kortikosteroidy k lokálnímu podání a jejich kombinace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 95.1 | D07AC01 | betamethason dipropionát | lok. | 1.00 | GM | 2.18 | |

| 98032 | DIPROSONE | ung 1x30gm | SCH | B |

| --- | --- | --- | --- | --- |

| 95.2 | D07AC01 | betamethason valerát | lok. | 1.00 | GM | 2.95 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 95.3 | D07AC02 | fluklorolon | lok. | 1.00 | GM | 3.32 | |

| | | | | | | | |

| 95.4 | D07AC04 | fluocinolon gel | lok. | 1.00 | GM | 2.44 | |

| | | | | | | | |

| 95.5 | D07AC04 | fluocinolon lotio (koncentrace do 0,025% včetně) | lok. | 1.00 | GM | 2.93 | |

| | | | | | | | |

| 95.6 | D07AC04 | fluocinolon lotio (koncentrace nad 0,025%) | lok. | 1.00 | GM | 3.91 | |

| | | | | | | | |

| 95.7 | D07AC04 | fluocinolon mast a krém (koncentrace do 0,025% včetně) | lok. | 1.00 | GM | 2.93 | |

| | | | | | | | |

| 95.8 | D07AC04 | fluocinolon mast a krém (koncentrace nad 0,025%) | lok. | 1.00 | GM | 3.91 | |

| | | | | | | | |

| 95.9 | D07AC06 | diflukortolon | lok. | 1.00 | GM | 3.42 | |

| | | | | | | | |

| 95.10 | D07AC08 | fluocinonid | lok. | 1.00 | GM | 2.93 | |

| | | | | | | | |

| 95.11 | D07AC09 | budesonid | lok. | 1.00 | GM | 3.18 | L/DER |

| | | | | | | | |

| 95.12 | D07AC12 | halometason | lok. | 1.00 | GM | 3.27 | |

| | | | | | | | |

| 95.13 | D07AC13 | mometazon do 10g v 1 balení včetně | lok. | 1.00 | GM | 6.70 | L/DER,ALG,PED |

| | | | | | | | |

| 95.14 | D07AC13 | mometazon nad 10g v jednom balení | lok. | 1.00 | GM | 5.00 | L/DER,ALG,PED |

| | | | | | | | |

| 95.15 | D07AC14 | methylprednisoloni aceponas | lok. | 1.00 | GM | 5.87 | L/DER,ALG,PED |

| | | | | | | | |

| 95.16 | D07AC17 | flutikason | lok. | 1.00 | GM | 3.42 | |

| | | | | | | | |

| 95.17 | D07AC18 | prednikarbat (do 10 g v 1 balení včetně) | lok. | 1.00 | GM | 6.70 | L/DER,ALG,PED |

| | | | | | | | |

| 95.18 | D07AC18 | prednikarbat (nad 10 g v 1 balení) | lok. | 1.00 | GM | 5.87 | L/DER,ALG,PED |

| | | | | | | | |

| 95.19 | D07AD01 | klobetasol | lok. | 1.00 | GM | 3.93 | L/DER |

| | | | | | | | |

| 95.20 | D07AD02 | halcinonid | lok. | 1.00 | ML | 3.93 | L/DER |

| 16890 | BETACORTON | drm sol 1x100ml | SBT | SK |

| --- | --- | --- | --- | --- |

| 97020 | BETACORTON | drm sol 1x100ml | SEG | CH |

| 95.1 | D07AC01 | betamethason dipropionát | lok. | 1.00 | GM | 2,13 | |

| 98032 | DIPROSONE | ung 1×30gm | SCH | B |

| --- | --- | --- | --- | --- |

| 95.2 | D07AC01 | betamethason valerát | lok. | 1.00 | GM | 2,88 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 95.3 | D07AC02 | fluklorolon | lok. | 1.00 | GM | 3,24 | |

| | | | | | | | |

| 95.4 | D07AC04 | fluocinolon gel | lok. | 1.00 | GM | 2,38 | |

| | | | | | | | |

| 95.5 | D07AC04 | fluocinolon lotio (koncentrace do 0,025% včetně) | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 95.6 | D07AC04 | fluocinolon lotio (koncentrace nad 0,025%) | lok. | 1.00 | GM | 3,82 | |

| | | | | | | | |

| 95.7 | D07AC04 | fluocinolon mast a krém (koncentrace do 0,025% včetně) | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 95.8 | D07AC04 | fluocinolon mast a krém (koncentrace nad 0,025%) | lok. | 1.00 | GM | 3,82 | |

| | | | | | | | |

| 95.9 | D07AC06 | diflukortolon | lok. | 1.00 | GM | 3,34 | |

| | | | | | | | |

| 95.10 | D07AC08 | fluocinonid | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 95.11 | D07AC09 | budesonid | lok. | 1.00 | GM | 3,11 | L/DER |

| | | | | | | | |

| 95.12 | D07AC12 | halometason | lok. | 1.00 | GM | 3,20 | |

| | | | | | | | |

| 95.13 | D07AC13 | mometazon do 10g v 1 balení včetně | lok. | 1.00 | GM | 6,55 | L/DER,ALG,PED |

| | | | | | | | |

| 95.14 | D07AC13 | mometazon nad 10g v jednom balení | lok. | 1.00 | GM | 4,89 | L/DER,ALG,PED |

| | | | | | | | |

| 95.15 | D07AC14 | methylprednisoloni aceponas | lok. | 1.00 | GM | 5,74 | L/DER,ALG,PED |

| | | | | | | | |

| 95.16 | D07AC17 | flutikason | lok. | 1.00 | GM | 3,34 | |

| | | | | | | | |

| 95.17 | D07AC18 | prednikarbat (do 10 g v 1 balení včetně) | lok. | 1.00 | GM | 6,55 | L/DER,ALG,PED |

| | | | | | | | |

| 95.18 | D07AC18 | prednikarbat (nad 10 g v 1 balení) | lok. | 1.00 | GM | 5,74 | L/DER,ALG,PED |

| | | | | | | | |

| 95.19 | D07AD01 | klobetasol | lok. | 1.00 | GM | 3,84 | L/DER |

| | | | | | | | |

| 95.20 | D07AD02 | halcinonid | lok. | 1.00 | ML | 3,84 | L/DER |

| 16890 | BETACORTON | drm sol 1×100ml | SBT | SK |

| --- | --- | --- | --- | --- |

| 97020 | BETACORTON | drm sol 1×100ml | SEG | CH |

| 96 | kortikosteroidy v kombinacích s antibiotiky nebo antiseptiky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 96.1 | D07BA01 | prednisolon/cloroxin | lok. | 1.00 | GM | 1.96 | |

| | | | | | | | |

| 96.2 | D07BA01 | prednisolon/hexamidin diisothionát | lok. | 1.00 | GM | 1.96 | |

| | | | | | | | |

| 96.3 | D07BB01 | flumetason a antiseptika | lok. | 1.00 | GM | 3.32 | |

| | | | | | | | |

| 96.4 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1.00 | GM | 1.92 | |

| 04178 | TRIAMCINOLON E LÉČIVA | ung 1x20gm | LEX | CZ |

| --- | --- | --- | --- | --- |

| 96.5 | D07BB03 | triamcinolon a antiseptika (lékové formy pěny) | lok. | 1.00 | GM | 1.42 | |

| | | | | | | | |

| 96.6 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1.00 | GM | 0.59 | |

| | | | | | | | |

| 96.7 | D07CA01 | hydrocortison a antibiotika (lékové formy mastí a krémů) | lok. | 1.00 | GM | 1.96 | |

| | | | | | | | |

| 96.8 | D07CA01 | hydrocortison a antibiotika (tekuté lékové formy) | lok. | 1.00 | ML | 1.96 | |

| | | | | | | | |

| 96.9 | D07CA01 | hydrocortison a kys. fusidová (lékové formy mastí a krémů) | lok. | 1.00 | GM | 4.40 | |

| | | | | | | | |

| 96.10 | D07CC01 | betamethason a gentamicin | lok. | 1.00 | GM | 2.50 | |

| | | | | | | | |

| 96.11 | D07CC01 | betamethason a kyselina fusidová (lékové formy mastí a krémů) | lok. | 1.00 | GM | 4.40 | |

| 96.1 | D07BA01 | prednisolon/cloroxin | lok. | 1.00 | GM | 1,92 | |

| | | | | | | | |

| 96.2 | D07BA01 | prednisolon/hexamidin diisothionát | lok. | 1.00 | GM | 1,92 | |

| | | | | | | | |

| 96.3 | D07BB01 | flumetason a antiseptika | lok. | 1.00 | GM | 3,24 | |

| | | | | | | | |

| 96.4 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1.00 | GM | 1,88 | |

| 04178 | TRIAMCINOLON E LÉČIVA | ung 1×20gm | LEX | CZ |

| --- | --- | --- | --- | --- |

| 96.5 | D07BB03 | triamcinolon a antiseptika (lékové formy pěny) | lok. | 1.00 | GM | 1,39 | |

| | | | | | | | |

| 96.6 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1.00 | GM | 0,58 | |

| | | | | | | | |

| 96.7 | D07CA01 | hydrocortison a antibiotika (lékové formy mastí a krémů) | lok. | 1.00 | GM | 1,92 | |

| | | | | | | | |

| 96.8 | D07CA01 | hydrocortison a antibiotika (tekuté lékové formy) | lok. | 1.00 | ML | 1,92 | |

| | | | | | | | |

| 96.9 | D07CA01 | hydrocortison a kys. fusidová (lékové formy mastí a krémů) | lok. | 1.00 | GM | 4,30 | |

| | | | | | | | |

| 96.10 | D07CC01 | betamethason a gentamicin | lok. | 1.00 | GM | 2,44 | |

| | | | | | | | |

| 96.11 | D07CC01 | betamethason a kyselina fusidová (lékové formy mastí a krémů) | lok. | 1.00 | GM | 4,30 | |

| | | | | | | | |

| 97 | kortikosteroidy v jiných kombinacích | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 97.1 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1.00 | ML | 1.60 | |

| | | | | | | | |

| 97.2 | D07XA01 | hydrokortison | lok. | 1.00 | ML | 1.96 | |

| | | | | | | | |

| 97.3 | D07XA02 | prednisolon/kyselina salicylová | lok. | 1.00 | ML | 1.32 | |

| | | | | | | | |

| 97.4 | D07XB01 | flumetason/dehet | lok. | 1.00 | ML | 4.40 | |

| | | | | | | | |

| 97.5 | D07XB01 | flumethason pivalat/kyselina salicylová | lok. | 1.00 | ML | 2.93 | |

| | | | | | | | |

| 97.6 | D07XB02 | triamcinolon | lok. | 1.00 | ML | 1.87 | |

| | | | | | | | |

| 97.7 | D07XC | diflucortolon/isoconasol | lok. | 1.00 | ML | 2.61 | |

| | | | | | | | |

| 97.8 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1.00 | ML | 2.61 | |

| 85864 | BELOSALIC | drm ung 1x30gm | BLU | CHO |

| --- | --- | --- | --- | --- |

| 97.9 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1.00 | ML | 2.61 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 97.10 | D07XD | halcinonid/kyselina salicylová | lok. | 1.00 | ML | 3.51 | |

| | | | | | | | |

| 97.11 | D07XD | halcinonid/močovina | lok. | 1.00 | GM | 3.51 | |

| 16888 | BETACORTON U | drm crm 1x20gm | SBT | SK |

| --- | --- | --- | --- | --- |

| 16893 | BETACORTON U MASTNÝ KRÉM | drm crm 1x20gm | SBT | SK |

| 97.1 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1.00 | ML | 1,56 | |

| | | | | | | | |

| 97.2 | D07XA01 | hydrokortison | lok. | 1.00 | ML | 1,92 | |

| | | | | | | | |

| 97.3 | D07XA02 | prednisolon/kyselina salicylová | lok. | 1.00 | ML | 1,29 | |

| | | | | | | | |

| 97.4 | D07XB01 | flumetason/dehet | lok. | 1.00 | GM | 4,30 | |

| | | | | | | | |

| 97.5 | D07XB01 | flumethason pivalat/kyselina salicylová | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 97.6 | D07XB02 | triamcinolon | lok. | 1.00 | GM | 1,83 | |

| | | | | | | | |

| 97.7 | D07XC | diflucortolon/isoconasol | lok. | 1.00 | GM | 2,55 | |

| | | | | | | | |

| 97.8 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1.00 | GM | 2,55 | |

| 85864 | BELOSALIC | drm ung 1×30gm | BLU | CHO |

| --- | --- | --- | --- | --- |

| 97.9 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1.00 | ML | 2,55 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 97.10 | D07XD | halcinonid/kyselina salicylová | lok. | 1.00 | ML | 3,43 | |

| | | | | | | | |

| 97.11 | D07XD | halcinonid/močovina | lok. | 1.00 | GM | 3,43 | |

| 16888 | BETACORTON U | drm crm 1×20gm | SBT | SK |

| --- | --- | --- | --- | --- |

| 16893 | BETACORTON U MASTNÝ KRÉM | drm crm 1×20gm | SBT | SK |

| 98 | antiseptika a desinficiencia | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 98.1 | D08AC02 | chlorhexidin | lok. | 1 000.00 | ML | 178.70 | |

| | | | | | | | |

| 98.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1.00 | GM | 0.32 | |

| 65998 | UNG.AC.BORICI 3% HERB.-BOFARMA | ung 1x1000gm (dÓza) | HEO | CZ |

| --- | --- | --- | --- | --- |

| 98.3 | D08AD | kyselina boritá (lékové formy roztoků) | lok. | 10.00 | GM | 1.32 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 98.4 | D08AG02 | polyvidon-jód (do 200 g masti v jednom balení včetně) | lok. | 1.00 | GM | 1.96 | |

| 16320 | BRAUNOVI DON MAST | ung 1x100gm-tuba | BMM | D |

| --- | --- | --- | --- | --- |

| 84421 | BRAUNOVI DON MAST | ung 1x100gm-tuba | BMB | CH |

| 98.5 | D08AG02 | polyvidon-jód (do 200 ml včetně roztoku v jednom balení) | lok. | 1.00 | ML | 0.64 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02981 | JODISOL ROZTOK | liq 1x80gm | SDH | CZ |

| --- | --- | --- | --- | --- |

| 98.6 | D08AG02 | polyvidon-jód (nad 200 ml roztoku v jednom balení) | lok. | 1.00 | ML | 0.49 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02983 | JODISOL ROZTOK | liq 1x760gm | SDH | CZ |

| --- | --- | --- | --- | --- |

| 15877 | BRAUNOL | drm sol 1x1000ml | BMM | D |

| 15879 | BRAUNOL | drm sol 1x250ml | BMM | D |

| 15880 | BRAUNOL | drm sol 1x500ml | BMM | D |

| 46055 | BRAUNOL | liq 1x250ml | BMB | CH |

| 46056 | BRAUNOL | liq 1x500ml | BMB | CH |

| 80553 | BRAUNOL | liq 1x1000ml | BMB | CH |

| 98.7 | D08AG02 | polyvidon-jód nad 200 g masti v jednom balení) | lok. | 1.00 | GM | 0.64 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 98.8 | D08AH | kloroxin | lok. | 1.00 | GM | 0.78 | |

| | | | | | | | |

| 98.9 | D08AJ | bromid benzododecinia (tinktura a roztok do 50 ml v jednom balení včetně) | lok. | 1.00 | ML | 0.29 | |

| | | | | | | | |

| 98.10 | D08AJ | bromid benzododecinia (tinktura a roztok nad 50 ml v jednom balení) | lok. | 1.00 | ML | 0.08 | H |

| 58237 | AJATIN PROFARMA TINKTURA | tct 1x1000ml | PSR | CZ |

| --- | --- | --- | --- | --- |

| 98.11 | D08AJ | chlorid karbetopendecinia (tinktura 50 ml v jednom balení včetně) | lok. | 1.00 | ML | 0.08 | H |

| | | | | | | | |

| 98.12 | D08AX | hexamidin/chlorhexidin | lok. | 1.00 | GM | 121.37 | H |

| | | | | | | | |

| 98.13 | D08AX | noxytiolin | lok. | 2.50 | GM | 492.11 | H |

| | | | | | | | |

| 98.14 | D08AX | noxytiolin/tetrakain | lok. | 2.50 | GM | 492.11 | H |

| | | | | | | | |

| 98.15 | D08AX | taurodin | lok. | 1.00 | GM | 94.48 | H |

| 98.1 | D08AC02 | chlorhexidin | lok. | 1 000.00 | ML | 174,64 | |

| | | | | | | | |

| 98.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1.00 | GM | 0,31 | |

| 65998 | UNG.AC.BORICI 3% HERB.-BOFARMA | ung 1×1000gm (dóza) | HEO | CZ |

| --- | --- | --- | --- | --- |

| 98.3 | D08AD | kyselina boritá (lékové formy roztoků) | lok. | 10.00 | GM | 1,29 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 98.4 | D08AG02 | polyvidon-jód (do 200 g masti v jednom balení včetně) | lok. | 1.00 | GM | 1,92 | |

| 16320 | BRAUNOVIDON MAST | ung 1×100gm-tuba | BMM | D |

| --- | --- | --- | --- | --- |

| 84421 | BRAUNOVIDON MAST | ung 1×100gm-tuba | BMB | CH |

| 98.5 | D08AG02 | polyvidon-jód (do 200 ml včetně roztoku v jednom balení) | lok. | 1.00 | ML | 0,63 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02981 | JODISOL ROZTOK | liq 1×80gm | SDH | CZ |

| --- | --- | --- | --- | --- |

| 98.6 | D08AG02 | polyvidon-jód (nad 200 ml roztoku v jednom balení) | lok. | 1.00 | ML | 0,48 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02983 | JODISOL ROZTOK | liq 1×760gm | SDH | CZ |

| --- | --- | --- | --- | --- |

| 15877 | BRAUNOL | drm sol 1×1000ml | BMM | D |

| 15879 | BRAUNOL | drm sol 1×250ml | BMM | D |

| 15880 | BRAUNOL | drm sol 1×500ml | BMM | D |

| 46055 | BRAUNOL | liq 1×250ml | BMB | CH |

| 46056 | BRAUNOL | liq 1×500ml | BMB | CH |

| 80553 | BRAUNOL | liq 1×1000ml | BMB | CH |

| 98.7 | D08AG02 | polyvidon-jód nad 200 g masti v jednom balení) | lok. | 1.00 | GM | 0,63 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 98.8 | D08AH | kloroxin | lok. | 1.00 | GM | 0,76 | |

| | | | | | | | |

| 98.9 | D08AJ | bromid benzododecinia (tinktura a roztok do 50 ml v jednom balení včetně) | lok. | 1.00 | ML | 0,28 | |

| | | | | | | | |

| 98.10 | D08AJ | bromid benzododecinia (tinktura a roztok nad 50 ml v jednom balení) | lok. | 1.00 | ML | 0,08 | H |

| 58237 | AJATIN PROFARMA TINKTURA | tct 1×1000ml | PSR | CZ |

| --- | --- | --- | --- | --- |

| 98.11 | D08AJ | chlorid karbetopendecinia (tinktura 50 ml v jednom balení včetně) | lok. | 1.00 | ML | 0,08 | H |

| | | | | | | | |

| 98.12 | D08AX | hexamidin/chlorhexidin | lok. | 1.00 | GM | 118,61 | H |

| | | | | | | | |

| 98.13 | D08AX | noxytiolin | lok. | 2.50 | GM | 480,94 | H |

| | | | | | | | |

| 98.14 | D08AX | noxytiolin/tetrakain | lok. | 2.50 | GM | 480,94 | H |

| | | | | | | | |

| 98.15 | D08AX | taurodin | lok. | 1.00 | GM | 92,34 | H |

| | | | | | | | |

| 99 | léčivé látky proti akné a jiné dermatologické léčivé látky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 99.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1.00 | GM | 3.69 | |

| 15389 | RETIN-A 0.025% | drm crm 1x30gm | JAN | B |

| --- | --- | --- | --- | --- |

| 49985 | LOCACID | crm 1x30gm 0.05% | PRH | F |

| 66170 | LOCACID | crm 1x30gm 0.05% | PFH | F |

| 97573 | RETIN-A KRÉM 0.025% | drm crm 1x30gm | CIL | CH |

| 99.2 | D10AD01 | tretinoin (lékové formy krémů a gelů koncentrace nad 0,05%) | lok. | 1.00 | GM | 4.40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 99.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1.00 | ML | 3.70 | |

| 64956 | AIROL | lot 1x50ml 0.05% | PRH | F |

| --- | --- | --- | --- | --- |

| 99.4 | D10AD01 | tretinoin (lékové formy roztoků koncentrace nad 0,05%) | lok. | 1.00 | ML | 4.40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 99.5 | D10AD03 | adapalen - léková forma krémů a gelů | lok. | 1.00 | GM | 4.00 | |

| | | | | | | | |

| 99.6 | D10AD54 | isotretinoin a erythromycin v kombinaci | lok. | 1.00 | GM | 2.93 | |

| | | | | | | | |

| 99.7 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1.00 | ML | 2.54 | |

| | | | | | | | |

| 99.8 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1.00 | GM | 1.42 | |

| 47279 | ECLARAN 5 | drm gel 1x45gm | PFG | F |

| --- | --- | --- | --- | --- |

| 99.9 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1.00 | ML | 0.39 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 99.10 | D10AF01 | klindamycin (tekuté lékové formy) | lok. | 1.00 | ML | 1.96 | |

| | | | | | | | |

| 99.11 | D10AF01 | klindamycin (lékové formy gelu) | lok. | 1.00 | GM | 1.96 | |

| | | | | | | | |

| 99.12 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1.00 | GM | 2.93 | |

| | | | | | | | |

| 99.13 | D10AF02 | erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení | lok. | 1.00 | ML | 2.01 | |

| 98204 | ERYFLUID | sol 1x30ml | PFH | F |

| --- | --- | --- | --- | --- |

| 99.14 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1.00 | ML | 1.62 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 75285 | ERYFLUID | sol 1x100ml | PFH | F |

| --- | --- | --- | --- | --- |

| 99.15 | D10AF52 | erythromycin v kombinaci se zinkem | lok. | 1.00 | ML | 2.93 | |

| | | | | | | | |

| 99.16 | D10AF52 | erythromycin v kombinaci s tretinoinem | lok. | 1.00 | ML | 3.75 | |

| | | | | | | | |

| 99.17 | D10AX03 | kyselina azelaová | lok. | 1.00 | GM | 1.96 | |

| | | | | | | | |

| 99.18 | D10BA01 | isotretinoin (do 10 MG včetně v jedné kapsli) | p.o. | 30.00 | MG | 65.90 | X |

| | | | | | | | |

| 99.19 | D10BA01 | isotretinoin (nad 10 MG v jedné kapsli) | p.o. | 30.00 | MG | 59.40 | X |

| | | | | | | | |

| 99.20 | D11AX | celulóza (lékové formy zásypů) | lok. | 1.00 | GM | 9.78 | L/DER |

| 99.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1.00 | GM | 3,61 | |

| 15389 | RETIN-A 0.025% | drm crm 1×30gm | JAN | B |

| --- | --- | --- | --- | --- |

| 49985 | LOCACID | crm 1×30gm 0.05% | PRH | F |

| 66170 | LOCACID | crm 1×30gm 0.05% | PFH | F |

| 97573 | RETIN-A KRÉM 0.025% | drm crm 1×30gm | CIL | CH |

| 99.2 | D10AD01 | tretinoin (lékové formy krémů a gelů koncentrace nad 0,05%) | lok. | 1.00 | GM | 4,30 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 99.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1.00 | ML | 3,62 | |

| 64956 | AIROL | lot 1×50ml 0.05% | PRH | F |

| --- | --- | --- | --- | --- |

| 99.4 | D10AD01 | tretinoin (lékové formy roztoků koncentrace nad 0,05%) | lok. | 1.00 | ML | 4,30 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 99.5 | D10AD03 | adapalen - léková forma krémů a gelů | lok. | 1.00 | GM | 3,91 | |

| | | | | | | | |

| 99.6 | D10AD54 | isotretinoin a erythromycin v kombinaci | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 99.7 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1.00 | ML | 2,48 | |

| | | | | | | | |

| 99.8 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1.00 | GM | 1,39 | |

| 47279 | ECLARAN 5 | drm gel 1×45gm | PFG | F |

| --- | --- | --- | --- | --- |

| 99.9 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1.00 | ML | 0,38 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 99.10 | D10AF01 | klindamycin (tekuté lékové formy) | lok. | 1.00 | ML | 1,92 | |

| 99.11 | D10AF01 | klindamycin (lékové formy gelu) | lok. | 1.00 | GM | 1,92 | |

| | | | | | | | |

| 99.12 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 99.13 | D10AF02 | erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení | lok. | 1.00 | ML | 1,96 | |

| 98204 | ERYFLUID | sol 1×30ml | PFH | F |

| --- | --- | --- | --- | --- |

| 99.14 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1.00 | ML | 1,58 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 75285 | ERYFLUID | sol 1×100ml | PFH | F |

| --- | --- | --- | --- | --- |

| 99.15 | D10AF52 | erythromycin v kombinaci se zinkem | lok. | 1.00 | ML | 2,86 | |

| | | | | | | | |

| 99.16 | D10AF52 | erythromycin v kombinaci s tretinoinem | lok. | 1.00 | ML | 3,66 | |

| | | | | | | | |

| 99.17 | D10AX03 | kyselina azelaová | lok. | 1.00 | GM | 1,92 | |

| | | | | | | | |

| 99.18 | D10BA01 | isotretinoin (do 10 MG včetně v jedné kapsli) | p.o. | 30.00 | MG | 64,40 | X |

| | | | | | | | |

| 99.19 | D10BA01 | isotretinoin (nad 10 MG v jedné kapsli) | p.o. | 30.00 | MG | 58,05 | X |

| | | | | | | | |

| 99.20 | D11AX | celulóza (lékové formy zásypů) | lok. | 1.00 | GM | 9,56 | L/DER |

| | | | | | | | |

| 100 | ostatní léčiva používaná u nemocí kůže | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 100.1 | D04AB01 | lidokain (lékové formy spreje, koncentrace 10%) | lok. | 1.00 | GM | 4.26 | O |

| 46125 | LIDOCAIN 10% | spr 1x38gm | EGI | H |

| --- | --- | --- | --- | --- |

| 100.2 | D11AF | fluorouracil (lékové formy mastí) | lok. | 1.00 | GM | 13.15 | L/DER,ONK |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 100.3 | D11AF | fluorouracil (lékové formy roztoků) | lok. | 1.00 | ML | 11.50 | L/DER |

| | | | | | | | |

| 100.4 | D11AX14 | tacrolimus v koncentraci 0,03% | lok. | 1.00 | GM | 28.80 | P |

| | | | | | | | |

| 100.5 | D11AX14 | tacrolimus v koncentraci 0,1 % | lok. | 1.00 | GM | 31.50 | P |

| 100.1 | D04AB01 | lidokain (lékové formy spreje, koncentrace 10%) | lok. | 1.00 | GM | 4,16 | O |

| 46125 | LIDOCAIN 10% | spr 1×38gm | EGI | H |

| --- | --- | --- | --- | --- |

| 100.2 | D11AF | fluorouracil (lékové formy mastí) | lok. | 1.00 | GM | 12,85 | L/DER,ONK |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 100.3 | D11AF | fluorouracil (lékové formy roztoků) | lok. | 1.00 | ML | 11,24 | L/DER |

| | | | | | | | |

| 100.4 | D11AX14 | tacrolimus v koncentraci 0,03% | lok. | 1.00 | GM | 28,15 | P |

| | | | | | | | |

| 100.5 | D11AX14 | tacrolimus v koncentraci 0,1 % | lok. | 1.00 | GM | 30,78 | P |

Léčbu tacrolimem předepisuje dermatovenerolog u pacientů s atopickou dermatitidou (AD), kteří netolerují klasickou terapii, nebo kteří na klasické terapii selhávají:

- a) u dětí do 6 let, které trpí středně těžkou a těžkou AD na hlavě a krku (4,5 – 9 klasifikace dle Rajka-Langeland),

- a) u dětí do 6 let, které trpí středně těžkou a těžkou AD na hlavě a krku (4,5 - 9 klasifikace dle Rajka-Langeland),

- b) u starších dětí a dospělých, kteří trpí těžkou AD na hlavě a krku (8 – 9 klasifikace dle Rajka - Langeland).

| 100.6 | D11AX15 | pimecrolimus | lok. | 1.00 | GM | 28.80 | P |

| 100.6 | D11AX15 | pimecrolimus | lok. | 1.00 | GM | 28,15 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu pimecrolimem předepisuje dermatovenerolog u pacientů s atopickou dermatitidou (AD), kteří netolerují klasickou terapii, nebo kteří na klasické terapii selhávají - u dětí, které trpí středně těžkou AD na hlavě a krku (4,5 – 7,5 klasifikace dle Rajka - Langeland).

@@ -3970,25 +4074,17 @@

| 101 | gynekologická chemoterapeutika a antimykotika k lokálnímu použití | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 101.1 | G01AA01 | nystatin | vag. | 100.00 | KU | 0.98 | |

| | | | | | | | |

| 101.2 | G01AA02 | natamycin (lékové formy s obsahem 100 mg) | vag. | 25.00 | MG | 6.64 | |

| 78213 | PIMAFUCIN | glo vag 3x100mg | YEU | NL |

| --- | --- | --- | --- | --- |

| 101.3 | G01AA02 | natamycin (lékové formy s obsahem méně než 100 mg) | vag. | 25.00 | MG | 4.11 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 101.4 | G01AA10 | klindamycin (lékové formy krémů) | vag. | 1.00 | GM | 11.00 | P |

| | | | | | | | |

| 101.5 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. čípků) | vag. | 1.00 | DF | 17.00 | |

| | | | | | | | |

| 101.6 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. krémů) | vag. | 5.00 | GM | 33.95 | |

| | | | | | | | |

| 101.7 | G01AA51 | nystatin kombinace s neomycinem a polymyxinem | vag. | 1.00 | DF | 11.30 | |

| | | | | | | | |

| 101.8 | G01AF01 | metronidazol | vag. | 0.50 | GM | 3.34 | |

| 101.1 | G01AA01 | nystatin | vag. | 100.00 | KU | 0,96 | |

| | | | | | | | |

| 101.2 | G01AA02 | natamycin (lékové formy s obsahem 100 mg) | vag. | 25.00 | MG | 6,49 | |

| 78213 | PIMAFUCIN | glo vag 3×100mg | YEU | NL |

| --- | --- | --- | --- | --- |

| 101.3 | G01AA02 | natamycin (lékové formy s obsahem méně než 100 mg) | vag. | 25.00 | MG | 4,02 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 101.4 | G01AA10 | klindamycin (lékové formy krémů) | vag. | 1.00 | GM | 10,75 | P |

Léčbu vaginálním klindamycinem předepisuje gynekolog:

@@ -3996,84 +4092,84 @@

- b) vaginitis s průkazem citlivosti bakteriálních kmenů na klindamycin.

| 02430 | ENTIZOL | tbl vag 10x500mg | ZPF | PL |

| --- | --- | --- | --- | --- |

| 101.9 | G01AF02 | klotrimazol (lékové formy vaginálních krémů) | vag. | 0.10 | GM | 12.68 | |

| 101.5 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. čípků) | vag. | 1.00 | DF | 16,61 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 101.6 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. krémů) | vag. | 5.00 | GM | 33,18 | |

| | | | | | | | |

| 101.7 | G01AA51 | nystatin kombinace s neomycinem a polymyxinem | vag. | 1.00 | DF | 11,04 | |

| | | | | | | | |

| 101.8 | G01AF01 | metronidazol | vag. | 0.50 | GM | 3,26 | |

| 02430 | ENTIZOL | tbl vag 10×500mg | ZPF | PL |

| --- | --- | --- | --- | --- |

| 101.9 | G01AF02 | klotrimazol (lékové formy vaginálních krémů) | vag. | 0.10 | GM | 12,39 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 68917 | JENAMAZOL 2% | crm vag 20gm+aplik. | VJP | D |

| --- | --- | --- | --- | --- |

| 101.10 | G01AF02 | klotrimazol (lékové formy vaginálních tablet) | vag. | 0.10 | GM | 8.10 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 58653 | CLOTRIMAZOL AL 100 | tbl vag 6x100mg+apl | APA | D |

| --- | --- | --- | --- | --- |

| 58654 | CLOTRIMAZOL AL 200 | tbl vag 3x200mg+apl | APA | D |

| 101.11 | G01AF04 | mikonazol | vag. | 0.10 | GM | 8.70 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 101.12 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.10 | GM | 12.78 | |

| | | | | | | | |

| 101.13 | G01AF05 | ekonazol (lékové formy vaginálních tablet, globulí a čípků) | vag. | 0.10 | GM | 30.99 | |

| | | | | | | | |

| 101.14 | G01AF11 | ketoconazol | vag. | 0.40 | GM | 13.44 | |

| | | | | | | | |

| 101.15 | G01AF12 | fenticonazol | vag. | 0.10 | GM | 13.44 | |

| | | | | | | | |

| 101.16 | G01AF17 | oxikonazol | vag. | 0.60 | GM | 109.90 | |

| | | | | | | | |

| 101.17 | G01AF20 | kombinace imidazolových derivátů -mikonazol a metronidazol (lékové formy vag. tablet) | vag. | 1.00 | DF | 6.35 | |

| | | | | | | | |

| 101.18 | G01AG02 | terkonazol (lékové formy vaginálních krémů) | vag. | 80.00 | MG | 12.88 | |

| | | | | | | | |

| 101.19 | G01AG02 | terkonazol (lékové formy vaginálních tablet) | vag. | 80.00 | MG | 31.28 | |

| | | | | | | | |

| 101.20 | G01AX12 | ciclopirox (vaginální čípky) | vag. | 1.00 | DF | 31.28 | |

| | | | | | | | |

| 101.21 | G01AX12 | ciclopirox (vaginální roztok) | vag. | 1.00 | DF | 17.60 | |

| | | | | | | | |

| 101.5 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. čípků) | vag. | 1.00 | DF | 17.00 | |

| | | | | | | | |

| 101.6 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. krémů) | vag. | 5.00 | GM | 33.95 | |

| | | | | | | | |

| 101.7 | G01AA51 | nystatin kombinace s neomycinem a polymyxinem | vag. | 1.00 | DF | 11.30 | |

| | | | | | | | |

| 101.8 | G01AF01 | metronidazol | vag. | 0.50 | GM | 3.34 | |

| 101.22 | G01AX12 | ciklopirox (vaginální krém - do 40 gm včetně v jednom balení) | vag. | 1.00 | GM | 4.69 | |

| | | | | | | | |

| 101.23 | G01AX12 | ciklopirox (vaginální krém - nad 40 gm v jednom balení) | vag. | 1.00 | GM | 3.11 | |

| 101.10 | G01AF02 | klotrimazol (lékové formy vaginálních tablet) | vag. | 0.10 | GM | 7,92 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 58653 | CLOTRIMAZOL AL 100 | tbl vag 6×100mg+apl | APA | D |

| --- | --- | --- | --- | --- |

| 58654 | CLOTRIMAZOL AL 200 | tbl vag 3×200mg+apl | APA | D |

| 101.11 | G01AF04 | mikonazol | vag. | 0.10 | GM | 8,50 | |

| | | | | | | | |

| 101.12 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.10 | GM | 12,49 | |

| | | | | | | | |

| 101.13 | G01AF05 | ekonazol (lékové formy vaginálních tablet, globulí a čípků) | vag. | 0.10 | GM | 30,29 | |

| | | | | | | | |

| 101.14 | G01AF11 | ketoconazol | vag. | 0.40 | GM | 13,13 | |

| | | | | | | | |

| 101.15 | G01AF12 | fenticonazol | vag. | 0.10 | GM | 13,13 | |

| | | | | | | | |

| 101.16 | G01AF17 | oxikonazol | vag. | 0.60 | GM | 107,41 | |

| | | | | | | | |

| 101.17 | G01AF20 | kombinace imidazolových derivátů -mikonazol a metronidazol ( lékové formy vag. tablet) | vag. | 1.00 | DF | 6,21 | |

| | | | | | | | |

| 101.18 | G01AG02 | terkonazol (lékové formy vaginálních krémů) | vag. | 80.00 | MG | 12,59 | |

| | | | | | | | |

| 101.19 | G01AG02 | terkonazol (lékové formy vaginálních tablet) | vag. | 80.00 | MG | 30,57 | |

| | | | | | | | |

| 101.20 | G01AX12 | ciclopirox (vaginální čípky) | vag. | 1.00 | DF | 30,57 | |

| | | | | | | | |

| 101.21 | G01AX12 | ciclopirox (vaginální roztok) | vag. | 1.00 | DF | 17,20 | |

| | | | | | | | |

| 101.22 | G01AX12 | ciklopirox (vaginální krém - do 40 gm včetně v jednom balení) | vag. | 1.00 | GM | 4,58 | |

| | | | | | | | |

| 101.23 | G01AX12 | ciklopirox (vaginální krém - nad 40 gm v jednom balení) | vag. | 1.00 | GM | 3,04 | |

| | | | | | | | |

| 102 | gynekologická antiseptika a antiinfektiva k lokálnímu použití | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 102.1 | G01AX | jiná antiinfektiva a antiseptika (tetraboritan sodný) | vag. | 1.00 | DF | 6.40 | |

| | | | | | | | |

| 102.2 | G01AX | laktobacillus | vag. | 1.00 | DF | 10.26 | |

| | | | | | | | |

| 102.3 | G01AX | nifuratel/nystatin (lékové formy vaginálních čípků) | vag. | 1.00 | DF | 17.60 | |

| | | | | | | | |

| 102.4 | G01AX | nifuratel/nystatin (lékové formy vaginálních krémů) | vag. | 5.00 | GM | 35.19 | |

| | | | | | | | |

| 102.5 | G01AX | nitrofurantoin | vag. | 0.20 | GM | 2.99 | |

| | | | | | | | |

| 102.6 | G01AX | sulfathiazol | vag. | 1.00 | DF | 6.60 | |

| | | | | | | | |

| 102.7 | G01AX03 | polykresulen | vag. | 90.00 | MG | 0.38 | |

| 41965 | VAGOTHYL | sol 1x50gm | PBA | PL |

| --- | --- | --- | --- | --- |

| 102.8 | G01AX11 | polyvidon-jód (vaginální čípky) | vag. | 0.20 | GM | 8.94 | |

| | | | | | | | |

| 102.9 | G01AX11 | polyvidon-jód (vaginální gel) | vag. | 0.20 | GM | 6.16 | |

| | | | | | | | |

| 102.10 | G01AX14 | laktobacilus a estriol - vaginální tablety | vag. | 1.00 | DF | 16.13 | |

| | | | | | | | |

| 102.11 | G02CC03 | benzydamin hydrochlorid | vag. | 1.00 | DF | 8.00 | |

| 102.1 | G01AX | jiná antiinfektiva a antiseptika (tetraboritan sodný) | vag. | 1.00 | DF | 6,25 | |

| | | | | | | | |

| 102.2 | G01AX | laktobacillus | vag. | 1.00 | DF | 10,03 | |

| | | | | | | | |

| 102.3 | G01AX | nifuratel/nystatin (lékové formy vaginálních čípků) | vag. | 1.00 | DF | 17,20 | |

| | | | | | | | |

| 102.4 | G01AX | nifuratel/nystatin (lékové formy vaginálních krémů) | vag. | 5.00 | GM | 34,39 | |

| | | | | | | | |

| 102.5 | G01AX | nitrofurantoin | vag. | 0.20 | GM | 2,92 | |

| | | | | | | | |

| 102.6 | G01AX | sulfathiazol | vag. | 1.00 | DF | 6,45 | |

| | | | | | | | |

| 102.7 | G01AX03 | polykresulen | vag. | 90.00 | MG | 0,37 | |

| 41965 | VAGOTHYL | sol 1×50gm | PBA | PL |

| --- | --- | --- | --- | --- |

| 102.8 | G01AX11 | polyvidon-jód (vaginální čípky) | vag. | 0.20 | GM | 8,74 | |

| | | | | | | | |

| 102.9 | G01AX11 | polyvidon-jód (vaginální gel) | vag. | 0.20 | GM | 6,02 | |

| | | | | | | | |

| 102.10 | G01AX14 | laktobacilus a estriol - vaginální tablety | vag. | 1.00 | DF | 15,76 | |

| | | | | | | | |

| 102.11 | G02CC03 | benzydamin hydrochlorid | vag. | 1.00 | DF | 7,82 | |

| | | | | | | | |

| 103 | léčiva zvyšující tonus dělohy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

@@ -4088,96 +4184,77 @@

- d) v poporodním období při závažné metrorhagii.

| 103.1 | G02AB01 | methylergometrin | parent. | 0.20 | MG | 18.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 103.2 | G02AB02 | ergotové alkaloidy | p.o. | 0.20 | MG | 1.12 | |

| | | | | | | | |

| 103.3 | G02AB03 | ergometrin | p.o. | 0.20 | MG | 1.12 | |

| | | | | | | | |

| 103.4 | G02AB03 | ergometrin | parent. | 0.20 | MG | 9.38 | |

| | | | | | | | |

| 103.5 | G02AD01 | dinoprost | parent. | 25.00 | MG | 651.85 | K/P |

| | | | | | | | |

| 103.6 | G02AD02 | dinoproston | p.o. | 0.50 | MG | 84.02 | H |

| | | | | | | | |

| 103.7 | G02AD02 | dinoproston | parent. | 0.50 | MG | 389.86 | K/P |

| | | | | | | | |

| 103.8 | G02AD02 | dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1.00 | DF | 770.00 | K/P |

| | | | | | | | |

| 103.9 | G02AD02 | dinoproston (nad 0,5 do 2 mg v jedné dávce včetně) | vag. | 1.00 | DF | 1 111.90 | K/P |

| | | | | | | | |

| 103.10 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1.00 | DF | 357.19 | K/P |

| 02289 | PROSTIN E2 | tbl vag 4x3mg | PMB | B |

| --- | --- | --- | --- | --- |

| 103.11 | G02AD02 | dinoproston (pesar) | vag. | 1.00 | DF | 2 200.00 | K/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 103.12 | G02AD04 | karboprost | parent. | 0.25 | MG | 633.92 | K/P |

| 10734 | PROSTIN 15 M INJ. | inj 1x1ml/250rg | PMB | B |

| --- | --- | --- | --- | --- |

| 103.13 | G02AD05 | sulproston | parent. | 0.50 | MG | 651.85 | K/P |

| 103.1 | G02AB01 | methylergometrin | parent. | 0.20 | MG | 17,59 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 103.2 | G02AB02 | ergotové alkaloidy | p.o. | 0.20 | MG | 1,09 | |

| | | | | | | | |

| 103.3 | G02AB03 | ergometrin | p.o. | 0.20 | MG | 1,09 | |

| | | | | | | | |

| 103.4 | G02AB03 | ergometrin | parent. | 0.20 | MG | 9,17 | |

| | | | | | | | |

| 103.5 | G02AD01 | dinoprost | parent. | 25.00 | MG | 637,05 | K/P |

| | | | | | | | |

| 103.6 | G02AD02 | dinoproston | p.o. | 0.50 | MG | 82,11 | H |

| | | | | | | | |

| 103.7 | G02AD02 | dinoproston | parent. | 0.50 | MG | 381,01 | K/P |

| | | | | | | | |

| 103.8 | G02AD02 | dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1.00 | DF | 752,52 | K/P |

| | | | | | | | |

| 103.9 | G02AD02 | dinoproston (nad 0,5 do 2 mg v jedné dávce včetně) | vag. | 1.00 | DF | 1 086,66 | K/P |

| | | | | | | | |

| 103.10 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1.00 | DF | 349,08 | K/P |

| 02289 | PROSTIN E2 | tbl vag 4×3mg | PMB | B |

| --- | --- | --- | --- | --- |

| 103.11 | G02AD02 | dinoproston (pesar) | vag. | 1.00 | DF | 2 150,06 | K/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 103.12 | G02AD04 | karboprost | parent. | 0.25 | MG | 619,53 | K/P |

| 10734 | PROSTIN 15 M INJ. | inj 1×1ml/250rg | PMB | B |

| --- | --- | --- | --- | --- |

| 103.13 | G02AD05 | sulproston | parent. | 0.50 | MG | 637,05 | K/P |

| | | | | | | | |

| 104 | léčiva snižující tonus dělohy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 104.1 | G02CA | hexoprenalin | p.o. | 1.50 | MG | 10.12 | P |

| | | | | | | | |

| 104.2 | G02CA | hexoprenalin | parent. | 25.00 | RG | 45.36 | U/P |

| 46293 | GYNIPRAL 25MCG KONC.PRO PŘ.INF. | inf cnc sol 5x5ml | NYC | A |

| --- | --- | --- | --- | --- |

| 75463 | GYNIPRAL 10 MCG/2ML | inj sol 5x2ml/10rg | NYC | A |

| 75464 | GYNIPRAL 25MCG KONCEN.ZUR INF. | inf 5x5ml/25rg | HNP | A |

| 104.3 | G02CA01 | ritodrin | p.o. | 40.00 | MG | 23.14 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 104.4 | G02CA01 | ritodrin | parent. | 40.00 | MG | 45.36 | U/P |

| | | | | | | | |

| 104.5 | G02CA03 | fenoterol | p.o. | 20.00 | MG | 23.14 | P |

| | | | | | | | |

| 104.6 | G02CA03 | fenoterol | parent. | 0.50 | MG | 45.36 | U/P |

| 104.1 | G02CA | hexoprenalin | p.o. | 1.50 | MG | 9,89 | P |

| | | | | | | | |

| 104.2 | G02CA | hexoprenalin | parent. | 25.00 | RG | 44,33 | U/P |

| 46293 | GYNIPRAL 25MCG KONC.PRO PŘ.INF. | inf cnc sol 5×5ml | NYC | A |

| --- | --- | --- | --- | --- |

| 75463 | GYNIPRAL 10 MCG/2ML | inj sol 5×2ml/10rg | NYC | A |

| 75464 | GYNIPRAL 25MCG KONCEN.ZUR INF. | inf 5×5ml/25rg | HNP | A |

| 104.3 | G02CA01 | ritodrin | p.o. | 40.00 | MG | 22,61 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 104.4 | G02CA01 | ritodrin | parent. | 40.00 | MG | 44,33 | U/P |

| | | | | | | | |

| 104.5 | G02CA03 | fenoterol | p.o. | 20.00 | MG | 22,61 | P |

| | | | | | | | |

| 104.6 | G02CA03 | fenoterol | parent. | 0.50 | MG | 44,33 | U/P |

Léčbu hexoprenalinem, ritodrinem a fenoterolem předepisuje gynekolog - parenterální formu při zahájení tokolytické léčby po 20. týdnu těhotenství, léčbě porodní dystokie, intrapartální akutní tokolýze; - p.o. formu pouze jako pokračování parenterální aplikace tokolytik.

| 104.7 | G02CX01 | atosiban infuse | parent. | 1.00 | DF | 2 511.00 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 104.8 | G02CX01 | atosiban injekce | parent. | 1.00 | DF | 817.00 | U/P |

Atosiban je indikován při předčasné děložní činnosti od 24. týdne gestace do ukončeného 33. týdne těhotenství u těhotných s:

- a) diabetes mellitus,

- b) kardiopatií,

- c) primární hypotenzí a tendencí ke kolapsovým stavům,

- d) thyreopatií,

- e) srdeční arytmií anebo

- f) u nichž byla indikována parenterální tokolýza v kontinuálním podání delším než 48 hodin.

| 105 | inhibitory prolaktinu | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 105.1 | G02CB | tergurid | p.o. | 1.00 | MG | 5.46 | |

| | | | | | | | |

| 105.2 | G02CB01 | bromokriptin | p.o. | 5.00 | MG | 11.43 | |

| 67514 | MEDOCRIPTINE | tbl 500x2.5mg-I | MOE | CY |

| --- | --- | --- | --- | --- |

| 105.3 | G02CB02 | lisurid | p.o. | 0.60 | MG | 2.49 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 105.4 | G02CB03 | kabergolin | p.o. | 70.00 | RG | 21.49 | P |

| 104.7 | G02CX01 | atosiban infuse | parent. | 1.00 | DF | 2 454,00 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 104.8 | G02CX01 | atosiban injekce | parent. | 1.00 | DF | 798,45 | U/P |

Atosiban je indikován při předčasné děložní činnosti od 24. týdne gestace do ukončeného 33. týdne těhotenství u těhotných s: a) diabetes mellitus, b) kardiopatií, c) primární hypotenzí a tendencí ke kolapsovým stavům, d) thyreopatií, e) srdeční arytmií anebo f) u nichž byla indikována parenterální tokolýza v kontinuálním podání delším než 48 hodin.

| 67514 | MEDOCRIPTINE | tbl 500×2.5mg-1 | MOE | CY |

| --- | --- | --- | --- | --- |

| 105.3 | G02CB02 | lisurid | p.o. | 0.60 | MG | 2,43 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 105.4 | G02CB03 | kabergolin | p.o. | 70.00 | RG | 21,00 | P |

Kabergolin je indikován při nesnášenlivosti nebo nedostatečné účinnosti léků ze skupiny dopaminergních agonistů (terguridu a přípravků s obsahem bromokriptinu) u nemocných s prolaktin secernujícími adenomy hypofýzy a s hyperprolaktinémií jiného původu, u nemocných s akromeglií reagující na léčbu dopaminergními agonisty a u žen v indikacích vyžadujících zástavu laktace.

@@ -4189,28 +4266,28 @@

- c) v indikaci zástava laktace nedosažení této zástavy obvyklým dávkováním.

| 105.5 | G02CB04 | quinagolid | p.o. | 75.00 | RG | 21.49 | Z |

| 105.5 | G02CB04 | quinagolid | p.o. | 75.00 | RG | 21,00 | Z |

| | | | | | | | |

| 106 | mužské pohlavní hormony | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 106.1 | G03BA03 | testosteron | p.o. | 0.12 | GM | 27.37 | L/END,ONK,GYN, SEX,URN |

| | | | | | | | |

| 106.2 | G03BA03 | testosteron | parent. | 18.00 | MG | 8.07 | L/END,ONK,GYN, SEX,URN |

| 00373 | AGOVIRIN-DEPOT | inj 5x2ml/50mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 106.3 | G03BB01 | mesterolon | p.o. | 50.00 | MG | 20.04 | L/END,ONK,GYN, SEX,URN |

| 106.1 | G03BA03 | testosteron | p.o. | 0.12 | GM | 26,75 | L/END,ONK,GYN, SEX,URN |

| | | | | | | | |

| 106.2 | G03BA03 | testosteron | parent. | 18.00 | MG | 7,89 | L/END,ONK,GYN, SEX,URN |

| 00373 | AGOVIRIN-DEPOT | inj 5×2ml/50mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 106.3 | G03BB01 | mesterolon | p.o. | 50.00 | MG | 19,59 | L/END,ONK,GYN, SEX,URN |

| | | | | | | | |

| 107 | ženské pohlavní hormony ze skupiny estrogenů, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 107.1 | G03CA | přirozené a semisyntetické estrogeny prosté, mestranol | p.o. | 0.15 | MG | 3.76 | |

| | | | | | | | |

| 107.2 | G03CA03 | estradiol (do 2 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 5.00 | P |

| | | | | | | | |

| 107.3 | G03CA03 | estradiol (nad 2 mg v jedné tabletě) | p.o. | 1.00 | DF | 4.18 | P |

| 107.1 | G03CA | přirozené a semisyntetické estrogeny prosté, mestranol | p.o. | 0.15 | MG | 3,67 | |

| | | | | | | | |

| 107.2 | G03CA03 | estradiol (do 2 mg v jedné tabletě včetně) | p.o. | 1.00 | DF | 4,89 | P |

| | | | | | | | |

| 107.3 | G03CA03 | estradiol (nad 2 mg v jedné tabletě) | p.o. | 1.00 | DF | 4,09 | P |

Estradiol v p.o. lékové formě předepisuje gynekolog, sexuolog nebo endokrinolog:

@@ -4218,42 +4295,42 @@

- b) k hormonální korekci v dětské a dorostové endokrinologii a gynekologii.

| 107.4 | G03CA04 | estriol | p.o. | 1.00 | DF | 3.84 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 09497 | OVESTIN 1 MG | tbl 30x1mg | ORG | NL |

| --- | --- | --- | --- | --- |

| 31315 | OVESTIN 2 MG | tbl 30x2mg | ORG | NL |

| 107.5 | G03CA57 | přírodní konj. estrogeny (do 300 μg včetně v jedné tabletě nebo tobolce) | p.o. | 1.00 | DF | 2.25 | |

| | | | | | | | |

| 107.6 | G03CA57 | přírodní konj. estrogeny (nad 300 μg v jedné tabletě nebo tobolce) | p.o. | 1.00 | DF | 4.50 | |

| 107.4 | G03CA04 | estriol | p.o. | 1.00 | DF | 3,75 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 09497 | OVESTIN 1 MG | tbl 30×1mg | ORG | NL |

| --- | --- | --- | --- | --- |

| 31315 | OVESTIN 2 MG | tbl 30×2mg | ORG | NL |

| 107.5 | G03CA57 | přírodní konj. estrogeny (do 300 µg včetně v jedné tabletě nebo tobolce) | p.o. | 1.00 | DF | 2,20 | |

| | | | | | | | |

| 107.6 | G03CA57 | přírodní konj. estrogeny (nad 300 µg v jedné tabletě nebo tobolce) | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 108 | ženské pohlavní hormony ze skupiny estrogenů, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 108.1 | G03CA03 | estradiol | Parent. | 1.00 | MG | 4.35 | |

| 00364 | AGOFOLLIN | inj sol 5x1ml/5mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 00365 | AGOFOLLIN-DEPOT | inj 1x2ml/10mg | BTA | SK |

| 108.2 | G03CA03 | estradiol | vag. | 25.00 | RG | 7,83 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 108.3 | G03CA03 | estradiol (léková forma nosní spray) | inhal. | 300.00 | RG | 5.00 | P |

| | | | | | | | |

| 108.4 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1.50 | MG | 5.00 | P |

| | | | | | | | |

| 108.5 | G03CA03 | estradiol (lékové formy vaginálních krémů) | vag. | 0.20 | MG | 2,46 | |

| | | | | | | | |

| 108.6 | G03CA03 | estradiol (s uvolněním 100 a více rg /den, v rámci 28. denního cyklu) | transd. | 1.00 | DF | 5.00 | P |

| | | | | | | | |

| 108.7 | G03CA03 | estradiol (s uvolněním méně než 50 RG/den, v rámci 28. denního cyklu) | transd. | 1.00 | DF | 4.18 | P |

| | | | | | | | |

| 108.8 | G03CA03 | estradiol (s uvolněním od 50 do 99 rg včetně /den, v rámci 28. denního cyklu) | transd. | 1.00 | DF | 5.00 | P |

| | | | | | | | |

| 108.9 | G03CA03 | estradiol implantát | parent. | 1.00 | DF | 900.00 | P |

| 108.1 | G03CA03 | estradiol | Parent. | 1.00 | MG | 4,25 | |

| 00364 | AGOFOLLIN | inj sol 5×1ml/5mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 00365 | AGOFOLLIN-DEPOT | inj 1×2ml/10mg | BTA | SK |

| 108.2 | G03CA03 | estradiol | vag. | 25.00 | RG | 7,65 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 108.3 | G03CA03 | estradiol (léková forma nosní spray) | inhal. | 300.00 | RG | 4,89 | P |

| | | | | | | | |

| 108.4 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1.50 | MG | 4,89 | P |

| | | | | | | | |

| 108.5 | G03CA03 | estradiol (lékové formy vaginálních krémů) | vag. | 0.20 | MG | 2,40 | |

| | | | | | | | |

| 108.6 | G03CA03 | estradiol (s uvolněním 100 a více rg /den, v rámci 28. denního cyklu) | transd. | 1.00 | DF | 4,89 | P |

| | | | | | | | |

| 108.7 | G03CA03 | estradiol (s uvolněním méně než 50 RG/den, v rámci 28. denního cyklu) | transd. | 1.00 | DF | 4,09 | P |

| | | | | | | | |

| 108.8 | G03CA03 | estradiol (s uvolněním od 50 do 99 rg včetně /den, v rámci 28. denního cyklu) | transd. | 1.00 | DF | 4,89 | P |

| | | | | | | | |

| 108.9 | G03CA03 | estradiol implantát | parent. | 1.00 | DF | 879,57 | P |

Estradiol v transd., parent. (implantát) a inhal. lékové formě předepisuje gynekolog, sexuolog nebo endokrinolog:

@@ -4261,450 +4338,446 @@

- b) k hormonální korekci v dětské a dorostové endokrinologii a gynekologii.

| 108.10 | G03CA03 | estradiol valerat | parent. | 1.00 | MG | 2.37 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 00529 | NEOFOLLIN | inj sol 5x1ml/5mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 108.11 | G03CA04 | estriol | parent. | 2.00 | MG | 4.30 | |

| | | | | | | | |

| 108.12 | G03CA04 | estriol (lékové formy vaginálních krémů) | vag. | 0.20 | MG | 1,50 | |

| | | | | | | | |

| 108.13 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.20 | MG | 2,14 | |

| | | | | | | | |

| 108.14 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.20 | MG | 0,93 | |

| | | | | | | | |

| 108.15 | G03CA09 | promestrien (lékové formy vaginálních krémů) | vag. | 10.00 | MG | 3,76 | |

| | | | | | | | |

| 108.16 | G03CA09 | promestrien (lékové formy vaginálních tobolek) | vag. | 10.00 | MG | 4,00 | |

| | | | | | | | |

| 108.17 | G03CC | promestrien a chlorquinaldol v kombinaci | vag. | 1.00 | DF | 5.50 | |

| 108.10 | G03CA03 | estradiol valerat | parent. | 1.00 | MG | 2,32 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 00529 | NEOFOLLIN | inj sol 5×1ml/5mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 108.11 | G03CA04 | estriol | parent. | 2.00 | MG | 4,20 | |

| | | | | | | | |

| 108.12 | G03CA04 | estriol (lékové formy vaginálních krémů) | vag. | 0.20 | MG | 1,47 | |

| | | | | | | | |

| 108.13 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.20 | MG | 2,09 | |

| | | | | | | | |

| 108.14 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.20 | MG | 0,91 | |

| | | | | | | | |

| 108.15 | G03CA09 | promestrien (lékové formy vaginálních krémů) | vag. | 10.00 | MG | 3,67 | |

| | | | | | | | |

| 108.16 | G03CA09 | promestrien (lékové formy vaginálních tobolek) | vag. | 10.00 | MG | 3,91 | |

| | | | | | | | |

| 108.17 | G03CC | promestrien a chlorquinaldol v kombinaci | vag. | 1.00 | DF | 5,38 | |

| | | | | | | | |

| 109 | ženské pohlavní hormony ze skupiny progestinů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 109.1 | G03DA02 | medroxyprogesteron | p.o. | 5.00 | MG | 2.94 | L/GYN,URN,END, INT,SEX |

| | | | | | | | |

| 109.2 | G03DA03 | hydroxyprogesteron | parent. | 10.00 | MG | 1.76 | L/GYN,URN,SEX |

| | | | | | | | |

| 109.3 | G03DA04 | progesteron | p.o. | 0.30 | GM | 15.60 | L/GYN,URN,END, INT,SEX |

| | | | | | | | |

| 109.4 | G03DA04 | progesteron | parent. | 5.00 | MG | 1.00 | L/GYN,URN,SEX |

| | | | | | | | |

| 109.5 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5.00 | MG | 3.85 | L/GYN,URN,SEX |

| | | | | | | | |

| 109.6 | G03DA04 | progesteron | vag. | 45 | MG | 15.60 | L/GYN,URN,END, INT,SEX |

| 23221 | CRINONE 8% | vag gel 6x1.125gm | MYB | GB |

| --- | --- | --- | --- | --- |

| 23222 | CRINONE 8% | vag gel 15x1.125gm | MYB | GB |

| 109.7 | G03DB01 | dydrogesteron | p.o. | 10.00 | MG | 5.20 | L/GYN,URN,END, INT,SEX,GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 109.8 | G03DB04 | nomegestrol | p.o. | 5.00 | MG | 5.20 | L/GYN,URN,END, INT,SEX,GER |

| | | | | | | | |

| 109.9 | G03DC02 | norethisteron | p.o. | 5.00 | MG | 2.81 | L/GYN,URN,END, INT,SEX,GER |

| | | | | | | | |

| 109.10 | G03DC03 | lynestrenol | p.o. | 5.00 | MG | 2.81 | L/GYN,URN,END, INT,SEX,GER |

| | | | | | | | |

| 109.11 | G03DC05 | tibolon | p.o. | 2.50 | MG | 14.50 | P |

| 109.1 | G03DA02 | medroxyprogesteron | p.o. | 5.00 | MG | 2,87 | L/GYN,URN,END, INT,SEX |

| | | | | | | | |

| 109.2 | G03DA03 | hydroxyprogesteron | parent. | 10.00 | MG | 1,72 | L/GYN,URN,SEX |

| | | | | | | | |

| 109.3 | G03DA04 | progesteron | p.o. | 0.30 | GM | 15,25 | L/GYN,URN,END, INT,SEX |

| | | | | | | | |

| 109.4 | G03DA04 | progesteron | parent. | 5.00 | MG | 0,98 | L/GYN,URN,SEX |

| | | | | | | | |

| 109.5 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5.00 | MG | 3,76 | L/GYN,URN,SEX |

| | | | | | | | |

| 109.6 | G03DA04 | progesteron | vag. | 45 | MG | 15,25 | L/GYN,URN,END, INT,SEX |

| 23221 | CRINONE 8% | vag gel 6×1.125gm | MYB | GB |

| --- | --- | --- | --- | --- |

| 23222 | CRINONE 8% | vag gel 15×1.125gm | MYB | GB |

| 109.7 | G03DB01 | dydrogesteron | p.o. | 10.00 | MG | 5,08 | L/GYN,URN,END, INT,SEX,GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 109.8 | G03DB04 | nomegestrol | p.o. | 5.00 | MG | 5,08 | L/GYN,URN,END, INT,SEX,GER |

| | | | | | | | |

| 109.9 | G03DC02 | norethisteron | p.o. | 5.00 | MG | 2,75 | L/GYN,URN,END, INT,SEX,GER |

| | | | | | | | |

| 109.10 | G03DC03 | lynestrenol | p.o. | 5.00 | MG | 2,75 | L/GYN,URN,END, INT,SEX,GER |

| | | | | | | | |

| 109.11 | G03DC05 | tibolon | p.o. | 2.50 | MG | 14,17 | P |

Léčbu tibolonem předepisuje gynekolog, endokrinolog k léčbě estrogen deficitního syndromu tam, kde jsou jiné hormonální přípravky kontraindikovány nebo kde jiné hormonální přípravky pacientka objektivně nesnáší.

| 110 | kombinace ženských pohlavních hormonů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 110.1 | G03EA02 | testosteron a estrogen | parent. | 1.00 | DF | 22.23 | L/GYN,END,SEX |

| 00464 | FOLIVIRIN | inj 5x2ml | BTA | SK |

| --- | --- | --- | --- | --- |

| 110.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1.00 | DF | 73.32 | L/GYN,END,SEX |

| | | | | | | | |

| 110.3 | G03FA01 | norethisteron a estrogen, fixní kombinace | transd. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.4 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 1 mg estradiolu v jedné tabletě | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.5 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 2 mg estradiolu v jedné tabletě | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.6 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace s obsahem do 1 mg estrogenu včetně | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.7 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace s obsahem nad 1 mg estrogenu | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.8 | G03FA14 | dydrogesteron a estradiol, fixní kombinace | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.9 | G03FA15 | dienogest a estradiol, fixní kombinace | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.10 | G03FA17 | drospirenon a estrogen | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.11 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.12 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.13 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | transd. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.14 | G03FB06 | medroxyprogesteron a estrogen, sekvenční přípravky | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.15 | G03FB08 | dydrogesteron a estrogen, sekvenční kombinace | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.16 | G03FB09 | levonorgestrel a estrogen, sekvenční kombinace | p.o. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.17 | G03FB09 | levonorgestrel a estrogen, sekvenční přípravky | transd. | 1.00 | DF | 4.50 | |

| | | | | | | | |

| 110.18 | G03HB01 | cyproteron/estradiol | p.o. | 1.00 | DF | 4.50 | |

| 110.1 | G03EA02 | testosteron a estrogen | parent. | 1.00 | DF | 21,73 | L/GYN,END,SEX |

| 00464 | FOLIVIRIN | inj 5×2ml | BTA | SK |

| --- | --- | --- | --- | --- |

| 110.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1.00 | DF | 71,66 | L/GYN,END,SEX |

| | | | | | | | |

| 110.3 | G03FA01 | norethisteron a estrogen, fixní kombinace | transd. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.4 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 1 mg estradiolu v jedné tabletě | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.5 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 2 mg estradiolu v jedné tabletě | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.6 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace s obsahem do1 mg estrogenu včetně | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.7 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace s obsahem nad 1 mg estrogenu | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.8 | G03FA14 | dydrogesteron a estradiol, fixní kombinace | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.9 | G03FA15 | dienogest a estradiol, fixní kombinace | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.10 | G03FA17 | drospirenon a estrogen | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.11 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.12 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.13 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | transd. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.14 | G03FB06 | medroxyprogesteron a estrogen, sekvenční přípravky | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.15 | G03FB08 | dydrogesteron a estrogen, sekvenční kombinace | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.16 | G03FB09 | levonorgestrel a estrogen, sekvenční kombinace | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.17 | G03FB09 | levonorgestrel a estrogen, sekvenční přípravky | transd. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 110.18 | G03HB01 | cyproteron/estradiol | p.o. | 1.00 | DF | 4,40 | |

| | | | | | | | |

| 111 | gonadotropiny a jiná stimulancia ovulace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 111.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250.00 | U | 24.59 | L/GYN,END,PED, SEX |

| | | | | | | | |

| 111.2 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250.00 | U | 10.71 | L/GYN,END,PED, SEX |

| 96314 | PREGNYL 5000 | inj pso Iqf 3x5000ut | ORG | NL |

| --- | --- | --- | --- | --- |

| 111.3 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250.00 | U | 14.98 | L/GYN,END,PED, SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11951 | PREGNYL 1500 | inj pso Iqf 3x1500ut | ORG | NL |

| --- | --- | --- | --- | --- |

| 111.4 | G03GA01 | rekombinantní choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250.00 | U | 19.60 | L/GYN,END,PED, SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 111.5 | G03GA02 | gonadotrofin lidský | parent. | 75.00 | U | 313.26 | Z |

| 111.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250.00 | U | 24,03 | L/GYN,END,PED, SEX |

| | | | | | | | |

| 111.2 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250.00 | U | 10,47 | L/GYN,END,PED, SEX |

| 96314 | PREGNYL 5000 | inj pso Iqf 3×5000ut | ORG | NL |

| --- | --- | --- | --- | --- |

| 111.3 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250.00 | U | 14,64 | L/GYN,END,PED, SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11951 | PREGNYL 1500 | inj pso Iqf 3×1500ut | ORG | NL |

| --- | --- | --- | --- | --- |

| 111.4 | G03GA01 | rekombinantní choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250.00 | U | 19,16 | L/GYN,END,PED, SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 111.5 | G03GA02 | gonadotrofin lidský | parent. | 75.00 | U | 306,15 | Z |

| 12979 | MENOGON | inj sic 10+10×solv. | FEI | D |

| --- | --- | --- | --- | --- |

| 15203 | MERIONAL 75 M.J. | inj pso Iqf 1x75ut | ISR | CZ |

| 15204 | MERIONAL 75 M.J. | inj pso Iqf 10x75ut | ISR | CZ |

| 43727 | MERIONAL 75 M.J. | inj sic 1x75ut+solv | IBS | CH |

| 43728 | MERIONAL 75 M.J. | inj sic 10x75ut+sol | IBS | CH |

| 111.6 | G03GA02 | gonadotrofin lidský vysoce čištěný | parent. | 75.00 | U | 600.00 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 111.7 | G03GA04 | urofollitrofin | parent. | 75.00 | U | 381.40 | Z |

| 15006 | FOSTIMON 75 M.J. | inj pso Iqf 1x75ut+s | ISR | CZ |

| --- | --- | --- | --- | --- |

| 15007 | FOSTIMON 75 M.J. | inj pso lqf 10x75ut+s | ISR | CZ |

| 111.8 | G03GA04 | urofollitrofin vysoce čištěný | parent. | 75.00 | U | 488.79 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 111.9 | G03GA05 | folitrofin alfa | parent. | 75.00 | U | 650.00 | Z |

| | | | | | | | |

| 111.10 | G03GA06 | folitrofin beta | parent. | 75.00 | U | 650.00 | Z |

| | | | | | | | |

| 111.11 | G03GA07 | lutropin alfa (rekombinantní lidský luteinizační hormon) | parent. | 75.00 | U | 650.00 | Z |

| | | | | | | | |

| 111.12 | G03GB02 | klomifen | p.o. | 9.00 | MG | 1.24 | L/GYN,END,SEX, URN |

| 42450 | CLOMHEXAL 50 | tbl 10x50mg | SFS | D |

| 15203 | MERIONAL 75 M.J. | inj pso Iqf 1×75ut | ISR | CZ |

| 15204 | MERIONAL 75 M.J. | inj pso Iqf 10×75ut | ISR | CZ |

| 43727 | MERIONAL 75 M.J. | inj sic 1×75ut+solv | IBS | CH |

| 43728 | MERIONAL 75 M.J. | inj sic 10×75ut+sol | IBS | CH |

| 111.6 | G03GA02 | gonadotrofin lidský vysoce čištěný | parent. | 75.00 | U | 586,38 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 111.7 | G03GA04 | urofollitrofin | parent. | 75.00 | U | 372,74 | Z |

| 15006 | FOSTIMON 75 M.J. | inj pso Iqf 1×75ut+s | ISR | CZ |

| --- | --- | --- | --- | --- |

| 15007 | FOSTIMON 75 M.J. | inj pso lqf 10×75ut+s | ISR | CZ |

| 111.8 | G03GA04 | urofollitrofin vysoce čištěný | parent. | 75.00 | U | 477,69 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 111.9 | G03GA05 | folitrofin alfa | parent. | 75.00 | U | 635,25 | Z |

| | | | | | | | |

| 111.10 | G03GA06 | folitrofin beta | parent. | 75.00 | U | 635,25 | Z |

| | | | | | | | |

| 111.11 | G03GA07 | lutropin alfa (rekombinantní lidský luteinizační hormon) | parent. | 75.00 | U | 635,25 | Z |

| | | | | | | | |

| 111.12 | G03GB02 | klomifen | p.o. | 9.00 | MG | 1,21 | L/GYN,END,SEX, URN |

| 42450 | CLOMHEXAL 50 | tbl 10×50mg | SFS | D |

| --- | --- | --- | --- | --- |

| 112 | ostatní pohlavní hormony, androgeny a modulátory hormonů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 112.1 | G03HA01 | cyproteron | parent. | 0.10 | GM | 121.67 | L/PSY,SEX, URN |

| 23342 | ANDROCUR DEPOT | inj sol 3x3ml/300mg | SAG | D |

| --- | --- | --- | --- | --- |

| 112.2 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.10 | GM | 166.20 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 112.3 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.10 | GM | 55.60 | |

| 03783 | ANDROCUR-50 | tbl 50x50mg | SAG | D |

| --- | --- | --- | --- | --- |

| 32094 | CYPROPLEX | por tbl nob 30x50mg | PHM | NL |

| 32095 | CYPROPLEX | por tbl nob 50x50mg | PHM | NL |

| 32096 | CYPROPLEX | por tbl nob 50x50mg | PHM | NL |

| 59354 | ANDROCUR 100 | tbl obd 50x100mg | SUE | F |

| 112.4 | G03XA01 | danazol | p.o. | 0.60 | GM | 78.16 | L/GYN,END,HEM, ALG,SEX |

| | | | | | | | |

| 112.5 | G03XA02 | gestrinon | p.o. | 0.70 | MG | 46.26 | L/GYN,END,HEM, ALG,SEX |

| 112.1 | G03HA01 | cyproteron | parent. | 0.10 | GM | 118,91 | L/PSY,SEX,URN |

| 23342 | ANDROCUR DEPOT | inj sol 3×3ml/300mg | SAG | D |

| --- | --- | --- | --- | --- |

| 112.2 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.10 | GM | 162,43 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 112.3 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.10 | GM | 54,34 | |

| 03783 | ANDROCUR-50 | tbl 50×50mg | SAG | D |

| --- | --- | --- | --- | --- |

| 32094 | CYPROPLEX | por tbl nob 30×50mg | PHM | NL |

| 32095 | CYPROPLEX | por tbl nob 50×50mg | PHM | NL |

| 32096 | CYPROPLEX | por tbl nob 50×50mg | PHM | NL |

| 59354 | ANDROCUR 100 | tbl obd 50×100mg | SUE | F |

| 112.4 | G03XA01 | danazol | p.o. | 0.60 | GM | 76,39 | L/GYN,END,HEM, ALG, SEX |

| | | | | | | | |

| 112.5 | G03XA02 | gestrinon | p.o. | 0.70 | MG | 45,21 | L/GYN,END,HEM, ALG,SEX |

| | | | | | | | |

| 113 | jiná urologika včetně spasmolytik | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 113.1 | G04AB01 | kyselina nalidixová | p.o. | 4.00 | GM | 8.55 | |

| | | | | | | | |

| 113.2 | G04AB03 | kyselina pipemidová | p.o. | 0.80 | GM | 19.55 | |

| | | | | | | | |

| 113.3 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2.58 | |

| | | | | | | | |

| 113.4 | G04BD02 | flavoxat | p.o. | 0.80 | GM | 12.96 | L/URN,GYN,SEX, GER |

| | | | | | | | |

| 113.5 | G04BD04 | oxybutynin | p.o. | 15.00 | MG | 12.96 | L/URN,GYN,SEX GER, PED |

| | | | | | | | |

| 113.6 | G04BD04 | oxybutynin | transd. | 1 | DF | 37,20 | L/URN,GYN,SEX GER, PED |

| | | | | | | | |

| 113.7 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15.00 | MG | 11.70 | L/URN,GYN,SEX, PED, GER |

| 66819 | MICTONETTEN | drg 50x5mg | APG | D |

| --- | --- | --- | --- | --- |

| 66820 | MICTONETTEN | drg 100x5mg | APG | D |

| 92255 | MICTONETTEN | drg 30x5mg | APG | D |

| 113.8 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15.00 | MG | 5.20 | L/URN,GYN,SEX, GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 92254 | MICTONORM | drg 30x15mg | APG | D |

| --- | --- | --- | --- | --- |

| 113.9 | G04BD07 | tolterodin | p.o. | 4.00 | MG 40.00 | P |

| --- | --- | --- | --- | --- | --- | --- |

| 113.1 | G04AB01 | kyselina nalidixová | p.o. | 4.00 | GM | 8,36 | |

| | | | | | | | |

| 113.2 | G04AB03 | kyselina pipemidová | p.o. | 0.80 | GM | 19,11 | |

| | | | | | | | |

| 113.3 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2,52 | |

| | | | | | | | |

| 113.4 | G04BD02 | flavoxat | p.o. | 0.80 | GM | 12,67 | L/URN,GYN,SEX, GER |

| | | | | | | | |

| 113.5 | G04BD04 | oxybutynin | p.o. | 15.00 | MG | 12,67 | L/URN,GYN,SEX GER, PED |

| | | | | | | | |

| 113.6 | G04BD04 | oxybutynin | transd. | 1 | DF | 36,36 | L/URN,GYN,SEX GER, PED |

| | | | | | | | |

| 113.7 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15.00 | MG | 11,43 | L/URN,GYN,SEX, PED, GER |

| 66819 | MICTONETTEN | drg 50×5mg | APG | D |

| --- | --- | --- | --- | --- |

| 66820 | MICTONETTEN | drg 100×5mg | APG | D |

| 92255 | MICTONETTEN | drg 30×5mg | APG | D |

| 113.8 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15.00 | MG | 5,08 | L/URN,GYN,SEX, GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 92254 | MICTONORM | drg 30×15mg | APG | D |

| --- | --- | --- | --- | --- |

| 113.9 | G04BD07 | tolterodin | p.o. | 4.00 | MG | 39,09 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčiva s obsahem tolterodinu jsou předepisována urologem, gynekologem, sexuologem a geriatrem při nesnášenlivosti (nutnost přerušení léčby pro závažné vedlejší účinky) nebo nedostatečné účinnosti (snížení urgentních nebo inkontinentních epizod o méně než 50% a počet mikcí o méně než 20%) jiných léků ze skupiny anticholinergik a spazmolytik (oxybutynin, propiverin) u nemocných postižených hyperaktivním měchýřem a nebo případy s těžkou hyperaktivitou měchýře (počet mikcí 10 a více za 24 hodin, z toho minimálně 1 mikce za noc, nejméně 1 episoda urgence, nebo 1 episoda inkontinence za 24 hodin) či urgentní inkontinence bez polakisurií. Po 3 měsících terapie tolterodinem bude hodnocen stav pacienta na základě anamnestických údajů před zahájením terapie antimuskariniky: pokud je frekvence inkontinetních nebo urgentních episod snížena o více než 50 %, nebo frekvence mikcí o více než 20%, lze terapii tolterodinem dále indikovat.

| 113.10 | G04BD09 | trospium chlorid | p.o. | 40.00 | MG | 11.84 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12527 | SPASMEX 15 | tbl 30x15mg | PFL | D |

| --- | --- | --- | --- | --- |

| 17162 | SPASMED 15 | por tbl flm 30x15mg | PMP | CZ |

| 17163 | SPASMED 15 | por tbl flm 50x15mg | PMP | CZ |

| 113.11 | G04BD08 | solifenacin | p.o. | 5.00 | MG | 40.00 | P |

| 113.10 | G04BD09 | trospium chlorid | p.o. | 40.00 | MG | 11,57 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12527 | SPASMEX 15 | tbl 30×15mg | PFL | D |

| --- | --- | --- | --- | --- |

| 17162 | SPASMED 15 | por tbl flm 30×15mg | PMP | CZ |

| 17163 | SPASMED 15 | por tbl flm 50×15mg | PMP | CZ |

| 113.11 | G04BD08 | solifenacin | p.o. | 5.00 | MG | 39,09 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčiva s obsahem solifenacinu jsou předepisována urologem a gynekologem při nesnášenlivosti (nutnost přerušení léčby pro významné vedlejší účinky) nebo nedostatečné účinnosti (snížení urgentních nebo inkontinentních epizod o méně než 50% a počet mikcí o méně než 20%) jiných léků ze skupiny anticholinergik a spazmolytik (oxybutynin, propiverin) u nemocných postižených hyperaktivním měchýřem a nebo případy s těžkou hyperaktivitou měchýře (počet mikcí 10 a více/24 hod., z toho minimálně jedna mikce za noc, nejméně jedna epizoda urgence, nebo jedna epizoda inkontinence/ 24 hod.) či urgentní inkontinence bez polakisurií.

Po 3 měsících terapie solifenacinem bude hodnocen stav pacienta na základě anamnestických údajů před zahájením terapie antimuskariniky. Pokud dojde k poklesu počtu mikcí/24 h nejméně o 20%, nebo poklesu urgentních epizod nejméně o 50%, nebo k poklesu inkontinentních epizod nejméně o 50%, je možné v terapii solifenacinem pokračovat.

| 113.12 | G04BD10 | darifenacin do 10 mg v jedné tabletě včetně | p.o. | 7.5 | MG | 12.96 | L/URN, GYN, SEX, PED, GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 113.13 | G04BD10 | darifenacin nad 10 mg v jedné tabletě | p.o. | 7.5 | MG | 9.07 | L/URN, GYN, SEX, PED, GER |

| | | | | | | | |

| 113.14 | G04BX | duloxetin | p.o. | 80.00 | MG | 46.00 | P |

Léčiva s obsahem duloxetinu jsou předepisována urologem nebo gynekologem u pacientek starších 18 let s prokázanou stresovou inkontinencí moči I a II stupně (některým z těchto vyšetření: urodynamickým, UZ a PWT), u kterých není primárně indikována chirurgická léčba. Po 3 měsících léčby duloxetinem je zhodnocen stav pacientky. Pokud frekvence epizod mimovolního úniku moči za týden poklesne pod 50% (za poslední týden před kontrolou), je léčba duloxetinem plně indikována a bude nadále hrazena z prostředků veřejného zdravotního pojištění. Po 6 měsících léčby je stav opět vyhodnocen (kritéria pro toto hodnocení jsou dotazník s počtem epizod inkontinence), užívání duloxetinu se přeruší na 1 měsíc a stav pacientky je opět vyhodnocen (celkový zdravotní stav, změna frekvence urgencí nebo epizod úniku moči a vedlejší účinky léku). Pokud ústup obtíží bude přetrvávat po dobu alespoň 1 měsíce i po vysazení duloxetinu, bude tato léčba ukončena a pacientka bude pozvána na kontrolu za 3 měsíce. Pokud dojde během 1-měsíčního přerušení léčby duloxetinem k obnovení obtíží (v původním rozsahu nebo ještě horším) je další podávání duloxetinu indikováno a hrazeno a to po dobu pokračování účinků léčby, tzn. snížení množství epizod úniku moči pod 50% výchozí hodnoty. Kontroly pacientky u specialisty (urologa nebo gynekologa) jsou nutné každé 3 měsíce ke zhodnocení účinků léčby a stavu pacientky. Pokud léčba trvá déle než 1 rok, je nutné kontrolní vyšetření pacientky (urodynamické event. UZ a vyhodnocení PWT).

| 113.12 | G04BD10 | darifenacin do 10 mg v jedné tabletě včetně | p.o. | 7.5 | MG | 12,67 | L/URN, GYN, SEX, PED, GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 113.13 | G04BD10 | darifenacin nad 10 mg v jedné tabletě | p.o. | 7.5 | MG | 8,86 | L/URN, GYN, SEX, PED, GER |

| | | | | | | | |

| 113.14 | G04BX | duloxetin | p.o. | 80.00 | MG | 44,96 | P |

Léčiva s obsahem duloxetinu jsou předepisována urologem nebo gynekologem u pacientek starších 18 let s prokázanou stresovou inkontinencí moči I a II stupně (některým z těchto vyšetření: urodynamickým, UZ a PVVT), u kterých není primárně indikována chirurgická léčba. Po 3 měsících léčby duloxetinem je zhodnocen stav pacientky. Pokud frekvence epizod mimovolního úniku moči za týden poklesne pod 50% (za poslední týden před kontrolou), je léčba duloxetinem plně indikována a bude nadále hrazena z prostředků veřejného zdravotního pojištění. Po 6 měsících léčby je stav opět vyhodnocen (kritéria pro toto hodnocení jsou dotazník s počtem epizod inkontinence), užívání duloxetinu se přeruší na 1 měsíc a stav pacientky je opět vyhodnocen (celkový zdravotní stav, změna frekvence urgencí nebo epizod úniku moči a vedlejší účinky léku). Pokud ústup obtíží bude přetrvávat po dobu alespoň 1 měsíce i po vysazení duloxetinu, bude tato léčba ukončena a pacientka bude pozvána na kontrolu za 3 měsíce. Pokud dojde během 1-měsíčního přerušení léčby duloxetinem k obnovení obtíží (v původním rozsahu nebo ještě horším) je další podávání duloxetinu indikováno a hrazeno a to po dobu pokračování účinků léčby, tzn. snížení množství epizod úniku moči pod 50% výchozí hodnoty. Kontroly pacientky u specialisty (urologa nebo gynekologa) jsou nutné každé 3 měsíce ke zhodnocení účinků léčby a stavu pacientky. Pokud léčba trvá déle než 1 rok, je nutné kontrolní vyšetření pacientky (urodynamické event. UZ a vyhodnocení PVVT).

| 114 | léčiva používaná při benigní hyperplasii prostaty a ostatní gynekologa | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 114.1 | C02CA04 | doxazosin | p.o. | 4.00 | MG | 12.75 | L/URN |

| 45214 | ZOXON 2 | tbl 30x2mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 45215 | ZOXON 4 | por tbl nob 30x4mg | ZEH | CZ |

| 64797 | KAMIREN 4 | tbl 30x4mg | KRK | SLO |

| 64798 | KAMIREN 2 | tbl 30x2mg | KRK | SLO |

| 95243 | ZOXON 4 | por tbl nob 100x4mg | ZEH | CZ |

| 114.2 | G04CA01 | alfuzosin | p.o. | 10 | MG | 14.40 | L/URN |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 114.3 | G04CA02 | tamsulosin | p.o. | 0.40 | MG | 14.40 | L/URN |

| | | | | | | | |

| 114.4 | G04CA03 | terazosin | p.o. | 5.00 | MG | 12.75 | L/URN |

| | | | | | | | |

| 114.5 | G04CB01 | finasterid | p.o. | 5.00 | MG | 14.40 | L/URN |

| 16273 | TERAZOSIN HEXAL 5 | por tbl nob 30x5mg | SFS | D |

| --- | --- | --- | --- | --- |

| 44312 | KORNAM 5 MG | por tbl nob 30x5mg | LEK | SLO |

| 114.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2.00 | DF | 9.20 | L/URN |

| | | | | | | | |

| 114.7 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 1x denně) | p.o. | 1.00 | DF | 9.20 | L/URN |

| | | | | | | | |

| 114.8 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 2 a víckrát denně) | p.o. | 2.00 | DF | 9.20 | L/URN |

| | | | | | | | |

| 114.9 | G04CX03 | mepartricin | p.o. | 150.00 | KU | 14.40 | L/URN |

| 114.1 | C02CA04 | doxazosin | p.o. | 4.00 | MG | 12,46 | L/URN |

| 45214 | ZOXON 2 | tbl 30×2mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 45215 | ZOXON 4 | por tbl nob 30×4mg | ZEH | CZ |

| 64797 | KAMIREN 4 | tbl 30×4mg | KRK | SLO |

| 64798 | KAMIREN 2 | tbl 30×2mg | KRK | SLO |

| 95243 | ZOXON 4 | por tbl nob100×4mg | ZEH | CZ |

| 114.2 | G04CA01 | alfuzosin | p.o. | 10 | MG | 14,07 | L/URN |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 114.3 | G04CA02 | tamsulosin | p.o. | 0.40 | MG | 14,07 | L/URN |

| | | | | | | | |

| 114.4 | G04CA03 | terazosin | p.o. | 5.00 | MG | 12,46 | L/URN |

| | | | | | | | |

| 114.5 | G04CB01 | finasterid | p.o. | 5.00 | MG | 14,07 | L/URN |

| 16273 | TERAZOSIN HEXAL 5 | por tbl nob 30×5mg | SFS | D |

| --- | --- | --- | --- | --- |

| 44312 | KORNAM 5 MG | por tbl nob 30×5mg | LEK | SLO |

| 114.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2.00 | DF | 8,99 | L/URN |

| | | | | | | | |

| 114.7 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 1x denně) | p.o. | 1.00 | DF | 8,99 | L/URN |

| | | | | | | | |

| 114.8 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 2 a víckrát denně) | p.o. | 2.00 | DF | 8,99 | L/URN |

| | | | | | | | |

| 114.9 | G04CX03 | mepartricin | p.o. | 150.00 | KU | 14,07 | L/URN |

| | | | | | | | |

| 115 | ostatní léčiva používaná u nemocí urogenitálního systému | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 115.1 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4.00 | DF | 17.72 | |

| 115.1 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4.00 | DF | 17,32 | |

| 60046 | BLEMAREN N | tbl eff 80 | EPF | D |

| --- | --- | --- | --- | --- |

| 115.2 | G04BC | rozpouštědla močových kamenů (ve formě prášku) | p.o. | 10.00 | GM | 6.58 | |

| 115.2 | G04BC | rozpouštědla močových kamenů (ve formě prášku) | p.o. | 10.00 | GM | 6,43 | |

| | | | | | | | |

| 116 | hormony předního laloku hypofýzy a jejich analoga | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 116.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59.93 | L/END |

| | | | | | | | |

| 116.2 | H01AC01 | somatropin | parent. | 2.00 | U | 602.76 | L/J5 |

| --- | --- | --- | --- |

| 116.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 58,57 | L/END |

| | | | | | | | |

| 116.2 | H01AC01 | somatropin | parent. | 2.00 | U | 589,08 | L/J5 |

| 61229 | GENOTROPIN 16 M.J.(5.3MG) | inj pso Iqf 5×16ut | PHA | S |

| --- | --- | --- | --- | --- |

| 66752 | GENOTROPIN 36 M.J.(12MG) | inj pso Iqf 5×36ut | PHA | S |

| 117 | hormony zadního laloku hypofýzy a jejich analoga | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 117.1 | H01BA02 | desmopresin | parent. | 4.00 | RG | 82.41 | O |

| | | | | | | | |

| 117.2 | H01BA02 | desmopresin (nosní kapky) | lok. | 25.00 | RG | 23.53 | |

| | | | | | | | |

| 117.3 | H01BA02 | desmopresin (nosní spray) | lok. | 25.00 | RG | 58.25 | |

| | | | | | | | |

| 117.4 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400.00 | RG | 125.00 | P |

| 117.1 | H01BA02 | desmopresin | parent. | 4.00 | RG | 80,54 | O |

| | | | | | | | |

| 117.2 | H01BA02 | desmopresin (nosní kapky) | lok. | 25.00 | RG | 23,00 | |

| | | | | | | | |

| 117.3 | H01BA02 | desmopresin (nosní spray) | lok. | 25.00 | RG | 56,93 | |

| | | | | | | | |

| 117.4 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400.00 | RG | 122,16 | P |

Léčba desmopresinem v tabletách je indikována u nemocných s diabetes insipidus, kde není možná aplikace desmopresinu intranasálně vzhledem k závažnému postižení nosní sliznice nebo v případě slepoty nemocného.

| 42452 | MINIRIN 0.2 MG TABLETY | por tbl nob 30x0.2mg | FEG | S |

| --- | --- | --- | --- | --- |

| 117.5 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1.00 | MG | 288.08 | H |

| | | | | | | | |

| 117.6 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1.00 | MG | 245.27 | H |

| | | | | | | | |

| 117.7 | H01BA05 | ornipresin | parent. | 5.00 | U | 27.57 | H |

| | | | | | | | |

| 117.8 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15.00 | U | 49.20 | H |

| | | | | | | | |

| 117.9 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15.00 | U | 21.96 | H |

| 117.5 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1.00 | MG | 281,54 | H |

| | | | | | | | |

| 117.6 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1.00 | MG | 239,70 | H |

| | | | | | | | |

| 117.7 | H01BA05 | ornipresin | parent. | 5.00 | U | 26,94 | H |

| | | | | | | | |

| 117.8 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15.00 | U | 48,08 | H |

| | | | | | | | |

| 117.9 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15.00 | U | 21,46 | H |

| | | | | | | | |

| 118 | hormony hypotalamu a jejich analoga | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 118.1 | H01AX01 | pegvisomant | parent. | 10.00 | MG | 2256.30 | Z |

| | | | | | | | |

| 118.2 | H01CA01 | gonadorelin (nasálně) | lok. | 1.20 | MG | 203.34 | Z |

| | | | | | | | |

| 118.3 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0.40 | MG | 134.00 | Z |

| | | | | | | | |

| 118.4 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0.40 | MG | 104.40 | Z |

| | | | | | | | |

| 118.5 | H01CB01 | somatostatin | parent. | 6.00 | MG | 7 704.44 | X |

| 66824 | SOMATOSTATIN-UCB 3 MG | inf pso Iqf 1x3mg | UCB | B |

| --- | --- | --- | --- | --- |

| 118.6 | H01CB02 | oktreotid | parent. | 1.00 | MG | 4 000.00 | H |

| | | | | | | | |

| 118.7 | H01CB02 | oktreotid s podáváním 1x za 28 dnů, s obsahem 10 mg | parent. | 357.00 | RG | 1 212.90 | X |

| | | | | | | | |

| 118.8 | H01CB02 | oktreotid s podáváním 1x za 28 dnů, s obsahem 20 mg | parent. | 714.00 | RG | 1 479.20 | X |

| | | | | | | | |

| 118.9 | H01CB02 | oktreotid s podáváním 1x za 28 dnů, s obsahem 30 mg | parent. | 1 072.00 | RG | 1 740.40 | X |

| | | | | | | | |

| 118.10 | H01CB03 | lantreotid s obsahem 120mg | parent. | 4.29 | MG | 1 973.60 | X |

| | | | | | | | |

| 118.11 | H01CB03 | lantreotid s obsahem 30mg | parent. | 2.14 | MG | 1 479.20 | X |

| | | | | | | | |

| 118.12 | H01CB03 | lantreotid s obsahem 60mg | parent. | 2.14 | MG | 1 445.90 | X |

| | | | | | | | |

| 118.13 | H01CB03 | lantreotid s obsahem 90mg | parent. | 3.21 | MG | 1 710.80 | X |

| | | | | | | | |

| 118.14 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu) | parent. | 0.25 | MG | 1 368.00 | Z |

| | | | | | | | |

| 118.15 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0.25 | MG | 1 368.00 | Z |

| | | | | | | | |

| 118.16 | H01CC02 | cetrorelix s obsahem 3 mg v 1 ampuli | parent. | 0.25 | MG | 570.30 | Z |

| 118.1 | H01AX01 | pegvisomant | parent. | 10.00 | MG | 2 256,30 | Z |

| | | | | | | | |

| 118.2 | H01CA01 | gonadorelin (nasálně) | lok. | 1.20 | MG | 198,72 | Z |

| | | | | | | | |

| 118.3 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0.40 | MG | 130,96 | Z |

| | | | | | | | |

| 118.4 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0.40 | MG | 102,03 | Z |

| | | | | | | | |

| 118.5 | H01CB01 | somatostatin | parent. | 6.00 | MG | 7 529,55 | X |

| 66824 | SOMATOSTATIN-UCB 3 MG | inf pso Iqf 1×3mg | UCB | B |

| --- | --- | --- | --- | --- |

| 118.6 | H01CB02 | oktreotid | parent. | 1.00 | MG | 3 909,20 | H |

| | | | | | | | |

| 118.7 | H01CB02 | oktreotid s podáváním 1× za 28 dnů, s obsahem 10 mg | parent. | 357.00 | RG | 1 185,37 | X |

| | | | | | | | |

| 118.8 | H01CB02 | oktreotid s podáváním 1× za 28 dnů, s obsahem 20 mg | parent. | 714.00 | RG | 1 445,62 | X |

| | | | | | | | |

| 118.9 | H01CB02 | oktreotid s podáváním 1× za 28 dnů, s obsahem 30 mg | parent. | 1 072.00 | RG | 1 700,89 | X |

| | | | | | | | |

| 118.10 | H01CB03 | lantreotid s obsahem 120mg | parent. | 4.29 | MG | 1 928,80 | X |

| | | | | | | | |

| 118.11 | H01CB03 | lantreotid s obsahem 30mg | parent. | 2.14 | MG | 1 445,62 | X |

| | | | | | | | |

| 118.12 | H01CB03 | lantreotid s obsahem 60mg | parent. | 2.14 | MG | 1 413,08 | X |

| | | | | | | | |

| 118.13 | H01CB03 | lantreotid s obsahem 90mg | parent. | 3.21 | MG | 1 671,96 | X |

| | | | | | | | |

| 118.14 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu) | parent. | 0.25 | MG | 1 336,95 | Z |

| | | | | | | | |

| 118.15 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0.25 | MG | 1 336,95 | Z |

| | | | | | | | |

| 118.16 | H01CC02 | cetrorelix s obsahem 3 mg v 1 ampuli | parent. | 0.25 | MG | 557,35 | Z |

| | | | | | | | |

| 119 | kortikosteroidy pro celkové použití, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 119.1 | H02AA02 | fludrokortison | p.o. | 0.10 | MG | 4.76 | |

| | | | | | | | |

| 119.2 | H02AB01 | betamethason | p.o. | 1.50 | MG | 3.42 | |

| | | | | | | | |

| 119.3 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.50 | MG | 9.29 | |

| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D |

| --- | --- | --- | --- | --- |

| 119.4 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.50 | MG | 3.42 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 119.5 | H02AB07 | prednison | p.o. | 10.00 | MG | 2.80 | |

| 02963 | PREDNISON 20 LÉČIVA | tbl 20x20mg-blistr | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 119.6 | H02AB08 | triamcinolon | p.o. | 7.50 | MG | 2.74 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 119.7 | H02AB09 | hydrokortison | p.o. | 30.00 | MG | 6.97 | |

| 76205 | HYDROCORTISON 10 MG JENAPHARM | por tbl nob 20x10mg | VJP | D |

| --- | --- | --- | --- | --- |

| 119.8 | H02AB10 | kortison | p.o. | 37.50 | MG | 5.07 | |

| 119.1 | H02AA02 | fludrokortison | p.o. | 0.10 | MG | 4,65 | |

| | | | | | | | |

| 119.2 | H02AB01 | betamethason | p.o. | 1.50 | MG | 3,34 | |

| | | | | | | | |

| 119.3 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.50 | MG | 9,08 | |

| 83994 | FORTECORTIN 4 | tbl 20×4mg | MEC | D |

| --- | --- | --- | --- | --- |

| 119.4 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.50 | MG | 3,34 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 119.5 | H02AB07 | prednison | p.o. | 10.00 | MG | 2,74 | |

| 02963 | PREDNISON 20 LÉČIVA | tbl 20×20mg-blistr | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 119.6 | H02AB08 | triamcinolon | p.o. | 7.50 | MG | 2,68 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 119.7 | H02AB09 | hydrokortison | p.o. | 30.00 | MG | 6,81 | |

| 76205 | HYDROCORTISON 10 MG JENAPHARM | por tbl nob 20×10mg | VJP | D |

| --- | --- | --- | --- | --- |

| 119.8 | H02AB10 | kortison | p.o. | 37.50 | MG | 4,95 | |

| | | | | | | | |

| 120 | kortikosteroidy pro celkové použití, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 120.1 | H02AB | mazipredon | parent. | 30.00 | MG | 17.79 | O |

| | | | | | | | |

| 120.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.40 | MG | 3.28 | O |

| | | | | | | | |

| 120.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.50 | MG | 24.50 | O |

| | | | | | | | |

| 120.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.50 | MG | 1.56 | O |

| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY |

| --- | --- | --- | --- | --- |

| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY |

| 120.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20.00 | MG | 22.10 | O |

| | | | | | | | |

| 120.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20.00 | MG | 11.40 | O |

| | | | | | | | |

| 120.7 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20.00 | MG | 16.60 | O |

| | | | | | | | |

| 120.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10.00 | MG | 17.46 | O |

| | | | | | | | |

| 120.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10.00 | MG | 12.51 | O |

| | | | | | | | |

| 120.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10.00 | MG | 17.30 | |

| | | | | | | | |

| 120.11 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10.00 | MG | 8.16 | |

| | | | | | | | |

| 120.12 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10.00 | MG | 4.59 | |

| | | | | | | | |

| 120.13 | H02AB08 | triamcinolon | parent. | 7.50 | MG | 13.64 | O |

| | | | | | | | |

| 120.14 | H02AB09 | hydrokortison | parent. | 30.00 | MG | 11.19 | O |

| 120.1 | H02AB | mazipredon | parent. | 30.00 | MG | 17,39 | O |

| | | | | | | | |

| 120.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.40 | MG | 3,21 | O |

| | | | | | | | |

| 120.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.50 | MG | 23,94 | O |

| | | | | | | | |

| 120.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.50 | MG | 1,52 | O |

| 01673 | DEXAMED | inj 100×2ml/8mg | MOE | CY |

| --- | --- | --- | --- | --- |

| 84090 | DEXAMED | inj 10×2ml/8mg | MOE | CY |

| 120.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20.00 | MG | 21,60 | O |

| | | | | | | | |

| 120.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20.00 | MG | 11,14 | O |

| | | | | | | | |

| 120.7 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20.00 | MG | 16,22 | O |

| | | | | | | | |

| 120.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10.00 | MG | 17,06 | O |

| | | | | | | | |

| 120.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10.00 | MG | 12,23 | O |

| | | | | | | | |

| 120.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10.00 | MG | 16,91 | |

| | | | | | | | |

| 120.11 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10.00 | MG | 7,97 | |

| | | | | | | | |

| 120.12 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10.00 | MG | 4,49 | |

| | | | | | | | |

| 120.13 | H02AB08 | triamcinolon | parent. | 7.50 | MG | 13,33 | O |

| | | | | | | | |

| 120.14 | H02AB09 | hydrokortison | parent. | 30.00 | MG | 10,94 | O |

| | | | | | | | |

| 121 | hormony štítné žlázy a jódová terapie | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 121.1 | H03AA | hormony štítné žlázy | p.o. | 1.00 | DF | 2.12 | |

| 121.1 | H03AA | hormony štítné žlázy | p.o. | 1.00 | DF | 2,07 | |

| 61160 | JODTHYROX | tbl 50 | MEC | D |

| --- | --- | --- | --- | --- |

| 121.2 | H03AA01 | levothyroxin sodný (do 50 rg v 1 tabletě včetně) | p.o. | 0.15 | MG | 1.86 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D |

| --- | --- | --- | --- | --- |

| 121.3 | H03AA01 | levothyroxin sodný (nad 100 rg v 1 tabletě) | p.o. | 0.15 | MG | 1.09 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 69191 | EUTHYROX 150 | tbl 100x150rg | MEC | D |

| --- | --- | --- | --- | --- |

| 121.4 | H03AA01 | levothyroxin sodný (nad 50 rg do 100 rg včetně v 1 tabletě) | p.o. | 0.15 | MG | 1.37 | |

| 121.2 | H03AA01 | levothyroxin sodný (do 50 rg v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,82 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 69189 | EUTHYROX 50 | tbl 100×50rg | MEC | D |

| --- | --- | --- | --- | --- |

| 121.3 | H03AA01 | levothyroxin sodný (nad 100 rg v 1 tabletě) | p.o. | 0.15 | MG | 1,07 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 69191 | EUTHYROX 150 | tbl 100×150rg | MEC | D |

| --- | --- | --- | --- | --- |

| 121.4 | H03AA01 | levothyroxin sodný (nad 50 rg do 100 rg včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,34 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 97186 | EUTHYROX 100 | tbl 100×100rg | MEC | D |

| --- | --- | --- | --- | --- |

| 121.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4.40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 121.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1.00 | DF | 4.40 | |

| 03875 | THYREOTOM | tbl 60x50rg | BCE | D |

| --- | --- | --- | --- | --- |

| 121.7 | H03CA | jódová terapie | p.o. | 200.00 | RG | 1.76 | |

| 121.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,30 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 121.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1.00 | DF | 1,65 | |

| 03875 | THYREOTOM | tbl 60×50rg | BCE | D |

| --- | --- | --- | --- | --- |

| 121.7 | H03CA | jódová terapie | p.o. | 200.00 | RG | 1,72 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 61158 | JODID 100 | tbl 100 | MEC | D |

@@ -4713,420 +4786,405 @@

| 122 | Tyreostatika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 122.1 | H03BA02 | propylthiouracil | p.o. | 0.10 | GM | 6.94 | |

| 14914 | PROPYCIL 50 | por tbl nob 100x50mg | HPB | D |

| --- | --- | --- | --- | --- |

| 122.2 | H03BB01 | karbimazol | p.o. | 15.00 | MG | 2.93 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 00066 | CARBIMAZOL-SLOVAKOFARMA | tbl 100x5mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 122.3 | H03BB02 | thiamazol | p.o. | 10.00 | MG | 2.83 | |

| | | | | | | | |

| 122.4 | H03BB02 | thiamazol | parent. | 10.00 | MG | 4.50 | H |

| | | | | | | | |

| 122.5 | H03BC01 | perchlorát draselný | p.o. | 0.20 | GM | 1.66 | |

| 122.1 | H03BA02 | propylthiouracil | p.o. | 0.10 | GM | 6,78 | |

| 14914 | PROPYCIL 50 | por tbl nob 100×50mg | HPB | D |

| --- | --- | --- | --- | --- |

| 122.2 | H03BB01 | karbimazol | p.o. | 15.00 | MG | 2,86 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 00066 | CARBIMAZOL-SLOVAKOFARMA | tbl 100×5mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 122.3 | H03BB02 | thiamazol | p.o. | 10.00 | MG | 2,77 | |

| | | | | | | | |

| 122.4 | H03BB02 | thiamazol | parent. | 10.00 | MG | 4,40 | H |

| | | | | | | | |

| 122.5 | H03BC01 | perchlorát draselný | p.o. | 0.20 | GM | 1,62 | |

| | | | | | | | |

| 123 | glukagon a homeostatika vápníku a ostatní hormonální léčiva | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 123.1 | H04AA01 | glukagon | parent. | 1.00 | MG | 404.62 | L/DIA |

| | | | | | | | |

| 123.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1.00 | MG | 819.51 | L/DIA |

| 83741 | GLUCAGEN 1 MG HYPOKIT | inj sic 1mg+sol+stŘ | NOO | DK |

| --- | --- | --- | --- | --- |

| 123.3 | H05AA02 | teriparatid | parent. | 20.00 | RG | 390.00 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 123.4 | H05BA01 | kalcitonin (lososí) | parent. | 100.00 | U | 118.09 | L/INT.ORT, END,GER |

| | | | | | | | |

| 123.5 | H05BA01 | kalcitonin (lososí) | inhal. | 200.00 | U | 45.90 | P |

Kalcitonin předepisuje internista, ortoped, revmatolog, gynekolog a endokrinolog u osteoporózy prokázané celotělovým denzitometrem (méně než -2,5 SD) nebo osteoporotické patologické zlomeniny pokud jsou tyto stavy spojené s výrazným algickým (bolestivým) syndromem, nereagujícím na běžnou analgetickou terapii. Po 3 měsících je vyhodnocen efekt léčby. Pokud došlo k ústupu algického syndromu, je možno pokračovat v další léčbě po dobu maximálně 6 měsíců.

| 123.6 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100.00 | U | 125.37 | L/INT,ORT, END,GER |

| | | | | | | | |

| 123.7 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100.00 | U | 157.39 | L/INT,ORT, END,GER |

| | | | | | | | |

| 123.8 | H05BX01 | cinacalcet | p.o. | 60.00 | MG | 392.45 | X |

| | | | | | | | |

| 124 | ostatní léčiva ze skupiny hormonů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 124.1 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.50 | MG | 3.42 | |

| | | | | | | | |

| 124.2 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.50 | MG | 4.79 | |

| 86606 | MEDROL 16 MG | por tbl nob 50x16mg-b | PMB | B |

| 123.1 | H04AA01 | glukagon | parent. | 1.00 | MG | 395,44 | L/DIA |

| | | | | | | | |

| 123.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1.00 | MG | 800,91 | L/DIA |

| 83741 | GLUCAGEN 1 MG HYPOKIT | inj sic 1mg+sol+stř | NOO | DK |

| --- | --- | --- | --- | --- |

| 123.3 | H05AA02 | teriparatid | parent. | 20.00 | RG | 390,00 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 123.4 | H05BA01 | kalcitonin (lososí) | parent. | 100.00 | U | 115,41 | L/INT,ORT, END,GER |

| | | | | | | | |

| 123.5 | H05BA01 | kalcitonin (lososí) | inhal. | 200.00 | U | 44,86 | P |

Kalcitonin předepisuje internista, ortoped, revmatolog, gynekolog a endokrinolog u osteoporózy prokázané celotělovým denzitometrem (méně než –2,5 SD) nebo osteoporotické patologické zlomeniny pokud jsou tyto stavy spojené s výrazným algickým (bolestivým) syndromem, nereagujícím na běžnou analgetickou terapii. Po 3 měsících je vyhodnocen efekt léčby. Pokud došlo k ústupu algického syndromu, je možno pokračovat v další léčbě po dobu maximálně 6 měsíců.

| 86606 | MEDROL 16 MG | por tblnob50×16mg-b | PMB | B |

| --- | --- | --- | --- | --- |

| 125 | tetracyklinová a amfenikolová antibiotika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 125.1 | J01AA02 | doxycyklin | p.o. | 0.10 | GM | 3.92 | |

| 04013 | DOXYBENE 200 MG TABLETY | por tbl nob 10x200mg | MCK | D |

| --- | --- | --- | --- | --- |

| 12737 | DOXYHEXAL 200 TABS | tbl 10x200mg | SFS | D |

| 12738 | DOXYHEXAL 200 TABS | tbl 20x200mg | SFS | D |

| 32953 | DOXYHEXAL TABS | tbl 10x100mg | SFS | D |

| 32954 | DOXYHEXAL TABS | tbl 20x100mg | SFS | D |

| 47718 | DOXYCYCLIN AL 100 | tbl 10x100mg | APA | D |

| 47719 | DOXYCYCLIN AL 100 | tbl 20x100mg | APA | D |

| 47720 | DOXYCYCLIN AL 200 | tbl 10x200mg | APA | D |

| 97654 | DOXYBENE 100MG | cps 10x100mg | MCK | D |

| 125.2 | J01AA02 | doxycyklin | parent. | 0.10 | GM | 91.28 | K |

| | | | | | | | |

| 125.3 | J01AA04 | lymecyklin | p.o. | 0.60 | GM | 3.92 | |

| | | | | | | | |

| 125.4 | J01AA06 | oxytetracyklin | p.o. | 1.00 | GM | 3.92 | |

| | | | | | | | |

| 125.5 | J01AA07 | tetracyklin | p.o. | 1.00 | GM | 3.92 | |

| | | | | | | | |

| 125.6 | J01AA08 | minocyklin | p.o. | 0.20 | GM | 7.84 | |

| | | | | | | | |

| 125.7 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94.63 | K |

| | | | | | | | |

| 125.8 | J01AA | doxycyklin v kombinaci s ambroxolem | p.o. | 1.00 | DF | 6.17 | |

| | | | | | | | |

| 125.9 | J01BA01 | chloramfenikol | p.o. | 3.00 | GM | 25.88 | |

| | | | | | | | |

| 125.10 | J01BA01 | chloramfenikol | parent. | 3.00 | GM | 267.93 | K |

| | | | | | | | |

| 125.11 | J01BA02 | thiamphenikol | parent. | 1.50 | GM | 176.31 | K |

| 125.1 | J01AA02 | doxycyklin | p.o. | 0.10 | GM | 3,83 | |

| 04013 | DOXYBENE 200 MG TABLETY | por tbl nob 10×200mg | MCK | D |

| --- | --- | --- | --- | --- |

| 12737 | DOXYHEXAL 200 TABS | tbl 10×200mg | SFS | D |

| 12738 | DOXYHEXAL 200 TABS | tbl 20×200mg | SFS | D |

| 32953 | DOXYHEXAL TABS | tbl 10×100mg | SFS | D |

| 32954 | DOXYHEXAL TABS | tbl 20×100mg | SFS | D |

| 47718 | DOXYCYCLIN AL 100 | tbl 10×100mg | APA | D |

| 47719 | DOXYCYCLIN AL 100 | tbl 20×100mg | APA | D |

| 47720 | DOXYCYCLIN AL 200 | tbl 10×200mg | APA | D |

| 97654 | DOXYBENE 100MG | cps 10×100mg | MCK | D |

| 125.2 | J01AA02 | doxycyklin | parent. | 0.10 | GM | 89,21 | K |

| | | | | | | | |

| 125.3 | J01AA04 | lymecyklin | p.o. | 0.60 | GM | 3,83 | |

| | | | | | | | |

| 125.4 | J01AA06 | oxytetracyklin | p.o. | 1.00 | GM | 3,83 | |

| | | | | | | | |

| 125.5 | J01AA07 | tetracyklin | p.o. | 1.00 | GM | 3,83 | |

| | | | | | | | |

| 125.6 | J01AA08 | minocyklin | p.o. | 0.20 | GM | 7,66 | |

| | | | | | | | |

| 125.7 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 92,48 | K |

| | | | | | | | |

| 125.8 | J01AA | doxycyklin v kombinaci s ambroxolem | p.o. | 1.00 | DF | 6,03 | |

| | | | | | | | |

| 125.9 | J01BA01 | chloramfenikol | p.o. | 3.00 | GM | 25,29 | |

| | | | | | | | |

| 125.10 | J01BA01 | chloramfenikol | parent. | 3.00 | GM | 261,85 | K |

| | | | | | | | |

| 125.11 | J01BA02 | thiamphenikol | parent. | 1.50 | GM | 172,31 | K |

| | | | | | | | |

| 126 | peniciliny se širokým spektrem, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 126.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2.00 | GM | 14.13 | |

| | | | | | | | |

| 126.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2.00 | GM | 17.20 | |

| | | | | | | | |

| 126.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 gm v 1 tabletě včetně | p.o. | 1.00 | GM | 10.10 | |

| 15896 | APO-AMOXI 500 | por cps dur 30x500mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 17628 | AMOXIHEXAL 500 | tbl obd 10x500mg | SFS | D |

| 17629 | AMOXIHEXAL 500 | tbl obd 20x500mg | SFS | D |

| 19503 | APO-AMOXI 500 | por cps dur 30x500mg | KAT | NL |

| 32557 | OSPAMOX 500 MG | por tbl flm 14x500mg | SZK | A |

| 44337 | AMOXIHEXAL 500 | tbl obd 10x500mg | HHC | D |

| 44338 | AMOXIHEXAL 500 | tbl obd 20x500mg | HHC | D |

| 66364 | OSPAMOX 250MG | cps 12x250mg | SZK | A |

| 66368 | OSPAMOX 500 MG | por tbl flm 12x500mg | SZK | A |

| 126.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1 tabletě | p.o. | 1.00 | GM | 9.06 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17623 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | SFS | D |

| --- | --- | --- | --- | --- |

| 17624 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | SFS | D |

| 17625 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | SFS | D |

| 17630 | AMOXIHEXAL 750 | tbl obd 10x750mg | SFS | D |

| 17631 | AMOXIHEXAL 750 | tbl obd 20x750mg | SFS | D |

| 17632 | AMOXIHEXAL 750 | tbl obd 50x750mg | SFS | D |

| 32558 | OSPAMOX 750 MG | por tbl flm 14x750mg | SZK | A |

| 32559 | OSPAMOX 1000 MG | por tbl flm 14x1000mg | SZK | A |

| 44339 | AMOXIHEXAL 750 | tbl obd 10x750mg | HHC | D |

| 44340 | AMOXIHEXAL 750 | tbl obd 20x750mg | HHC | D |

| 44341 | AMOXIHEXAL 750 | tbl obd 50x750mg | HHC | D |

| 44342 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | HHC | D |

| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D |

| 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HHC | D |

| 65929 | AMOXICILLIN AL 1000 | tbl obd 10x1000mg | APA | D |

| 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D |

| 66369 | OSPAMOX 750 MG | por tbl flm 12x750mg | SZK | A |

| 66370 | OSPAMOX 1000 MG | por tbl flm 12x1000mg | SZK | A |

| 126.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 gm včetně v 5 mililitrech) | p.o. | 1.00 | GM | 11.67 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17620 | AMOXIHEXAL | plv sus 1x100ml | SFS | D |

| --- | --- | --- | --- | --- |

| 17622 | AMOXIHEXAL FORTE | plv sus 1x100ml | SFS | D |

| 44345 | AMOXIHEXAL | plv sus 1x100ml | AAG | D |

| 44347 | AMOXIHEXAL FORTE | plv sus 1x100ml | AAG | D |

| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL |

| 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | SZK | A |

| 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | SZK | A |

| 126.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 gm v 5 mililitrech) | p.o. | 1.00 | GM | 10.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17626 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | SFS | D |

| --- | --- | --- | --- | --- |

| 17627 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | SFS | D |

| 17633 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | SFS | D |

| 17634 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | SFS | D |

| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D |

| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | HHC | D |

| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D |

| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | HHC | D |

| 126.7 | J01CA06 | bakampicilin | p.o. | 1.20 | GM | 16.62 | |

| 126.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2.00 | GM | 13,81 | |

| | | | | | | | |

| 126.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2.00 | GM | 16,81 | |

| | | | | | | | |

| 126.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 gm v 1 tabletě včetně | p.o. | 1.00 | GM | 9,87 | |

| 15896 | APO-AMOXI 500 | por cps dur 30×500mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 17628 | AMOXIHEXAL 500 | tbl obd 10×500mg | SFS | D |

| 17629 | AMOXIHEXAL 500 | tbl obd 20×500mg | SFS | D |

| 19503 | APO-AMOXI 500 | por cps dur 30×500mg | KAT | NL |

| 32557 | OSPAMOX 500 MG | por tbl flm 14×500mg | SZK | A |

| 44337 | AMOXIHEXAL 500 | tbl obd 10×500mg | HHC | D |

| 44338 | AMOXIHEXAL 500 | tbl obd 20×500mg | HHC | D |

| 66364 | OSPAMOX 250MG | cps 12×250mg | SZK | A |

| 66368 | OSPAMOX 500 MG | por tbl flm 12×500mg | SZK | A |

| 126.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1 tabletě | p.o. | 1.00 | GM | 8,85 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17623 | AMOXIHEXAL 1000 | tbl obd 10×1000mg | SFS | D |

| --- | --- | --- | --- | --- |

| 17624 | AMOXIHEXAL 1000 | tbl obd 20×1000mg | SFS | D |

| 17625 | AMOXIHEXAL 1000 | tbl obd 50×1000mg | SFS | D |

| 17630 | AMOXIHEXAL 750 | tbl obd 10×750mg | SFS | D |

| 17631 | AMOXIHEXAL 750 | tbl obd 20×750mg | SFS | D |

| 17632 | AMOXIHEXAL 750 | tbl obd 50×750mg | SFS | D |

| 32558 | OSPAMOX 750 MG | por tbl flm 14×750mg | SZK | A |

| 32559 | OSPAMOX 1000 MG | por tbl flm 14×1000mg | SZK | A |

| 44339 | AMOXIHEXAL 750 | tbl obd 10×750mg | HHC | D |

| 44340 | AMOXIHEXAL 750 | tbl obd 20×750mg | HHC | D |

| 44341 | AMOXIHEXAL 750 | tbl obd 50×750mg | HHC | D |

| 44342 | AMOXIHEXAL 1000 | tbl obd 10×1000mg | HHC | D |

| 44343 | AMOXIHEXAL 1000 | tbl obd 20×1000mg | HHC | D |

| 44344 | AMOXIHEXAL 1000 | tbl obd 50×1000mg | HHC | D |

| 65929 | AMOXICILLIN AL 1000 | tbl obd 10×1000mg | APA | D |

| 65958 | AMOXICILLIN AL 1000 | tbl obd 20×1000mg | APA | D |

| 66369 | OSPAMOX 750 MG | por tbl flm 12×750mg | SZK | A |

| 66370 | OSPAMOX 1000 MG | por tbl flm 12×1000mg | SZK | A |

| 126.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 gm včetně v 5 mililitrech) | p.o. | 1.00 | GM | 11,41 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17620 | AMOXIHEXAL | plv sus 1×100ml | SFS | D |

| --- | --- | --- | --- | --- |

| 17622 | AMOXIHEXAL FORTE | plv sus 1×100ml | SFS | D |

| 44345 | AMOXIHEXAL | plv sus 1×100ml | AAG | D |

| 44347 | AMOXIHEXAL FORTE | plv sus 1×100ml | AAG | D |

| 62050 | DUOMOX 500 | tbl 20×500mg | YEU | NL |

| 66366 | OSPAMOX 250MG/5ML | gra sus 1×60ml | SZK | A |

| 66367 | OSPAMOX 375MG/5ML | gra sus 1×60ml | SZK | A |

| 126.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 gm v 5 mililitrech) | p.o. | 1.00 | GM | 9,77 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17626 | AMOXIHEXAL 1000 TABS | tbl sol 12×1000mg | SFS | D |

| --- | --- | --- | --- | --- |

| 17627 | AMOXIHEXAL 1000 TABS | tbl sol 24×1000mg | SFS | D |

| 17633 | AMOXIHEXAL 750 TABS | tbl sol 12×750mg | SFS | D |

| 17634 | AMOXIHEXAL 750 TABS | tbl sol 24×750mg | SFS | D |

| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12×750mg | HHC | D |

| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24×750mg | HHC | D |

| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12×1000mg | HHC | D |

| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24×1000mg | HHC | D |

| 126.7 | J01CA06 | bakampicilin | p.o. | 1.20 | GM | 16,24 | |

| | | | | | | | |

| 127 | peniciliny se širokým spektrem, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 127.1 | J01CA01 | ampicilin | parent. | 2.00 | GM | 43.35 | K |

| 86197 | AMPICILIN 0.5 BIOTIKA | inj sic 50x500mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 127.2 | J01CA09 | azlocilin | parent. | 12.00 | GM | 637.48 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 127.3 | J01CA12 | piperacilin | parent. | 14.00 | GM | 1 297.98 | U/ATB |

| | | | | | | | |

| 127.4 | J01CA13 | tikarcilin | parent. | 15.00 | GM | 1 980.92 | U/ATB |

| | | | | | | | |

| 127.5 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2.00 | GM | 145.95 | U/ATB |

| | | | | | | | |

| 127.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1.00 | GM | 97.91 | U/ATB |

| | | | | | | | |

| 127.7 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15.00 | GM | 1 613.32 | U/ATB |

| 93170 | TIMENTIN 3.2 GM | inj sic 4x3.2gm | SKW | GB |

| --- | --- | --- | --- | --- |

| 127.8 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14.00 | GM | 1 782.82 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 127.9 | J01CR50 | kombinace penicilinů | parent. | 3.00 | DF | 71.80 | U |

| 127.1 | J01CA01 | ampicilin | parent. | 2.00 | GM | 42,37 | K |

| 86197 | AMPICILIN 0.5 BIOTIKA | inj sic 50×500mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 127.2 | J01CA09 | azlocilin | parent. | 12.00 | GM | 623,01 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 127.3 | J01CA12 | piperacilin | parent. | 14.00 | GM | 1 268,52 | U/ATB |

| | | | | | | | |

| 127.4 | J01CA13 | tikarcilin | parent. | 15.00 | GM | 1 935,95 | U/ATB |

| | | | | | | | |

| 127.5 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2.00 | GM | 142,64 | U/ATB |

| | | | | | | | |

| 127.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1.00 | GM | 95,69 | U/ATB |

| | | | | | | | |

| 127.7 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15.00 | GM | 1 576,70 | U/ATB |

| 93170 | TIMENTIN 3.2 GM | inj sic 4×3.2gm | SKW | GB |

| --- | --- | --- | --- | --- |

| 127.8 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14.00 | GM | 1 742,35 | U/ATB |

| | | | | | | | |

| 127.9 | J01CR50 | kombinace penicilinů | parent. | 3.00 | DF | 70,17 | U |

| | | | | | | | |

| 128 | peniciliny citlivé k betalaktamáze, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 128.1 | J01CE02 | fenoxymethyl penicilin ( od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2.00 | GM | 17.95 | |

| 45996 | OSPEN 500 | por tblf lm 30x500ku | SZK | A |

| --- | --- | --- | --- | --- |

| 92435 | V-PENICILIN 0.8 MEGA BIOTIKA | por tbl nob 30x800ku | BTA | SK |

| 92806 | V-PENICILIN 500 MG SLOVAKOFARMA | tbl 30x500mg-blistr | ZEH | SK |

| 128.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2.00 | GM | 19.75 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 92434 | V-PENICILIN 0.4 MEGA BIOTIKA | por tbl nob 30x400ku | BTA | SK |

| --- | --- | --- | --- | --- |

| 92805 | V-PENICILIN 250 MG SLOVAKOFARMA | tbl 30x250mg-blistr | ZEH | SK |

| 128.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2.00 | GM | 16.85 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D |

| --- | --- | --- | --- | --- |

| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20x750mg-bli | ZEH | SK |

| 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30x750mg-bli | ZEH | SK |

| 45997 | OSPEN 1000 | por tbl flm 30x1000ku | SZK | A |

| 45998 | OSPEN 1500 | por tbl flm 30x1500ku | SZK | A |

| 49513 | PENBENE 1 000 000 | tbl obd 30x1mu | MCK | D |

| 128.1 | J01CE02 | fenoxymethylpenicilin ( od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2.00 | GM | 17,54 | |

| 45996 | OSPEN 500 | por tbl flm 30×500ku | SZK | A |

| --- | --- | --- | --- | --- |

| 92435 | V-PENICILIN 0.8 MEGA BIOTIKA | por tbl nob 30×800ku | BTA | SK |

| 92806 | V-PENICILIN 500 MG SLOVAKOFARMA | tbl 30×500mg-blistr | ZEH | SK |

| 128.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2.00 | GM | 19,30 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 92434 | V-PENICILIN 0.4 MEGA BIOTIKA | por tbl nob 30×400ku | BTA | SK |

| --- | --- | --- | --- | --- |

| 92805 | V-PENICILIN 250 MG SLOVAKOFARMA | tbl 30×250mg-blistr | ZEH | SK |

| 128.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2.00 | GM | 16,47 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01881 | PENBENE 1 000 000 | tbl obd 21×1mu | MCK | D |

| --- | --- | --- | --- | --- |

| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20×750mg-bli | ZEH | SK |

| 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30×750mg-bli | ZEH | SK |

| 45997 | OSPEN 1000 | por tbl flm 30×1000ku | SZK | A |

| 45998 | OSPEN 1500 | por tbl flm 30×1500ku | SZK | A |

| 49513 | PENBENE 1 000 000 | tbl obd 30×1mu | MCK | D |

| 57778 | PENBENE 1 500 000 | tbl obd 21 | MCK | D |

| 65356 | PENBENE 1 000 000 | tbl obd 12x1mu | MCK | D |

| 66359 | OSPEN 1000 | por tbl flm 12x1000ku | SZK | A |

| 66360 | OSPEN 1500 | por tbl flm 12x1500ku | SZK | A |

| 92436 | V-PENICILIN 1.2 MEGA BIOTIKA | por tbl nob 30x1.2mu | BTA | SK |

| 128.4 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2.00 | GM | 69.99 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 128.5 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2.00 | GM | 26.30 | |

| | | | | | | | |

| 128.6 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 14.19 | |

| 56442 | PENCLEN | tbl 30x350mg-bli | ZEH | SK |

| --- | --- | --- | --- | --- |

| 128.7 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2.00 | GM | 25.91 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49549 | OSPEN 400 | sir 1x150ml | SZK | A |

| --- | --- | --- | --- | --- |

| 76213 | OSPEN 750 KRKA | por sus 1x60ml/9gm | KRK | SLO |

| 65356 | PENBENE 1 000 000 | tbl obd 12×1mu | MCK | D |

| 66359 | OSPEN 1000 | por tbl flm 12×1000ku | SZK | A |

| 66360 | OSPEN 1500 | por tbl flm 12×1500ku | SZK | A |

| 92436 | V-PENICILIN 1.2 MEGA BIOTIKA | por tbl nob 30×1.2mu | BTA | SK |

| 128.4 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2.00 | GM | 68,40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 128.5 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2.00 | GM | 25,70 | |

| | | | | | | | |

| 128.6 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 13,87 | |

| 56442 | PENCLEN | tbl 30×350mg-bli | ZEH | SK |

| --- | --- | --- | --- | --- |

| 128.7 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2.00 | GM | 25,32 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 49549 | OSPEN 400 | sir 1×150ml | SZK | A |

| --- | --- | --- | --- | --- |

| 76213 | OSPEN 750 KRKA | por sus 1×60ml/9gm | KRK | SLO |

| 129 | peniciliny citlivé k betalaktamáze, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 129.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.60 | GM | 121.29 | K |

| 01093 | PENICILIN G 1.0 DRAS.SOL BIOT. | inj sic 10x1mu | BTA | SK |

| --- | --- | --- | --- | --- |

| 129.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.60 | GM | 49.06 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 93405 | PENICILIN G 5.0 DRAS.SOL BIOT. | inj sic 10x5mu | BTA | SK |

| --- | --- | --- | --- | --- |

| 129.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2.00 | MU | 70.63 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 129.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2.00 | MU | 26.93 | K |

| 01764 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | SZK | A |

| --- | --- | --- | --- | --- |

| 129.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2.00 | MU | 79.58 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 129.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2.00 | MU | 38.84 | K |

| 01102 | PROKAIN PENICILIN G 1.5 BIOTIKA | inj sic 10x1.5mu | BTA | SK |

| --- | --- | --- | --- | --- |

| 129.7 | J01CE30 | kombinace | parent. | 0.50 | DF | 10.31 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02723 | PENDEPON COMPOSITUM | inj sic 10x1.5mu | BTA | SK |

| 129.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.60 | GM | 118,54 | K |

| 01093 | PENICILIN G 1.0 DRAS.SOL BIOT. | inj sic 10×1mu | BTA | SK |

| --- | --- | --- | --- | --- |

| 129.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.60 | GM | 47,95 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 93405 | PENICILIN G 5.0 DRAS.SOL BIOT. | inj sic 10×5mu | BTA | SK |

| --- | --- | --- | --- | --- |

| 129.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2.00 | MU | 69,03 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 129.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2.00 | MU | 26,32 | K |

| 01764 | RETARPEN 2.4 M.U.I. | inj sic 50×2.4mu | SZK | A |

| --- | --- | --- | --- | --- |

| 129.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2.00 | MU | 77,77 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 129.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2.00 | MU | 37,96 | K |

| 01102 | PROKAIN PENICILIN G 1.5 BIOTIKA | inj sic 10×1.5mu | BTA | SK |

| --- | --- | --- | --- | --- |

| 129.7 | J01CE30 | kombinace | parent. | 0.50 | DF | 10,08 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02723 | PENDEPON COMPOSITUM | inj sic 10×1.5mu | BTA | SK |

| --- | --- | --- | --- | --- |

| 130 | peniciliny rezistentní k betalaktamáze a kombinace penicilinů včetně inhibitorů betalaktamáz, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 130.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 28.74 | |

| | | | | | | | |

| 130.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39.98 | |

| | | | | | | | |

| 130.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 28.74 | |

| | | | | | | | |

| 130.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39.98 | |

| | | | | | | | |

| 130.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1.00 | GM | 28.65 | |

| | | | | | | | |

| 130.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 1 g v 1 tabletě) | p.o. | 1.00 | GM | 18.56 | |

| | | | | | | | |

| 130.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1.00 | GM | 26.12 | |

| | | | | | | | |

| 130.8 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg do 1 g v 1 tabletě včetně) | p.o. | 1.00 | GM | 24.51 | |

| | | | | | | | |

| 130.9 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1.00 | GM | 37.62 | |

| | | | | | | | |

| 130.10 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1.00 | GM | 28.50 | |

| 44793 | AUGMENTIN DUO | por plv sus 1x140ml | SKW | GB |

| --- | --- | --- | --- | --- |

| 84792 | AUGMENTIN DUO | por plv sus 1x70ml | SKW | GB |

| 130.11 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.50 | GM | 73.32 | |

| 130.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 28,09 | |

| | | | | | | | |

| 130.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39,07 | |

| | | | | | | | |

| 130.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 28,09 | |

| | | | | | | | |

| 130.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39,07 | |

| | | | | | | | |

| 130.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1.00 | GM | 28,00 | |

| | | | | | | | |

| 130.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 1 g v 1 tabletě) | p.o. | 1.00 | GM | 18,14 | |

| | | | | | | | |

| 130.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1.00 | GM | 25,53 | |

| | | | | | | | |

| 130.8 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg do 1 g v 1 tabletě včetně) | p.o. | 1.00 | GM | 23,95 | |

| | | | | | | | |

| 130.9 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1.00 | GM | 36,77 | |

| | | | | | | | |

| 130.10 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1.00 | GM | 27,85 | |

| 44793 | AUGMENTIN DUO | por plv sus 1×140ml | SKW | GB |

| --- | --- | --- | --- | --- |

| 84792 | AUGMENTIN DUO | por plv sus 1×70ml | SKW | GB |

| 130.11 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.50 | GM | 71,66 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17149 | UNASYN | por tbl flm 12×375mg | PFI | I |

| --- | --- | --- | --- | --- |

| 72881 | UNASYN | tbl obd 12×375mg | PFI | TR |

| 130.12 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.50 | GM | 76.85 | |

| | | | | | | | |

| 130.12 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.50 | GM | 75,11 | |

| 131 | jiná betalaktamová antibiotika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 131.1 | J01DB01 | cefalexin (pevné lékové formy) | p.o. | 2.00 | GM | 38.13 | |

| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | SZK | A |

| --- | --- | --- | --- | --- |

| 131.2 | J01DB01 | cefalexin (tekuté lékové formy) | p.o. | 2.00 | GM | 39.53 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | SZK | A |

| --- | --- | --- | --- | --- |

| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | SZK | A |

| 131.3 | J01DC02 | cefuroxim axetil (pevné lékové formy) | p.o. | 1.00 | GM | 87.73 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 18499 | XORIMAX 125 MG POTAH.TABLETY | por tbl flm 10x125mg | SZK | A |

| --- | --- | --- | --- | --- |

| 18523 | XORIMAX 250 MG POTAH.TABLETY | por tbl flm 10x250mg | SZK | A |

| 18547 | XORIMAX 500 MG POTAH.TABLETY | por tbl flm 10x500mg | SZK | A |

| 131.4 | J01DC02 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1.00 | GM | 134.70 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 131.5 | J01DC04 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.50 | GM | 57.45 | |

| 16450 | VERCEF 250 MG | cps 3x7=21 bli | IRI | IRL |

| --- | --- | --- | --- | --- |

| 53153 | VERCEF 250MG | cps 7x3(blistr) | RDD | IND |

| 131.6 | J01DC04 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.50 | GM | 53.80 | |

| | | | | | | | |

| 131.7 | J01DC04 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.50 | GM | 84.00 | |

| | | | | | | | |

| 131.8 | J01DC04 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.50 | GM | 70.20 | |

| | | | | | | | |

| 131.9 | J01DB05 | cefadroxil (pevné lékové formy) | p.o. | 2.00 | GM | 38.13 | |

| | | | | | | | |

| 131.10 | J01DB05 | cefadroxil (tekuté lékové formy) | p.o. | 2.00 | GM | 40.92 | |

| | | | | | | | |

| 131.11 | J01DD08 | cefixim | p.o. | 0.40 | GM | 91.00 | ATB |

| | | | | | | | |

| 131.12 | J01DD10 | cefetamet | p.o. | 1.00 | GM | 91.00 | ATB |

| | | | | | | | |

| 131.13 | J01DD13 | cefpodoxim | p.o. | 0.40 | GM | 87.73 | ATB |

| | | | | | | | |

| 131.14 | J01DD14 | ceftibuten | p.o. | 0.40 | GM | 87.73 | ATB |

| | | | | | | | |

| 131.15 | J01DC10 | cefprozil (pevné lékové formy) | p.o. | 1.00 | GM | 87.73 | |

| | | | | | | | |

| 131.16 | J01DC10 | cefprozil (tekuté lékové formy) | p.o. | 1.00 | GM | 134.70 | |

| 131.1 | J01DB01 | cefalexin (pevné lékové formy) | p.o. | 2.00 | GM | 37,26 | |

| 66357 | OSPEXIN 1000MG | tbl obd 12×1000mg | SZK | A |

| --- | --- | --- | --- | --- |

| 131.2 | J01DB01 | cefalexin (tekuté lékové formy) | p.o. | 2.00 | GM | 38,63 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 66354 | OSPEXIN 250MG/5ML | gra sus 1×60ml | SZK | A |

| --- | --- | --- | --- | --- |

| 66355 | OSPEXIN 375MG/5ML | gra sus 1×60ml | SZK | A |

| 131.3 | J01DC02 | cefuroxim axetil (pevné lékové formy) | p.o. | 1.00 | GM | 85,74 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 18499 | XORIMAX 125 MG POTAH.TABLETY | por tbl flm 10×125mg | SZK | A |

| --- | --- | --- | --- | --- |

| 18523 | XORIMAX 250 MG POTAH.TABLETY | por tbl flm 10×250mg | SZK | A |

| 18547 | XORIMAX 500 MG POTAH.TABLETY | por tbl flm 10×500mg | SZK | A |

| 131.4 | J01DC02 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1.00 | GM | 131,64 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 131.5 | J01DC04 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.50 | GM | 56,15 | |

| 16450 | VERCEF 250 MG | cps 3×7=21 bli | IRI | IRL |

| --- | --- | --- | --- | --- |

| 53153 | VERCEF 250MG | cps 7×3(blistr) | RDD | IND |

| 131.6 | J01DC04 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.50 | GM | 52,58 | |

| | | | | | | | |

| 131.7 | J01DC04 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.50 | GM | 82,09 | |

| | | | | | | | |

| 131.8 | J01DC04 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.50 | GM | 68,61 | |

| | | | | | | | |

| 131.9 | J01DB05 | cefadroxil (pevné lékové formy) | p.o. | 2.00 | GM | 37,26 | |

| | | | | | | | |

| 131.10 | J01DB05 | cefadroxil (tekuté lékové formy) | p.o. | 2.00 | GM | 39,99 | |

| | | | | | | | |

| 131.11 | J01DD08 | cefixim | p.o. | 0.40 | GM | 88,93 | ATB |

| | | | | | | | |

| 131.12 | J01DD10 | cefetamet | p.o. | 1.00 | GM | 88,93 | ATB |

| | | | | | | | |

| 131.13 | J01DD13 | cefpodoxim | p.o. | 0.40 | GM | 85,74 | ATB |

| | | | | | | | |

| 131.14 | J01DD14 | ceftibuten | p.o. | 0.40 | GM | 85,74 | ATB |

| | | | | | | | |

| 131.15 | J01DC10 | cefprozil (pevné lékové formy) | p.o. | 1.00 | GM | 85,74 | |

| | | | | | | | |

| 131.16 | J01DC10 | cefprozil (tekuté lékové formy) | p.o. | 1.00 | GM | 131,64 | |

| | | | | | | | |

| 132 | jiná betalaktamová antibiotika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 132.1 | J01CF04 | oxacilin | parent. | 2.00 | GM | 95.80 | K |

| | | | | | | | |

| 132.2 | J01DD62 | cefoperazon a inhibitor beta-laktamázy | parent. | 2.00 | GM | 397.00 | U/ATB |

| | | | | | | | |

| 132.3 | J01DB03 | cefalotin | parent. | 4.00 | GM | 125.17 | U/ATB |

| | | | | | | | |

| 132.4 | J01DB04 | cefazolin | parent. | 3.00 | GM | 120.93 | U/ATB |

| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F |

| --- | --- | --- | --- | --- |

| 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F |

| 132.5 | J01DC01 | cefoxitin | parent. | 6.00 | GM | 937.79 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 132.6 | J01DC02 | cefuroxim | parent. | 4.00 | GM | 329.10 | U/ATB |

| 64831 | AXETINE 1.5GM | inj sic 10x1.5gm | MOE | CY |

| --- | --- | --- | --- | --- |

| 64833 | AXETINE 1.5GM | inj sic 100x1.5gm | MOE | CY |

| 64835 | AXETINE 750 MG | inj sic 10x750mg | MOE | CY |

| 64837 | AXETINE 750 MG | inj sic 100x750mg | MOE | CY |

| 132.7 | J01DC04 | cefamandol | parent. | 6.00 | GM | 575.27 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 132.8 | J01DD01 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6.00 | GM | 477.44 | U/ATB |

| 15669 | CEFTAX 1000 | inj sic 1x1000mg | HIK | P |

| --- | --- | --- | --- | --- |

| 49193 | CEFTAX 1000 | inj plv sol 10x1000mg | HIK | P |

| 83050 | SEFOTAK 1 G | inj plv sol 1x1gm | ICZ | CZ |

| 132.9 | J01DD01 | cefotaxim nad 1 g v jedné ampuli | parent. | 6.00 | GM | 440.56 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 132.10 | J01DD02 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6.00 | GM | 1 736.18 | U/ATB |

| | | | | | | | |

| 132.11 | J01DD02 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6.00 | GM | 1 679.42 | U/ATB |

| 76353 | FORTUM 1 G | inj plv sol 1x1gm | GWE |

| --- | --- | --- | --- |

| 76354 | FORTUM 2 G | inj plv sol 1x2gm | GWE |

| 132.12 | J01DD03 | cefsulodin | parent. | 6.00 | GM | 615.68 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 132.13 | J01DD04 | ceftriaxon | parent. | 2.00 | GM | 508.60 | ambulantně: K/P ústavně: U/ATB |

| 132.1 | J01CF04 | oxacilin | parent. | 2.00 | GM | 93,63 | K |

| | | | | | | | |

| 132.2 | J01DD62 | cefoperazon a inhibitor beta-laktamázy | parent. | 2.00 | GM | 387,99 | U/ATB |

| | | | | | | | |

| 132.3 | J01DB03 | cefalotin | parent. | 4.00 | GM | 122,33 | U/ATB |

| | | | | | | | |

| 132.4 | J01DB04 | cefazolin | parent. | 3.00 | GM | 118,18 | U/ATB |

| 02205 | CEFAZOLINE PANPHARMA | inj sic 25×1gm | LPA | F |

| --- | --- | --- | --- | --- |

| 84018 | CEFAZOLINE PANPHARMA | inj sic 50×1gm | LPA | F |

| 132.5 | J01DC01 | cefoxitin | parent. | 6.00 | GM | 916,50 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 132.6 | J01DC02 | cefuroxim | parent. | 4.00 | GM | 321,63 | U/ATB |

| 64831 | AXETINE 1.5GM | inj sic 10×1.5gm | MOE | CY |

| --- | --- | --- | --- | --- |

| 64833 | AXETINE 1.5GM | inj sic 100×1.5gm | MOE | CY |

| 64835 | AXETINE 750 MG | inj sic 10×750mg | MOE | CY |

| 64837 | AXETINE 750 MG | inj sic 100×750mg | MOE | CY |

| 132.7 | J01DC04 | cefamandol | parent. | 6.00 | GM | 562,21 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 132.8 | J01DD01 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6.00 | GM | 466,60 | U/ATB |

| 15669 | CEFTAX 1000 | inj sic 1×1000mg | HIK | P |

| --- | --- | --- | --- | --- |

| 49193 | CEFTAX 1000 | inj plv sol 10×1000mg | HIK | P |

| 83050 | SEFOTAK 1 G | inj plv sol 1×1gm | ICZ | CZ |

| 132.9 | J01DD01 | cefotaxim nad 1 g v jedné ampuli | parent. | 6.00 | GM | 430,56 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 132.10 | J01DD02 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6.00 | GM | 1 696,77 | U/ATB |

| | | | | | | | |

| 132.11 | J01DD02 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6.00 | GM | 1 641,30 | U/ATB |

| 76353 | FORTUM 1 G | inj plv sol 1×1gm | GWE | I |

| --- | --- | --- | --- | --- |

| 76354 | FORTUM 2 G | inj plv sol 1×2gm | GWE | I |

| 132.12 | J01DD03 | cefsulodin | parent. | 6.00 | GM | 601,70 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 132.13 | J01DD04 | ceftriaxon | parent. | 2.00 | GM | 497,05 | ambulantně: K/P ústavně: U/ATB |

Léčbu ceftriaxonem v ambulantní péči předepisuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog k:

@@ -5139,385 +5197,382 @@

| 58756 | CEFTRIAXON TORREX 2 G | inj plv sol 1x2gm | TRX | A |

| --- | --- | --- | --- | --- |

| 132.14 | J01DD07 | ceftizoxim | parent. | 4.00 | GM | 615.68 | U/ATB |

| | | | | | | | |

| 132.15 | J01DE01 | cefepim | parent. | 4.00 | GM | 1 445.00 | U/ATB |

| | | | | | | | |

| 132.16 | J01DB08 | cefapirin | parent. | 4.00 | GM | 194.73 | U/ATB |

| | | | | | | | |

| 132.17 | J01DD12 | cefoperazon | parent. | 6.00 | GM | 1 297.00 | U/ATB |

| | | | | | | | |

| 132.18 | J01DE02 | cefpirom | parent. | 4.00 | GM | 1 638.40 | U/ATB |

| | | | | | | | |

| 132.19 | J01DF01 | aztreonam | parent. | 4.00 | GM | 1 645.60 | U/ATB |

| | | | | | | | |

| 132.20 | J01DH | ertapenem | parent. | 1.00 | GM | 1 885.39 | U/ATB |

| | | | | | | | |

| 132.21 | J01DH02 | meropenem | parent. | 2.00 | GM | 2 194.52 | U/ATB |

| | | | | | | | |

| 132.22 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2.00 | GM | 2 238.99 | U/ATB |

| 132.14 | J01DD07 | ceftizoxim | parent. | 4.00 | GM | 601,70 | U/ATB |

| | | | | | | | |

| 132.15 | J01DE01 | cefepim | parent. | 4.00 | GM | 1 412,20 | U/ATB |

| | | | | | | | |

| 132.16 | J01DB08 | cefapirin | parent. | 4.00 | GM | 190,31 | U/ATB |

| | | | | | | | |

| 132.17 | J01DD12 | cefoperazon | parent. | 6.00 | GM | 1 267,56 | U/ATB |

| | | | | | | | |

| 132.18 | J01DE02 | cefpirom | parent. | 4.00 | GM | 1 601,21 | U/ATB |

| | | | | | | | |

| 132.19 | J01DF01 | aztreonam | parent. | 4.00 | GM | 1 608,24 | U/ATB |

| | | | | | | | |

| 132.20 | J01DH | ertapenem | parent. | 1.00 | GM | 1 842,59 | U/ATB |

| | | | | | | | |

| 132.21 | J01DH02 | meropenem | parent. | 2.00 | GM | 2 144,70 | U/ATB |

| | | | | | | | |

| 132.22 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2.00 | GM | 2 188,16 | U/ATB |

| | | | | | | | |

| 133 | sulfonamidy a trimetoprim | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 133.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.40 | GM | 11.60 | |

| 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D |

| --- | --- | --- | --- | --- |

| 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D |

| 133.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.40 | GM | 8.94 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D |

| --- | --- | --- | --- | --- |

| 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D |

| 133.3 | J01EB05 | sulfafurazol | p.o. | 4.00 | GM | 13.64 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 133.4 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 127.04 | K |

| | | | | | | | |

| 133.5 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6.40 | |

| 75022 | COTRIMOXAZOL AL FORTE | tbl 10x960mg | APA | D |

| --- | --- | --- | --- | --- |

| 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D |

| 133.6 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17.06 | |

| | | | | | | | |

| 133.7 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22.39 | |

| | | | | | | | |

| 133.8 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6.94 | |

| | | | | | | | |

| 133.9 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23.07 | |

| | | | | | | | |

| 133.10 | J01EE04 | sulfamoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6.94 | |

| | | | | | | | |

| 133.11 | J01EE04 | sulfamoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23.07 | |

| | | | | | | | |

| 133.12 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6.94 | |

| 133.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.40 | GM | 11,34 | |

| 89812 | TRIPRIM 100MG | tbl 10×100mg | MCK | D |

| --- | --- | --- | --- | --- |

| 89813 | TRIPRIM 100MG | tbl 20×100mg | MCK | D |

| 133.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.40 | GM | 8,74 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 89815 | TRIPRIM 200MG | tbl 10×200mg | MCK | D |

| --- | --- | --- | --- | --- |

| 89816 | TRIPRIM 200MG | tbl 20×200mg | MCK | D |

| 133.3 | J01EB05 | sulfafurazol | p.o. | 4.00 | GM | 13,33 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 133.4 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 124,16 | K |

| | | | | | | | |

| 133.5 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,25 | |

| 75022 | COTRIMOXAZOL AL FORTE | tbl 10×960mg | APA | D |

| --- | --- | --- | --- | --- |

| 75023 | COTRIMOXAZOL AL FORTE | tbl 20×960mg | APA | D |

| 133.6 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 16,67 | |

| | | | | | | | |

| 133.7 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 21,88 | |

| | | | | | | | |

| 133.8 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,78 | |

| | | | | | | | |

| 133.9 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,55 | |

| | | | | | | | |

| 133.10 | J01EE04 | sulfamoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,78 | |

| | | | | | | | |

| 133.11 | J01EE04 | sulfamoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,55 | |

| | | | | | | | |

| 133.12 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,78 | |

| | | | | | | | |

| 134 | makrolidová antibiotika a jejich kombinace s antibakteriálními léčivy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 134.1 | J01FA | telithromycin | p.o. | 800.00 | MG | 96.80 | U/ATB |

| | | | | | | | |

| 134.2 | J01FA01 | erythromycin | parent. | 1.00 | GM | 717.50 | K |

| | | | | | | | |

| 134.3 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1.00 | GM | 19.09 | |

| | | | | | | | |

| 134.4 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1.00 | GM | 33.69 | |

| 55585 | MEROMYCIN | plv sus 1x100ml | MCK | D |

| --- | --- | --- | --- | --- |

| 134.5 | J01FA02 | spiramycin | p.o. | 3.00 | GM | 42.75 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 134.6 | J01FA02 | spiramycin | parent. | 4.50 | MU | 653.19 | K |

| 17129 | ROVAMYCINE PLV.PRO INF.1.5MIU | plv inf 1x1.5mu | AVM | F |

| --- | --- | --- | --- | --- |

| 134.7 | J01FA05 | oleandomycin | p.o. | 1.00 | GM | 14.59 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 134.8 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 38.67 | |

| | | | | | | | |

| 134.9 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.30 | GM | 31.60 | |

| 10855 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm 10x150mg | MCK | D |

| --- | --- | --- | --- | --- |

| 10857 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm 14x150mg | MCK | D |

| 10875 | ROXITHROMYCIN-RATIOPHARM 300 MG | por tbl flm 10x300mg | MCK | D |

| 134.10 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2.00 | GM | 30.08 | |

| | | | | | | | |

| 134.11 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1.00 | GM | 40.45 | |

| | | | | | | | |

| 134.12 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.50 | GM | 36.00 | |

| | | | | | | | |

| 134.13 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.50 | GM | 59.85 | |

| | | | | | | | |

| 134.14 | J01FA09 | klaritromycin | parent. | 1.00 | GM | 658.62 | K |

| | | | | | | | |

| 134.15 | J01FA10 | azithromycin (pevné lékové formy) | p.o. | 0.30 | GM | 50.40 | |

| | | | | | | | |

| 134.16 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.30 | GM | 89.77 | |

| | | | | | | | |

| 134.17 | J01FA10 | azitromycin | parent. | 0.50 | GM | 426.89 | K |

| | | | | | | | |

| 134.18 | J01FA13 | dirythromycin | p.o. | 0.50 | GM | 42.75 | |

| | | | | | | | |

| 134.19 | J01FG02 | quinupristin v kombinaci s dalfopristinem | parent | 1.00 | DF | 2 492.00 | U/ATB |

| | | | | | | | |

| 134.20 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5.00 | DF | 32.16 | |

| 134.1 | J01FA | telithromycin | p.o. | 800.00 | MG | 94,60 | U/ATB |

| | | | | | | | |

| 134.2 | J01FA01 | erythromycin | parent. | 1.00 | GM | 701,21 | K |

| | | | | | | | |

| 134.3 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1.00 | GM | 18,66 | |

| | | | | | | | |

| 134.4 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1.00 | GM | 32,93 | |

| 55585 | MEROMYCIN | plv sus 1×100ml | MCK | D |

| --- | --- | --- | --- | --- |

| 134.5 | J01FA02 | spiramycin | p.o. | 3.00 | GM | 41,78 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 134.6 | J01FA02 | spiramycin | parent. | 4.50 | MU | 638,36 | K |

| 17129 | ROVAMYCINE PLV.PRO INF.1.5 MIU | plv inf 1×1.5mu | AVM | F |

| --- | --- | --- | --- | --- |

| 134.7 | J01FA05 | oleandomycin | p.o. | 1.00 | GM | 14,26 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 134.8 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 37,79 | |

| | | | | | | | |

| 134.9 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.30 | GM | 30,88 | |

| 10855 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm 10×150mg | MCK | D |

| --- | --- | --- | --- | --- |

| 10857 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm 14×10mg | MCK | D |

| 10875 | ROXITHROMYCIN-RATIOPHARM 300 MG | por tbl flm 10×300mg | MCK | D |

| 134.10 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2.00 | GM | 29,40 | |

| | | | | | | | |

| 134.11 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1.00 | GM | 39,53 | |

| | | | | | | | |

| 134.12 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.50 | GM | 35,18 | |

| | | | | | | | |

| 134.13 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.50 | GM | 58,49 | |

| | | | | | | | |

| 134.14 | J01FA09 | klaritromycin | parent. | 1.00 | GM | 643,67 | K |

| | | | | | | | |

| 134.15 | J01FA10 | azithromycin (pevné lékové formy) | p.o. | 0.30 | GM | 49,26 | |

| | | | | | | | |

| 134.16 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.30 | GM | 87,73 | |

| | | | | | | | |

| 134.17 | J01FA10 | azitromycin | parent. | 0.50 | GM | 417,20 | K |

| | | | | | | | |

| 134.18 | J01FA13 | dirythromycin | p.o. | 0.50 | GM | 41,78 | |

| | | | | | | | |

| 134.19 | J01FG02 | quinupristin v kombinaci s dalfopristinem | parent | 1.00 | DF | 2 435,43 | U/ATB |

| | | | | | | | |

| 134.20 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5.00 | DF | 31,43 | |

| | | | | | | | |

| 135 | linkosamidová antibiotika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 135.1 | J01FF01 | klindamycin (do 0,3 gm včetně v jedné ampuli) | parent. | 1.80 | GM | 457.90 | U/ATB |

| | | | | | | | |

| 135.2 | J01FF01 | klindamycin (nad 0,3 gm v jedné ampuli) | parent. | 1.80 | GM | 419.90 | U/ATB |

| | | | | | | | |

| 135.3 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.20 | GM | 42.15 | |

| | | | | | | | |

| 135.4 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.20 | GM | 129.70 | |

| | | | | | | | |

| 135.5 | J01FF02 | linkomycin | parent. | 1.80 | GM | 49.17 | U/ATB |

| | | | | | | | |

| 135.6 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.80 | GM | 29.33 | ATB |

| 91997 | NELOREN | cps 16x500mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 135.7 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.80 | GM | 160.62 | ATB |

| 135.1 | J01FF01 | klindamycin (do 0,3 gm včetně v jedné ampuli) | parent. | 1.80 | GM | 447,51 | U/ATB |

| | | | | | | | |

| 135.2 | J01FF01 | klindamycin (nad 0,3 gm v jedné ampuli) | parent. | 1.80 | GM | 410,37 | U/ATB |

| | | | | | | | |

| 135.3 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.20 | GM | 41,19 | |

| | | | | | | | |

| 135.4 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.20 | GM | 126,76 | |

| | | | | | | | |

| 135.5 | J01FF02 | linkomycin | parent. | 1.80 | GM | 48,05 | U/ATB |

| | | | | | | | |

| 135.6 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.80 | GM | 28,66 | ATB |

| 91997 | NELOREN | cps 16×500mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 135.7 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.80 | GM | 156,97 | ATB |

| | | | | | | | |

| 136 | aminoglykosidová antibiotika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 136.1 | J01GA01 | streptomycin | parent. | 1.00 | GM | 117.10 | |

| 13797 | STREPTOMYCIN 1GM | plv sol 10x1gm/lahv | BAK | BG |

| --- | --- | --- | --- | --- |

| 136.2 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43.84 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 136.3 | J01GB01 | tobramycin (léková forma – inhalační roztok) | inhal. | 0.60 | GM | 2 975.00 | P |

| 136.1 | J01GA01 | streptomycin | parent. | 1.00 | GM | 114,44 | |

| 13797 | STREPTOMYCIN 1GM | plv sol 10×1gm/lahv | BAK | BG |

| --- | --- | --- | --- | --- |

| 136.2 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 42,84 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 136.3 | J01GB01 | tobramycin (léková forma - inhalační roztok) | inhal. | 0.60 | GM | 2 907,47 | P |

Tobramycin v inhalační formě je indikován u pacientů s cystickou fibrózou infikovaných Pseudomonas aeruginosa, starších 6-ti let.

| 136.4 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23.02 | U/ATB |

| | | | | | | | |

| 136.5 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 45.18 | U/ATB |

| | | | | | | | |

| 136.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1.00 | DF | 152.06 | U/ATB |

| | | | | | | | |

| 136.7 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130.00 | MG | 411.98 | U/ATB |

| | | | | | | | |

| 136.8 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23.61 | U/ATB |

| | | | | | | | |

| 136.9 | J01GB05 | neomycin | parent. | 1.00 | GM | 122.34 | U/ATB |

| | | | | | | | |

| 136.10 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1.00 | GM | 666.90 | U/ATB |

| | | | | | | | |

| 136.11 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1.00 | GM | 358.80 | U/ATB |

| | | | | | | | |

| 136.12 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 519.93 | U/ATB |

| | | | | | | | |

| 136.13 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304.57 | U/ATB |

| | | | | | | | |

| 136.14 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1.00 | GM | 620.27 | U/ATB |

| | | | | | | | |

| 136.15 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1.00 | GM | 516.90 | U/ATB |

| 136.4 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 22,50 | U/ATB |

| | | | | | | | |

| 136.5 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 44,15 | U/ATB |

| | | | | | | | |

| 136.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1.00 | DF | 148,61 | U/ATB |

| | | | | | | | |

| 136.7 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130.00 | MG | 2 357,23 | U/ATB |

| | | | | | | | |

| 136.8 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,07 | U/ATB |

| | | | | | | | |

| 136.9 | J01GB05 | neomycin | parent. | 1.00 | GM | 119,56 | U/ATB |

| | | | | | | | |

| 136.10 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1.00 | GM | 651,76 | U/ATB |

| | | | | | | | |

| 136.11 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1.00 | GM | 350,66 | U/ATB |

| | | | | | | | |

| 136.12 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 508,13 | U/ATB |

| | | | | | | | |

| 136.13 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 297,66 | U/ATB |

| | | | | | | | |

| 136.14 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1.00 | GM | 606,19 | U/ATB |

| | | | | | | | |

| 136.15 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1.00 | GM | 505,17 | U/ATB |

| | | | | | | | |

| 137 | chinolonová chemoterapeutika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 137.1 | J01MA | trovafloxacin | p.o. | 0.20 | GM | 24.50 | P |

| 137.1 | J01MA | trovafloxacin | p.o. | 0.20 | GM | 23,94 | P |

K léčbě trovafloxacinem je třeba konzultace a schválení antibiotického střediska.

| 137.2 | J01MA | trovafloxacin | parent. | 0.20 | GM | 212.23 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 137.3 | J01MA01 | ofloxacin | p.o. | 0.40 | GM | 19.00 | |

| 12349 | ZANOCIN 200MG | tbl obd 10x200mg | RXY | IND |

| --- | --- | --- | --- | --- |

| 17412 | ZANOCIN 200MG | tbl obd 10x200mg | IRI | IRL |

| 137.4 | J01MA01 | ofloxacin | parent. | 0.40 | GM | 212.23 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 137.5 | J01MA02 | ciprofloxacin | p.o. | 1.00 | GM | 19.00 | |

| 15653 | CIPLOX 250 | tbl obd 10x250mg | SDD | CZ |

| --- | --- | --- | --- | --- |

| 15654 | CIPLOX 250 | tbl obd 50x250mg | SDD | CZ |

| 15658 | CIPLOX 500 | tbl obd 10x500mg | SDD | CZ |

| 15659 | CIPLOX 500 | tbl obd 50x500mg | SDD | CZ |

| 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND |

| 44986 | CIPLOX 500 | tbl obd 50x500mg | CIA | IND |

| 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND |

| 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND |

| 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO |

| 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO |

| 137.6 | J01MA02 | ciprofloxacin – infúze | parent. | 0.50 | GM | 212.23 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15651 | CIPLOX | inf 1x100ml(plast) | SDD | CZ |

| --- | --- | --- | --- | --- |

| 56830 | CIPLOX | inf 1x100ml(plast) | CIA | IND |

| 59830 | CIPRINOL 200MG/100ML | inf 1x100ml/200mg | KRK | SLO |

| 137.7 | J01MA02 | ciprofloxacin – injekce | parent. | 0.50 | GM | 186.84 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 96040 | CIPRINOL 100MG/10ML | inf 5x10ml/100mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 137.8 | J01MA03 | pefloxacin | p.o. | 0.80 | GM | 19.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 137.9 | J01MA03 | pefloxacin | parent. | 0.80 | GM | 93.26 | U/ATB |

| | | | | | | | |

| 137.10 | J01MA04 | enoxacin | p.o. | 0.80 | GM | 19.00 | |

| | | | | | | | |

| 137.11 | J01MA06 | norfloxacin | p.o. | 0.80 | GM | 19.00 | |

| 01660 | NORFLOXACIN-RATIOPHARM 400MG | por tbl flm 20x400mg | MCK | D |

| --- | --- | --- | --- | --- |

| 42549 | NORFLOXACIN-RATIOPHARM 400MG | por tbl flm 14x400mg | MCK | D |

| 44090 | GYRABLOCK 400 | por tbl flm 500x400mg | MOE | CY |

| 44091 | GYRABLOCK 400 | por tbl flm 1000x400mg | MOE | CY |

| 93465 | NOLICIN | tbl obd 20x400mg | KRK | SLO |

| 137.12 | J01MA07 | lomefloxacin | p.o. | 0.80 | GM | 19.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 137.13 | J01MA08 | fleroxacin | p.o. | 0.40 | GM | 19.00 | |

| | | | | | | | |

| 137.14 | J01MA08 | fleroxacin | parent. | 0.40 | GM | 212.23 | U/ATB |

| | | | | | | | |

| 137.15 | J01MA09 | sparfloxacin | p.o. | 0.20 | GM | 19.00 | P |

| 137.2 | J01MA | trovafloxacin | parent. | 0.20 | GM | 207,41 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 137.3 | J01MA01 | ofloxacin | p.o. | 0.40 | GM | 18,57 | |

| 12349 | ZANOCIN 200MG | tbl obd 10×200mg | RXY | IND |

| --- | --- | --- | --- | --- |

| 17412 | ZANOCIN 200MG | tbl obd 10×200mg | IRI | IRL |

| 137.4 | J01MA01 | ofloxacin | parent. | 0.40 | GM | 207,41 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 137.5 | J01MA02 | ciprofloxacin | p.o. | 1.00 | GM | 18,57 | |

| 15653 | CIPLOX 250 | tbl obd 10×250mg | SDD | CZ |

| --- | --- | --- | --- | --- |

| 15654 | CIPLOX 250 | tbl obd 50×250mg | SDD | CZ |

| 15658 | CIPLOX 500 | tbl obd 10×500mg | SDD | CZ |

| 15659 | CIPLOX 500 | tbl obd 50×500mg | SDD | CZ |

| 44985 | CIPLOX 500 | tbl obd 10×500mg | CIA | IND |

| 44986 | CIPLOX 500 | tbl obd 50×500mg | CIA | IND |

| 44988 | CIPLOX 250 | tbl obd 10×250mg | CIA | IND |

| 44989 | CIPLOX 250 | tbl obd 50×250mg | CIA | IND |

| 94453 | CIPRINOL 250 | tbl obd 10×250mg | KRK | SLO |

| 96039 | CIPRINOL 500 | tbl obd 10×500mg | KRK | SLO |

| 137.6 | J01MA02 | ciprofloxacin - infúze | parent. | 0.50 | GM | 207,41 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15651 | CIPLOX | inf 1×100ml(plast) | SDD | CZ |

| --- | --- | --- | --- | --- |

| 56830 | CIPLOX | inf 1×100ml(plast) | CIA | IND |

| 59830 | CIPRINOL 200MG/100ML | inf 1×100ml/200mg | KRK | SLO |

| 137.7 | J01MA02 | ciprofloxacin - injekce | parent. | 0.50 | GM | 182,60 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 96040 | CIPRINOL 100MG/10ML | inf 5×10ml/100mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 137.8 | J01MA03 | pefloxacin | p.o. | 0.80 | GM | 18,57 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 137.9 | J01MA03 | pefloxacin | parent. | 0.80 | GM | 91,14 | U/ATB |

| | | | | | | | |

| 137.10 | J01MA04 | enoxacin | p.o. | 0.80 | GM | 18,57 | |

| | | | | | | | |

| 137.11 | J01MA06 | norfloxacin | p.o. | 0.80 | GM | 18,57 | |

| 01660 | NORFLOXACIN-RATIOPHARM 400MG | por tbl flm 20×400mg | MCK | D |

| --- | --- | --- | --- | --- |

| 42549 | NORFLOXACIN-RATIOPHARM 400MG | por tbl flm 14×400mg | MCK | D |

| 44090 | GYRABLOCK 400 | por tbl flm 500×400mg | MOE | CY |

| 44091 | GYRABLOCK 400 | por tbl flm 1000×400mg | MOE | CY |

| 93465 | NOLICIN | tbl obd 20×400mg | KRK | SLO |

| 137.12 | J01MA07 | lomefloxacin | p.o. | 0.80 | GM | 18,57 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 137.13 | J01MA08 | fleroxacin | p.o. | 0.40 | GM | 18,57 | |

| | | | | | | | |

| 137.14 | J01MA08 | fleroxacin | parent. | 0.40 | GM | 207,41 | U/ATB |

| | | | | | | | |

| 137.15 | J01MA09 | sparfloxacin | p.o. | 0.20 | GM | 18,57 | P |

K léčbě sparfloxacinem je třeba konzultace a schválení antibiotického střediska.

| 137.16 | J01MA12 | levofloxacin | parent | 0.25 | GM | 212.13 | U/ATB |

| | | | | | | | |

| 137.17 | J01MA12 | levofloxacin do 250 mg v jedné tabletě včetně | p.o. | 0.25 | GM | 75.00 | U/ATB |

| | | | | | | | |

| 137.18 | J01MA12 | levofloxacin nad 250 mg v jedné tabletě | p.o. | 0.25 | GM | 60.00 | U/ATB |

| | | | | | | | |

| 137.19 | J01MA14 | moxifloxacin | p.o. | 0.40 | GM | 60.00 | U/ATB |

| 137.16 | J01MA12 | levofloxacin | parent | 0.25 | GM | 207,31 | U/ATB |

| | | | | | | | |

| 137.17 | J01MA12 | levofloxacin do 250 mg v jedné tabletě včetně | p.o. | 0.25 | GM | 73,30 | U/ATB |

| | | | | | | | |

| 137.18 | J01MA12 | levofloxacin nad 250 mg v jedné tabletě | p.o. | 0.25 | GM | 58,64 | U/ATB |

| | | | | | | | |

| 137.19 | J01MA14 | moxifloxacin | p.o. | 0.40 | GM | 58,64 | U/ATB |

| | | | | | | | |

| 138 | ostatní antibiotika či chemoterapeutika, včetně močových chemoterapeutik | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 138.1 | J01XA01 | vankomycin | parent. | 2.00 | GM | 1 149.00 | U/ATB |

| | | | | | | | |

| 138.2 | J01XA02 | teikoplanin | parent. | 0.40 | GM | 2 243.50 | U/ATB |

| | | | | | | | |

| 138.3 | J01XB01 | kolistin | p.o. | 3.00 | MU | 42.82 | U/ATB |

| | | | | | | | |

| 138.4 | J01XB01 | kolistin | parent. | 3.00 | MU | 109.34 | U/ATB |

| | | | | | | | |

| 138.5 | J01XB02 | polymyxin | parent. | 0.15 | GM | 103.09 | U/ATB |

| | | | | | | | |

| 138.6 | J01XX08 | linezolid | p.o. | 1.20 | GM | 4 811.98 | U/ATB |

| 03902 | ZYVOXID | por tbl flm 10x600mg | PMB | B |

| --- | --- | --- | --- | --- |

| 138.7 | J01XX08 | linezolid | parent | 1.20 | GM | 4 741.52 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03708 | ZYVOXID | inf sol 10x300ml | FRK | N |

| 138.1 | J01XA01 | vankomycin | parent. | 2.00 | GM | 1 122,92 | U/ATB |

| | | | | | | | |

| 138.2 | J01XA02 | teikoplanin | parent. | 0.40 | GM | 2 192,57 | U/ATB |

| | | | | | | | |

| 138.3 | J01XB01 | kolistin | p.o. | 3.00 | MU | 41,85 | U/ATB |

| | | | | | | | |

| 138.4 | J01XB01 | kolistin | parent. | 3.00 | MU | 106,86 | U/ATB |

| | | | | | | | |

| 138.5 | J01XB02 | polymyxin | parent. | 0.15 | GM | 100,75 | U/ATB |

| | | | | | | | |

| 138.6 | J01XX08 | linezolid | p.o. | 1.20 | GM | 4 702,75 | U/ATB |

| 03902 | ZYVOXID | por tbl flm 10×600mg | PMB | B |

| --- | --- | --- | --- | --- |

| 138.7 | J01XX08 | linezolid | parent | 1.20 | GM | 4 633,89 | U/ATB |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03708 | ZYVOXID | inf sol 10×300ml | FRK | N |

| --- | --- | --- | --- | --- |

| 139 | imidazolová chemoteraputika pro celkové použití a jiné antibakteriální látky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 139.1 | G01AX05 | nifuratel | p.o. | 0.60 | GM | 12.50 | |

| | | | | | | | |

| 139.2 | J01XD01 | metronidazol | p.o. | 2.00 | GM | 13.33 | |

| 02427 | ENTIZOL | tbl 20x250mg | ZPF | PL |

| --- | --- | --- | --- | --- |

| 139.3 | J01XD01 | metronidazol | p.rect. | 2.00 | GM | 8.36 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 139.4 | J01XD01 | metronidazol | parent. | 1.50 | GM | 170.90 | U |

| 81678 | METRONIDAZOL-SERAG | inf sol 1x100ml | SWS | D |

| --- | --- | --- | --- | --- |

| 139.5 | J01XD02 | tinidazol | p.o. | 2.00 | GM | 13.80 | |

| | | | | | | | |

| 139.6 | J01XD03 | ornidazol | p.o. | 1.50 | GM | 22.00 | |

| | | | | | | | |

| 139.7 | J01XD03 | ornidazol | parent. | 1.00 | GM | 50.44 | U |

| | | | | | | | |

| 139.8 | J01XE01 | nitrofurantoin | p.o. | 0.20 | GM | 6.57 | |

| 139.1 | G01AX05 | nifuratel | p.o. | 0.60 | GM | 12,22 | |

| | | | | | | | |

| 139.2 | J01XD01 | metronidazol | p.o. | 2.00 | GM | 13,03 | |

| 02427 | ENTIZOL | tbl 20×250mg | ZPF | PL |

| --- | --- | --- | --- | --- |

| 139.3 | J01XD01 | metronidazol | p.rect. | 2.00 | GM | 8,17 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 139.4 | J01XD01 | metronidazol | parent. | 1.50 | GM | 167,02 | U |

| 81678 | METRONIDAZOL-SERAG | inf sol 1×100ml | SWS | D |

| --- | --- | --- | --- | --- |

| 139.5 | J01XD02 | tinidazol | p.o. | 2.00 | GM | 13,49 | |

| | | | | | | | |

| 139.6 | J01XD03 | ornidazol | p.o. | 1.50 | GM | 21,50 | |

| | | | | | | | |

| 139.7 | J01XD03 | ornidazol | parent. | 1.00 | GM | 49,30 | U |

| | | | | | | | |

| 139.8 | J01XE01 | nitrofurantoin | p.o. | 0.20 | GM | 6,42 | |

| | | | | | | | |

| 140 | antimykotika pro systémové užití | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 140.1 | D01BA01 | griseofulvin | p.o. | 0.50 | GM | 9.97 | |

| | | | | | | | |

| 140.2 | D01BA02 | terbinafin | p.o. | 0.25 | GM | 31.50 | L/DER |

| | | | | | | | |

| 140.3 | J02AA01 | amfotericin | parent. | 35.00 | MG | 279.36 | U |

| | | | | | | | |

| 140.4 | J02AA01 | amfotericin na tukových nosičích | parent. | 35.00 | MG | 1 517.80 | U/ATB |

| | | | | | | | |

| 140.5 | J02AB01 | mikonazol | parent. | 1.00 | GM | 469.63 | U |

| | | | | | | | |

| 140.6 | J02AB02 | ketokonazol | p.o. | 0.20 | GM | 15.00 | |

| | | | | | | | |

| 140.7 | J02AC01 | flukonazol | parent. | 0.20 | GM | 550.00 | U/P |

Parenterální flukonazol je indikován v indikaci léčby těžké, život ohrožující systémové mykózy.

Profylakticky: u imunokompromitovaných pacientů nebo pacientů připravovaných k transplantaci.

| 58431 | DIFLAZON | inf sol 1x100ml | KRK | SLO |

| --- | --- | --- | --- | --- |

| 65989 | MYCOMAX INF | inf 1x100ml/200mg | ZEH | CZ |

| 140.8 | J02AC01 | flukonazol – ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.20 | GM | 249.07 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 16638 | MYKOHEXAL 100 | por cps dur 28x100mg | SFS | D |

| --- | --- | --- | --- | --- |

| 66032 | MYCOMAX 50 | cps 7x50mg | ZEH | CZ |

| 66033 | MYCOMAX 50 | cps 28x50mg | ZEH | CZ |

| 66036 | MYCOMAX 100 | cps 28x100mg | ZEH | CZ |

| 66037 | MYCOMAX 100 | cps 7x100mg | ZEH | CZ |

| 140.9 | J02AC01 | flukonazol – tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.20 | GM | 349.25 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 140.10 | J02AC01 | flukonazol (pevné lékové formy 150 mg v 1 tabletě) | p.o. | 0.15 | GM | 193.65 | P |

| 10689 | FORCAN - 150 | por cps dur 1x150mg | CIA | IND |

| --- | --- | --- | --- | --- |

| 10743 | MYCOSYST 150 MG | cps 4x150mg | GED | H |

| 16396 | FORCAN - 150 | por cps dur 1x150mg | SDD | CZ |

| 31800 | MYKOHEXAL 150 | por cps dur 1x150mg | SFS | D |

| 47439 | MYCOMAX 150 | por cps dur 3x150mg | ZEH | CZ |

| 59788 | DIFLAZON 150 | cps 1x150mg | KRK | SLO |

| 59875 | MYCOSYST 150 MG | cps 1x150mg | GED | H |

| 59876 | MYCOSYST 150 MG | cps 2x150mg | GED | H |

| 66039 | MYCOMAX 150 | por cps dur 1x150mg | ZEH | CZ |

| 140.11 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.20 | GM | 479.01 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 64950 | DIFLUCAN 50MG/5ML | plv sus 1x35ml | PFC | F |

| --- | --- | --- | --- | --- |

| 140.12 | J02AC01 | flukonazol (nad 50 do 100mg v 5 ml sirupu včetně) | p.o. | 0.20 | GM | 436.59 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 140.13 | J02AC02 | itrakonazol | parent. | 0.20 | GM | 3 520.00 | U/ATB |

| | | | | | | | |

| 140.14 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0.20 | GM | 76.50 | P |

| | | | | | | | |

| 140.15 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.20 | GM | 91.20 | P |

| | | | | | | | |

| 140.16 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.20 | GM | 371.70 | P |

| | | | | | | | |

| 140.17 | J02AC03 | vorikonazol | p.o. | 0.40 | GM | 2 655,50 | U/ATB |

| | | | | | | | |

| 140.18 | J02AC03 | vorikonazol | parent. | 0.40 | GM | 9 857,80 | U/ATB |

| | | | | | | | |

| 140.19 | J02AX01 | flucytosin | p.o. | 10.00 | GM | 858.22 | P |

| 140.1 | D01BA01 | griseofulvin | p.o. | 0.50 | GM | 9,74 | |

| | | | | | | | |

| 140.2 | D01BA02 | terbinafin | p.o. | 0.25 | GM | 30,78 | L/DER |

| | | | | | | | |

| 140.3 | J02AA01 | amfotericin | parent. | 35.00 | MG | 273,02 | U |

| | | | | | | | |

| 140.4 | J02AA01 | amfotericin na tukových nosičích | parent. | 35.00 | MG | 1 483,35 | U/ATB |

| | | | | | | | |

| 140.5 | J02AB01 | mikonazol | parent. | 1.00 | GM | 458,97 | U |

| | | | | | | | |

| 140.6 | J02AB02 | ketokonazol | p.o. | 0.20 | GM | 14,66 | |

| | | | | | | | |

| 140.7 | J02AC01 | flukonazol | parent. | 0.20 | GM | 537,52 | U/P |

Parenterální flukonazol je indikován v indikaci léčby těžké, život ohrožující systémové mykózy. Profylakticky: u imunokompromitovaných pacientů nebo pacientů připravovaných k transplantaci.

| 58431 | DIFLAZON | inf sol 1×100ml | KRK | SLO |

| --- | --- | --- | --- | --- |

| 65989 | MYCOMAX INF | inf 1×100ml/200mg | ZEH | CZ |

| 140.8 | J02AC01 | flukonazol – ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.20 | GM | 243,42 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 16638 | MYKOHEXAL 100 | por cps dur 28×100mg | SFS | D |

| --- | --- | --- | --- | --- |

| 66032 | MYCOMAX 50 | cps 7×50mg | ZEH | CZ |

| 66033 | MYCOMAX 50 | cps 28×50mg | ZEH | CZ |

| 66036 | MYCOMAX 100 | cps 28×100mg | ZEH | CZ |

| 66037 | MYCOMAX 100 | cps 7×100mg | ZEH | CZ |

| 140.9 | J02AC01 | flukonazol – tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.20 | GM | 341,32 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 140.10 | J02AC01 | flukonazol ( pevné lékové formy 150 mg v 1 tabletě) | p.o. | 0.15 | GM | 189,25 | P |

| 10689 | FORCAN-150 | por cps dur 1×150mg | CIA | IND |

| --- | --- | --- | --- | --- |

| 10743 | MYCOSYST 150 MG | cps 4×150mg | GED | H |

| 16396 | FORCAN-150 | por cps dur 1×150mg | SDD | CZ |

| 31800 | MYKOHEXAL 150 | por cps dur 1×150mg | SFS | D |

| 47439 | MYCOMAX 150 | por cps dur 3×150mg | ZEH | CZ |

| 59788 | DIFLAZON 150 | cps 1×150mg | KRK | SLO |

| 59875 | MYCOSYST 150 MG | cps 1×150mg | GED | H |

| 59876 | MYCOSYST 150 MG | cps 2×150mg | GED | H |

| 66039 | MYCOMAX 150 | por cps dur 1×150mg | ZEH | CZ |

| 140.11 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.20 | GM | 468,14 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 64950 | DIFLUCAN 50MG/5ML | plv sus 1×35ml | PFC | F |

| --- | --- | --- | --- | --- |

| 140.12 | J02AC01 | flukonazol (nad 50 do 100mg v 5 ml sirupu včetně) | p.o. | 0.20 | GM | 426,68 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 140.13 | J02AC02 | itrakonazol | parent. | 0.20 | GM | 3 440,10 | U/ATB |

| | | | | | | | |

| 140.14 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0.20 | GM | 74,76 | P |

| | | | | | | | |

| 140.15 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.20 | GM | 89,13 | P |

| | | | | | | | |

| 140.16 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.20 | GM | 363,26 | P |

| | | | | | | | |

| 140.17 | J02AC03 | vorikonazol | p.o. | 0.40 | GM | 2 595,22 | U/ATB |

| | | | | | | | |

| 140.18 | J02AC03 | vorikonazol | parent. | 0.40 | GM | 9 634,03 | U/ATB |

| | | | | | | | |

| 140.19 | J02AX01 | flucytosin | p.o. | 10.00 | GM | 838,74 | P |

Perorální flukonazol, itrakonazol a flucytosin pro krátkodobou léčbu předepisuje gynekolog nebo dermatolog na základě kultivačního nebo mikroskopického vyšetření u:

@@ -5545,44 +5600,44 @@

Itrakonazol v tekutých lékových formách je indikován k léčbě orální a oesophageální kandidózy a profylakticky u imunokompromitovaných pacientů.

| 140.20 | J02AX01 | flucytosin | parent. | 10.00 | GM | 2 710.83 | U/P |

| 140.20 | J02AX01 | flucytosin | parent. | 10.00 | GM | 2 649,29 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Parenterální flucytosin je indikován v indikaci léčby těžké, život ohrožující systémové mykózy.

Profylakticky: u imunokompromitovaných pacientů včetně pacientů připravovaných k transplantaci.

| 140.21 | J02AX04 | caspofungin s obsahem 50 mg v jedné ampulce | parent. | 1.00 | DF | 17 259.00 | U/ATB |

| | | | | | | | |

| 140.22 | J02AX04 | caspofungin s obsahem 70 mg v jedné ampulce | parent. | 1.00 | DF | 24 163.00 | U/ATB |

| 140.21 | J02AX04 | caspofungin s obsahem 50 mg v jedné ampulce | parent. | 1.00 | DF | 16 867,22 | U/ATB |

| | | | | | | | |

| 140.22 | J02AX04 | caspofungin s obsahem 70 mg v jedné ampulce | parent. | 1.00 | DF | 23 614,50 | U/ATB |

| | | | | | | | |

| 141 | ostatní antimykobakteriální látky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 141.1 | J04AB02 | rifampicin | p.o. | 0.60 | GM | 12.76 | |

| 48463 | ARFICIN 300 MG | cps 100x300mg | BUO | SK |

| --- | --- | --- | --- | --- |

| 141.2 | J04AB03 | rifamycin | parent. | 0.60 | GM | 244.40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 141.3 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 113.69 | P |

| 141.1 | J04AB02 | rifampicin | p.o. | 0.60 | GM | 12,47 | |

| 48463 | ARFICIN 300 MG | cps 100×300mg | BUO | SK |

| --- | --- | --- | --- | --- |

| 141.2 | J04AB03 | rifamycin | parent. | 0.60 | GM | 238,85 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 141.3 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 111,11 | P |

Léčbu rifabutinem předepisuje pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.

| 91946 | MYCOBUTIN 150 | cps 30x150mg | PHA | I |

| --- | --- | --- | --- | --- |

| 141.4 | J04AB30 | kapreomycin | parent. | 1.00 | GM | 553.11 | |

| | | | | | | | |

| 141.5 | J04AC01 | Isoniazid | p.o. | 0.30 | GM | 2.04 | |

| | | | | | | | |

| 141.6 | J04AK01 | pyrazinamid | p.o. | 1.50 | GM | 14.63 | |

| | | | | | | | |

| 141.7 | J04AK02 | ethambutol | p.o. | 1.20 | GM | 12.22 | |

| | | | | | | | |

| 141.8 | J04BA02 | dapson | p.o. | 50.00 | MG | 1.37 | |

| 91946 | MYCOBUTIN 150 | cps 30×150mg | PHA | I |

| --- | --- | --- | --- | --- |

| 141.4 | J04AB30 | kapreomycin | parent. | 1.00 | GM | 540,55 | |

| | | | | | | | |

| 141.5 | J04AC01 | Isoniazid | p.o. | 0.30 | GM | 1,99 | |

| | | | | | | | |

| 141.6 | J04AK01 | pyrazinamid | p.o. | 1.50 | GM | 14,30 | |

| | | | | | | | |

| 141.7 | J04AK02 | ethambutol | p.o. | 1.20 | GM | 11,94 | |

| | | | | | | | |

| 141.8 | J04BA02 | dapson | p.o. | 50.00 | MG | 1,34 | |

| | | | | | | | |

| 142 | systémová antivirotika pro léčbu herpetických, cytomegalovirových infekcí a některých dalších virových infekcí | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

@@ -5595,32 +5650,32 @@

- c) profylaxe po alogenní transplantaci kostní dřeně.

| 142.1 | J05AB01 | aciklovir | parent. | 4.00 | GM | 1 438.30 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.2 | J05AB01 | aciklovir do 200 mg včetně | p.o. | 4.00 | GM | 199.70 | |

| | | | | | | | |

| 142.3 | J05AB01 | aciklovir nad 200 mg | p.o. | 4.00 | GM | 175.50 | |

| | | | | | | | |

| 142.4 | J05AB01 | aciklovir (suspense) | p.o. | 4.00 | GM | 272.00 | P |

| 142.1 | J05AB01 | aciklovir | parent. | 4.00 | GM | 1 405,65 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.2 | J05AB01 | aciklovir do 200 mg včetně | p.o. | 4.00 | GM | 195,17 | |

| | | | | | | | |

| 142.3 | J05AB01 | aciklovir nad 200 mg | p.o. | 4.00 | GM | 171,52 | |

| | | | | | | | |

| 142.4 | J05AB01 | aciklovir (suspense) | p.o. | 4.00 | GM | 265,83 | P |

Aciklovir suspenze je indikován u dětí v indikaci herpes zoster.

| 142.5 | J05AB04 | ribavirin | p.o. | 1.00 | GM | 604.96 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.6 | J05AB06 | ganciklovir | p.o. | 3.00 | GM | 1 862.06 | P |

| | | | | | | | |

| 142.7 | J05AB06 | ganciklovir | parent. | 0.50 | GM | 1 490.26 | U/P |

| 02064 | CYMEVENE | inf sic 1x500mg | HLR | CH |

| --- | --- | --- | --- | --- |

| 16547 | CYMEVENE | inf sic 1x500mg | RCE | CZ |

| 142.8 | J05AB09 | famciklovir | p.o. | 0.75 | GM | 195.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.9 | J05AB11 | valaciklovir | p.o. | 3.00 | GM | 195.00 | P |

| 142.5 | J05AB04 | ribavirin | p.o. | 1.00 | GM | 591,23 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.6 | J05AB06 | ganciklovir | p.o. | 3.00 | GM | 1 819,79 | P |

| | | | | | | | |

| 142.7 | J05AB06 | ganciklovir | parent. | 0.50 | GM | 1 456,43 | U/P |

| 02064 | CYMEVENE | inf sic 1×500mg | HLR | CH |

| --- | --- | --- | --- | --- |

| 16547 | CYMEVENE | inf sic 1×500mg | RCE | CZ |

| 142.8 | J05AB09 | famciklovir | p.o. | 0.75 | GM | 190,57 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.9 | J05AB11 | valaciklovir | p.o. | 3.00 | GM | 190,57 | P |

Léčbu ganciklovirem a valganciclovirem předepisuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:

@@ -5630,20 +5685,20 @@

- c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.

| 142.10 | J05AB12 | cidofovir | parent. | 375.00 | MG | 27 628.50 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.11 | J05AB14 | valganciklovir | p.o. | 0.90 | GM | 1 943.81 | P |

| 97249 | VALCYTE 450 MG | por tbl flm 60x450mg | HLR | D |

| --- | --- | --- | --- | --- |

| 142.12 | J05AB15 | brivudin | p.o. | 125 | MG | 195.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.13 | J05AD01 | foskarnet | parent. | 6.50 | GM | 3 006.25 | U/P |

| | | | | | | | |

| 142.14 | J05AH01 | zanamivir | inhal. | 20.00 | MG | 121.00 | P |

| 142.10 | J05AB12 | cidofovir | parent. | 375.00 | MG | 27 001,33 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.11 | J05AB14 | valganciklovir | p.o. | 0.90 | GM | 1 899,69 | P |

| 97249 | VALCYTE 450 MG | por tbl flm 60×450mg | HLR | D |

| --- | --- | --- | --- | --- |

| 142.12 | J05AB15 | brivudin | p.o. | 125 | MG | 190,57 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 142.13 | J05AD01 | foskarnet | parent. | 6.50 | GM | 2 938,01 | U/P |

| | | | | | | | |

| 142.14 | J05AH01 | zanamivir | inhal. | 20.00 | MG | 118,25 | P |

Zanamivir je indikován v indikaci léčby influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkováni proti influenze nebo tam, kde očkování selhalo, u následujících skupin pacientů:

@@ -5655,7 +5710,7 @@

Z veřejného zdravotního pojištění je pro jednu terapeutickou kůru hrazeno jedno balení určené k pětidenní léčbě. Zanamivir u výše uvedených skupin předepisuje ošetřující lékař pouze v době chřipkové epidemie vyhlášené krajskou hygienickou stanicí.

| 142.15 | J05AH02 | oseltamivir | p.o. | 150.00 | MG | 121.00 | P |

| 142.15 | J05AH02 | oseltamivir | p.o. | 150.00 | MG | 118,25 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Oseltamivir je indikován v indikaci léčby influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkováni proti influenze nebo tam, kde očkování selhalo, u následujících skupin pacientů:

@@ -5668,12 +5723,12 @@

Z veřejného zdravotního pojištění je pro jednu terapeutickou kůru hrazeno jedno balení určené k pětidenní léčbě. Oseltamivir u výše uvedených skupin předepisuje ošetřující lékař pouze v době chřipkové epidemie vyhlášené krajskou hygienickou stanicí.

| 142.16 | J05AX05 | inosin pranobex | p.o. | 1.00 | GM | 27.35 | P |

| 142.16 | J05AX05 | inosin pranobex | p.o. | 1.00 | GM | 26,73 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu inosin pranobexem předepisuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.

| 16591 | ISOPRINOSINE | tbl 50x500mg | EWP | CZ |

| 16591 | ISOPRINOSINE | tbl 50×500mg | EWP | CZ |

| --- | --- | --- | --- | --- |

| 143 | Antiretrovirotika |

@@ -5683,79 +5738,79 @@

Léčbu lamivudinem dále předepisuje ošetřující lékař u chronické virové hepatitidy typu B.

| 143.1 | J05AE | inhibitory proteáz (lopinavir,ritonavir v kombinaci) | p.o. | 6.00 | DF | 507.60 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.2 | J05AE | atazanavir | p.o. | 0.3 | GM | 399.25 | P |

| | | | | | | | |

| 143.3 | J05AE01 | saquinavir | p.o. | 1.80 | GM | 399.25 | P |

| 25493 | FORTOVASE 200 MG | por cps mol 180x200mg | RRG | GB |

| --- | --- | --- | --- | --- |

| 143.4 | J05AE02 | indinavir | p.o. | 2.40 | GM | 399.25 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.5 | J05AE03 | ritonavir | p.o. | 1.20 | GM | 399.25 | P |

| | | | | | | | |

| 143.6 | J05AE04 | nelfinavir | p.o. | 2.25 | GM | 399.25 | P |

| | | | | | | | |

| 143.7 | J05AE07 | fosamprenavir | p.o. | 1.40 | GM | 399.25 | P |

| | | | | | | | |

| 143.8 | J05AF01 | zidovudin | p.o. | 1.50 | GM | 685.28 | P |

| | | | | | | | |

| 143.9 | J05AF01 | zidovudin | parent. | 1.00 | GM | 2 613.03 | U/P |

| 46406 | RETROVIR | inf cnc 5x20ml/200mg | GWB | GB |

| --- | --- | --- | --- | --- |

| 86100 | RETROVIR | inf cnc 5x20ml/200mg | GOK | GB |

| 143.10 | J05AF02 | didanosin | p.o. | 0.40 | GM | 236.43 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.11 | J05AF03 | zalcitabin | p.o. | 2.25 | MG | 235.25 | P |

| | | | | | | | |

| 143.12 | J05AF04 | stavudin | p.o. | 80.00 | MG | 271.90 | P |

| | | | | | | | |

| 143.13 | J05AF05 | lamivudin do 100 mg v jedné tabletě včetně respektive do 5 mg v jednom mililitru včetně | p.o. | 0.30 | GM | 260.30 | P |

| 02087 | ZEFFIX 5MG/ML | sol 1x240ml/1.2g | GWL | GB |

| --- | --- | --- | --- | --- |

| 27035 | ZEFFIX 100 MG | por tbl flm 28x100mg | GLA | GB |

| 27036 | ZEFFIX 100 MG | por tbl flm 84x100mg | GLA | GB |

| 27037 | ZEFFIX 5MG/ML | sol 1x240ml/1.2g | GLA | GB |

| 94802 | ZEFFIX 5MG/ML | sol 1x240ml/1.2g | GWE | D |

| 143.14 | J05AF05 | lamivudin nad 100 mg v jedné tabletě respektive nad 5 mg v jednom mililitru | p.o. | 0.30 | GM | 243.01 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.15 | J05AF06 | abacavir | p.o. | 600.00 | MG | 328.76 | P |

| 26863 | ZIAGEN | por tbl flm60x300mg | GLA | GB |

| --- | --- | --- | --- | --- |

| 143.16 | J05AF07 | tenofovir disoproxil | p.o. | 245.00 | MG | 460.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.17 | J05AF08 | adefovir dipivoxil | p.o. | 10.00 | MG | 610.00 | X |

| | | | | | | | |

| 143.18 | J05AF09 | emtricitabin | p.o. | 200.00 | MG | 255.00 | P |

| | | | | | | | |

| 143.19 | J05AF30 | abacavir, lamivudin a zidovudin v kombinaci | p.o. | 2.00 | DF | 788.69 | P |

| 143.1 | J05AE | inhibitory proteáz (lopinavir,ritonavir v kombinaci) | p.o. | 6.00 | DF | 496,08 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.2 | J05AE | atazanavir | p.o. | 0.3 | GM | 390,19 | P |

| | | | | | | | |

| 143.3 | J05AE01 | saquinavir | p.o. | 1.80 | GM | 390,19 | P |

| 25493 | FORTOVASE 200 MG | por cps mol 180×200mg | RRG | GB |

| --- | --- | --- | --- | --- |

| 143.4 | J05AE02 | indinavir | p.o. | 2.40 | GM | 390,19 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.5 | J05AE03 | ritonavir | p.o. | 1.20 | GM | 390,19 | P |

| | | | | | | | |

| 143.6 | J05AE04 | nelfinavir | p.o. | 2.25 | GM | 390,19 | P |

| | | | | | | | |

| 143.7 | J05AE07 | fosamprenavir | p.o. | 1.40 | GM | 390,19 | P |

| | | | | | | | |

| 143.8 | J05AF01 | zidovudin | p.o. | 1.50 | GM | 669,72 | P |

| | | | | | | | |

| 143.9 | J05AF01 | zidovudin | parent. | 1.00 | GM | 2 553,71 | U/P |

| 46406 | RETROVIR | inf cnc 5×20ml/200mg | GWB | GB |

| --- | --- | --- | --- | --- |

| 86100 | RETROVIR | inf cnc 5×20ml/200mg | GOK | GB |

| 143.10 | J05AF02 | didanosin | p.o. | 0.40 | GM | 231,06 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.11 | J05AF03 | zalcitabin | p.o. | 2.25 | MG | 229,91 | P |

| | | | | | | | |

| 143.12 | J05AF04 | stavudin | p.o. | 80.00 | MG | 265,73 | P |

| | | | | | | | |

| 143.13 | J05AF05 | lamivudin do 100 mg v jedné tabletě včetně respektive do 5 mg v jednom mililitru včetně | p.o. | 0.30 | GM | 254,39 | P |

| 02087 | ZEFFIX 5MG/ML | sol 1×240ml/1.2g | GWL | GB |

| --- | --- | --- | --- | --- |

| 27035 | ZEFFIX 100 MG | por tbl flm 28×100mg | GLA | GB |

| 27036 | ZEFFIX 100 MG | por tbl flm 84×100mg | GLA | GB |

| 27037 | ZEFFIX 5MG/ML | sol 1×240ml/1.2g | GLA | GB |

| 94802 | ZEFFIX 5MG/ML | sol 1×240ml/1.2g | GWE | D |

| 143.14 | J05AF05 | lamivudin nad 100 mg v jedné tabletě respektive nad 5 mg v jednom mililitru | p.o. | 0.30 | GM | 237,49 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.15 | J05AF06 | abacavir | p.o. | 600.00 | MG | 321,30 | P |

| 26863 | ZIAGEN | por tbl flm 60×300mg | GLA | GB |

| --- | --- | --- | --- | --- |

| 143.16 | J05AF07 | tenofovir disoproxil | p.o. | 245.00 | MG | 449,56 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.17 | J05AF08 | adefovir dipivoxil | p.o. | 10.00 | MG | 596,15 | X |

| | | | | | | | |

| 143.18 | J05AF09 | emtricitabin | p.o. | 200.00 | MG | 249,21 | P |

| | | | | | | | |

| 143.19 | J05AF30 | abacavir, lamivudin a zidovudin v kombinaci | p.o. | 2.00 | DF | 770,79 | P |

| 26808 | TRIZIVIR | por tbl flm 60 | GLA | GB |

| --- | --- | --- | --- | --- |

| 26809 | TRIZIVIR | por tbl flm 60 | GLA | GB |

| 30158 | TRIZIVIR | por tbl flm 60 | GOW | GB |

| 143.20 | J05AF30 | jiné kombinace antiretrovirových virostatik (lamivudin a zidovudin) | p.o. | 2.00 | DF | 522.13 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.21 | J05AG01 | nevirapin | p.o. | 0.40 | GM | 343.34 | P |

| | | | | | | | |

| 143.22 | J05AG03 | efavirenz | p.o. | 0.60 | GM | 387.90 | P |

| | | | | | | | |

| 143.23 | J05AX07 | enfuvirtid | parent. | 180.00 | MG | 1492.00 | P |

| 143.20 | J05AF30 | jiné kombinace antiretrovirových virostatik (lamivudin a zidovudin) | p.o. | 2.00 | DF | 510,28 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 143.21 | J05AG01 | nevirapin | p.o. | 0.40 | GM | 335,55 | P |

| | | | | | | | |

| 143.22 | J05AG03 | efavirenz | p.o. | 0.60 | GM | 379,09 | P |

| | | | | | | | |

| 143.23 | J05AX07 | enfuvirtid | parent. | 180.00 | MG | 1 492,00 | P |

Enfuvirtid je hrazen u HIV pozitivních pacientů, pokud selhala antiretrovirová terapie z důvodů vzniku rezistence či závažných vedlejších příznaků.

@@ -5769,7 +5824,7 @@

| 144.2 | J07AX | jiné bakteriální vakcíny (protistafylokoková vakcína) | parent. | | | plně | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 94269 | POLYSTAFANA | inj 10x0.5ml/5.4ut | SVF | CZ |

| 94269 | POLYSTAFANA | inj 10×0.5ml/5.4ut | SVF | CZ |

| --- | --- | --- | --- | --- |

| 145 | Zvířecí imunoglobuliny proti záškrtu | | | | | | |

@@ -5786,7 +5841,7 @@

Sérum proti hadímu jedu předepisuje lékař k léčbě uštknutí zmijí obecnou.

| 13790 | VIPER VENOM ANTITOXIN | inj 1x5ml/500ut | BIM | PL |

| 13790 | VIPER VENOM ANTITOXIN | inj 1×5ml/500ut | BIM | PL |

| --- | --- | --- | --- | --- |

| 147 | Zvířecí imunoglobuliny proti botulismu | | | | | | |

@@ -5810,33 +5865,33 @@

Sérum proti vzteklině předepisuje infekcionista k profylaxi nebo terapii vztekliny.

| 42843 | FAVIRAB | inj sol 1x5ml/2ku | AVS | F |

| 42843 | FAVIRAB | inj sol 1×5ml/2ku | AVS | F |

| --- | --- | --- | --- | --- |

| 150 | imunoglobuliny, normální lidské, pro extravaskulární aplikaci | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 150.1 | J06BA01 | imunoglobuliny, norm. lidské, k extravaskulární aplikaci 5 ml a více v jedné ampuli | parent. | 1.00 | DF | 600.00 | O |

| | | | | | | | |

| 150.2 | J06BA01 | imunoglobuliny, norm. lidské, k extravaskulární aplikaci do velikosti méně než 5 ml v jedné ampuli | parent. | 1.00 | DF | 247.24 | O |

| 57669 | PASTEUR.HUM.IMMUNOGL.GRIFOLS 16 | inj 1x2ml/320mg | GFO | E |

| 150.1 | J06BA01 | imunoglobuliny, norm. lidské, k extravaskulární aplikaci 5 ml a více v jedné ampuli | parent. | 1.00 | DF | 586,38 | O |

| | | | | | | | |

| 150.2 | J06BA01 | imunoglobuliny, norm. lidské, k extravaskulární aplikaci do velikosti méně než 5 ml v jedné ampuli | parent. | 1.00 | DF | 241,63 | O |

| 57669 | PASTEUR.HUM.IMMUNOGL.GRIFOLS 16 | inj 1×2ml/320mg | GFO | E |

| --- | --- | --- | --- | --- |

| 151 | imunoglobuliny, normální lidské, pro intravaskulární aplikaci | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 151.1 | J06BA | imunoglobuliny, norm. lidské ( k extravaskulární aplikaci), kombinace s histaminem | parent. | 1.00 | DF | 83.84 | O |

| 87736 | HISTAGLOBIN | inj 3x12mg+sol. | BBL | CH |

| --- | --- | --- | --- | --- |

| 151.2 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci | parent. | 1.00 | GM | 956.88 | B |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 151.3 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM) | parent. | 1.00 | GM | 1 955.16 | U |

| | | | | | | | |

| 151.4 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci se sníženým obsahem IgA | parent. | 1.00 | GM | 1 400.00 | B/P |

| 151.1 | J06BA | imunoglobuliny, norm. lidské ( k extravaskulární aplikaci), kombinace s histaminem | parent. | 1.00 | DF | 81,94 | O |

| 87736 | HISTAGLOBIN | inj 3×12mg+sol. | BBL | CH |

| --- | --- | --- | --- | --- |

| 151.2 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci | parent. | 1.00 | GM | 935,16 | B |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 151.3 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM) | parent. | 1.00 | GM | 1 910,78 | U |

| | | | | | | | |

| 151.4 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci se sníženým obsahem IgA | parent. | 1.00 | GM | 1 368,22 | B/P |

Jako lék druhé volby s přítomností prokázaných protilátek proti IgA.

@@ -5845,43 +5900,43 @@

| | | | | | | | |

| 152.1 | J06BB02 | imunoglobulin proti tetanu | parent. | | | plně | B |

| 57804 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1x1ml/250ut-str | GFO | E |

| --- | --- | --- | --- | --- |

| 57805 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1x2ml/500ut-str | GFO | E |

| 83607 | TETABULIN S/D | inj sol 1x1ml/250ut+s | BXG | A |

| 57804 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1×1ml/250ut-str | GFO | E |

| --- | --- | --- | --- | --- |

| 57805 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1×2ml/500ut-str | GFO | E |

| 83607 | TETABULIN S/D | inj sol 1×1ml/250ut+s | BXG | A |

| 153 | lidské imunoglobuliny proti hepatitidě | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 153.1 | J06BB04 | imunoglobulin proti hepatitidě B | parent. | | | plně | K |

| 48851 | PASTEURISED HUM.ANTIHEP.B GFO | inj sol 1x0.5ml/100ut | GFO | E |

| --- | --- | --- | --- | --- |

| 57419 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1x3ml/600ut | GFO | E |

| 57420 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1x5ml/1000ut | GFO | E |

| 97558 | NEOHEPATECT | inf sol 1x2ml/100ut | BTP | D |

| 97559 | NEOHEPATECT | inf sol 1x10ml/500ut | BTP | D |

| 97560 | NEOHEPATECT | inf sol 1x40ml/2ku | BTP | D |

| 97897 | HEPATECT | inj 1x2ml | BTP | D |

| 97898 | HEPATECT | inj 1x10ml | BTP | D |

| 48851 | PASTEURISED HUM.ANTIHEP.B GFO | inj sol 1×0.5ml/100ut | GFO | E |

| --- | --- | --- | --- | --- |

| 57419 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1×3ml/600ut | GFO | E |

| 57420 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1×5ml/1000ut | GFO | E |

| 97558 | NEOHEPATECT | inf sol 1×2ml/100ut | BTP | D |

| 97559 | NEOHEPATECT | inf sol 1×10ml/500ut | BTP | D |

| 97560 | NEOHEPATECT | inf sol 1×40ml/2ku | BTP | D |

| 97897 | HEPATECT | inj 1×2ml | BTP | D |

| 97898 | HEPATECT | inj 1×10ml | BTP | D |

| 154 | lidské imunoglobuliny proti vzteklině | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 154.1 | J06BB05 | imunoglobulin proti rabies | parent. | | | plně | K/P |

| | | | | | | | |

| 155 | ostatní lidské specifické imunoglobuliny | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 155.1 | J06BB01 | anti-d (rh) imunoglobulin (do 100 rg v jedné ampuli včetně) | parent. | 250.00 | RG | 1 407.96 | K |

| | | | | | | | |

| 155.2 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 rg v jedné ampuli) | parent. | 250.00 | RG | 1 163.43 | K |

| 57573 | PARTOBULIN S/D | inj 1x1ml/250rg | BXG | A |

| --- | --- | --- | --- | --- |

| 155.3 | J06BB03 | imunoglobulin proti neštovicíma pásovému oparu | parent. | 1.00 | KU | 32 724.00 | K/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 155.1 | J06BB01 | anti-d (rh) imunoglobulin (do 100 rg v jedné ampuli včetně) | parent. | 250.00 | RG | 1 376,00 | K |

| | | | | | | | |

| 155.2 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 rg v jedné ampuli) | parent. | 250.00 | RG | 1 137,02 | K |

| 57573 | PARTOBULIN S/D | inj 1×1ml/250rg | BXG | A |

| --- | --- | --- | --- | --- |

| 155.3 | J06BB03 | imunoglobulin proti a pásovému oparu | neštovicím | parent. | 1.00 | KU | 31 981,17 | K/P |

| --- | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu imunoglobuliny proti neštovicím a pásovému oparu předepisuje infekcionista, onkolog, hematolog a pediatr u:

@@ -5893,7 +5948,7 @@

- d) varicelózní primární pneumonitis.

| 155.4 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1.00 | GM | 4 745.64 | U/P |

| 155.4 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1.00 | GM | 4 637,91 | U/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu imunoglobulinem proti cytomegalovirové infekci předepisuje infekcionista, onkolog, hematolog nebo pediatr u:

@@ -5904,19 +5959,19 @@

- c) profylaxe cytomegalovirových infekcí u transplantovaných pacientů při pozitivitě dárce nebo příjemce. Imunoglobulin proti cytomegalovirové infekci je hrazen dle symbolu U.

| 94862 | CYTOTECT BIOTEST | inf sol 1x10ml-amp | BTP | D |

| --- | --- | --- | --- | --- |

| 94863 | CYTOTECT BIOTEST | inf sol 1x20ml-amp | BTP | D |

| 94864 | CYTOTECT BIOTEST | inf sol 1x50ml-lah | BTP | D |

| 155.5 | J06BB12 | protiencefalický globulin | parent. | 1.00 | ML | 300.65 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 155.6 | J06BB16 | palivizumab do 50 mg v jedné ampuli včetně | parent | 1.00 | DF | 19 633.00 | X |

| | | | | | | | |

| 155.7 | J06BB16 | palivizumab nad 50 mg v jedné ampuli | parent. | 1.00 | DF | 32 444.61 | X |

| 27636 | SYNAGIS 100 MG | inj pso Iqf 1x100mg | ABB | GB |

| 94862 | CYTOTECT BIOTEST | inf sol 1×10ml-amp | BTP | D |

| --- | --- | --- | --- | --- |

| 94863 | CYTOTECT BIOTEST | inf sol 1×20ml-amp | BTP | D |

| 94864 | CYTOTECT BIOTEST | inf sol 1×50ml-lah | BTP | D |

| 155.5 | J06BB12 | protiencefalický globulin | parent. | 1.00 | ML | 293,83 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 155.6 | J06BB16 | palivizumab do 50 mg v jedné ampuli včetně | parent | 1.00 | DF | 19 187,33 | X |

| | | | | | | | |

| 155.7 | J06BB16 | palivizumab nad 50 mg v jedné ampuli | parent. | 1.00 | DF | 31 708,12 | X |

| 27636 | SYNAGIS 100 MG | inj pso Iqf 1×100mg | ABB | GB |

| --- | --- | --- | --- | --- |

| 156 | očkovací látky proti tetanu | | | | | | |

@@ -5924,17 +5979,17 @@

| | | | | | | | |

| 156.1 | J07AM01 | tetanový toxoid | parent. | | | plně | K |

| 83443 | TETAVAX | inj 1x0.5ml-stŘ. | AVS | F |

| --- | --- | --- | --- | --- |

| 83444 | TETAVAX | inj 20x0.5ml-stŘ. | AVS | F |

| 83445 | TETAVAX | inj 1x10ml-lahv. | AVS | F |

| 83447 | TETAVAX | inj 10x20ml-lahv. | AVS | F |

| 83525 | TETAVAX | inj 20x0.5ml-amp. | AVS | F |

| 83526 | TETAVAX | inj 10x10ml-lahv. | AVS | F |

| 83622 | ALTEANA | inj 10x0.5ml/40ut | SVF | CZ |

| 156.2 | J07AM51 | tetanový anatoxin, s anatoxinem záškrtu kombinace | parent. | 1.00 | DF | 11.67 | O/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 83443 | TETAVAX | inj 1×0.5ml-stř. | AVS | F |

| --- | --- | --- | --- | --- |

| 83444 | TETAVAX | inj 20×0.5ml-stř. | AVS | F |

| 83445 | TETAVAX | inj 1×10ml-lahv. | AVS | F |

| 83447 | TETAVAX | inj 10×20ml-lahv. | AVS | F |

| 83525 | TETAVAX | inj 20×0.5ml-amp. | AVS | F |

| 83526 | TETAVAX | inj 10×10ml-lahv. | AVS | F |

| 83622 | ALTEANA | inj 10×0.5ml/40ut | SVF | CZ |

| 156.2 | J07AM51 | tetanový anatoxin, s anatoxinem záškrtu | kombinace | parent. | 1.00 | DF | 11,41 | O/P |

| --- | --- | --- | --- | --- | --- | --- | --- | --- |

Vybrané vakcíny jsou indikovány u splenektomovaných pacientů po nebo před výkonem a u pacientů po transplantaci krvetvorných buněk.

@@ -5943,26 +5998,26 @@

Vybrané vakcíny jsou indikovány u splenektomovaných pacientů po nebo před výkonem a u pacientů po transplantaci krvetvorných buněk.

| 157.1 | J07AG01 | hemofilus influenze B, čistěný purifikovaný antigen | parent. | 1.00 | DF | 212.30 | O/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 157.2 | J07AL01 | pneumokoková vakcína | parent. | 1.00 | DF | 227.36 | O/P |

| 85534 | PNEUMO 23 | inj 1x0.5ml+střik. | AVS | F |

| --- | --- | --- | --- | --- |

| 157.3 | J07AX | jiné bakteriální vakcíny (protipseudomonádová vakcína) | parent. | 1.00 | DF | 206.02 | O |

| | | | | | | | |

| 157.4 | J07AX | jiné bakteriální vakcíny (směs bakterinů) | parent. | 1.00 | DF | 26.15 | K |

| | | | | | | | |

| 157.5 | J07AX | jiné bakteriální vakcíny (uropatogenní vakcína) | parent. | 1.00 | DF | 280.47 | O |

| 157.1 | J07AG01 | hemofilus influenze B, čistěný purifikovaný antigen | parent. | 1.00 | DF | 207,48 | O/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 157.2 | J07AL01 | pneumokoková vakcína | parent. | 1.00 | DF | 222,20 | O/P |

| 85534 | PNEUMO 23 | inj 1×0.5ml+střik | AVS | F |

| --- | --- | --- | --- | --- |

| 157.3 | J07AX | jiné bakteriální vakcíny (protipseudomonádová vakcína) | parent. | 1.00 | DF | 201,34 | O |

| | | | | | | | |

| 157.4 | J07AX | jiné bakteriální vakcíny (směs bakterinů) | parent. | 1.00 | DF | 25,56 | K |

| | | | | | | | |

| 157.5 | J07AX | jiné bakteriální vakcíny (uropatogenní vakcína) | parent. | 1.00 | DF | 274,10 | O |

| | | | | | | | |

| 158 | očkovací látky proti tuberkulóze | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 158.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1.00 | DF | 223.55 | H |

| 58227 | BCG VACCINE SSI | inj sic 10x10dáv+so | SST | DK |

| 158.1 | J07AN01 | tuberkulosa, živé mykobakterium atenuované | parent. | 1.00 | DF | 218,48 | H |

| 58227 | BCG VACCINE SSI | inj sic 10×10dáv+so | SST | DK |

| --- | --- | --- | --- | --- |

| 159 | očkovací látky proti vzteklině | | | | | | |

@@ -5970,9 +6025,9 @@

| | | | | | | | |

| 159.1 | J07BG01 | inaktivovaný celý virus vztekliny | parent. | | | plně | K |

| 75379 | RABIPUR | inj sic 1x2.5ut+sol | CBG | D |

| --- | --- | --- | --- | --- |

| 90996 | RABIPUR | inj sic 5x2.5ut+sol | CBG | D |

| 75379 | RABIPUR | inj sic 1×2.5ut+sol | CBG | D |

| --- | --- | --- | --- | --- |

| 90996 | RABIPUR | inj sic 5×2.5ut+sol | CBG | D |

| 93706 | VERORAB | inj sic 1dav.+0.5ml | AVS | F |

| 160 | ostatní očkovací látky a imunoglobuliny a ostatní antiinfektiva pro systémovou aplikaci |

@@ -5982,385 +6037,385 @@

Meningokokus, bivalentni polysacharidový antigen a meningokokus C, purifikovaný polysacharidový antigen konjugovaný je hrazen po nebo před výkonem u splenektomovaných pacientů.

| 160.1 | J07AH03 | meningokokus, bivalentní čištěný polysacharidový antigen | parent. | 1.00 | DF | 101.83 | O/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 76063 | MENINGOCOCCAL POLYS.A+C VACCINE | inj sic 1x1dav+str | AVS | F |

| --- | --- | --- | --- | --- |

| 160.2 | J07AH07 | meningokokus C, purifikovaný polysacharidový antigen konjugovaný | parent. | 1.00 | DF | 420.00 | O/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 160.3 | J07BB02 | chřipka, čištěný antigen | parent. | 1.00 | DF | 140.00 | O/P |

| 160.1 | J07AH03 | meningokokus, bivalentní čištěný polysacharidový antigen | parent. | 1.00 | DF | 99,52 | O/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 76063 | MENINGOCOCCAL POLYS.A+C VACCINE | inj sic 1×1dav+str | AVS | F |

| --- | --- | --- | --- | --- |

| 160.2 | J07AH07 | meningokokus C, purifikovaný polysacharidový antigen konjugovaný | parent. | 1.00 | DF | 410,47 | O/P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 160.3 | J07BB02 | chřipka, čištěný antigen | parent. | 1.00 | DF | 136,82 | O/P |

Vakcína je indikována u pacientů nad 65 let věku a u pacientů po splenektomii, po transplantaci krvetvorných buněk a u pacientů, kteří trpí závažným chronickým farmakologicky řešeným onemocněním srdce a cév, nebo dýchacích cest, nebo ledvin nebo diabetem a to pokud nejsou očkováni proti chřipce v rámci pravidelného, či zvláštního očkování podle vyhl. MZ č. 439/2000 Sb., o očkování proti infekčním nemocem, ve znění pozdějších předpisů.

| 160.4 | J07BF03 | dětská obrna, trivalentní, inaktivovaný celý virus | parent. | 1.00 | DF | 95.30 | O/P |

| | | | | | | | |

| 160.5 | J07BJ01 | zarděnky, živý oslabený virus | parent. | 1.00 | DF | 74.00 | O/P |

| 160.4 | J07BF03 | dětská obrna, trivalentní, inaktivovaný celý virus | parent. | 1.00 | DF | 93,14 | O/P |

| | | | | | | | |

| 160.5 | J07BJ01 | zarděnky, živý oslabený virus | parent. | 1.00 | DF | 72,32 | O/P |

| | | | | | | | |

| 161 | ostatní léčiva ze skupiny antibiotik, chemoterapeutik, imunoglobulinů nebo očkovacích látek | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 161.1 | J01MB05 | kyselina oxolinová | p.o. | 1.00 | GM | 9.00 | |

| 161.1 | J01MB05 | kyselina oxolinová | p.o. | 1.00 | GM | 8,80 | |

| | | | | | | | |

| 162 | cytostatika ze skupiny alkylačních látek, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 162.1 | L01AA01 | cyklofosfamid | p.o. | 0.10 | GM | 5.18 | |

| 94174 | CYCLOPHOSPHAMIDE ORION | tbl obd 50x50mg | ONA | SF |

| --- | --- | --- | --- | --- |

| 162.2 | L01AA02 | chlorambucil (do 2 mg v jedné tabletě včetně) | p.o. | 1.00 | MG | 4.50 | |

| | | | | | | | |

| 162.3 | L01AA02 | chlorambucil (nad 2 mg v jedné tabletě) | p.o. | 1.00 | MG | 3.72 | |

| | | | | | | | |

| 162.4 | L01AA03 | melfalan (do 2 mg v jedné tabletě včetně) | p.o. | 1.00 | MG | 4.30 | |

| | | | | | | | |

| 162.5 | L01AA03 | melfalan (nad 2 mg v jedné tabletě) | p.o. | 1.00 | MG | 2.88 | |

| | | | | | | | |

| 162.6 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1.00 | MG | 4.89 | L/ONK,HEM |

| 162.1 | L01AA01 | cyklofosfamid | p.o. | 0.10 | GM | 5,06 | |

| 94174 | CYCLOPHOSPHAMIDE ORION | tbl obd 50×50mg | ONA | SF |

| --- | --- | --- | --- | --- |

| 162.2 | L01AA02 | chlorambucil (do 2 mg v jedné tabletě včetně) | p.o. | 1.00 | MG | 4,40 | |

| | | | | | | | |

| 162.3 | L01AA02 | chlorambucil (nad 2 mg v jedné tabletě) | p.o. | 1.00 | MG | 3,64 | |

| | | | | | | | |

| 162.4 | L01AA03 | melfalan (do 2 mg v jedné tabletě včetně) | p.o. | 1.00 | MG | 4,20 | |

| | | | | | | | |

| 162.5 | L01AA03 | melfalan (nad 2 mg v jedné tabletě) | p.o. | 1.00 | MG | 2,81 | |

| | | | | | | | |

| 162.6 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1.00 | MG | 4,78 | L/ONK,HEM |

| | | | | | | | |

| 163 | cytostatika ze skupiny alkylačních látek, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 163.1 | L01AA01 | cyklofosfamid | parent. | 10.00 | MG | 3.52 | B |

| 84230 | ENDOXAN 500 MG | inj plv sol 1x500mg | BXH | D |

| --- | --- | --- | --- | --- |

| 84231 | ENDOXAN 1 G | inj plv sol 1x1gm | BXH | D |

| 163.2 | L01AA03 | melfalan | parent. | 1.00 | MG | 12.61 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 163.3 | L01AA05 | chlormethin | parent. | 1.00 | MG | 34.22 | B/ONK,HEM |

| | | | | | | | |

| 163.4 | L01AA06 | ifosfamid (do 500 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 1.30 | B/ONK,HEM |

| | | | | | | | |

| 163.5 | L01AA06 | ifosfamid (nad 500 mg v jedné ampuli) | parent. | 1.00 | MG | 1.23 | B/ONK,HEM |

| 49984 | HOLOXAN 2 G | inj plv sol 1x2gm | BXH | D |

| --- | --- | --- | --- | --- |

| 163.6 | L01AB01 | busulfán | parent. | 1.00 | MG | 180.00 | B/ONK,HEM |

| | | | | | | | |

| 163.7 | L01AX04 | dakarbazin | parent. | 10.00 | MG | 7.90 | B/ONK,HEM |

| 163.1 | L01AA01 | cyklofosfamid | parent. | 10.00 | MG | 3,44 | B |

| 84230 | ENDOXAN 500 MG | inj plv sol 1×500mg | BXH | D |

| --- | --- | --- | --- | --- |

| 84231 | ENDOXAN 1 G | inj plv sol 1×1gm | BXH | D |

| 163.2 | L01AA03 | melfalan | parent. | 1.00 | MG | 12,32 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 163.3 | L01AA05 | chlormethin | parent. | 1.00 | MG | 33,44 | B/ONK,HEM |

| | | | | | | | |

| 163.4 | L01AA06 | ifosfamid (do 500 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 1,27 | B/ONK,HEM |

| | | | | | | | |

| 163.5 | L01AA06 | ifosfamid (nad 500 mg v jedné ampuli) | parent. | 1.00 | MG | 1,20 | B/ONK,HEM |

| 49984 | HOLOXAN 2 G | inj plv sol 1×2gm | BXH | D |

| --- | --- | --- | --- | --- |

| 163.6 | L01AB01 | busulfán | parent. | 1.00 | MG | 175,91 | B/ONK,HEM |

| | | | | | | | |

| 163.7 | L01AX04 | dakarbazin | parent. | 10.00 | MG | 7,72 | B/ONK,HEM |

| | | | | | | | |

| 164 | antimetabolity – analoga listové kyseliny, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 164.1 | L01BA01 | metotrexát | p.o. | 1.00 | MG | 1.52 | |

| 91922 | METHOTREXAT LACHEMA 10 | tbl 100x10mg | PVL | CZ |

| 164.1 | L01BA01 | metotrexát | p.o. | 1.00 | MG | 1,49 | |

| 91922 | METHOTREXAT LACHEMA 10 | tbl 100×10mg | PVL | CZ |

| --- | --- | --- | --- | --- |

| 165 | antimetabolity – analoga listové kyseliny, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 165.1 | L01BA01 | metotrexát (do 5 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 9.09 | B |

| | | | | | | | |

| 165.2 | L01BA01 | metotrexát (nad 5 do 500 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 3.12 | B |

| 11191 | METHOTREXATE-TEVA 25MG/ML | inj 1x2ml/50mg-lah | PHM | NL |

| --- | --- | --- | --- | --- |

| 11192 | METHOTREXATE-TEVA 25MG/ML | inj 5x2ml/50mg-amp | PHM | NL |

| 11193 | METHOTREXATE-TEVA 25MG/ML | inj 1x4ml/100mg-lah | PHM | NL |

| 11194 | METHOTREXATE-TEVA 25MG/ML | inj 1x8ml/200mg-lah | PHM | NL |

| 11195 | METHOTREXATE-TEVA 25MG/ML | inj 1x20ml/500mg-la | PHM | NL |

| 64784 | METHOTREXAT EBEWE | inf 1x5ml/500mg | EBP | A |

| 87564 | METHOTREXAT LACHEMA 50 | inj sic 10x50mg | PVL | CZ |

| 93964 | METHOTREXAT LACHEMA 50 | inj 10x5ml/50mg | PVL | CZ |

| 165.3 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10.00 | MG | 4.89 | B |

| | | | | | | | |

| 165.4 | L01BA03 | raltitrexed | parent. | 1.00 | DF | 7 498.20 | X |

| | | | | | | | |

| 165.5 | L01BA04 | pemetrexed | parent. | 500.00 | MG | 39 327.00 | X |

| 165.1 | L01BA01 | metotrexát (do 5 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 8,88 | B |

| | | | | | | | |

| 165.2 | L01BA01 | metotrexát (nad 5 do 500 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 3,05 | B |

| 11191 | METHOTREXATE-TEVA 25MG/ML | inj 1×2ml/50mg-lah | PHM | NL |

| --- | --- | --- | --- | --- |

| 11192 | METHOTREXATE-TEVA 25MG/ML | inj 5×2ml/50mg-amp | PHM | NL |

| 11193 | METHOTREXATE-TEVA 25MG/ML | inj 1×4ml/100mg-lah | PHM | NL |

| 11194 | METHOTREXATE-TEVA 25MG/ML | inj 1×8ml/200mg-lah | PHM | NL |

| 11195 | METHOTREXATE-TEVA 25MG/ML | inj 1×20ml/500mg-la | PHM | NL |

| 64784 | METHOTREXAT EBEWE | inf 1×5ml/500mg | EBP | A |

| 87564 | METHOTREXAT LACHEMA 50 | inj sic 10×50mg | PVL | CZ |

| 93964 | METHOTREXAT LACHEMA 50 | inj 10×5ml/50mg | PVL | CZ |

| 165.3 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10.00 | MG | 4,78 | B |

| | | | | | | | |

| 165.4 | L01BA03 | raltitrexed | parent. | 1.00 | DF | 7 327,99 | X |

| | | | | | | | |

| 165.5 | L01BA04 | pemetrexed | parent. | 500.00 | MG | 39 327,00 | X |

| | | | | | | | |

| 166 | antimetabolity – analoga purinů a pyrimidinů, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 166.1 | L01BB02 | merkaptopurin | p.o. | 10.00 | MG | 6.21 | L/ONK,HEM |

| | | | | | | | |

| 166.2 | L01BB03 | tioguanin | p.o. | 10.00 | MG | 9.34 | L/ONK,HEM |

| | | | | | | | |

| 166.3 | L01BB05 | fludarabin | p.o. | 1.00 | MG | 87.20 | L/ONK,HEM |

| 58897 | FLUDARA | tbl obd 15x10mg | SAG | D |

| --- | --- | --- | --- | --- |

| 58898 | FLUDARA | tbl obd 20x10mg | SAG | D |

| 166.4 | L01BC | azaribin | p.o. | 1.00 | MG | 8.50 | L/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 166.5 | L01BC02 | fluorouracil | p.o. | 10.00 | MG | 1.47 | L/ONK,HEM |

| | | | | | | | |

| 166.6 | L01BC03 | tegafur | p.o. | 10.00 | MG | 1.17 | L/ONK,HEM |

| 10407 | FTORAFUR | cps 100x400mg | GRX | LV |

| --- | --- | --- | --- | --- |

| 166.7 | L01BC06 | capecitabin do 150 mg v jedné tabletě včetně | p.o. | 1.00 | DF | 35.58 | X |

| | | | | | | | |

| 166.8 | L01BC06 | capecitabin nad 150 mg v jedné tabletě | p.o. | 1.00 | DF | 117.97 | X |

| 166.1 | L01BB02 | merkaptopurin | p.o. | 10.00 | MG | 6,07 | L/ONK,HEM |

| | | | | | | | |

| 166.2 | L01BB03 | tioguanin | p.o. | 10.00 | MG | 9,13 | L/ONK,HEM |

| | | | | | | | |

| 166.3 | L01BB05 | fludarabin | p.o. | 1.00 | MG | 85,22 | L/ONK,HEM |

| 58897 | FLUDARA | tbl obd 15×10mg | SAG | D |

| --- | --- | --- | --- | --- |

| 58898 | FLUDARA | tbl obd 20×10mg | SAG | D |

| 166.4 | L01BC | azaribin | p.o. | 1.00 | MG | 8,31 | L/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 166.5 | L01BC02 | fluorouracil | p.o. | 10.00 | MG | 1,44 | L/ONK,HEM |

| | | | | | | | |

| 166.6 | L01BC03 | tegafur | p.o. | 10.00 | MG | 1,14 | L/ONK,HEM |

| 10407 | FTORAFUR | cps 100×400mg | GRX | LV |

| --- | --- | --- | --- | --- |

| 166.7 | L01BC06 | capecitabin do 150 mg v jedné tabletě včetně | p.o. | 1.00 | DF | 34,77 | X |

| | | | | | | | |

| 166.8 | L01BC06 | capecitabin nad 150 mg v jedné tabletě | p.o. | 1.00 | DF | 115,29 | X |

| | | | | | | | |

| 167 | antimetabolity – analoga purinů, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 167.1 | L01BB04 | cladribin | parent. | 1.00 | MG | 884.61 | B/ONK,HEM |

| | | | | | | | |

| 167.2 | L01BB05 | fludarabin | parent. | 1.00 | MG | 127.60 | B/ONK,HEM |

| 59058 | FLUDARA | inj sic 5x50mg | SHI | I |

| --- | --- | --- | --- | --- |

| 77008 | FLUDARA | inj sic 5x50mg | SAG | D |

| 167.1 | L01BB04 | cladribin | parent. | 1.00 | MG | 864,53 | B/ONK,HEM |

| | | | | | | | |

| 167.2 | L01BB05 | fludarabin | parent. | 1.00 | MG | 124,70 | B/ONK,HEM |

| 59058 | FLUDARA | inj sic 5×50mg | SHI | I |

| --- | --- | --- | --- | --- |

| 77008 | FLUDARA | inj sic 5×50mg | SAG | D |

| 168 | antimetabolity – analoga pyrimidinů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 168.1 | L01BC01 | cytarabin (do 100 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 1.18 | B/ONK,HEM |

| 08796 | CYTOSAR 100 MG | inj sic 1x100mg+sol | PPU | B |

| --- | --- | --- | --- | --- |

| 13874 | ALEXAN 100MG/5ML | inf cnc sol 10x5ml | EBP | A |

| 13875 | ALEXAN 40MG/2ML | inf cnc sol 30x2ml | EBP | A |

| 13876 | ALEXAN 40MG/2ML | inf cnc sol 10x2ml | EBP | A |

| 168.2 | L01BC01 | cytarabin (nad 100 mg v jedné ampuli) | parent. | 1.00 | MG | 0.95 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13872 | ALEXAN 500MG/10ML | inf cnc sol 1x10ml | EBP | A |

| --- | --- | --- | --- | --- |

| 13873 | ALEXAN 1000MG/20ML | inf cnc sol 1x20ml | EBP | A |

| 65423 | CYTOSAR 1 G | inj sic 1x1 gm | PPU | B |

| 85837 | CYTOSAR 500 MG | inj sic 1x500mg+sol | PPU | B |

| 168.3 | L01BC02 | fluorouracil | parent. | 10.00 | MG | 2.58 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11171 | FLUOROURACIL-TEVA | inj sol 1x5ml/250mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 11173 | FLUOROURACIL-TEVA | inj sol 1x10ml/500mg | PHM | NL |

| 11175 | FLUOROURACIL-TEVA | inj sol 1x20ml/1000mg | PHM | NL |

| 11393 | LA-FU 50 MG/ML | inj sol 1x10ml | PVL | CZ |

| 11394 | LA-FU 50 MG/ML | inj sol 10x10ml | PVL | CZ |

| 12665 | 5-FLUOROURACIL EBEWE | inj 1x10ml/500mg | EBP | A |

| 12666 | 5-FLUOROURACIL EBEWE | inj 1x20ml/1000mg | EBP | A |

| 12667 | 5-FLUOROURACIL EBEWE | inj 1x100ml/5000mg | EBP | A |

| 32752 | FLUORO-URACIL ICN | inj sol 5x20ml/1gm | IAB | CH |

| 32753 | FLUORO-URACIL ICN | inj sol 1x100ml/5gm | IAB | CH |

| 32761 | FLUOROURACIL-TEVA | inj sol 1x100ml/5gm | PHM | NL |

| 56055 | 5-FLUOROURACIL EBEWE | inj 1x5ml/250mg | EBP | A |

| 168.4 | L01BC03 | tegafur | parent. | 10.00 | MG | 2.83 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 168.5 | L01BC05 | gemcitabin | parent. | 1.00 | MG | 5.68 | X |

| 84335 | GEMZAR 200 MG | inf plv sol 1x200mg | LIL | F |

| --- | --- | --- | --- | --- |

| 84336 | GEMZAR 1 G | inf plv sol 1x1gm | LIL | F |

| 168.1 | L01BC01 | cytarabin (do 100 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 1,15 | B/ONK,HEM |

| 08796 | CYTOSAR 100 MG | inj sic 1×100mg+sol | PPU | B |

| --- | --- | --- | --- | --- |

| 13874 | ALEXAN 100MG/5ML | inf cnc sol 10×5ml | EBP | A |

| 13875 | ALEXAN 40MG/2ML | inf cnc sol 30×2ml | EBP | A |

| 13876 | ALEXAN 40MG/2ML | inf cnc sol 10×2ml | EBP | A |

| 168.2 | L01BC01 | cytarabin (nad 100 mg v jedné ampuli) | parent. | 1.00 | MG | 0,93 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13872 | ALEXAN 500MG/10ML | inf cnc sol 1×10ml | EBP | A |

| --- | --- | --- | --- | --- |

| 13873 | ALEXAN 1000MG/20ML | inf cnc sol 1×20ml | EBP | A |

| 65423 | CYTOSAR 1 G | inj sic 1×1gm | PPU | B |

| 85837 | CYTOSAR 500 MG | inj sic 1×500mg+sol | PPU | B |

| 168.3 | L01BC02 | fluorouracil | parent. | 10.00 | MG | 2,52 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11171 | FLUOROURACIL-TEVA | inj sol 1×5ml/250mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 11173 | FLUOROURACIL-TEVA | inj sol 1×10ml/500mg | PHM | NL |

| 11175 | FLUOROURACIL-TEVA | inj sol 1×20ml/1000mg | PHM | NL |

| 11393 | LA-FU 50 MG/ML | inj sol 1×10ml | PVL | CZ |

| 11394 | LA-FU 50 MG/ML | inj sol 10×10ml | PVL | CZ |

| 12665 | 5-FLUOROURACIL EBEWE | inj 1×10ml/500mg | EBP | A |

| 12666 | 5-FLUOROURACIL EBEWE | inj 1×20ml/1000mg | EBP | A |

| 12667 | 5-FLUOROURACIL EBEWE | inj 1×100ml/5000mg | EBP | A |

| 32752 | FLUORO-URACIL ICN | inj sol 5×20ml/1gm | IAB | CH |

| 32753 | FLUORO-URACIL ICN | inj sol 1×100ml/5gm | IAB | CH |

| 32761 | FLUOROURACIL-TEVA | inj sol 1×100ml/5gm | PHM | NL |

| 56055 | 5-FLUOROURACIL EBEWE | inj 1×5ml/250mg | EBP | A |

| 168.4 | L01BC03 | tegafur | parent. | 10.00 | MG | 2,77 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 168.5 | L01BC05 | gemcitabin | parent. | 1.00 | MG | 5,55 | X |

| 84335 | GEMZAR 200 MG | inf plv sol 1×200mg | LIL | F |

| --- | --- | --- | --- | --- |

| 84336 | GEMZAR 1 G | inf plv sol 1×1gm | LIL | F |

| 169 | alkaloidy z rodu vinca a analoga | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 169.1 | L01CA01 | vinblastin | parent. | 1.00 | MG | 26.54 | B/ONK,HEM |

| | | | | | | | |

| 169.2 | L01CA02 | vinkristin | parent. | 1.00 | MG | 165.00 | B/ONK,HEM |

| 11420 | VINCRISTINE-TEVA | inj 1x1ml/1mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 11421 | VINCRISTINE-TEVA | inj 1x2ml/2mg | PHM | NL |

| 11422 | VINCRISTINE-TEVA | inj 1x5ml/5mg | PHM | NL |

| 169.3 | L01CA04 | vinorelbin | p.o. | 1.00 | MG | 108.35 | X |

| | | | | | | | |

| 169.4 | L01CA04 | vinorelbin | parent. | 1.00 | MG | 102.85 | X |

| 169.1 | L01CA01 | vinblastin | parent. | 1.00 | MG | 25,94 | B/ONK,HEM |

| | | | | | | | |

| 169.2 | L01CA02 | vinkristin | parent. | 1.00 | MG | 161,25 | B/ONK,HEM |

| 11420 | VINCRISTINE-TEVA | inj 1×1ml/1mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 11421 | VINCRISTINE-TEVA | inj 1×2ml/2mg | PHM | NL |

| 11422 | VINCRISTINE-TEVA | inj 1×5ml/5mg | PHM | NL |

| 169.3 | L01CA04 | vinorelbin | p.o. | 1.00 | MG | 105,89 | X |

| | | | | | | | |

| 169.4 | L01CA04 | vinorelbin | parent. | 1.00 | MG | 100,52 | X |

| | | | | | | | |

| 170 | deriváty podofylotoxinu, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 170.1 | L01CB01 | etoposid | p.o. | 1.00 | MG | 2.84 | L/ONK,HEM |

| 93696 | LASTET 25 | cps 40x25mg | NKU | J |

| --- | --- | --- | --- | --- |

| 93697 | LASTET 50 | cps 20x50mg | NKU | J |

| 93698 | LASTET 100 | cps 10x100mg | NKU | J |

| 170.1 | L01CB01 | etoposid | p.o. | 1.00 | MG | 2,78 | L/ONK,HEM |

| 93696 | LASTET 25 | cps 40×25mg | NKU | J |

| --- | --- | --- | --- | --- |

| 93697 | LASTET 50 | cps 20×50mg | NKU | J |

| 93698 | LASTET 100 | cps 10×100mg | NKU | J |

| 171 | deriváty podofylotoxinu, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 171.1 | L01CB01 | etoposid | parent. | 1.00 | MG | 2.91 | B/ONK,HEM |

| 11390 | ETOPOSIDE-TEVA | inf cnc 1x10ml/200mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 171.2 | L01CB02 | teniposid | parent. | 1.00 | MG | 6.06 | B/ONK,HEM |

| 171.1 | L01CB01 | etoposid | parent. | 1.00 | MG | 2,84 | B/ONK,HEM |

| 11390 | ETOPOSIDE-TEVA | inf cnc 1×10ml/200mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 171.2 | L01CB02 | teniposid | parent. | 1.00 | MG | 5,92 | B/ONK,HEM |

| | | | | | | | |

| 172 | taxany | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 172.1 | L01CD01 | paclitaxel | parent. | 1.00 | MG | 133.20 | X |

| 05953 | PAXENE | inf cnc sol 1x50ml | IXP | CZ |

| --- | --- | --- | --- | --- |

| 16069 | ONXOL | inf cnc sol 1x25ml | IXP | CZ |

| 16070 | ONXOL | inf cnc sol 1x50ml | IXP | CZ |

| 27309 | PAXENE | inf cnc sol 1x25ml | NRT | GB |

| 28068 | PAXENE | inf cnc sol 1x50ml | NRT | GB |

| 45155 | PAXENE | inf cnc sol 1x25ml | IXP | CZ |

| 172.2 | L01CD02 | docetaxel | parent. | 1.00 | MG | 233.50 | X |

| 172.1 | L01CD01 | paclitaxel | parent. | 1.00 | MG | 130,18 | X |

| 05953 | PAXENE | inf cnc sol 1×50ml | IXP | CZ |

| --- | --- | --- | --- | --- |

| 16069 | ONXOL | inf cnc sol 1×25ml | IXP | CZ |

| 16070 | ONXOL | inf cnc sol 1×50ml | IXP | CZ |

| 27309 | PAXENE | inf cnc sol 1×25ml | NRT | GB |

| 28068 | PAXENE | inf cnc sol 1×50ml | NRT | GB |

| 45155 | PAXENE | inf cnc sol 1×25ml | IXP | CZ |

| 172.2 | L01CD02 | docetaxel | parent. | 1.00 | MG | 228,20 | X |

| | | | | | | | |

| 173 | antracykliny a jejich deriváty | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 173.1 | L01DA01 | daktinomycin | parent. | 1.00 | MG | 664.85 | B/ONK,HEM |

| | | | | | | | |

| 173.2 | L01DB01 | doxorubicin (do 40 mg včetně v jedné ampuli) | parent. | 1.00 | MG | 29.05 | B/ONK,HEM |

| 32975 | DOXORUBICIN-TEVA 0.2% | inj sol 1x10mg/5ml | PHM | NL |

| --- | --- | --- | --- | --- |

| 173.3 | L01DB01 | doxorubicin (nad 40 mg v jedné ampuli) | parent. | 1.00 | MG | 28.90 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32977 | DOXORUBICIN-TEVA 0.2% | inj sol 1x50mg/25ml | PHM | NL |

| --- | --- | --- | --- | --- |

| 32978 | DOXORUBICIN-TEVA 0.2% | injsol 1x200mg/100ml | PHM | NL |

| 173.4 | L01DB02 | daunorubicin | parent. | 1.00 | MG | 19.21 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 173.5 | L01DB03 | epirubicin | parent. | 1.00 | MG | 35.85 | B/ONK,HEM |

| 58289 | FARMORUBICIN PFS | inj 1x25ml/50mg | PUH | I |

| --- | --- | --- | --- | --- |

| 173.6 | L01DB04 | aklarubicin | parent. | 1.00 | MG | 19.21 | B/ONK,HEM |

| | | | | | | | |

| 173.7 | L01DB05 | zorubicin | parent. | 1.00 | MG | 19.21 | B/ONK,HEM |

| | | | | | | | |

| 173.8 | L01DB06 | idarubicin | p.o. | 1.00 | MG | 247.20 | X |

| | | | | | | | |

| 173.9 | L01DB06 | idarubicin | parent. | 1.00 | MG | 640.30 | B/ONK,HEM |

| | | | | | | | |

| 173.10 | L01DB07 | mitoxantron | parent. | 1.00 | MG | 53.96 | B/ONK,HEM |

| | | | | | | | |

| 173.11 | L01XX32 | bortezomibum | parent. | 3.50 | MG | 36 000.00 | X |

| 173.1 | L01DA01 | daktinomycin | parent. | 1.00 | MG | 649,76 | B/ONK,HEM |

| | | | | | | | |

| 173.2 | L01DB01 | doxorubicin (do 40 mg včetně v jedné ampuli) | parent. | 1.00 | MG | 28,39 | B/ONK,HEM |

| 32975 | DOXORUBICIN-TEVA 0.2% | inj sol 1×10mg/5ml | PHM | NL |

| --- | --- | --- | --- | --- |

| 173.3 | L01DB01 | doxorubicin (nad 40 mg v jedné ampuli) | parent. | 1.00 | MG | 28,24 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32977 | DOXORUBICIN-TEVA 0.2% | inj sol 1×50mg/25ml | PHM | NL |

| --- | --- | --- | --- | --- |

| 32978 | DOXORUBICIN-TEVA 0.2% | inj sol 1×200mg/100ml | PHM | NL |

| 173.4 | L01DB02 | daunorubicin | parent. | 1.00 | MG | 18,77 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 173.5 | L01DB03 | epirubicin | parent. | 1.00 | MG | 35,04 | B/ONK,HEM |

| 58289 | FARMORUBICIN PFS | inj 1×25ml/50mg | PUH | I |

| --- | --- | --- | --- | --- |

| 173.6 | L01DB04 | aklarubicin | parent. | 1.00 | MG | 18,77 | B/ONK,HEM |

| | | | | | | | |

| 173.7 | L01DB05 | zorubicin | parent. | 1.00 | MG | 18,77 | B/ONK,HEM |

| | | | | | | | |

| 173.8 | L01DB06 | idarubicin | p.o. | 1.00 | MG | 241,59 | X |

| | | | | | | | |

| 173.9 | L01DB06 | idarubicin | parent. | 1.00 | MG | 625,77 | B/ONK,HEM |

| | | | | | | | |

| 173.10 | L01DB07 | mitoxantron | parent. | 1.00 | MG | 52,74 | B/ONK,HEM |

| | | | | | | | |

| 173.11 | L01XX32 | bortezomibum | parent. | 3.50 | MG | 36 000,00 | X |

| | | | | | | | |

| 174 | ostatní cytotoxická antibiotika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 174.1 | L01DC01 | bleomycin | parent. | 1.00 | MG | 50.09 | B/ONK,HEM |

| 03404 | BLEOCIN | inj sic 1x15mg | NKU | J |

| --- | --- | --- | --- | --- |

| 174.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 61.40 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 174.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1.00 | MG | 54.50 | B/ONK,HEM |

| 83440 | MITOMYCIN C KYOWA | inj plv sol 5x20mg | KYA | J |

| 174.1 | L01DC01 | bleomycin | parent. | 1.00 | MG | 48,95 | B/ONK,HEM |

| 03404 | BLEOCIN | inj sic 1×15mg | NKU | J |

| --- | --- | --- | --- | --- |

| 174.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 60,01 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 174.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1.00 | MG | 53,26 | B/ONK,HEM |

| 83440 | MITOMYCIN C KYOWA | inj plv sol 5×20mg | KYA | J |

| --- | --- | --- | --- | --- |

| 175 | platinová cytostatika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 175.1 | L01XA01 | cisplatina | parent. | 1.00 | MG | 7.45 | B/ONK,HEM |

| 92302 | CISPLATIN EBEWE | inf cnc sol 1x100ml | EBP | A |

| --- | --- | --- | --- | --- |

| 96454 | PLATIDIAM 25 | inf cnc sol 5x50ml | PVL | CZ |

| 175.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 6.45 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 90777 | CYCLOPLATIN 50 | inf plv sol 10x50mg | PVL | CZ |

| --- | --- | --- | --- | --- |

| 175.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1.00 | MG | 3.65 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10830 | CARBOPLATIN-TEVA | inj 1x45ml/450mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 14327 | CARBOPLATIN-TEVA | inj sol 1x60ml/600mg | PHM | NL |

| 175.4 | L01XA03 | oxaliplatina | parent. | 1.00 | MG | 106.50 | X |

| 175.1 | L01XA01 | cisplatina | parent. | 1.00 | MG | 7,28 | B/ONK,HEM |

| 92302 | CISPLATIN EBEWE | inf cnc sol 1×100ml | EBP | A |

| --- | --- | --- | --- | --- |

| 96454 | PLATIDIAM 25 | inf cnc sol 5×50ml | PVL | CZ |

| 175.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. | 1.00 | MG | 6,30 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 90777 | CYCLOPLATIN 50 | inf plv sol 10×50mg | PVL | CZ |

| --- | --- | --- | --- | --- |

| 175.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1.00 | MG | 3,57 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10830 | CARBOPLATIN-TEVA | inj 1×45ml/450mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 14327 | CARBOPLATIN-TEVA | inj sol 1×60ml/600mg | PHM | NL |

| 175.4 | L01XA03 | oxaliplatina | parent. | 1.00 | MG | 104,08 | X |

| | | | | | | | |

| 176 | ostatní cytostatika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 176.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1.00 | MG | 5.72 | L/ONK,HEM |

| | | | | | | | |

| 176.2 | L01AD02 | lomustin (nad 10 do 40 mg v jedné tabletě včetně) | p.o. | 1.00 | MG | 5.63 | L/ONK,HEM |

| 64652 | CEENU LOMUSTINE (CCNU) 40 MG | cps 20x40mg | BMS | I |

| --- | --- | --- | --- | --- |

| 176.3 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1.00 | MG | 4.39 | L/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 64653 | CEENU LOMUSTINE (CCNU) 100 MG | cps 20x100mg | BMS | I |

| --- | --- | --- | --- | --- |

| 176.4 | L01AX03 | temozolomid | p. 0. | 370.00 | MG | 13 369.00 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 27705 | TEMODAL 20 MG | por cps dur 5x20mg | SBS | B |

| --- | --- | --- | --- | --- |

| 27707 | TEMODAL 100 MG | por cps dur 5x100mg | SBS | B |

| 27709 | TEMODAL 250 MG | por cps dur 5x250mg | SBS | B |

| 176.5 | L01XB01 | prokarbazin | p.o. | 10.00 | MG | 2.44 | L/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 176.6 | L01XX05 | hydroxymočovina | p.o. | 0.10 | GM | 1.80 | L/ONK,HEM, URN |

| | | | | | | | |

| 176.7 | L01XX14 | tretinoin | p.o. | 10.00 | MG | 98.65 | L/ONK,HEM, URN |

| | | | | | | | |

| 176.8 | L01XX25 | bexaroten | p.o. | 75.00 | MG | 451.30 | X |

| | | | | | | | |

| 176.9 | L01XX28 | imatinib | p.o. | 400.00 | MG | 2 672.95 | X |

| | | | | | | | |

| 176.10 | L01XX33 | celecoxib | p.o. | 400.00 | MG | 45.40 | P |

| 176.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1.00 | MG | 5,59 | L/ONK,HEM |

| | | | | | | | |

| 176.2 | L01AD02 | lomustin (nad 10 do 40 mg v jedné tabletě včetně) | p.o. | 1.00 | MG | 5,50 | L/ONK,HEM |

| 64652 | CEENU LOMUSTINE (CCNU) 40 MG | cps 20×40mg | BMS | I |

| --- | --- | --- | --- | --- |

| 176.3 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1.00 | MG | 4,29 | L/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 64653 | CEENU LOMUSTINE (CCNU) 100 MG | cps 20×100mg | BMS | I |

| --- | --- | --- | --- | --- |

| 176.4 | L01AX03 | temozolomid | p. o. | 370.00 | MG | 13 065,52 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 27705 | TEMODAL 20 MG | por cps dur 5×20mg | SBS | B |

| --- | --- | --- | --- | --- |

| 27707 | TEMODAL 100 MG | por cps dur 5×100mg | SBS | B |

| 27709 | TEMODAL 250 MG | por cps dur 5×250mg | SBS | B |

| 176.5 | L01XB01 | prokarbazin | p.o. | 10.00 | MG | 2,38 | L/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 176.6 | L01XX05 | hydroxymočovina | p.o. | 0.10 | GM | 1,76 | L/ONK,HEM, URN |

| | | | | | | | |

| 176.7 | L01XX14 | tretinoin | p.o. | 10.00 | MG | 96,41 | L/ONK,HEM, URN |

| | | | | | | | |

| 176.8 | L01XX25 | bexaroten | p.o. | 75.00 | MG | 441,06 | X |

| | | | | | | | |

| 176.9 | L01XX28 | imatinib | p.o. | 400.00 | MG | 2 612,27 | X |

| | | | | | | | |

| 176.10 | L01XX33 | celecoxib | p.o. | 400.00 | MG | 44,37 | P |

Celecoxib předepisuje gastroenterolog, onkolog nebo chirurg v indikaci snížení počtu adenomatosních střevních polypů u familiární adenomatosní polyposy (FAP) jako přídatnou léčbu po chirurgickém výkonu.

| 176.11 | L01XX34 | erlotinib | p.o. | 1.00 | MG | 19.10 | X |

| 176.11 | L01XX34 | erlotinib | p.o. | 1.00 | MG | 18,67 | X |

| | | | | | | | |

| 177 | ostatní cytostatika kromě platinových, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 177.1 | L01AC01 | thiotepa | parent. | 1.00 | MG | 21.31 | B/ONK,HEM |

| | | | | | | | |

| 177.2 | L01AD01 | karmustin | parent. | 1.00 | MG | 9.73 | B/ONK,HEM |

| 53666 | BICNU(STERILE CARMUSTINE/BCNU/) | inj sic 1x100mg+sol | BQB | I |

| --- | --- | --- | --- | --- |

| 177.3 | L01AD04 | streptozocin | parent. | 10.00 | MG | 14.81 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 177.4 | L01AD05 | fotemustin | parent. | 1.00 | MG | 94.48 | X |

| 55407 | MUSTOPHORAN | inj pso lqf 1x208mg+so | THN | B |

| --- | --- | --- | --- | --- |

| 177.5 | L01XC02 | rituximab | parent. | 10.00 | MG | 1 090.87 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 177.6 | L01XC03 | trastuzumab | parent. | 1.00 | DF | 25 414.00 | X |

| | | | | | | | |

| 177.7 | L01XC04 | alemtuzumab | parent. | 1.00 | MG | 442.20 | X |

| | | | | | | | |

| 177.8 | L01XC06 | cetuximab | parent. | 1.00 | MG | 67.92 | X |

| | | | | | | | |

| 177.9 | L01XC07 | bevacizumab | parent. | 1.00 | MG | 105.41 | X |

| | | | | | | | |

| 177.10 | L01XD02 | verteporfin | parent. | 15.00 | MG | 44 000.00 | K/P |

| 177.1 | L01AC01 | thiotepa | parent. | 1.00 | MG | 20,83 | B/ONK,HEM |

| | | | | | | | |

| 177.2 | L01AD01 | karmustin | parent. | 1.00 | MG | 9,51 | B/ONK,HEM |

| 53666 | BICNU(STERILE CARMUSTINE/BCNU/) | inj sic 1×100mg+sol | BQB | I |

| --- | --- | --- | --- | --- |

| 177.3 | L01AD04 | streptozocin | parent. | 10.00 | MG | 14,47 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 177.4 | L01AD05 | fotemustin | parent. | 1.00 | MG | 92,34 | X |

| 55407 | MUSTOPHORAN | inj sol fl×208mg+so | THN | B |

| --- | --- | --- | --- | --- |

| 177.5 | L01XC02 | rituximab | parent. | 10.00 | MG | 1 066,11 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 177.6 | L01XC03 | trastuzumab | parent. | 1.00 | DF | 24 837,10 | X |

| | | | | | | | |

| 177.7 | L01XC04 | alemtuzumab | parent. | 1.00 | MG | 432,16 | X |

| | | | | | | | |

| 177.8 | L01XC06 | cetuximab | parent. | 1.00 | MG | 66,38 | X |

| | | | | | | | |

| 177.9 | L01XC07 | bevacizumab | parent. | 1.00 | MG | 105,41 | X |

| | | | | | | | |

| 177.10 | L01XD02 | verteporfin | parent. | 15.00 | MG | 43 001,20 | K/P |

Verteporfin k fotodynamické terapii /PDT/ předepisuje oftalmolog u nemocných se subfoveálně lokalizovanou převážně klasickou chorioideální neovaskularizací objektivizovanou angiografickým vyšetřením.

@@ -6370,252 +6425,253 @@

Indikace k PDT musí být potvrzena vedoucím příslušného centra. PDT bude prováděna na pracovištích, která splní nutné personální i přístrojové podmínky k zajištění dostupnosti pro nemocné.

| 177.11 | L01XD03 | methylaminolevulinát | lok. | 2.00 | GM | 8 600.00 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 177.12 | L01XX01 | amsakrin | parent. | 1.00 | MG | 25.80 | B/ONK,HEM |

| | | | | | | | |

| 177.13 | L01XX02 | asparagináza | parent. | 1.00 | MG | 2 784.54 | B/ONK,HEM |

| | | | | | | | |

| 177.14 | L01XX09 | miltefosin | lok. | 60.00 | MG | 9.78 | |

| | | | | | | | |

| 177.15 | L01XX11 | estramustin | parent. | 1.00 | MG | 0.91 | B/ONK,HEM, URN |

| 58800 | ESTRACYT | inj sic 10x300mg+so | PIR | I |

| --- | --- | --- | --- | --- |

| 177.16 | L01XX17 | topotekan | parent. | 1.00 | MG | 2 913.06 | X |

| | | | | | | | |

| 177.17 | L01XX19 | irinotekan | parent. | 1.00 | MG | 50.68 | X |

| | | | | | | | |

| 177.18 | L01XX27 | oxid arsenitý | parent. | 1.00 | DF | 12 028.00 | X |

| 177.11 | L01XD03 | methylaminolevulinát | lok. | 2.00 | GM | 8 600,00 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 177.12 | L01XX01 | amsakrin | parent. | 1.00 | MG | 25,21 | B/ONK,HEM |

| | | | | | | | |

| 177.13 | L01XX02 | asparagináza | parent. | 1.00 | MG | 2 721,33 | B/ONK,HEM |

| | | | | | | | |

| 177.14 | L01XX09 | miltefosin | lok. | 60.00 | MG | 9,56 | |

| | | | | | | | |

| 177.15 | L01XX11 | estramustin | parent. | 1.00 | MG | 0,89 | B/ONK,HEM, URN |

| 58800 | ESTRACYT | inj sic 10×300mg+so | PIR | I |

| --- | --- | --- | --- | --- |

| 177.16 | L01XX17 | topotekan | parent. | 1.00 | MG | 2 846,93 | X |

| | | | | | | | |

| 177.17 | L01XX19 | irinotekan | parent. | 1.00 | MG | 49,53 | X |

| | | | | | | | |

| 177.18 | L01XX27 | oxid arsenitý | parent. | 1.00 | DF | 12 028,00 | X |

| | | | | | | | |

| 178 | hormonální léčiva s cytostatickým účinkem | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 178.1 | L01XX11 | estramustin | p.o. | 10.00 | MG | 3.21 | L/ONK,HEM,URN |

| 58742 | ESTRACYT | cps 100x140mg | PIK | I |

| --- | --- | --- | --- | --- |

| 178.2 | L02AB01 | megestrol (pevné lékové formy) | p.o. | 160.00 | MG | 39.89 | L/ONK,HEM,URN GYN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32103 | MEGAPLEX 160 MG | por tbl nob 30x160mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 58936 | MEGACE 160 MG | tbl 100x160mg | HAG | D |

| 178.3 | L02AB01 | megestrol (tekuté lékové formy) | p.o. | 160.00 | MG | 70.97 | P |

| 178.1 | L01XX11 | estramustin | p.o. | 10.00 | MG | 3,14 | L/ONK,HEM,URN |

| 58742 | ESTRACYT | cps 100×140mg | PIK | I |

| --- | --- | --- | --- | --- |

| 178.2 | L02AB01 | megestrol (pevné lékové formy) | p.o. | 160.00 | MG | 38,98 | L/ONK,HEM,URN GYN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32103 | MEGAPLEX 160 MG | por tbl nob ×160mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 58936 | MEGACE 160 MG | tbl 100×160mg | HAG | D |

| 178.3 | L02AB01 | megestrol (tekuté lékové formy) | p.o. | 160.00 | MG | 69,36 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Indikován v případech kachexie u manifestního AIDS a v případech, kdy nádorová kachexie je kontraindikací kurativní protinádorové terapie.

| 53145 | MEGACE SUSP. | sus por 1x240ml | BYE | E |

| --- | --- | --- | --- | --- |

| 178.4 | L02AB02 | medroxyprogesteron | p.o. | 1.00 | GM | 144.54 | L/ONK,HEM,URN GYN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32121 | MEDROPLEX 100 MG | por tbl nob 100x100mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 178.5 | L02AB02 | medroxyprogesteron | parent. | 1.00 | GM | 639.00 | L/ONK,GYN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 87805 | DEPO-PROVERA | inj sus 1x1ml-lag | PMB | B |

| --- | --- | --- | --- | --- |

| 178.6 | L02AB03 | gestonoron | parent. | 1.00 | MG | 1.12 | L/ONK,GYN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 178.7 | L02AE01 | buserelin | inhal. | 1.00 | MG | 233.29 | Z |

| | | | | | | | |

| 178.8 | L02AE01 | buserelin | parent. | 1.00 | MG | 253.00 | K/P |

| | | | | | | | |

| 178.9 | L02AE01 | buserelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1.00 | MG | 1 719.80 | K/P |

| | | | | | | | |

| 178.10 | L02AE01 | buserelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1.00 | MG | 1 576.70 | K/P |

| | | | | | | | |

| 178.11 | L02AE02 | leuprorelin | parent. | 1.00 | MG | 253.00 | K/P |

| | | | | | | | |

| 178.12 | L02AE02 | leuprorelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1.00 | MG | 1 294.40 | K/P |

| | | | | | | | |

| 178.13 | L02AE02 | leuprorelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1.00 | MG | 1 218.60 | K/P |

| | | | | | | | |

| 178.14 | L02AE03 | goserelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1.00 | MG | 1 294.40 | K/P |

| | | | | | | | |

| 178.15 | L02AE03 | goserelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1.00 | MG | 1 269.20 | K/P |

| | | | | | | | |

| 178.16 | L02AE04 | triptorelin | parent. | 1.00 | DF | 226.70 | K/P |

| | | | | | | | |

| 178.17 | L02AE04 | triptorelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1.00 | MG | 1 288.90 | K/P |

| | | | | | | | |

| 178.18 | L02AE04 | triptorelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1.00 | MG | 1 218.50 | K/P |

| 53145 | MEGACE SUSP. | sus por 1×240ml | BYE | E |

| --- | --- | --- | --- | --- |

| 178.4 | L02AB02 | medroxyprogesteron | p.o. | 1.00 | GM | 141,26 | L/ONK,HEM,URN GYN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32121 | MEDROPLEX 100 MG | por tblnob 100×100mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 178.5 | L02AB02 | medroxyprogesteron | parent. | 1.00 | GM | 624,49 | L/ONK,GYN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 87805 | DEPO-PROVERA | inj sus 1×1ml-lag | PME | B |

| --- | --- | --- | --- | --- |

| 178.6 | L02AB03 | gestonoron | parent. | 1.00 | MG | 1,09 | L/ONK,GYN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 178.7 | L02AE01 | buserelin | inhal. | 1.00 | MG | 227,99 | Z |

| | | | | | | | |

| 178.8 | L02AE01 | buserelin | parent. | 1.00 | MG | 247,26 | K/P |

| | | | | | | | |

| 178.9 | L02AE01 | buserelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1.00 | MG | 1 680,76 | K/P |

| | | | | | | | |

| 178.10 | L02AE01 | buserelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1.00 | MG | 1 540,91 | K/P |

| | | | | | | | |

| 178.11 | L02AE02 | leuprorelin | parent. | 1.00 | MG | 247,26 | K/P |

| | | | | | | | |

| 178.12 | L02AE02 | leuprorelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1.00 | MG | 1 265,02 | K/P |

| | | | | | | | |

| 178.13 | L02AE02 | leuprorelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1.00 | MG | 1 190,94 | K/P |

| | | | | | | | |

| 178.14 | L02AE03 | goserelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1.00 | MG | 1 265,02 | K/P |

| | | | | | | | |

| 178.15 | L02AE03 | goserelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1.00 | MG | 1 240,39 | K/P |

| | | | | | | | |

| 178.16 | L02AE04 | triptorelin | parent. | 1.00 | DF | 221,55 | K/P |

| | | | | | | | |

| 178.17 | L02AE04 | triptorelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1.00 | MG | 1 259,64 | K/P |

| | | | | | | | |

| 178.18 | L02AE04 | triptorelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1.00 | MG | 1 190,84 | K/P |

Léčbu předepisuje onkolog, urolog, endokrinolog, dětský endokrinolog nebo gynekolog k: a) léčbě karcinomu prsní žlázy u premenopauzálních a perimenopauzálních žen (goserelin); b) léčbě karcinomu prostaty (buserelin, leuprorelin, goserelin, triptorelin); c) léčbě myomatosy spojené s poruchou fertility nebo její těžké formy vyžadující předoperační redukci nálezu (leuprorelin, goserelin, triptorelin); d) léčbě těžkých, jinak konzervativně nereagujících forem endometriózy (leuprorelin, goserelin, triptorelin); e) léčbě pubertas praecox (leuprorelin, triptorelin); f) indukci ovulace při in vitro fertilizaci pouze na základě předchozího schválení revizním lékařem (goserelin, triptorelin)

| 179 | antagonisté hormonů a příbuzné látky používané v onkologii | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 179.1 | L02AA01 | diethylstilbestrol | p.o. | 10.00 | MG | 3.32 | L/ONK,HEM,URN GYN,SEX |

| | | | | | | | |

| 179.2 | L02AA01 | diethylstilbestrol | parent. | 10.00 | MG | 6.55 | B/ONK,HEM, URN,SEX |

| | | | | | | | |

| 179.3 | L02AA02 | polyestradiol fosfát | parent. | 1.00 | MG | 3.18 | B/ONK,HEM, URN,SEX |

| | | | | | | | |

| 179.4 | L02AA03 | ethinylestradiol | p.o. | 1.00 | MG | 4.06 | L/ONK,HEM,URN GYN,SEX |

| | | | | | | | |

| 179.5 | L02AA04 | fosfestrol | p.o. | 0.10 | GM | 3.32 | L/ONK,HEM,URN GYN,SEX |

| | | | | | | | |

| 179.6 | L02AA04 | fosfestrol | parent. | 0.10 | GM | 4.79 | B/ONK,HEM, URN,SEX |

| | | | | | | | |

| 179.7 | L02BA01 | tamoxifen (do 20 mg v 1 tabletě včetně) | p.o. | 20.00 | MG | 5.00 | |

| 10703 | TAMIFEN 10 | por tbl nob 100x10mg | MOE | CY |

| --- | --- | --- | --- | --- |

| 31581 | TAMOPLEX 10 MG | por tbl nob 100x10mg-I | PHM | NL |

| 31586 | TAMOPLEX 20 MG | por tbl nob 100x20mg-l | PHM | NL |

| 44056 | TAMOXIFEN EBEWE 10 MG | por tbl nob 30x10mg | EBP | A |

| 44057 | TAMOXIFEN EBEWE 20 MG | por tbl nob 30x20mg | EBP | A |

| 67039 | TAMIFEN 10 | por tbl nob 30x10mg | MOE | CY |

| 88392 | TAMOXIFEN LACHEMA 10 | tbl 100x10mg | PVL | CZ |

| 179.8 | L02BA01 | tamoxifen (nad 20 mg v 1 tabletě) | p.o. | 20.00 | MG | 3.65 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 44058 | TAMOXIFEN EBEWE 30 MG | por tbl nob 30x30mg | EBP | A |

| --- | --- | --- | --- | --- |

| 44059 | TAMOXIFEN EBEWE 40 MG | por tbl nob 30x40mg | EBP | A |

| 179.9 | L02BA02 | toremifen | p.o. | 60.00 | MG | 9.96 | L/ONK |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 179.10 | L02BA03 | fulvestrant | parent | 8.30 | MG | 500.00 | X |

| | | | | | | | |

| 179.11 | L02BB01 | flutamid | p.o. | 0.75 | GM | 67.30 | L/ONK,URN,SEX, END |

| 16036 | APO-FLUTAMIDE | tbl obd 100x250mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 16579 | APO-FLUTAMIDE | tbl obd 100x250mg | KAT | NL |

| 31736 | FLUTAPLEX | por tbl nob 100x250mg | PHM | NL |

| 54521 | ANDRAXAN | tbl obd 100x250mg | MCI | CZ |

| 58741 | APO-FLUTAMIDE | tbl obd 100x250mg | APT | CND |

| 179.12 | L02BB02 | nilutamid | p.o. | 0.30 | GM | 158.30 | L/ONK,URN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 179.13 | L02BB03 | bicalutamid do 50 mg včetně | p.o. | 50.00 | MG | 128.00 | P |

| | | | | | | | |

| 179.14 | L02BB03 | bicalutamid nad 50 mg | p.o. | 50.00 | MG | 107.14 | P |

| 179.1 | L02AA01 | diethylstilbestrol | p.o. | 10.00 | MG | 3,24 | L/ONK,HEM,URN GYN,SEX |

| | | | | | | | |

| 179.2 | L02AA01 | diethylstilbestrol | parent. | 10.00 | MG | 6,40 | B/ONK,HEM, URN,SEX |

| | | | | | | | |

| 179.3 | L02AA02 | polyestradiol fosfát | parent. | 1.00 | MG | 3,11 | B/ONK,HEM, URN,SEX |

| | | | | | | | |

| 179.4 | L02AA03 | ethinylestradiol | p.o. | 1.00 | MG | 3,97 | L/ONK,HEM,URN GYN,SEX |

| | | | | | | | |

| 179.5 | L02AA04 | fosfestrol | p.o. | 0.10 | GM | 3,24 | L/ONK,HEM,URN GYN,SEX |

| | | | | | | | |

| 179.6 | L02AA04 | fosfestrol | parent. | 0.10 | GM | 4,68 | B/ONK,HEM, URN,SEX |

| | | | | | | | |

| 179.7 | L02BA01 | tamoxifen (do 20 mg v 1 tabletě včetně) | p.o. | 20.00 | MG | 4,89 | |

| 10703 | TAMIFEN 10 | por tbl nob 100×10mg | MOE | CY |

| --- | --- | --- | --- | --- |

| 31581 | TAMOPLEX 10 MG | por tbl nob 100×10mg-l | PHM | NL |

| 31586 | TAMOPLEX 20 MG | por tbl nob 100×20mg-l | PHM | NL |

| 44056 | TAMOXIFEN EBEWE 10 MG | por tbl nob 30×10mg | EBP | A |

| 44057 | TAMOXIFEN EBEWE 20 MG | por tbl nob 30×20mg | EBP | A |

| 67039 | TAMIFEN 10 | por tbl nob 30×10mg | MOE | CY |

| 88392 | TAMOXIFEN LACHEMA 10 | tbl 100×10mg | PVL | CZ |

| 179.8 | L02BA01 | tamoxifen (nad 20 mg v 1 tabletě) | p.o. | 20.00 | MG | 3,57 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 44058 | TAMOXIFEN EBEWE 30 MG | por tbl nob 30×30mg | EBP | A |

| --- | --- | --- | --- | --- |

| 44059 | TAMOXIFEN EBEWE 40 MG | por tbl nob 30×40mg | EBP | A |

| 179.9 | L02BA02 | toremifen | p.o. | 60.00 | MG | 9,73 | L/ONK |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 179.10 | L02BA03 | fulvestrant | parent | 8.30 | MG | 488,65 | X |

| | | | | | | | |

| 179.11 | L02BB01 | flutamid | p.o. | 0.75 | GM | 65,77 | L/ONK,URN,SEX, END |

| 16036 | APO-FLUTAMIDE | tbl obd 100×250mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 16579 | APO-FLUTAMIDE | tbl obd 100×250mg | KAT | NL |

| 31736 | FLUTAPLEX | por tbl nob 100×250mg | PHM | NL |

| 54521 | ANDRAXAN | tbl obd 100×250mg | MCI | CZ |

| 58741 | APO-FLUTAMIDE | tbl obd 100×250mg | APT | CND |

| 179.12 | L02BB02 | nilutamid | p.o. | 0.30 | GM | 154,71 | L/ONK,URN,SEX |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 179.13 | L02BB03 | bicalutamid do 50 mg včetně | p.o. | 50.00 | MG | 125,09 | P |

| | | | | | | | |

| 179.14 | L02BB03 | bicalutamid nad 50 mg | p.o. | 50.00 | MG | 104,71 | P |

Léčba bicalutamidem 50 mg je indikována u pacientů s karcinomem prostaty, u kterých léčba flutamidem vede k rozvoji závažných nežádoucích účinků.

Léčba bicalutamidem 150 mg je předepisována urologem a onkologem jako časná adjuvantní léčba u nemocných s klinicky lokalizovaným karcinomem prostaty po radikální prostatektomii s rizikovými faktory (Gleason skoré ≥ 7, perineurální šíření nádoru, pozitivní chirurgické okraje), nebo u nemocných s klinicky lokalizovaným karcinomem prostaty jako konkomitantní a adjuvantní léčba k radioterapii.

Léčba bicalutamidem 150 mg je předepisována urologem a onkologem jako časná adjuvantní léčba u nemocných s klinicky lokalizovaným karcinomem prostaty po radikální prostatektomii s rizikovými faktory (Gleason skore ≥ 7, perineurální šíření nádoru, pozitivní chirurgické okraje), nebo u nemocných s klinicky lokalizovaným karcinomem prostaty jako konkomitantní a adjuvantní léčba k radioterapii.

| 180 | inhibitory steroidních hormonů používané v onkologii | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 180.1 | L02BG01 | aminogluthetimid | p.o. | 1.00 | GM | 62.45 | L/ONK,END |

| | | | | | | | |

| 180.2 | L02BG02 | formestan | parent. | 18.00 | MG | 235.90 | X |

| | | | | | | | |

| 180.3 | L02BG03 | anastrozol | p.o. | 1.00 | MG | 144.40 | X |

| | | | | | | | |

| 180.4 | L02BG04 | letrozol | p.o. | 2.50 | MG | 144.40 | X |

| 56509 | FEMARA | por tbl flm 30x2.5mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 180.5 | L02BG06 | exemestan | p.o. | 25.00 | MG | 144.40 | X |

| 180.1 | L02BG01 | aminogluthetimid | p.o. | 1.00 | GM | 61,03 | L/ONK,END |

| | | | | | | | |

| 180.2 | L02BG02 | formestan | parent. | 18.00 | MG | 230,55 | X |

| | | | | | | | |

| 180.3 | L02BG03 | anastrozol | p.o. | 1.00 | MG | 141,12 | X |

| | | | | | | | |

| 180.4 | L02BG04 | letrozol | p.o. | 2.50 | MG | 141,12 | X |

| 56509 | FEMARA | por tbl flm30×2.5mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 180.5 | L02BG06 | exemestan | p.o. | 25.00 | MG | 141,12 | X |

| | | | | | | | |

| 181 | Imunostimulační a imunomodulační léčiva včetně interferonů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 181.1 | L03AA02 | filgrastim | parent. | 1.00 | MG | 9 070.60 | X |

| | | | | | | | |

| 181.2 | L03AA13 | pegfilgrastim | parent. | 1.00 | MG | 5 620.00 | X |

| | | | | | | | |

| 181.3 | L03AA03 | molgramostim (do 0,3 mgG včetně v jedné ampuli) | parent. | 1.00 | MG | 13 613.27 | X |

| | | | | | | | |

| 181.4 | L03AA03 | molgramostim (nad 0,3 mg v jedné ampuli) | parent. | 1.00 | MG | 11 843.67 | X |

| | | | | | | | |

| 181.5 | L03AA10 | lenograstim | parent. | 1.00 | MG | 12 477.40 | X |

| | | | | | | | |

| 181.6 | L03AB01 | interferon alfa natural | parent. | 1.00 | MU | 219.09 | X |

| | | | | | | | |

| 181.7 | L03AB03 | interferon gamma | parent. | 1.00 | MU | 1 531.33 | X |

| | | | | | | | |

| 181.8 | L03AB04 | interferon alfa-2a - aplikční forma „pera“ | parent. | 1.00 | MU | 219.09 | X |

| | | | | | | | |

| 181.9 | L03AB04 | interferon alfa-2a do 10 MU v 1 ampuli vč. - jiné aplikační formy | parent. | 1.00 | MU | 219.09 | X |

| 16555 | ROFERON-A 9 MIU/0.5ML | sol inj5x9mu/0.5ml | RCE | CZ |

| --- | --- | --- | --- | --- |

| 181.10 | L03AB04 | interferon alfa-2a nad 10 MU v 1 ampuli vč. – jiné aplikační formy | parent. | 1.00 | MU | 202.50 | X |

| | | | | | | | |

| 181.11 | L03AB05 | interferon alfa-2b - aplikční forma „pera“ | parent. | 1.00 | MU | 219.09 | X |

| | | | | | | | |

| 181.12 | L03AB05 | interferon alfa-2b do 10 MU v 1 ampuli včetně - jiné aplikační formy | parent. | 1.00 | MU | 219.09 | X |

| | | | | | | | |

| 181.13 | L03AB05 | interferon alfa-2b nad 10 MU v 1 ampuli -jiné aplikační formy | parent. | 1.00 | MU | 202.50 | X |

| | | | | | | | |

| 181.14 | L03AB06 | interferon alfa-n 1 do 9MU v 1 ampuli včetně | parent. | 1.00 | MU | 219.09 | X |

| | | | | | | | |

| 181.15 | L03AB06 | interferon alfa-n1 více než 9MU v 1 ampuli | parent. | 1.00 | MU | 202.50 | X |

| | | | | | | | |

| 181.16 | L03AB07 | interferon beta - 1a do 22 rg v 1 amp. včetně | parent. | 1.00 | MU | 409.37 | X |

| | | | | | | | |

| 181.17 | L03AB07 | interferon beta - 1a nad 22 rg do 44 rg v 1 amp. včetně | parent. | 1.00 | MU | 314.00 | X |

| | | | | | | | |

| 181.18 | L03AB07 | interferon beta-1a výhradně pro intramuskulární podání | parent. | 1.00 | MU | 988.70 | X |

| | | | | | | | |

| 181.19 | L03AB08 | interferon beta-1b | parent. | 1.00 | MU | 276.80 | X |

| | | | | | | | |

| 181.20 | L03AB09 | interferon alfacon – 1 | parent. | 1.00 | MU | 219.09 | X |

| | | | | | | | |

| 181.21 | L03AB10 | peginterferon alfa- 2b | parent. | 1.00 | RG | 72.83 | X |

| | | | | | | | |

| 181.22 | L03AB11 | peginterferon alfa- 2a | parent. | 1.00 | RG | 47.40 | X |

| | | | | | | | |

| 181.23 | L03AC01 | aldesleukin | parent. | 1.00 | MG | 7 141.00 | X |

| 181.1 | L03AA02 | filgrastim | parent. | 1.00 | MG | 8 864,70 | X |

| | | | | | | | |

| 181.2 | L03AA13 | pegfilgrastim | parent. | 1.00 | MG | 5 620,00 | X |

| | | | | | | | |

| 181.3 | L03AA03 | molgramostim (do 0,3 mgG včetně v jedné ampuli) | parent. | 1.00 | MG | 13 304,25 | X |

| | | | | | | | |

| 181.4 | L03AA03 | molgramostim (nad 0,3 mg v jedné ampuli) | parent. | 1.00 | MG | 11 574,82 | X |

| | | | | | | | |

| 181.5 | L03AA10 | lenograstim | parent. | 1.00 | MG | 12 194,16 | X |

| | | | | | | | |

| 181.6 | L03AB01 | interferon alfa natural | parent. | 1.00 | MU | 214,12 | X |

| | | | | | | | |

| 181.7 | L03AB03 | interferon gamma | parent. | 1.00 | MU | 1 496,57 | X |

| | | | | | | | |

| 181.8 | L03AB04 | interferon alfa-2a - aplikční forma „pera“ | parent. | 1.00 | MU | 214,12 | X |

| | | | | | | | |

| 181.9 | L03AB04 | interferon alfa-2a do 10 MU v 1 ampuli vč. - jiné aplikační formy | parent. | 1.00 | MU | 214,12 | X |

| 16555 | ROFERON-A 9 MIU/0.5ML | sol inj 5×9mu/0.5ml | RCE | CZ |

| --- | --- | --- | --- | --- |

| 181.10 | L03AB04 | interferon alfa-2a nad 10 MU v 1 ampuli vč. – jiné aplikační formy | parent. | 1.00 | MU | 197,90 | X |

| | | | | | | | |

| 181.11 | L03AB05 | interferon alfa-2b - aplikční forma „pera“ | parent. | 1.00 | MU | 214,12 | X |

| | | | | | | | |

| 181.12 | L03AB05 | interferon alfa-2b do 10 MU v 1 ampuli včetně - jiné aplikační formy | parent. | 1.00 | MU | 214,12 | X |

| | | | | | | | |

| 181.13 | L03AB05 | interferon alfa-2b nad 10 MU v 1 ampuli -jiné aplikační formy | parent. | 1.00 | MU | 197,90 | X |

| | | | | | | | |

| 181.14 | L03AB06 | interferon alfa-n 1 do 9MU v 1 ampuli včetně | parent. | 1.00 | MU | 214,12 | X |

| | | | | | | | |

| 181.15 | L03AB06 | interferon alfa-n1 více než 9MU v 1 ampuli | parent. | 1.00 | MU | 197,90 | X |

| | | | | | | | |

| 181.16 | L03AB07 | interferon beta - 1a do 22 rg v 1 amp. včetně | parent. | 1.00 | MU | 400,08 | X |

| | | | | | | | |

| 181.17 | L03AB07 | interferon beta - 1a nad 22 rg do 44 rg v 1 amp. včetně | parent. | 1.00 | MU | 306,87 | X |

| | | | | | | | |

| 181.18 | L03AB07 | interferon beta-1a výhradně pro intramuskulární podání | parent. | 1.00 | MU | 966,26 | X |

| | | | | | | | |

| 181.19 | L03AB08 | interferon beta-1b | parent. | 1.00 | MU | 270,52 | X |

| | | | | | | | |

| 181.20 | L03AB09 | interferon alfacon -1 | parent. | 1.00 | MU | 214,12 | X |

| | | | | | | | |

| 181.21 | L03AB10 | peginterferon alfa- 2b | parent. | 1.00 | RG | 71,18 | X |

| | | | | | | | |

| 181.22 | L03AB11 | peginterferon alfa- 2a | parent. | 1.00 | RG | 46,32 | X |

| | | | | | | | |

| 181.23 | L03AC01 | aldesleukin | parent. | 1.00 | MG | 6 978,90 | X |

| | | | | | | | |

| 182 | ostatní imunostimulační a imunomodulační léčiva | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 182.1 | L03AX | bac. propionibacterii acnes | parent. | 1.00 | MG | 72.83 | O/ONK |

| | | | | | | | |

| 182.2 | L03AX | dialyzát lidských leukocytů | parent. | 1.00 | DF | 844.00 | P |

| 182.1 | L03AX | bac. propionibacterii acnes | parent. | 1.00 | MG | 71,18 | O/ONK |

| | | | | | | | |

| 182.2 | L03AX | dialyzát lidských leukocytů | parent. | 1.00 | DF | 824,84 | P |

Dialyzát lidských leukocytů předepisuje lékař odbornosti alergolog a klinický imunolog nemocným se středně těžkou a těžkou primární nebo sekundární poruchou celulární imunity, prokázanou laboratorním imunologickým vyšetřením.

| 182.3 | L03AX | dialyzát vepřových leukocytů | p.o. | 1.00 | BA | 60% | L/ALG,IMU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 182.4 | L03AX | laktobacillus acidophilus | parent. | 3.00 | DF | 587.57 | O/GYN |

| 86711 | SOLCOTRICHOVAC | inj sus 3x0.5ml | IAB | CH |

| | | | | | | | |

| 182.4 | L03AX | laktobacillus acidophilus | parent. | 3.00 | DF | 574,23 | O/GYN |

| 86711 | SOLCOTRICHOVAC | inj sus 3×0.5ml | IAB | CH |

| --- | --- | --- | --- | --- |

| 182.5 | L03AX | směs bakteriálních lyzátů | lok. | 1.00 | BA | 60% | L/ALG,ORL |

| | | | | | | | |

| 182.6 | L03AX | směs bakteriálních lyzátů | p.o. | 1.00 | BA | 60% | |

| | | | | | | | |

| 182.7 | L03AX | thymostimulin (do 10 mg včetně v jedné ampuli) | parent. | 1.00 | MG | 64.86 | Z |

| | | | | | | | |

| 182.8 | L03AX | thymostimulin (nad 10 mg v jedné ampuli) | parent. | 1.00 | MG | 45.31 | Z |

| | | | | | | | |

| 182.9 | L03AX | vaccin. staphyl. phagolys. | lok. | 1.00 | ML | 36.51 | L/ALG,ORL |

| | | | | | | | |

| 182.10 | L03AX | vaccin. staphyl. phagolys. | parent. | 1.00 | DF | 72.98 | O |

| | | | | | | | |

| 182.11 | L03AX03 | BCG vakcína | lok. | 1.00 | MG | 37.00 | O/ONK,URN |

| | | | | | | | |

| 182.12 | L03AX13 | glatirameracetat kopolymer | parent. | 20.00 | MG | 1 106.56 | X |

| 182.7 | L03AX | thymostimulin (do 10 mg včetně v jedné ampuli) | parent. | 1.00 | MG | 63,39 | Z |

| | | | | | | | |

| 182.8 | L03AX | thymostimulin (nad 10 mg v jedné ampuli) | parent. | 1.00 | MG | 44,28 | Z |

| | | | | | | | |

| 182.9 | L03AX | vaccin. staphyl. phagolys. | lok. | 1.00 | ML | 35,68 | L/ALG,ORL |

| | | | | | | | |

| 182.10 | L03AX | vaccin. staphyl. phagolys. | parent. | 1.00 | DF | 71,32 | O |

| | | | | | | | |

| 182.11 | L03AX03 | BCG vakcína | lok. | 1.00 | MG | 36,16 | O/ONK,URN |

| | | | | | | | |

| 182.12 | L03AX13 | glatirameracetat kopolymer | parent. | 20.00 | MG | 1 081,44 | X |

| | | | | | | | |

| 183 | imunosupresivní léčiva, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 183.1 | L04AA01 | cyklosporin | p.o. | 250.00 | MG | 240.70 | P |

| 183.1 | L04AA01 | cyklosporin | p.o. | 250.00 | MG | 235,24 | P |

Léčba cyklosporinem je indikována:

@@ -6641,12 +6697,12 @@

- k) u myasthenia gravis předepisuje neurolog.

- l) u těžké generalizované formy atopické dermatitidy se syndromem hyper-IgE.

| 183.2 | L04AA05 | tacrolimus do 0,5 mg v jedné tabletě včetně | p.o. | 5.00 | MG | 407.30 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 183.3 | L04AA05 | tacrolimus nad 0,5 mg v jedné tabletě | p.o. | 5.00 | MG | 329.40 | P |

- I) u těžké generalizované formy atopické dermatitidy se syndromem hyper-IgE.

| 183.2 | L04AA05 | tacrolimus do 0,5 mg v jedné tabletě včetně | p.o. | 5.00 | MG | 398,05 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 183.3 | L04AA05 | tacrolimus nad 0,5 mg v jedné tabletě | p.o. | 5.00 | MG | 321,92 | P |

Léčbu tacrolimem předepisuje lékař pracující v transplantačních centrech v indikaci:

@@ -6656,17 +6712,17 @@

- 3. transplantace jater

| 183.4 | L04AA06 | kyselina mykophenolová | p.o. | 2.00 | GM | 447.08 | P |

| 183.4 | L04AA06 | kyselina mykophenolová | p.o. | 2.00 | GM | 436,93 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu mykofenolovou kyselinou předepisuje lékař pracující v transplantačních centrech v indikaci profylaxe rejekce štěpu proti hostiteli pouze u pacientů, u kterých byla provedena alogenní transplantace ledvin nebo transplantace srdce nebo plic. Podává se v kombinaci s cyklosporinem a kortikosteroidy.

| 183.5 | L04AA10 | sirolimus | p.o. | 6.00 | MG | 630.20 | P |

| 183.5 | L04AA10 | sirolimus | p.o. | 6.00 | MG | 615,89 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Sirolimus předepisují lékaři transplantačních center u transplantací ledvin jako profylaktickou imunosupresi s prednisonem a redukovanou dávkou cyklosporinu nebo bez něj nebo v případě nefrotoxicity kalcineurinových inhibitorů jako jejich náhrada.

| 183.6 | L04AA13 | leflunomid | p.o. | 20.00 | MG | 79.10 | P |

| 183.6 | L04AA13 | leflunomid | p.o. | 20.00 | MG | 77,30 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu leflunomidem předepisuje revmatolog u pacientů s těžkou formou:

@@ -6675,150 +6731,150 @@

- b) psoriatické artritidy.

| 183.7 | L04AA18 | everolimus | p.o. | 1.50 | MG | 315.10 | P |

| 183.7 | L04AA18 | everolimus | p.o. | 1.50 | MG | 307,95 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Everolimus předepisují lékaři transplantačních center u transplantací ledvin jako profylaktickou imunosupresi s prednisonem a redukovanou dávkou cyklosporinu nebo bez něj nebo v případě nefrotoxicity kalcineurinových inhibitorů jako jejich náhrada.

| 183.8 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 1.81 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 14317 | IMURAN 25 MG | tbl obd 100x25mg | HNN | D |

| --- | --- | --- | --- | --- |

| 23322 | AZAPRINE 25 MG | por tbl flm 100x25mg | IXP | CZ |

| 49023 | IMURAN 25 MG | tbl obd 100x25mg | GAE | PL |

| 183.9 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10.00 | MG | 1.12 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 23323 | AZAPRINE 50 MG | por tbl flm 100x50mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 183.10 | L04AX02 | thalidomidum do 50mg v jedné tabletě včetně | p.o. | 100.00 | MG | 174.00 | X |

| | | | | | | | |

| 183.11 | L04AX02 | thalidomidum nad 50mg v jedné tabletě | p.o. | 100.00 | MG | 124.00 | X |

| 183.8 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10.00 | MG | 1,77 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 14317 | IMURAN 25 MG | tbl obd 100×25mg | HNN | D |

| --- | --- | --- | --- | --- |

| 23322 | AZAPRINE 25 MG | por tbl flm 100×25mg | IXP | CZ |

| 49023 | IMURAN 25 MG | tbl obd 100×25mg | GAE | PL |

| 183.9 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10.00 | MG | 1,09 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 23323 | AZAPRINE 50 MG | por tbl flm 100×50mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 183.10 | L04AX02 | thalidomidum do 50mg v jedné tabletě včetně | p.o. | 100.00 | MG | 170,05 | X |

| | | | | | | | |

| 183.11 | L04AX02 | thalidomidum nad 50mg v jedné tabletě | p.o. | 100.00 | MG | 121,19 | X |

| | | | | | | | |

| 184 | imunosupresivní léčiva ostatní cesty aplikace a ostatní cytostatika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 184.1 | L04AA01 | cyklosporin | parent. | 1.00 | MG | 2.52 | U/J10 |

| 15643 | SANDIMMUN | inf cnc sol 10x5ml | NAI | CZ |

| --- | --- | --- | --- | --- |

| 88514 | SANDIMMUN | inf cnc sol 10x5ml | NPA | CH |

| 184.2 | L04AA02 | muromonab-CD3 | parent. | 5.00 | MG | 11 129.25 | U/J10 |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 184.3 | L04AA03 | antilymfocytární IG | parent. | 10.00 | MG | 103.87 | U/J10 |

| | | | | | | | |

| 184.4 | L04AA04 | antithymocytární IG (infuze) | parent. | 1.00 | MG | 69.40 | U/J10 |

| | | | | | | | |

| 184.5 | L04AA04 | antithymocytární IG (injekce) | parent. | 1.00 | MG | 121.46 | U/J10 |

| | | | | | | | |

| 184.6 | L04AA05 | tacrolimus | parent. | 5.00 | MG | 1 544.69 | H |

| 57631 | PROGRAF 5 MG/ML | inf cnc sol10x1ml/5mg | FUJ | IRL |

| --- | --- | --- | --- | --- |

| 184.7 | L04AA08 | daclizumab | parent. | 350.00 | MG | 139 608.00 | U/J10 |

| | | | | | | | |

| 184.8 | L04AA09 | basiliximab | parent. | 20.00 | MG | 50 354.15 | H |

| | | | | | | | |

| 184.9 | L04AA11 | etanerceptum | parent. | 7.00 | MG | 391.80 | X |

| | | | | | | | |

| 184.10 | L04AA12 | infliximab | parent. | 375.00 | MG | 66 975.00 | X |

| | | | | | | | |

| 184.11 | L04AA17 | adalimumab | parent. | 2 | DF | 41 316.38 | X |

| | | | | | | | |

| 184.12 | L04AA21 | efalizumab | parent. | 1.00 | MG | 69.48 | X |

| | | | | | | | |

| 184.13 | L04AX01 | azathioprin | parent. | 1.00 | MG | 9.82 | U/J10 |

| 184.1 | L04AA01 | cyklosporin | parent. | 1.00 | MG | 2,46 | U/J10 |

| 15643 | SANDIMMUN | inf cnc sol 10×5ml | NAI | CZ |

| --- | --- | --- | --- | --- |

| 88514 | SANDIMMUN | inf cnc sol 10×5ml | NPA | CH |

| 184.2 | L04AA02 | muromonab-CD3 | parent. | 5.00 | MG | 10 876,62 | U/J10 |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 184.3 | L04AA03 | antilymfocytární IG | parent. | 10.00 | MG | 101,51 | U/J10 |

| | | | | | | | |

| 184.4 | L04AA04 | antithymocytární IG (infuze) | parent. | 1.00 | MG | 67,82 | U/J10 |

| | | | | | | | |

| 184.5 | L04AA04 | antithymocytární IG (injekce) | parent. | 1.00 | MG | 118,70 | U/J10 |

| | | | | | | | |

| 184.6 | L04AA05 | tacrolimus | parent. | 5.00 | MG | 1 509,63 | H |

| 57631 | PROGRAF 5 MG/ML | inf cnc sol 10×1ml/5mg | FUJ | IRL |

| --- | --- | --- | --- | --- |

| 184.7 | L04AA08 | daclizumab | parent. | 350.00 | MG | 136 438,90 | U/J10 |

| | | | | | | | |

| 184.8 | L04AA09 | basiliximab | parent. | 20.00 | MG | 49 211,11 | H |

| | | | | | | | |

| 184.9 | L04AA11 | etanerceptum | parent. | 7.00 | MG | 1 360,21 | X |

| | | | | | | | |

| 184.10 | L04AA12 | infliximab | parent. | 375.00 | MG | 65 454,67 | X |

| | | | | | | | |

| 184.11 | L04AA17 | adalimumab | parent. | 2 | DF | 40 378,50 | X |

| | | | | | | | |

| 184.12 | L04AA21 | efalizumab | parent. | 1.00 | MG | 69,48 | X |

| | | | | | | | |

| 184.13 | L04AX01 | azathioprin | parent. | 1.00 | MG | 9,60 | U/J10 |

| | | | | | | | |

| 185 | nesteroidní protizánětlivá léčiva ze skupiny butylpyrazolidinů a derivátů kyseliny octové, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 185.1 | M01AA | butylpyrazolidiny | p.o. | 3.00 | DF | 3.32 | |

| | | | | | | | |

| 185.2 | M01AA05 | klofezon | p.o. | 0.60 | GM | 3.32 | |

| | | | | | | | |

| 185.3 | M01AB | deriváty kyseliny octové | p.o. | 70.00 | MG | 1.76 | |

| | | | | | | | |

| 185.4 | M01AB01 | indometacin | p.o. | 0.10 | GM | 2.47 | |

| | | | | | | | |

| 185.5 | M01AB02 | sulindac | p.o. | 0.40 | GM | 4.36 | |

| | | | | | | | |

| 185.6 | M01AB03 | tolmetin | p.o. | 0.70 | GM | 4.36 | |

| | | | | | | | |

| 185.7 | M01AB05 | diklofenak | p.o. | 0.10 | GM | 3.60 | |

| 75605 | DICLOFENAC AL 25 | tbl obd 100x25mg | APA | D |

| --- | --- | --- | --- | --- |

| 185.8 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku | p.o. | 0.10 | GM | 3.80 | |

| | | | | | | | |

| 185.9 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 3.60 | |

| | | | | | | | |

| 185.10 | M01AB09 | lonazolak | p.o. | 0.60 | GM | 3.60 | |

| | | | | | | | |

| 185.11 | M01AB16 | aceklofenak | p.o. | 0.20 | GM | 3.60 | |

| | | | | | | | |

| 185.12 | M01AB55 | diklofenak/misoprostol (na obsah diklofenaku) | p.o. | 0.10 | GM | 29.33 | Z |

| 185.1 | M01AA | butylpyrazolidiny | p.o. | 3.00 | DF | 3,24 | |

| | | | | | | | |

| 185.2 | M01AA05 | klofezon | p.o. | 0.60 | GM | 3,24 | |

| | | | | | | | |

| 185.3 | M01AB | deriváty kyseliny octové | p.o. | 70.00 | MG | 1,72 | |

| | | | | | | | |

| 185.4 | M01AB01 | indometacin | p.o. | 0.10 | GM | 2,41 | |

| | | | | | | | |

| 185.5 | M01AB02 | sulindac | p.o. | 0.40 | GM | 4,26 | |

| | | | | | | | |

| 185.6 | M01AB03 | tolmetin | p.o. | 0.70 | GM | 4,26 | |

| | | | | | | | |

| 185.7 | M01AB05 | diklofenak | p.o. | 0.10 | GM | 3,52 | |

| 75605 | DICLOFENAC AL 25 | tbl obd 100×25mg | APA | D |

| --- | --- | --- | --- | --- |

| 185.8 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku | p.o. | 0.10 | GM | 3,71 | |

| | | | | | | | |

| 185.9 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 3,52 | |

| | | | | | | | |

| 185.10 | M01AB09 | lonazolak | p.o. | 0.60 | GM | 3,52 | |

| | | | | | | | |

| 185.11 | M01AB16 | aceklofenak | p.o. | 0.20 | GM | 3,52 | |

| | | | | | | | |

| 185.12 | M01AB55 | diklofenak/misoprostol (na obsah diklofenaku) | p.o. | 0.10 | GM | 28,66 | Z |

| | | | | | | | |

| 186 | nesteroidní protizánětlivá léčiva ze skupiny derivátů kyseliny propionové a fenamátů, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 186.1 | M01AE01 | ibuprofen | p.o. | 1.20 | GM | 3.31 | |

| 15301 | APO-IBUPROFEN 400 MG | tbl obd 100x400mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 17907 | APO-IBUPROFEN 400 MG | tbl obd 100x400mg | KAT | NL |

| 186.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.20 | GM | 19.55 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 186.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.50 | GM | 3.60 | |

| | | | | | | | |

| 186.4 | M01AE02 | naproxen (tekuté lékové formy), | p.o. | 0.50 | GM | 13.15 | |

| | | | | | | | |

| 186.5 | M01AE03 | ketoprofen | p.o. | 0.15 | GM | 3.60 | |

| | | | | | | | |

| 186.6 | M01AE07 | suprofen | p.o. | 0.40 | GM | 3.60 | |

| | | | | | | | |

| 186.7 | M01AE08 | pirprofen | p.o. | 0.80 | GM | 3.60 | |

| | | | | | | | |

| 186.8 | M01AE09 | flurbiprofen | p.o. | 0.20 | GM | 3.60 | |

| | | | | | | | |

| 186.9 | M01AE10 | indoprofen | p.o. | 0.60 | GM | 3.60 | |

| | | | | | | | |

| 186.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.60 | GM | 3.60 | |

| | | | | | | | |

| 186.11 | M01AE12 | oxaprozin | p.o. | 0.90 | GM | 8.25 | P |

| 186.1 | M01AE01 | ibuprofen | p.o. | 1.20 | GM | 3,23 | |

| 15301 | APO-IBUPROFEN 400 MG | tbl obd 100×400mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 17907 | APO-IBUPROFEN 400 MG | tbl obd 100×400mg | KAT | NL |

| 186.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.20 | GM | 19,11 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 186.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.50 | GM | 3,52 | |

| | | | | | | | |

| 186.4 | M01AE02 | naproxen (tekuté lékové formy), | p.o. | 0.50 | GM | 12,85 | |

| | | | | | | | |

| 186.5 | M01AE03 | ketoprofen | p.o. | 0.15 | GM | 3,52 | |

| | | | | | | | |

| 186.6 | M01AE07 | suprofen | p.o. | 0.40 | GM | 3,52 | |

| | | | | | | | |

| 186.7 | M01AE08 | pirprofen | p.o. | 0.80 | GM | 3,52 | |

| | | | | | | | |

| 186.8 | M01AE09 | flurbiprofen | p.o. | 0.20 | GM | 3,52 | |

| | | | | | | | |

| 186.9 | M01AE10 | indoprofen | p.o. | 0.60 | GM | 3,52 | |

| | | | | | | | |

| 186.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.60 | GM | 3,52 | |

| | | | | | | | |

| 186.11 | M01AE12 | oxaprozin | p.o. | 0.90 | GM | 8,06 | P |

Oxaprozin se podává při léčbě akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů, kteří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena.

| 186.12 | M01AE17 | dexketoprofen | p.o. | 75.00 | MG | 4.52 | |

| | | | | | | | |

| 186.13 | M01AG02 | kyselina tolfenámová | p.o. | 0.30 | GM | 4.29 | |

| 186.12 | M01AE17 | dexketoprofen | p.o. | 75.00 | MG | 4,42 | |

| | | | | | | | |

| 186.13 | M01AG02 | kyselina tolfenámová | p.o. | 0.30 | GM | 4,19 | |

| | | | | | | | |

| 187 | ostatní nesteroidní protizánětlivá léčiva pro perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 187.1 | M01AC01 | piroxikam | p.o. | 20.00 | MG | 2.00 | |

| 14997 | APO-PIROXICAM 20 | cps 100x20mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 17159 | APO-PIROXICAM 20 | cps 100x20mg | KAT | NL |

| 97710 | APO-PIROXICAM 20 | cps 100x20mg | APT | CND |

| 187.2 | M01AC01 | piroxikam (lékové formy s rychlým nástupem účinku) | p.o. | 20.00 | MG | 3.80 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 187.3 | M01AC02 | tenoxikam | p.o. | 20.00 | MG | 2.00 | |

| | | | | | | | |

| 187.4 | M01AC05 | lornoxikam | p.o. | 12.00 | MG | 2.00 | |

| | | | | | | | |

| 187.5 | M01AC06 | meloxikam | p.o. | 15.00 | MG | 6.50 | |

| 187.1 | M01AC01 | piroxikam | p.o. | 20.00 | MG | 1,95 | |

| 14997 | APO-PIROXICAM 20 | cps 100×20mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 17159 | APO-PIROXICAM 20 | cps 100×20mg | KAT | NL |

| 97710 | APO-PIROXICAM 20 | cps 100×20mg | APT | CND |

| 187.2 | M01AC01 | piroxikam (lékové formy s rychlým nástupem účinku) | p.o. | 20.00 | MG | 3,71 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 187.3 | M01AC02 | tenoxikam | p.o. | 20.00 | MG | 1,95 | |

| | | | | | | | |

| 187.4 | M01AC05 | lornoxikam | p.o. | 12.00 | MG | 1,95 | |

| | | | | | | | |

| 187.5 | M01AC06 | meloxikam | p.o. | 15.00 | MG | 6,35 | |

Léčiva skupiny specifických COX 2 inhibitorů jsou předepisována revmatologem nebo ortopedem osobám s níže uvedeným rizikem:

@@ -6840,105 +6896,105 @@

Léčiva ze skupiny specifických COX-2 inhibitorů jsou kontraindikována u nemocných s ICHS, infarktem myokardu a je třeba dbát zvýšené opatrnosti v případě jejich indikování u pacientů trpících hypertenzí, hyperlipidémií, diabetem mellitus, periferním onemocněním tepen i kuřáků. Podávání COX-2 inhibitorů je třeba omezit na co nejkratší dobu a nejnižší účinnou dávku. Etoricoxib je navíc kontraindikován u nekompenzované hypertenze.

| 13280 | RECOXA 15 | por tbl nob 10x15mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 13281 | RECOXA 15 | por tbl nob 20x15mg | ZEH | CZ |

| 187.6 | M01AH01 | celecoxib | p.o. | 0.20 | GM | 22.70 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 187.7 | M01AH03 | valdecoxib 10 mg | p.o. | 1.00 | DF | 22.70 | P |

| | | | | | | | |

| 187.8 | M01AH03 | valdecoxib 20 mg | p.o. | 1.00 | DF | 25.90 | P |

| | | | | | | | |

| 187.9 | M01AH03 | valdecoxib 40 mg | p.o. | 1.00 | DF | 24.30 | P |

| 13280 | RECOXA 15 | por tbl nob 10×15mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 13281 | RECOXA 15 | por tbl nob 20×15mg | ZEH | CZ |

| 187.6 | M01AH01 | celecoxib | p.o. | 0.20 | GM | 22,18 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 187.7 | M01AH03 | valdecoxib 10 mg | p.o. | 1.00 | DF | 22,18 | P |

| | | | | | | | |

| 187.8 | M01AH03 | valdecoxib 20 mg | p.o. | 1.00 | DF | 25,31 | P |

| | | | | | | | |

| 187.9 | M01AH03 | valdecoxib 40 mg | p.o. | 1.00 | DF | 23,75 | P |

V indikaci osteoartróza a revmatoidní artritida je předepisována denní dávka valdecoxibu do 20 mg včetně, v indikaci primární dysmenorea denní dávka valdecoxibu v prvním dni do 80 mg včetně a následující dny do 40 mg včetně.

| 187.10 | M01AH05 | etoricoxib 120 mg v 1 tbl | p.o. | 60.00 | MG | 25.90 | P |

| 187.10 | M01AH05 | etoricoxib 120 mg v 1 tbl | p.o. | 60.00 | MG | 25,31 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Etoricoxib v síle 120 mg v 1 tbl je hrazen při akutním dnavém záchvatu.

| 187.11 | M01AH05 | etoricoxib 60 mg v 1 tbl | p.o. | 1.00 | DF | 22.70 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 187.12 | M01AH05 | etoricoxib 90 mg v 1 tbl | p.o. | 1.00 | DF | 25.90 | P |

| | | | | | | | |

| 187.13 | M01AX01 | nabumeton | p.o. | 1.00 | GM | 6.50 | P |

| 187.11 | M01AH05 | etoricoxib 60 mg v 1 tbl | p.o. | 1.00 | DF | 22,18 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 187.12 | M01AH05 | etoricoxib 90 mg v 1 tbl | p.o. | 1.00 | DF | 25,31 | P |

| | | | | | | | |

| 187.13 | M01AX01 | nabumeton | p.o. | 1.00 | GM | 6,35 | P |

Nabumeton se podává při léčbě akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů, kteří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena.

| 187.14 | M01AX04 | azapropazon | p.o. | 0.75 | GM | 6.50 | |

| | | | | | | | |

| 187.15 | M01AX13 | proquazon | p.o. | 0.90 | GM | 6.50 | |

| | | | | | | | |

| 187.16 | M01AX17 | nimesulid | p.o. | 0.20 | GM | 6.50 | |

| 187.14 | M01AX04 | azapropazon | p.o. | 0.75 | GM | 6,35 | |

| | | | | | | | |

| 187.15 | M01AX13 | proquazon | p.o. | 0.90 | GM | 6,35 | |

| | | | | | | | |

| 187.16 | M01AX17 | nimesulid | p.o. | 0.20 | GM | 6,35 | |

| | | | | | | | |

| 188 | nesteroidní protizánětlivá léčiva ze skupiny derivátů kyseliny octové, ze skupiny derivátů kyseliny propionové a fenamátů, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 188.1 | M01AA | butylpyrazolidiny | parent. | 1.00 | DF | 6.89 | |

| | | | | | | | |

| 188.2 | M01AB01 | indometacin | p.rect. | 0.10 | GM | 3.27 | |

| | | | | | | | |

| 188.3 | M01AB01 | indometacin | parent. | 0.10 | GM | 12.66 | |

| | | | | | | | |

| 188.4 | M01AB03 | tolmetin | p.rect. | 0.70 | GM | 10.56 | |

| | | | | | | | |

| 188.5 | M01AB05 | diklofenak | p.rect. | 0.10 | GM | 7.65 | |

| | | | | | | | |

| 188.6 | M01AB05 | diklofenak | parent. | 0.10 | GM | 9.90 | |

| 67548 | ALMIRAL | inj 100x3ml/75mg | MOE | CY |

| --- | --- | --- | --- | --- |

| 188.7 | M01AB09 | lonazolak | p.rect. | 0.60 | GM | 10.56 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 188.8 | M01AC01 | piroxikam | p.rect. | 20.00 | MG | 7.65 | |

| | | | | | | | |

| 188.9 | M01AC01 | piroxikam | parent. | 20.00 | MG | 11.73 | |

| | | | | | | | |

| 188.10 | M01AC02 | tenoxikam | p.rect. | 20.00 | MG | 10.75 | |

| | | | | | | | |

| 188.11 | M01AC02 | tenoxikam | parent. | 20.00 | MG | 11.73 | |

| | | | | | | | |

| 188.12 | M01AC05 | lornoxikam | parent. | 12.00 | MG | 11.73 | |

| | | | | | | | |

| 188.13 | M01AC06 | meloxikam | p.rect. | 15.00 | MG | 13.00 | P |

| 188.1 | M01AA | butylpyrazolidiny | parent. | 1.00 | DF | 6,73 | |

| | | | | | | | |

| 188.2 | M01AB01 | indometacin | p.rect. | 0.10 | GM | 3,20 | |

| | | | | | | | |

| 188.3 | M01AB01 | indometacin | parent. | 0.10 | GM | 12,37 | |

| | | | | | | | |

| 188.4 | M01AB03 | tolmetin | p.rect. | 0.70 | GM | 10,32 | |

| | | | | | | | |

| 188.5 | M01AB05 | diklofenak | p.rect. | 0.10 | GM | 7,48 | |

| | | | | | | | |

| 188.6 | M01AB05 | diklofenak | parent. | 0.10 | GM | 9,68 | |

| 67548 | ALMIRAL | inj 100×3ml/75mg | MOE | CY |

| --- | --- | --- | --- | --- |

| 188.7 | M01AB09 | lonazolak | p.rect. | 0.60 | GM | 10,32 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 188.8 | M01AC01 | piroxikam | p.rect. | 20.00 | MG | 7,48 | |

| | | | | | | | |

| 188.9 | M01AC01 | piroxikam | parent. | 20.00 | MG | 11,46 | |

| | | | | | | | |

| 188.10 | M01AC02 | tenoxikam | p.rect. | 20.00 | MG | 10,51 | |

| | | | | | | | |

| 188.11 | M01AC02 | tenoxikam | parent. | 20.00 | MG | 11,46 | |

| | | | | | | | |

| 188.12 | M01AC05 | lornoxikam | parent. | 12.00 | MG | 11,46 | |

| | | | | | | | |

| 188.13 | M01AC06 | meloxikam | p.rect. | 15.00 | MG | 12,70 | P |

Meloxikam se podává při léčbě akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů, kteří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena.

| 188.14 | M01AC06 | meloxikam | parent. | 15.00 | MG | 39.00 | P |

| 188.14 | M01AC06 | meloxikam | parent. | 15.00 | MG | 38,11 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Meloxikam parenterální se podává při léčbě akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů, kteří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena a to v případě, že nelze použít tabletovou a čípkovou formu.

| 188.15 | M01AE01 | ibuprofen | p.rect. | 1.20 | GM | 9.38 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 188.16 | M01AE01 | ibuprofen | parent. | 1.20 | GM | 13.73 | |

| | | | | | | | |

| 188.17 | M01AE02 | naproxen | p.rect. | 0.50 | GM | 10.75 | |

| | | | | | | | |

| 188.18 | M01AE02 | naproxen | parent. | 0.50 | GM | 13.73 | |

| | | | | | | | |

| 188.19 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 8.37 | |

| | | | | | | | |

| 188.20 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 15.45 | |

| 76657 | KETONAL | inj 10x2ml/100mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 188.21 | M01AE11 | kyselina tiaprofenová | p.rect. | 0.60 | GM | 10.75 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 188.22 | M01AG | etofenamat | parent. | 1.00 | GM | 13.73 | |

| | | | | | | | |

| 188.23 | M01AH04 | parecoxib do 3 amp v 1 bal. včetně | parent. | 80.00 | MG | 334.00 | P |

| | | | | | | | |

| 188.24 | M01AH04 | parecoxib nad 3 amp v 1 bal. | parent. | 80.00 | MG | 334.00 | O/P |

| 188.15 | M01AE01 | ibuprofen | p.rect. | 1.20 | GM | 9,17 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 188.16 | M01AE01 | ibuprofen | parent. | 1.20 | GM | 13,42 | |

| | | | | | | | |

| 188.17 | M01AE02 | naproxen | p.rect. | 0.50 | GM | 10,51 | |

| | | | | | | | |

| 188.18 | M01AE02 | naproxen | parent. | 0.50 | GM | 13,42 | |

| | | | | | | | |

| 188.19 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 8,18 | |

| | | | | | | | |

| 188.20 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 15,10 | |

| 76657 | KETONAL | inj 10×2ml/100mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 188.21 | M01AE11 | kyselina tiaprofenová | p.rect. | 0.60 | GM | 10,51 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 188.22 | M01AG | etofenamat | parent. | 1.00 | GM | 13,42 | |

| | | | | | | | |

| 188.23 | M01AH04 | parecoxib do 3 amp v 1 bal. včetně | parent. | 80.00 | MG | 326,42 | P |

| | | | | | | | |

| 188.24 | M01AH04 | parecoxib nad 3 amp v 1 bal. | parent. | 80.00 | MG | 326,42 | O/P |

Léčiva skupiny specifických COX-2 inhibitorů jsou předepisována revmatologem nebo ortopedem osobám s níže uvedeným rizikem:

@@ -6958,7 +7014,7 @@

Léčiva ze skupiny specifických COX-2 inhibitorů jsou kontraindikována u nemocných s ICHS, infarktem myokardu a neúplně kompenzovanou hypertenzí. Jejich podávání je třeba omezit na co nejkratší dobu a nejnižší účinnou dávku. Parecoxib je hrazen pro léčbu pooperační bolesti u pacientů s nesnášenlivostí opioidních analgetik nebo u pacientů s vředovou chorobou nebo krvácením do GIT v anamnéze.

| 188.25 | M01AX17 | nimesulid | p.rect. | 0.20 | GM | 13.00 | P |

| 188.25 | M01AX17 | nimesulid | p.rect. | 0.20 | GM | 12,70 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Nimesulid k p.rect. aplikaci je indikován k léčbě akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů, kteří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena.

@@ -6966,179 +7022,177 @@

| 189 | specifická antirevmatika a ostatní léčiva užívaná při nemocech muskuloskeletálního systému | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 189.1 | M01CB01 | aurothiomalát sodný | parent. | 2.40 | MG | 6.10 | L/REV |

| 02780 | TAUREDON 50 | inj sol 10x0.5ml/50mg | AKZ | D |

| --- | --- | --- | --- | --- |

| 02781 | TAUREDON 20 | inj sol 10x0.5ml/20mg | AKZ | D |

| 189.2 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.50 | GM | 27.28 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 66755 | METALCAPTASE 150 | tbl obd 50x150mg | HEL | D |

| --- | --- | --- | --- | --- |

| 189.3 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.50 | GM | 22.56 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 66753 | METALCAPTASE 300 | tbl obd 50x300mg | HEL | D |

| --- | --- | --- | --- | --- |

| 189.4 | N02BA | lysin acetylsalicylát | parent. | 3.00 | GM | 40.37 | |

| | | | | | | | |

| 189.5 | N02BA | lysin salicylát | parent. | 3.00 | GM | 41.79 | |

| | | | | | | | |

| 189.6 | N02BA04 | salicylát sodný | parent. | 3.00 | GM | 38.58 | |

| 189.1 | M01CB01 | aurothiomalát sodný | parent. | 2.40 | MG | 5,96 | L/REV |

| 02780 | TAUREDON 50 | inj sol 10×0.5ml/50mg | AKZ | D |

| --- | --- | --- | --- | --- |

| 02781 | TAUREDON 20 | inj sol 10×0.5ml/20mg | AKZ | D |

| 189.2 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.50 | GM | 26,66 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 66755 | METALCAPTASE 150 | tbl obd 50×150mg | HEL | D |

| --- | --- | --- | --- | --- |

| 189.3 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.50 | GM | 22,05 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 66753 | METALCAPTASE 300 | tbl obd 50×300mg | HEL | D |

| --- | --- | --- | --- | --- |

| 189.4 | N02BA | lysin acetylsalicylát | parent. | 3.00 | GM | 39,45 | |

| | | | | | | | |

| 189.5 | N02BA | lysin salicylát | parent. | 3.00 | GM | 40,84 | |

| | | | | | | | |

| 189.6 | N02BA04 | salicylát sodný | parent. | 3.00 | GM | 37,70 | |

| | | | | | | | |

| 190 | lokálně aplikovaná nesteroidní protizánětlivá léčiva | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 190.1 | M02AA | ketofenylbutazon do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.2 | M02AA | kombinace ibuprofenu a heparinoidu do 50 g včetně v jednom balení | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.3 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití, nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0.70 | |

| | | | | | | | |

| 190.4 | M02AA05 | benzydamin | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.5 | M02AA06 | etofenamát do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.6 | M02AA06 | etofenamát nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0.70 | |

| 190.7 | M02AA07 | piroxikam do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0.85 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 190.8 | M02AA07 | piroxikam nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0.70 | |

| | | | | | | | |

| 190.9 | M02AA10 | ketoprofen do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.10 | M02AA10 | ketoprofen nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0.70 | |

| | | | | | | | |

| 190.11 | M02AA10 | ketoprofen spray (dle obsahu ketoprofenu) | lok. | 150.00 | MG | 5.50 | |

| | | | | | | | |

| 190.12 | M02AA13 | ibuprofen do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.13 | M02AA13 | ibuprofen nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0.70 | |

| | | | | | | | |

| 190.14 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2.00 | DF | 5.08 | |

| | | | | | | | |

| 190.15 | M02AA15 | diklofenak do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.16 | M02AA15 | diklofenak nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0.70 | |

| 16580 | DOLMINA GEL | drm gel 1x100gm | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 67550 | ALMIRAL GEL | gel 1x250gm | MOE | CY |

| 190.17 | M02AA17 | kyselina niflumová nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0.70 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 190.18 | M02AA21 | tolectin do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.19 | M02AA21 | tolectin nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0.70 | |

| | | | | | | | |

| 190.20 | M02AA23 | indomethacin do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.21 | M02AA23 | indomethacin nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0.70 | |

| | | | | | | | |

| 190.22 | M02AA23 | indomethacin spray | lok. | 1.00 | ML | 0.85 | |

| | | | | | | | |

| 190.23 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.24 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1.00 | GM | 0.85 | |

| | | | | | | | |

| 190.25 | M02AX10 | různé | lok. | 1.00 | GM | 0.21 | |

| 83872 | UNGUENTUM CAMPHOR.VASEL. 10% MVM | drm ung 1x1000gm | MVM | CZ |

| 190.1 | M02AA | ketofenylbutazon do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.2 | M02AA | kombinace ibuprofenu a heparinoidu do 50 g včetně v jednom balení | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.3 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití, nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0,68 | |

| | | | | | | | |

| 190.4 | M02AA05 | benzydamin | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.5 | M02AA06 | etofenamat do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.6 | M02AA06 | etofenamat nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0,68 | |

| | | | | | | | |

| 190.7 | M02AA07 | piroxikam do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.8 | M02AA07 | piroxikam nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0,68 | |

| | | | | | | | |

| 190.9 | M02AA10 | ketoprofen do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.10 | M02AA10 | ketoprofen nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0,68 | |

| | | | | | | | |

| 190.11 | M02AA10 | ketoprofen spray (dle obsahu ketoprofenu) | lok. | 150.00 | MG | 5,38 | |

| | | | | | | | |

| 190.12 | M02AA13 | ibuprofen do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.13 | M02AA13 | ibuprofen nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0,68 | |

| | | | | | | | |

| 190.14 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2.00 | DF | 4,96 | |

| | | | | | | | |

| 190.15 | M02AA15 | diklofenak do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.16 | M02AA15 | diklofenak nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0,68 | |

| 16580 | DOLMINA GEL | drm gel 1×100gm | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 67550 | ALMIRAL GEL | gel 1×250gm | MOE | CY |

| 190.17 | M02AA17 | kyselina niflumová nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0,68 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 190.18 | M02AA21 | tolectin do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.19 | M02AA21 | tolectin nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0,68 | |

| | | | | | | | |

| 190.20 | M02AA23 | indomethacin do 50 g masti včetně v jednom balení | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.21 | M02AA23 | indomethacin nad 50 g masti v jednom balení | lok. | 1.00 | GM | 0,68 | |

| | | | | | | | |

| 190.22 | M02AA23 | indomethacin spray | lok. | 1.00 | ML | 0,83 | |

| | | | | | | | |

| 190.23 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.24 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1.00 | GM | 0,83 | |

| | | | | | | | |

| 190.25 | M02AX10 | různé | lok. | 1.00 | GM | 0,21 | |

| 83872 | UNGUENTUM CAMPHOR.VASEL.10% MVM | drm ung 1×1000gm | MVM | CZ |

| --- | --- | --- | --- | --- |

| 191 | svalová relaxancia | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 191.1 | M03AA01 | alkuronium | parent. | 20.00 | MG | 70.43 | H |

| | | | | | | | |

| 191.2 | M03AA02 | tubokurarin | parent. | 30.00 | MG | 55.82 | H |

| | | | | | | | |

| 191.3 | M03AB | decamethonium | parent. | 10.00 | MG | 23.76 | H |

| 191.4 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100.00 | MG | 63.84 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 191.5 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100.00 | MG | 40.52 | H |

| | | | | | | | |

| 191.6 | M03AC02 | gallamin | parent. | 100.00 | MG | 43.11 | H |

| | | | | | | | |

| 191.7 | M03AC01 | pankuronium | parent. | 10.00 | MG | 113.59 | H |

| | | | | | | | |

| 191.8 | M03AC03 | vekuronium | parent. | 10.00 | MG | 113.59 | H |

| | | | | | | | |

| 191.9 | M03AC04 | atrakurium | parent. | 50.00 | MG | 98.58 | H |

| | | | | | | | |

| 191.10 | M03AC06 | pipekuronium | parent. | 10.00 | MG | 103.48 | H |

| | | | | | | | |

| 191.11 | M03AC09 | rokuroniumbromid | parent. | 50.00 | MG | 200.00 | H |

| | | | | | | | |

| 191.12 | M03AC10 | mivacuronium | parent. | 10.00 | MG | 123.20 | H |

| 42587 | MIVACRON | inj 5x10ml/20mg | WFD | GB |

| --- | --- | --- | --- | --- |

| 42588 | MIVACRON | inj 5x10ml/20mg | GAK | I |

| 42589 | MIVACRON | inj 5x5ml/10mg | GAK | I |

| 42590 | MIVACRON | inj 5x5ml/10mg | WFD | GB |

| 191.13 | M03AC11 | cisatracurium | parent. | 10.00 | MG | 208.40 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| --- | --- | --- | --- |

| 191.14 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100.00 | U | 8 167.68 | X |

| | | | | | | | |

| 191.15 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100.00 | U | 2 041.92 | X |

| | | | | | | | |

| 191.16 | M03CA01 | dantrolen | parent. | 0.10 | GM | 7 008.60 | T |

| 191.1 | M03AA01 | alkuronium | parent. | 20.00 | MG | 68,83 | H |

| | | | | | | | |

| 191.2 | M03AA02 | tubokurarin | parent. | 30.00 | MG | 54,55 | H |

| | | | | | | | |

| 191.3 | M03AB | decamethonium | parent. | 10.00 | MG | 23,22 | H |

| | | | | | | | |

| 191.4 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100.00 | MG | 62,39 | H |

| | | | | | | | |

| 191.5 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100.00 | MG | 39,60 | H |

| | | | | | | | |

| 191.6 | M03AC02 | gallamin | parent. | 100.00 | MG | 42,13 | H |

| | | | | | | | |

| 191.7 | M03AC01 | pankuronium | parent. | 10.00 | MG | 111,01 | H |

| | | | | | | | |

| 191.8 | M03AC03 | vekuronium | parent. | 10.00 | MG | 111,01 | H |

| | | | | | | | |

| 191.9 | M03AC04 | atrakurium | parent. | 50.00 | MG | 96,34 | H |

| | | | | | | | |

| 191.10 | M03AC06 | pipekuronium | parent. | 10.00 | MG | 101,13 | H |

| | | | | | | | |

| 191.11 | M03AC09 | rokuroniumbromid | parent. | 50.00 | MG | 195,46 | H |

| | | | | | | | |

| 191.12 | M03AC10 | mivacuronium | parent. | 10.00 | MG | 120,40 | H |

| 42587 | MIVACRON | inj 5×10ml/20mg | WFD | GB |

| --- | --- | --- | --- | --- |

| 42588 | MIVACRON | inj 5×10ml/20mg | GAK | I |

| 42589 | MIVACRON | inj 5×5ml/10mg | GAK | I |

| 42590 | MIVACRON | inj 5×5ml/10mg | WFD | GB |

| 191.13 | M03AC11 | cisatracurium | parent. | 10.00 | MG | 203,67 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 18771 | NIMBEX FORTE | inj sol 1×30ml/150mg | GXM | I |

| --- | --- | --- | --- | --- |

| 18772 | NIMBEX | inj sol 5×2.5ml/5mg | GXM | I |

| 18773 | NIMBEX | inj sol 5×10ml/20mg | GXM | I |

| 56517 | NIMBEX FORTE | inj sol 1×30ml/150mg | GWE | GB |

| 99581 | NIMBEX FORTE | inj sol 1×30ml/150mg | GAK | I |

| 191.14 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100.00 | U | 7 982,27 | X |

| | | | | | | | |

| 191.15 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100.00 | U | 1 995,57 | X |

| | | | | | | | |

| 191.16 | M03CA01 | dantrolen | parent. | 0.10 | GM | 6 849,50 | T |

| | | | | | | | |

| 192 | antiuratika a ostatní hrazené přípravky skupiny M nezařazené do jiných skupin | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 192.1 | M04AA01 | allopurinol | p.o. | 0.40 | GM | 3.28 | |

| | | | | | | | |

| 192.2 | M04AB02 | sulfinpyrazon | p.o. | 0.30 | GM | 5.08 | |

| | | | | | | | |

| 192.3 | M04AB03 | benzbromaron | p.o. | 0.10 | GM | 1.86 | |

| | | | | | | | |

| 192.4 | M04AC01 | kolchicin | p.o. | 1.00 | MG | 5.61 | |

| 62380 | COLCHICUM-DISPERT | tbl obd 50x500rg | SVP | D |

| 192.1 | M04AA01 | allopurinol | p.o. | 0.40 | GM | 3,21 | |

| | | | | | | | |

| 192.2 | M04AB02 | sulfinpyrazon | p.o. | 0.30 | GM | 4,96 | |

| | | | | | | | |

| 192.3 | M04AB03 | benzbromaron | p.o. | 0.10 | GM | 1,82 | |

| | | | | | | | |

| 192.4 | M04AC01 | kolchicin | p.o. | 1.00 | MG | 5,48 | |

| 62380 | COLCHICUM-DISPERT | tbl obd 50×500rg | SVP | D |

| --- | --- | --- | --- | --- |

| 193 | léčiva působící na mineralizaci kostí | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 193.1 | G03XC01 | raloxifen | p.o. | 60.00 | MG | 29.45 | P |

Raloxifen: léčbu předepisuje internista, endokrinolog, revmatolog, ortoped, gynekolog u postmenopauzálních žen s osteoporózou prokázanou celotělovým denzitometrem (T skóre méně než -2,5 SD) nebo u žen s osteoporotickou zlomeninou v 2. volbě při nesnášenlivosti bisfosfonátů. Léčba trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.

| 193.2 | M05BA02 | kyselina klodronová | parent. | 1.50 | GM | 2 305.80 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 94548 | BONEFOS | inf cnc 5x5ml/300mg | SOT | SF |

| --- | --- | --- | --- | --- |

| 193.3 | M05BA02 | kyselina klodronová do 400 mg v jedné tabletě včetně | p.o. | 1.60 | GM | 197.94 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 94460 | BONEFOS 400 MG | cps 100x400mg | SOT | SF |

| --- | --- | --- | --- | --- |

| 193.4 | M05BA02 | kyselina klodronová nad 400 mg do 520 mg v jedné tabletě včetně | p.o. | 1.60 | GM | 304.54 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 193.5 | M05BA02 | kyselina klodronová nad 520 mg do 800 mg v jedné tabletě včetně | p.o. | 1.60 | GM | 197.94 | P |

| 193.1 | G03XC01 | raloxifen | p.o. | 60.00 | MG | 28,78 | P |

Raloxifen: léčbu předepisuje internista, endokrinolog, revmatolog, ortoped, gynekolog u postmenopauzálních žen s osteoporózou prokázánou celotělovým denzitometrem (T skóre méně než -2,5 SD) nebo u žen s osteoporotickou zlomeninou v 2. volbě při nesnášenlivosti bisfosfonátů. Léčba trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.

| 193.2 | M05BA02 | kyselina klodronová | parent. | 1.50 | GM | 2 253,46 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 94548 | BONEFOS | inf cnc 5×5ml/300mg | SOT | SF |

| --- | --- | --- | --- | --- |

| 193.3 | M05BA02 | kyselina klodronová do 400 mg v jedné tabletě včetně | p.o. | 1.60 | GM | 193,45 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 94460 | BONEFOS 400 MG | cps 100×400mg | SOT | SF |

| --- | --- | --- | --- | --- |

| 193.4 | M05BA02 | kyselina klodronová nad 400 mg do 520 mg v jedné tabletě včetně | p.o. | 1.60 | GM | 297,63 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 193.5 | M05BA02 | kyselina klodronová nad 520 mg do 800 mg v jedné tabletě včetně | p.o. | 1.60 | GM | 193,45 | P |

Léčbu kyselinou klodronovou předepisuje onkolog, hematolog, internista, ortoped u pacientů s:

@@ -7146,10 +7200,10 @@

- b) mnohočetným myelomem.

| 56638 | BONEFOS 800 MG | tbl obd 60x800mg | SOT | SF |

| --- | --- | --- | --- | --- |

| 193.6 | M05BA03 | kyselina pamidronová | parent. | 60.00 | MG | 3 758.01 | P |

| 56638 | BONEFOS 800 MG | tbl obd 60×800mg | SOT | SF |

| --- | --- | --- | --- | --- |

| 193.6 | M05BA03 | kyselina pamidronová | parent. | 60.00 | MG | 3 672,70 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu kyselinou pamidronovou předepisuje onkolog, hematolog, internista, ortoped, revmatolog, endokrinolog u pacientů s:

@@ -7160,13 +7214,13 @@

- c) manifestní Pagetovou chorobou.

| 193.7 | M05BA04 | kyselina alendronová s obsahem do 10 mg v jedné tabletě včetně | p.o. | 10.00 | MG | 18.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32656 | LINDRON | por tbl nob 28x10mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 193.8 | M05BA04 | kyselina alendronová s obsahem nad 10 mg v jedné tabletě | p.o. | 10.00 | MG | 21.00 | P |

| 193.7 | M05BA04 | kyselina alendronová s obsahem do 10 mg v jedné tabletě včetně | p.o. | 10.00 | MG | 17,59 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32656 | LINDRON | por tbl nob 28×10mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 193.8 | M05BA04 | kyselina alendronová s obsahem nad 10 mg v jedné tabletě | p.o. | 10.00 | MG | 20,52 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu kyselinou alendronovou předepisuje internista, ortoped, revmatolog, endokrinolog, gynekolog u:

@@ -7177,7 +7231,7 @@

Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky je indikována pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.

| 193.9 | M05BA06 | kyselina ibandronová | parent. | 2.00 | MG | 2 717.00 | P |

| 193.9 | M05BA06 | kyselina ibandronová | parent. | 2.00 | MG | 2 655,32 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu kyselinou ibandronovou parent. a v p.o. tabletě o síle 50 mg, předepisuje onkolog, hematolog, internista, ortoped u pacientů s:

@@ -7186,10 +7240,10 @@

- b) mnohočetným myelomem.

| 26244 | BONDRONAT 6 MG/6 ML | inf cnc sol 1x6ml | RRG | GB |

| --- | --- | --- | --- | --- |

| 193.10 | M05BA06 | kyselina ibandronová s obsahem do 2,5 mg v jedné tabletě včetně | p.o. | 1 | DF | 18.00 | P |

| 26244 | BONDRONAT 6 MG/6 ML | inf cnc sol 1×6ml | RRG | GB |

| --- | --- | --- | --- | --- |

| 193.10 | M05BA06 | kyselina ibandronová s obsahem do 2,5 mg v jedné tabletě včetně | p.o. | 1 | DF | 17,59 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu kyselinou ibandronovou p.o. předepisuje internista, ortoped, revmatolog, endokrinolog, gynekolog u:

@@ -7200,14 +7254,14 @@

Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky je indikována pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.

| 193.11 | M05BA06 | kyselina ibandronová s obsahem 50 mg v jedné tabletě | p.o. | 1 | DF | 197.94 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 193.12 | M05BA06 | kyselina ibandronová s obsahem 150 mg v jedné tabletě | p.o. | 1 | DF | 630.00 | P |

| | | | | | | | |

| 193.13 | M05BA07 | kyselina risedronová do 5 mg v 1 tabletě včetně | p.o. | 5.00 | MG | 18.00 | P |

| | | | | | | | |

| 193.14 | M05BA07 | kyselina risedronová nad 5 mg v 1 tabletě | p.o. | 5.00 | MG | 21.00 | P |

| 193.11 | M05BA06 | kyselina ibandronová s obsahem 50 mg v jedné tabletě | p.o. | 1 | DF | 193,45 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 193.12 | M05BA06 | kyselina ibandronová s obsahem 150 mg v jedné tabletě | p.o. | 1 | DF | 615,70 | P |

| | | | | | | | |

| 193.13 | M05BA07 | kyselina risedronová do 5 mg v 1 tabletě včetně | p.o. | 5.00 | MG | 17,59 | P |

| | | | | | | | |

| 193.14 | M05BA07 | kyselina risedronová nad 5 mg v 1 tabletě | p.o. | 5.00 | MG | 20,52 | P |

Léčbu kyselinou risedronovou předepisuje internista, ortoped, revmatolog, endokrinolog, gynekolog u:

@@ -7217,20 +7271,18 @@

Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky je indikována pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty

| 193.15 | M05BA08 | kyselina zoledronová do 4 mg v 1 amp. včetně | parent. | 4.00 | MG | 8 150.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 193.16 | M05BA08 | kyselina zoledronová nad 4 mg v 1 amp. | parent. | 4.00 | MG | 11114.30 | P |

| 193.15 | M05BA08 | kyselina zoledronová do 4 mg v 1 amp. včetně | parent. | 4.00 | MG | 7 965,00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 193.16 | M05BA08 | kyselina zoledronová nad 4 mg v 1 amp. | parent. | 4.00 | MG | 10 862,01 | P |

Léčba kyselinou zoledronovou je předepisována onkologem, hematologem, urologem a pneumologem u pacientů:

- a) v 1.linii léčby osteoblastických a smíšených kostních metastáz solidních tumorů a ve 2.linii léčby osteolytických lesí mnohočetného myelomu,

- b) s hyperkalcémií vyvolanou nádorovým onemocněním nereagujícím dostatečně na předchozí aplikaci jiných bisfosfonátů.

Léčba kyselinou zoledronovou je předepisována internistou, ortopedem, revmatologem nebo endokrinologem u pacientů s Pagetovou chorobou.

| 193.17 | M05BX03 | stroncium-ranelát | p.o. | 2.00 | GM | 40.85 | P |

- b) s hyperkalcémií vyvolanou nádorovým onemocněním nereagujícím dostatečně na předchozí aplikaci jiných bisfosfonátů. Léčba kyselinou zoledronovou je předepisována internistou, ortopedem, revmatologem nebo endokrinologem u pacientů s Pagetovou chorobou.

| 193.17 | M05BX03 | stroncium-ranelát | p.o. | 2.00 | GM | 39,92 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu stroncium-ranelátem předepisuje internista, ortoped, revmatolog, endokrinolog a gynekolog u pacientek:

@@ -7243,7 +7295,7 @@

Léčba delší než 2 roky je indikována pouze u pacientek s prokazatelnou zástavou úbytku kostní density.

| 193.18 | M05B | Kys. alendronová v kombinaci s vitamínem D3 (na kys. alendronovou) | p.o. | 10.00 | MG | 23.00 | P |

| 193.18 | M05B | Kys. alendronová v kombinaci s vitamínem D3 (na kys. alendronovou) | p.o. | 10.00 | MG | 22,48 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu kyselinou alendronovou v kombinaci s vitamínem D3 předepisuje internista, ortoped, revmatolog, endokrinolog, gynekolog u:

@@ -7257,613 +7309,610 @@

| 194 | ostatní léčiva používaná u nemocí muskuloskeletálního systému | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 194.1 | M01AX05 | glukosamin sulfat | p.o. | 1.00 | DF | 11.43 | L/REV, ORT |

| | | | | | | | |

| 194.2 | M01AX21 | diacerein | p.o. | 100.00 | MG | 15.24 | L/REV, ORT |

| | | | | | | | |

| 194.3 | M01AX25 | chondroitin sulfat | p.o. | 1.60 | GM | 14.66 | L/REV, ORT |

| | | | | | | | |

| 194.4 | M03BA52 | carisoprodol a paracetamol v kombinaci | p.o. | 3.00 | DF | 2.50 | |

| | | | | | | | |

| 194.5 | M03BX01 | baklofen (do 10 mg v jedné tabletě včetně) | p.o. | 50.00 | MG | 9.97 | |

| | | | | | | | |

| 194.6 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50.00 | MG | 6.31 | |

| | | | | | | | |

| 194.7 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12.00 | MG | 21.50 | L/NEU,ORT,REV |

| | | | | | | | |

| 194.8 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12.00 | MG | 15.84 | L/NEU,ORT,REV |

| | | | | | | | |

| 194.9 | M03BX04 | tolperison | p.o. | 200.00 | MG | 4.38 | |

| 194.10 | M03BX04 | tolperison | parent. | 200.00 | MG | 9.58 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 194.11 | M03BX05 | thiocolchicosid | p.o. | 12.00 | MG | 9.97 | |

| | | | | | | | |

| 194.12 | M03BX05 | thiocolchicosid | parent. | 12.00 | MG | 39.10 | |

| | | | | | | | |

| 194.13 | M03BX07 | tetrazepam | p.o. | 0.10 | GM | 9.97 | |

| | | | | | | | |

| 194.14 | M09AB52 | multienzymy (obsahující Pankreatin, trypsin, chymotrypsin, bromelain, papain, amylasu, lipasu, rutosid) | p.o. | 6.00 | DF | 8.80 | P |

| 194.1 | M01AX05 | glukosamin sulfat | p.o. | 1.00 | DF | 11,17 | L/REV, ORT |

| | | | | | | | |

| 194.2 | M01AX21 | diacerein | p.o. | 100.00 | MG | 14,89 | L/REV, ORT |

| | | | | | | | |

| 194.3 | M01AX25 | chondroitin sulfat | p.o. | 1.60 | GM | 14,33 | L/REV, ORT |

| | | | | | | | |

| 194.4 | M03BA52 | carisoprodol a paracetamol v kombinaci | p.o. | 3.00 | DF | 2,44 | |

| | | | | | | | |

| 194.5 | M03BX01 | baklofen (do 10 mg v jedné tabletě včetně) | p.o. | 50.00 | MG | 9,74 | |

| | | | | | | | |

| 194.6 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50.00 | MG | 6,17 | |

| | | | | | | | |

| 194.7 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12.00 | MG | 21,01 | L/NEU,ORT,REV |

| | | | | | | | |

| 194.8 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12.00 | MG | 15,48 | L/NEU,ORT,REV |

| | | | | | | | |

| 194.9 | M03BX04 | tolperison | p.o. | 200.00 | MG | 4,28 | |

| | | | | | | | |

| 194.10 | M03BX04 | tolperison | parent. | 200.00 | MG | 9,36 | |

| | | | | | | | |

| 194.11 | M03BX05 | thiocolchicosid | p.o. | 12.00 | MG | 9,74 | |

| | | | | | | | |

| 194.12 | M03BX05 | thiocolchicosid | parent. | 12.00 | MG | 38,21 | |

| | | | | | | | |

| 194.13 | M03BX07 | tetrazepam | p.o. | 0.10 | GM | 9,74 | |

| | | | | | | | |

| 194.14 | M09AB52 | multienzymy (obsahující pankreatin, trypsin, chymotrypsin, bromelain, papain, amylasu, lipasu, rutosid) | p.o. | 6.00 | DF | 8,60 | P |

Léčbu multienzymovými přípravky předepisuje onkolog, chirurg, internista nebo dermatolog u lymfedémů v souvislosti s radikální operací nebo s radioterapií pro malignitu, za podmínky, že ke kontrole lymfedému nedostačuje fyzikální léčba, nebo tuto nelze aplikovat.

| 194.15 | N02BB02 | metamizol sodný (do 1 g v 1 ampuli včetně) | parent. | 3.00 | GM | 44.53 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 194.16 | N02BB02 | metamizol sodný (nad 1 g v 1 ampuli) | parent. | 3.00 | GM | 18.48 | O |

| | | | | | | | |

| 194.17 | N02BB73 | aminophenazon v kombinaci s psycholeptiky | parent. | 1.00 | DF | 8.10 | O |

| | | | | | | | |

| 194.18 | N02BE01 | paracetamol (do 150 mg v jednom čípku včetně) | p.rect. | 3.00 | GM | 74.01 | |

| 86009 | BEN-U-RON 125MG | sup 5x125mg | BNC | D |

| --- | --- | --- | --- | --- |

| 194.19 | N02BE01 | paracetamol (nad 150 mg v jednom čípku) | p.rect. | 3.00 | GM | 24.81 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 86014 | BEN-U-RON 500MG | sup 10x500mg | BNC | D |

| --- | --- | --- | --- | --- |

| 86015 | BEN-U-RON 1000MG | sup 10x1000mg | BNC | D |

| 194.20 | N02BE01 | paracetamol | parent. | 3.00 | GM | 44.53 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 194.21 | N02BE05 | propacetamol | parent. | 1.00 | GM | 41.84 | O |

| | | | | | | | |

| 194.22 | M09AX01 | kyselina hyaluronová | parent. | 3.60 | MG | 195.52 | P |

Léčbu kyselinou hyaluronovou předepisuje ortoped nebo revmatolog:

součást léčby primární osteoarthrózy kolenních kloubů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.

| 194.15 | N02BB02 | metamizol sodný (do 1 g v 1 ampuli včetně) | parent. | 3.00 | GM | 43,52 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 194.16 | N02BB02 | metamizol sodný (nad 1 g v 1 ampuli) | parent. | 3.00 | GM | 18,06 | O |

| | | | | | | | |

| 194.17 | N02BB73 | aminophenazon v kombinaci s psycholeptiky | parent. | 1.00 | DF | 7,92 | O |

| | | | | | | | |

| 194.18 | N02BE01 | paracetamol (do 150 mg v jednom čípku včetně) | p.rect. | 3.00 | GM | 72,33 | |

| 86009 | BEN-U-RON 125MG | sup 5×125mg | BNC | D |

| --- | --- | --- | --- | --- |

| 194.19 | N02BE01 | paracetamol (nad 150 mg v jednom čípku) | p.rect. | 3.00 | GM | 24,25 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 86014 | BEN-U-RON 500MG | sup 10×500mg | BNC | D |

| --- | --- | --- | --- | --- |

| 86015 | BEN-U-RON 1000MG | sup 10×1000mg | BNC | D |

| 194.20 | N02BE01 | paracetamol | parent. | 3.00 | GM | 43,52 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 194.21 | N02BE05 | propacetamol | parent. | 1.00 | GM | 40,89 | O |

| | | | | | | | |

| 194.22 | M09AX01 | kyselina hyaluronová | parent. | 3.60 | MG | 191,08 | P |

Léčbu kyselinou hyaluronovou předepisuje ortoped nebo revmatolog: součást léčby primární osteoarthrózy kolenních kloubů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.

| 195 | lokální anestetika ze skupiny esterů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 195.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100.00 | GM | 15.45 | H |

| | | | | | | | |

| 195.2 | N01BA | estery aminobenzoové kyseliny | parent. | 100.00 | ML | 19.55 | O |

| | | | | | | | |

| 195.3 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1.00 | ML | 1.37 | O |

| | | | | | | | |

| 195.4 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1.00 | ML | 0.49 | O |

| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml/500mg | ARD | CZ |

| --- | --- | --- | --- | --- |

| 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml/1gm | ARD | CZ |

| 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml/1.25gm | ARD | CZ |

| 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml/2.5gm | ARD | CZ |

| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x250ml | ARD | CZ |

| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x500ml/5gm | ARD | CZ |

| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml | ARD | CZ |

| 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x200ml | ARD | CZ |

| 89216 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x200ml | ARD | CZ |

| 195.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100.00 | GM | 15,10 | H |

| | | | | | | | |

| 195.2 | N01BA | estery aminobenzoové kyseliny | parent. | 100.00 | ML | 19,11 | O |

| | | | | | | | |

| 195.3 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1.00 | ML | 1,34 | O |

| | | | | | | | |

| 195.4 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1.00 | ML | 0,48 | O |

| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1×250ml/500mg | ARD | CZ |

| --- | --- | --- | --- | --- |

| 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1×500ml/1gm | ARD | CZ |

| 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1×250ml/1.25gm | ARD | CZ |

| 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1×500ml/2.5gm | ARD | CZ |

| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1×250ml | ARD | CZ |

| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1×500ml/5gm | ARD | CZ |

| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1×200ml | ARD | CZ |

| 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1×200ml | ARD | CZ |

| 89216 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1×200ml | ARD | CZ |

| 196 | lokální anestetika ze skupiny amidů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 196.1 | N01BB | trimekain | lok. | 1.00 | GM | 1.18 | O |

| | | | | | | | |

| 196.2 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1.00 | ML | 0.73 | O |

| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ |

| --- | --- | --- | --- | --- |

| 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ |

| 196.3 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1.00 | ML | 1.43 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 196.4 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1.00 | ML | 0.40 | O |

| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ |

| --- | --- | --- | --- | --- |

| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ |

| 196.5 | N01BB | trimekain (koncentrace 2%) | parent. | 1.00 | ML | 1.22 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 196.6 | N01BB | trimekain/adrenalin | parent. | 1.00 | ML | 2.35 | O |

| | | | | | | | |

| 196.7 | N01BB01 | bupivakain | parent. | 1.00 | ML | 3.52 | O |

| 06623 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 1x50ml | SLH | D |

| --- | --- | --- | --- | --- |

| 06624 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 10x50ml | SLH | D |

| 06625 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 50x50ml | SLH | D |

| 06634 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 10x50ml | SLH | D |

| 06635 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 50x50ml | SLH | D |

| 196.8 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1.00 | ML | 31.75 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 196.9 | N01BB02 | lidokain | parent. | 1.00 | ML | 1.22 | O |

| | | | | | | | |

| 196.10 | N01BB02 | lidokain (obsah 11 ml) | lok. | 1.00 | ML | 3.902 | P |

| | | | | | | | |

| 196.11 | N01BB02 | lidokain (obsah 6 ml) | lok. | 1.00 | ML | 5.60 | P |

| 196.1 | N01BB | trimekain | lok. | 1.00 | GM | 1,15 | O |

| | | | | | | | |

| 196.2 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1.00 | ML | 0,71 | O |

| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1×250ml 0.5% | ARD | CZ |

| --- | --- | --- | --- | --- |

| 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1×500ml 0.5% | ARD | CZ |

| 196.3 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1.00 | ML | 1,40 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 196.4 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1.00 | ML | 0,39 | O |

| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1×250ml 1% | ARD | CZ |

| --- | --- | --- | --- | --- |

| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1×500ml 1% | ARD | CZ |

| 196.5 | N01BB | trimekain (koncentrace 2%) | parent. | 1.00 | ML | 1,19 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 196.6 | N01BB | trimekain/adrenalin | parent. | 1.00 | ML | 2,30 | O |

| | | | | | | | |

| 196.7 | N01BB01 | bupivakain | parent. | 1.00 | ML | 3,44 | O |

| 06623 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 1×50ml | SLH | D |

| --- | --- | --- | --- | --- |

| 06624 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 10×50ml | SLH | D |

| 06625 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 50×50ml | SLH | D |

| 06634 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 10×50ml | SLH | D |

| 06635 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 50×50ml | SLH | D |

| 196.8 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1.00 | ML | 31,03 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 196.9 | N01BB02 | lidokain | parent. | 1.00 | ML | 1,19 | O |

| | | | | | | | |

| 196.10 | N01BB02 | lidokain (obsah 11 ml) | lok. | 1.00 | ML | 3,81 | P |

| | | | | | | | |

| 196.11 | N01BB02 | lidokain (obsah 6 ml) | lok. | 1.00 | ML | 5,47 | P |

Autokatetrizace močových cest prováděná pacientem v domácí péči.

| 196.12 | N01BB03 | mepivakain | parent. | 1.00 | ML | 3.52 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 196.13 | N01BB08 | artikain | parent. | 1.00 | ML | 4.15 | O |

| | | | | | | | |

| 196.14 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1.00 | ML | 9.86 | O |

| | | | | | | | |

| 196.15 | N01BB09 | levobupivacain | parent. | 1.00 | ML | 11.60 | O |

| 17962 | NAROPIN 2 MG/ML | inf sol 5x100ml/200mg | AZC | D |

| --- | --- | --- | --- | --- |

| 46610 | NAROPIN 2 MG/ML | inf sol 5x100ml/200mg | AZC | S |

| 56038 | NAROPIN 2 MG/ML | inj sol 5x10ml/20mg | AZC | S |

| 196.16 | N01BB10 | ropivacain | parent. | 1.00 | ML | 11.60 | 0 |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03755 | CHIROCAINE 2.5 MG/ML | inj sol 10x10ml | ABB | I |

| --- | --- | --- | --- | --- |

| 196.17 | N01BB51 | bupivakain/adrenalin | parent. | 1.00 | ML | 3.81 | O |

| 196.12 | N01BB03 | mepivakain | parent. | 1.00 | ML | 3,44 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 196.13 | N01BB08 | artikain | parent. | 1.00 | ML | 4,06 | O |

| | | | | | | | |

| 196.14 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1.00 | ML | 9,64 | O |

| | | | | | | | |

| 196.15 | N01BB09 | levobupivacain | parent. | 1.00 | ML | 11,34 | O |

| 17962 | NAROPIN 2 MG/ML | inf sol 5×100ml/200mg | AZC | D |

| --- | --- | --- | --- | --- |

| 46610 | NAROPIN 2 MG/ML | inf sol 5×100ml/200mg | AZC | S |

| 56038 | NAROPIN 2 MG/ML | inj sol 5×10ml/20mg | AZC | S |

| 196.16 | N01BB10 | ropivacain | parent. | 1.00 | ML | 11,34 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03755 | CHIROCAINE 2.5 MG/ML | inj sol 10×10ml | ABB | I |

| --- | --- | --- | --- | --- |

| 196.17 | N01BB51 | bupivakain/adrenalin | parent. | 1.00 | ML | 3,72 | O |

| | | | | | | | |

| 197 | lokální anestetika ze skupiny amidů v kombinaci s adrenalinem nebo jinou vazokonstrikční látkou | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 197.1 | N01BB52 | lidokain/adrenalin | parent. | 1.00 | ML | 2.35 | O |

| | | | | | | | |

| 197.2 | N01BB58 | artikain/adrenalin | parent. | 1.00 | ML | 4.44 | O |

| 93109 | SUPRACAIN 4% | inj 10x2ml | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 197.3 | N01BX01 | ethylchlorid | lok. | 100.00 | ML | 93.36 | O |

| 197.1 | N01BB52 | lidokain/adrenalin | parent. | 1.00 | ML | 2,30 | O |

| | | | | | | | |

| 197.2 | N01BB58 | artikain/adrenalin | parent. | 1.00 | ML | 4,34 | O |

| 93109 | SUPRACAIN 4% | inj 10×2ml | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 197.3 | N01BX01 | ethylchlorid | lok. | 100.00 | ML | 91,24 | O |

| | | | | | | | |

| 198 | analgetika – anodyna (opioidy) ze skupiny derivátů morfinu, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 198.1 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.10 | GM | 43.88 | |

| 80408 | VENDAL RETARD 100MG | tbl obd 30x100mg | LAR | A |

| --- | --- | --- | --- | --- |

| 94312 | MST CONTINUS 100MG | tbl ret 60x100mg | NPP | GB |

| 198.2 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.10 | GM | 73.73 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 198.3 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.10 | GM | 49.44 | |

| 80406 | VENDAL RETARD 30MG | tbl obd 30x30mg | LAR | A |

| --- | --- | --- | --- | --- |

| 198.4 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.10 | GM | 47.15 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 80407 | VENDAL RETARD 60MG | tbl obd 30x60mg | LAR | A |

| --- | --- | --- | --- | --- |

| 94311 | MST CONTINUS 60MG | tbl ret 60x60mg | NPP | GB |

| 198.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, 100 a více mg v jedné dávce) | p.o. | 0.10 | GM | 53.90 | |

| | | | | | | | |

| 198.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.10 | GM | 61.60 | |

| | | | | | | | |

| 198.7 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.10 | GM | 58.36 | |

| | | | | | | | |

| 198.8 | N02AA01 | morfin (tekuté lékové formy, do 200 mg včetně v jednom balení) | p.o. | 0.10 | GM | 39.10 | |

| | | | | | | | |

| 198.9 | N02AA01 | morfin (tekuté lékové formy, nad 200 mg v jednom balení) | p.o. | 0.10 | GM | 17.60 | |

| | | | | | | | |

| 198.10 | N02AA03 | hydromorfon do 4 mg v 1 tbl včetně | p.o. | 20.00 | MG | 98.60 | |

| | | | | | | | |

| 198.11 | N02AA03 | hydromorfon nad 4 mg do 8 mg v 1 tbl včetně | p.o. | 20.00 | MG | 93.34 | |

| | | | | | | | |

| 198.12 | N02AA03 | hydromorfon nad 8 mg do 24 mg v 1 tbl včetně | p.o. | 20.00 | MG | 88.50 | |

| | | | | | | | |

| 198.13 | N02AB02 | pethidin | p.o. | 0.40 | GM | 41.30 | |

| | | | | | | | |

| 199 | analgetika – anodyna (opioidy) ze skupiny analogů morfinu, perorálni podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 199.1 | N02AA05 | oxycodon do 20 mg v jedné tabletě včetně | p.o. | 75.00 | MG | 125.10 | |

| | | | | | | | |

| 199.2 | N02AA05 | oxycodon více než 20 mg do 40 mg v jedné tabletě včetně | p.o. | 75.00 | MG | 118.47 | |

| | | | | | | | |

| 199.3 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 75.00 | MG | 109.58 | |

| | | | | | | | |

| 199.4 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.15 | GM | 27.84 | |

| 10123 | DHC CONTINUS 60 MG | por tbl ret 60x60mg b | NPP | GB |

| --- | --- | --- | --- | --- |

| 199.5 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.15 | GM | 23.95 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 199.6 | N02AC05 | benzitramid | p.o. | 10.00 | MG | 12.71 | |

| | | | | | | | |

| 199.7 | N02AD01 | pentazocin | p.o. | 0.20 | GM | 22.39 | |

| 08968 | FORTRAL | tbl 100x50mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 199.8 | N02AX01 | tilidin | p.o. | 0.20 | GM | 19.78 | |

| | | | | | | | |

| 199.9 | N02AX02 | tramadol hydrochlorid (pevné lékové formy neretardované) | p.o. | 0.30 | GM | 14.90 | |

| | | | | | | | |

| 199.10 | N02AX02 | tramadol hydrochlorid (tekuté lékové formy) | p.o. | 0.30 | GM | 24.44 | |

| | | | | | | | |

| 199.11 | N02AX02 | tramadol hydrochlorid (pevné lékové formy retardované) | p.o. | 0.30 | GM | 23.52 | |

| | | | | | | | |

| 199.12 | N02AX52 | tramadol hydrochlorid v kombinaci s paracetamolem | p.o. | 1.00 | DF | 5.00 | |

| 198.1 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.10 | GM | 42,88 | |

| 80408 | VENDAL RETARD 100MG | tbl obd 30×100mg | LAR | A |

| --- | --- | --- | --- | --- |

| 94312 | MST CONTINUS 100MG | tbl ret 60×100mg | NPP | GB |

| 198.2 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.10 | GM | 72,06 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 198.3 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.10 | GM | 48,32 | |

| 80406 | VENDAL RETARD 30MG | tbl obd 30×30mg | LAR | A |

| --- | --- | --- | --- | --- |

| 198.4 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.10 | GM | 46,08 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 80407 | VENDAL RETARD 60MG | tbl obd 30×60mg | LAR | A |

| --- | --- | --- | --- | --- |

| 94311 | MST CONTINUS 60MG | tbl ret 60×60mg | NPP | GB |

| 198.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, 100 a více mg v jedné dávce) | p.o. | 0.10 | GM | 52,68 | |

| | | | | | | | |

| 198.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.10 | GM | 60,20 | |

| | | | | | | | |

| 198.7 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.10 | GM | 57,04 | |

| | | | | | | | |

| 198.8 | N02AA01 | morfin (tekuté lékové formy, do 200 mg včetně v jednom balení) | p.o. | 0.10 | GM | 38,21 | |

| | | | | | | | |

| 198.9 | N02AA01 | morfin (tekuté lékové formy, nad 200 mg v jednom balení) | p.o. | 0.10 | GM | 17,20 | |

| | | | | | | | |

| 198.10 | N02AA03 | hydromorfon do 4 mg v 1 tbl včetně | p.o. | 20.00 | MG | 96,36 | |

| | | | | | | | |

| 198.11 | N02AA03 | hydromorfon nad 4 mg do 8 mg v 1 tbl včetně | p.o. | 20.00 | MG | 91,22 | |

| | | | | | | | |

| 198.12 | N02AA03 | hydromorfon nad 8 mg do 24 mg v 1 tbl včetně | p.o. | 20.00 | MG | 86,49 | |

| | | | | | | | |

| 198.13 | N02AB02 | pethidin | p.o. | 0.40 | GM | 40,36 | |

| | | | | | | | |

| 199 | analgetika – anodyna (opioidy) ze skupiny analogů morfinu, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 199.1 | N02AA05 | oxycodon do 20 mg v jedné tabletě včetně | p.o. | 75.00 | MG | 122,26 | |

| | | | | | | | |

| 199.2 | N02AA05 | oxycodon více než 20 mg do 40 mg v jedné tabletě včetně | p.o. | 75.00 | MG | 115,78 | |

| | | | | | | | |

| 199.3 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 75.00 | MG | 107,09 | |

| | | | | | | | |

| 199.4 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.15 | MG | 27,21 | |

| 10123 | DHC CONTINUS 60 MG | por tbl ret 60×60mg b | NPP | GB |

| --- | --- | --- | --- | --- |

| 199.5 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.15 | GM | 23,41 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 199.6 | N02AC05 | benzitramid | p.o. | 10.00 | MG | 12,42 | |

| | | | | | | | |

| 199.7 | N02AD01 | pentazocin | p.o. | 0.20 | GM | 21,88 | |

| 08968 | FORTRAL | tbl 100×50mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 199.8 | N02AX01 | tilidin | p.o. | 0.20 | GM | 19,33 | |

| | | | | | | | |

| 199.9 | N02AX02 | tramadol hydrochlorid (pevné lékové formy neretardované) | p.o. | 0.30 | GM | 14,56 | |

| | | | | | | | |

| 199.10 | N02AX02 | tramadol hydrochlorid ( tekuté lékové formy) | p.o. | 0.30 | GM | 23,89 | |

| | | | | | | | |

| 199.11 | N02AX02 | tramadol hydrochlorid (pevné lékové formy retardované) | p.o. | 0.30 | GM | 22,99 | |

| | | | | | | | |

| 199.12 | N02AX52 | tramadol hydrochlorid v kombinaci s paracetamolem | p.o. | 1.00 | DF | 4,89 | |

| | | | | | | | |

| 200 | analgetika – anodyna (opioidy) ze skupiny analogů morfinu, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 200.1 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent | 1.00 | MG | 137.80 | O |

| 30101 | FENTANYL TORREX 50MCG/ML | inj 5x2ml/100rg | TRX | A |

| --- | --- | --- | --- | --- |

| 200.2 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1.00 | MG | 101.48 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 30102 | FENTANYL TORREX 50MCG/ML | inj 5x10ml/500rg | TRX | A |

| --- | --- | --- | --- | --- |

| 200.3 | N01AH02 | alfentanyl | parent. | 1.50 | MG | 46.89 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 87721 | RAPIFEN | inj sol 5x2ml/1mg | JAN | B |

| --- | --- | --- | --- | --- |

| 200.4 | N01AH03 | sufentanyl (do 10 rg v ampuli včetně) | parent. | 0.60 | MG | 1 342.74 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 93701 | SUFENTA | inj 5x2ml/10rg | JAN | B |

| --- | --- | --- | --- | --- |

| 200.5 | N01AH03 | sufentanyl (nad 10 do 50 rg v ampuli včetně) | parent. | 0.60 | MG | 644.02 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21043 | SUFENTANIL TORREX 5 MCG/ML | inj sol 10x10ml/50rg | TRX | A |

| --- | --- | --- | --- | --- |

| 21044 | SUFENTANIL TORREX 5 MCG/ML | inj sol 20x10ml/50rg | TRX | A |

| 30779 | SUFENTANIL TORREX 5 MCG/ML | inj sol 5x10ml/50rg | TRX | A |

| 85526 | SUFENTA FORTE | inj 5x1ml/50rg | JAN | B |

| 200.6 | N01AH03 | sufentanyl (nad 50 rg v ampuli) | parent. | 0.60 | MG | 718.96 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21088 | SUFENTANIL TORREX 50 MCG/ML | inj sol 5x5ml/250rg | TRX | A |

| --- | --- | --- | --- | --- |

| 21089 | SUFENTANIL TORREX 50 MCG/ML | inj sol 10x5ml/250rg | TRX | A |

| 21090 | SUFENTANIL TORREX 50 MCG/ML | inj sol20x5ml/250rg | TRX | A |

| 21091 | SUFENTANIL TORREX 50 MCG/ML | inj sol 10x20ml/1mg | TRX | A |

| 21092 | SUFENTANIL TORREX 50 MCG/ML | inj sol 20x20ml/1mg | TRX | A |

| 30783 | SUFENTANIL TORREX 50 MCG/ML | inj sol 5x20ml/1mg | TRX | A |

| 93702 | SUFENTA FORTE | inj 5x5ml/250rg | JAN | B |

| 200.7 | N01AH06 | remifentanyl | parent. | 1.00 | MG | 251.19 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17712 | ULTIVA 2 MG | inj plv sol 5x2mg | GXM | I |

| --- | --- | --- | --- | --- |

| 17713 | ULTIVA 5 MG | inj plv sol 5x5mg | GXM | I |

| 86162 | ULTIVA 2 MG | inj plv sol 5x2mg | GWB | GB |

| 86163 | ULTIVA 5 MG | inj plv sol 5x5mg | GWB | GB |

| 200.8 | N01AH51 | fentanyl v kombinacích | parent. | 4.00 | ML | 38.22 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 200.9 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30.00 | MG | 15.45 | O |

| | | | | | | | |

| 200.10 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30.00 | MG | 9.33 | O |

| | | | | | | | |

| 200.11 | N02AB02 | pethidin (do 50 mg v jedné ampuli včetně) | parent. | 0.40 | GM | 55.68 | O |

| | | | | | | | |

| 200.12 | N02AB02 | pethidin (nad 50 mg v jedné ampuli) | parent. | 0.40 | GM | 34.44 | O |

| | | | | | | | |

| 200.13 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1.00 | DF | 692.35 | P |

| | | | | | | | |

| 200.14 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1.00 | DF | 207.03 | P |

| 17315 | FENTAHEXAL 25 | drm emp tdr 3x2.5mg | HHO | D |

| --- | --- | --- | --- | --- |

| 200.15 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1.00 | DF | 393.39 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17303 | FENTAHEXAL 50 | drm emp tdr 3x5mg | HHO | D |

| --- | --- | --- | --- | --- |

| 17304 | FENTAHEXAL 50 | drm emp tdr 5x5mg | HHO | D |

| 200.16 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1.00 | DF | 596.13 | P |

| 200.1 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1.00 | MG | 134,67 | O |

| 30101 | FENTANYL TORREX 50MCG/ML | inj 5×2ml/100rg | TRX | A |

| --- | --- | --- | --- | --- |

| 200.2 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1.00 | MG | 99,18 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 30102 | FENTANYL TORREX 50MCG/ML | inj 5×10ml/500rg | TRX | A |

| --- | --- | --- | --- | --- |

| 200.3 | N01AH02 | alfentanyl | parent. | 1.50 | MG | 45,83 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 87721 | RAPIFEN | inj sol 5×2ml/1mg | JAN | B |

| --- | --- | --- | --- | --- |

| 200.4 | N01AH03 | sufentanyl (do 10 rg v ampuli včetně) | parent. | 0.60 | MG | 1 312,26 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 93701 | SUFENTA | inj 5×2ml/10rg | JAN | B |

| --- | --- | --- | --- | --- |

| 200.5 | N01AH03 | sufentanyl (nad 10 do 50 rg v ampuli včetně) | parent. | 0.60 | MG | 629,40 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21043 | SUFENTANIL TORREX 5 MCG/ML | inj sol 10×10ml/50rg | TRX | A |

| --- | --- | --- | --- | --- |

| 21044 | SUFENTANIL TORREX 5 MCG/ML | inj sol 20×10ml/50rg | TRX | A |

| 30779 | SUFENTANIL TORREX 5 MCG/ML | inj sol 5×10ml/50rg | TRX | A |

| 85526 | SUFENTA FORTE | inj 5×1ml/50rg | JAN | B |

| 200.6 | N01AH03 | sufentanyl (nad 50 rg v ampuli) | parent. | 0.60 | MG | 702,64 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21088 | SUFENTANIL TORREX 50 MCG/ML | inj sol 5×5ml/250rg | TRX | A |

| --- | --- | --- | --- | --- |

| 21089 | SUFENTANIL TORREX 50 MCG/ML | inj sol 10×5ml/250rg | TRX | A |

| 21090 | SUFENTANIL TORREX 50 MCG/ML | inj sol 20×5ml/250rg | TRX | A |

| 21091 | SUFENTANIL TORREX 50 MCG/ML | inj sol 10×20ml/1mg | TRX | A |

| 21092 | SUFENTANIL TORREX 50 MCG/ML | inj sol 20×20ml/1mg | TRX | A |

| 30783 | SUFENTANIL TORREX 50 MCG/ML | inj sol 5×20ml/1mg | TRX | A |

| 93702 | SUFENTA FORTE | inj 5×5ml/250rg | JAN | B |

| 200.7 | N01AH06 | remifentanyl | parent. | 1.00 | MG | 245,49 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17712 | ULTIVA 2 MG | inj plv sol 5×2mg | GXM | I |

| --- | --- | --- | --- | --- |

| 17713 | ULTIVA 5 MG | inj plv sol 5×5mg | GXM | I |

| 86162 | ULTIVA 2 MG | inj plv sol 5×2mg | GWB | GB |

| 86163 | ULTIVA 5 MG | inj plv sol 5×5mg | GWB | GB |

| 200.8 | N01AH51 | fentanyl v kombinacích | parent. | 4.00 | ML | 37,35 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 200.9 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30.00 | MG | 15,10 | O |

| | | | | | | | |

| 200.10 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30.00 | MG | 9,12 | O |

| | | | | | | | |

| 200.11 | N02AB02 | pethidin (do 50 mg v jedné ampuli včetně) | parent. | 0.40 | GM | 54,42 | O |

| | | | | | | | |

| 200.12 | N02AB02 | pethidin (nad 50 mg v jedné ampuli) | parent. | 0.40 | GM | 33,66 | O |

| | | | | | | | |

| 200.13 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1.00 | DF | 676,63 | P |

| | | | | | | | |

| 200.14 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1.00 | DF | 202,33 | P |

| 17315 | FENTAHEXAL 25 | drm emp tdr 3×2.5mg | HHO | D |

| --- | --- | --- | --- | --- |

| 200.15 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1.00 | DF | 384,46 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17303 | FENTAHEXAL 50 | drm emp tdr 3×5mg | HHO | D |

| --- | --- | --- | --- | --- |

| 17304 | FENTAHEXAL 50 | drm emp tdr 5×5mg | HHO | D |

| 200.16 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1.00 | DF | 582,60 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Fentanyl s řízeným uvolňováním ve formě náplasti je indikován v případě, kdy jiné opiody nejsou pro pacienta vhodné.

| 200.17 | N02AC03 | piritramid | parent. | 300.00 | MG | 94.43 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 200.18 | N02AD01 | pentazocin | parent. | 0.20 | GM | 87.35 | O |

| 08966 | FORTRAL | inj 10x1ml/30mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 200.19 | N02AE01 | buprenorfin | subling. | 1.20 | MG | 80.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 200.20 | N02AE01 | buprenorfin | parent. | 1.20 | MG | 200.40 | O |

| | | | | | | | |

| 200.21 | N02AE01 | buprenorfin (s řízeným uvolňováním 35 mikrogramu za hodinu) | transd. | 1.00 | DF | 232.85 | P |

| | | | | | | | |

| 200.22 | N02AE01 | buprenorfin (s řízeným uvolňováním 50,5 mikrogramu za hodinu) | transd. | 1.00 | DF | 339.19 | P |

| | | | | | | | |

| 200.23 | N02AE01 | buprenorfin (s řízeným uvolňováním 70 mikrogramu za hodinu) | transd. | 1.00 | DF | 440.04 | P |

| 200.17 | N02AC03 | piritramid | parent. | 300.00 | MG | 92,29 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 200.18 | N02AD01 | pentazocin | parent. | 0.20 | GM | 85,37 | O |

| 08966 | FORTRAL | inj 10×1ml/30mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 200.19 | N02AE01 | buprenorfin | subling. | 1.20 | MG | 78,18 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 200.20 | N02AE01 | buprenorfin | parent. | 1.20 | MG | 195,85 | O |

| | | | | | | | |

| 200.21 | N02AE01 | buprenorfin (s řízeným uvolňováním 35 mikrogramu za hodinu) | transd. | 1.00 | DF | 227,56 | P |

| | | | | | | | |

| 200.22 | N02AE01 | buprenorfin (s řízeným uvolňováním 50,5 mikrogramu za hodinu) | transd. | 1.00 | DF | 331,49 | P |

| | | | | | | | |

| 200.23 | N02AE01 | buprenorfin (s řízeným uvolňováním 70 mikrogramu za hodinu) | transd. | 1.00 | DF | 430,05 | P |

Buprenorfin s řízeným uvolňováním ve formě náplasti je indikován v případě, kdy jiné opiody nejsou pro pacienta vhodné.

| 200.24 | N02AF01 | butorfanol | parent. | 12.00 | MG | 83.10 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 200.25 | N02AF02 | nalbufin | parent. | 80.00 | MG | 69.21 | O |

| | | | | | | | |

| 200.26 | N02AX01 | tilidin | parent. | 0.20 | GM | 16.37 | O |

| | | | | | | | |

| 200.27 | N02AX02 | tramadol hydrochlorid | p.rect. | 0.30 | GM | 41.60 | |

| 12822 | TRAMADOL LANNACHER 100 MG | sup 5x100mg | LAR | A |

| --- | --- | --- | --- | --- |

| 32084 | TRALGIT SUPP. | rct sup 10x100mg | ZEH | SK |

| 200.28 | N02AX02 | tramadol hydrochlorid (do 50 mg v jedné ampuli včetně) | parent. | 0.30 | GM | 82.30 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12477 | TRAMABENE 50 INJEKCE | inj 5x1ml/50mg | MCK | D |

| --- | --- | --- | --- | --- |

| 32090 | TRALGIT 50 INJ | inj sol 5x1ml/50mg | ZEH | SK |

| 32091 | TRALGIT 50 INJ | inj sol 10x1ml/50mg | ZEH | SK |

| 92363 | TRAMADOL LANNACHER 50 MG/1 ML | inj 5x1ml/50mg | LAR | A |

| 200.29 | N02AX02 | tramadol hydrochlorid (nad 50 mg v jedné ampuli) | parent. | 0.30 | GM | 43.00 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12478 | TRAMABENE 100 INJEKCE | inj 5x2ml/100mg | MCK | D |

| --- | --- | --- | --- | --- |

| 32087 | TRALGIT 100 INJ | inj sol 5x2ml/100mg | ZEH | SK |

| 32088 | TRALGIT 100 INJ | inj sol 10x2ml/100mg | ZEH | SK |

| 92364 | TRAMADOL LANNACHER 100MG/2ML | inj 5x2ml/100mg | LAR | A |

| 201 | analgetika - antipyretika ze skupiny derivátů kyseliny salicylové, peroroální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 201.1 | N02BA | lysin acetylsalicylát (do 100 mg v jedné tabletě včetně) | p.o. | 3.00 | GM | 8.65 | |

| | | | | | | | |

| 201.2 | N02BA | lysin acetylsalicylát (nad 100 mg v jedné tabletě) | p.o. | 3.00 | GM | 6.45 | |

| | | | | | | | |

| 201.3 | N02BA01 | kyselina acetylsalicylová | p.o. | 3.00 | GM | 6.30 | |

| 00011 | ACYLPYRIN | tbl 10x500mg | SLO | SK |

| --- | --- | --- | --- | --- |

| 201.4 | N02BA02 | aloxiprin | p.o. | 3.00 | GM | 6.45 | |

| | | | | | | | |

| 201.5 | N02BA03 | cholin salicylát | p.o. | 3.00 | GM | 8.65 | |

| | | | | | | | |

| 201.6 | N02BA11 | diflunisal | p.o. | 0.75 | GM | 5.72 | |

| | | | | | | | |

| 202 | ostatní analgetika – antipyretika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 202.1 | N02BE01 | paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně) | p.o. | 3.00 | GM | 8.67 | |

| | | | | | | | |

| 202.2 | N02BE01 | paracetamol (pevné lékové formy nad 125 mg v jedné tabletě) | p.o. | 3.00 | GM | 4.94 | |

| 03837 | PARALEN 500 | tbl 10x500mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 15385 | APO-ACETAMINOPHEN 500 MG | tbl 100x500mg | CMG | IRL |

| 83608 | APO-ACETAMINOPHEN 500MG | tbl 100x500mg | APT | CND |

| 202.3 | N02BE01 | paracetamol (tekuté lékové formy) | p.o. | 3.00 | GM | 8.65 | |

| 200.24 | N02AF01 | butorfanol | parent. | 12.00 | MG | 81,21 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 200.25 | N02AF02 | nalbufin | parent. | 80.00 | MG | 67,64 | O |

| | | | | | | | |

| 200.26 | N02AX01 | tilidin | parent. | 0.20 | GM | 16,00 | O |

| | | | | | | | |

| 200.27 | N02AX02 | tramadol hydrochlorid | p.rect. | 0.30 | GM | 40,66 | |

| 12822 | TRAMADOL LANNACHER 100 MG | sup 5×100mg | LAR | A |

| --- | --- | --- | --- | --- |

| 32084 | TRALGIT SUPP. | ret sup 10×100mg | ZEH | SK |

| 200.28 | N02AX02 | tramadol hydrochlorid (do 50 mg v jedné ampuli včetně) | parent. | 0.30 | GM | 80,43 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12477 | TRAMABENE 50 INJEKCE | inj 5×1ml/50mg | MCK | D |

| --- | --- | --- | --- | --- |

| 32090 | TRALGIT 50 INJ | inj sol 5×1ml/50mg | ZEH | SK |

| 32091 | TRALGIT 50 INJ | inj sol 10×1ml/50mg | ZEH | SK |

| 92363 | TRAMADOL LANNACHER 50 MG/1 ML | inj 5×1ml/50mg | LAR | A |

| 200.29 | N02AX02 | tramadol hydrochlorid (nad 50 mg v jedné ampuli) | parent. | 0.30 | GM | 42,02 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12478 | TRAMABENE 100 INJEKCE | inj 5×2ml/100mg | MCK | D |

| --- | --- | --- | --- | --- |

| 32087 | TRALGIT 100 INJ | inj sol 5×2ml/100mg | ZEH | SK |

| 32088 | TRALGIT 100 INJ | inj sol 10×2ml/100mg | ZEH | SK |

| 92364 | TRAMADOL LANNACHER 100MG/2ML | inj 5×2ml/100mg | LAR | A |

| 201 | analgetika-antipyretika ze skupiny derivátů kyseliny salicylové, peroroální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 201.1 | N02BA | lysin acetylsalicylát (do 100 mg v jedné tabletě včetně) | p.o. | 3.00 | GM | 8,45 | |

| | | | | | | | |

| 201.2 | N02BA | lysin acetylsalicylát (nad 100 mg v jedné tabletě) | p.o. | 3.00 | GM | 6,30 | |

| | | | | | | | |

| 201.3 | N02BA01 | kyselina acetylsalicylová | p.o. | 3.00 | GM | 6,16 | |

| 00011 | ACYLPYRIN | tbl 10×500mg | SLO | SK |

| --- | --- | --- | --- | --- |

| 201.4 | N02BA02 | aloxiprin | p.o. | 3.00 | GM | 6,30 | |

| | | | | | | | |

| 201.5 | N02BA03 | cholin salicylát | p.o. | 3.00 | GM | 8,45 | |

| | | | | | | | |

| 201.6 | N02BA11 | diflunisal | p.o. | 0.75 | GM | 5,59 | |

| | | | | | | | |

| 202 | o statní analgetika –antipyretika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 202.1 | N02BE01 | paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně) | p.o. | 3.00 | GM | 8,47 | |

| | | | | | | | |

| 202.2 | N02BE01 | paracetamol (pevné lékové formy nad 125 mg v jedné tabletě) | p.o. | 3.00 | GM | 4,83 | |

| 03837 | PARALEN 500 | tbl 10×500mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 15385 | APO-ACETAMINOPHEN 500 MG | tbl 100×500mg | CMG | IRL |

| 83608 | APO-ACETAMINOPHEN 500MG | tbl 100×500mg | APT | CND |

| 202.3 | N02BE01 | paracetamol (tekuté lékové formy) | p.o. | 3.00 | GM | 8,45 | |

| | | | | | | | |

| 203 | antimigrenika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 203.1 | N02CA01 | dihydroergotamin | p.o. | 4.00 | MG | 1.23 | |

| | | | | | | | |

| 203.2 | N02CA01 | dihydroergotamin | parent. | 4.00 | MG | 111.52 | |

| | | | | | | | |

| 203.3 | N02CA01 | dihydroergotamin nosní spray | inhal. | 1.00 | MG | 50.00 | |

| | | | | | | | |

| 203.4 | N02CA07 | lisurid | p.o. | 75.00 | RG | 0.73 | |

| | | | | | | | |

| 203.5 | N02CA52 | ergotamin, kombinace | p.o. | 4.00 | DF | 9.38 | |

| | | | | | | | |

| 203.6 | N02CC01 | sumatriptan | parent. | 1.00 | DF | 899.35 | X |

| | | | | | | | |

| 203.7 | N02CC01 | sumatriptan (do 50 mg včetně v jedné tabletě) | p.o. | 50.00 | MG | 94.50 | |

| | | | | | | | |

| 203.8 | N02CC01 | sumatriptan (nad 50 mg v jedné tabletě) | p.o. | 50.00 | MG | 70.87 | |

| | | | | | | | |

| 203.9 | N02CC01 | sumatriptan (nosní sprej) | inhal. | 1.00 | DF | 292.50 | P |

| 203.1 | N02CA01 | dihydroergotamin | p.o. | 4.00 | MG | 1,20 | |

| | | | | | | | |

| 203.2 | N02CA01 | dihydroergotamin | parent. | 4.00 | MG | 108,99 | |

| | | | | | | | |

| 203.3 | N02CA01 | dihydroergotamin nosní spray | inhal. | 1.00 | MG | 48,87 | |

| | | | | | | | |

| 203.4 | N02CA07 | lisurid | p.o. | 75.00 | RG | 0,71 | |

| | | | | | | | |

| 203.5 | N02CA52 | ergotamin, kombinace | p.o. | 4.00 | DF | 9,17 | |

| | | | | | | | |

| 203.6 | N02CC01 | sumatriptan | parent. | 1.00 | DF | 878,93 | X |

| | | | | | | | |

| 203.7 | N02CC01 | sumatriptan (do 50 mg včetně v jedné tabletě) | p.o. | 50.00 | MG | 92,35 | |

| | | | | | | | |

| 203.8 | N02CC01 | sumatriptan (nad 50 mg v jedné tabletě) | p.o. | 50.00 | MG | 69,26 | |

| | | | | | | | |

| 203.9 | N02CC01 | sumatriptan (nosní sprej) | inhal. | 1.00 | DF | 285,86 | P |

Léčbu inhalačním sumatriptanem a zolmitriptanem předepisuje neurolog k terapii těžkého migrenozního záchvatu s časným zvracením, nejvíce v počtu 2 balení (4 dávky) za měsíc.

| 79382 | IMIGRAN 10 MG | nas spr sol 2x0.1ml | GXM | I |

| --- | --- | --- | --- | --- |

| 93078 | IMIGRAN 10 MG | spr nas 2x0.1 ml | GWE | I |

| 203.10 | N02CC02 | naratriptan | p.o. | 2.50 | MG | 94.50 | |

| | | | | | | | |

| 203.11 | N02CC03 | zolmitriptan | p.o. | 2.50 | MG | 94.50 | |

| | | | | | | | |

| 203.12 | N02CC03 | zolmitriptan (nosní sprej) | inhal. | 1.00 | DF | 292.50 | P |

| | | | | | | | |

| 203.13 | N02CC04 | rizatriptan | p.o. | 10.00 | MG | 94.50 | |

| | | | | | | | |

| 203.14 | N02CC06 | eletriptan | p.o. | 40.00 | MG | 94.50 | |

| | | | | | | | |

| 203.15 | N02CC07 | frovatriptan | p.o. | 2.5 | MG | 94.50 | |

| | | | | | | | |

| 203.16 | N02CX | lysin acetylsalicylát v kombinaci s metoklopramidem | p.o. | 1.00 | DF | 21.66 | |

| | | | | | | | |

| 203.17 | N02CX | pipethiaden | p.o. | 3.00 | DF | 2.54 | |

| | | | | | | | |

| 203.18 | N02CX01 | pizotifen | p.o. | 1.50 | MG | 5.87 | |

| | | | | | | | |

| 203.19 | N02CX06 | oxetoron | p.o. | 0.12 | GM | 5.87 | |

| 79382 | IMIGRAN 10 MG | nas spr sol 2×0.1 ml | GXM | I |

| --- | --- | --- | --- | --- |

| 93078 | IMIGRAN 10 MG | spr nas 2×0.1ml | GWE | I |

| 203.10 | N02CC02 | naratriptan | p.o. | 2.50 | MG | 92,35 | |

| | | | | | | | |

| 203.11 | N02CC03 | zolmitriptan | p.o. | 2.50 | MG | 92,35 | |

| | | | | | | | |

| 203.12 | N02CC03 | zolmitriptan (nosní sprej) | inhal. | 1.00 | DF | 285,86 | P |

| | | | | | | | |

| 203.13 | N02CC04 | rizatriptan | p.o. | 10.00 | MG | 92,35 | |

| | | | | | | | |

| 203.14 | N02CC06 | eletriptan | p.o. | 40.00 | MG | 92,35 | |

| | | | | | | | |

| 203.15 | N02CC07 | frovatriptan | p.o. | 2.5 | MG | 92,35 | |

| | | | | | | | |

| 203.16 | N02CX | lysin acetylsalicylát v kombinaci s metoklopramidem | p.o. | 1.00 | DF | 21,17 | |

| | | | | | | | |

| 203.17 | N02CX | pipethiaden | p.o. | 3.00 | DF | 2,48 | |

| | | | | | | | |

| 203.18 | N02CX01 | pizotifen | p.o. | 1.50 | MG | 5,74 | |

| | | | | | | | |

| 203.19 | N02CX06 | oxetoron | p.o. | 0.12 | GM | 5,74 | |

| | | | | | | | |

| 204 | antiepileptika ze skupiny barbiturátů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 204.1 | N03AA | fenobarbital pseudonorefedr. | p.o. | 0.10 | GM | 2.05 | |

| | | | | | | | |

| 204.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.10 | GM | 6.08 | |

| 68578 | PHENAEMALETTEN | tbl 50x15mg | DET | D |

| --- | --- | --- | --- | --- |

| 204.3 | N03AA02 | fenobarbital (do 40 mg včetně v jedné ampuli) | parent. | 0.10 | GM | 126.25 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 204.4 | N03AA02 | fenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.10 | GM | 2.27 | |

| 68579 | PHENAEMAL 0.1 | tbl 50x100mg | DET | D |

| --- | --- | --- | --- | --- |

| 204.5 | N03AA02 | fenobarbital (nad 40 mg v jedné ampuli) | parent. | 0.10 | GM | 13.46 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 84449 | LUMINAL | inj 5x1ml/200mg | DET | D |

| --- | --- | --- | --- | --- |

| 204.6 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 | GM | 11.76 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13731 | LISKANTIN | tbl 100x250mg | DET | D |

| --- | --- | --- | --- | --- |

| 204.7 | N03AA03 | primidon (tekuté lékové formy) | p.o. | 1.25 | GM | 45.51 | |

| 204.1 | N03AA | fenobarbital pseudonorefedr. | p.o. | 0.10 | GM | 2,00 | |

| | | | | | | | |

| 204.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.10 | GM | 5,94 | |

| 68578 | PHENAEMALETTEN | tbl 50×15mg | DET | D |

| --- | --- | --- | --- | --- |

| 204.3 | N03AA02 | fenobarbital (do 40 mg včetně v jedné ampuli) | parent. | 0.10 | GM | 123,38 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 204.4 | N03AA02 | fenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.10 | GM | 2,22 | |

| 68579 | PHENAEMAL 0.1 | tbl 50×100mg | DET | D |

| --- | --- | --- | --- | --- |

| 204.5 | N03AA02 | fenobarbital (nad 40 mg v jedné ampuli) | parent. | 0.10 | GM | 13,15 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 84449 | LUMINAL | inj 5×1ml/200mg | DET | D |

| --- | --- | --- | --- | --- |

| 204.6 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 | GM | 11,49 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13731 | LISKANTIN | tbl 100×250mg | DET | D |

| --- | --- | --- | --- | --- |

| 204.7 | N03AA03 | primidon (tekuté lékové formy) | p.o. | 1.25 | GM | 44,48 | |

| | | | | | | | |

| 205 | antiepileptika ze skupiny hydantoinátů, oxazolidinů a sukcinimidů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 205.1 | N03AB02 | fenytoin | p.o. | 0.30 | GM | 2.40 | |

| 00297 | SODANTON | tbl 20x100mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 62234 | EPILAN D GEROT | tbl 100x100mg | GER | A |

| 205.2 | N03AB02 | fenytoin | parent. | 0.30 | GM | 116.04 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 205.3 | N03AB04 | mefenytoin | p.o. | 0.40 | GM | 2.44 | |

| | | | | | | | |

| 205.4 | N03AB52 | fenytoin, kombinace | p.o. | 3.00 | DF | 2.40 | |

| 205.1 | N03AB02 | fenytoin | p.o. | 0.30 | GM | 2,35 | |

| 00297 | SODANTON | tbl 20×100mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 62234 | EPILAN D GEROT | tbl 100×100mg | GER | A |

| 205.2 | N03AB02 | fenytoin | parent. | 0.30 | GM | 113,41 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 205.3 | N03AB04 | mefenytoin | p.o. | 0.40 | GM | 2,38 | |

| | | | | | | | |

| 205.4 | N03AB52 | fenytoin, kombinace | p.o. | 3.00 | DF | 2,35 | |

| 02625 | SANEPIL | tbl 20 (blistr) | ZEH | SK |

| --- | --- | --- | --- | --- |

| 205.5 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 16.78 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 92041 | PETINIMID | por cpsmol 100x250mg | GER | A |

| --- | --- | --- | --- | --- |

| 205.6 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 22.69 | |

| 205.5 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 16,40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 92041 | PETINIMID | por cpsmol100×250mg | GER | A |

| --- | --- | --- | --- | --- |

| 205.6 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 22,17 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02035 | SUXILEP | gtt 50gm 50% | GMD | D |

| --- | --- | --- | --- | --- |

| 11037 | SUXILEP | gtt 50gm 50% | PHW | D |

| 205.7 | N03AD03 | mesuximid | p.o. | 0.90 | GM | 24.78 | |

| 205.7 | N03AD03 | mesuximid | p.o. | 0.90 | GM | 24,22 | |

| | | | | | | | |

| 206 | antiepileptika ze skupiny benzodiazepinů a karboxamidů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 206.1 | N03AE01 | klonazepam | parent. | 8.00 | MG | 230.32 | O |

| 14989 | RIVOTRIL | inj 5x1ml/1mg+solv. | RCE | CZ |

| --- | --- | --- | --- | --- |

| 206.2 | N03AE01 | klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně) | p.o. | 8.00 | MG | 24.15 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 14957 | RIVOTRIL 0.5 MG | tbl 50x0.5mg | RCE | CZ |

| --- | --- | --- | --- | --- |

| 206.3 | N03AE01 | klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě) | p.o. | 8.00 | MG | 12.71 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 206.4 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8.00 | MG | 33.60 | |

| 14000 | RIVOTRIL 2.5MG/ML | por gtt sol 1x10ml | ROX | I |

| --- | --- | --- | --- | --- |

| 206.5 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1.00 | GM | 12.16 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15305 | APO-CARBAMAZEPINE | tbl 100x200mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 17999 | APO-CARBAMAZEPINE | tbl 100x200mg | KAT | NL |

| 62309 | APO-CARBAMAZEPINE | tbl 100x200mg | APT | CND |

| 98080 | NEUROTOP | tbl 50x200mg | GER | A |

| 206.6 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1.00 | GM | 16.94 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 16444 | TEGRETOL CR 200 | tbl ret 50x200mg | NAI | CZ |

| --- | --- | --- | --- | --- |

| 16445 | TEGRETOL CR 400 | tbl ret 30x400mg | NAI | CZ |

| 92039 | TEGRETOL CR 200 | tbl ret 50x200mg | NPA | CH |

| 93619 | TEGRETOL CR 400 | tbl ret 30x400mg | NPA | CH |

| 96305 | NEUROTOP RETARD 300 | tbl ret 50x300mg | GER | A |

| 96306 | NEUROTOP RETARD 600 | tbl ret 50x600mg | GER | A |

| 206.7 | N03AF01 | karbamazepin (tekuté lékové formy) | p.o. | 1.00 | GM | 42.52 | |

| | | | | | | | |

| 206.8 | N03AF02 | oxcarbazepin | p.o. | 1.00 | GM | 11.10 | |

| 206.1 | N03AE01 | klonazepam | parent. | 8.00 | MG | 225,09 | O |

| 14989 | RIVOTRIL | inj 5×1ml/1mg+solv. | RCE | CZ |

| --- | --- | --- | --- | --- |

| 206.2 | N03AE01 | klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně) | p.o. | 8.00 | MG | 23,60 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 14957 | RIVOTRIL 0.5 MG | tbl 50×0.5mg | RCE | CZ |

| --- | --- | --- | --- | --- |

| 206.3 | N03AE01 | klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě) | p.o. | 8.00 | MG | 12,42 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 206.4 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8.00 | MG | 32,84 | |

| 14000 | RIVOTRIL 2.5MG/ML | por gtt sol 1×10ml | ROX | I |

| --- | --- | --- | --- | --- |

| 206.5 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1.00 | GM | 11,88 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15305 | APO-CARBAMAZEPINE | tbl 100×200mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 17999 | APO-CARBAMAZEPINE | tbl 100×200mg | KAT | NL |

| 62309 | APO-CARBAMAZEPINE | tbl 100×200mg | APT | CND |

| 98080 | NEUROTOP | tbl 50×200mg | GER | A |

| 206.6 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1.00 | GM | 16,56 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 16444 | TEGRETOL CR 200 | tbl ret 50×200mg | NAI | CZ |

| --- | --- | --- | --- | --- |

| 16445 | TEGRETOL CR 400 | tbl ret 30×400mg | NAI | CZ |

| 92039 | TEGRETOL CR 200 | tbl ret 50×200mg | NPA | CH |

| 93619 | TEGRETOL CR 400 | tbl ret 30×400mg | NPA | CH |

| 96305 | NEUROTOP RETARD 300 | tbl ret 50×300mg | GER | A |

| 96306 | NEUROTOP RETARD 600 | tbl ret 50×600mg | GER | A |

| 206.7 | N03AF01 | karbamazepin (tekuté lékové formy) | p.o. | 1.00 | GM | 41,55 | |

| | | | | | | | |

| 206.8 | N03AF02 | oxcarbazepin | p.o. | 1.00 | GM | 10,85 | |

| | | | | | | | |

| 207 | antiepileptika ze skupiny derivátů mastných kyselin | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 207.1 | N03AG01 | natrium valproát | parent. | 1.50 | GM | 1 150.14 | K |

| 54238 | ORFIRIL 100 MG/ML INJEKTIONSLÖ. | inj sol 5x3ml/300mg | DET | D |

| --- | --- | --- | --- | --- |

| 207.2 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy do 300 mg v jedné tabletě) | p.o. | 1.50 | GM | 28.46 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 207.3 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.50 | GM | 26.20 | |

| | | | | | | | |

| 207.4 | N03AG01 | natrium valproát (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.50 | GM | 17.22 | |

| 08768 | CONVULEX 150 | por cps dur 100x150mg | GER | A |

| --- | --- | --- | --- | --- |

| 207.5 | N03AG01 | natrium valproát (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.50 | GM | 14.95 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 207.6 | N03AG01 | natrium valproát (retardované pevné lékové formy do 300 mg v jedné tabletě včetně) | p.o. | 1.50 | GM | 24.33 | |

| | | | | | | | |

| 207.7 | N03AG01 | natrium valproát (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.50 | GM | 24.35 | |

| 58787 | CONVULEX CR 500 MG | tbl ret 50x500mg | GER | A |

| --- | --- | --- | --- | --- |

| 207.8 | N03AG01 | natrium valproát (tekuté lékové formy) | p.o. | 1.50 | GM | 24.97 | |

| 207.1 | N03AG01 | natrium valproát | parent. | 1.50 | GM | 1 124,03 | K |

| 54238 | ORFIRIL 100 MG/ML INJEKTIONSLÖ. | inj sol 5×3ml/300mg | DET | D |

| --- | --- | --- | --- | --- |

| 207.2 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy do 300 mg v jedné tabletě) | p.o. | 1.50 | GM | 27,81 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 207.3 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.50 | GM | 25,61 | |

| | | | | | | | |

| 207.4 | N03AG01 | natrium valproát (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.50 | GM | 16,83 | |

| 08768 | CONVULEX 150 | por cps dur 100×150mg | GER | A |

| --- | --- | --- | --- | --- |

| 207.5 | N03AG01 | natrium valproát (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.50 | GM | 14,61 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 207.6 | N03AG01 | natrium valproát (retardované pevné lékové formy do 300 mg v jedné tabletě včetně) | p.o. | 1.50 | GM | 23,78 | |

| | | | | | | | |

| 207.7 | N03AG01 | natrium valproát (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.50 | GM | 23,80 | |

| 58787 | CONVULEX CR 500 MG | tbl ret 50×500mg | GER | A |

| --- | --- | --- | --- | --- |

| 207.8 | N03AG01 | natrium valproát (tekuté lékové formy) | p.o. | 1.50 | GM | 24,40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 08770 | CONVULEX | gtt 100ml | GER | A |

| --- | --- | --- | --- | --- |

| 207.9 | N03AG02 | valpromid | p.o. | 1.50 | GM | 24.32 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 207.10 | N03AG04 | vigabatrin | p.o. | 2.00 | GM | 116.75 | P |

| | | | | | | | |

| 207.11 | N03AG06 | tiagabin | p.o. | 30.00 | MG | 119.70 | P |

| 207.9 | N03AG02 | valpromid | p.o. | 1.50 | GM | 23,77 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 207.10 | N03AG04 | vigabatrin | p.o. | 2.00 | GM | 114,10 | P |

| | | | | | | | |

| 207.11 | N03AG06 | tiagabin | p.o. | 30.00 | MG | 116,98 | P |

Léčbu tiagabinem a vigabatrinem předepisuje neurolog či psychiatr pro léčbu epileptických záchvatů u pacientů splňujících nejméně jedno z následujících kritérií:

@@ -7876,43 +7925,43 @@

| 208 | ostatní antiepileptika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.1 | N03AX03 | sultiam | p.o. | 0.40 | GM | 15.87 | L/PSY,NEU |

| 55852 | OSPOLOT | tbl obd 50x200mg | DET | D |

| --- | --- | --- | --- | --- |

| 208.2 | N03AX09 | lamotrigin (disperzní forma nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 175.75 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.3 | N03AX09 | lamotrigin (disperzní forma od 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 124.76 | P |

| 41870 | LAMOTRI HEXAL 100 TAB SUS | por tbl sus 30x100mg | SFS | D |

| --- | --- | --- | --- | --- |

| 41886 | LAMOTRI HEXAL 100 TAB SUS | por tbl sus 50x100mg | SFS | D |

| 208.4 | N03AX09 | lamotrigin (disperzní forma do 2 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 500.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.5 | N03AX09 | lamotrigin (disperzní forma nad 2 mg do 5 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 300.00 | P |

| 208.1 | N03AX03 | sultiam | p.o. | 0.40 | GM | 15,51 | L/PSY,NEU |

| 55852 | OSPOLOT | tbl obd 50×200mg | DET | D |

| --- | --- | --- | --- | --- |

| 208.2 | N03AX09 | lamotrigin (disperzní forma nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 171,76 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.3 | N03AX09 | lamotrigin (disperzní forma od 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 121,93 | P |

| 41870 | LAMOTRI HEXAL 100 TAB SUS | por tbl sus 30×100mg | SFS | D |

| --- | --- | --- | --- | --- |

| 41886 | LAMOTRI HEXAL 100 TAB SUS | por tbl sus 50×100mg | SFS | D |

| 208.4 | N03AX09 | lamotrigin (disperzní forma do 2 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 488,65 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.5 | N03AX09 | lamotrigin (disperzní forma nad 2 mg do 5 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 293,19 | P |

Lamotrigin, disperzní léková forma: předepisuje psychiatr, neurolog pro děti do 15 let, které nemohou být léčeny tabletovou formou.

| 208.6 | N03AX09 | lamotrigin (nad 25mg do 50 mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 50.59 | L/PSY, NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17761 | LAMOTRIGIN-RATIOPHARM 50 MG | por tbl nob 30x50mg | KPT | E |

| --- | --- | --- | --- | --- |

| 18618 | PLEXXO 50 MG | por tbl nob 30x50mg | DET | CZ |

| 19873 | LAMOTRIGIN ACTAVIS 50 MG | por tbl nob 30x50mg | AHF | IS |

| 23775 | EPIRAL 50 | por tbl nob 30x50mg | ZEH | CZ |

| 48952 | LAMOTRIGIN-RATIOPHARM 50 MG | por tbl nob 30x50mg | SXP | GR |

| 48971 | LAMOTRIGIN-RATIOPHARM 50 MG | por tbl nob 30x50mg | SXQ | P |

| 48990 | LAMOTRIGIN-RATIOPHARM 50 MG | por tbl nob 30x50mg | MCK | D |

| 208.7 | N03AX09 | lamotrigin (nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 56.62 | L/PSY, NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.8 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 47.00 | L/PSY, NEU |

| 208.6 | N03AX09 | lamotrigin (nad 25mg do 50 mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 49,44 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17761 | LAMOTRIGIN-RATIOPHARM 50 MG | por tbl nob 30×50mg | KPT | E |

| --- | --- | --- | --- | --- |

| 18618 | PLEXXO 50 MG | por tbl nob 30×50mg | DET | CZ |

| 19873 | LAMOTRIGIN ACTAVIS 50 MG | por tbl nob 30×50mg | AHF | IS |

| 23775 | EPIRAL 50 | por tbl nob 30×50mg | ZEH | CZ |

| 48952 | LAMOTRIGIN-RATIOPHARM 50 MG | por tbl nob 30×50mg | SXP | GR |

| 48971 | LAMOTRIGIN-RATIOPHARM 50 MG | por tbl nob 30×50mg | SXQ | P |

| 48990 | LAMOTRIGIN-RATIOPHARM 50 MG | por tbl nob 30×50mg | MCK | D |

| 208.7 | N03AX09 | lamotrigin (nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 55,33 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.8 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 45,93 | L/PSY,NEU |

| 17780 | LAMOTRIGIN-RATIOPHARM 100 MG | por tbl nob 30×100mg | KPT | E |

| --- | --- | --- | --- | --- |

@@ -7927,20 +7976,20 @@

| 49228 | LAMOTRIGIN-RATIOPHARM 100 MG | por tbl nob 30×100mg | SXQ | P |

| 49247 | LAMOTRIGIN-RATIOPHARM 100 MG | por tbl nob 30×100mg | MCK | D |

| 208.9 | N03AX10 | felbamat | p.o. | 2.40 | GM | 274.54 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.10 | N03AX11 | topiramat tablety (do 25 mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 140.10 | P |

| | | | | | | | |

| 208.11 | N03AX11 | topiramat tablety (nad 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 113.60 | P |

| | | | | | | | |

| 208.12 | N03AX11 | topiramat tobolky (do 15 mg včetně v jedné tobolce) | p.o. | 0.30 | GM | 285.00 | P |

| | | | | | | | |

| 208.13 | N03AX11 | topiramat tobolky (nad 15 mg do 25 mg včetně v jedné tobolce) | p.o. | 0.30 | GM | 175.75 | P |

| 208.9 | N03AX10 | felbamat | p.o. | 2.40 | GM | 268,31 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.10 | N03AX11 | topiramat tablety (do 25 mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 136,92 | P |

| | | | | | | | |

| 208.11 | N03AX11 | topiramat tablety (nad 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 111,02 | P |

| | | | | | | | |

| 208.12 | N03AX11 | topiramat tobolky (do 15 mg včetně v jedné tobolce) | p.o. | 0.30 | GM | 278,53 | P |

| | | | | | | | |

| 208.13 | N03AX11 | topiramat tobolky (nad 15 mg do 25 mg včetně v jedné tobolce) | p.o. | 0.30 | GM | 171,76 | P |

Topiramat - léková forma tobolky: předepisuje psychiatr, neurolog pro děti do 15 let, které nemohou být, z jakýchkoliv důvodů, léčeny tabletovou formou.

| 208.14 | N03AX11 | topiramat tablety (nad 25 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 125.20 | P |

| 208.14 | N03AX11 | topiramat tablety (nad 25 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.30 | GM | 122,36 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu topiramatem předepisuje neurolog či psychiatr pro léčbu epileptických záchvatů u pacientů splňujících nejméně jedno z následujících kritérií:

@@ -7953,12 +8002,12 @@

Léčbu topiramatem předepisuje neurolog k profylaktické léčbě těžké migrény (více než 3 záchvaty za měsíc), nebo komplikované migrény u pacientů, kde nebylo dosaženo dostatečné terapeutické odpovědi (redukce počtu a intenzity záchvatů o 50%) nebo, kde pacienti netolerovali léky prvé volby (betablokátory, blokátory kalciových kanálů, valproáty, amitriptylin).

| 208.15 | N03AX12 | gabapentin | p.o. | 1.80 | GM | 88.00 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.16 | N03AX16 | pregabalin | p.o. | 300.00 | MG | 119.70 | P |

| | | | | | | | |

| 208.17 | N03AX14 | levetiracetam | p.o. | 2.00 | GM | 126.00 | P |

| 208.15 | N03AX12 | gabapentin | p.o. | 1.80 | GM | 86,00 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 208.16 | N03AX16 | pregabalin | p.o. | 300.00 | MG | 116,98 | P |

| | | | | | | | |

| 208.17 | N03AX14 | levetiracetam | p.o. | 2.00 | GM | 123,14 | P |

Léčbu levetiracetamem a pregabalinem předepisuje neurolog či psychiatr pro léčbu epileptických záchvatů u pacientů splňujících nejméně jedno z následujících kritérií:

@@ -7973,172 +8022,172 @@

| 209 | Anticholinergní antiparkinsonika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 209.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 7.15 | |

| | | | | | | | |

| 209.2 | N04AA02 | biperiden | p.o. | 10.00 | MG | 12.22 | |

| | | | | | | | |

| 209.3 | N04AA02 | biperiden | parent. | 10.00 | MG | 56.89 | O |

| 01973 | AKINETON | inj 5x1ml/5mg | EBP | A |

| --- | --- | --- | --- | --- |

| 209.4 | N04AA03 | metixen | p.o. | 40.00 | MG | 18.09 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 209.5 | N04AA04 | procyklidin | p.o. | 25.00 | MG | 8.80 | |

| 03481 | KEMADRIN | por tbl nob 100x5mg | GWE | D |

| --- | --- | --- | --- | --- |

| 03483 | KEMADRIN | por tbl nob 100x5mg | WFD | GB |

| 209.6 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1.71 | O |

| | | | | | | | |

| 209.7 | N04AC01 | benzatropin | p.o. | 2.00 | MG | 3.12 | |

| 209.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 6,99 | |

| | | | | | | | |

| 209.2 | N04AA02 | biperiden | p.o. | 10.00 | MG | 11,94 | |

| | | | | | | | |

| 209.3 | N04AA02 | biperiden | parent. | 10.00 | MG | 55,60 | O |

| 01973 | AKINETON | inj 5×1ml/5mg | EBP | A |

| --- | --- | --- | --- | --- |

| 209.4 | N04AA03 | metixen | p.o. | 40.00 | MG | 17,68 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 209.5 | N04AA04 | procyklidin | p.o. | 25.00 | MG | 8,60 | |

| 03481 | KEMADRIN | por tbl nob 100×5mg | GWE | D |

| --- | --- | --- | --- | --- |

| 03483 | KEMADRIN | por tbl nob 100×5mg | WFD | GB |

| 209.6 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,67 | O |

| | | | | | | | |

| 209.7 | N04AC01 | benzatropin | p.o. | 2.00 | MG | 3,05 | |

| | | | | | | | |

| 210 | dopaminergní antiparkinsonika ze skupiny levodopy a jejich derivátů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 210.1 | N04BA01 | levodopa | p.o. | 3.50 | GM | 24.64 | |

| | | | | | | | |

| 210.2 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy do 0,125 gm včetně v jedné tabletě) | p.o. | 0.60 | GM | 32.75 | |

| 14955 | MADOPAR HBS | por cps dur30x125mg | RCE | CZ |

| --- | --- | --- | --- | --- |

| 210.3 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy nad 0,125 gm v jedné tabletě) | p.o. | 0.60 | GM | 26.69 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 210.4 | N04BA02 | levodopa/benserazid | p.o. | 0.60 | GM | 22.00 | |

| 15050 | MADOPAR 25030 | por tbl nob 100x250mg | RCE | CZ |

| --- | --- | --- | --- | --- |

| 210.5 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.60 | GM | 29.62 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 210.6 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.60 | GM | 19.31 | |

| 45244 | ISICOM 250 MG | tbl 100x275mg | DET | D |

| --- | --- | --- | --- | --- |

| 210.7 | N04BA03 | levodopa/karbidopa a entacapon (do 125 mg v 1 tabletě) | p.o. | 1.00 | DF | 35.17 | X |

| | | | | | | | |

| 210.8 | N04BA03 | levodopa/karbidopa a entacapon (nad 125 mg v 1 tabletě) | p.o. | 1.00 | DF | 37.85 | X |

| 210.1 | N04BA01 | levodopa | p.o. | 3.50 | GM | 24,08 | |

| | | | | | | | |

| 210.2 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy do 0,125 gm včetně v jedné tabletě) | p.o. | 0.60 | GM | 32,01 | |

| 14955 | MADOPAR HBS | por cps dur30×125mg | RCE | CZ |

| --- | --- | --- | --- | --- |

| 210.3 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy nad 0,125 gm v jedné tabletě) | p.o. | 0.60 | GM | 26,08 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 210.4 | N04BA02 | levodopa/benserazid | p.o. | 0.60 | GM | 21,50 | |

| 15050 | MADOPAR 250 | por tbl nob 100×250mg | RCE | CZ |

| --- | --- | --- | --- | --- |

| 210.5 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.60 | GM | 28,95 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 210.6 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.60 | GM | 18,87 | |

| 45244 | ISICOM 250 MG | tbl 100×275mg | DET | D |

| --- | --- | --- | --- | --- |

| 210.7 | N04BA03 | levodopa/karbidopa a entacapon (do 125 mg v 1 tabletě) | p.o. | 1.00 | DF | 34,37 | X |

| | | | | | | | |

| 210.8 | N04BA03 | levodopa/karbidopa a entacapon (nad 125 mg v 1 tabletě) | p.o. | 1.00 | DF | 36,99 | X |

| | | | | | | | |

| 211 | antiparkinsonika z ostatních skupin | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 211.1 | N04BB01 | amantadin | parent. | 0.20 | GM | 4.25 | H |

| | | | | | | | |

| 211.2 | N04BB01 | amantadin hydrochlorid | p.o. | 0.20 | GM | 5.52 | L/NEU,PSY,GER |

| | | | | | | | |

| 211.3 | N04BB01 | amantadin sulfát | p.o. | 0.20 | GM | 7.33 | L/NEU,PSY,GER |

| | | | | | | | |

| 211.4 | N04BC03 | dihydroergokriptin | p.o. | 10.00 | MG | 15.30 | X |

| | | | | | | | |

| 211.5 | N04BC04 | ropinirol do 2 mg v jedné tabletě včetně | p.o. | 6.00 | MG | 69.18 | X |

| | | | | | | | |

| 211.6 | N04BC04 | ropinirol nad 2 mg v jedné tabletě | p.o. | 6.00 | MG | 63.17 | X |

| | | | | | | | |

| 211.7 | N04BC05 | pramipexol | p.o. | 2.50 | MG | 105.25 | X |

| | | | | | | | |

| 211.8 | N04BD01 | Selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.00 | MG | 5.49 | L/NEU,PSY,GER |

| 03073 | APO-SELEG | por tbl nob 100x5mg | APT | CND |

| --- | --- | --- | --- | --- |

| 03074 | APO-SELEG | por tbl nob 50x5mg | APT | CND |

| 13017 | NIAR | por tbl nob 30x5mg | AAW | D |

| 15307 | APO-SELEG | por tbl nob 100x5mg | CMG | IRL |

| 15308 | APO-SELEG | por tbl nob 50x5mg | CMG | IRL |

| 17408 | APO-SELEG | por tbl nob 100x5mg | KAT | NL |

| 17409 | APO-SELEG | por tbl nob 50x5mg | KAT | NL |

| 59279 | SELEGILIN-RATIOPHARM 5 MG | por tbl nob 50x5mg | MCK | D |

| 211.9 | N04BD01 | selegilin nad 5 mg v 1 tabletě | p.o. | 5.00 | MG | 5.10 | L/NEU,PSY,GER |

| | | | | | | | |

| 211.10 | N04BX01 | tolkapon | p.o. | 0.45 | GM | 175.08 | X |

| | | | | | | | |

| 211.11 | N04BX02 | entacapon | p.o. | 1.00 | GM | 145.00 | X |

| 211.1 | N04BB01 | amantadin | parent. | 0.20 | GM | 4,15 | H |

| | | | | | | | |

| 211.2 | N04BB01 | amantadin hydrochlorid | p.o. | 0.20 | GM | 5,39 | L/NEU,PSY,GER |

| | | | | | | | |

| 211.3 | N04BB01 | amantadin sulfát | p.o. | 0.20 | GM | 7,16 | L/NEU,PSY,GER |

| | | | | | | | |

| 211.4 | N04BC03 | dihydroergokriptin | p.o. | 10.00 | MG | 14,95 | X |

| | | | | | | | |

| 211.5 | N04BC04 | ropinirol do 2 mg v jedné tabletě včetně | p.o. | 6.00 | MG | 67,61 | X |

| | | | | | | | |

| 211.6 | N04BC04 | ropinirol nad 2 mg v jedné tabletě | p.o. | 6.00 | MG | 61,74 | X |

| | | | | | | | |

| 211.7 | N04BC05 | pramipexol | p.o. | 2.50 | MG | 102,86 | X |

| | | | | | | | |

| 211.8 | N04BD01 | selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.00 | MG | 5,37 | L/NEU,PSY,GER |

| 03073 | APO-SELEG | por tbl nob 100×5mg | APT | CND |

| --- | --- | --- | --- | --- |

| 03074 | APO-SELEG | por tbl nob 50×5mg | APT | CND |

| 13017 | NIAR | por tbl nob 30×5mg | AAW | D |

| 15307 | APO-SELEG | por tbl nob 100×5mg | CMG | IRL |

| 15308 | APO-SELEG | por tbl nob 50×5mg | CMG | IRL |

| 17408 | APO-SELEG | por tbl nob 100×5mg | KAT | NL |

| 17409 | APO-SELEG | por tbl nob 50×5mg | KAT | NL |

| 59279 | SELEGILIN-RATIOPHARM 5 MG | por tbl nob 50×5mg | MCK | D |

| 211.9 | N04BD01 | selegilin nad 5 mg v 1 tabletě | p.o. | 5.00 | MG | 4,98 | L/NEU,PSY,GER |

| | | | | | | | |

| 211.10 | N04BX01 | tolkapon | p.o. | 0.45 | GM | 171,11 | X |

| | | | | | | | |

| 211.11 | N04BX02 | entacapon | p.o. | 1.00 | GM | 141,71 | X |

| | | | | | | | |

| 212 | antiparkinsonika působící na MAO nebo COMT | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 212.1 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3.00 | MG | 159.40 | X |

| 13531 | HIZEST 0.05 MG | por tbl nob 30x0.05mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 13532 | HIZEST 0.05 MG | por tbl nob 100x0.05mg | IXP | CZ |

| 212.2 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3.00 | MG | 131.12 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13533 | HIZEST 0.25 MG | por tbl nob 30x0.25mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 13534 | HIZEST 0.25 MG | por tbl nob 100x0.25mg | IXP | CZ |

| 212.3 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3.00 | MG | 119.66 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13535 | HIZEST 1 MG | por tbl nob 30x1mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 13536 | HIZEST 1 MG | por tbl nob 100x1mg | IXP | CZ |

| 212.1 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3.00 | MG | 155,78 | X |

| 13531 | HIZEST 0.05 MG | por tbl nob 30×0.05mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 13532 | HIZEST 0.05 MG | por tbl nob 100×0.05mg | IXP | CZ |

| 212.2 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3.00 | MG | 128,14 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13533 | HIZEST 0.25 MG | por tbl nob 30×0.25mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 13534 | HIZEST 0.25 MG | por tbl nob 100×0.25mg | IXP | CZ |

| 212.3 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3.00 | MG | 116,94 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13535 | HIZEST 1 MG | por tbl nob 30×1mg | IXP | CZ |

| --- | --- | --- | --- | --- |

| 13536 | HIZEST 1 MG | por tbl nob 100×1mg | IXP | CZ |

| 213 | antipsychotika, neuroleptika pro perorální podání, neuroleptika – fenothiaziny, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 213.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 12.19 | |

| | | | | | | | |

| 213.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 6.58 | |

| 62313 | PLEGOMAZIN 100 MG | por tbl obd30x100mg | EGI | H |

| --- | --- | --- | --- | --- |

| 213.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.30 | GM | 62.76 | |

| | | | | | | | |

| 213.4 | N05AA02 | levomepromazin | p.o. | 0.30 | GM | 16.94 | |

| | | | | | | | |

| 213.5 | N05AA03 | promazin | p.o. | 0.30 | GM | 13.49 | |

| | | | | | | | |

| 213.6 | N05AB03 | perfenazin | p.o. | 30.00 | MG | 1.83 | |

| | | | | | | | |

| 213.7 | N05AB04 | prochlorperazin | p.o. | 0.10 | GM | 12.42 | |

| | | | | | | | |

| 213.8 | N05AB06 | trifluoperazin | p.o. | 20.00 | MG | 6.99 | |

| | | | | | | | |

| 213.9 | N05AB08 | thioproperazin | p.o. | 75.00 | MG | 6.70 | |

| | | | | | | | |

| 213.10 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50.00 | MG | 5.72 | L/NEU,PSY,GER |

| | | | | | | | |

| 213.11 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50.00 | MG | 5.19 | L/NEU,PSY,GER |

| | | | | | | | |

| 213.12 | N05AC02 | thioridazin | p.o. | 0.30 | GM | 10.03 | |

| 213.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 11,91 | |

| | | | | | | | |

| 213.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 6,43 | |

| 62313 | PLEGOMAZIN 100 MG | por tbl obd 30×100mg | EGI | H |

| --- | --- | --- | --- | --- |

| 213.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.30 | GM | 61,34 | |

| | | | | | | | |

| 213.4 | N05AA02 | levomepromazin | p.o. | 0.30 | GM | 16,56 | |

| | | | | | | | |

| 213.5 | N05AA03 | promazin | p.o. | 0.30 | GM | 13,18 | |

| | | | | | | | |

| 213.6 | N05AB03 | perfenazin | p.o. | 30.00 | MG | 1,79 | |

| | | | | | | | |

| 213.7 | N05AB04 | prochlorperazin | p.o. | 0.10 | GM | 12,14 | |

| | | | | | | | |

| 213.8 | N05AB06 | trifluoperazin | p.o. | 20.00 | MG | 6,83 | |

| | | | | | | | |

| 213.9 | N05AB08 | thioproperazin | p.o. | 75.00 | MG | 6,55 | |

| | | | | | | | |

| 213.10 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50.00 | MG | 5,59 | L/NEU,PSY,GER |

| | | | | | | | |

| 213.11 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50.00 | MG | 5,07 | L/NEU,PSY,GER |

| | | | | | | | |

| 213.12 | N05AC02 | thioridazin | p.o. | 0.30 | GM | 9,80 | |

| | | | | | | | |

| 214 | neuroleptika - butyrofenony a indolové deriváty perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 214.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8.00 | MG | 6.06 | |

| 10575 | APO-HALOPERIDOL 5 | por tbl nob 100x5mg | APT | CND |

| --- | --- | --- | --- | --- |

| 15310 | APO-HALOPERIDOL 5 | por tbl nob 100x5mg | CMG | IRL |

| 15311 | APO-HALOPERIDOL 1 | por tbl nob 100x1 mg | CMG | IRL |

| 98291 | APO-HALOPERIDOL | tbl 100x1 mg | APT | CND |

| 214.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8.00 | MG | 10.12 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 214.3 | N05AD02 | trifluperidol (pevné lékové formy) | p.o. | 2.00 | MG | 3.91 | |

| | | | | | | | |

| 214.4 | N05AD02 | trifluperidol (tekuté lékové formy) | p.o. | 2.00 | MG | 7.72 | |

| | | | | | | | |

| 214.5 | N05AD03 | melperon | p.o. | 0.30 | GM | 24.94 | |

| | | | | | | | |

| 214.6 | N05AE03 | sertindol | p.o. | 1.00 | DF | 107.18 | P |

| 13039 | SERDOLECT 4 MG | por tbl flm 30x4mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 214.7 | N05AE04 | ziprasidon | p.o. | 80.00 | MG | 107.18 | P |

| 214.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8.00 | MG | 5,92 | |

| 10575 | APO-HALOPERIDOL 5 | por tbl nob 100×5mg | APT | CND |

| --- | --- | --- | --- | --- |

| 15310 | APO-HALOPERIDOL 5 | por tbl nob 100×5mg | CMG | IRL |

| 15311 | APO-HALOPERIDOL 1 | por tbl nob 100×1mg | CMG | IRL |

| 98291 | APO-HALOPERIDOL | tbl 100×1mg | APT | CND |

| 214.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8.00 | MG | 9,89 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 214.3 | N05AD02 | trifluperidol (pevné lékové formy) | p.o. | 2.00 | MG | 3,82 | |

| | | | | | | | |

| 214.4 | N05AD02 | trifluperidol (tekuté lékové formy) | p.o. | 2.00 | MG | 7,54 | |

| | | | | | | | |

| 214.5 | N05AD03 | melperon | p.o. | 0.30 | GM | 24,37 | |

| | | | | | | | |

| 214.6 | N05AE03 | sertindol | p.o. | 1.00 | DF | 104,75 | P |

| 13039 | SERDOLECT 4 MG | por tbl flm 30×4mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 214.7 | N05AE04 | ziprasidon | p.o. | 80.00 | MG | 104,75 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Ziprasidon a sertindol předepisuje psychiatr u dospělých pacientů se schizofrenií při nevhodnosti léčby risperidonem pro neúčinnost nebo nežádoucí účinky.

@@ -8146,214 +8195,214 @@

| 215 | neuroleptika - thioxantheny, difenylbutylpiperidiny, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 215.1 | N05AF | oxyprotepin | p.o. | 20.00 | MG | 18.28 | |

| | | | | | | | |

| 215.2 | N05AF01 | flupentixol | p.o. | 6.00 | MG | 15.70 | |

| 88143 | FLUANXOL 1 MG | drg 100x1mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 215.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 26.39 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 215.4 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.30 | GM | 8.18 | |

| | | | | | | | |

| 215.5 | N05AF03 | chlorprothixen (nad 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 13.27 | |

| | | | | | | | |

| 215.6 | N05AF05 | zuklopenthixol | p.o. | 30.00 | MG | 13.27 | |

| 57823 | CISORDINOL 10 MG | por tbl flm 50x10mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 57827 | CISORDINOL 25 MG | por tbl flm 50x25mg | LUN | DK |

| 215.7 | N05AG02 | pimozid | p.o. | 4.00 | MG | 10.76 | |

| | | | | | | | |

| 215.8 | N05AG03 | penfluridol | p.o. | 6.00 | MG | 6.01 | |

| 215.1 | N05AF | oxyprotepin | p.o. | 20.00 | MG | 17,87 | |

| | | | | | | | |

| 215.2 | N05AF01 | flupentixol | p.o. | 6.00 | MG | 15,34 | |

| 88143 | FLUANXOL 1 MG | drg 100×1mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 215.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 25,79 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 215.4 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.30 | GM | 7,99 | |

| | | | | | | | |

| 215.5 | N05AF03 | chlorprothixen (nad 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 12,97 | |

| | | | | | | | |

| 215.6 | N05AF05 | zuklopenthixol | p.o. | 30.00 | MG | 12,97 | |

| 57823 | CISORDINOL 10 MG | por tbl flm 50×10mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 57827 | CISORDINOL 25 MG | por tbl flm 50×25mg | LUN | DK |

| 215.7 | N05AG02 | pimozid | p.o. | 4.00 | MG | 10,52 | |

| | | | | | | | |

| 215.8 | N05AG03 | penfluridol | p.o. | 6.00 | MG | 5,87 | |

| | | | | | | | |

| 216 | neuroleptika - diazepiny, oxazepiny, thiazepiny, benzamidy, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 216.1 | N05AH01 | loxapin | p.o. | 0.10 | GM | 52.20 | L/PSY |

| | | | | | | | |

| 216.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 57.16 | L/PSY,NEU |

| 42824 | CLOZAPIN DESITIN 25 MG | por tbl nob 30x25mg | SBV | NL |

| --- | --- | --- | --- | --- |

| 216.3 | N05AH02 | klozapin (nad 25 do 50 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 50.20 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 216.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 46.03 | L/PSY |

| 42825 | CLOZAPIN DESITIN 100 MG | por tbl nob 30x100mg | SBV | NL |

| --- | --- | --- | --- | --- |

| 216.5 | N05AH03 | olanzapin | p.o. | 10.00 | MG | 107.18 | P |

| 216.1 | N05AH01 | loxapin | p.o. | 0.10 | GM | 51,02 | L/PSY |

| | | | | | | | |

| 216.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 55,86 | L/PSY, NEU |

| 42824 | CLOZAPIN DESITIN 25 MG | por tbl nob 30×25mg | SBV | NL |

| --- | --- | --- | --- | --- |

| 216.3 | N05AH02 | klozapin (nad 25 do 50 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 49,06 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 216.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.30 | GM | 44,99 | L/PSY |

| 42825 | CLOZAPIN DESITIN 100 MG | por tbl nob 30×100mg | SBV | NL |

| --- | --- | --- | --- | --- |

| 216.5 | N05AH03 | olanzapin | p.o. | 10.00 | MG | 104,75 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Olanzapin předepisuje psychiatr u dospělých pacientů se schizofrenií nebo bipolární afektivní poruchou při nevhodnosti léčby risperidonem pro neúčinnost nebo nežádoucí účinky. Toto omezení se nevztahuje pro prevenci rekurentní bipolární afektivní poruchy.

| 216.6 | N05AH04 | quetiapin do 25 mg včetně v jedné tabletě | p.o. | 0.40 | GM | 227.56 | P |

| 216.6 | N05AH04 | quetiapin do 25 mg včetně v jedné tabletě | p.o. | 0.40 | GM | 222,39 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Quetiapin v dávce do 25 mg v jedné tabletě předepisuje neurolog nebo psychiatr u dospělých pacientů s psychotickými komplikacemi (organická halucinóza, syndrom s bludy) dopaminergní léčby Parkinsonovy nemoci.

| 216.7 | N05AH04 | quetiapin nad 25 mg v jedné tabletě | p.o. | 0.40 | GM | 107,18 | P |

| 216.7 | N05AH04 | quetiapin nad 25 mg v jedné tabletě | p.o. | 0.40 | GM | 104,75 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Quetiapin nad 25 mg v jedné tabletě indikuje psychiatr u dospělých pacientů se schizofrenní nebo manickou epizodou bipolární afektivní poruchy při nevhodnosti léčby risperidonem pro neúčinnost nebo nežádoucí účinky.

| 216.8 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.80 | GM | 31.80 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11468 | PROSULPIN 50 MG | tbl 60x50mg | PMP | CZ |

| --- | --- | --- | --- | --- |

| 46751 | SULPIROL 50 | por cps dur 100x50mg | SFS | D |

| 48877 | SULPIROL 50 | por cps dur 100x50mg | HPZ | PL |

| 216.9 | N05AL01 | sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.80 | GM | 18.90 | L/PSY, NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 07387 | PROSULPIN 200 MG | por tbl nob 30x200mg | PMP | CZ |

| --- | --- | --- | --- | --- |

| 11149 | PROSULPIN 200 MG | por tbl nob 60x200mg | PMP | CZ |

| 46741 | SULPIROL 200 | por tbl nob 20x200mg | HEX | D |

| 46743 | SULPIROL 200 | por tbl nob 100x200mg | HEX | D |

| 46746 | SULPIROL 200 | por tbl nob 100x200mg | SFS | D |

| 46748 | SULPIROL 200 | por tbl nob 20x200mg | SFS | D |

| 48872 | SULPIROL 200 | por tbl nob 20x200mg | HPZ | PL |

| 48874 | SULPIROL 200 | por tbl nob 100x200mg | HPZ | PL |

| 216.10 | N05AL03 | tiaprid (pevné lékové formy) | p.o. | 0.40 | GM | 14.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 99926 | TIAPRA | por tbl flm50x100mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 216.11 | N05AL03 | tiaprid (tekuté lékové formy) | p.o. | 0.40 | GM | 37.70 | |

| | | | | | | | |

| 216.12 | N05AL05 | amisulprid (pevné lékové formy) nad 50 mg v jedné tabletě | p.o. | 400.00 | MG | 74.05 | L/PSY |

| | | | | | | | |

| 216.13 | N05AL05 | amisulprid (pevné lékové formy) do 50 mg v jedné tabletě včetně | p.o. | 1.00 | DF | 16.70 | L/PSY.NEU |

| 216.8 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.80 | GM | 31,08 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11468 | PROSULPIN 50 MG | tbl 60×50mg | PMP | CZ |

| --- | --- | --- | --- | --- |

| 46751 | SULPIROL 50 | por cps dur 100×50mg | SFS | D |

| 48877 | SULPIROL 50 | por cps dur 100×50mg | HPZ | PL |

| 216.9 | N05AL01 | sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.80 | GM | 18,47 | L/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 07387 | PROSULPIN 200 MG | por tbl nob 30×200mg | PMP | CZ |

| --- | --- | --- | --- | --- |

| 11149 | PROSULPIN 200 MG | por tbl nob 60×200mg | PMP | CZ |

| 46741 | SULPIROL 200 | por tbl nob 20×200mg | HEX | D |

| 46743 | SULPIROL 200 | por tbl nob 100×200mg | HEX | D |

| 46746 | SULPIROL 200 | por tbl nob 100×200mg | SFS | D |

| 46748 | SULPIROL 200 | por tbl nob 20×200mg | SFS | D |

| 48872 | SULPIROL 200 | por tbl nob 20×200mg | HPZ | PL |

| 48874 | SULPIROL 200 | por tbl nob 100×200mg | HPZ | PL |

| 216.10 | N05AL03 | tiaprid (pevné lékové formy) | p.o. | 0.40 | GM | 13,68 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 99926 | TIAPRA | por tbl flm50×100mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 216.11 | N05AL03 | tiaprid (tekuté lékové formy) | p.o. | 0.40 | GM | 36,84 | |

| | | | | | | | |

| 216.12 | N05AL05 | amisulprid (pevné lékové formy) nad 50 mg v jedné tabletě | p.o. | 400.00 | MG | 72,37 | L/PSY |

| | | | | | | | |

| 216.13 | N05AL05 | amisulprid (pevné lékové formy) do 50 mg v jedné tabletě včetně | p.o. | 1.00 | DF | 16,32 | L/PSY.NEU |

| | | | | | | | |

| 217 | ostatní antipsychotika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 217.1 | N05AX08 | risperidon (s obsahem do 1 mg včetně) | p.o. | 5.00 | MG | 30.00 | L/PSY, NEU, GER, INT |

| 10527 | RISPEN 1 | por tbl flm 20x1mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 42525 | RISPEN 1 | por tbl flm 50x1mg | ZEH | CZ |

| 48799 | RISPERIDON-RATIOPHARM 1 MG | por tbl flm 20x1mg | AHF | IS |

| 48805 | RISPERIDON-RATIOPHARM 1 MG | por tbl flm 50x1mg | AHF | IS |

| 217.2 | N05AX08 | risperidon (s obsahem nad 1 mg) | p.o. | 5.00 | MG | 31.00 | L/PSY, NEU, GER, INT |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10528 | RISPEN 2 | por tbl flm 20x2mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 10529 | RISPEN 3 | por tbl flm 20x3mg | ZEH | CZ |

| 10530 | RISPEN 4 | por tbl flm 20x4mg | ZEH | CZ |

| 42527 | RISPEN 2 | por tbl flm 50x2mg | ZEH | CZ |

| 42529 | RISPEN 3 | por tbl flm 50x3mg | ZEH | CZ |

| 42531 | RISPEN 4 | por tbl flm 50x4mg | ZEH | CZ |

| 48767 | RISPERIDON-RATIOPHARM 2 MG | por tbl flm 20x2mg | AHF | IS |

| 48773 | RISPERIDON-RATIOPHARM 2 MG | por tbl flm 50x2mg | AHF | IS |

| 48815 | RISPERIDON-RATIOPHARM 3 MG | por tbl flm 20x3mg | AHF | IS |

| 48821 | RISPERIDON-RATIOPHARM 3 MG | por tbl flm 50x3mg | AHF | IS |

| 217.3 | N05AX08 | risperidon (tekuté lékové formy) | p.o. | 5.00 | MG | 97.75 | L/PSY, NEU, GER, INT |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 217.4 | N05AX11 | zotepin | p.o. | 0.20 | GM | 74.05 | L/PSY |

| | | | | | | | |

| 217.5 | N05AX12 | aripiprazol | p.o. | 1 | DF | 128.62 | P |

| 217.1 | N05AX08 | risperidon (s obsahem do 1 mg včetně) | p.o. | 5.00 | MG | 29,32 | L/PSY, NEU, GER, INT |

| 10527 | RISPEN 1 | por tbl flm 20×1mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 42525 | RISPEN 1 | por tbl flm 50×1mg | ZEH | CZ |

| 48799 | RISPERIDON-RATIOPHARM 1 MG | por tbl flm 20×1mg | AHF | IS |

| 48805 | RISPERIDON-RATIOPHARM 1 MG | por tbl flm 50×1mg | AHF | IS |

| 217.2 | N05AX08 | risperidon (s obsahem nad 1 mg) | p.o. | 5.00 | MG | 30,30 | L/PSY,NEU,GER, INT |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10528 | RISPEN 2 | por tbl flm 20×2mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 10529 | RISPEN 3 | por tbl flm 20×3mg | ZEH | CZ |

| 10530 | RISPEN 4 | por tbl flm 20×4mg | ZEH | CZ |

| 42527 | RISPEN 2 | por tbl flm 50×2mg | ZEH | CZ |

| 42529 | RISPEN 3 | por tbl flm 50×3mg | ZEH | CZ |

| 42531 | RISPEN 4 | por tbl flm 50×4mg | ZEH | CZ |

| 48767 | RISPERIDON-RATIOPHARM 2 MG | por tbl flm 20×2mg | AHF | IS |

| 48773 | RISPERIDON-RATIOPHARM 2 MG | por tbl flm 50×2mg | AHF | IS |

| 48815 | RISPERIDON-RATIOPHARM 3 MG | por tbl flm 20×3mg | AHF | IS |

| 48821 | RISPERIDON-RATIOPHARM 3 MG | por tbl flm 50×3mg | AHF | IS |

| 217.3 | N05AX08 | risperidon (tekuté lékové formy) | p.o. | 5.00 | MG | 95,53 | L/PSY, NEU, GER, INT |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 217.4 | N05AX11 | zotepin | p.o. | 0.20 | GM | 72,37 | L/PSY |

| | | | | | | | |

| 217.5 | N05AX12 | aripiprazol | p.o. | 1 | DF | 125,70 | P |

Aripriprazol předepisuje psychiatr u dospělých pacientů se schizofrenií při neúčinnosti či nesnášenlivosti léčby alespoň dvěma antipsychotiky 2.generace. V této indikaci bude indikována pouze 1 tableta denně v síle 10 mg nebo 15 mg nebo 30 mg.

| 218 | Lithium | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 218.1 | N05AN01 | lithium do 0,3 g včetně v jedné tabletě | p.o. | 1.00 | GM | 4.72 | |

| 02481 | LITHIUM CARBONICUM SLOVAKOFARMA | tbl 100x300mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 218.2 | N05AN01 | lithium nad 0,3 g v jedné tabletě | p.o. | 1.00 | GM | 3.14 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04385 | CONTEMNOL | tbl ret 100x500mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 219 | antipsychotika, neuroleptika ostatní cesty aplikace – nedepotní přípravky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 219.1 | N05AA01 | chlorpromazin | parent. | 0.10 | GM | 25.37 | O |

| | | | | | | | |

| 219.2 | N05AA02 | levomepromazin | parent. | 0.10 | GM | 30.89 | O |

| | | | | | | | |

| 219.3 | N05AD01 | haloperidol | parent. | 8.00 | MG | 16.72 | O |

| | | | | | | | |

| 219.4 | N05AD02 | trifluperidol | parent. | 2.00 | MG | 5.52 | O |

| | | | | | | | |

| 219.5 | N05AD03 | melperon | parent. | 0.30 | GM | 50.10 | O |

| | | | | | | | |

| 219.6 | N05AD08 | droperidol | parent. | 25.00 | MG | 50.10 | O |

| | | | | | | | |

| 219.7 | N05AE04 | ziprasidon | parent. | 40.00 | MG | 177.00 | H |

| | | | | | | | |

| 219.8 | N05AF | oxyprotepin | parent. | 1.00 | MG | 2.55 | O |

| | | | | | | | |

| 219.9 | N05AF03 | chlorprothixen | parent. | 50.00 | MG | 3.03 | O |

| | | | | | | | |

| 219.10 | N05AF05 | zuklopenthixol | parent. | 30.00 | MG | 94.25 | O |

| 93253 | CISORDINOL-ACUTARD | inj 10x2ml/100mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 219.11 | N05AH02 | klozapin | parent. | 0.30 | GM | 86.22 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 219.12 | N05AH03 | olanzapin | parent. | 10.00 | MG | 177.00 | H |

| 25937 | ZYPREXA 10 MG | inj plv sol 1x10mg | ELH | NL |

| --- | --- | --- | --- | --- |

| 32601 | ZYPREXA INTRAMUSCULAR | inj plv sol 1x10mg | LPF | D |

| 219.13 | N05AL01 | sulpirid | parent. | 0.80 | GM | 71.33 | O/PSY, NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 219.14 | N05AL03 | tiaprid | parent. | 0.40 | GM | 41.88 | O |

| 99929 | TIAPRA 100MG/2ML | inj sol 10x2ml | ZEH | SK |

| --- | --- | --- | --- | --- |

| 220 | antipsychotika, neuroleptika ostatní cesty aplikace – depotní přípravky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 220.1 | N05AB02 | flufenazin | parent. | 1.00 | MG | 3.92 | O |

| 03514 | MODITEN DEPOT | inj 5x1ml/25mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 220.2 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.30 | MG | 9.82 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 220.3 | N05AF01 | flupentixol | parent. | 4.00 | MG | 15.16 | O |

| 91830 | FLUANXOL DEPOT | inj 10x2ml/40mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 220.4 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15.00 | MG | 11.78 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 220.5 | N05AG01 | fluspirilen | parent. | 0.70 | MG | 12.39 | O |

| | | | | | | | |

| 220.6 | N05AX08 | risperidon s obsahem do 25 mg v jedné ampuli včetně | parent. | 1.80 | MG | 288.09 | P |

| | | | | | | | |

| 220.7 | N05AX08 | risperidon s obsahem nad 25 mg do 49 mg v jedné ampuli včetně | parent. | 1.80 | MG | 262.00 | P |

| | | | | | | | |

| 220.8 | N05AX08 | risperidon s obsahem 50 mg a více v 1 amp. | parent. | 1.80 | MG | 247.46 | P |

| 218.1 | N05AN01 | lithium do 0,3 g včetně v jedné tabletě | p.o. | 1.00 | GM | 4,61 | |

| 02481 | LITHIUM CARBONICUM SLOVAKOFARMA | tbl 100×300mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 218.2 | N05AN01 | lithium nad 0,3 g v jedné tabletě | p.o. | 1.00 | GM | 3,07 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04385 | CONTEMNOL | tbl ret 100×500mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 219 | antipsychotika, neuroleptika ostatní cesty aplikace - nedepotní přípravky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 219.1 | N05AA01 | chlorpromazin | parent. | 0.10 | GM | 24,79 | O |

| | | | | | | | |

| 219.2 | N05AA02 | levomepromazin | parent. | 0.10 | GM | 30,19 | O |

| | | | | | | | |

| 219.3 | N05AD01 | haloperidol | parent. | 8.00 | MG | 16,34 | O |

| | | | | | | | |

| 219.4 | N05AD02 | trifluperidol | parent. | 2.00 | MG | 5,39 | O |

| | | | | | | | |

| 219.5 | N05AD03 | melperon | parent. | 0.30 | GM | 48,96 | O |

| | | | | | | | |

| 219.6 | N05AD08 | droperidol | parent. | 25.00 | MG | 48,96 | O |

| | | | | | | | |

| 219.7 | N05AE04 | ziprasidon | parent. | 40.00 | MG | 172,98 | H |

| | | | | | | | |

| 219.8 | N05AF | oxyprotepin | parent. | 1.00 | MG | 2,49 | O |

| | | | | | | | |

| 219.9 | N05AF03 | chlorprothixen | parent. | 50.00 | MG | 2,96 | O |

| | | | | | | | |

| 219.10 | N05AF05 | zuklopenthixol | parent. | 30.00 | MG | 92,11 | O |

| 93253 | CISORDINOL-ACUTARD | inj 10×2ml/100mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 219.11 | N05AH02 | klozapin | parent. | 0.30 | GM | 84,26 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 219.12 | N05AH03 | olanzapin | parent. | 10.00 | MG | 172,98 | H |

| 25937 | ZYPREXA 10 MG | inj plv sol 1×10mg | ELH | NL |

| --- | --- | --- | --- | --- |

| 32601 | ZYPREXA INTRAMUSCULAR | inj plv sol 1×10mg | LPF | D |

| 219.13 | N05AL01 | sulpirid | parent. | 0.80 | GM | 69,71 | O/PSY,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 219.14 | N05AL03 | tiaprid | parent. | 0.40 | GM | 40,93 | O |

| 99929 | TIAPRA 100MG/2ML | inj sol 10×2ml | ZEH | SK |

| --- | --- | --- | --- | --- |

| 220 | antipsychotika, neuroleptika ostatní cesty aplikace - depotní přípravky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 220.1 | N05AB02 | flufenazin | parent. | 1.00 | MG | 3,83 | O |

| 03514 | MODITEN DEPOT | inj 5×1ml/25mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 220.2 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.30 | MG | 9,60 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 220.3 | N05AF01 | flupentixol | parent. | 4.00 | MG | 14,82 | O |

| 91830 | FLUANXOL DEPOT | inj 10×2ml/40mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 220.4 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15.00 | MG | 11,51 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 220.5 | N05AG01 | fluspirilen | parent. | 0.70 | MG | 12,11 | O |

| | | | | | | | |

| 220.6 | N05AX08 | risperidon s obsahem do 25 mg v jedné ampuli včetně | parent. | 1.80 | MG | 281,55 | P |

| | | | | | | | |

| 220.7 | N05AX08 | risperidon s obsahem nad 25 mg do 49 mg v jedné ampuli včetně | parent. | 1.80 | MG | 256,05 | P |

| | | | | | | | |

| 220.8 | N05AX08 | risperidon s obsahem 50 mg a více v 1 amp. | parent. | 1.80 | MG | 241,84 | P |

Risperidon ve formě depotní injekce je předepisován psychiatrem a hrazen u dospělých pacientů se schizofrenií s dobrou prognózou, kteří splňují všechny níže uvedené podmínky zároveň:

@@ -8368,365 +8417,365 @@

| 221 | anxiolytika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 221.1 | N05BA01 | diazepam | p.o. | 10.00 | MG | 0.68 | |

| 02478 | DIAZEPAM SLOVAKOFARMA 10 MG | tbl 20x10mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 221.2 | N05BA02 | chlordiazepoxid | p.o. | 30.00 | MG | 0.68 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 221.3 | N05BA03 | medazepam | p.o. | 20.00 | MG | 0.68 | |

| | | | | | | | |

| 221.4 | N05BA04 | oxazepam | p.o. | 50.00 | MG | 0.68 | |

| | | | | | | | |

| 221.5 | N05BA05 | klorazepát draselný | p.o. | 20.00 | MG | 0.68 | |

| | | | | | | | |

| 221.6 | N05BA06 | lorazepam | p.o. | 2.50 | MG | 0.68 | |

| | | | | | | | |

| 221.7 | N05BA08 | bromazepam | p.o. | 10.00 | MG | 0.68 | |

| | | | | | | | |

| 221.8 | N05BA09 | klobazam | p.o. | 20.00 | MG | 0.68 | |

| | | | | | | | |

| 221.9 | N05BA11 | prazepam | p.o. | 30.00 | MG | 0.68 | |

| | | | | | | | |

| 221.10 | N05BA12 | alprazolam (1 mg a více v jedné tabletě) | p.o. | 1.00 | MG | 2.49 | P |

| 221.1 | N05BA01 | diazepam | p.o. | 10.00 | MG | 0,66 | |

| 02478 | DIAZEPAM SLOVAKOFARMA 10 MG | tbl 20×10mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 221.2 | N05BA02 | chlordiazepoxid | p.o. | 30.00 | MG | 0,66 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 221.3 | N05BA03 | medazepam | p.o. | 20.00 | MG | 0,66 | |

| | | | | | | | |

| 221.4 | N05BA04 | oxazepam | p.o. | 50.00 | MG | 0,66 | |

| | | | | | | | |

| 221.5 | N05BA05 | klorazepát draselný | p.o. | 20.00 | MG | 0,66 | |

| | | | | | | | |

| 221.6 | N05BA06 | lorazepam | p.o. | 2.50 | MG | 0,66 | |

| | | | | | | | |

| 221.7 | N05BA08 | bromazepam | p.o. | 10.00 | MG | 0,66 | |

| | | | | | | | |

| 221.8 | N05BA09 | klobazam | p.o. | 20.00 | MG | 0,66 | |

| | | | | | | | |

| 221.9 | N05BA11 | prazepam | p.o. | 30.00 | MG | 0,66 | |

| | | | | | | | |

| 221.10 | N05BA12 | alprazolam (1 mg a více v jedné tabletě) | p.o. | 1.00 | MG | 2,43 | P |

Léčbu alprazolamem předepisuje psychiatr, neurolog nebo internista: léčba panické úzkosti.

| 40634 | NEUROL SR 1.0 | por tbl pro 30x1mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 40649 | NEUROL SR 2.0 | por tbl pro 30x2mg | ZEH | CZ |

| 221.11 | N05BA12 | alprazolam (do 1 mg v jedné tabletě) | p.o. | 1.00 | MG | 0.68 | |

| | | | | | | | |

| 221.12 | N05BA23 | tofisopam | p.o. | 0.15 | GM | 0.68 | |

| | | | | | | | |

| 221.13 | N05BB01 | hydroxyzin | p.o. | 75.00 | MG | 0.68 | |

| | | | | | | | |

| 221.14 | N05BC01 | meprobamat | p.o. | 1.20 | GM | 0.68 | |

| | | | | | | | |

| 221.15 | N05BE01 | buspiron | p.o. | 30.00 | MG | 2.51 | |

| | | | | | | | |

| 221.16 | N05BX01 | mefenoxalon | p.o. | 1.20 | GM | 16.38 | |

| 40634 | NEUROL SR 1.0 | por tbl pro 30×1mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 40649 | NEUROL SR 2.0 | por tbl pro 30×2mg | ZEH | CZ |

| 221.11 | N05BA12 | alprazolam (do 1 mg v jedné tabletě) | p.o. | 1.00 | MG | 0,66 | |

| | | | | | | | |

| 221.12 | N05BA23 | tofisopam | p.o. | 0.15 | GM | 0,66 | |

| | | | | | | | |

| 221.13 | N05BB01 | hydroxyzin | p.o. | 75.00 | MG | 0,66 | |

| | | | | | | | |

| 221.14 | N05BC01 | meprobamat | p.o. | 1.20 | GM | 0,66 | |

| | | | | | | | |

| 221.15 | N05BE01 | buspiron | p.o. | 30.00 | MG | 2,45 | |

| | | | | | | | |

| 221.16 | N05BX01 | mefenoxalon | p.o. | 1.20 | GM | 16,01 | |

| | | | | | | | |

| 222 | anxiolytika a hypnotika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 222.1 | N05BA01 | diazepam | parent. | 10.00 | MG | 6.98 | |

| 30097 | DIAZEPAM BIOTIKA | inj sol 10x2ml/10mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 96610 | APAURIN | inj sol 10x2ml/10mg | KRK | SLO |

| 222.2 | N05BA01 | diazepam (do 5 mg v jednom čípku včetně) | p.rect. | 10.00 | MG | 108.16 | L/NEU,PSY,PED |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04326 | STESOLID 5 MG | enm 5x2.5ml/5mg | ALO | N |

| --- | --- | --- | --- | --- |

| 222.3 | N05BA01 | diazepam (nad 5 mg v jednom čípku) | p.rect. | 10.00 | MG | 67.14 | L/NEU,PSY,PED |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04327 | STESOLID 10 MG | enm 5x2.5ml/10mg | ALO | N |

| --- | --- | --- | --- | --- |

| 222.4 | N05BA05 | klorazepát draselný | parent. | 20.00 | MG | 14.66 | |

| | | | | | | | |

| 222.5 | N05CA01 | pentobarbital | parent. | 0.10 | GM | 23.32 | H |

| | | | | | | | |

| 222.6 | N05CM | dexmedetomidin | parent. | 500.00 | RG | 1 300.00 | H |

| 222.1 | N05BA01 | diazepam | parent. | 10.00 | MG | 6,82 | |

| 30097 | DIAZEPAM BIOTIKA | inj sol 10×2ml/10mg | BTA | SK |

| --- | --- | --- | --- | --- |

| 96610 | APAURIN | inj sol 10×2ml/10mg | KRK | SLO |

| 222.2 | N05BA01 | diazepam (do 5 mg v jednom čípku včetně) | p.rect. | 10.00 | MG | 105,70 | L/NEU,PSY,PED |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04326 | STESOLID 5 MG | enm 5×2.5ml/5mg | ALO | N |

| --- | --- | --- | --- | --- |

| 222.3 | N05BA01 | diazepam (nad 5 mg v jednom čípku) | p.rect. | 10.00 | MG | 65,62 | L/NEU,PSY,PED |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04327 | STESOLID 10 MG | enm 5×2.5ml/10mg | ALO | N |

| --- | --- | --- | --- | --- |

| 222.4 | N05BA05 | klorazepát draselný | parent. | 20.00 | MG | 14,33 | |

| | | | | | | | |

| 222.5 | N05CA01 | pentobarbital | parent. | 0.10 | GM | 22,79 | H |

| | | | | | | | |

| 222.6 | N05CM | dexmedetomidin | parent. | 500.00 | RG | 1 270,49 | H |

| | | | | | | | |

| 223 | Antidepresiva neselektivně inhibující zpětné vychytávání monoaminů, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 223.1 | N06AA01 | desipramin | p.o. | 0.10 | GM | 17.11 | |

| | | | | | | | |

| 223.2 | N06AA02 | imipramin | p.o. | 0.10 | GM | 9.90 | |

| | | | | | | | |

| 223.3 | N06AA04 | klomipramin | p.o. | 0.10 | GM | 14.49 | |

| 08557 | ANAFRANIL 25 | por tbl obd 30x25mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 16028 | ANAFRANIL SR 75 | tbl ret 20x75mg | NAI | CZ |

| 16029 | ANAFRANIL 25 | tbl obd 30x25mg | NAI | CZ |

| 93828 | ANAFRANIL SR 75 | por tbl ret 20x75mg | NPA | CH |

| 223.4 | N06AA05 | opipramol | p.o. | 0.15 | GM | 12.02 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 223.5 | N06AA07 | lofepramin | p.o. | 105.00 | MG | 14.66 | |

| | | | | | | | |

| 223.6 | N06AA08 | dibenzepin | p.o. | 0.30 | GM | 14.90 | |

| 02641 | NOVERIL 240 | por tbl ret 20x240mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 16313 | NOVERIL 240 | por tbl ret 20x240mg | NAI | CZ |

| 223.7 | N06AA09 | amitriptylin | p.o. | 75.00 | MG | 2.85 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 87167 | AMITRIPTYLIN-SLOVAKOFARMA | tbl obd 50x28.3mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 223.8 | N06AA10 | nortriptylin | p.o. | 75.00 | MG | 9.02 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12343 | NORTRILEN | tbl 50x25mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 223.9 | N06AA16 | dosulepin | p.o. | 150.00 | MG | 9.78 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04207 | PROTHIADEN 25 | drg 30x25mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 223.10 | N06AA21 | maprotilin | p.o. | 100.00 | MG | 12.28 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04257 | LUDIOMIL 75 | drg 20x75mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 16312 | LUDIOMIL 75 | drg 20x75mg | NAI | CZ |

| 45757 | MAPROTIBENE 25 MG | por tbl flm 20x25mg | MCK | D |

| 223.1 | N06AA01 | desipramin | p.o. | 0.10 | GM | 16,72 | |

| | | | | | | | |

| 223.2 | N06AA02 | imipramin | p.o. | 0.10 | GM | 9,68 | |

| | | | | | | | |

| 223.3 | N06AA04 | klomipramin | p.o. | 0.10 | GM | 14,16 | |

| 08557 | ANAFRANIL 25 | por tbl obd 30×25mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 16028 | ANAFRANIL SR 75 | tbl ret 20×75mg | NAI | CZ |

| 16029 | ANAFRANIL 25 | tbl obd 30×25mg | NAI | CZ |

| 93828 | ANAFRANIL SR 75 | por tbl ret 20×75mg | NPA | CH |

| 223.4 | N06AA05 | opipramol | p.o. | 0.15 | GM | 11,75 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 223.5 | N06AA07 | lofepramin | p.o. | 105.00 | MG | 14,33 | |

| | | | | | | | |

| 223.6 | N06AA08 | dibenzepin | p.o. | 0.30 | GM | 14,56 | |

| 02641 | NOVERIL 240 | por tbl ret 20×240mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 16313 | NOVERIL 240 | por tbl ret 20×240mg | NAI | CZ |

| 223.7 | N06AA09 | amitriptylin | p.o. | 75.00 | MG 2,79 | |

| --- | --- | --- | --- | --- | --- | --- |

| 87167 | AMITRIPTYLIN-SLOVAKOFARMA | tbl obd 50×28.3mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 223.8 | N06AA10 | nortriptylin | p.o. | 75.00 | MG | 8,82 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12343 | NORTRILEN | tbl 50×25mg | LUN | DK |

| --- | --- | --- | --- | --- |

| 223.9 | N06AA16 | dosulepin | p.o. | 150.00 | MG | 9,56 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04207 | PROTHIADEN 25 | drg 30×25mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 223.10 | N06AA21 | maprotilin | p.o. | 100.00 | MG | 12,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 04257 | LUDIOMIL 75 | drg 20×75mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 16312 | LUDIOMIL 75 | drg 20×75mg | NAI | CZ |

| 45757 | MAPROTIBENE 25 MG | por tbl flm 20×25mg | MCK | D |

| 224 | Antidepresiva selektivně inhibující zpětné vychytávání monoaminů, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 224.1 | N06AB03 | fluoxetin | p.o. | 20.00 | MG | 12.00 | |

| 15302 | APO-FLUOXETINE | cps 30x20mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 15303 | APO-FLUOXETINE | cps 100x20mg | CMG | IRL |

| 17116 | APO-FLUOXETINE | cps 30x20mg | KAT | NL |

| 17118 | APO-FLUOXETINE | cps 100x20mg | KAT | NL |

| 44397 | APO-FLUOXETINE | cps 30x20mg | APT | CND |

| 44398 | APO-FLUOXETINE | cps 100x20mg | APT | CND |

| 48878 | FLUOXIN | por cps dur 20x20mg | HPZ | PL |

| 48879 | FLUOXIN | por cps dur 50x20mg | HPZ | PL |

| 48880 | FLUOXIN | por cps dur 100x20mg | HPZ | PL |

| 54422 | MAGRILAN | cps 10x20mg | MOE | CY |

| 54423 | MAGRILAN | cps 30x20mg | MOE | CY |

| 59274 | FLUMIREX | cps 30x20mg | CHN | H |

| 64656 | FLUOXIN | por cps dur 20x20mg | SFS | D |

| 64657 | FLUOXIN | por cps dur 50x20mg | SFS | D |

| 64658 | FLUOXIN | por cps dur 100x20mg | SFS | D |

| 95457 | FLUOXETIN-RATIOPHARM 20 MG | por cps dur 30x20mg | MCK | D |

| 95458 | FLUOXETIN-RATIOPHARM 20 MG | por cpsdur 100x20mg | MCK | D |

| 98791 | DEPREX LÉČIVA | por cps dur 30x20mg | ZEH | CZ |

| 224.2 | N06AB04 | citalopram do 10 mg v jedné tabletě včetně | p.o. | 20.00 | MG | 13.50 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03976 | CITALEC 10 | tbl obd 30x10mg-bli | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 15778 | ZYLORAM 10 MG TABLETY | por tbl flm 28x10mg | IRI | IRL |

| 48469 | CITA 10 MG | por tbl flm 28x10mg | ARN | D |

| 48472 | CITA 10 MG | por tbl flm 56x10mg | ARN | D |

| 95925 | CITALOPRAM PLIVA 10 MG | por tbl flm 28x10mg | AWD | D |

| 95926 | CITALOPRAM PLIVA 10 MG | por tbl flm 28x10mg | KRZ | PL |

| 95927 | CITALOPRAM PLIVA 10 MG | por tbl flm 28x10mg | PPL | GB |

| 224.3 | N06AB04 | citalopram nad 10 mg v jedné tabletě | p.o. | 20.00 | MG | 12.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03978 | CITALEC 20 | tbl obd 30x20mg-bli | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 15170 | CITALON 20 MG | por tbl flm 28x20mg | SZG | D |

| 15788 | ZYLORAM 20 MG TABLETY | por tbl flm 28x20mg | IRI | IRL |

| 16107 | ZYLORAM 40 MG TABLETY | por tbl flm 28x40mg | IRI | IRL |

| 48493 | CITA 20 MG | por tbl flm 28x20mg | ARN | D |

| 48496 | CITA 20 MG | por tbl flm 56x20mg | ARN | D |

| 48517 | CITA 40 MG | por tbl flm 28x40mg | ARN | D |

| 95928 | CITALOPRAM PLIVA 20 MG | por tbl flm 28x20mg | AWD | D |

| 95929 | CITALOPRAM PLIVA 20 MG | por tbl flm 28x20mg | PPL | GB |

| 95930 | CITALOPRAM PLIVA 20 MG | por tbl flm 28x20mg | KRZ | PL |

| 95931 | CITALOPRAM PLIVA 40 MG | por tbl flm 28x40mg | AWD | D |

| 95932 | CITALOPRAM PLIVA 40 MG | por tbl flm 28x40mg | PPL | GB |

| 95933 | CITALOPRAM PLIVA 40 MG | por tbl flm 28x40mg | KRZ | PL |

| 224.4 | N06AB04 | citalopram, tekuté lékové formy | p.o. | 20.00 | MG | 13.80 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 224.5 | N06AB05 | paroxetin | p.o. | 20.00 | MG | 12.00 | |

| 10479 | PAROLEX 40 | por tbl flm 30x40mg-b | HPZ | PL |

| --- | --- | --- | --- | --- |

| 10482 | PAROLEX 20 | por tbl flm 60x20mg-b | HPZ | PL |

| 10488 | PAROLEX 20 | por tbl flm 30x20mg-b | HPZ | PL |

| 13854 | PAROLEX 20 | por tbl flm 60x20mg-b | SFS | D |

| 13860 | PAROLEX 20 | por tbl flm 30x20mg-b | SFS | D |

| 13868 | PAROLEX 40 | por tbl flm 30x40mg-b | SFS | D |

| 15312 | APO-PAROX | por tbl flm 30x20mg | CMG | IRL |

| 15313 | APO-PAROX | por tbl flm 100x20mg | CMG | IRL |

| 17112 | APO-PAROX | por tbl flm 30x20mg | KAT | NL |

| 17113 | APO-PAROX | por tbl flm 100x20mg | KAT | NL |

| 30860 | APO-PAROX | por tbl flm 30x20mg | APT | CND |

| 30861 | APO-PAROX | por tbl flm 100x20mg | APT | CND |

| 41158 | PAROLEX 20 | por tbl flm 60x20mg-b | HED | DK |

| 46384 | PAROXETIN-RATIOPHARM 20 MG | por tbl flm 30x20mg | MCK | D |

| 96215 | PAROLEX 20 | por tbl flm 30x20mg-b | HED | DK |

| 96217 | PAROLEX 40 | por tbl flm 30x40mg-b | HED | DK |

| 224.6 | N06AB06 | sertralin | p.o. | 50.00 | MG | 12.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02352 | SERTRALIN HEXAL 50 | por tbl flm 28x50mg b | HED | DK |

| --- | --- | --- | --- | --- |

| 02398 | SERTRALIN HEXAL 50 | por tbl flm 28x50mg b | SFS | D |

| 03049 | SERTRALIN HEXAL 100 | por tbl flm 28x100mg-b | HED | DK |

| 03060 | SERTRALIN HEXAL 100 | por tbl flm 28x100mg-b | SFS | D |

| 15448 | SERTRALIN HEXAL 50 | por tbl flm 28x50mg b | GEA | DK |

| 15465 | SERTRALIN HEXAL 100 | por tbl flm 28x100mg-b | GEA | DK |

| 15817 | SERLIFT 50 MG | por tbl flm 30x50mg | IRI | IRL |

| 15819 | SERLIFT 100 MG | por tbl flm30x100mg | IRI | IRL |

| 16116 | SERTRALIN-RATIOPHARM 50 MG | por tbl flm 30x50mg | MCK | D |

| 16136 | SERTRALIN-RATIOPHARM 50 MG | por tbl flm 30x50mg | AHK | IS |

| 16137 | SERTRALIN-RATIOPHARM 50 MG | por tbl flm 30x50mg | AHF | IS |

| 16216 | SERTRALIN-RATIOPHARM 100 MG | por tbl flm 30x100mg | AHF | IS |

| 16217 | SERTRALIN-RATIOPHARM 100 MG | por tbl flm 30x100mg | AHK | IS |

| 16218 | SERTRALIN-RATIOPHARM 100 MG | por tbl flm 30x100mg | MCK | D |

| 17716 | SERLIFT 100 MG | por tbl flm 30x100mg | VUM | SK |

| 17718 | SERLIFT 50 MG | por tbl flm 30x50mg | VUM | SK |

| 17901 | APO-SERTRAL 100 | por cps dur 30x100mg | KAT | NL |

| 17904 | APO-SERTRAL 50 | por cps dur 30x50mg | KAT | NL |

| 17906 | APO-SERTRAL 50 | por cps dur 100x50mg | KAT | NL |

| 17909 | APO-SERTRAL 50 | por cps dur 30x50mg | CMG | IRL |

| 17911 | APO-SERTRAL 50 | por cps dur 100x50mg | CMG | IRL |

| 17912 | APO-SERTRAL 100 | por cps dur 30x100mg | CMG | IRL |

| 17964 | ASENTRA 50 | por tbl flm 56x50mg | KRK | SLO |

| 17965 | ASENTRA 50 | por tbl flm 84x50mg | KRK | SLO |

| 17966 | ASENTRA 100 | por tbl flm 56x100mg | KRK | SLO |

| 17967 | ASENTRA 100 | por tbl flm 84x100mg | KRK | SLO |

| 23778 | STIMULOTON 100 MG | por tbl flm 28x100mg | EGI | H |

| 31866 | ASENTRA 50 | por tbl flm 28x50mg | KRK | SLO |

| 31867 | ASENTRA 100 | por tbl flm 28x100mg | KRK | SLO |

| 32660 | STIMULOTON 50 MG | por tbl flm 30x50mg | EGI | H |

| 32743 | SERTRALIN IREX 50 MG | por tbl flm 28x50mg | OMA | IS |

| 47325 | SERTRALIN IREX 100 MG | por tbl flm 28x100mg | OMA | IS |

| 59556 | SERLIFT 50 MG | por tbl flm 30x50mg | RXY | IND |

| 59560 | SERLIFT 100 MG | por tbl flm 30x100mg | RXY | IND |

| 224.7 | N06AB08 | fluvoxamin ( do 50 mg v jedné tabletě včetně) | p.o. | 100.00 | MG | 13.50 | |

| | | | | | | | |

| 224.8 | N06AB08 | fluvoxamin (nad 50 mg v jedné tabletě) | p.o. | 100.00 | MG | 12.00 | |

| | | | | | | | |

| 224.9 | N06AB10 | escitalopram | p.o. | 10.00 | MG | 12.00 | |

| 224.1 | N06AB03 | fluoxetin | p.o. | 20.00 | MG | 11,73 | |

| 15302 | APO-FLUOXETINE | cps 30×20mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 15303 | APO-FLUOXETINE | cps 100×20mg | CMG | IRL |

| 17116 | APO-FLUOXETINE | cps 30×20mg | KAT | NL |

| 17118 | APO-FLUOXETINE | cps 100×20mg | KAT | NL |

| 44397 | APO-FLUOXETINE | cps 30×20mg | APT | CND |

| 44398 | APO-FLUOXETINE | cps 100×20mg | APT | CND |

| 48878 | FLUOXIN | por cps dur 20×20mg | HPZ | PL |

| 48879 | FLUOXIN | por cps dur 50×20mg | HPZ | PL |

| 48880 | FLUOXIN | por cps dur 100×20mg | HPZ | PL |

| 54422 | MAGRILAN | cps 10×20mg | MOE | CY |

| 54423 | MAGRILAN | cps 30×20mg | MOE | CY |

| 59274 | FLUMIREX | cps 30×20mg | CHN | H |

| 64656 | FLUOXIN | por cps dur 20×20mg | SFS | D |

| 64657 | FLUOXIN | por cps dur 50×20mg | SFS | D |

| 64658 | FLUOXIN | por cps dur 100×20mg | SFS | D |

| 95457 | FLUOXETIN-RATIOPHARM 20 MG | por cps dur 30×20mg | MCK | D |

| 95458 | FLUOXETIN-RATIOPHARM 20 MG | por cps dur 100×20mg | MCK | D |

| 98791 | DEPREX LÉČIVA | por cps dur 30×20mg | ZEH | CZ |

| 224.2 | N06AB04 | citalopram do 10 mg v jedné tabletě včetně | p.o. | 20.00 | MG | 13,19 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03976 | CITALEC 10 | tbl obd 30×10mg-bli | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 15778 | ZYLORAM 10 MG TABLETY | por tbl flm 28×10mg | IRI | IRL |

| 48469 | CITA 10 MG | por tbl flm 28×10mg | ARN | D |

| 48472 | CITA 10 MG | por tbl flm 56×10mg | ARN | D |

| 95925 | CITALOPRAM PLIVA 10 MG | por tbl flm 28×10mg | AWD | D |

| 95926 | CITALOPRAM PLIVA 10 MG | por tbl flm 28×10mg | KRZ | PL |

| 95927 | CITALOPRAM PLIVA 10 MG | por tbl flm 28×10mg | PPL | GB |

| 224.3 | N06AB04 | citalopram nad 10 mg v jedné tabletě | p.o. | 20.00 | MG | 11,73 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 03978 | CITALEC 20 | tbl obd 30×20mg-bli | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 15170 | CITALON 20 MG | por tbl flm 28×20mg | SZG | D |

| 15788 | ZYLORAM 20 MG TABLETY | por tbl flm 28×20mg | IRI | IRL |

| 16107 | ZYLORAM 40 MG TABLETY | por tbl flm 28×40mg | IRI | IRL |

| 48493 | CITA 20 MG | por tbl flm 28×20mg | ARN | D |

| 48496 | CITA 20 MG | por tbl flm 56×20mg | ARN | D |

| 48517 | CITA 40 MG | por tbl flm 28×40mg | ARN | D |

| 95928 | CITALOPRAM PLIVA 20 MG | por tbl flm 28×20mg | AWD | D |

| 95929 | CITALOPRAM PLIVA 20 MG | por tbl flm 28×20mg | PPL | GB |

| 95930 | CITALOPRAM PLIVA 20 MG | por tbl flm 28×20mg | KRZ | PL |

| 95931 | CITALOPRAM PLIVA 40 MG | por tbl flm 28×40mg | AWD | D |

| 95932 | CITALOPRAM PLIVA 40 MG | por tbl flm 28×40mg | PPL | GB |

| 95933 | CITALOPRAM PLIVA 40 MG | por tbl flm 28×40mg | KRZ | PL |

| 224.4 | N06AB04 | citalopram, tekuté lékové formy | p.o. | 20.00 | MG | 13,49 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 224.5 | N06AB05 | paroxetin | p.o. | 20.00 | MG | 11,73 | |

| 10479 | PAROLEX 40 | por tbl flm 30×40mg-b | HPZ | PL |

| --- | --- | --- | --- | --- |

| 10482 | PAROLEX 20 | por tbl flm 60×20mg-b | HPZ | PL |

| 10488 | PAROLEX 20 | por tbl flm 30×20mg-b | HPZ | PL |

| 13854 | PAROLEX 20 | por tbl flm 60×20mg-b | SFS | D |

| 13860 | PAROLEX 20 | por tbl flm 30×20mg-b | SFS | D |

| 13868 | PAROLEX 40 | por tbl flm 30×40mg-b | SFS | D |

| 15312 | APO-PAROX | por tbl flm 30×20mg | CMG | IRL |

| 15313 | APO-PAROX | por tbl flm 100×20mg | CMG | IRL |

| 17112 | APO-PAROX | por tbl flm 30×20mg | KAT | NL |

| 17113 | APO-PAROX | por tbl flm 100×20mg | KAT | NL |

| 30860 | APO-PAROX | por tbl flm 30×20mg | APT | CND |

| 30861 | APO-PAROX | por tbl flm 100×20mg | APT | CND |

| 41158 | PAROLEX 20 | por tbl flm 60×20mg-b | HED | DK |

| 46384 | PAROXETIN-RATIOPHARM 20 MG | por tbl flm 30×20mg | MCK | D |

| 96215 | PAROLEX 20 | por tbl flm 30×20mg-b | HED | DK |

| 96217 | PAROLEX 40 | por tbl flm 30×40mg-b | HED | DK |

| 224.6 | N06AB06 | sertralin | p.o. | 50.00 | MG | 11,73 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 02352 | SERTRALIN HEXAL 50 | por tbl flm28×50mg b | HED | DK |

| --- | --- | --- | --- | --- |

| 02398 | SERTRALIN HEXAL 50 | por tbl flm 28×50mg b | SFS | D |

| 03049 | SERTRALIN HEXAL 100 | por tbl flm 28×100mg-b | HED | DK |

| 03060 | SERTRALIN HEXAL 100 | por tbl flm28×100mg-b | SFS | D |

| 15448 | SERTRALIN HEXAL 50 | por tbl flm 28×50mg b | GEA | DK |

| 15465 | SERTRALIN HEXAL 100 | por tbl flm 28×100mg-b | GEA | DK |

| 15817 | SERLIFT 50 MG | por tbl flm 30×50mg | IRI | IRL |

| 15819 | SERLIFT 100 MG | por tbl flm 30×100mg | IRI | IRL |

| 16116 | SERTRALIN-RATIOPHARM 50 MG | por tbl flm 30×50mg | MCK | D |

| 16136 | SERTRALIN-RATIOPHARM 50 MG | por tbl flm 30×50mg | AHK | IS |

| 16137 | SERTRALIN-RATIOPHARM 50 MG | por tbl flm 30×50mg | AHF | IS |

| 16216 | SERTRALIN-RATIOPHARM 100 MG | por tbl flm 30×100mg | AHF | IS |

| 16217 | SERTRALIN-RATIOPHARM 100 MG | por tbl flm 30×100mg | AHK | IS |

| 16218 | SERTRALIN-RATIOPHARM 100 MG | por tbl flm 30×100mg | MCK | D |

| 17716 | SERLIFT 100 MG | por tbl flm 30×100mg | VUM | SK |

| 17718 | SERLIFT 50 MG | por tbl flm 30×50mg | VUM | SK |

| 17901 | APO-SERTRAL 100 | por cps dur 30×100mg | KAT | NL |

| 17904 | APO-SERTRAL 50 | por cps dur 30×50mg | KAT | NL |

| 17906 | APO-SERTRAL 50 | por cps dur 100×50mg | KAT | NL |

| 17909 | APO-SERTRAL 50 | por cps dur 30×50mg | CMG | IRL |

| 17911 | APO-SERTRAL 50 | por cps dur 100×50mg | CMG | IRL |

| 17912 | APO-SERTRAL 100 | por cps dur 30×100mg | CMG | IRL |

| 17964 | ASENTRA 50 | por tbl flm 56×50mg | KRK | SLO |

| 17965 | ASENTRA 50 | por tbl flm 84×50mg | KRK | SLO |

| 17966 | ASENTRA 100 | por tbl flm 56×100mg | KRK | SLO |

| 17967 | ASENTRA 100 | por tbl flm 84×100mg | KRK | SLO |

| 23778 | STIMULOTON 100 MG | por tbl flm 28×100mg | EGI | H |

| 31866 | ASENTRA 50 | por tbl flm 28×50mg | KRK | SLO |

| 31867 | ASENTRA 100 | por tbl flm 28×100mg | KRK | SLO |

| 32660 | STIMULOTON 50 MG | por tbl flm 30×50mg | EGI | H |

| 32743 | SERTRALIN IREX 50 MG | por tbl flm 28×50mg | OMA | IS |

| 47325 | SERTRALIN IREX 100 MG | por tbl flm 28×100mg | OMA | IS |

| 59556 | SERLIFT 50 MG | por tbl flm 30×50mg | RXY | IND |

| 59560 | SERLIFT 100 MG | por tbl flm 30×100mg | RXY | IND |

| 224.7 | N06AB08 | fluvoxamin ( do 50 mg v jedné tabletě včetně) | p.o. | 100.00 | MG | 13,19 | |

| | | | | | | | |

| 224.8 | N06AB08 | fluvoxamin (nad 50 mg v jedné tabletě) | p.o. | 100.00 | MG | 11,73 | |

| | | | | | | | |

| 224.9 | N06AB10 | escitalopram | p.o. | 10.00 | MG | 11,73 | |

| | | | | | | | |

| 225 | Antidepresiva působící inhibičně na monoaminooxidázu a ostatní antidepresiva, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 225.1 | N06AF01 | isocarbaxazid | p.o. | 15.00 | MG | 4.30 | L/PSY,SEX,NEU, |

| | | | | | | | |

| 225.2 | N06AF04 | tranylcypromin | p.o. | 10.00 | MG | 5.03 | L/PSY,SEX,NEU |

| | | | | | | | |

| 225.3 | N06AG02 | moklobemid do 150mg v jedné tabletě včetně | p.o. | 0.30 | GM | 13.50 | L/PSY,SEX,NEU, INT,GER |

| 15226 | APO-MOCLOB 150 | por tbl flm 30x150mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 15228 | APO-MOCLOB 150 | por tbl flm 100x150mg | CMG | IRL |

| 18703 | APO-MOCLOB 150 | por tbl flm 30x150mg | KAT | NL |

| 18705 | APO-MOCLOB 150 | por tbl flm 100x150mg | KAT | NL |

| 225.4 | N06AG02 | moklobemid nad 150 mg v jedné tabletě | p.o. | 0.30 | GM | 12.00 | L/PSY,SEX,NEU, INT,GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15229 | APO-MOCLOB 300 | por tbl flm 30x300mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 15231 | APO-MOCLOB 300 | por tbl flm 100x300mg | CMG | IRL |

| 18706 | APO-MOCLOB 300 | por tbl flm 30x300mg | KAT | NL |

| 18708 | APO-MOCLOB 300 | por tbl flm 100x300mg | KAT | NL |

| 225.5 | N06AX03 | mianserin do 10 mg v jedné tabletě včetně | p.o. | 60.00 | MG | 13.50 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 45769 | MIABENE 10 MG | por tbl flm 20x10mg | MCK | D |

| --- | --- | --- | --- | --- |

| 225.6 | N06AX03 | mianserin nad 10 mg v jedné tabletě | p.o. | 60.00 | MG | 12.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 45771 | MIABENE 30 MG | por tbl flm 20x30mg | MCK | D |

| --- | --- | --- | --- | --- |

| 225.7 | N06AX05 | trazodon | p.o. | 0.30 | GM | 12.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 225.8 | N06AX05 | trazodon, tablety s řízeným uvolňováním | p.o. | 0.30 | GM | 14.20 | |

| | | | | | | | |

| 225.9 | N06AX06 | nefazodon hydrochlorid | p.o. | 400.00 | MG | 18.63 | L/PSY,SEX,NEU |

| | | | | | | | |

| 225.10 | N06AX09 | viloxazin | p.o. | 0.20 | GM | 12.80 | L/PSY,SEX,NEU |

| | | | | | | | |

| 225.11 | N06AX11 | mirtazapin | p.o. | 30.00 | MG | 13.50 | L/PSY,SEX,NEU |

| 16647 | MIRZATEN 45 | por tbl flm 30x45mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 17664 | MIRZATEN 15 | por tbl flm 30x15mg | KRK | SLO |

| 17685 | MIRZATEN 30 | por tbl flm 30x30mg | KRK | SLO |

| 49805 | ESPRITAL 15 | por tbl flm 30x15mg | ZEH | CZ |

| 49806 | ESPRITAL 30 | por tbl flm 30x30mg | ZEH | CZ |

| 49807 | ESPRITAL 45 | por tbl flm 30x45mg | ZEH | CZ |

| 225.12 | N06AX12 | bupropion | p.o. | 200.00 | MG | 14.60 | L/PSY,SEX,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 225.13 | N06AX14 | tianeptin | p.o. | 37.50 | MG | 12.00 | |

| | | | | | | | |

| 225.14 | N06AX16 | venlafaxin | p.o. | 100.00 | MG | 18.00 | L/NEU,PSY,SEX |

| | | | | | | | |

| 225.15 | N06AX17 | milnacipran | p.o. | 100.00 | MG | 18.00 | L/NEU,PSY,SEX |

| | | | | | | | |

| 225.16 | N06AX18 | reboxetin | p.o. | 8.00 | MG | 12.00 | |

| | | | | | | | |

| 225.17 | N06AX21 | duloxetin | p.o. | 60.00 | MG | 60.00 | P |

| 225.1 | N06AF01 | isocarbaxazid | p.o. | 15.00 | MG | 4,20 | L/PSY,SEX,NEU, |

| | | | | | | | |

| 225.2 | N06AF04 | tranylcypromin | p.o. | 10.00 | MG | 4,92 | L/PSY,SEX,NEU |

| | | | | | | | |

| 225.3 | N06AG02 | moklobemid do 150mg v jedné tabletě včetně | p.o. | 0.30 | GM | 13,19 | L/PSY,SEX,NEU, INT,GER |

| 15226 | APO-MOCLOB 150 | por tbl flm 30×150mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 15228 | APO-MOCLOB 150 | por tbl flm 100×150mg | CMG | IRL |

| 18703 | APO-MOCLOB 150 | por tbl flm 30×150mg | KAT | NL |

| 18705 | APO-MOCLOB 150 | por tbl flm 100×150mg | KAT | NL |

| 225.4 | N06AG02 | moklobemid nad 150 mg v jedné tabletě | p.o. | 0.30 | GM | 11,73 | L/PSY,SEX,NEU, INT,GER |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 15229 | APO-MOCLOB 300 | por tbl flm 30×300mg | CMG | IRL |

| --- | --- | --- | --- | --- |

| 15231 | APO-MOCLOB 300 | por tbl flm 100×300mg | CMG | IRL |

| 18706 | APO-MOCLOB 300 | por tbl flm 30×300mg | KAT | NL |

| 18708 | APO-MOCLOB 300 | por tbl flm 100×300mg | KAT | NL |

| 225.5 | N06AX03 | mianserin do 10 mg v jedné tabletě včetně | p.o. | 60.00 | MG | 13,19 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 45769 | MIABENE 10 MG | por tbl flm 20×10mg | MCK | D |

| --- | --- | --- | --- | --- |

| 225.6 | N06AX03 | mianserin nad 10 mg v jedné tabletě | p.o. | 60.00 | MG | 11,73 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 45771 | MIABENE 30 MG | por tbl flm 20×30mg | MCK | D |

| --- | --- | --- | --- | --- |

| 225.7 | N06AX05 | trazodon | p.o. | 0.30 | GM | 11,73 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 225.8 | N06AX05 | trazodon, tablety s řízeným uvolňováním | p.o. | 0.30 | GM | 13,88 | |

| | | | | | | | |

| 225.9 | N06AX06 | nefazodon hydrochlorid | p.o. | 400.00 | MG | 18,21 | L/PSY,SEX,NEU |

| | | | | | | | |

| 225.10 | N06AX09 | viloxazin | p.o. | 0.20 | GM | 12,51 | L/PSY,SEX,NEU |

| | | | | | | | |

| 225.11 | N06AX11 | mirtazapin | p.o. | 30.00 | MG | 13,19 | L/PSY,SEX,NEU |

| 16647 | MIRZATEN 45 | por tbl flm 30×45mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 17664 | MIRZATEN 15 | por tbl flm 30×15mg | KRK | SLO |

| 17685 | MIRZATEN 30 | por tbl flm 30×30mg | KRK | SLO |

| 49805 | ESPRITAL 15 | por tbl flm 30×15mg | ZEH | CZ |

| 49806 | ESPRITAL 30 | por tbl flm 30×30mg | ZEH | CZ |

| 49807 | ESPRITAL 45 | por tbl flm 30×45mg | ZEH | CZ |

| 225.12 | N06AX12 | bupropion | p.o. | 200.00 | MG | 14,27 | L/PSY,SEX,NEU |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 225.13 | N06AX14 | tianeptin | p.o. | 37.50 | MG | 11,73 | |

| | | | | | | | |

| 225.14 | N06AX16 | venlafaxin | p.o. | 100.00 | MG | 17,59 | L/NEU,PSY,SEX |

| | | | | | | | |

| 225.15 | N06AX17 | milnacipran | p.o. | 100.00 | MG | 17,59 | L/NEU,PSY,SEX |

| | | | | | | | |

| 225.16 | N06AX18 | reboxetin | p.o. | 8.00 | MG | 11,73 | |

| | | | | | | | |

| 225.17 | N06AX21 | duloxetin | p.o. | 60.00 | MG | 58,64 | P |

Předepisuje neurolog k léčbě diabetické neuropatické bolesti u pacientů, kteří neměli dostatečnou terapeutickou odpověď (nedošlo ke zmírnění bolesti alespoň o 50% dle VAS) nebo netolerovali léky první volby (amitritylin, karbamazepin). Kontrola účinnosti léčby duloxetinem v této indikaci je provedena nejpozději po 4 týdnech a pokud nedošlo k dostatečné terapeutické odpovědi, není léčba dále indikována.

| 225.18 | V11 | hyperici extractum siccum (LI 160) | p.o. | 900.00 | MG | 6.50 | |

| | | | | | | | |

| 225. 19 | V11 | hyperici extractum siccum normatum (ostatní) | p.o. | 900.00 | MG | 2.00 | |

| 225.18 | V11 | hyperici extractum siccum (LI 160) | p.o. | 900.00 | MG | 6,35 | |

| | | | | | | | |

| 225. 19 | V11 | hyperici extractum siccum normatum (ostatní) | p.o. | 900.00 | MG | 1,95 | |

| | | | | | | | |

| 226 | Antidepresiva, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 226.1 | N05CD03 | flunitrazepam | parent. | 1.00 | MG | 6.61 | O |

| | | | | | | | |

| 226.2 | N05CD08 | midazolam (do 5 mg v jedné ampuli včetně) | parent. | 15.00 | MG | 74.03 | O |

| | | | | | | | |

| 226.3 | N05CD08 | midazolam (nad 5 mg v jedné ampuli) | parent. | 15.00 | MG | 51.03 | O |

| | | | | | | | |

| 226.4 | N06AA01 | desipramin | parent. | 0.10 | GM | 96.44 | O |

| | | | | | | | |

| 226.5 | N06AA02 | imipramin | parent. | 0.10 | GM | 48.39 | O |

| | | | | | | | |

| 226.6 | N06AA04 | klomipramin | parent. | 0.10 | GM | 95.76 | O |

| 02884 | ANAFRANIL | inj 10x2ml/25mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 15618 | ANAFRANIL | inj sol 10x2ml/25mg | NAI | CZ |

| 226.7 | N06AA08 | dibenzepin | parent. | 0.30 | GM | 96.44 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 226.8 | N06AA09 | amitriptylin | parent. | 75.00 | MG | 30.79 | O |

| | | | | | | | |

| 226.9 | N06AA21 | maprotilin | parent. | 100.00 | MG | 108.64 | O |

| | | | | | | | |

| 226.10 | N06AB04 | citalopram | parent. | 20.00 | MG | 228.29 | O/PSY, SEX |

| 60113 | SEROPRAM | inf cnc sol 10x1ml | LUN | DK |

| 226.1 | N05CD03 | flunitrazepam | parent. | 1.00 | MG | 6,46 | O |

| | | | | | | | |

| 226.2 | N05CD08 | midazolam (do 5 mg v jedné ampuli včetně) | parent. | 15.00 | MG | 72,35 | O |

| | | | | | | | |

| 226.3 | N05CD08 | midazolam (nad 5 mg v jedné ampuli) | parent. | 15.00 | MG | 49,87 | O |

| | | | | | | | |

| 226.4 | N06AA01 | desipramin | parent. | 0.10 | GM | 94,25 | O |

| | | | | | | | |

| 226.5 | N06AA02 | imipramin | parent. | 0.10 | GM | 47,29 | O |

| | | | | | | | |

| 226.6 | N06AA04 | klomipramin | parent. | 0.10 | GM | 93,59 | O |

| 02884 | ANAFRANIL | inj 10×2ml/25mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 15618 | ANAFRANIL | inj sol 10×2ml/25mg | NAI | CZ |

| 226.7 | N06AA08 | dibenzepin | parent. | 0.30 | GM | 94,25 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 226.8 | N06AA09 | amitriptylin | parent. | 75.00 | MG | 30,09 | O |

| | | | | | | | |

| 226.9 | N06AA21 | maprotilin | parent. | 100.00 | MG | 106,17 | O |

| | | | | | | | |

| 226.10 | N06AB04 | citalopram | parent. | 20.00 | MG | 223,11 | O/PSY, SEX |

| 60113 | SEROPRAM | inf cnc sol 10×1ml | LUN | DK |

| --- | --- | --- | --- | --- |

| 227 | stimulancia a nootropika a léčiva určená k léčbě demence | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 227.1 | N06BA04 | methylphenidat | p.o. | 30.00 | MG | 9.00 | L/NEU,PSY,PED, SEX |

| 15622 | RITALIN | por tbl nob 30x10mg | NAI | CZ |

| --- | --- | --- | --- | --- |

| 83328 | RITALIN | tbl 30x10mg | NPA | CH |

| 227.2 | N06BA07 | modafinil | p.o. | 300.00 | MG | 320.00 | P |

| 227.1 | N06BA04 | methylphenidat | p.o. | 30.00 | MG | 8,80 | L/NEU,PSY,PED, SEX |

| 15622 | RITALIN | por tbl nob 30×10mg | NAI | CZ |

| --- | --- | --- | --- | --- |

| 83328 | RITALIN | tbl 30×10mg | NPA | CH |

| 227.2 | N06BA07 | modafinil | p.o. | 300.00 | MG | 312,74 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčba modafinilem je předepisována ošetřujícím lékařem specializovaného pracoviště pro poruchy spánku, resp. spánkové laboratoře a hrazena u pacientů:

@@ -8737,14 +8786,14 @@

Pokud po 3 měsících není dosaženo zásadní změny a uspokojivého výsledku (nemocný je schopen zapojení do pracovního procesu), není léčba modafinilem dále indikována.

| 227.3 | N06BX01 | meklofenoxat | parent. | 0.50 | GM | 83.53 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 227.4 | N06BX02 | pyritinol | parent. | 0.30 | GM | 57.25 | H |

| | | | | | | | |

| 227.5 | N06BX02 | pyritinol (pevné lékové formy) | p.o. | 0.30 | GM | 3.90 | |

| | | | | | | | |

| 227.6 | N06BX02 | pyritinol (tekuté lékové formy) | p.o. | 0.30 | GM | 17.80 | P |

| 227.3 | N06BX01 | meklofenoxat | parent. | 0.50 | GM | 81,63 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 227.4 | N06BX02 | pyritinol | parent. | 0.30 | GM | 55,95 | H |

| | | | | | | | |

| 227.5 | N06BX02 | pyritinol (pevné lékové formy) | p.o. | 0.30 | GM | 3,81 | |

| | | | | | | | |

| 227.6 | N06BX02 | pyritinol (tekuté lékové formy) | p.o. | 0.30 | GM | 17,40 | P |

Pyritinol, tekuté lékové formy, předepisuje neurolog a psychiatr v uvedených indikacích u dětí. U dospělých neurolog, psychiatr a geriatr pouze při současné poruše polykání, s nejméně jednou z následujících diagnóz:

@@ -8758,16 +8807,16 @@

5) DMO.

| 227.7 | N06BX03 | piracetam | parent. | 6.00 | GM | 57.25 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11337 | GERATAM 3 G | inj 4x15ml/3gm | UCB | B |

| --- | --- | --- | --- | --- |

| 227.8 | N06BX03 | piracetam (pevné lékové formy) | p.o. | 2.40 | GM | 3.50 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 227.9 | N06BX03 | piracetam (tekuté lékové formy) | p.o. | 2.40 | GM | 17.80 | P |

| 227.7 | N06BX03 | piracetam | parent. | 6.00 | GM | 55,95 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11337 | GERATAM 3 G | inj 4×15ml/3gm | UCB | B |

| --- | --- | --- | --- | --- |

| 227.8 | N06BX03 | piracetam (pevné lékové formy) | p.o. | 2.40 | GM | 3,42 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 227.9 | N06BX03 | piracetam (tekuté lékové formy) | p.o. | 2.40 | GM | 17,40 | P |

Piracetam, tekuté lékové formy, předepisuje neurolog a psychiatr v uvedených indikacích u dětí. U dospělých neurolog, psychiatr a geriatr pouze při současné poruše polykání, s nejméně jednou z následujících diagnóz:

@@ -8781,18 +8830,18 @@

5) DMO.

| 227.10 | N06BX18 | vinpocetin | p.o. | 15.00 | MG | 3.90 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 227.11 | N06BX18 | vinpocetin | parent. | 15.00 | MG | 24.98 | H |

| | | | | | | | |

| 227.12 | N06DX01 | memantin | p.o. | 20.00 | MG | 100.00 | P |

| 227.10 | N06BX18 | vinpocetin | p.o. | 15.00 | MG | 3,81 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 227.11 | N06BX18 | vinpocetin | parent. | 15.00 | MG | 24,41 | H |

| | | | | | | | |

| 227.12 | N06DX01 | memantin | p.o. | 20.00 | MG | 97,73 | P |

Léčbu memantinem předepisuje neurolog, psychiatr nebo geriatr pacientům, u kterých je diagnosticky vyloučena demence jiného typu než Alzheimerova a potvrzena diagnóza Alzheimerovy demence (ACH) se stupněm postižení vyjádřeným dle škály MMSE (Mini-Mental State Examination) v rozmezí 17-6 bodů.

Po 12. týdnech (3 měsíce) od zahájení podávání memantinu je provedeno další vyšetření pacienta škálou MMSE. Léčba memantinem je hrazena z prostředků zdravotního pojištění při setrvání skóre, nebo jeho poklesu o nejvíce 2 body ve srovnání s hodnotou MMSE dosahovanou pacientem před zahájením léčby memantinem. Další kontroly MMSE jsou prováděny nejméně po každých 3 měsících léčby. Léčba memantinem není indikována u pacientů, u nichž po 6, 9 atd. měsících od zahájení léčby nedojde k objektivně prokazatelnému terapeutickému účinku (tj. zastavení progrese anebo pokles menší než 2 body dle škály MMSE oproti původnímu stavu) a dále při zjištěném skóre škály MMSE pod 6 bodů škály. Tato kritéria se vztahují i na léčbu pacientů trvající v rámci stanovených kritérií déle než 9 měsíců.

| 227.13 | N06DX02 | extrakty z Ginkgo biloba (pevné i tekuté lékové formy) | p.o. | 120.00 | MG | 4.50 | |

| 227.13 | N06DX02 | extrakty z Ginkgo biloba (pevné i tekuté lékové formy) | p.o. | 120.00 | MG | 4,40 | |

| | | | | | | | |

| 228 | parasympatomimetika ze skupiny inhibitorů cholinesterázy, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

@@ -8801,145 +8850,145 @@

Po 12. týdnech (3 měsíce) od zahájení podávání IAchE je provedeno další vyšetření pacienta škálou MMSE. Léčba IAchE je indikována při setrvání skóre, nebo jeho poklesu o nejvíce 2 body ve srovnání s hodnotou MMSE dosahovanou pacientem před zahájením léčby IAchE. Další kontroly MMSE jsou prováděny nejméně po každých 3 měsících léčby. Léčba IAchE není indikována u pacientů, u nichž po 6, 9 atd. měsících od zahájení léčby nedojde k objektivně prokazatelnému terapeutickému účinku (tj. zastavení progrese anebo pokles menší než 2 body dle škály MMSE oproti původnímu stavu) a dále při zjištěném skóre škály MMSE 12 bodů. Tato kritéria se vztahují i na léčbu pacientů trvající v rámci stanovených kritérií déle než 9 měsíců.

| 228.1 | N06DA02 | donepezil do 5mg v jedné tabletě včetně | p.o. | 1.00 | DF | 46.17 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 228.2 | N07AA03 | distigmin | p.o. | 5.00 | MG | 5.79 | |

| 02130 | UBRETID 5 MG | por tbl nob 50x5mg | NYC | A |

| --- | --- | --- | --- | --- |

| 02360 | UBRETID 5 MG | por tbl nob 20x5mg | NYC | A |

| 228.3 | N06DA02 | donepezil nad 5 mg v jedné tabletě | p.o. | 1.00 | DF | 90.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 228.4 | N06DA03 | rivastigmin do 1,5 mg v jedné tabletě včetně | p.o. | 2.00 | DF | 46.17 | P |

| | | | | | | | |

| 228.5 | N06DA03 | rivastigmin nad 1,5 mg v jedné tabletě | p.o. | 2.00 | DF | 90.00 | P |

| | | | | | | | |

| 228.6 | N06DA04 | galantamin do 4 mg v jedné tabletě včetně | p.o. | 2.00 | DF | 46.17 | P |

| | | | | | | | |

| 228.7 | N06DA04 | galantamin nad 4 mg v jedné tabletě | p.o. | 2.00 | DF | 90.00 | P |

| | | | | | | | |

| 228.8 | N07AA01 | neostigmin | p.o. | 60.00 | MG | 19.75 | |

| 53940 | SYNTOSTIGMIN | tbl 20x15mg(blistr) | ZEH | SK |

| --- | --- | --- | --- | --- |

| 228.9 | N07AA02 | pyridostigmin (do 10 mg v jedné tabletě včetně) | p.o. | 180.00 | MG | 19.33 | |

| | | | | | | | |

| 228.10 | N07AA02 | pyridostigmin (nad 10 mg v jedné tabletě) | p.o. | 180.00 | MG | 17.65 | L/NEU |

| 228.1 | N06DA02 | donepezil do 5mg v jedné tabletě včetně | p.o. | 1.00 | DF | 45,12 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 228.2 | N07AA03 | distigmin | p.o. | 5.00 | MG | 5,66 | |

| 02130 | UBRETID 5 MG | por tbl nob 50×5mg | NYC | A |

| --- | --- | --- | --- | --- |

| 02360 | UBRETID 5 MG | por tbl nob 20×5mg | NYC | A |

| 228.3 | N06DA02 | donepezil nad 5 mg v jedné tabletě | p.o. | 1.00 | DF | 87,96 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 228.4 | N06DA03 | rivastigmin do 1,5 mg v jedné tabletě včetně | p.o. | 2.00 | DF | 45,12 | P |

| | | | | | | | |

| 228.5 | N06DA03 | rivastigmin nad 1,5 mg v jedné tabletě | p.o. | 2.00 | DF | 87,96 | P |

| | | | | | | | |

| 228.6 | N06DA04 | galantamin do 4 mg v jedné tabletě včetně | p.o. | 2.00 | DF | 45,12 | P |

| | | | | | | | |

| 228.7 | N06DA04 | galantamin nad 4 mg v jedné tabletě | p.o. | 2.00 | DF | 87,96 | P |

| | | | | | | | |

| 228.8 | N07AA01 | neostigmin | p.o. | 60.00 | MG | 19,30 | |

| 53940 | SYNTOSTIGMIN | tbl 20×15mg(blistr) | ZEH | SK |

| --- | --- | --- | --- | --- |

| 228.9 | N07AA02 | pyridostigmin (do 10 mg v jedné tabletě včetně) | p.o. | 180.00 | MG | 18,89 | |

| | | | | | | | |

| 228.10 | N07AA02 | pyridostigmin (nad 10 mg v jedné tabletě) | p.o. | 180.00 | MG | 17,25 | L/NEU |

| | | | | | | | |

| 229 | parasympatomimetika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 229.1 | N07AA01 | neostigmin | parent. | 2.00 | MG | 18.20 | |

| 00612 | SYNTOSTIGMIN | inj 10x1ml/0.5mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 229.2 | N07AA02 | pyridostigmin | parent. | 10.00 | MG | 113.20 | |

| | | | | | | | |

| 229.3 | N07AA02 | distigmin | parent. | 0.25 | MG | 5.62 | |

| 229.1 | N07AA01 | neostigmin | parent. | 2.00 | MG | 17,79 | |

| 00612 | SYNTOSTIGMIN | inj 10×1ml/0.5mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 229.2 | N07AA02 | pyridostigmin | parent. | 10.00 | MG | 110,63 | |

| | | | | | | | |

| 229.3 | N07AA02 | distigmin | parent. | 0.25 | MG | 5,49 | |

| | | | | | | | |

| 230 | léčiva používaná při léčbě závratí a ostatní léčiva užívaná u nemocí nervového systému | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 230.1 | N07AA30 | ambenonium | p.o. | 60.00 | MG | 18.60 | |

| 20327 | MYTELASE | por tbl nob 50x10mg | SXQ | P |

| --- | --- | --- | --- | --- |

| 230.2 | N07CA01 | betahistin | p.o. | 24.00 | MG | 7.88 | |

| | | | | | | | |

| 230.3 | N07CA02 | cinarizin (do 25 mg včetně v jedné tabletě) | p.o. | 90.00 | MG | 1.86 | |

| | | | | | | | |

| 230.4 | N07CA02 | cinarizin (nad 25 mg v jedné tabletě) | p.o. | 90.00 | MG | 1.56 | |

| | | | | | | | |

| 230.5 | N07CA03 | flunarizin | p.o. | 10.00 | MG | 4.79 | |

| | | | | | | | |

| 230.6 | N07CA52 | cinarizin, kombinace (s dimenhydrinátem) | p.o. | 3.00 | DF | 4.79 | |

| 230.1 | N07AA30 | ambenonium | p.o. | 60.00 | MG | 18,18 | |

| 20327 | MYTELASE | por tbl nob 50×10mg | SXQ | P |

| --- | --- | --- | --- | --- |

| 230.2 | N07CA01 | betahistin | p.o. | 24.00 | MG | 7,70 | |

| | | | | | | | |

| 230.3 | N07CA02 | cinarizin (do 25 mg včetně v jedné tabletě) | p.o. | 90.00 | MG | 1,82 | |

| | | | | | | | |

| 230.4 | N07CA02 | cinarizin (nad 25 mg v jedné tabletě) | p.o. | 90.00 | MG | 1,52 | |

| | | | | | | | |

| 230.5 | N07CA03 | flunarizin | p.o. | 10.00 | MG | 4,68 | |

| | | | | | | | |

| 230.6 | N07CA52 | cinarizin, kombinace (s dimenhydrinátem) | p.o. | 3.00 | DF | 4,68 | |

| | | | | | | | |

| 231 | ostatní léčiva používaná u nemocí centrálního nervového systému | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 231.1 | A11DA | thiamin (vit. B1), prostý | parent. | 75.00 | MG | 5.50 | H |

| | | | | | | | |

| 231.2 | A11DA01 | thiamin (vit. B1) | parent. | 50.00 | MG | 5.50 | H |

| 92502 | THIABENE | inj 6x2ml/100mg | MCK | D |

| --- | --- | --- | --- | --- |

| 231.3 | A11DB | kombinace vitamínů (vitamin B1, B6, B12) | parent. | 10.00 | ML | 93.80 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11485 | MILGAMMA N | inj 5x2ml | SLH | D |

| --- | --- | --- | --- | --- |

| 11486 | MILGAMMA N | inj 25x2ml | SLH | D |

| 11487 | MILGAMMA N | inj 100x2ml | SLH | D |

| 11488 | MILGAMMA N | inj 500x2ml | SLH | D |

| 231.4 | A11HA02 | pyridoxin hydrochlorid (vitamín B6) | parent. | 0.16 | GM | 16.58 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 231.5 | A11HA03 | tokoferol (vitamin E, do 30 mg/ml včetně) | parent. | 0.20 | GM | 69.90 | H |

| | | | | | | | |

| 231.6 | A11HA03 | tokoferol (vitamin E, nad 30 mg/ml) | parent. | 0.20 | GM | 7.58 | H |

| | | | | | | | |

| 231.7 | A11HA04 | riboflavin (vitamin B2) | parent. | 20.00 | MG | 6.11 | H |

| | | | | | | | |

| 231.8 | N01AB01 | halotan | inhal. | 100.00 | ML | 304.96 | H |

| | | | | | | | |

| 231.9 | N01AB06 | isofluran | inhal. | 100.00 | ML | 1 559.92 | H |

| 55405 | AERRANE | inh sol 1x250ml | BXI | B |

| --- | --- | --- | --- | --- |

| 231.10 | N01AB07 | desfluran | inhal. | 100.00 | ML | 1 125.60 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 231.11 | N01AB08 | sevofluoran | inhal. | 100.00 | ML | 2 290.62 | H |

| | | | | | | | |

| 231.12 | N01AF01 | metohexital | parent. | 0.50 | GM | 142.63 | H |

| | | | | | | | |

| 231.13 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.50 | GM | 60.41 | H |

| | | | | | | | |

| 231.14 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.50 | GM | 38.85 | H |

| | | | | | | | |

| 231.15 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 1.00 | GM | 234.04 | O |

| | | | | | | | |

| 231.16 | N01AX03 | ketamin (koncetrace do 1% včetně) | parent. | 1.00 | GM | 240.19 | O |

| | | | | | | | |

| 231.17 | N01AX04 | propanidid | parent. | 1.00 | GM | 32.11 | O |

| | | | | | | | |

| 231.18 | N01AX07 | etomidát | parent. | 50.00 | MG | 162.72 | O |

| | | | | | | | |

| 231.19 | N01AX10 | propofol - 2% koncentrace | parent. | 10.00 | ML | 139.00 | O |

| | | | | | | | |

| 231.20 | N01AX10 | propofol - koncentrace do 1 % včetně | parent. | 10.00 | ML | 87.00 | O |

| 32497 | PROPOFOL 1% FRESENIUS | inj/inf eml 1x100ml | FRK | A |

| --- | --- | --- | --- | --- |

| 32498 | PROPOFOL 1% FRESENIUS | inj/inf eml10x100ml | FRK | A |

| 45370 | PROPOFOL ABBOTT | inj eml 5x20ml-am | ABB | E |

| 45371 | PROPOFOL ABBOTT | inj eml 5x20ml | ABB | E |

| 45408 | PROPOFOL ABBOTT | inj eml 1x100ml | ABB | E |

| 53441 | PROPOFOL ABBOTT | inj eml 5x20ml-am | ABN | USA |

| 53442 | PROPOFOL ABBOTT | inj eml 5x20ml-la | ABN | USA |

| 53444 | PROPOFOL ABBOTT | inj eml 1x100ml | ABN | USA |

| 56664 | PROPOFOL GENTHON 10 MG/ML | inj eml 5x20ml/200mg | GNN | D |

| 231.21 | N07XX01 | tirilazad | parent. | 150.00 | MG | 5 226.44 | X |

| 231.1 | A11DA | thiamin (vit. B1), prostý | parent. | 75.00 | MG | 5,38 | H |

| | | | | | | | |

| 231.2 | A11DA01 | thiamin (vit. B1) | parent. | 50.00 | MG | 5,38 | H |

| 92502 | THIABENE | inj 6×2ml/100mg | MCK | D |

| --- | --- | --- | --- | --- |

| 231.3 | A11DB | kombinace vitamínů (vitamin B1, B6, B12) | parent. | 10.00 | ML | 91,67 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11485 | MILGAMMA N | inj 5×2ml | SLH | D |

| --- | --- | --- | --- | --- |

| 11486 | MILGAMMA N | inj 25×2ml | SLH | D |

| 11487 | MILGAMMA N | inj 100×2ml | SLH | D |

| 11488 | MILGAMMA N | inj 500×2ml | SLH | D |

| 231.4 | A11HA02 | pyridoxin hydrochlorid (vitamín B6) | parent. | 0.16 | GM | 16,20 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 231.5 | A11HA03 | tokoferol (vitamin E, do 30 mg/ml včetně) | parent. | 0.20 | GM | 68,31 | H |

| | | | | | | | |

| 231.6 | A11HA03 | tokoferol (vitamin E, nad 30 mg/ml) | parent. | 0.20 | GM | 7,41 | H |

| | | | | | | | |

| 231.7 | A11HA04 | riboflavin (vitamin B2) | parent. | 20.00 | MG | 5,97 | H |

| | | | | | | | |

| 231.8 | N01AB01 | halotan | inhal. | 100.00 | ML | 298,04 | H |

| | | | | | | | |

| 231.9 | N01AB06 | isofluran | inhal. | 100.00 | ML | 1 524,51 | H |

| 55405 | AERRANE | inh sol 1×250ml | BXI | B |

| --- | --- | --- | --- | --- |

| 231.10 | N01AB07 | desfluran | inhal. | 100.00 | ML | 1 100,05 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 231.11 | N01AB08 | sevofluoran | inhal. | 100.00 | ML | 2 238,62 | H |

| | | | | | | | |

| 231.12 | N01AF01 | metohexital | parent. | 0.50 | GM | 139,39 | H |

| | | | | | | | |

| 231.13 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.50 | GM | 59,04 | H |

| | | | | | | | |

| 231.14 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.50 | GM | 37,97 | H |

| | | | | | | | |

| 231.15 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 1.00 | GM | 228,73 | O |

| | | | | | | | |

| 231.16 | N01AX03 | ketamin (koncetrace do 1% včetně) | parent. | 1.00 | GM | 234,74 | O |

| | | | | | | | |

| 231.17 | N01AX04 | propanidid | parent. | 1.00 | GM | 31,38 | O |

| | | | | | | | |

| 231.18 | N01AX07 | etomidát | parent. | 50.00 | MG | 159,03 | O |

| | | | | | | | |

| 231.19 | N01AX10 | propofol - 2% koncentrace | parent. | 10.00 | ML | 135,84 | O |

| | | | | | | | |

| 231.20 | N01AX10 | propofol - koncentrace do 1 % včetně | parent. | 10.00 | ML | 85,03 | O |

| 32497 | PROPOFOL 1% FRESENIUS | inj/inf eml 1×100ml | FRK | A |

| --- | --- | --- | --- | --- |

| 32498 | PROPOFOL 1% FRESENIUS | inj/inf eml 10×100ml | FRK | A |

| 45370 | PROPOFOL ABBOTT | inj eml 5×20ml-am | ABB | E |

| 45371 | PROPOFOL ABBOTT | inj eml 5×20ml | ABB | E |

| 45408 | PROPOFOL ABBOTT | inj eml 1×100ml | ABB | E |

| 53441 | PROPOFOL ABBOTT | inj eml 5×20ml-am | ABN | USA |

| 53442 | PROPOFOL ABBOTT | inj eml 5×20ml-la | ABN | USA |

| 53444 | PROPOFOL ABBOTT | inj eml 1×100ml | ABN | USA |

| 56664 | PROPOFOL GENTHON 10 MG/ML | inj eml 5×20ml/200mg | GNN | D |

| 231.21 | N07XX01 | tirilazad | parent. | 150.00 | MG | 5 107,80 | X |

| | | | | | | | |

| 232 | Antimalarika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 232.1 | P01BA01 | chlorochin | p.o. | 0.50 | GM | 2.79 | |

| 00098 | DELAGIL | tbl 30x250mg | IHU | H |

| --- | --- | --- | --- | --- |

| 232.2 | P01BA02 | hydroxychlorochin | p.o. | 0.40 | GM | 17.66 | P |

| 232.1 | P01BA01 | chlorochin | p.o. | 0.50 | GM | 2,73 | |

| 00098 | DELAGIL | tbl 30×250mg | IHU | H |

| --- | --- | --- | --- | --- |

| 232.2 | P01BA02 | hydroxychlorochin | p.o. | 0.40 | GM | 17,26 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu hydroxychlorochinem předepisuje infekcionista, revmatolog a dermatolog u:

@@ -8952,200 +9001,200 @@

- d) diskoidní formy lupus erythematodes.

| 232.3 | P01BC02 | meflochin | p.o. | 1.00 | GM | 308.40 | P |

| 232.3 | P01BC02 | meflochin | p.o. | 1.00 | GM | 301,40 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu meflochinem předepisuje infekcionista v léčbě tropické malárie (z oblastí s vysokou rezistencí vůči chlorochinu na Plasmodium falciparum).

| 92441 | MEPHAQUIN | tbl obd 6x250mg | MHA | CH |

| --- | --- | --- | --- | --- |

| 232.4 | P01BD01 | pyrimethamin | p.o. | 75.00 | MG | 15.93 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 232.5 | P01BD51 | pyrimethamin, kombinace | p.o. | 75.00 | MG | 50.83 | |

| 92441 | MEPHAQUIN | tbl obd 6×250mg | MHA | CH |

| --- | --- | --- | --- | --- |

| 232.4 | P01BD01 | pyrimethamin | p.o. | 75.00 | MG | 15,57 | |

| | | | | | | | |

| 232.5 | P01BD51 | pyrimethamin, kombinace | p.o. | 75.00 | MG | 49,68 | |

| | | | | | | | |

| 233 | Anthelmintika a antiektoparazitika a ostatní léčiva ze skupiny léčiv používaných u parazitárních nemocí | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 233.1 | P01CX01 | pentamidin isethionát | parent. | 0.28 | GM | 1 047.13 | X |

| | | | | | | | |

| 233.2 | P02CA01 | mebendazol | p.o. | 0.20 | GM | 13.60 | |

| | | | | | | | |

| 233.3 | P02CA02 | tiabendazol | p.o. | 3.00 | GM | 125.42 | |

| | | | | | | | |

| 233.4 | P02CA03 | albendazol | p.o. | 0.40 | GM | 59.78 | |

| 91146 | ZENTEL | tbl obd 2x200mg | SKM | F |

| --- | --- | --- | --- | --- |

| 233.5 | P02CB01 | piperazin | p.o. | 2.00 | GM | 3.96 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 233.6 | P02CE01 | levamizol | p.o. | 0.15 | GM | 29.55 | |

| | | | | | | | |

| 233.7 | P02CX01 | pyrvinium | p.o. | 0.30 | GM | 17.69 | |

| | | | | | | | |

| 233.8 | P02DA01 | niklosamid | p.o. | 2.00 | GM | 131.19 | |

| | | | | | | | |

| 233.9 | P03AB02 | Lindan (lékové formy gelu) | lok. | 1.00 | GM | 2.54 | |

| | | | | | | | |

| 233.10 | P03AB02 | Lindan (lékové formy lotia) | lok. | 1.00 | ML | 1.08 | |

| 97547 | JACUTIN | eml 1x200ml/600mg | HEM | D |

| --- | --- | --- | --- | --- |

| 233.11 | P03AB02 | Lindan (lékové formy spreje) | lok. | 1.00 | ML | 1.17 | |

| | | | | | | | |

| 233.12 | P03AC | esdepallethrin | lok. | 1.00 | ML | 1.17 | |

| | | | | | | | |

| 233.13 | P03AC04 | permerthrin | lok. | 1.00 | ML | 1.17 | |

| 233.1 | P01CX01 | pentamidin isethionát | parent. | 0.28 | GM | 1 023,36 | X |

| | | | | | | | |

| 233.2 | P02CA01 | mebendazol | p.o. | 0.20 | GM | 13,29 | |

| | | | | | | | |

| 233.3 | P02CA02 | tiabendazol | p.o. | 3.00 | GM | 122,57 | |

| | | | | | | | |

| 233.4 | P02CA03 | albendazol | p.o. | 0.40 | GM | 58,42 | |

| 91146 | ZENTEL | tbl obd 2×200mg | SKM | F |

| --- | --- | --- | --- | --- |

| 233.5 | P02CB01 | piperazin | p.o. | 2.00 | GM | 3,87 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 233.6 | P02CE01 | levamizol | p.o. | 0.15 | GM | 28,88 | |

| | | | | | | | |

| 233.7 | P02CX01 | pyrvinium | p.o. | 0.30 | GM | 17,29 | |

| | | | | | | | |

| 233.8 | P02DA01 | niklosamid | p.o. | 2.00 | GM | 128,21 | |

| | | | | | | | |

| 233.9 | P03AB02 | Lindan (lékové formy gelu) | lok. | 1.00 | GM | 2,48 | |

| | | | | | | | |

| 233.10 | P03AB02 | Lindan (lékové formy lotia) | lok. | 1.00 | ML | 1,06 | |

| 97547 | JACUTIN | eml 1×200ml/600mg | HEM | D |

| --- | --- | --- | --- | --- |

| 233.11 | P03AB02 | Lindan (lékové formy spreje) | lok. | 1.00 | ML | 1,14 | |

| | | | | | | | |

| 233.12 | P03AC | esdepallethrin | lok. | 1.00 | ML | 1,14 | |

| | | | | | | | |

| 233.13 | P03AC04 | permerthrin | lok. | 1.00 | ML | 1,14 | |

| | | | | | | | |

| 234 | nosní protialergická léčiva včetně kortikoidů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 234.1 | R01AC01 | natrium kromoglykát (nad 15 mililitrů v jednom balení) | lok. | 40.00 | MG | 13.09 | L/ALG,TRN,ORL |

| 42545 | CROMOSOL | nas spr sol 1x28ml | ICN | PL |

| --- | --- | --- | --- | --- |

| 49933 | CROMOHEXAL | nas spr sol 1x30ml | SFS | D |

| 97616 | CROMOHEXAL | nas spr sol 1x30ml | SFS | D |

| 234.2 | R01AC01 | natrium kromoglykát (do 15 mililitrů včetně v jednom balení) | lok. | 40.00 | MG | 13.88 | L/ALG,TRN,ORL |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12582 | ALLERGOCROM | spr nas 1x15ml | URS | D |

| --- | --- | --- | --- | --- |

| 49932 | CROMOHEXAL | nas spr sol 1x15ml | SFS | D |

| 53742 | ALLERGO-COMOD NOSNÍ SPREJ | spr nas 1x15ml | URS | D |

| 76418 | CROMOBENE NOSNÍ SPRAY | spr nas 1x15ml | MCK | D |

| 97615 | CROMOHEXAL | nas spr sol 1x15ml | SFS | D |

| 234.3 | R01AC02 | levokabastin | lok. | 0.60 | MG | 10.80 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 234.4 | R01AC03 | azelastin | lok. | 0.56 | MG | 10.80 | |

| | | | | | | | |

| 234.5 | R01AD01 | beclomethason dipropionát | lok. | 0.40 | MG | 4.09 | |

| 66006 | BECLOMET NASAL AQUA | nas sprsus23ml/200d | OKU | SF |

| --- | --- | --- | --- | --- |

| 234.6 | R01AD04 | flunisolid | lok. | 0.15 | MG | 6.10 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 234.7 | R01AD05 | budesonid lokálně do 50 rg v jedné dávce včetně | lok. | 0.30 | MG | 6.10 | |

| 55427 | TAFEN NASAL 50 MCG | nas spr sus 200dÁv | LEK | SLO |

| --- | --- | --- | --- | --- |

| 234.8 | R01AD05 | budesonid lokálně nad 50 rg v jedné dávce | lok. | 0.30 | MG | 5.50 | |

| | | | | | | | |

| 234.9 | R01AD08 | flutikason – léková forma nosní kapky | lok. | 0.20 | MG | 6.10 | |

| | | | | | | | |

| 234.10 | R01AD08 | flutikason – léková forma vodní nosní sprej | lok. | 0.20 | MG | 6.10 | |

| | | | | | | | |

| 234.11 | R01AD09 | momethason | lok. | 200.00 | RG | 10.00 | L/ALG,TRN,ORL |

| | | | | | | | |

| 234.12 | R01AD11 | triamcinolon acetonid | lok. | 220.00 | RG | 7.20 | L/ALG,TRN,ORL |

| | | | | | | | |

| 234.13 | R01AX03 | ipratropium bromid | lok. | 240.00 | RG | 8.20 | L/ALG,TRN,ORL |

| 234.1 | R01AC01 | natrium kromoglykát (nad 15 mililitrů v jednom balení) | lok. | 40.00 | MG | 12,79 | L/ALG,TRN,ORL |

| 42545 | CROMOSOL | nas spr sol 1×28ml | ICN | PL |

| --- | --- | --- | --- | --- |

| 49933 | CROMOHEXAL | nas spr sol 1×30ml | SFS | D |

| 97616 | CROMOHEXAL | nas spr sol 1×30ml | SFS | D |

| 234.2 | R01AC01 | natrium kromoglykát (do 15 mililitrů včetně v jednom balení) | lok. | 40.00 | MG | 13,56 | L/ALG,TRN,ORL |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 12582 | ALLERGOCROM | spr nas 1×15ml | URS | D |

| --- | --- | --- | --- | --- |

| 49932 | CROMOHEXAL | nas spr sol 1×15ml | SFS | D |

| 53742 | ALLERGO-COMOD NOSNÍ SPREJ | spr nas 1×15ml | URS | D |

| 76418 | CROMOBENE NOSNÍ SPRAY | spr nas 1×15ml | MCK | D |

| 97615 | CROMOHEXAL | nas spr sol 1×15ml | SFS | D |

| 234.3 | R01AC02 | levokabastin | lok. | 0.60 | MG | 10,55 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 234.4 | R01AC03 | azelastin | lok. | 0.56 | MG | 10,55 | |

| | | | | | | | |

| 234.5 | R01AD01 | beclomethason dipropionát | lok. | 0.40 | MG | 4,00 | |

| 66006 | BECLOMET NASAL AQUA | nas spr sus 23ml/200d | OKU | SF |

| --- | --- | --- | --- | --- |

| 234.6 | R01AD04 | flunisolid | lok. | 0.15 | MG | 5,96 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 234.7 | R01AD05 | budesonid lokálně do 50 rg v jedné dávce včetně | lok. | 0.30 | MG | 5,96 | |

| 55427 | TAFEN NASAL 50 MCG | nas spr sus 200dáv | LEK | SLO |

| --- | --- | --- | --- | --- |

| 234.8 | R01AD05 | budesonid lokálně nad 50 rg v jedné dávce | lok. | 0.30 | MG | 5,38 | |

| | | | | | | | |

| 234.9 | R01AD08 | flutikason – léková forma nosní kapky | lok. | 0.20 | MG | 5,96 | |

| | | | | | | | |

| 234.10 | R01AD08 | flutikason – léková forma vodní nosní sprej | lok. | 0.20 | MG | 5,96 | |

| | | | | | | | |

| 234.11 | R01AD09 | momethason | lok. | 200.00 | RG | 9,77 | L/ALG,TRN,ORL |

| | | | | | | | |

| 234.12 | R01AD11 | triamcinolon acetonid | lok. | 220.00 | RG | 7,04 | L/ALG,TRN,ORL |

| | | | | | | | |

| 234.13 | R01AX03 | ipratropium bromid | lok. | 240.00 | RG | 8,01 | L/ALG,TRN,ORL |

| | | | | | | | |

| 235 | inhalační sympatomimetika včetně kombinací | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.1 | R03AC02 | bezfreonový salbutamol (lékové formy aerosolu k inhalaci vdechem aktivované) | inhal. | 0.80 | MG | 7.23 | |

| | | | | | | | |

| 235.2 | R03AC02 | bezfreonový salbutamol (lékové formy aerosolu) | inhal. | 0.80 | MG | 3.37 | |

| | | | | | | | |

| 235.3 | R03AC02 | freonový salbutamol (lékové formy aerosolu k inhalaci vdechem aktivované) | inhal. | 0.80 | MG | 7.23 | |

| | | | | | | | |

| 235.4 | R03AC02 | freonový salbutamol (lékové formy aerosolu) | inhal. | 0.80 | MG | 3.37 | |

| | | | | | | | |

| 235.5 | R03AC02 | salbutamol (lékové formy prášku k inhalaci) | inhal. | 0.80 | MG | 7.23 | |

| 83047 | VENTODISKS 400 | inh plv dos 15x8dávek | GWE | F |

| --- | --- | --- | --- | --- |

| 235.6 | R03AC02 | salbutamol (lékové formy roztoku) | inhal. | 10.00 | MG | 12.86 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.7 | R03AC03 | terbutalin (lékové formy aerosolu) | inhal. | 2.00 | MG | 3.52 | |

| | | | | | | | |

| 235.8 | R03AC03 | terbutalin (lékové formy prášku k inhalaci) | inhal. | 2.00 | MG | 7.23 | |

| | | | | | | | |

| 235.9 | R03AC04 | fenoterol (lékové formy aerosolu bezfreonové) | inhal. | 0.60 | MG | 3.86 | |

| 235.1 | R03AC02 | bezfreonový salbutamol (lékové formy aerosolu k inhalaci vdechem aktivované) | inhal. | 0.80 | MG | 7,07 | |

| | | | | | | | |

| 235.2 | R03AC02 | bezfreonový salbutamol (lékové formy aerosolu) | inhal. | 0.80 | MG | 3,29 | |

| | | | | | | | |

| 235.3 | R03AC02 | freonový salbutamol (lékové formy aerosolu k inhalaci vdechem aktivované) | inhal. | 0.80 | MG | 7,07 | |

| | | | | | | | |

| 235.4 | R03AC02 | freonový salbutamol (lékové formy aerosolu) | inhal. | 0.80 | MG | 3,29 | |

| | | | | | | | |

| 235.5 | R03AC02 | salbutamol (lékové formy prášku k inhalaci) | inhal. | 0.80 | MG | 7,07 | |

| 83047 | VENTODISKS 400 | inh plv dosl 5×8dávek | GWE | F |

| --- | --- | --- | --- | --- |

| 235.6 | R03AC02 | salbutamol (lékové formy roztoku) | inhal. | 10.00 | MG | 12,57 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.7 | R03AC03 | terbutalin (lékové formy aerosolu) | inhal. | 2.00 | MG | 3,44 | |

| | | | | | | | |

| 235.8 | R03AC03 | terbutalin (lékové formy prášku k inhalaci) | inhal. | 2.00 | MG | 7,07 | |

| | | | | | | | |

| 235.9 | R03AC04 | fenoterol (lékové formy aerosolu bezfreonové) | inhal. | 0.60 | MG | 3,77 | |

| 64881 | BEROTEC N 100 MCG | inh sol pss 200dáv | BGP | D |

| --- | --- | --- | --- | --- |

| 235.10 | R03AC04 | fenoterol (lékové formy aerosolu) | inhal. | 0.60 | MG | 2.74 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.11 | R03AC04 | fenoterol (lékové formy prášku k inhalaci) | inhal. | 0.60 | MG | 7.23 | |

| | | | | | | | |

| 235.12 | R03AC04 | fenoterol (lékové formy roztoku) | inhal. | 4.00 | MG | 24.64 | |

| | | | | | | | |

| 235.13 | R03AC06 | hexoprenalin (lékové formy aerosolu) | inhal. | 1.50 | MG | 2.74 | |

| | | | | | | | |

| 235.14 | R03AC12 | salmeterol (lékové formy aerosolu) | inhal. | 0.10 | MG | 20.63 | P |

| 235.15 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) do 0,025 mg včetně v jedné dávce | inhal. | 0.10 | MG | 25.85 | P |

| | | | | | | | |

| 235.16 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) nad 0,025 mg v jedné dávce | inhal. | 0.10 | MG | 23.60 | P |

| | | | | | | | |

| 235.17 | R03AC13 | formoterol (lékové formy prášku k inhalaci) do 4,5 rg včetně v jedné dávce | inhal. | 24.00 | RG | 25.85 | P |

| | | | | | | | |

| 235.18 | R03AC13 | formoterol (lékové formy prášku k inhalaci) nad 4,5 rg v jedné dávce | inhal. | 24.00 | RG | 23.60 | P |

| 15708 | FORMOTEROL-RATIOPHARM 12 MCG | inh cps 60x12rg+apl | MCK | D |

| --- | --- | --- | --- | --- |

| 235.19 | R03AC13 | formoterol (lékové formy aerosolu) | inhal. | 24.00 | RG | 20.63 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu inhalačním salmeterolem a formoterolem předepisuje alergolog/klinický imunolog a pneumolog (ALG,TRN) u nemocných s diagnózou asthma bronchiale, od středně těžkého perzistujícího stupně (stupeň 3) tam, kde astma není pod dobrou kontrolou při podávání inhalačního kortikosteroidu ve střední dávce a dobré spolupráci pacienta.

| 235.10 | R03AC04 | fenoterol (lékové formy aerosolu) | inhal. | 0.60 | MG | 2,68 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.11 | R03AC04 | fenoterol (lékové formy prášku k inhalaci) | inhal. | 0.60 | MG | 7,07 | |

| | | | | | | | |

| 235.12 | R03AC04 | fenoterol (lékové formy roztoku) | inhal. | 4.00 | MG | 24,08 | |

| | | | | | | | |

| 235.13 | R03AC06 | hexoprenalin (lékové formy aerosolu) | inhal. | 1.50 | MG | 2,68 | |

| | | | | | | | |

| 235.14 | R03AC12 | salmeterol (lékové formy aerosolu) | inhal. | 0.10 | MG | 20,16 | P |

| | | | | | | | |

| 235.15 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) do 0,025 mg včetně v jedné dávce | inhal. | 0.10 | MG | 25,26 | P |

| | | | | | | | |

| 235.16 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) nad 0,025 mg v jedné dávce | inhal. | 0.10 | MG | 23,06 | P |

| | | | | | | | |

| 235.17 | R03AC13 | formoterol (lékové formy prášku k inhalaci) do 4,5 rg včetně v jedné dávce | inhal. | 24.00 | RG | 25,26 | P |

| | | | | | | | |

| 235.18 | R03AC13 | formoterol (lékové formy prášku k inhalaci) nad 4,5 rg v jedné dávce | inhal. | 24.00 | RG | 23,06 | P |

| 15708 | FORMOTEROL-RATIOPHARM 12 MCG | inh cps 60×12rg+apl | MCK | D |

| --- | --- | --- | --- | --- |

| 235.19 | R03AC13 | formoterol (lékové formy aerosolu) | inhal. | 24.00 | RG | 20,16 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu inhalačním salmeterolem a formoterolem předepisuje alergolog/klinický imunolog a Pneumolog (ALG,TRN) u nemocných s diagnózou asthma bronchiale, od středně těžkého perzistujícího stupně (stupeň 3) tam, kde astma není pod dobrou kontrolou při podávání inhalačního kortikosteroidu ve střední dávce a dobré spolupráci pacienta.

Léčbu inhalačním salmeterolem a formoterolem předepisuje pneumolog (TRN) u nemocných s diagnózou CHOPN od středního stadia (stadium II) u symptomatických nemocných léčených inhalačními bronchodilatancii s krátkodobým účinkem a u nemocných se 2 a více exacerbacemi za rok. Podmínkou indikace je dobrá spolupráce pacienta včetně nekouření.

| 235.20 | R03AK03 | bezfreonový fenoterol kombinace s ipratropiem (lékové formy aerosolu) | inhal. | 6.00 | DF | 6.30 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.21 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy prášku k inhalaci) | inhal. | 3.00 | DF | 13.65 | |

| | | | | | | | |

| 235.22 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy roztoku) | inhal. | 4.00 | ML | 21.66 | |

| | | | | | | | |

| 235.23 | R03AK03 | fenoterol kombinace s kromoglykátem (lékové formy aerosolu) | inhal. | 1.00 | DF | 1.31 | L/ALG,TRN |

| | | | | | | | |

| 235.24 | R03AK03 | freonový fenoterol kombinace s ipratropiem (lékové formy aerosolu) | inhal. | 6.00 | DF | 5.07 | |

| | | | | | | | |

| 235.25 | R03AK04 | salbutamol v kombinaci s bromidem ipratropia | inhal. | 6.00 | DF | 7.70 | L/ALG,TRN |

| | | | | | | | |

| 235.26 | R03AK04 | salbutamol v kombinaci s kromoglykátem | inhal. | 8.00 | DF | 12.32 | L/ALG,TRN |

| | | | | | | | |

| 235.27 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/100 | inhal. | 2.00 | DF | 29.96 | P |

| | | | | | | | |

| 235.28 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/250 | inhal. | 2.00 | DF | 40.82 | P |

| | | | | | | | |

| 235.29 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/500 | inhal. | 2.00 | DF | 58.04 | P |

| 235.20 | R03AK03 | bezfreonový fenoterol kombinace s ipratropiem (lékové formy aerosolu) | inhal. | 6.00 | DF | 6,16 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.21 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy prášku k inhalaci) | inhal. | 3.00 | DF | 13,34 | |

| | | | | | | | |

| 235.22 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy roztoku) | inhal. | 4.00 | ML | 21,17 | |

| | | | | | | | |

| 235.23 | R03AK03 | fenoterol kombinace s kromoglykátem (lékové formy aerosolu) | inhal. | 1.00 | DF | 1,28 | L/ALG,TRN |

| | | | | | | | |

| 235.24 | R03AK03 | freonový fenoterol kombinace s ipratropiem (lékové formy aerosolu) | inhal. | 6.00 | DF | 4,95 | |

| | | | | | | | |

| 235.25 | R03AK04 | salbutamol v kombinaci s bromidem ipratropia | inhal. | 6.00 | DF | 7,53 | L/ALG,TRN |

| | | | | | | | |

| 235.26 | R03AK04 | salbutamol v kombinaci s kromoglykátem | inhal. | 8.00 | DF | 12,04 | L/ALG,TRN |

| | | | | | | | |

| 235.27 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/100 | inhal. | 2.00 | DF | 29,28 | P |

| | | | | | | | |

| 235.28 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/250 | inhal. | 2.00 | DF | 39,89 | P |

| | | | | | | | |

| 235.29 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/500 | inhal. | 2.00 | DF | 56,72 | P |

Léčbu inhalační fixní kombinací (salmeterol/flutikason) předepisuje alergolog/klinický imunolog a pneumolog (ALG,TRN) u nemocných s diagnózou asthma bronchiale (jako lék 2. volby), od středně těžkého perzistujícího stupně (stupeň 3) tam, kde astma není pod dobrou kontrolou při podávání inhalačního kortikosteroidu a dobré spolupráci pacienta.

Léčbu inhalační fixní kombinací (salmeterol/flutikason v dávce 50/500μg) předepisuje pneumolog (TRN) u nemocných s diagnózou CHOPN od těžkého stadia (stadium III) u symptomatických nemocných a u nemocných se 2 a více exacerbacemi za rok. Podmínkou této indikace je dobrá spolupráce pacienta včetně nekouření. Pokud nepřinese léčba fixní kombinací do 3 měsíců klinické zlepšení, není doporučeno v této léčbě dále pokračovat.

| 235.30 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma aerosolu, 25/50 | inhal. | 4.00 | DF | 29.47 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.31 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma aerosolu) 25/125 | inhal. | 4.00 | DF | 30.40 | P |

| | | | | | | | |

| 235.32 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma aerosolu) 25/250 | inhal. | 4.00 | DF | 40.16 | P |

| 235.30 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma aerosolu, 25/50 | inhal. | 4.00 | DF | 28,80 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.31 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma aerosolu) 25/125 | inhal. | 4.00 | DF | 29,71 | P |

| | | | | | | | |

| 235.32 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma aerosolu) 25/250 | inhal. | 4.00 | DF | 39,25 | P |

Léčbu inhalační fixní kombinací salmeterol a flutikason předepisuje alergolog/klinický imunolog a pneumolog (ALG,TRN) u nemocných s diagnózou asthma bronchiale od středně těžkého perzistujícího stupně (stupeň 3), tam, kde astma není pod dobrou kontrolou při podávání inhalačního kortikosteroidu a při dobré spolupráci pacienta.

| 235.33 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 100/6 | inhal. | 2.00 | DF | 20.47 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.34 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 200/6 | inhal. | 2.00 | DF | 26.45 | P |

| | | | | | | | |

| 235.35 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 400/12 | inhal. | 2.00 | DF | 47.40 | P |

| 235.33 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 100/6 | inhal. | 2.00 | DF | 20,01 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 235.34 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 200/6 | inhal. | 2.00 | DF | 25,85 | P |

| | | | | | | | |

| 235.35 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 400/12 | inhal. | 2.00 | DF | 46,32 | P |

Léčbu inhalační fixní kombinací (budesonid/formoterol) předepisuje alergolog/klinický imunolog a pneumolog (ALG,TRN) u nemocných s diagnózou asthma bronchiale, od středně těžkého perzistujícího stupně (stupeň 3) tam, kde astma není pod dobrou kontrolou při podávání inhalačního kortikosteroidu a dobré spolupráci pacienta.

@@ -9154,100 +9203,101 @@

| 236 | inhalační kortikosteroidy a anticholinergika, aerosol | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 236.1 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) do 50 rg včetně v jedné dávce | inhal. | 0.80 | MG | 12.70 | |

| 236.1 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) do 50 rg včetně v jedné dávce | inhal. | 0.80 | MG | 12,41 | |

| 47374 | ECOBEC 50 MCG | inh sol pss 200dáv | IXP | CZ |

| --- | --- | --- | --- | --- |

| 236.2 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) nad 100 rg v jedné dávce | inhal. | 0.80 | MG | 5.07 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 47743 | CLENIL SPRAY 250 MCG | inh sol pss 1x50mg | CHS | I |

| --- | --- | --- | --- | --- |

| 236.3 | R03BA01 | beklomethason (aplikační forma aerosolu bezfreonové JET) nad 100 rg v jedné dávce | inhal. | 0.80 | MG | 8.90 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 236.4 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) nad 50 rg do 100 rg včetně v jedné dávce | inhal. | 0.80 | MG | 6.22 | |

| 47742 | CLENIL SPRAY 100 MCG | inh sol pss 1x20mg | CHS | I |

| --- | --- | --- | --- | --- |

| 236.5 | R03BA01 | beklomethason (lékové formy aerosolu freonové) do 100 rg včetně v jedné dávce | inhal. | 0.80 | MG | 6.35 | |

| | | | | | | | |

| 236.6 | R03BA01 | beklomethason (lékové formy aerosolu freonové) nad 100 rg v jedné dávce | inhal. | 0.80 | MG | 5.20 | |

| | | | | | | | |

| 236.7 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové do 200 rg včetně v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.80 | MG | 21.44 | |

| | | | | | | | |

| 236.8 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové do 200 rg včetně v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.80 | MG | 20.32 | |

| | | | | | | | |

| 236.9 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové nad 200 rg v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.80 | MG | 16.48 | |

| | | | | | | | |

| 236.10 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové do 200 rg včetně v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.80 | MG | 11.96 | |

| | | | | | | | |

| 236.11 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové do 200 rgG včetně v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.80 | MG | 12.64 | |

| | | | | | | | |

| 236.12 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové nad 200 rg v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.80 | MG | 9.68 | |

| | | | | | | | |

| 236.13 | R03BA01 | beklomethason (lékové formy aerosolu vdechem bezfreonové aktivované nad 200 rg v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.80 | MG | 17.44 | |

| | | | | | | | |

| 236.14 | R03BA01 | beklomethason (lékové formy aerosolu vdechem freonové aktivované nad 200 rg v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.80 | MG | 10.24 | |

| | | | | | | | |

| 236.15 | R03BA02 | budesonid (lékové formy aerosolu) | inhal. | 0.80 | MG | 10.50 | |

| | | | | | | | |

| 236.16 | R03BA02 | budesonid (lékové formy suspense k inhalaci) do 0,25 mg včetně v 1 ml | inhal. | 0.80 | MG | 20.77 | |

| | | | | | | | |

| 236.17 | R03BA02 | budesonid (lékové formy suspense k inhalaci) nad 0,25 mg v 1 ml. | inhal. | 0.80 | MG | 16.81 | |

| | | | | | | | |

| 236.18 | R03BA03 | flunisolid (lékové formy aerosolu) | inhal. | 1.00 | MG | 10.50 | |

| | | | | | | | |

| 236.19 | R03BA05 | flutikason (lékové formy aerosolu) | inhal. | 0.60 | MG | 10.50 | |

| | | | | | | | |

| 236.20 | R03BA08 | ciclesonid | inhal. | 160 | RG | 10.80 | |

| | | | | | | | |

| 236.21 | R03BB01 | bromid ipratropia (bezfreonové lékové formy) | inhal. | 0.12 | MG | 5.40 | |

| | | | | | | | |

| 236.22 | R03BB01 | bromid ipratropia (lékové formy aerosolu) | inhal. | 0.12 | MG | 4.84 | |

| | | | | | | | |

| 236.23 | R03BB01 | bromid ipratropia (lékové formy roztoku) | inhal. | 4.00 | ML | 33.34 | L/ALG,TRN,ORL |

| 236.2 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) nad 100 rg v jedné dávce | inhal. | 0.80 | MG | 4,95 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 47743 | CLENIL SPRAY 250 MCG | inh sol pss 1×50mg | CHS | I |

| --- | --- | --- | --- | --- |

| 236.3 | R03BA01 | beklomethason (aplikační forma aerosolu bezfreonové JET) nad 100 rg v jedné dávce | inhal. | 0.80 | MG | 8,70 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 236.4 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) nad 50 rg do 100 rg včetně v jedné dávce | inhal. | 0.80 | MG | 6,08 | |

| 47742 | CLENIL SPRAY 100 MCG | inh sol pss 1×20mg | CHS | I |

| --- | --- | --- | --- | --- |

| 236.5 | R03BA01 | beklomethason (lékové formy aerosolu freonové) do 100 rg včetně v jedné dávce | inhal. | 0.80 | MG | 6,21 | |

| | | | | | | | |

| 236.6 | R03BA01 | beklomethason (lékové formy aerosolu freonové) nad 100 rg v jedné dávce | inhal. | 0.80 | MG | 5,08 | |

| | | | | | | | |

| 236.7 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové do 200 rg včetně v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.80 | MG | 20,95 | |

| | | | | | | | |

| 236.8 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové do 200 rg včetně v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.80 | MG | 19,86 | |

| | | | | | | | |

| 236.9 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované bezfreonové nad 200 rg v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.80 | MG | 16,11 | |

| | | | | | | | |

| 236.10 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové do 200 rg včetně v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.80 | MG | 11,69 | |

| | | | | | | | |

| 236.11 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové do 200 rgG včetně v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.80 | MG | 12,35 | |

| | | | | | | | |

| 236.12 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové nad 200 rg v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.80 | MG | 9,46 | |

| | | | | | | | |

| 236.13 | R03BA01 | beklomethason (lékové formy aerosolu vdechem bezfreonové aktivované nad 200 rg v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.80 | MG | 17,04 | |

| | | | | | | | |

| 236.14 | R03BA01 | beklomethason (lékové formy aerosolu vdechem freonové aktivované nad 200 rg v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.80 | MG | 10,01 | |

| | | | | | | | |

| 236.15 | R03BA02 | budesonid (lékové formy aerosolu) | inhal. | 0.80 | MG | 10,26 | |

| | | | | | | | |

| 236.16 | R03BA02 | budesonid (lékové formy suspense k inhalaci) do 0,25 mg včetně v 1 ml | inhal. | 0.80 | MG | 20,30 | |

| | | | | | | | |

| 236.17 | R03BA02 | budesonid (lékové formy suspense k inhalaci) nad 0,25 mg v 1 ml. | inhal. | 0.80 | MG | 16,43 | |

| | | | | | | | |

| 236.18 | R03BA03 | flunisolid (lékové formy aerosolu) | inhal. | 1.00 | MG | 10,26 | |

| | | | | | | | |

| 236.19 | R03BA05 | flutikason (lékové formy aerosolu) | inhal. | 0.60 | MG | 10,26 | |

| | | | | | | | |

| 236.20 | R03BA08 | ciclesonid | inhal. | 160 | RG | 10,55 | |

| | | | | | | | |

| 236.21 | R03BB01 | bromid ipratropia (bezfreonové lékové formy) | inhal. | 0.12 | MG | 5,28 | |

| | | | | | | | |

| 236.22 | R03BB01 | bromid ipratropia (lékové formy aerosolu) | inhal. | 0.12 | MG | 4,73 | |

| | | | | | | | |

| 236.23 | R03BB01 | bromid ipratropia (lékové formy roztoku) | inhal. | 4.00 | ML | 32,58 | L/ALG,TRN,ORL |

| | | | | | | | |

| 237 | inhalační kortikosteroidy a anticholinergika, ostatní lékové formy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 237.1 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) do 0,1 mg včetně v jedné dávce | inhal. | 0.80 | MG | 20.77 | |

| 237.2 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) nad 0,2 mg v jedné dávce | inhal. | 0.80 | MG | 14.40 | |

| | | | | | | | |

| 237.3 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) více než 0,1 mg do 0,2 mg včetně v jedné dávce | inhal. | 0.80 | MG | 17.60 | |

| | | | | | | | |

| 237.4 | R03BA02 | budesonid (lékové formy prášku k inhalaci, do 100 rg v 1 dávce včetně) | inhal. | 0.80 | MG | 20.77 | |

| | | | | | | | |

| 237.5 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 100 rg do 200 rg v 1 dávce včetně) | inhal. | 0.80 | MG | 17.60 | |

| 17706 | PULMAX 200 MCG | inh plv 100x200rg | NWI | IRL |

| --- | --- | --- | --- | --- |

| 17707 | PULMAX 200 MCG | inh plv 200x200rg | NWI | IRL |

| 237.6 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 200 rg v 1 dávce) | inhal. | 0.80 | MG | 14.40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17709 | PULMAX 400 MCG | inh plv 100x400rg | NWI | IRL |

| --- | --- | --- | --- | --- |

| 237.7 | R03BA03 | flunisolid (lékové formy prášku k inhalaci) | inhal. | 1.00 | MG | 20.77 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 237.8 | R03BA05 | flutikason (lékové formy prášku k inhalaci do 100 rg včetně v jedné dávce) | inhal. | 0.60 | MG | 30.00 | |

| | | | | | | | |

| 237.9 | R03BA05 | flutikason (lék. formy prášku k inhalaci nad 100 rg do 250 rg včetně v jedné dávce) | inhal. | 0.60 | MG | 26.75 | |

| | | | | | | | |

| 237.10 | R03BA05 | flutikason (lékové formy prášku k inhalaci nad 250 rg v jedné dávce) | inhal. | 0.60 | MG | 22.30 | |

| | | | | | | | |

| 237.11 | R03BB01 | bromid ipratropia (lékové formy prášku k inhalaci) | inhal. | 0.12 | MG | 2.21 | |

| 75847 | ATROVENT INHALETTEN | cps inh 100x0.2mg | BGP | D |

| --- | --- | --- | --- | --- |

| 237.12 | R03BB04 | tiotropium | inhal. | 18.00 | RG | 50.00 | P |

| 237.1 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) do 0,1 mg včetně v jedné dávce | inhal. | 0.80 | MG | 20,30 | |

| | | | | | | | |

| 237.2 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) nad 0,2 mg v jedné dávce | inhal. | 0.80 | MG | 14,07 | |

| | | | | | | | |

| 237.3 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) více než 0,1 mg do 0,2 mg včetně v jedné dávce | inhal. | 0.80 | MG | 17,20 | |

| | | | | | | | |

| 237.4 | R03BA02 | budesonid (lékové formy prášku k inhalaci, do 100 rg v 1 dávce včetně) | inhal. | 0.80 | MG | 20,30 | |

| | | | | | | | |

| 237.5 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 100 rg do 200 rg v 1 dávce včetně) | inhal. | 0.80 | MG | 17,20 | |

| 17706 | PULMAX 200 MCG | inh plv 100×200rg | NWI | IRL |

| --- | --- | --- | --- | --- |

| 17707 | PULMAX 200 MCG | inh plv 200×200rg | NWI | IRL |

| 237.6 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 200 rg v 1 dávce) | inhal. | 0.80 | MG | 14,07 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 17709 | PULMAX 400 MCG | inh plv 100×400rg | NWI | IRL |

| --- | --- | --- | --- | --- |

| 237.7 | R03BA03 | flunisolid (lékové formy prášku k inhalaci) | inhal. | 1.00 | MG | 20,30 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 237.8 | R03BA05 | flutikason (lékové formy prášku k inhalaci do 100 rg včetně v jedné dávce) | inhal. | 0.60 | MG | 29,32 | |

| | | | | | | | |

| 237.9 | R03BA05 | flutikason (lék. formy prášku k inhalaci nad 100 rg do 250 rg včetně v jedné dávce) | inhal. | 0.60 | MG | 26,14 | |

| | | | | | | | |

| 237.10 | R03BA05 | flutikason (lékové formy prášku k inhalaci nad 250 rg v jedné dávce) | inhal. | 0.60 | MG | 21,79 | |

| | | | | | | | |

| 237.11 | R03BB01 | bromid ipratropia (lékové formy prášku k inhalaci) | inhal. | 0.12 | MG | 2,16 | |

| 75847 | ATROVENT INHALETTEN | cps inh 100×0.2mg | BGP | D |

| --- | --- | --- | --- | --- |

| 237.12 | R03BB04 | tiotropium | inhal. | 18.00 | RG | 48,87 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu tiotropiem předepisuje pneumolog (TRN) u nemocných s diagnózou CHOPN stadia II., III. a IV. (podle dřívější verze GOLD stadium IIb a III), kteří dodržují léčebný režim včetně zákazu kouření.

@@ -9255,93 +9305,93 @@

| 238 | ostatní inhalační antiastmatika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 238.1 | R03BC01 | natrium kromoglykát (lékové formy aerosolu vdechem aktivované) | inhal. | 40.00 | MG | 21.65 | |

| | | | | | | | |

| 238.2 | R03BC01 | natrium kromoglykát (lékové formy aerosolu) | inhal. | 40.00 | MG | 17.50 | |

| | | | | | | | |

| 238.3 | R03BC01 | natrium kromoglykát (lékové formy prášku k inhalaci) | inhal. | 80.00 | MG | 21.65 | |

| | | | | | | | |

| 238.4 | R03BC01 | natrium kromoglykát (lékové formy prášku k insuflaci) | lok. | 40.00 | MG | 19.11 | |

| | | | | | | | |

| 238.5 | R03BC01 | natrium kromoglykát (lékové formy roztoku) | inhal. | 80.00 | MG | 13.49 | |

| | | | | | | | |

| 238.6 | R03BC03 | nedokromil | inhal. | 8.00 | MG | 25.14 | L/ALG,TRN |

| 56242 | TILADE MINT | aer 2x(112x2mg/dáv) | FPR | GB |

| 238.1 | R03BC01 | natrium kromoglykát (lékové formy aerosolu vdechem aktivované) | inhal. | 40.00 | MG | 21,16 | |

| | | | | | | | |

| 238.2 | R03BC01 | natrium kromoglykát (lékové formy aerosolu) | inhal. | 40.00 | MG | 17,10 | |

| | | | | | | | |

| 238.3 | R03BC01 | natrium kromoglykát (lékové formy prášku k inhalaci) | inhal. | 80.00 | MG | 21,16 | |

| | | | | | | | |

| 238.4 | R03BC01 | natrium kromoglykát (lékové formy prášku k insuflaci) | lok. | 40.00 | MG | 18,68 | |

| | | | | | | | |

| 238.5 | R03BC01 | natrium kromoglykát (lékové formy roztoku) | inhal. | 80.00 | MG | 13,18 | |

| | | | | | | | |

| 238.6 | R03BC03 | nedokromil | inhal. | 8.00 | MG | 24,57 | L/ALG,TRN |

| 56242 | TILADE MINT | aer 2×(112×2mg/dáv) | FPR | GB |

| --- | --- | --- | --- | --- |

| 239 | antiastmatika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 239.1 | R03CA02 | efedrin | p.o. | 50.00 | MG | 1.42 | |

| | | | | | | | |

| 239.2 | R03CB03 | orciprenalin | p.o. | 60.00 | MG | 6.55 | |

| | | | | | | | |

| 239.3 | R03CC02 | salbutamol (pevné lékové formy) | p.o. | 12.00 | MG | 6.19 | |

| 91085 | SALBUTAMOL WZF POLFA 4 MG | por tbl nob 30x4mg | WZF | PL |

| --- | --- | --- | --- | --- |

| 239.4 | R03CC02 | salbutamol (tekuté lékové formy) | p.o. | 12.00 | MG | 13.10 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 239.5 | R03CC03 | terbutalin | p.o. | 15.00 | MG | 6.19 | |

| | | | | | | | |

| 239.6 | R03CC05 | hexoprenalin | p.o. | 1.50 | MG | 6.19 | |

| | | | | | | | |

| 239.7 | R03CC08 | prokaterol (pevné lékové formy) | p.o. | 0.10 | MG | 6.15 | |

| 94493 | LONTERMIN | tbl 20x0.05mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 239.8 | R03CC08 | prokaterol (tekuté lékové formy) | p.o. | 0.10 | MG | 15.45 | |

| | | | | | | | |

| 239.9 | R03CC13 | klenbuterol (pevné lékové formy) | p.o. | 0.04 | MG | 6.36 | |

| | | | | | | | |

| 239.10 | R03CC13 | klenbuterol (tekuté lékové formy) | p.o. | 0.04 | MG | 21.26 | |

| 239.1 | R03CA02 | efedrin | p.o. | 50.00 | MG | 1,39 | |

| | | | | | | | |

| 239.2 | R03CB03 | orciprenalin | p.o. | 60.00 | MG | 6,40 | |

| | | | | | | | |

| 239.3 | R03CC02 | salbutamol (pevné lékové formy) | p.o. | 12.00 | MG | 6,05 | |

| 91085 | SALBUTAMOL WZF POLFA 4 MG | por tbl nob 30×4mg | WZF | PL |

| --- | --- | --- | --- | --- |

| 239.4 | R03CC02 | salbutamol (tekuté lékové formy) | p.o. | 12.00 | MG | 12,80 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 239.5 | R03CC03 | terbutalin | p.o. | 15.00 | MG | 6,05 | |

| | | | | | | | |

| 239.6 | R03CC05 | hexoprenalin | p.o. | 1.50 | MG | 6,05 | |

| | | | | | | | |

| 239.7 | R03CC08 | prokaterol (pevné lékové formy) | p.o. | 0.10 | MG | 6,01 | |

| 94493 | LONTERMIN | tbl 20×0.05mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 239.8 | R03CC08 | prokaterol (tekuté lékové formy) | p.o. | 0.10 | MG | 15,10 | |

| | | | | | | | |

| 239.9 | R03CC13 | klenbuterol (pevné lékové formy) | p.o. | 0.04 | MG | 6,22 | |

| | | | | | | | |

| 239.10 | R03CC13 | klenbuterol (tekuté lékové formy) | p.o. | 0.04 | MG | 20,78 | |

| | | | | | | | |

| 240 | antiastmatika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 240.1 | R03CA02 | efedrin | parent. | 50.00 | MG | 5.27 | O |

| 00447 | EPHEDRIN BIOTIKA | inj 10x1ml/50mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 240.2 | R03CB03 | orciprenalin | parent. | 0.50 | MG | 7.28 | O |

| | | | | | | | |

| 240.3 | R03CC03 | terbutalin | parent. | 0.50 | MG | 19.84 | O |

| | | | | | | | |

| 240.4 | R03CC05 | hexoprenalin | parent. | 5.00 | RG | 19.84 | O |

| 240.1 | R03CA02 | efedrin | parent. | 50.00 | MG | 5,15 | O |

| 00447 | EPHEDRIN BIOTIKA | inj 10×1ml/50mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 240.2 | R03CB03 | orciprenalin | parent. | 0.50 | MG | 7,11 | O |

| | | | | | | | |

| 240.3 | R03CC03 | terbutalin | parent. | 0.50 | MG | 19,39 | O |

| | | | | | | | |

| 240.4 | R03CC05 | hexoprenalin | parent. | 5.00 | RG | 19,39 | O |

| | | | | | | | |

| 241 | ostatní antiastmatika, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 241.1 | R03DA04 | teofylin (retardované lékové formy druhé skupiny do 250 mg včetně v jedné tabletě) | p.o. | 0.40 | GM | 4.36 | |

| 76650 | AFONILUM SR 250 MG | por cps pro50x250mg | AAW | D |

| --- | --- | --- | --- | --- |

| 241.2 | R03DA04 | teofylin (retardované lékové formy druhé skupiny nad 250 mg v jedné tabletě) | p.o. | 0.40 | GM | 4.04 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 241.3 | R03DA04 | teofylin (retardované lékové formy první skupiny) | p.o. | 0.40 | GM | 2.38 | |

| 98064 | SPOPHYLLIN RETARD 250MG | tbl ret 50x250mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 241.4 | R03DA05 | aminofylin | p.o. | 0.60 | GM | 4.40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 241.5 | R03DA05 | aminofylin (retardované lékové formy do 150 mg včetně) | p.o. | 0.60 | GM | 9.92 | |

| | | | | | | | |

| 241.6 | R03DA05 | aminofylin (retardované lékové formy nad 150 do 250 mg včetně) | p.o. | 0.60 | GM | 4.79 | |

| | | | | | | | |

| 241.7 | R03DA05 | aminofylin (retardované lékové formy nad 250 mg) | p.o. | 0.60 | GM | 4.73 | |

| | | | | | | | |

| 241.8 | R03DC01 | zafirlukast | p.o. | 40 | MG | 41.50 | P |

| | | | | | | | |

| 241.9 | R03DC03 | montelukast | p.o. | 1.00 | DF | 45.00 | P |

| 241.1 | R03DA04 | teofylin (retardované lékové formy druhé skupiny do 250 mg včetně v jedné tabletě) | p.o. | 0.40 | GM | 4,26 | |

| 76650 | AFONILUM SR 250 MG | por cps pro50×250mg | AAW | D |

| --- | --- | --- | --- | --- |

| 241.2 | R03DA04 | teofylin (retardované lékové formy druhé skupiny nad 250 mg v jedné tabletě) | p.o. | 0.40 | GM | 3,95 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 241.3 | R03DA04 | teofylin (retardované lékové formy první skupiny) | p.o. | 0.40 | GM | 2,33 | |

| 98064 | SPOPHYLLIN RETARD 250MG | tbl ret 50×250mg | ZEH | SK |

| --- | --- | --- | --- | --- |

| 241.4 | R03DA05 | aminofylin | p.o. | 0.60 | GM | 4,30 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 241.5 | R03DA05 | aminofylin (retardované lékové formy do 150 mg včetně) | p.o. | 0.60 | GM | 9,69 | |

| | | | | | | | |

| 241.6 | R03DA05 | aminofylin (retardované lékové formy nad 150 do 250 mg včetně) | p.o. | 0.60 | GM | 4,68 | |

| | | | | | | | |

| 241.7 | R03DA05 | aminofylin (retardované lékové formy nad 250 mg) | p.o. | 0.60 | GM | 4,62 | |

| | | | | | | | |

| 241.8 | R03DC01 | zafirlukast | p.o. | 40 | MG | 40,56 | P |

| | | | | | | | |

| 241.9 | R03DC03 | montelukast | p.o. | 1.00 | DF | 43,98 | P |

Léčba antileukotrieny u dospělých je předepisována alergologem nebo pneumologem u perzistujících forem bronchiálního astmatu v následujících indikacích: a) aspirin – senzitivní (nesteroidními antiflogistiky indukované astma), b) astma v kombinaci s nosní polypózou, c) námahou indukované astma, d) astma s prokázanou dobrou odpovídavostí na léčbu antileukotrieny v dětském věku, e) astma, kde nedostačuje dlouhodobá léčba inhalačními kortikosteroidy, beta2-mimetiky s prodlouženým účinkem, teofyliny s prodlouženým účinkem, nebo nelze tyto léky podávat pro prokázanou intoleranci. V případě neúspěchu kombinované terapie s antileukotrieny do třech měsíců po jejím zahájení, není další preskripce antileukotrienů indikována.

@@ -9372,50 +9422,50 @@

| 242 | ostatní antiastmatika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 242.1 | R03DA05 | aminofylin | p.rect. | 0.60 | GM | 6.35 | |

| | | | | | | | |

| 242.2 | R03DA05 | aminofylin | parent. | 0.60 | GM | 29.23 | O |

| 93129 | AMINOPHYLLINUM LEK | inj 10x10ml/250mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 96371 | AMINOPHYLLINUM LEK | inj 50x10ml/250mg | LEK | SLO |

| 242.1 | R03DA05 | aminofylin | p.rect. | 0.60 | GM | 6,21 | |

| | | | | | | | |

| 242.2 | R03DA05 | aminofylin | parent. | 0.60 | GM | 28,57 | O |

| 93129 | AMINOPHYLLINUM LEK | inj 10×10ml/250mg | LEK | SLO |

| --- | --- | --- | --- | --- |

| 96371 | AMINOPHYLLINUM LEK | inj 50×10ml/250mg | LEK | SLO |

| 243 | Expektorancia kromě kombinací, perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 243.1 | R05CB01 | acetylcystein | p.o. | 0.50 | GM | 2.25 | |

| | | | | | | | |

| 243.2 | R05CB02 | bromhexin | p.o. | 24.00 | MG | 2.08 | |

| | | | | | | | |

| 243.3 | R05CB03 | karbocystein | p.o. | 1.50 | GM | 3.60 | |

| | | | | | | | |

| 243.4 | R05CB06 | ambroxol | p.o. | 0.15 | GM | 4.50 | |

| 43950 | AMBROXOL AL 30 | tbl 20x30mg | APA | D |

| --- | --- | --- | --- | --- |

| 243.5 | R05CB15 | erdostein | p.o. | 600.00 | MG | 3.12 | |

| 243.1 | R05CB01 | acetylcystein | p.o. | 0.50 | GM | 2,20 | |

| | | | | | | | |

| 243.2 | R05CB02 | bromhexin | p.o. | 24.00 | MG | 2,03 | |

| | | | | | | | |

| 243.3 | R05CB03 | karbocystein | p.o. | 1.50 | GM | 3,52 | |

| | | | | | | | |

| 243.4 | R05CB06 | ambroxol | p.o. | 0.15 | GM | 4,40 | |

| 43950 | AMBROXOL AL 30 | tbl 20×30mg | APA | D |

| --- | --- | --- | --- | --- |

| 243.5 | R05CB15 | erdostein | p.o. | 600.00 | MG | 3,05 | |

| | | | | | | | |

| 244 | Expektorancia kromě kombinací, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 244.1 | R05CB01 | acetylcystein | inhal. | 1.60 | GM | 12.07 | |

| | | | | | | | |

| 244.2 | R05CB01 | acetylcystein | parent. | 0.50 | GM | 16.76 | |

| 88941 | ACC INJEKT | inj sol 100x3ml/300mg | HEX | D |

| --- | --- | --- | --- | --- |

| 244.3 | R05CB02 | bromhexin | inhal. | 24.00 | MG | 3.47 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 244.4 | R05CB02 | bromhexin | parent. | 24.00 | MG | 40.37 | |

| | | | | | | | |

| 244.5 | R05CB06 | ambroxol | parent. | 0.15 | GM | 226.02 | |

| | | | | | | | |

| 244.6 | R05CB06 | ambroxol (koncentrat k infuzi) | parent. | 1.00 | DF | 336.70 | H |

| | | | | | | | |

| 244.7 | R05CB13 | alfadornáza | inhal. | 2.50 | MG | 983.85 | P |

| 244.1 | R05CB01 | acetylcystein | inhal. | 1.60 | GM | 11,80 | |

| | | | | | | | |

| 244.2 | R05CB01 | acetylcystein | parent. | 0.50 | GM | 16,38 | |

| 88941 | ACC INJEKT | inj sol 100×3ml/300mg | HEX | D |

| --- | --- | --- | --- | --- |

| 244.3 | R05CB02 | bromhexin | inhal. | 24.00 | MG | 3,39 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 244.4 | R05CB02 | bromhexin | parent. | 24.00 | MG | 39,45 | |

| | | | | | | | |

| 244.5 | R05CB06 | ambroxol | parent. | 0.15 | GM | 220,89 | |

| | | | | | | | |

| 244.6 | R05CB06 | ambroxol (koncentrat k infuzi) | parent. | 1.00 | DF | 329,06 | H |

| | | | | | | | |

| 244.7 | R05CB13 | alfadornáza | inhal. | 2.50 | MG | 961,52 | P |

Léčbu alfadornázou předepisuje ošetřující lékař na doporučení specializovaného pracoviště, které zajišťuje péči o pacienty s cystickou fibrózou, při zajištění dobré spolupráce pacienta:

@@ -9423,406 +9473,405 @@

- b) při častých respiračních infekcích vyžadujících antibiotickou léčbu.

| 244.8 | R05CB15 | erdostein | inhal. | 450.00 | MG | 8.31 | |

| 244.8 | R05CB15 | erdostein | inhal. | 450.00 | MG | 8,12 | |

| | | | | | | | |

| 245 | antitusika ze skupiny derivátů opioidů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 245.1 | R05DA01 | ethylmorfin do 15 mg včetně | p.o. | 50.00 | MG | 6.02 | |

| 44590 | DIOLAN 15MG | tbl 10x15mg(blistr) | ZEH | SK |

| --- | --- | --- | --- | --- |

| 245.2 | R05DA01 | ethylmorfin nad 15 mg | p.o. | 50.00 | MG | 5.36 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 44589 | DIOLAN 30MG | tbl 10x30mg(blistr) | ZEH | SK |

| --- | --- | --- | --- | --- |

| 245.3 | R05DA04 | kodein | p.o. | 0.10 | GM | 12.69 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 56993 | CODEIN SLOVAKOFARMA 30MG | tbl 10x30mg-blistr | ZEH | SK |

| 245.1 | R05DA01 | ethylmorfin do 15 mg včetně | p.o. | 50.00 | MG | 5,88 | |

| 44590 | DIOLAN 15MG | tbl 10×15mg(blistr) | ZEH | SK |

| --- | --- | --- | --- | --- |

| 245.2 | R05DA01 | ethylmorfin nad 15 mg | p.o. | 50.00 | MG | 5,24 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 44589 | DIOLAN 30MG | tbl 10×30mg(blistr) | ZEH | SK |

| --- | --- | --- | --- | --- |

| 245.3 | R05DA04 | kodein | p.o. | 0.10 | GM | 12,40 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 56993 | CODEIN SLOVAKOFARMA 30MG | tbl 10×30mg-blistr | ZEH | SK |

| --- | --- | --- | --- | --- |

| 246 | ostatní antitusika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 246.1 | R05DA08 | folkodin | p.o. | 50.00 | MG | 3.67 | |

| | | | | | | | |

| 246.2 | R05DA09 | dextromethorphan | p.o. | 90.00 | MG | 3.67 | |

| | | | | | | | |

| 246.3 | R05DA20 | kombinace antitusik | p.o. | 3.00 | DF | 3.67 | |

| | | | | | | | |

| 246.4 | R05DB03 | klobutinol | p.o. | 120.00 | MG | 6.50 | |

| | | | | | | | |

| 246.5 | R05DB03 | klobutinol | parent. | 120.00 | MG | 112.03 | H |

| | | | | | | | |

| 246.6 | R05DB05 | pentoxyverin (do 8 mg v jednom čípku včetně) | p.rect. | 100.00 | MG | 139.11 | L/PED |

| | | | | | | | |

| 246.7 | R05DB05 | pentoxyverin (nad 8 mg v jednom čípku) | p.rect. | 100.00 | MG | 63.40 | L/PED |

| | | | | | | | |

| 246.8 | R05DB13 | butamirát (pevné lékové formy) | p.o. | 25.00 | MG | 1.04 | |

| | | | | | | | |

| 246.9 | R05DB13 | butamirát (tekuté lékové formy-kapky) | p.o. | 25.00 | MG | 11.70 | |

| 14725 | TUSSIN | por gtt sol 1x25ml | IXP | CZ |

| --- | --- | --- | --- | --- |

| 246.10 | R05DB13 | butamirát (tekuté lékové formy-sirup) | p.o. | 25.00 | MG | 3.83 | |

| | | | | | | | |

| 246.11 | R05DB18 | prednoxdiazin | p.o. | 300.00 | MG | 1.96 | |

| | | | | | | | |

| 246.12 | R05DB19 | dropropizin | p.o. | 25.00 | MG | 0.88 | |

| | | | | | | | |

| 246.13 | R05DB27 | levodropropizin (tekuté lékové formy –kapky) | p.o. | 120.00 | MG | 4.13 | |

| | | | | | | | |

| 246.14 | R05DB27 | levodropropizin (tekuté lékové formy –sirup) | p.o. | 120.00 | MG | 4.60 | |

| | | | | | | | |

| 246.15 | R05FB02 | butamirát a guaifenesin v kombinaci (tekuté lékové formy) | p.o. | 25.00 | MG | 10.56 | |

| 246.1 | R05DA08 | folkodin | p.o. | 50.00 | MG | 3,59 | |

| | | | | | | | |

| 246.2 | R05DA09 | dextromethorphan | p.o. | 90.00 | MG | 3,59 | |

| | | | | | | | |

| 246.3 | R05DA20 | kombinace antitusik | p.o. | 3.00 | DF | 3,59 | |

| | | | | | | | |

| 246.4 | R05DB03 | klobutinol | p.o. | 120.00 | MG | 6,35 | |

| | | | | | | | |

| 246.5 | R05DB03 | klobutinol | parent. | 120.00 | MG | 109,49 | H |

| | | | | | | | |

| 246.6 | R05DB05 | pentoxyverin (do 8 mg v jednom čípku včetně) | p.rect. | 100.00 | MG | 135,95 | L/PED |

| | | | | | | | |

| 246.7 | R05DB05 | pentoxyverin (nad 8 mg v jednom čípku) | p.rect. | 100.00 | MG | 61,96 | L/PED |

| | | | | | | | |

| 246.8 | R05DB13 | butamirát (pevné lékové formy) | p.o. | 25.00 | MG | 1,02 | |

| | | | | | | | |

| 246.9 | R05DB13 | butamirát (tekuté lékové formy-kapky) | p.o. | 25.00 | MG | 11,43 | |

| 14725 | TUSSIN | por gtt sol 1×25ml | IXP | CZ |

| --- | --- | --- | --- | --- |

| 246.10 | R05DB13 | butamirát (tekuté lékové formy-sirup) | p.o. | 25.00 | MG | 3,74 | |

| | | | | | | | |

| 246.11 | R05DB18 | prednoxdiazin | p.o. | 300.00 | MG | 1,92 | |

| | | | | | | | |

| 246.12 | R05DB19 | dropropizin | p.o. | 25.00 | MG | 0,86 | |

| | | | | | | | |

| 246.13 | R05DB27 | levodropropizin (tekuté lékové formy -kapky) | p.o. | 120.00 | MG | 4,04 | |

| | | | | | | | |

| 246.14 | R05DB27 | levodropropizin (tekuté lékové formy -sirup) | p.o. | 120.00 | MG | 4,50 | |

| | | | | | | | |

| 246.15 | R05FB02 | butamirát a guaifenesin v kombinaci (tekuté lékové formy) | p.o. | 25.00 | MG | 10,32 | |

| | | | | | | | |

| 247 | nesedativní antihistaminika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 247.1 | R06AA07 | difenylpyralin | p.o. | 10.00 | MG | 7.72 | |

| | | | | | | | |

| 247.2 | R06AE06 | oxatomid | p.o. | 60.00 | MG | 5.50 | |

| | | | | | | | |

| 247.3 | R06AE07 | cetirizin | p.o. | 10.00 | MG | 5.50 | |

| 02927 | LETIZEN | por tbl flm 50x10mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 99600 | ZODAC | por tbl flm 90x10mg | ZEH | CZ |

| 247.4 | R06AE09 | levocetirizin | p.o. | 5.00 | MG | 5.50 | |

| | | | | | | | |

| 247.5 | R06AX13 | loratadin | p.o. | 10.00 | MG | 5.50 | |

| | | | | | | | |

| 247.6 | R06AX27 | desloratadin | p.o. | 5.00 | MG | 5.50 | |

| 247.1 | R06AA07 | difenylpyralin | p.o. | 10.00 | MG | 7,54 | |

| | | | | | | | |

| 247.2 | R06AE06 | oxatomid | p.o. | 60.00 | MG | 5,38 | |

| | | | | | | | |

| 247.3 | R06AE07 | cetirizin | p.o. | 10.00 | MG | 5,38 | |

| 02927 | LETIZEN | por tbl flm 50×10mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 99600 | ZODAC | por tbl flm 90×10mg | ZEH | CZ |

| 247.4 | R06AE09 | levocetirizin | p.o. | 5.00 | MG | 5,38 | |

| | | | | | | | |

| 247.5 | R06AX13 | loratadin | p.o. | 10.00 | MG | 5,38 | |

| | | | | | | | |

| 247.6 | R06AX27 | desloratadin | p.o. | 5.00 | MG | 5,38 | |

| | | | | | | | |

| 248 | sedativní antihistaminika pro perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 248.1 | R06AA | embramin | p.o. | 50.00 | MG | 1.32 | |

| | | | | | | | |

| 248.2 | R06AA02 | difenhydramin (pevné lékové formy) | p.o. | 0.20 | GM | 8.36 | |

| | | | | | | | |

| 247.3 | R06AA02 | difenhydramin (tekuté lékové formy) | p.o. | 0.20 | GM | 8.54 | |

| | | | | | | | |

| 248.4 | R06AA04 | klemastin | p.o. | 2.00 | MG | 6.56 | |

| | | | | | | | |

| 248.5 | R06AB03 | dimetinden (pevné lékové formy) | p.o. | 4.00 | MG | 5.50 | |

| | | | | | | | |

| 248.6 | R06AB03 | dimetinden (tekuté lékové formy) | p.o. | 4.00 | MG | 8.54 | |

| | | | | | | | |

| 248.7 | R06AB56 | dexbromfeniramin, kombinace | p.o. | 2.00 | DF | 8.50 | |

| | | | | | | | |

| 248.8 | R06AD02 | prometazin (pevné lékové formy) | p.o. | 25.00 | MG | 4.04 | |

| | | | | | | | |

| 248.9 | R06AD02 | prometazin (tekuté lékové formy) | p.o. | 25.00 | MG | 8.54 | |

| | | | | | | | |

| 248.10 | R06AD03 | thiethylperazin | p.o. | 13.00 | MG | 3.31 | |

| | | | | | | | |

| 248.11 | R06AK | kombinace antihistaminik | p.o. | 2.00 | DF | 1.08 | |

| | | | | | | | |

| 248.12 | R06AX | bisulepin | p.o. | 4.00 | MG | 4.37 | |

| 02479 | DITHIADEN | tbl 20x2mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 248.13 | R06AX01 | bamipin | p.o. | 0.10 | GM | 5.50 | |

| | | | | | | | |

| 248.14 | R06AX02 | cyproheptadin | p.o. | 12.00 | MG | 5.50 | |

| | | | | | | | |

| 248.15 | R06AX09 | azatadin | p.o. | 2.00 | MG | 5.50 | |

| | | | | | | | |

| 248.16 | R06AX11 | astemizol | p.o. | 10.00 | MG | 5.50 | |

| | | | | | | | |

| 248.17 | R06AX12 | terfenadin | p.o. | 0.12 | GM | 5.50 | |

| | | | | | | | |

| 248.18 | R06AX17 | ketotifen | p.o. | 2.00 | MG | 5.50 | |

| | | | | | | | |

| 248.19 | R06AX18 | akrivastin | p.o. | 24.00 | MG | 5.50 | |

| | | | | | | | |

| 248.20 | R06AX25 | mizolastin | p.o. | 10.00 | MG | 5.50 | |

| | | | | | | | |

| 248.21 | R06AX26 | fexofenadin | p.o. | 120.00 | MG | 5.50 | |

| 248.1 | R06AA | embramin | p.o. | 50.00 | MG | 1,29 | |

| | | | | | | | |

| 248.2 | R06AA02 | difenhydramin (pevné lékové formy) | p.o. | 0.20 | GM | 8,17 | |

| | | | | | | | |

| 247.3 | R06AA02 | difenhydramin (tekuté lékové formy) | p.o. | 0.20 | GM | 8,35 | |

| | | | | | | | |

| 248.4 | R06AA04 | klemastin | p.o. | 2.00 | MG | 6,41 | |

| | | | | | | | |

| 248.5 | R06AB03 | dimetinden (pevné lékové formy) | p.o. | 4.00 | MG | 5,38 | |

| | | | | | | | |

| 248.6 | R06AB03 | dimetinden (tekuté lékové formy) | p.o. | 4.00 | MG | 8,35 | |

| | | | | | | | |

| 248.7 | R06AB56 | dexbromfeniramin, kombinace | p.o. | 2.00 | DF | 8,31 | |

| | | | | | | | |

| 248.8 | R06AD02 | prometazin (pevné lékové formy) | p.o. | 25.00 | MG | 3,95 | |

| | | | | | | | |

| 248.9 | R06AD02 | prometazin (tekuté lékové formy) | p.o. | 25.00 | MG | 8,35 | |

| | | | | | | | |

| 248.10 | R06AD03 | thiethylperazin | p.o. | 13.00 | MG | 3,23 | |

| | | | | | | | |

| 248.11 | R06AK | kombinace antihistaminik | p.o. | 2.00 | DF | 1,06 | |

| | | | | | | | |

| 248.12 | R06AX | bisulepin | p.o. | 4.00 | MG | 4,27 | |

| 02479 | DITHIADEN | tbl 20×2mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 248.13 | R06AX01 | bamipin | p.o. | 0.10 | GM | 5,38 | |

| | | | | | | | |

| 248.14 | R06AX02 | cyproheptadin | p.o. | 12.00 | MG | 5,38 | |

| | | | | | | | |

| 248.15 | R06AX09 | azatadin | p.o. | 2.00 | MG | 5,38 | |

| | | | | | | | |

| 248.16 | R06AX11 | astemizol | p.o. | 10.00 | MG | 5,38 | |

| | | | | | | | |

| 248.17 | R06AX12 | terfenadin | p.o. | 0.12 | GM | 5,38 | |

| | | | | | | | |

| 248.18 | R06AX17 | ketotifen | p.o. | 2.00 | MG | 5,38 | |

| | | | | | | | |

| 248.19 | R06AX18 | akrivastin | p.o. | 24.00 | MG | 5,38 | |

| | | | | | | | |

| 248.20 | R06AX25 | mizolastin | p.o. | 10.00 | MG | 5,38 | |

| | | | | | | | |

| 248.21 | R06AX26 | fexofenadin | p.o. | 120.00 | MG | 5,38 | |

| | | | | | | | |

| 249 | antihistaminika, ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 249.1 | R06AA04 | klemastin | parent. | 2.00 | MG | 32.44 | O |

| | | | | | | | |

| 249.2 | R06AD02 | prometazin | parent. | 25.00 | MG | 7.48 | O |

| | | | | | | | |

| 249.3 | R06AD03 | thiethylperazin | p.rect. | 13.00 | MG | 21.65 | |

| 09847 | TORECAN | sup 6x6.5mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 249.4 | R06AD03 | thiethylperazin | parent. | 13.00 | MG | 27.52 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 91836 | TORECAN | inj 5x1ml/6.5mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 249.5 | R06AX | bisulepin | parent. | 4.00 | MG | 26.28 | O |

| | | | | | | | |

| 249.6 | R06AX | medosulepin/vápník | parent. | 2.00 | DF | 30.79 | O |

| 249.1 | R06AA04 | klemastin | parent. | 2.00 | MG | 31,70 | O |

| | | | | | | | |

| 249.2 | R06AD02 | prometazin | parent. | 25.00 | MG | 7,31 | O |

| | | | | | | | |

| 249.3 | R06AD03 | thiethylperazin | p.rect. | 13.00 | MG | 21,16 | |

| 09847 | TORECAN | sup 6×6.5mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 249.4 | R06AD03 | thiethylperazin | parent. | 13.00 | MG | 26,90 | O |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 91836 | TORECAN | inj 5×1ml/6.5mg | KRK | SLO |

| --- | --- | --- | --- | --- |

| 249.5 | R06AX | bisulepin | parent. | 4.00 | MG | 25,68 | O |

| | | | | | | | |

| 249.6 | R06AX | medosulepin/vápník | parent. | 2.00 | DF | 30,09 | O |

| | | | | | | | |

| 250 | ostatní léčiva používaná u nemocí respiračního systému | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 250.1 | R05CA03 | guaifenesin | parent. | 0.90 | GM | 16.57 | |

| | | | | | | | |

| 250.2 | R05CB05 | mesna | inhal. | 600.00 | MG | 38.39 | |

| 250.1 | R05CA03 | guaifenesin | parent. | 0.90 | GM | 16,19 | |

| | | | | | | | |

| 250.2 | R05CB05 | mesna | inhal. | 600.00 | MG | 37,52 | |

| 03614 | MISTABRON | sol 6x3ml/600mg | UCB | B |

| --- | --- | --- | --- | --- |

| 250.3 | R07AA01 | kolfosceril palmitát | parent. | 160.00 | MG | 15 458.00 | T |

| | | | | | | | |

| 250.4 | R07AA02 | přirozené fosfolipidy (zvířecího původu) | parent. | 160.00 | MG | 15 458.00 | T |

| | | | | | | | |

| 250.5 | R07AA30 | beraktant | parent. | 160.00 | MG | 15 458.00 | T |

| 250.3 | R07AA01 | kolfosceril palmitát | parent. | 160.00 | MG | 15 107,10 | T |

| | | | | | | | |

| 250.4 | R07AA02 | přirozené fosfolipidy (zvířecího původu) | parent. | 160.00 | MG | 15 107,10 | T |

| | | | | | | | |

| 250.5 | R07AA30 | beraktant | parent. | 160.00 | MG | 15 107,10 | T |

| | | | | | | | |

| 251 | Oftalmologika – antibiotika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 251.1 | S01AA | neomycin/polymyxin/fenylefrin | lok. | 1.00 | ML | 19.55 | L/OPH |

| | | | | | | | |

| 251.2 | S01AA01 | chloramfenikol (lékové formy očních kapek) | lok. | 1.00 | ML | 2.79 | |

| | | | | | | | |

| 251.3 | S01AA01 | chloramfenikol (lékové formy očních mastí) | lok. | 1.00 | GM | 4.64 | |

| | | | | | | | |

| 251.4 | S01AA11 | gentamicin | lok. | 1.00 | ML | 3.21 | |

| | | | | | | | |

| 251.5 | S01AA12 | tobramycin (lékové formy očních kapek) | lok. | 1.00 | ML | 3.21 | |

| | | | | | | | |

| 251.6 | S01AA12 | tobramycin (lékové formy očních mastí) | lok. | 1.00 | GM | 3.21 | |

| | | | | | | | |

| 251.7 | S01AA13 | acidum fusidicum | lok. | 1.00 | ML | 6.42 | |

| | | | | | | | |

| 251.8 | S01AA24 | kanamycin | lok. | 1.00 | ML | 3.21 | |

| | | | | | | | |

| 251.9 | S01AA25 | azidamfenikol | lok. | 1.00 | ML | 3.21 | |

| | | | | | | | |

| 251.10 | S01AA30 | neomycin/bacitracin | lok. | 1.00 | GM | 6.27 | |

| 01076 | OPHTHALMO-FRAMYKOIN | ung oph 1x5gm | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 251.11 | S01AA30 | neomycin/polymyxin | lok. | 1.00 | ML | 19.55 | L/OPH |

| | | | | | | | |

| 251.12 | S01AX11 | ofloxacin | lok. | 1.00 | ML | 14.40 | L/OPH |

| | | | | | | | |

| 251.13 | S01AX13 | ciprofloxacin | lok. | 1.00 | ML | 14.40 | L/OPH |

| | | | | | | | |

| 251.14 | S01AX17 | lomefloxacin k lokálnímu podání | lok. | 1.00 | ML | 14.40 | L/OPH |

| 251.1 | S01AA | neomycin/polymyxin/fenylefrin | lok. | 1.00 | ML | 19,11 | L/OPH |

| | | | | | | | |

| 251.2 | S01AA01 | chloramfenikol (lékové formy očních kapek) | lok. | 1.00 | ML | 2,73 | |

| | | | | | | | |

| 251.3 | S01AA01 | chloramfenikol (lékové formy očních mastí) | lok. | 1.00 | GM | 4,53 | |

| | | | | | | | |

| 251.4 | S01AA11 | gentamicin | lok. | 1.00 | ML | 3,14 | |

| | | | | | | | |

| 251.5 | S01AA12 | tobramycin (lékové formy očních kapek) | lok. | 1.00 | ML | 3,14 | |

| | | | | | | | |

| 251.6 | S01AA12 | tobramycin (lékové formy očních mastí) | lok. | 1.00 | GM | 3,14 | |

| | | | | | | | |

| 251.7 | S01AA13 | acidum fusidicum | lok. | 1.00 | ML | 6,27 | |

| | | | | | | | |

| 251.8 | S01AA24 | kanamycin | lok. | 1.00 | ML | 3,14 | |

| | | | | | | | |

| 251.9 | S01AA25 | azidamfenikol | lok. | 1.00 | ML | 3,14 | |

| | | | | | | | |

| 251.10 | S01AA30 | neomycin/bacitracin | lok. | 1.00 | GM | 6,13 | |

| 01076 | OPHTHALMO-FRAMYKOIN | ung oph 1×5gm | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 251.11 | S01AA30 | neomycin/polymyxin | lok. | 1.00 | ML | 19,11 | L/OPH |

| | | | | | | | |

| 251.12 | S01AX11 | ofloxacin | lok. | 1.00 | ML | 14,07 | L/OPH |

| | | | | | | | |

| 251.13 | S01AX13 | ciprofloxacin | lok. | 1.00 | ML | 14,07 | L/OPH |

| | | | | | | | |

| 251.14 | S01AX17 | lomefloxacin k lokálnímu podání | lok. | 1.00 | ML | 14,07 | L/OPH |

| | | | | | | | |

| 252 | Oftalmologika - chemoterapeutika a antiseptika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 252.1 | S01AB | sulfathiazol | lok. | 1.00 | GM | 3.42 | |

| | | | | | | | |

| 252.2 | S01AB04 | sulfacetamid | lok. | 1.00 | ML | 6.70 | |

| 93577 | SULPHACETAMIDE 10%-POLPHARMA | gtt oph 12x0.5ml | ZPF | PL |

| --- | --- | --- | --- | --- |

| 252.3 | S01AX | jiná antiinfektiva (lékové formy očních kapek) | lok. | 1.00 | ML | 2.62 | |

| | | | | | | | |

| 252.4 | S01AX | jiná antiinfektiva (lékové formy očních mastí) | lok. | 1.00 | GM | 4.46 | |

| 252.1 | S01AB | sulfathiazol | lok. | 1.00 | GM | 3,34 | |

| | | | | | | | |

| 252.2 | S01AB04 | sulfacetamid | lok. | 1.00 | ML | 6,55 | |

| 93577 | SULPHACETAMIDE 10%-POLPHARMA | gtt oph 12×0.5ml | ZPF | PL |

| --- | --- | --- | --- | --- |

| 252.3 | S01AX | jiná antiinfektiva (lékové formy očních kapek) | lok. | 1.00 | ML | 2,56 | |

| | | | | | | | |

| 252.4 | S01AX | jiná antiinfektiva (lékové formy očních mastí) | lok. | 1.00 | GM | 4,36 | |

| | | | | | | | |

| 253 | Oftalmologika – antivirotika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 253.1 | S01AD02 | trifluorothimidin (lékové formy očních kapek) | lok. | 1.00 | ML | 53.23 | L/OPH |

| | | | | | | | |

| 253.2 | S01AD02 | trifluorothimidin (lékové formy očních mastí) | lok. | 1.00 | GM | 73.91 | L/OPH |

| | | | | | | | |

| 253.3 | S01AD03 | aciklovir | lok. | 1.00 | GM | 86.43 | L/OPH |

| 15375 | ZOVIRAX | oph ung 1x4.5gm | GWB | GB |

| 253.1 | S01AD02 | trifluorothimidin (lékové formy očních kapek) | lok. | 1.00 | ML | 52,02 | L/OPH |

| | | | | | | | |

| 253.2 | S01AD02 | trifluorothimidin (lékové formy očních mastí) | lok. | 1.00 | GM | 72,23 | L/OPH |

| | | | | | | | |

| 253.3 | S01AD03 | aciklovir | lok. | 1.00 | GM | 84,47 | L/OPH |

| 15375 | ZOVIRAX | oph ung 1×4.5gm | GWB | GB |

| --- | --- | --- | --- | --- |

| 254 | Oftalmologika – kortikosteroidy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 254.1 | S01BA01 | dexamethason (lékové formy očních kapek) | lok. | 1.00 | ML | 3.47 | |

| | | | | | | | |

| 254.2 | S01BA01 | dexamethason (lékové formy očních mastí) | lok. | 1.00 | GM | 3.62 | |

| | | | | | | | |

| 254.3 | S01BA02 | hydrokortison | lok. | 1.00 | GM | 6.04 | |

| | | | | | | | |

| 254.4 | S01BA03 | kortison | lok. | 1.00 | ML | 19.57 | L/OPH |

| 00757 | CORTISON SPOFA | gtt 1x3ml/15mg | SPX | CZ |

| --- | --- | --- | --- | --- |

| 254.5 | S01BA04 | prednizolon (lékové formy očních kapek) | lok. | 1.00 | ML | 17.00 | L/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 254.6 | S01BA04 | prednizolon (lékové formy očních mastí) | lok. | 1.00 | GM | 17.00 | L/OPH |

| | | | | | | | |

| 254.7 | S01BA07 | fluorometholon | lok. | 1.00 | ML | 17.00 | L/OPH |

| 56868 | FLUMETOL S | gtt oph 1x10ml/0.02gm | FTF | I |

| 254.1 | S01BA01 | dexamethason (lékové formy očních kapek) | lok. | 1.00 | ML | 3,39 | |

| | | | | | | | |

| 254.2 | S01BA01 | dexamethason (lékové formy očních mastí) | lok. | 1.00 | GM | 3,54 | |

| | | | | | | | |

| 254.3 | S01BA02 | hydrokortison | lok. | 1.00 | GM | 5,90 | |

| | | | | | | | |

| 254.4 | S01BA03 | kortison | lok. | 1.00 | ML | 19,13 | L/OPH |

| 00757 | CORTISON SPOFA | gtt 1×3ml/15mg | SPX | CZ |

| --- | --- | --- | --- | --- |

| 254.5 | S01BA04 | prednizolon (lékové formy očních kapek) | lok. | 1.00 | ML | 16,61 | L/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 254.6 | S01BA04 | prednizolon (lékové formy očních mastí) | lok. | 1.00 | GM | 16,61 | L/OPH |

| | | | | | | | |

| 254.7 | S01BA07 | fluorometholon | lok. | 1.00 | ML | 16,61 | L/OPH |

| 56868 | FLUMETOL S | gtt oph 1×10ml/0.02gm | FTF | I |

| --- | --- | --- | --- | --- |

| 255 | Oftalmologika - nesteroidní protizánětlivá léčiva | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 255.1 | S01BC01 | indometacin | lok. | 1.00 | ML | 17.00 | |

| | | | | | | | |

| 255.2 | S01BC02 | oxyfenbutazon | lok. | 1.00 | GM | 14.66 | |

| | | | | | | | |

| 255.3 | S01BC03 | diklofenak | lok. | 1.00 | ML | 17.00 | L/OPH |

| 58230 | UNICLOPHEN UNIMED PHARMA | gtt oph 1x10ml 0.1% | UPA | SK |

| --- | --- | --- | --- | --- |

| 255.4 | S01BC04 | flurbiprofen | lok. | 1.00 | ML | 17.00 | L/OPH |

| 255.1 | S01BC01 | indometacin | lok. | 1.00 | ML | 16,61 | |

| | | | | | | | |

| 255.2 | S01BC02 | oxyfenbutazon | lok. | 1.00 | GM | 14,33 | |

| | | | | | | | |

| 255.3 | S01BC03 | diklofenak | lok. | 1.00 | ML | 16,61 | L/OPH |

| 58230 | UNICLOPHEN UNIMED PHARMA | gtt oph 1×10ml 0.1% | UPA | SK |

| --- | --- | --- | --- | --- |

| 255.4 | S01BC04 | flurbiprofen | lok. | 1.00 | ML | 16,61 | L/OPH |

| | | | | | | | |

| 256 | oftalmologika - kombinace protizánětlivých léků s antiinfektivy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 256.1 | S01AA20 | antibiotika v kombinaci s jinými léčivy | lok. | 1.00 | ML | 3.21 | |

| | | | | | | | |

| 256.2 | S01AA20 | neomycin/bacitracin/hydrokortison | lok. | 1.00 | GM | 6.92 | |

| 01077 | OPHTHALMO-FRAMYKOIN COMP. | ung oph 1x5gm | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 256.3 | S01CA | chloramfenikol/dexamethason | lok. | 1.00 | ML | 17.60 | L/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 256.4 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních kapek) | lok. | 1.00 | ML | 12.00 | L/OPH |

| | | | | | | | |

| 256.5 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních mastí) | lok. | 1.00 | GM | 15.40 | L/OPH |

| 02547 | MAXITROL | ung oph 1x3.5gm | ACU | B |

| --- | --- | --- | --- | --- |

| 256.6 | S01CA01 | dexamethason a tobramycin (lékové formy očních kapek) | lok. | 1.00 | ML | 12.00 | L/OPH |

| | | | | | | | |

| 256.7 | S01CA01 | oxytetracyklin/dexamethason | lok. | 1.00 | GM | 17.60 | L/OPH |

| | | | | | | | |

| 256.8 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních kapek) | lok. | 1.00 | ML | 12.00 | L/OPH |

| | | | | | | | |

| 256.9 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních mastí) | lok. | 1.00 | GM | 15.40 | L/OPH |

| | | | | | | | |

| 256.10 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních kapek) | lok. | 1.00 | ML | 12.00 | L/OPH |

| | | | | | | | |

| 256.11 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních mastí) | lok. | 1.00 | GM | 15.40 | L/OPH |

| | | | | | | | |

| 256.12 | S01CA05 | gentamicin/betamethason (lékové formy očních kapek) | lok. | 1.00 | ML | 12.00 | L/OPH,ORL |

| | | | | | | | |

| 256.13 | S01CA05 | gentamicin/betamethason (lékové formy očních mastí) | lok. | 1.00 | GM | 15.40 | L/OPH,ORL |

| | | | | | | | |

| 256.14 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních kapek) | lok. | 1.00 | ML | 19.55 | L/OPH |

| | | | | | | | |

| 256.15 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních mastí) | lok. | 1.00 | GM | 24.44 | L/OPH |

| 256.1 | S01AA20 | antibiotika v kombinaci s jinými léčivy | lok. | 1.00 | ML | 3,14 | |

| | | | | | | | |

| 256.2 | S01AA20 | neomycin/bacitracin/hydrokortison | lok. | 1.00 | GM | 6,76 | |

| 01077 | OPHTHALMO-FRAMYKOIN COMP. | ung oph 1×5gm | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 256.3 | S01CA | chloramfenikol/dexamethason | lok. | 1.00 | ML | 17,20 | L/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 256.4 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních kapek) | lok. | 1.00 | ML | 11,73 | L/OPH |

| | | | | | | | |

| 256.5 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních mastí) | lok. | 1.00 | GM | 15,05 | L/OPH |

| 02547 | MAXITROL | ung oph 1×3.5gm | ACU | B |

| --- | --- | --- | --- | --- |

| 256.6 | S01CA01 | dexamethason a tobramycin (lékové formy očních kapek) | lok. | 1.00 | ML | 11,73 | L/OPH |

| | | | | | | | |

| 256.7 | S01CA01 | oxytetracyklin/dexamethason | lok. | 1.00 | GM | 17,20 | L/OPH |

| | | | | | | | |

| 256.8 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních kapek) | lok. | 1.00 | ML | 11,73 | L/OPH |

| | | | | | | | |

| 256.9 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních mastí) | lok. | 1.00 | GM | 15,05 | L/OPH |

| | | | | | | | |

| 256.10 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních kapek) | lok. | 1.00 | ML | 11,73 | L/OPH |

| | | | | | | | |

| 256.11 | S01CA05 | betamethason a antiinfektiva (betamethason a chloramfenikol - lékové formy očních mastí) | lok. | 1.00 | GM | 15,05 | L/OPH |

| | | | | | | | |

| 256.12 | S01CA05 | gentamicin/betamethason (lékové formy očních kapek) | lok. | 1.00 | ML | 11,73 | L/OPH,ORL |

| | | | | | | | |

| 256.13 | S01CA05 | gentamicin/betamethason (lékové formy očních mastí) | lok. | 1.00 | GM | 15,05 | L/OPH,ORL |

| | | | | | | | |

| 256.14 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních kapek) | lok. | 1.00 | ML | 19,11 | L/OPH |

| | | | | | | | |

| 256.15 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních mastí) | lok. | 1.00 | GM | 23,89 | L/OPH |

| | | | | | | | |

| 257 | antiglaukomatika ze skupiny sympatomimetik a parasympatomimetik | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 257.1 | S01EA01 | epinefrin | lok. | 1.00 | ML | 26.65 | L/OPH |

| | | | | | | | |

| 257.2 | S01EA02 | dipivefrin | lok. | 1.00 | ML | 26.65 | L/OPH |

| | | | | | | | |

| 257.3 | S01EA04 | klonidin | lok. | 1.00 | ML | 10.70 | L/OPH |

| 13725 | ARUCLONIN 1/8% | gtt oph 1x10ml/12.5mg | MNN | D |

| --- | --- | --- | --- | --- |

| 13726 | ARUCLONIN 1/16% | gtt oph 1x10ml/6.25mg | MNN | D |

| 49501 | ARUCLONIN 1/16% | gtt oph 1x10ml/6.25mg | CHV | D |

| 257.4 | S01EA05 | brimonidin | lok. | 1.00 | ML | 59.80 | P |

| 257.1 | S01EA01 | epinefrin | lok. | 1.00 | ML | 26,05 | L/OPH |

| | | | | | | | |

| 257.2 | S01EA02 | dipivefrin | lok. | 1.00 | ML | 26,05 | L/OPH |

| | | | | | | | |

| 257.3 | S01EA04 | klonidin | lok. | 1.00 | ML | 10,46 | L/OPH |

| 13725 | ARUCLONIN 1/8% | gtt oph 1×10ml/12.5mg | MNN | D |

| --- | --- | --- | --- | --- |

| 13726 | ARUCLONIN 1/16% | gtt oph 1×10ml/6.25mg | MNN | D |

| 49501 | ARUCLONIN 1/16% | gtt oph 1×10ml/6.25mg | CHV | D |

| 257.4 | S01EA05 | brimonidin | lok. | 1.00 | ML | 58,44 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu brimonidinem předepisuje oční lékař u pacientů s glaukomem při netoleranci nebo neúčinnosti betablokátorů.

| 257.5 | S01EB01 | pilokarpin (lékové formy gelu) | lok. | 1.00 | GM | 29.00 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 257.6 | S01EB01 | pilokarpin (lékové formy očních kapek, koncentrace do 1 % včetně) | lok. | 1.00 | ML | 5.50 | |

| | | | | | | | |

| 257.7 | S01EB01 | pilokarpin (lékové formy očních kapek, koncentrace více než 1%) | lok. | 1.00 | ML | 6.17 | |

| 04146 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | gtt oph 1x10ml/200mg | CHV | D |

| --- | --- | --- | --- | --- |

| 13401 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | oph gtt sol 1x10ml | CUA | D |

| 13402 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | oph gtt sol 3x10ml | CUA | D |

| 57337 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | gtt oph 3x10ml/200mg | CHV | D |

| 257.8 | S01EB01 | pilokarpin (lékové formy olejových očních kapek) | lok. | 1.00 | ML | 9.70 | |

| | | | | | | | |

| 257.9 | S01EB02 | karbachol (koncentrace do 1% včetně) | lok. | 1.00 | ML | 8.50 | L/OPH |

| | | | | | | | |

| 257.10 | S01EB02 | karbachol (koncentrace nad 1% do 1,5% včetně) | lok. | 1.00 | ML | 6.06 | L/OPH |

| | | | | | | | |

| 257.11 | S01EB02 | karbachol (koncentrace nad 1,5%) | lok. | 1.00 | ML | 6.60 | L/OPH |

| | | | | | | | |

| 257.12 | S01EB06 | neostigmin | lok. | 1.00 | ML | 13.88 | L/OPH |

| 257.5 | S01EB01 | pilokarpin (lékové formy gelu) | lok. | 1.00 | GM | 28,34 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 257.6 | S01EB01 | pilokarpin (lékové formy očních kapek, koncentrace do 1 % včetně) | lok. | 1.00 | ML | 5,38 | |

| | | | | | | | |

| 257.7 | S01EB01 | pilokarpin (lékové formy očních kapek, koncentrace více než 1%) | lok. | 1.00 | ML | 6,03 | |

| 04146 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | gtt oph 1×10ml/200mg | CHV | D |

| --- | --- | --- | --- | --- |

| 13401 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | oph gtt sol 1×10ml | CUA | D |

| 13402 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | oph gtt sol 3×10ml | CUA | D |

| 57337 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | gtt oph 3×10ml/200mg | CHV | D |

| 257.8 | S01EB01 | pilokarpin (lékové formy olejových očních kapek) | lok. | 1.00 | ML | 9,48 | |

| | | | | | | | |

| 257.9 | S01EB02 | karbachol (koncentrace do 1 % včetně) | lok. | 1.00 | ML | 8,31 | L/OPH |

| | | | | | | | |

| 257.10 | S01EB02 | karbachol (koncentrace nad 1% do 1,5% včetně) | lok. | 1.00 | ML | 5,92 | L/OPH |

| | | | | | | | |

| 257.11 | S01EB02 | karbachol (koncentrace nad 1,5%) | lok. | 1.00 | ML | 6,45 | L/OPH |

| | | | | | | | |

| 257.12 | S01EB06 | neostigmin | lok. | 1.00 | ML | 13,56 | L/OPH |

| | | | | | | | |

| 258 | antiglaukomatika ze skupiny beta-blokátorů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 258.1 | S01ED01 | timolol (koncentrace do 0,25% včetně) | lok. | 1.00 | ML | 12.80 | |

| 01760 | TIMOLOL-POS 0.25% | gtt oph 3x5ml | URS | D |

| --- | --- | --- | --- | --- |

| 03478 | ARUTIMOL 0.25% | oph gtt sol 1x5ml | CUA | D |

| 03479 | ARUTIMOL 0.25% | oph gtt sol 3x5ml | CUA | D |

| 12729 | TIMOHEXAL 0.1% | gtt oph 1x5ml/5mg | HEX | D |

| 12730 | TIMOHEXAL 0.25% | gtt oph 1x5ml/12.5mg | HEX | D |

| 12732 | TIMOHEXAL 0.1% | gtt oph 3x5ml/5mg | HEX | D |

| 12733 | TIMOHEXAL 0.25% | gtt oph 3x5ml/12.5mg | HEX | D |

| 14562 | TIMOHEXAL 0.1% | oph gtt sol 1x5ml | SFS | D |

| 14563 | TIMOHEXAL 0.1% | oph gtt sol 3x5ml | SFS | D |

| 14564 | TIMOHEXAL 0.25% | oph gtt sol 1x5ml | SFS | D |

| 14565 | TIMOHEXAL 0.25% | oph gtt sol 3x5ml | SFS | D |

| 44546 | TIMO-COMOD 0.25% | gtt oph 1x10ml/25mg | URS | D |

| 70474 | ARUTIMOL 0.25% | oph gtt sol 3x5ml | CHV | D |

| 76186 | ARUTIMOL 0.25% | oph gtt sol 1x5ml | CHV | D |

| 87113 | TIMOLOL-POS 0.25% | gtt oph 1x5ml | URS | D |

| 96021 | OFTENSIN 0.25% | gtt oph 1x5ml | ZPF | PL |

| 258.2 | S01ED01 | timolol (koncentrace nad 0,25%) | lok. | 1.00 | ML | 14.49 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01759 | TIMOLOL-POS 0.5% | gtt oph 3x5ml | URS | D |

| --- | --- | --- | --- | --- |

| 12731 | TIMOHEXAL 0.5% | gtt oph 1x5ml/25mg | HEX | D |

| 12734 | TIMOHEXAL 0.5% | gtt oph 3x5ml/25mg | HEX | D |

| 14566 | TIMOHEXAL 0.5% | oph gtt sol 1x5ml | SFS | D |

| 14567 | TIMOHEXAL 0.5% | oph gtt sol 3x5ml | SFS | D |

| 14579 | UNI TIMOLOL 0.5% UNIMED PHARMA | oph gtt sol 1x10ml | UPA | SK |

| 19599 | UNI TIMOLOL 0.5% UNIMED PHARMA | oph gtt sol 1x5ml | UPA | SK |

| 21450 | UNI TIMOLOL 0.5% UNIMED PHARMA | oph gtt sol 3x5ml | UPA | SK |

| 32553 | ARUTIMOL 0.50% | oph gtt sol 1x5ml | CUA | D |

| 32556 | ARUTIMOL 0.50% | oph gtt sol 3x5ml | CUA | D |

| 44547 | TIMO-COMOD 0.5% | gtt oph 1x10ml/50mg | URS | D |

| 70475 | ARUTIMOL 0.50% | oph gtt sol 3x5ml | CHV | D |

| 76187 | ARUTIMOL 0.50% | oph gtt sol 1x5ml | CHV | D |

| 87114 | TIMOLOL-POS 0.5% | gtt oph 1x5ml | URS | D |

| 96019 | OFTENSIN 0.5% | gtt oph 1x5ml | ZPF | PL |

| 258.3 | S01ED02 | betaxolol | lok. | 1.00 | ML | 20.00 | L/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 258.4 | S01ED03 | levobunolol | lok. | 1.00 | ML | 20.00 | L/OPH |

| | | | | | | | |

| 258.5 | S01ED04 | metipranolol | lok. | 1.00 | ML | 13.20 | |

| | | | | | | | |

| 258.6 | S01ED05 | carteolol | lok. | 1.00 | ML | 20.00 | L/OPH |

| | | | | | | | |

| 258.7 | S01ED51 | timolol v kombinaci s dorzolamidem | lok. | 1.00 | ML | 81.46 | P |

| 258.1 | S01ED01 | timolol (koncentrace do 0,25% včetně) | lok. | 1.00 | ML | 12,51 | |

| 01760 | TIMOLOL-POS 0.25% | gtt oph 3×5ml | URS | D |

| --- | --- | --- | --- | --- |

| 03478 | ARUTIMOL 0.25% | oph gtt sol 1×5ml | CUA | D |

| 03479 | ARUTIMOL 0.25% | oph gtt sol 3×5ml | CUA | D |

| 12729 | TIMOHEXAL 0.1% | gtt oph 1×5ml/5mg | HEX | D |

| 12730 | TIMOHEXAL 0.25% | gtt oph 1×5ml/12.5mg | HEX | D |

| 12732 | TIMOHEXAL 0.1% | gtt oph 3×5ml/5mg | HEX | D |

| 12733 | TIMOHEXAL 0.25% | gtt oph 3×5ml/12.5mg | HEX | D |

| 14562 | TIMOHEXAL 0.1% | oph gtt sol 1×5ml | SFS | D |

| 14563 | TIMOHEXAL 0.1% | oph gtt sol 3×5ml | SFS | D |

| 14564 | TIMOHEXAL 0.25% | oph gtt sol 1×5ml | SFS | D |

| 14565 | TIMOHEXAL 0.25% | oph gtt sol 3×5ml | SFS | D |

| 44546 | TIMO-COMOD 0.25% | gtt oph 1×10ml/25mg | URS | D |

| 70474 | ARUTIMOL 0.25% | oph gtt sol 3×5ml | CHV | D |

| 76186 | ARUTIMOL 0.25% | oph gtt sol 1×5ml | CHV | D |

| 87113 | TIMOLOL-POS 0.25% | gtt oph 1×5ml | URS | D |

| 96021 | OFTENSIN 0.25% | gtt oph 1×5ml | ZPF | PL |

| 258.2 | S01ED01 | timolol (koncentrace nad 0,25%) | lok. | 1.00 | ML | 14,16 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 01759 | TIMOLOL-POS 0.5% | gtt oph 3×5ml | URS | D |

| --- | --- | --- | --- | --- |

| 12731 | TIMOHEXAL 0.5% | gtt oph 1×5ml/25mg | HEX | D |

| 12734 | TIMOHEXAL 0.5% | gtt oph 3×5ml/25mg | HEX | D |

| 14566 | TIMOHEXAL 0.5% | oph gtt sol 1×5ml | SFS | D |

| 14567 | TIMOHEXAL 0.5% | oph gtt sol 3×5ml | SFS | D |

| 14579 | UNI TIMOLOL 0.5% UNIMED PHARMA | oph gtt sol 1×10ml | UPA | SK |

| 19599 | UNI TIMOLOL 0.5% UNIMED PHARMA | oph gtt sol 1×5ml | UPA | SK |

| 21450 | UNI TIMOLOL 0.5% UNIMED PHARMA | oph gtt sol 3×5ml | UPA | SK |

| 32553 | ARUTIMOL 0.50% | oph gtt sol 1×5ml | CUA | D |

| 32556 | ARUTIMOL 0.50% | oph gtt sol 3×5ml | CUA | D |

| 44547 | TIMO-COMOD 0.5% | gtt oph 1×10ml/50mg | URS | D |

| 70475 | ARUTIMOL 0.50% | oph gtt sol 3×5ml | CHV | D |

| 76187 | ARUTIMOL 0.50% | oph gtt sol 1×5ml | CHV | D |

| 87114 | TIMOLOL-POS 0.5% | gtt oph 1×5ml | URS | D |

| 96019 | OFTENSIN 0.5% | gtt oph 1×5ml | ZPF | PL |

| 258.3 | S01ED02 | betaxolol | lok. | 1.00 | ML | 19,55 | L/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 258.4 | S01ED03 | levobunolol | lok. | 1.00 | ML | 19,55 | L/OPH |

| | | | | | | | |

| 258.5 | S01ED04 | metipranolol | lok. | 1.00 | ML | 12,90 | |

| | | | | | | | |

| 258.6 | S01ED05 | carteolol | lok. | 1.00 | ML | 19,55 | L/OPH |

| | | | | | | | |

| 258.7 | S01ED51 | timolol v kombinaci s dorzolamidem | lok. | 1.00 | ML | 79,61 | P |

Dorsolamid/timolol je hrazen u pacientů s glaukomem s otevřeným úhlem, oční hypertenzí, psudoexfoliativním glaukomem nebo ostatními sekundárními glaukomy. Léčba je předepisována očním lékařem v případě neúčinnosti monoterapie betablokátory nebo alfamimetiky.

| 258.8 | S01ED51 | timolol v kombinaci s latanoprostem | lok. | 1.00 | ML | 220.60 | P |

| 258.8 | S01ED51 | timolol v kombinaci s latanoprostem | lok. | 1.00 | ML | 215,59 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Latanoprost/timolol v kombinaci předepisuje oční lékař u nemocných, kteří trpí glaukomem s otevřeným úhlem a oční hypertenzí, při neúčinnosti beta-blokátorů a není-li operační výkon indikován.

@@ -9830,197 +9879,197 @@

| 259 | ostatní antiglaukomatika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 259.1 | S01EB51 | pilokarpin v kombinaci s timololem | lok. | 1.00 | ML | 21.07 | L/OPH |

| | | | | | | | |

| 259.2 | S01EC01 | acetazolamid | p.o. | 0.75 | GM | 6.53 | |

| 00113 | DILURAN | tbl 20x250mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 259.3 | S01EC01 | acetazolamid (lékové formy s řízeným uvolňováním) | p.o. | 0.75 | GM | 29.33 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 259.4 | S01EC02 | diklofenamid | p.o. | 0.10 | GM | 6.26 | |

| | | | | | | | |

| 259.5 | S01EC03 | dorzolamid | lok. | 1.00 | ML | 59.80 | P |

| 259.1 | S01EB51 | pilokarpin v kombinaci s timololem | lok. | 1.00 | ML | 20,59 | L/OPH |

| | | | | | | | |

| 259.2 | S01EC01 | acetazolamid | p.o. | 0.75 | GM | 6,38 | |

| 00113 | DILURAN | tbl 20×250mg | ZEH | CZ |

| --- | --- | --- | --- | --- |

| 259.3 | S01EC01 | acetazolamid (lékové formy s řízeným uvolňováním) | p.o. | 0.75 | GM | 28,66 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 259.4 | S01EC02 | diklofenamid | p.o. | 0.10 | GM | 6,12 | |

| | | | | | | | |

| 259.5 | S01EC03 | dorzolamid | lok. | 1.00 | ML | 58,44 | P |

Léčba dorzolamidem je předepisována v případě neúčinnosti monoterapie betablokátory nebo alfamimetiky nebo v případě netolerance těchto léčiv.

| 259.6 | S01EC04 | brinzolamid | lok. | 1.00 | ML | 59.80 | P |

| 259.6 | S01EC04 | brinzolamid | lok. | 1.00 | ML | 58,44 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčba brinzolamidem včetně kombinací je předepisována v případě neúčinnosti monoterapie betablokátory nebo alfamimetiky nebo v případě netolerance těchto léčiv.

| 259.7 | S01EE01 | latanoprost | lok. | 1.00 | ML | 184.00 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 259.8 | S01EE02 | unoproston | lok. | 1.00 | ML | 94.98 | P |

| | | | | | | | |

| 259.9 | S01EE03 | bimatoprost | lok. | 1.00 | ML | 153.33 | P |

| | | | | | | | |

| 259.10 | S01EE04 | travoprost | lok. | 1.00 | ML | 184.00 | P |

| 259.7 | S01EE01 | latanoprost | lok. | 1.00 | ML | 179,82 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 259.8 | S01EE02 | unoproston | lok. | 1.00 | ML | 92,82 | P |

| | | | | | | | |

| 259.9 | S01EE03 | bimatoprost | lok. | 1.00 | ML | 149,85 | P |

| | | | | | | | |

| 259.10 | S01EE04 | travoprost | lok. | 1.00 | ML | 179,82 | P |

Latanoprost, unoproston, bimatoprost a travoprost předepisuje oční lékař u nemocných, kteří trpí glaukomem s otevřeným úhlem a oční hypertenzí vedle beta-blokátorů, alfa agonistů a inhibitorů karboanhydrázy a není-li operační výkon indikován.

| 260 | mydriatika a cykloplegika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 260.1 | S01FA01 | atropin (koncentrace do 0,5% včetně) | lok. | 1.00 | ML | 4.83 | |

| 83770 | ATROPIN-POS 0.5% | oph gtt sol 1x10ml | URS | D |

| --- | --- | --- | --- | --- |

| 260.2 | S01FA01 | atropin (koncentrace nad 0,5%) | lok. | 1.00 | ML | 5.46 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 83771 | ATROPIN-POS 1% | oph gtt sol 1x10ml | URS | D |

| --- | --- | --- | --- | --- |

| 260.3 | S01FA04 | cyklopentolát | lok. | 1.00 | ML | 26.34 | O/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 45558 | CYCLOGYL 1% | gtt oph 1x15ml 1% | ACU | B |

| --- | --- | --- | --- | --- |

| 260.4 | S01FA06 | tropikamid | lok. | 1.00 | ML | 8.52 | O/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21155 | MYDRUM | oph gtt sol 1x10ml | CHV | D |

| --- | --- | --- | --- | --- |

| 57999 | MYDRUM | oph gtt sol 1x10ml | CUA | D |

| 260.5 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. | 1.00 | ML | 40.33 | O/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 41338 | NEOSYNEPHRIN-POS 10% | oph gtt sol 1x10ml | URS | D |

| 260.1 | S01FA01 | atropin (koncentrace do 0,5% včetně) | lok. | 1.00 | ML | 4,72 | |

| 83770 | ATROPIN-POS 0.5% | oph gtt sol1×10ml | URS | D |

| --- | --- | --- | --- | --- |

| 260.2 | S01FA01 | atropin (koncentrace nad 0,5%) | lok. | 1.00 | ML | 5,34 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 83771 | ATROPIN-POS 1% | oph gtt sol 1×10ml | URS | D |

| --- | --- | --- | --- | --- |

| 260.3 | S01FA04 | cyklopentolát | lok. | 1.00 | ML | 25,74 | O/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 45558 | CYCLOGYL 1% | gtt oph 1×15ml 1% | ACU | B |

| --- | --- | --- | --- | --- |

| 260.4 | S01FA06 | tropikamid | lok. | 1.00 | ML | 8,33 | O/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 21155 | MYDRUM | oph gtt sol 1×10ml | CHV | D |

| --- | --- | --- | --- | --- |

| 57999 | MYDRUM | oph gtt sol 1×10ml | CUA | D |

| 260.5 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. | 1.00 | ML | 39,41 | O/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 41338 | NEOSYNEPHRIN-POS 10% | oph gtt sol 1×10ml | URS | D |

| --- | --- | --- | --- | --- |

| 261 | dekongescenty a antialergika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 261.1 | S01GA52 | tetryzolin/antihistaminikum | lok. | 1.00 | ML | 4.06 | L/OPH,ALG |

| | | | | | | | |

| 261.2 | S01GX01 | natrium kromoglykát (lékové formy očních a nosních kapek) | lok. | 1.00 | ML | 5.23 | L/OPH,ALG,ORL |

| 261.1 | S01GA52 | tetryzolin/antihistaminikum | lok. | 1.00 | ML | 3,97 | L/OPH,ALG |

| | | | | | | | |

| 261.2 | S01GX01 | natrium kromoglykát (lékové formy očních a nosních kapek) | lok. | 1.00 | ML | 5,11 | L/OPH,ALG,ORL |

| 54241 | ALLERGOCROM KOMBI (OČNÍ+NOSNÍ) | oph 10ml+nas 15ml | URS | D |

| --- | --- | --- | --- | --- |

| 57944 | CROMOHEXAL COMBI | oph 10ml+nas15ml sol | SFS | D |

| 57944 | CROMOHEXAL COMBI | oph10ml+nas15ml sol | SFS | D |

| 83651 | CROMOHEXAL COMBI | oph 10ml+nas 15ml | HEX | D |

| 261.3 | S01GX01 | natrium kromoglykát (lékové formy očních kapek) | lok. | 1.00 | ML | 4.06 | |

| | | | | | | | |

| 261.4 | S01GX02 | levokabastin | lok. | 1.00 | ML | 17.60 | L/OPH,ALG |

| | | | | | | | |

| 261.5 | S01GX03 | kyselina spaglumová | lok. | 1.00 | ML | 14.66 | L/OPH,ALG |

| | | | | | | | |

| 261.6 | S01GX05 | lodoxamid | lok. | 1.00 | ML | 14.66 | L/OPH,ALG |

| | | | | | | | |

| 261.7 | S01GX06 | emedastin | lok. | 1.00 | ML | 17.60 | L/OPH,ALG |

| | | | | | | | |

| 261.8 | S01GX07 | azelastin | lok. | 1.00 | ML | 17.60 | L/OPH,ALG |

| | | | | | | | |

| 261.9 | S01GX08 | ketotifen | lok. | 1.00 | ML | 25.00 | L/OPH,ALG |

| | | | | | | | |

| 261.10 | S01GX09 | olopatadin | lok. | 1.00 | ML | 25.00 | L/OPH,ALG |

| | | | | | | | |

| 261.11 | S01GX10 | epinastin | lok. | 5.00 | ML | 125.00 | L/OPH,ALG |

| 261.3 | S01GX01 | natrium kromoglykát (lékové formy očních kapek) | lok. | 1.00 | ML | 3,97 | |

| | | | | | | | |

| 261.4 | S01GX02 | levokabastin | lok. | 1.00 | ML | 17,20 | L/OPH,ALG |

| | | | | | | | |

| 261.5 | S01GX03 | kyselina spaglumová | lok. | 1.00 | ML | 14,33 | L/OPH,ALG |

| | | | | | | | |

| 261.6 | S01GX05 | Iodoxamid | lok. | 1.00 | ML | 14,33 | L/OPH,ALG |

| | | | | | | | |

| 261.7 | S01GX06 | emedastin | lok. | 1.00 | ML | 17,20 | L/OPH, ALG |

| | | | | | | | |

| 261.8 | S01GX07 | azelastin | lok. | 1.00 | ML | 17,20 | L/OPH, ALG |

| | | | | | | | |

| 261.9 | S01GX08 | ketotifen | lok. | 1.00 | ML | 24,43 | L/OPH, ALG |

| | | | | | | | |

| 261.10 | S01GX09 | olopatadin | lok. | 1.00 | ML | 24,43 | L/OPH, ALG |

| | | | | | | | |

| 261.11 | S01GX10 | epinastin | lok. | 5.00 | ML | 122,16 | L/OPH, ALG |

| | | | | | | | |

| 262 | anestetika lokální a jiná oftalmologika | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 262.1 | S01HA | místní anestetika | lok. | 1.00 | ML | 11.83 | L/OPH |

| | | | | | | | |

| 262.2 | S01HA02 | oxybuprokain | lok. | 1.00 | ML | 11.52 | L/OPH |

| 15514 | NOVESIN 0.4% | oph gtt sol 1x10ml | NAI | CZ |

| --- | --- | --- | --- | --- |

| 20053 | BENOXI 0.4 % UNIMED PHARMA | oph gtt sol 1x10ml | UPA | SK |

| 66524 | NOVESIN 0.4% | oph gtt sol 1x10ml | NAH | CH |

| 262.3 | S01KA01 | kyselina hyaluronová | lok. | 1.00 | ML | 1 376.58 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 262.4 | S01XA | jodid draselný a sodný | lok. | 1.00 | ML | 4.89 | |

| 56119 | JODID DRASELNY+SODNY 2% UNIM.PH | oph gtt sol 1x10ml | UPA | SK |

| --- | --- | --- | --- | --- |

| 262.5 | S01XA | tolazolin (koncentrace 10%) | lok. | 1.00 | GM | 14.91 | L/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 262.6 | S01XA01 | guajazulen | lok. | 1.00 | GM | 3.98 | |

| | | | | | | | |

| 262.7 | S01XA02 | retinol | lok. | 1.00 | GM | 2.93 | |

| | | | | | | | |

| 262.8 | S01XA04 | jodid draselný | lok. | 1.00 | ML | 4.89 | |

| 56118 | JODID DRASELNY 2% UNIMED PHARMA | oph gtt sol 1x10ml | UPA | SK |

| --- | --- | --- | --- | --- |

| 262.9 | S01XA11 | nandrolon | lok. | 1.00 | ML | 11.20 | |

| | | | | | | | |

| 262.10 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1.00 | ML | 3.03 | |

| | | | | | | | |

| 262.11 | S01XA20 | umělé slzy a jiné indiferentní přípravky (v lékové formě gelu) | lok. | 1.00 | GM | 3.03 | |

| | | | | | | | |

| 262.12 | S02DA30 | kombinace fenazon a lidokain | lok. | 1.00 | GM | 3.80 | |

| 262.1 | S01 HA | místní anestetika | lok. | 1.00 | ML | 11,56 | L/OPH |

| | | | | | | | |

| 262.2 | S01HA02 | oxybuprokain | lok. | 1.00 | ML | 11,26 | L/OPH |

| 15514 | NOVESIN 0.4% | oph gtt sol 1×10ml | NAI | CZ |

| --- | --- | --- | --- | --- |

| 20053 | BENOXI 0.4 % UNIMED PHARMA | oph gtt sol 1×10ml | UPA | SK |

| 66524 | NOVESIN 0.4% | oph gtt sol 1×10ml | NAH | CH |

| 262.3 | S01KA01 | kyselina hyaluronová | lok. | 1.00 | ML | 1 345,33 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 262.4 | S01XA | jodid draselný a sodný | lok. | 1.00 | ML | 4,78 | |

| 56119 | JODID DRASELNÝ+SODNY 2% UNIM.PH | oph gtt sol 1×10ml | UPA | SK |

| --- | --- | --- | --- | --- |

| 262.5 | S01XA | tolazolin (koncentrace 10%) | lok. | 1.00 | GM | 14,57 | L/OPH |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 262.6 | S01XA01 | guajazulen | lok. | 1.00 | GM | 3,89 | |

| | | | | | | | |

| 262.7 | S01XA02 | retinol | lok. | 1.00 | GM | 2,86 | |

| | | | | | | | |

| 262.8 | S01XA04 | jodid draselný | lok. | 1.00 | ML | 4,78 | |

| 56118 | JODID DRASELNÝ 2% UNIMED PHARMA | oph gtt sol 1×10ml | UPA | SK |

| --- | --- | --- | --- | --- |

| 262.9 | S01XA11 | nandrolon | lok. | 1.00 | ML | 10,95 | |

| | | | | | | | |

| 262.10 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1.00 | ML | 2,96 | |

| | | | | | | | |

| 262.11 | S01XA20 | umělé slzy a jiné indiferentní přípravky (v lékové formě gelu) | lok. | 1.00 | GM | 2,96 | |

| | | | | | | | |

| 262.12 | S02DA30 | kombinace fenazon a lidokain | lok. | 1.00 | GM | 3,71 | |

| | | | | | | | |

| 263 | ostatní léčiva používaná u nemocí senzorických orgánů | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 263.1 | S02AA11 | polymyxin B | lok. | 1.00 | ML | 2.64 | L/ORL |

| | | | | | | | |

| 263.2 | S02BA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1.00 | ML | 22.92 | L/ORL, PED |

| 84575 | OTOBACID N | aur gtt sol 1x6gm | AWA | D |

| --- | --- | --- | --- | --- |

| 263.3 | S02CA03 | hydrokortizon a antiinfektiva v kombinaci | lok. | 1.00 | ML | 27.37 | L/ORL |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13317 | CIPROBAY HC OTIC | sus oto 1x10ml | ALC | E |

| 263.1 | S02AA11 | polymyxin B | lok. | 1.00 | ML | 2,58 | L/ORL |

| | | | | | | | |

| 263.2 | S02BA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1.00 | ML | 22,40 | L/ORL, PED |

| 84575 | OTOBACID N | aur gtt sol 1×6gm | AWA | D |

| --- | --- | --- | --- | --- |

| 263.3 | S02CA03 | hydrokortizon a antiinfektiva v kombinaci | lok. | 1.00 | ML | 26,75 | L/ORL |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 13317 | CIPROBAY HC OTIC | sus oto 1×10ml | ALC | E |

| --- | --- | --- | --- | --- |

| 264 | terapeutické extrakty alergenů standardizované perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 264.1 | V01AA | II. generace (IC a IR do 100 j. včetně, JSA, JSK, SQ, SU, STU), pro sublng. podání, úvodní dávka | p.o. | 1.00 | DF | 308.40 | L/ALG |

| | | | | | | | |

| 264.2 | V01AA | II. generace (IC a IR do 300 j. včetně), pro sublng. podání, úvodní dávka | p.o. | 1.00 | DF | 1 233.04 | L/ALG |

| | | | | | | | |

| 264.3 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), udržovací dávka | p.o. | 1.00 | DF | 498.16 | L/ALG |

| | | | | | | | |

| 264.4 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), úvodní dávka | p.o. | 1.00 | DF | 285.74 | L/ALG |

| 47393 | H-AL POLLENS PER OS | por gtt sol 6x9ml-jsk | SVF | CZ |

| --- | --- | --- | --- | --- |

| 54545 | H-AL POLLENS PER OS | por gtt sol 6x9ml-jsk | SVF | CZ |

| 264.5 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU,STU), pro sublng. podání, udržovací dávka | p.o. | 1.00 | DF | 616.52 | L/ALG |

| 264.1 | V01AA | II. generace (IC a IR do 100 j. včetně, JSA, JSK, SQ, SU, STU), pro sublng. podání, úvodní dávka | p.o. | 1.00 | DF | 301,40 | L/ALG |

| | | | | | | | |

| 264.2 | V01AA | II. generace (IC a IR do 300j. včetně), pro sublng. podání, úvodní dávka | p.o. | 1.00 | DF | 1 205,05 | L/ALG |

| | | | | | | | |

| 264.3 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), udržovací dávka | p.o. | 1.00 | DF | 486,85 | L/ALG |

| | | | | | | | |

| 264.4 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), úvodní dávka | p.o. | 1.00 | DF | 279,25 | L/ALG |

| 47393 | H-AL POLLENS PER OS | por gtt sol 6×9ml-jsk | SVF | CZ |

| --- | --- | --- | --- | --- |

| 54545 | H-AL POLLENS PER OS | por gtt sol 6×9ml-jsk | SVF | CZ |

| 264.5 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU,STU), pro sublng. podání, udržovací dávka | p.o. | 1.00 | DF | 602,52 | L/ALG |

| | | | | | | | |

| 265 | terapeutické extrakty alergenů nestandardizované perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 265.1 | V01AA | I. generace (PNU), udržovací dávka | p.o. | 1.00 | DF | 415.47 | L/ALG |

| | | | | | | | |

| 265.2 | V01AA | I. generace (PNU), úvodní dávka, hmyzí | p.o. | 1.00 | DF | 165.28 | L/ALG |

| 47405 | H-AL INSECTS PER OS | por gttsol6x9ml-pnu | SVF | CZ | V01AA |

| 265.1 | V01AA | I. generace (PNU), udržovací dávka | p.o. | 1.00 | DF | 406,04 | L/ALG |

| | | | | | | | |

| 265.2 | V01AA | I. generace (PNU), úvodní dávka, hmyzí | p.o. | 1.00 | DF | 161,53 | L/ALG |

| 47405 | H-AL INSECTS PER OS | por gtt sol 6×9ml-pnu | SVF | CZ | V01AA |

| --- | --- | --- | --- | --- | --- |

| 47406 | H-AL INSECTS PER OS | por gttsol6x9ml-pnu | SVF | CZ | V01AA |

| 265.3 | V01AA | I. generace (PNU), úvodní dávka | p.o. | 1.00 | DF | 88.46 | L/ALG |

| 47406 | H-AL INSECTS PER OS | por gtt sol 6×9ml-pnu | SVF | CZ | V01AA |

| 265.3 | V01AA | I. generace (PNU), úvodní dávka | p.o. | 1.00 | DF | 86,45 | L/ALG |

| | | | | | | | |

| 266 | terapeutické extrakty alergenů standardizované ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 266.1 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), depotní, udržovací dávka | parent. | 1.00 | TDD | 5.96 | L/ALG |

| | | | | | | | |

| 266.2 | V01AA | II. generace (SQ), depotní, udržovací dávka – hmyzí alergeny (včela, vosa) | parent. | 1.00 | TDD | 8.14 | P |

| 266.1 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), depotní, udržovací dávka | parent. | 1.00 | TDD | 5,82 | L/ALG |

| | | | | | | | |

| 266.2 | V01AA | II. generace (SQ), depotní, udržovací dávka - hmyzí alergeny (včela, vosa) | parent. | 1.00 | TDD | 7,96 | P |

Hmyzí alergeny (včela, vosa) jsou indikovány u pacientů s alergií na hmyzí bodnutí prokázanou přítomností specifických IgE protilátek.

| 266.3 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), depotní, úvodní dávka | parent. | 1.00 | BA | 1 233.60 | L/ALG |

| 266.3 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), depotní, úvodní dávka | parent. | 1.00 | BA | 1 205,60 | L/ALG |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 50341 | H-AL DEPOT(POLLENS-INIC.LÉČBA) | inj sus 300jsk/3ml | SVF | CZ |

@@ -10028,30 +10077,30 @@

| 50342 | H-AL DEPOT(POLLENS-INIC.LÉČBA) | inj sus 1000jsk/1ml | SVF | CZ |

| 50343 | H-AL DEPOT(POLLENS-INIC.LÉČBA) | inj sus 10000jsk/1ml | SVF | CZ |

| 266.4 | V01AA | II. generace (SQ), depotní, úvodní dávka, hmyzí alergeny (včela, vosa) | parent. | 1.00 | BA | 3 498.00 | P |

| 266.4 | V01AA | II. generace (SQ), depotní, úvodní dávka, hmyzí alergeny (včela, vosa) | parent. | 1.00 | BA | 3 418,60 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Hmyzí alergeny (včela, vosa) jsou indikovány u pacientů s alergií na hmyzí bodnutí prokázanou přítomností specifických IgE protilátek.

| 266.5 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU,RG), vodné, udržovací dávka | parent. | 1.00 | DF | 749.06 | L/ALG |

| | | | | | | | |

| 266.6 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU,RG), vodné, úvodní dávka | parent. | 1.00 | DF | 228.70 | L/ALG |

| 266.5 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU,RG), vodné, udržovací dávka | parent. | 1.00 | DF | 732,06 | L/ALG |

| | | | | | | | |

| 266.6 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU,RG), vodné, úvodní dávka | parent. | 1.00 | DF | 223,51 | L/ALG |

| | | | | | | | |

| 267 | terapeutické extrakty alergenů nestandardizované ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 267.1 | V01AA | I. generace (PNU), depotní, udržovací dávka | parent. | 1.00 | BA | 265.93 | L/ALG |

| | | | | | | | |

| 267.2 | V01AA | I. generace (PNU), depotní, úvodní dávka | parent. | 1.00 | DF | 38.50 | L/ALG |

| 267.1 | V01AA | I. generace (PNU), depotní, udržovací dávka | parent. | 1.00 | BA | 259,89 | L/ALG |

| | | | | | | | |

| 267.2 | V01AA | I. generace (PNU), depotní, úvodní dávka | parent. | 1.00 | DF | 37,63 | L/ALG |

| 83558 | H-AL POLLENS(JAR.SM.CAS.)DEPOT | inj 250pnu-1ml | SVF | CZ | V01AA |

| --- | --- | --- | --- | --- | --- |

| 83560 | H-AL POLLENS(SM.PODZIMNI)DEPOT | inj 250pnu-1ml | SVF | CZ | V01AA |

| 83562 | H-AL POLLENS(SMĚS TRAV I)DEPOT | inj 250pnu-1ml | SVF | CZ | V01AA |

| 267.3 | V01AA | I. generace (PNU), vodné, udržovací dávka | parent. | 1.00 | DF | 442.69 | L/ALG |

| | | | | | | | |

| 267.4 | V01AA | I. generace (PNU), vodné, úvodní dávka | parent. | 1.00 | DF | 69.48 | L/ALG |

| 83562 | H-AL POLLENS(SMĚS TRAV l)DEPOT | inj 250pnu-1ml | SVF | CZ | V01AA |

| 267.3 | V01AA | I. generace (PNU), vodné, udržovací dávka | parent. | 1.00 | DF | 432,64 | L/ALG |

| | | | | | | | |

| 267.4 | V01AA | I. generace (PNU), vodné, úvodní dávka | parent. | 1.00 | DF | 67,90 | L/ALG |

| | | | | | | | |

| 268 | základní antidota a fágové lyzáty | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

@@ -10066,45 +10115,45 @@

| | | | | | | | |

| 268.5 | V03AB08 | dusitan sodný | parent. | | | Plně | K |

| | | | | | | | |

| 268.6 | V03AB14 | protamin | parent. | 1.00 | ML | 6.01 | K |

| | | | | | | | |

| 268.7 | V03AB15 | naloxon | parent. | 0.40 | MG | 11.83 | K |

| 94763 | NALOXONE WZF POLFA | inj 10x1ml/0.4mg | WZF | PL |

| --- | --- | --- | --- | --- |

| 268.8 | V03AB16 | ethanol (koncentrace 10%) | parent. | 100.00 | ML | 20.43 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 268.9 | V03AB19 | fysostigmin | parent. | 1.00 | MG | 10.31 | K |

| | | | | | | | |

| 268.10 | V03AB24 | digitalisový antitoxin | parent. | 80.00 | MG | 32 726.64 | K |

| | | | | | | | |

| 268.11 | V03AB25 | flumazenil | parent. | 0.50 | MG | 754.48 | K |

| 16551 | ANEXATE | inj 5x5ml/0.5mg | RCE | CZ |

| 268.6 | V03AB14 | Protamin | parent. | 1.00 | ML | 5,87 | K |

| | | | | | | | |

| 268.7 | V03AB15 | naloxon | parent. | 0.40 | MG | 11,56 | K |

| 94763 | NALOXONE WZF POLFA | inj 10×1ml/0.4mg | WZF | PL |

| --- | --- | --- | --- | --- |

| 268.8 | V03AB16 | ethanol (koncentrace 10%) | parent. | 100.00 | ML | 19,97 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 268.9 | V03AB19 | fysostigmin | parent. | 1.00 | MG | 10,08 | K |

| | | | | | | | |

| 268.10 | V03AB24 | digitalisový antitoxin | parent. | 80.00 | MG | 31 983,75 | K |

| | | | | | | | |

| 268.11 | V03AB25 | flumazenil | parent. | 0.50 | MG | 737,35 | K |

| 16551 | ANEXATE | inj 5×5ml/0.5mg | RCE | CZ |

| --- | --- | --- | --- | --- |

| 269 | antidota používaná při otravě organofosfáty | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 269.1 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.50 | MG | 8.11 | |

| 00394 | ATROPIN BIOTIKA 1MG | inj 10x1ml/1mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 269.2 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.50 | MG | 15.15 | |

| 269.1 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.50 | MG | 7,93 | |

| 00394 | ATROPIN BIOTIKA 1MG | inj 10×1ml/1mg | HBS | SK |

| --- | --- | --- | --- | --- |

| 269.2 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.50 | MG | 14,81 | |

| | | | | | | | |

| 270 | antidota používaná při otravě některými těžkými kovy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 270.1 | V03AC01 | deferoxamin | parent. | 1.00 | GM | 386.74 | K |

| 01445 | DESFERAL | inj plv sol 10x500mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 16470 | DESFERAL | inj plv sol 10x500mg | NAI | CZ |

| 270.2 | V03AC02 | deferipron | p.o. | 5.25 | GM | 473.76 | P |

| 270.1 | V03AC01 | deferoxamin | parent. | 1.00 | GM | 377,96 | K |

| 01445 | DESFERAL | inj plv sol 10×500mg | NPA | CH |

| --- | --- | --- | --- | --- |

| 16470 | DESFERAL | inj plv sol 10×500mg | NAI | CZ |

| 270.2 | V03AC02 | deferipron | p.o. | 5.25 | GM | 463,01 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Léčivý přípravek je předepisován u nemocných s laboratorně dokumentovaným přetížením železem při prokázané alergii či intoleranci desferioxaminu nebo u nemocných, u nichž nelze zajistit parenterálním podáváním dostatečnou terapeutickou dávkou chelátoru.

@@ -10115,117 +10164,118 @@

| 272 | antidota používaná při léčbě cytostatiky perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 272.1 | V03AF01 | mesna | p.o. | 1.20 | GM | 290.85 | B/ONK,HEM |

| | | | | | | | |

| 272.2 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60.00 | MG | 111.91 | |

| 96963 | CALCIUMFOLINAT EBEWE 15MG | por cps dur 20x15mg | EBP | A |

| --- | --- | --- | --- | --- |

| 272.3 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60.00 | MG | 115.42 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 96964 | CALCIUMFOLINAT EBEWE 100MG | por cps dur 20x100mg | EBP | A |

| 272.1 | V03AF01 | mesna | p.o. | 1.20 | GM | 284,25 | B/ONK,HEM |

| | | | | | | | |

| 272.2 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60.00 | MG | 109,37 | |

| 96963 | CALCIUMFOLINAT EBEWE 15MG | por cps dur 20×15mg | EBP | A |

| --- | --- | --- | --- | --- |

| 272.3 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60.00 | MG | 112,80 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 96964 | CALCIUMFOLINAT EBEWE 100MG | por cps dur20×100mg | EBP | A |

| --- | --- | --- | --- | --- |

| 273 | antidota používaná při léčbě cytostatiky ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 273.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.20 | GM | 29.72 | B/ONK,HEM |

| | | | | | | | |

| 273.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.40 | GM | 48.39 | B/ONK,HEM |

| 05954 | UROMITEXAN 400MG | inj sol 15x4ml/400mg | BXH | D |

| --- | --- | --- | --- | --- |

| 273.3 | V03AF02 | dexrazoxan | parent. | 0.50 | GM | 4 329.50 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 96542 | CARDIOXANE | inj sic 1x500mg | CNC | NL |

| --- | --- | --- | --- | --- |

| 273.4 | V03AF03 | kalcium folinát | parent. | 60.00 | MG | 234.23 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11184 | LEUCOVORIN-TEVA | inj 1x5ml/50mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 11185 | LEUCOVORIN-TEVA | inj 1x10ml/100mg | PHM | NL |

| 11186 | LEUCOVORIN-TEVA | inj 5x10ml/100mg | PHM | NL |

| 11187 | LEUCOVORIN-TEVA | inj 1x20ml/200mg | PHM | NL |

| 273.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.20 | GM | 29,05 | B/ONK,HEM |

| | | | | | | | |

| 273.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.40 | GM | 47,29 | B/ONK,HEM |

| 05954 | UROMITEXAN 400MG | inj sol 15×4ml/400mg | BXH | D |

| --- | --- | --- | --- | --- |

| 273.3 | V03AF02 | dexrazoxan | parent. | 0.50 | GM | 4 231,22 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 96542 | CARDIOXANE | inj sic 1×500mg | CNC | NL |

| --- | --- | --- | --- | --- |

| 273.4 | V03AF03 | kalcium folinát | parent. | 60.00 | MG | 228,91 | B/ONK,HEM |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 11184 | LEUCOVORIN-TEVA | inj 1×5ml/50mg | PHM | NL |

| --- | --- | --- | --- | --- |

| 11185 | LEUCOVORIN-TEVA | inj 1×10ml/100mg | PHM | NL |

| 11186 | LEUCOVORIN-TEVA | inj 5×10ml/100mg | PHM | NL |

| 11187 | LEUCOVORIN-TEVA | inj 1×20ml/200mg | PHM | NL |

| 11188 | LEUCOVORIN-TEVA | inj 1×30ml/300mg | PHM | NL |

| 11189 | LEUCOVORIN-TEVA | inj 1x35ml/350mg | PHM | NL |

| 11190 | LEUCOVORIN-TEVA | inj 1x50ml/500mg | PHM | NL |

| 12441 | LEUCOVORIN CA LACHEMA 20 | inj sol 10x2ml/20mg | PVL | CZ |

| 12442 | LEUCOVORIN CA LACHEMA 50 | inj sol 5x5ml/50mg | PVL | CZ |

| 58033 | CALCIUMFOLINAT EBEWE 100MG | inj sol 1x10ml/100mg | EBP | A |

| 91561 | LEUCOVORIN CA LACHEMA 25 | inj plv sol 10x25mg | PVL | CZ |

| 96966 | CALCIUMFOLINAT EBEWE 30MG | inj sol 5x3ml/30mg | EBP | A |

| 273.5 | V03AF05 | amifostin | parent. | 1.70 | GM | 19 500.00 | X |

| | | | | | | | |

| 273.6 | V03AF06 | natrium folinát | parent. | 60.00 | MG | 234.23 | B/ONK, HEM |

| | | | | | | | |

| 273.7 | V03AF07 | rasburikaza | parent. | 1.00 | DF | 2 500.00 | H |

| 11189 | LEUCOVORIN-TEVA | inj 1×35ml/350mg | PHM | NL |

| 11190 | LEUCOVORIN-TEVA | inj 1×50ml/500mg | PHM | NL |

| 12441 | LEUCOVORIN CA LACHEMA 20 | inj sol 10×2ml/20mg | PVL | CZ |

| 12442 | LEUCOVORIN CA LACHEMA 50 | inj sol 5×5ml/50mg | PVL | CZ |

| 58033 | CALCIUMFOLINAT EBEWE 100MG | inj sol 1×10ml/100mg | EBP | A |

| 91561 | LEUCOVORIN CA LACHEMA 25 | inj plv sol 10×25mg | PVL | CZ |

| 96966 | CALCIUMFOLINAT EBEWE 30MG | inj sol 5×3ml/30mg | EBP | A |

| 273.5 | V03AF05 | amifostin | parent. | 1.70 | GM | 19 057,35 | X |

| | | | | | | | |

| 273.6 | V03AF06 | natrium folinát | parent. | 60.00 | MG | 228,91 | B/ONK, HEM |

| | | | | | | | |

| 273.7 | V03AF07 | rasburikaza | parent. | 1.00 | DF | 2 443,25 | H |

| | | | | | | | |

| 274 | testy sekrece hormonů hypofýzy, diagnostiky funkce ledvin a funkce štítné žlázy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 274.1 | V04CD01 | metyrapon | p.o. | 3.00 | GM | 386.77 | K/END |

| | | | | | | | |

| 274.2 | V04CJ02 | protirelin | parent. | 0.20 | MG | 215.75 | O |

| | | | | | | | |

| 274.3 | V04CH01 | inulin | parent. | 5.00 | GM | 489.33 | O |

| 274.1 | V04CD01 | metyrapon | p.o. | 3.00 | GM | 377,99 | K/END |

| | | | | | | | |

| 274.2 | V04CJ02 | protirelin | parent. | 0.20 | MG | 210,85 | O |

| | | | | | | | |

| 274.3 | V04CH01 | inulin | parent. | 5.00 | GM | 478,22 | O |

| | | | | | | | |

| 275 | tuberkulinový test | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 275.1 | V04CF01 | tuberkulin | parent. | 0.60 | RG | 277.44 | H |

| 68918 | TUBERCULIN PPD RT 23 SSI | inj 10x1.5ml/0.6rg | SST | DK |

| --- | --- | --- | --- | --- |

| 68919 | TUBERCULIN PPD RT 23 SSI | inj 1x5ml/2rg | SST | DK |

| 68920 | TUBERCULIN PPD RT 23 SSI | inj 10x5ml/2rg | SST | DK |

| 275.1 | V04CF01 | tuberkulin | parent. | 0.60 | RG | 271,14 | H |

| 68918 | TUBERCULIN PPD RT 23 SSI | inj 10×1.5ml/0.6rg | SST | DK |

| --- | --- | --- | --- | --- |

| 68919 | TUBERCULIN PPD RT 23 SSI | inj 1×5ml/2rg | SST | DK |

| 68920 | TUBERCULIN PPD RT 23 SSI | inj 10×5ml/2rg | SST | DK |

| 276 | testy pro alergické choroby | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 276.1 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | intrader. | 1.00 | BA | 134.61 | O/ALG |

| 47427 | D-AL POLLENS | inj sol 1x5ml-jsk | SVF | CZ |

| --- | --- | --- | --- | --- |

| 47428 | D-AL POLLENS | inj sol 1x5ml-pnu | SVF | CZ |

| 47429 | D-AL POLLENS | inj sol 1x5ml-pnu | SVF | CZ |

| 47430 | D-AL INSECTS | inj sol 1x5ml-pnu | SVF | CZ |

| 47431 | D-AL FOODS | inj sol 1x5ml-pnu | SVF | CZ |

| 47432 | D-AL DUSTS | inj sol 1x5ml-pnu | SVF | CZ |

| 47433 | D-AL(MIT,MYCO,DMX,BACTO) | inj sol 1x5ml-pnu | SVF | CZ |

| 47434 | D-AL DUSTS | inj sol 1x5ml-pnu | SVF | CZ |

| 54551 | D-AL POLLENS | inj sol 1x5ml-jsk | SVF | CZ |

| 276.2 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | PRICK test | 1.00 | BA | 522.52 | O/ALG |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 47485 | ALYOSTAL PRICK | sol 1x3ml-ic 100/ml | SLG | F |

| --- | --- | --- | --- | --- |

| 53626 | ALYOSTAL PRICK | sol 1x3ml-ir 100/ml | SLG | F |

| 70500 | SOLUPRICK SQ | sol 1x3ml | AAS | DK |

| 84226 | SOLUPRICK SQ | sol 1x1ml/10rg | AAS | DK |

| 84227 | SOLUPRICK SQ | sol 1x1ml/100rg | AAS | DK |

| 84228 | SOLUPRICK SQ | sol 1x1ml/300rg | AAS | DK |

| 84296 | D-AL PRICK TEST | sol 1x3ml-jsk | SVF | CZ |

| 84304 | D-AL PRICK TEST | sol 1x3ml-pnu | SVF | CZ |

| 276.3 | V04CL | testy pro alergické choroby (diagnostické alergeny, kontrola) | PRICK test | 1.00 | BA | 363.86 | O/ALG |

| | | | | | | | |

| 276.4 | V04CL | testy pro alergické choroby (diagnostické alergeny, souprava) | intrader. | 1.00 | BA | 495.05 | O/ALG |

| 276.1 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | intrader. | 1.00 | BA | 131,55 | O/ALG |

| 47427 | D-AL POLLENS | inj sol 1×5ml-jsk | SVF | CZ |

| --- | --- | --- | --- | --- |

| 47428 | D-AL POLLENS | inj sol 1×5ml-pnu | SVF | CZ |

| 47429 | D-AL POLLENS | inj sol 1×5ml-pnu | SVF | CZ |

| 47430 | D-AL INSECTS | inj sol 1×5ml-pnu | SVF | CZ |

| 47431 | D-AL FOODS | inj sol 1×5ml-pnu | SVF | CZ |

| 47432 | D-AL DUSTS | inj sol 1×5ml-pnu | SVF | CZ |

| 47433 | D-AL(MIT,MYCO,DMX,BACTO) | inj sol 1×5ml-pnu | SVF | CZ |

| 47434 | D-AL DUSTS | inj sol 1×5ml-pnu | SVF | CZ |

| 54551 | D-AL POLLENS | inj sol 1×5ml-jsk | SVF | CZ |

| 276.2 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | PRICK test | 1.00 | BA | 510,66 | O/ALG |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 47485 | ALYOSTAL PRICK | sol 1×3ml-ic 100/ml | SLG | F |

| --- | --- | --- | --- | --- |

| 53626 | ALYOSTAL PRICK | sol 1×3ml-ir 100/ml | SLG | F |

| 70500 | SOLUPRICK SQ | sol 1×3ml | AAS | DK |

| 84226 | SOLUPRICK SQ | sol 1×1ml/10rg | AAS | DK |

| 84227 | SOLUPRICK SQ | sol 1×1ml/100rg | AAS | DK |

| 84228 | SOLUPRICK SQ | sol 1×1ml/300rg | AAS | DK |

| 84296 | D-AL PRICK TEST | sol 1×3ml-jsk | SVF | CZ |

| 84304 | D-AL PRICK TEST | sol 1×3ml-pnu | SVF | CZ |

| 276.3 | V04CL | testy pro alergické choroby (diagnostické alergeny, kontrola) | PRICK test | 1.00 | BA | 355,60 | O/ALG |

| | | | | | | | |

| 276.4 | V04CL | testy pro alergické choroby (diagnostické alergeny, souprava) | intrader. | 1.00 | BA | 483,81 | O/ALG |

| | | | | | | | |

| 277 | ostatní léčiva k diagnostickým a terapeutickým účelům perorální podání | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 277.1 | V03AE02 | sevelamer do 403 mg v jedné tabletě včetně | p.o. | 400.00 | MG | 20.70 | P |

| | | | | | | | |

| 277.2 | V03AE02 | sevelamer nad 403 mg v jedné tabletě | p.o. | 400.00 | MG | 18.60 | P |

| | | | | | | | |

| 277.3 | V03AE03 | lanthankarbonát | p.o. | 2.25 | GM | 267.10 | P |

| 277.1 | V03AE02 | sevelamer do 403 mg v jedné tabletě včetně | p.o. | 400.00 | MG | 20,23 | P |

| | | | | | | | |

| 277.2 | V03AE02 | sevelamer nad 403 mg v jedné tabletě | p.o. | 400.00 | MG | 18,18 | P |

| | | | | | | | |

| 277.3 | V03AE03 | lanthankarbonát | p.o. | 2.25 | GM | 261,04 | P |

Léčbu sevelamerem a lanthankarbonátem předepisuje nefrolog se zkušenostmi s diagnostikou a léčbou komplikací renální osteopatie na pracovištích, kde jsou k dispozici všechny potřebné diagnostické metody a vazba na chirurgické pracoviště provádějící parathyreoidektomie, a to pouze pacientům, kteří splňují alespoň jedno z následujících kriterií:

@@ -10241,235 +10291,235 @@

Kontroly účinnosti podávání sevelameru jsou prováděny nejméně jednou za 3 měsíce léčby. Podávání je ukončeno pokud je při kontrole zjištěna hyperfosfatemie vyšší než 2,5mmol/l.

| 277.4 | V04CX | jiná diagnostika (přípravky uvolňující C02) | p.o. | 1.00 | DF | 20.91 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 277.5 | V04CX | urea | p.o. | 1.00 | DF | 1 510.74 | H |

| 54292 | HELICOBACTER TEST INFAI | por plv sol 1x75mg | IFI | D |

| 277.4 | V04CX | jiná diagnostika (přípravky uvolňující C02) | p.o. | 1.00 | DF | 20,44 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 277.5 | V04CX | urea | p.o. | 1.00 | DF | 1 476,45 | H |

| 54292 | HELICOBACTER TEST INFAI | por plv sol 1×75mg | IFI | D |

| --- | --- | --- | --- | --- |

| 278 | ostatní léčiva k diagnostickým a terapeutickým účelům ostatní cesty aplikace | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 278.1 | V03AK | tkáňová lepidla | lok. | 1.00 | ML | 2 866.09 | X |

| 90502 | TISSUCOL KIT | glu 0.5ml(3x+2xsol) | BXG | A |

| --- | --- | --- | --- | --- |

| 90503 | TISSUCOL KIT | glu 1ml(3x+2xsolv.) | BXG | A |

| 90504 | TISSUCOL KIT | glu 2ml(3x+2xsolv.) | BXG | A |

| 90505 | TISSUCOL KIT | glu 5ml(3x+2xsolv.) | BXG | A |

| 278.2 | V03AK | tkáňová lepidla | lok. | 1.00 | C2 | 177.24 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 278.3 | V03AX | antistafylokokový fág. lyzát | lok. | 20.00 | ML | 321.60 | |

| | | | | | | | |

| 278.4 | V04CE01 | galaktóza | parent. | 1.00 | DF | 903.92 | O |

| | | | | | | | |

| 278.5 | V04CG03 | histamin | parent. | 10.00 | MG | 10.07 | O |

| | | | | | | | |

| 278.6 | V04CG30 | kofein a benzoát sodný | parent. | 0.10 | GM | 5.47 | O |

| | | | | | | | |

| 278.7 | V04CJ01 | thyreotropin | parent. | 1.80 | MG | 24895.00 | X |

| | | | | | | | |

| 278.8 | V04CK01 | sekretin | parent. | 29.00 | RG | 919.90 | O |

| | | | | | | | |

| 278.9 | V04CM01 | gonadorelin (do 25 RG v jedné ampuli včetně) | parent. | 0.10 | MG | 225.63 | O |

| | | | | | | | |

| 278.10 | V04CM01 | gonadorelin (nad 25 RG v jedné ampuli) | parent. | 0.10 | MG | 680.30 | O |

| | | | | | | | |

| 278.11 | V04CX | jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1.00 | ML | 114.51 | O |

| | | | | | | | |

| 278.12 | V04CX | jiná diagnostika (fluorescein, 10% koncentrace) | parent. | 1.00 | ML | 34.56 | O |

| 18960 | FLUORESCITE | inj sol 12x5ml 10% | SNU | B |

| --- | --- | --- | --- | --- |

| 278.13 | V04CX | jiná diagnostika (fluorescein, 25% koncentrace) | parent. | 1.00 | ML | 126.50 | O |

| | | | | | | | |

| 278.14 | V04CX | jiná diagnostika (sulfanum ceruleum) | subkut. | 50.00 | MG | 251.00 | O |

| 278.1 | V03AK | tkáňová lepidla | lok. | 1.00 | ML | 2 801,03 | X |

| 90502 | TISSUCOL KIT | glu 0.5ml(3×+2×sol) | BXG | A |

| --- | --- | --- | --- | --- |

| 90503 | TISSUCOL KIT | glu 1ml(3×+2×solv.) | BXG | A |

| 90504 | TISSUCOL KIT | glu 2ml(3×+2×solv.) | BXG | A |

| 90505 | TISSUCOL KIT | glu 5ml(3×+2×solv.) | BXG | A |

| 278.2 | V03AK | tkáňová lepidla | lok. | 1.00 | C2 | 173,22 | X |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 278.3 | V03AX | antistafylokokový fág. lyzát | lok. | 20.00 | ML | 314,30 | |

| | | | | | | | |

| 278.4 | V04CE01 | galaktóza | parent. | 1.00 | DF | 883,40 | O |

| | | | | | | | |

| 278.5 | V04CG03 | histamin | parent. | 10.00 | MG | 9,84 | O |

| | | | | | | | |

| 278.6 | V04CG30 | kofein a benzoát sodný | parent. | 0.10 | GM | 5,35 | O |

| | | | | | | | |

| 278.7 | V04CJ01 | thyreotropin | parent. | 1.80 | MG | 24 895,00 | X |

| | | | | | | | |

| 278.8 | V04CK01 | sekretin | parent. | 29.00 | RG | 899,02 | O |

| | | | | | | | |

| 278.9 | V04CM01 | gonadorelin (do 25 RG v jedné ampuli včetně) | parent. | 0.10 | MG | 220,51 | O |

| | | | | | | | |

| 278.10 | V04CM01 | gonadorelin (nad 25 RG v jedné ampuli) | parent. | 0.10 | MG | 664,86 | O |

| | | | | | | | |

| 278.11 | V04CX | jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1.00 | ML | 111,91 | O |

| | | | | | | | |

| 278.12 | V04CX | jiná diagnostika (fluorescein, 10% koncentrace) | parent. | 1.00 | ML | 33,78 | O |

| 18960 | FLUORESCITE | inj sol 12×5ml 10% | SNU | B |

| --- | --- | --- | --- | --- |

| 278.13 | V04CX | jiná diagnostika (fluorescein, 25% koncentrace) | parent. | 1.00 | ML | 123,63 | O |

| | | | | | | | |

| 278.14 | V04CX | jiná diagnostika (sulfanum ceruleum) | subkut. | 50.00 | MG | 245,30 | O |

| | | | | | | | |

| 279 | výživa bez fenylalaninu a ostatních aminokyselin, kombinace aminokyseliny/sacharidy/minerály/vitamíny | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 279.1 | V06CA | výživa bez fenylalaninu (bílkovinný hydrolyzát) | p.o. | 1.00 | GM | 5.14 | L/J4 |

| | | | | | | | |

| 279.2 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin) | p.o. | 1.00 | GM | 11.45 | L/J4 |

| 54508 | P-AM UNIVERSAL | plv 6x500gm | SHS | GB |

| --- | --- | --- | --- | --- |

| 279.3 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro děti mladší 12 měsíců) | p.o. | 1.00 | GM | 20.86 | L/J4 |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 279.4 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro těhotné) | p.o. | 1.00 | GM | 12.17 | L/J4 |

| | | | | | | | |

| 279.5 | V06CA | výživa bez fenylalaninu (suplementovaný bílkovinný hydrolyzát) | p.o. | 1.00 | GM | 5.33 | L/J4 |

| | | | | | | | |

| 279.6 | V06XX | výživa bez fenylalaninu - definované směsi aminokyselin (práškové formy na obsah aminokyselin) | p.o. | 1.00 | GM | 12.93 | L/J4 |

| 33002 | XPHE JUNIOR SE | por plv sus 1x500gm | MTX | D |

| --- | --- | --- | --- | --- |

| 33004 | XPHE KID SE | por plv sus 1x500gm | MTX | D |

| 33006 | MILUPA PKU 2 | por plv sol 1x500gm | MLP | D |

| 33010 | MILUPA PKU 3 | por plv sol 1x500gm | MLP | D |

| 33264 | HUMANA PHELICS 2 | por plv sol 1x400gm | HUG | D |

| 33265 | HUMANA PHELICS 3 | por plv sol 1x400gm | HUG | D |

| 33266 | HUMANA PHELICS 4 | por plv sol 1x400gm | HUG | D |

| 33267 | HUMANA PHELICS 5 | por plv sol 1x400gm | HUG | D |

| 279.7 | V06XX | výživa bez fenylalaninu - definované směsi aminokyselin pro děti mladší 12 měsíců (práškové formy na obsah aminokyselin) | p.o. | 1.00 | GM | 20.86 | P |

| 279.1 | V06CA | výživa bez fenylalaninu (bílkovinný hydrolyzát) | p.o. | 1.00 | GM | 5,02 | L/J4 |

| | | | | | | | |

| 279.2 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin) | p.o. | 1.00 | GM | 11,19 | L/J4 |

| 54508 | P-AM UNIVERSAL | plv 6×500gm | SHS | GB |

| --- | --- | --- | --- | --- |

| 279.3 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro děti mladší 12 měsíců) | p.o. | 1.00 | GM | 20,39 | L/J4 |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 279.4 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro těhotné) | p.o. | 1.00 | GM | 11,89 | L/J4 |

| | | | | | | | |

| 279.5 | V06CA | výživa bez fenylalaninu (suplementovaný bílkovinný hydrolyzát) | p.o. | 1.00 | GM | 5,21 | L/J4 |

| | | | | | | | |

| 279.6 | V06XX | výživa bez fenylalaninu - definované směsi aminokyselin (práškové formy na obsah aminokyselin) | p.o. | 1.00 | GM | 12,64 | L/J4 |

| 33002 | XPHE JUNIOR SE | por plv sus 1×500gm | MTX | D |

| --- | --- | --- | --- | --- |

| 33004 | XPHE KID SE | por plv sus 1×500gm | MTX | D |

| 33006 | MILUPA PKU 2 | por plv sol 1×500gm | MLP | D |

| 33010 | MILUPA PKU 3 | por plv sol 1×500gm | MLP | D |

| 33264 | HUMANA PHELICS 2 | por plv sol 1×400gm | HUG | D |

| 33265 | HUMANA PHELICS 3 | por plv sol 1×400gm | HUG | D |

| 33266 | HUMANA PHELICS 4 | por plv sol 1×400gm | HUG | D |

| 33267 | HUMANA PHELICS 5 | por plv sol 1×400gm | HUG | D |

| 279.7 | V06XX | výživa bez fenylalaninu - definované směsi aminokyselin pro děti mladší 12 měsíců (práškové formy na obsah aminokyselin) | p.o. | 1.00 | GM | 20,39 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Přípravky, které jsou předepisovány na specializovaném pracovišti pro léčbu dědičných poruch metabolismu, jsou u nestabilních pacientů indikovány do 18 měsíců věku.

| 33013 | P-AM 1 | por plv sol 1x500gm | SHS | GB |

| --- | --- | --- | --- | --- |

| 33263 | HUMANA PHELICS 1 | por plv sol 1x400gm | HUG | D |

| 279.8 | V06XX | výživa bez fenylalaninu - definované směsi aminokyselin pro těhotné (práškové formy na obsah aminokyselin) | p.o. | 1.00 | GM | 12.17 | L/J4 |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 279.9 | V06XX | výživa bez fenylalaninu - definované směsi aminokyselin (dávkované formy na obsah aminokyselin) | p.o. | 1.00 | GM | 13.39 | L/J4 |

| | | | | | | | |

| 279.10 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - cyklus močoviny (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 14.11 | L/J4 |

| | | | | | | | |

| 279.11 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - cyklus močoviny (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 15.89 | L/J4 |

| | | | | | | | |

| 279.12 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin aminokyseliny s rozvětvenými řetězci (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 12.38 | L/J4 |

| | | | | | | | |

| 279.13 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin aminokyseliny s rozvětvenými řetězci (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 13.96 | L/J4 |

| | | | | | | | |

| 279.14 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin metylmalonová a propionová acidémie (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 12.38 | L/J4 |

| | | | | | | | |

| 279.15 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin metylmalonová a propionová acidémie (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 13.96 | L/J4 |

| | | | | | | | |

| 279.16 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - leucin (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 13.99 | L/J4 |

| | | | | | | | |

| 279.17 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - leucin (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 14.82 | L/J4 |

| | | | | | | | |

| 279.18 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - glutarová acidémie (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 13.90 | L/J4 |

| | | | | | | | |

| 279.19 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - glutarová acidémie (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 15.93 | L/J4 |

| | | | | | | | |

| 279.20 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin homocystinurie (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 12.38 | L/J4 |

| | | | | | | | |

| 279.21 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin homocystinurie (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 13.96 | L/J4 |

| | | | | | | | |

| 279.22 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - lysin (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 13.12 | L/J4 |

| | | | | | | | |

| 279.23 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - lysin (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 14.82 | L/J4 |

| | | | | | | | |

| 279.24 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin- tyrosin (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 12.73 | L/J4 |

| | | | | | | | |

| 279.25 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - tyrosin (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 14.38 | L/J4 |

| 33188 | MILUPA TYR 2 | por plv sol 1x500gm | MLP | D |

| --- | --- | --- | --- | --- |

| 279.26 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - neketotická hyperglycinémie, na obsah aminokyselin | p.o. | 1.00 | GM | 40.59 | L/J4 |

| 33013 | P-AM 1 | por plv sol 1×500gm | SHS | GB |

| --- | --- | --- | --- | --- |

| 33263 | HUMANA PHELICS 1 | por plv sol 1×400gm | HUG | D |

| 279.8 | V06XX | výživa bez fenylalaninu - definované směsi aminokyselin pro těhotné (práškové formy na obsah aminokyselin) | p.o. | 1.00 | GM | 11,89 | L/J4 |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 279.9 | V06XX | výživa bez fenylalaninu - definované směsi aminokyselin (dávkované formy na obsah aminokyselin) | p.o. | 1.00 | GM | 13,09 | L/J4 |

| | | | | | | | |

| 279.10 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - cyklus močoviny (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 13,79 | L/J4 |

| | | | | | | | |

| 279.11 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - cyklus močoviny (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 15,53 | L/J4 |

| | | | | | | | |

| 279.12 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin aminokyseliny s rozvětvenými řetězci (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 12,10 | L/J4 |

| | | | | | | | |

| 279.13 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin aminokyseliny s rozvětvenými řetězci (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 13,64 | L/J4 |

| | | | | | | | |

| 279.14 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin metylmalonová a propionová acidémie (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 12,10 | L/J4 |

| | | | | | | | |

| 279.15 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin metylmalonová a propionová acidémie (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 13,64 | L/J4 |

| | | | | | | | |

| 279.16 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - leucin (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 13,67 | L/J4 |

| | | | | | | | |

| 279.17 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - leucin (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 14,48 | L/J4 |

| | | | | | | | |

| 279.18 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - glutarová acidémie (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 13,58 | L/J4 |

| | | | | | | | |

| 279.19 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - glutarová acidémie (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 15,57 | L/J4 |

| | | | | | | | |

| 279.20 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin homocystinurie (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 12,10 | L/J4 |

| | | | | | | | |

| 279.21 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin homocystinurie (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 13,64 | L/J4 |

| | | | | | | | |

| 279.22 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - lysin (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 12,82 | L/J4 |

| | | | | | | | |

| 279.23 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - lysin (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 14,48 | L/J4 |

| | | | | | | | |

| 279.24 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin- tyrosin (věk do 1 roku, na obsah aminokyselin) | p.o. | 1.00 | GM | 12,44 | L/J4 |

| | | | | | | | |

| 279.25 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - tyrosin (věk nad 1 rok, na obsah aminokyselin) | p.o. | 1.00 | GM | 14,05 | L/J4 |

| 33188 | MILUPA TYR 2 | por plv sol 1×500gm | MLP | D |

| --- | --- | --- | --- | --- |

| 279.26 | V06XX | výživa pro jiné dědičné poruchy metabolismu aminokyselin - neketotická hyperglycinémie, na obsah aminokyselin | p.o. | 1.00 | GM | 39,67 | L/J4 |

| | | | | | | | |

| 280 | kombinace sacharidy/proteiny/minerály/vitamíny, příp. tuk a jiné kombinace pro výživu | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 280.1 | A11JA | kombinace vitamínů | parent. | 10.00 | ML | 116.07 | H |

| 42594 | VITALIPID N INFANT | inf cnc sol 10x10ml | FKA | S |

| --- | --- | --- | --- | --- |

| 280.2 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 80.00 | GM | 87.40 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 280.3 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500.00 | ML | 74.25 | Z |

| | | | | | | | |

| 280.4 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 100.00 | GM | 44.87 | Z |

| | | | | | | | |

| 280.5 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500.00 | ML | 79.38 | Z |

| | | | | | | | |

| 280.6 | V06DC | kombinace sacharidů | p.o. | 100.00 | GM | 21.47 | Z |

| | | | | | | | |

| 280.7 | V06DX | kombinace s vysokým obsahem mléčné bílkoviny a kalcia | p.o. | 100.00 | GM | 21.47 | Z |

| | | | | | | | |

| 280.8 | V06DX | MCT olej | p.o. | 100.00 | ML | 204.52 | L/J4 |

| | | | | | | | |

| 280.9 | V06XX | enterální výživa - polymerní výživa bez tuku, zvláštní použití (práškové formy) | p.o. | 100.00 | GM | 109.25 | Z |

| | | | | | | | |

| 280.10 | V06XX | enterální výživa - polymerní výživa bez tuku, zvláštní použití (tekuté formy) | p.o. | 500.00 | ML | 74.25 | Z |

| | | | | | | | |

| 280.11 | V06XX | enterální výživa - polymerní výživa, standartní (práškové formy) | p.o. | 100.00 | GM | 44.87 | Z |

| | | | | | | | |

| 280.12 | V06XX | enterální výživa - polymerní výživa, standartní (tekuté formy) | p.o. | 500.00 | ML | 79.38 | Z |

| | | | | | | | |

| 280.13 | V06XX | enterální výživa - polymerní výživa, zvláštní použití (práškové formy) | p.o. | 100.00 | GM | 44.87 | Z |

| | | | | | | | |

| 280.14 | V06XX | enterální výživa - polymerní výživa, zvláštní použití (tekuté formy) | p.o. | 500.00 | ML | 79.38 | Z |

| | | | | | | | |

| 280.15 | V06XX | enterální výživa - polymerní výživa, (ketogenní dieta) | p.o. | 100.00 | GM | 393.33 | Z |

| | | | | | | | |

| 280.16 | V06XX | enterální výživa - oligopeptidy, standartní (práškové formy) | p.o. | 100.00 | GM | 44.87 | Z |

| | | | | | | | |

| 280.17 | V06XX | enterální výživa - oligopeptidy, standartní (tekuté formy) | p.o. | 500.00 | ML | 153.75 | Z |

| | | | | | | | |

| 280.18 | V06XX | enterální výživa - oligopeptidy, zvláštní použití (práškové formy) | p.o. | 100.00 | GM | 44.87 | Z |

| | | | | | | | |

| 280.19 | V06XX | enterální výživa - oligopeptidy, zvláštní použití (tekuté formy) | p.o. | 500.00 | ML | 79.38 | Z |

| | | | | | | | |

| 280.20 | V06XX | enterální výživa - modulární výživa, zvláštní použití - kombinace sacharidů (práškové formy) | p.o. | 100.00 | GM | 21.47 | Z |

| | | | | | | | |

| 280.21 | V06XX | enterální výživa - modulární výživa, zvláštní použití - kombinace sacharidů (tekuté formy) | p.o. | 500.00 | ML | 79.38 | H |

| | | | | | | | |

| 280.22 | V06XX | enterální výživa - modulární výživa, zvláštní použití - kombinace hydrofilních polysacharidů (práškové formy) | p.o. | 100.00 | GM | 73.56 | Z |

| | | | | | | | |

| 280.23 | V06XX | enterální výživa - modulární výživa, zvláštní použití - kombinace s vysokým obsahem mléčné bílkoviny (práškové formy) | p.o. | 100.00 | GM | 21.47 | Z |

| | | | | | | | |

| 280.24 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - MCT olej | p.o. | 100.00 | ML | 191.19 | L/J4 |

| | | | | | | | |

| 280.25 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - GTO olej | p.o. | 100.00 | ML | 204.52 | L/J4 |

| | | | | | | | |

| 280.26 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - LORENZO olej | p.o. | 100.00 | ML | 1024.51 | L/J4 |

| | | | | | | | |

| 280.27 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolizmu živin - doplňky výživy pro poruchy metabolizmu sacharidů | p.o. | 100.00 | GM | 426.49 | L/J4 |

| | | | | | | | |

| 280.28 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - doplňky výživy pro poruchy metabolizmu tuků | p.o. | 100.00 | GM | 112.02 | L/J4 |

| 33172 | MILUPA BASIC-F | por plv sol 1x600gm | MLP | D |

| --- | --- | --- | --- | --- |

| 280.29 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - doplňky výživy pro poruchy metabolizmu bílkovin | p.o. | 100.00 | GM | 199.94 | L/J4 |

| | | | | | | | |

| 280.30 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - doplňky výživy pro poruchy metabolizmu cholesterolu | p.o. | 100.00 | GM | 555.55 | L/J4 |

| 280.1 | A11JA | kombinace vitamínů | parent. | 10.00 | ML | 113,44 | H |

| 42594 | VITALIPID N INFANT | inf cnc sol 10×10ml | FKA | S |

| --- | --- | --- | --- | --- |

| 280.2 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 80.00 | GM | 85,42 | Z |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 280.3 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500.00 | ML | 72,56 | Z |

| | | | | | | | |

| 280.4 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 100.00 | GM | 43,85 | Z |

| | | | | | | | |

| 280.5 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500.00 | ML | 77,58 | Z |

| | | | | | | | |

| 280.6 | V06DC | kombinace sacharidů | p.o. | 100.00 | GM | 20,98 | Z |

| | | | | | | | |

| 280.7 | V06DX | kombinace s vysokým obsahem mléčné bílkoviny a kalcia | p.o. | 100.00 | GM | 20,98 | Z |

| | | | | | | | |

| 280.8 | V06DX | MCT olej | p.o. | 100.00 | ML | 199,88 | L/J4 |

| | | | | | | | |

| 280.9 | V06XX | enterální výživa - polymerní výživa bez tuku, zvláštní použití (práškové formy) | p.o. | 100.00 | GM | 106,77 | Z |

| | | | | | | | |

| 280.10 | V06XX | enterální výživa - polymerní výživa bez tuku, zvláštní použití (tekuté formy) | p.o. | 500.00 | ML | 72,56 | Z |

| | | | | | | | |

| 280.11 | V06XX | enterální výživa - polymerní výživa, standartní (práškové formy) | p.o. | 100.00 | GM | 43,85 | Z |

| | | | | | | | |

| 280.12 | V06XX | enterální výživa - polymerní výživa, standartní (tekuté formy) | p.o. | 500.00 | ML | 77,58 | Z |

| | | | | | | | |

| 280.13 | V06XX | enterální výživa - polymerní výživa, zvláštní použití (práškové formy) | p.o. | 100.00 | GM | 43,85 | Z |

| | | | | | | | |

| 280.14 | V06XX | enterální výživa - polymerní výživa, zvláštní použití (tekuté formy) | p.o. | 500.00 | ML | 77,58 | Z |

| | | | | | | | |

| 280.15 | V06XX | enterální výživa - polymerní výživa, (ketogenní dieta) | p.o. | 100.00 | GM | 384,40 | Z |

| | | | | | | | |

| 280.16 | V06XX | enterální výživa - oligopeptidy, standartní (práškové formy) | p.o. | 100.00 | GM | 43,85 | Z |

| | | | | | | | |

| 280.17 | V06XX | enterální výživa - oligopeptidy, standartní (tekuté formy) | p.o. | 500.00 | ML | 150,26 | Z |

| | | | | | | | |

| 280.18 | V06XX | enterální výživa - oligopeptidy, zvláštní použití (práškové formy) | p.o. | 100.00 | GM | 43,85 | Z |

| | | | | | | | |

| 280.19 | V06XX | enterální výživa - oligopeptidy, zvláštní použití (tekuté formy) | p.o. | 500.00 | ML | 77,58 | Z |

| | | | | | | | |

| 280.20 | V06XX | enterální výživa - modulární výživa, zvláštní použití - kombinace sacharidů (práškové formy) | p.o. | 100.00 | GM | 20,98 | Z |

| | | | | | | | |

| 280.21 | V06XX | enterální výživa - modulární výživa, zvláštní použití - kombinace sacharidů (tekuté formy) | p.o. | 500.00 | ML | 77,58 | H |

| | | | | | | | |

| 280.22 | V06XX | enterální výživa - modulární výživa, zvláštní použití - kombinace hydrofilních polysacharidů (práškové formy) | p.o. | 100.00 | GM | 71,89 | Z |

| | | | | | | | |

| 280.23 | V06XX | enterální výživa - modulární výživa, zvláštní použití - kombinace s vysokým obsahem mléčné bílkoviny (práškové formy) | p.o. | 100.00 | GM | 20,98 | Z |

| | | | | | | | |

| 280.24 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - MCT olej | p.o. | 100.00 | ML | 186,85 | L/J4 |

| | | | | | | | |

| 280.25 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - GTO olej | p.o. | 100.00 | ML | 199,88 | L/J4 |

| | | | | | | | |

| 280.26 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - LORENZO olej | p.o. | 100.00 | ML | 1 001,25 | L/J4 |

| | | | | | | | |

| 280.27 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolizmu živin - doplňky výživy pro poruchy metabolizmu sacharidů | p.o. | 100.00 | GM | 416,81 | L/J4 |

| | | | | | | | |

| 280.28 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - doplňky výživy pro poruchy metabolizmu tuků | p.o. | 100.00 | GM | 109,48 | L/J4 |

| 33172 | MILUPA BASIC-F | por plv sol 1×600gm | MLP | D |

| --- | --- | --- | --- | --- |

| 280.29 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - doplňky výživy pro poruchy metabolizmu bílkovin | p.o. | 100.00 | GM | 195,40 | L/J4 |

| | | | | | | | |

| 280.30 | V06XX | speciální doplňky výživy pro dědičné poruchy metabolismu živin - doplňky výživy pro poruchy metabolizmu cholesterolu | p.o. | 100.00 | GM | 542,94 | L/J4 |

| | | | | | | | |

| 281 | aminokyseliny včetně kombinací s polypeptidy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 281.1 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | 5.00 | DF | 90.13 | L/J7 |

| 281.1 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | 5.00 | DF | 88,08 | L/J7 |

| 88115 | KETOSTERIL | tbl obd 100 | FRE | D |

| --- | --- | --- | --- | --- |

| 88116 | KETOSTERIL | tbl obd 300=3x100 | FRE | D |

| 88117 | KETOSTERIL | tbl obd 1500=15x100 | FRE | D |

| 281.2 | V06XX | arginin | p.o. | 1.00 | GM | 12.60 | L/J4 |

| | | | | | | | |

| 281.3 | V06XX | citrulin | p.o. | 1.00 | GM | 57.40 | L/J4 |

| | | | | | | | |

| 281.4 | V06XX | cystin | p.o. | 1.00 | GM | 35.33 | L/J4 |

| | | | | | | | |

| 281.5 | V06XX | glutamin | p.o. | 1.00 | GM | 18.00 | L/J4 |

| | | | | | | | |

| 281.6 | V06XX | isoleucin | p.o. | 1.00 | GM | 60.60 | L/J4 |

| | | | | | | | |

| 281.7 | V06XX | karnitin | p.o. | 1.00 | GM | 183.14 | L/J4 |

| | | | | | | | |

| 281.8 | V06XX | valin | p.o. | 1.00 | GM | 35.08 | L/J4 |

| 88116 | KETOSTERIL | tbl obd 300=3×100 | FRE | D |

| 88117 | KETOSTERIL | tbl obd 1500=15×100 | FRE | D |

| 281.2 | V06XX | arginin | p.o. | 1.00 | GM | 12,31 | L/J4 |

| | | | | | | | |

| 281.3 | V06XX | citrulin | p.o. | 1.00 | GM | 56,10 | L/J4 |

| | | | | | | | |

| 281.4 | V06XX | cystin | p.o. | 1.00 | GM | 34,53 | L/J4 |

| | | | | | | | |

| 281.5 | V06XX | glutamin | p.o. | 1.00 | GM | 17,59 | L/J4 |

| | | | | | | | |

| 281.6 | V06XX | isoleucin | p.o. | 1.00 | GM | 59,22 | L/J4 |

| | | | | | | | |

| 281.7 | V06XX | karnitin | p.o. | 1.00 | GM | 178,98 | L/J4 |

| | | | | | | | |

| 281.8 | V06XX | valin | p.o. | 1.00 | GM | 34,28 | L/J4 |

| | | | | | | | |

| 282 | náhrady mléka | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 282.1 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | 100.00 | GM | 10.25 | L/J4 |

| | | | | | | | |

| 282.2 | V06 | kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) | p.o. | 100.00 | GM | 345.00 | P |

| 282.1 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | 100.00 | GM | 10,02 | L/J4 |

| | | | | | | | |

| 282.2 | V06 | kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) | p.o. | 100.00 | GM | 337,17 | P |

Náhrady mléka, speciální kojenecká výživa s obsahem jednotlivých aminokyselin. Přípravky jsou předepisovány v případě neúspěchu terapie přípravky obsahujícími extenzivní hydrolyzáty bílkovin v následujících indikacích:

@@ -10485,50 +10535,50 @@

Ve výše uvedených případech předepisuje dětem nejvýše do 3 let věku lékař se specializací v oboru dětské lékařství, dětská gastroenterologie a hepatologie nebo alergologie a klinická imunologie. Po 6 měsících by měl být proveden pokus o reexpozici proteinovým hydrolyzátem.

| 282.3 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka s nízkým obsahem laktózy) | p.o. | 100.00 | GM | 2.25 | P |

| 282.3 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka s nízkým obsahem laktózy) | p.o. | 100.00 | GM | 2,20 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Terapie intolerance laktózy, předepisuje dětský lékař a praktický lékař pro děti a dorost.

| 282.4 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka) | p.o. | 100.00 | GM | 26.50 | P |

| 282.4 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka) | p.o. | 100.00 | GM | 25,90 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Přípravky ordinuje dětský lékař a neonatolog, dále předepisuje praktický lékař pro děti a dorost jako kompletní výživu kojenců nedonošených a kojenců s nízkou porodní hmotností od narození do dosažení hmotnosti 3500 g.

| 282.5 | V06DE | kombinace aminokyseliny/sacharidy/minerály/ vitamíny (mléčné proteinové hydrolyzáty s nízkým obsahem laktózy) | p.o. | 100.00 | GM | 24.45 | P |

| 282.5 | V06DE | kombinace aminokyseliny/sacharidy/minerály/ vitamíny (mléčné proteinové hydrolyzáty s nízkým obsahem laktózy) | p.o. | 100.00 | GM | 23,89 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Terapie alergie na bílkovinu kravského mléka, malabsorpce, předepisuje dětský lékař a praktický lékař pro děti a dorost.

| 282.6 | V06DE | kombinace aminokyseliny/sacharidy/minerály/ vitamíny (mléčné proteinové hydrolyzáty) | p.o. | 100.00 | GM | 21.66 | P |

| 282.6 | V06DE | kombinace aminokyseliny/sacharidy/minerály/ vitamíny (mléčné proteinové hydrolyzáty) | p.o. | 100.00 | GM | 21,17 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Terapie alergie na bílkovinu kravského mléka, předepisuje dětský lékař a praktický lékař pro děti a dorost.

| 282.7 | V06XX | náhrady mléka s obsahem bílkoviny kravského mléka | p.o. | 100.00 | GM | 26.50 | P |

| 282.7 | V06XX | náhrady mléka s obsahem bílkoviny kravského mléka | p.o. | 100.00 | GM | 25,90 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 33100 | NESTLÉ ALPREM | por plv sol 1x400gm | NNA | NL |

| --- | --- | --- | --- | --- |

| 282.8 | V06XX | náhrady mléka s mléčným proteinovým hydrolyzátem | p.o. | 100.00 | GM | 21.66 | P |

| 33100 | NESTLÉ ALPREM | por plv sol 1×400gm | NNA | NL |

| --- | --- | --- | --- | --- |

| 282.8 | V06XX | náhrady mléka s mléčným proteinovým hydrolyzátem | p.o. | 100.00 | GM | 21,17 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Terapie alergie na bílkovinu kravského mléka, malabsorpce, předepisuje dětský lékař a praktický lékař pro děti a dorost.

| 282.9 | V06XX | náhrady mléka s nízkým obsahem laktózy a bílkoviny kravského mléka | p.o. | 100.00 | GM | 2.25 | P |

| 282.9 | V06XX | náhrady mléka s nízkým obsahem laktózy a bílkoviny kravského mléka | p.o. | 100.00 | GM | 2,20 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Terapie intolerance laktózy, předepisuje dětský lékař a praktický lékař pro děti a dorost.

| 282.10 | V06XX | náhrady mléka s nízkým obsahem laktózy a mléčným proteinovým hydrolyzátem | p.o. | 100.00 | GM | 24.45 | P |

| 282.10 | V06XX | náhrady mléka s nízkým obsahem laktózy a mléčným proteinovým hydrolyzátem | p.o. | 100.00 | GM | 23,89 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

Terapie alergie na bílkovinu kravského mléka, malabsorpce, předepisuje dětský lékař a praktický lékař pro děti a dorost.

| 282.11 | V06XX | speciální kojenecká výživa s obsahem jednotlivých aminokyselin | p.o. | 100.00 | GM | 345.00 | P |

| 282.11 | V06XX | speciální kojenecká výživa s obsahem jednotlivých aminokyselin | p.o. | 100.00 | GM | 337,17 | P |

| --- | --- | --- | --- | --- | --- | --- | --- |

@@ -10545,328 +10595,328 @@

| 282.12 | V06XX | speciální kojenecká výživa s hydrolyzátem sojové bílkoviny a vepřového kolagenu | p.o. | 100.00 | GM | 140.00 | L/J4 |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 282.13 | V06XX | náhrady mléka s obsahem sojové bílkoviny | p.o. | 100.00 | GM | 47.21 | L/J4 |

| 33200 | NUTRILON 1 SOYA | por plv sol 1x400gm | NUT | NL |

| --- | --- | --- | --- | --- |

| 283 | Rozpouštědla a irigační roztoky a ostatní léčiva ze skupiny várií | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 283.1 | V07AB | voda pro injekci (do 2 ml v jedné ampuli včetně) | parent. | 1.00 | ML | 2.69 | |

| | | | | | | | |

| 283.2 | V07AB | voda pro injekci (nad 2 do 10 ml v jedné ampuli včetně) | parent. | 10.00 | ML | 3.32 | |

| 00387 | AQUA PRO INJECTIONE BIOTIKA | inj 10x10ml-amp.pl. | BTA | SK |

| --- | --- | --- | --- | --- |

| 00388 | AQUA PRO INJECTIONE BIOTIKA | inj 50x10ml-amp.pl. | BTA | SK |

| 55807 | AQUA PRO INJECTIONE BIOTIKA | inj 100x10ml-amp.pl. | BTA | SK |

| 283.3 | V07AB | voda pro injekci nad 10 ml v jedné ampuli nebo lahvi | parent. | 100.00 | ML | 13.98 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10559 | AQUA PRO INJECTIONE BRAUN | inj sol 10x250ml-pe | BMM | D |

| --- | --- | --- | --- | --- |

| 10560 | AQUA PRO INJECTIONE BRAUN | inj sol 10x500ml-pe | BMM | D |

| 10561 | AQUA PRO INJECTIONE BRAUN | injsol 10x1000ml-pe | BMM | D |

| 31424 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x250ml-skl | FKI | I |

| 31425 | STERILE WATER F.INJ.FRESENIUS | par Iqf 16x250ml-skl | FKI | I |

| 31426 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x500ml-skl | FKI | I |

| 31427 | STERILE WATER F.INJ.FRESENIUS | par Iqf 12x500ml-skl | FKI | I |

| 31428 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x1000ml-skl | FKI | I |

| 31429 | STERILE WATER F.INJ.FRESENIUS | par Iqf 6x1000ml-skl | FKI | I |

| 53363 | AQUA PRO INJECTIONE INFUSIA | sol 1x250ml(sklo) | IHO | CZ |

| 53364 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml(sklo) | IHO | CZ |

| 57773 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(vak) | BFH | E |

| 57775 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(vak) | BFH | E |

| 57776 | WATER FOR INJECTIONS BIEFFE | inf 1x1000ml(vak) | BFH | E |

| 69789 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x500ml | ARD | CZ |

| 70484 | WATER FOR INJECTIONS BIEFFE | inf 1x1000ml(vak) | BFF | I |

| 70528 | AQUA PRO INJECTIONE MEDICAMENTA | par Iqf 1x500ml | MVM | CZ |

| 80486 | AQUA PRO INJECTIONE MEDICAMENTA | par Iqf 1x250ml | MVM | CZ |

| 83943 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x500ml(vak) | INK | CZ |

| 85557 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(vak) | BFF | I |

| 85558 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(vak) | BFF | I |

| 89244 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x250ml | ARD | CZ |

| 91876 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml(plast) | IHO | CZ |

| 92782 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x1000ml(vak) | INK | CZ |

| 92783 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x2000ml(vak) | INK | CZ |

| 95564 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x500ml-pe | FKI | I |

| 95565 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x1000ml-pe | FKI | I |

| 95566 | STERILE WATER F.INJ.FRESENIUS | par Iqf 20x500ml-pe | FKI | I |

| 95567 | STERILE WATER F.INJ.FRESENIUS | par Iqf 12x1000ml-pe | FKI | I |

| 97058 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x5000ml(vak) | INK | CZ |

| 97726 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(sklo) | BFF | I |

| 97727 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(sklo) | BFF | I |

| 98539 | VODA NA INJEKCI VIAFLO | par Iqf 35x150ml | BFH | E |

| 99208 | VODA NA INJEKCI VIAFLO | par Iqf 30x250ml | BFH | E |

| 99814 | VODA NA INJEKCI VIAFLO | par Iqf 20x500ml | BFH | E |

| 99826 | VODA NA INJEKCI VIAFLO | par Iqf 10x1000ml | BFH | E |

| 282.12 | V06XX | speciální kojenecká výživa s hydrolyzátem sojové bílkoviny a vepřového kolagenu | p.o. | 100.00 | GM | 136,82 | L/J4 |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 282.13 | V06XX | náhrady mléka s obsahem sojové bílkoviny | p.o. | 100.00 | GM | 46,14 | L/J4 |

| 33200 | NUTRILON 1 SOYA | por plv sol 1×400gm | NUT | NL |

| --- | --- | --- | --- | --- |

| 283 | Rozpouštědla a irigační roztoky a ostatní léčiva ze skupiny varií | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 283.1 | V07AB | voda pro injekci (do 2 ml v jedné ampuli včetně) | parent. | 1.00 | ML | 2,63 | |

| | | | | | | | |

| 283.2 | V07AB | voda pro injekci (nad 2 do 10 ml v jedné ampuli včetně) | parent. | 10.00 | ML | 3,24 | |

| 00387 | AQUA PRO INJECTIONE BIOTIKA | inj 10×10ml-amp.pl. | BTA | SK |

| --- | --- | --- | --- | --- |

| 00388 | AQUA PRO INJECTIONE BIOTIKA | inj 50×10ml-amp.pl. | BTA | SK |

| 55807 | AQUA PRO INJECTIONE BIOTIKA | inj 100×10ml-amp.pl. | BTA | SK |

| 283.3 | V07AB | voda pro injekci nad 10 ml v jedné ampuli nebo lahvi | parent. | 100.00 | ML | 13,66 | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 10559 | AQUA PRO INJECTIONE BRAUN | inj sol 10×250ml-pe | BMM | D |

| --- | --- | --- | --- | --- |

| 10560 | AQUA PRO INJECTIONE BRAUN | inj sol 10×500ml-pe | BMM | D |

| 10561 | AQUA PRO INJECTIONE BRAUN | inj sol 10×1000ml-pe | BMM | D |

| 31424 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1×250ml-skl | FKI | I |

| 31425 | STERILE WATER F.INJ.FRESENIUS | par Iqf 16×250ml-skl | FKI | I |

| 31426 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1×500ml-skl | FKI | I |

| 31427 | STERILE WATER F.INJ.FRESENIUS | par Iqf 12×500ml-skl | FKI | I |

| 31428 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1×1000ml-skl | FKI | I |

| 31429 | STERILE WATER F.INJ.FRESENIUS | par Iqf 6×1000ml-skl | FKI | I |

| 53363 | AQUA PRO INJECTIONE INFUSIA | sol 1×250ml(sklo) | IHO | CZ |

| 53364 | AQUA PRO INJECTIONE INFUSIA | sol 1×500ml(sklo) | IHO | CZ |

| 57773 | WATER FOR INJECTIONS BIEFFE | inf 1×250ml(vak) | BFH | E |

| 57775 | WATER FOR INJECTIONS BIEFFE | inf 1×500ml(vak) | BFH | E |

| 57776 | WATER FOR INJECTIONS BIEFFE | inf 1×1000ml(vak) | BFH | E |

| 69789 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1×500ml | ARD | CZ |

| 70484 | WATER FOR INJECTIONS BIEFFE | inf 1×1000ml(vak) | BFF | I |

| 70528 | AQUA PRO INJECTIONE MEDICAMENTA | par Iqf 1×500ml | MVM | CZ |

| 80486 | AQUA PRO INJECTIONE MEDICAMENTA | par Iqf 1×250ml | MVM | CZ |

| 83943 | AQUA PRO INJECTIONE MEDIEKOS | sol 1×500ml(vak) | INK | CZ |

| 85557 | WATER FOR INJECTIONS BIEFFE | inf 1×250ml(vak) | BFF | I |

| 85558 | WATER FOR INJECTIONS BIEFFE | inf 1×500ml(vak) | BFF | I |

| 89244 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1×250ml | ARD | CZ |

| 91876 | AQUA PRO INJECTIONE INFUSIA | sol 1×500ml(plast) | IHO | CZ |

| 92782 | AQUA PRO INJECTIONE MEDIEKOS | sol 1×1000ml(vak) | INK | CZ |

| 92783 | AQUA PRO INJECTIONE MEDIEKOS | sol 1×2000ml(vak) | INK | CZ |

| 95564 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1×500ml-pe | FKI | I |

| 95565 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1×1000ml-pe | FKI | I |

| 95566 | STERILE WATER F.INJ.FRESENIUS | par Iqf 20×500ml-pe | FKI | I |

| 95567 | STERILE WATER F.INJ.FRESENIUS | par Iqf 12×1000ml-pe | FKI | I |

| 97058 | AQUA PRO INJECTIONE MEDIEKOS | sol 1×5000ml(vak) | INK | CZ |

| 97726 | WATER FOR INJECTIONS BIEFFE | inf 1×250ml(sklo) | BFF | I |

| 97727 | WATER FOR INJECTIONS BIEFFE | inf 1×500ml(sklo) | BFF | I |

| 98539 | VODA NA INJEKCI VIAFLO | par Iqf 35×150ml | BFH | E |

| 99208 | VODA NA INJEKCI VIAFLO | par Iqf 30×250ml | BFH | E |

| 99814 | VODA NA INJEKCI VIAFLO | par Iqf 20×500ml | BFH | E |

| 99826 | VODA NA INJEKCI VIAFLO | par Iqf 10×1000ml | BFH | E |

| 284 | vodorozpustné nefrotropní hyperosmolární RTG kontrastní látky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 284.1 | V08AA01 | kyselina diatrizoová | parent. | 10.00 | ML | 45.00 | K |

| | | | | | | | |

| 284.2 | V08AA03 | iodamid (koncentrace 300 mg l/ml) | parent. | 10.00 | ML | 41.06 | K |

| | | | | | | | |

| 284.3 | V08AA03 | iodamid (koncentrace 380 mg l/ml) | parent. | 10.00 | ML | 44.97 | K |

| | | | | | | | |

| 284.4 | V08AA03 | iodamid (koncentrace 410 mg l/ml) | parent. | 10.00 | ML | 87.40 | K |

| | | | | | | | |

| 284.5 | V08AA05 | kyselina ioxitalamová | p.o. | 10.00 | ML | 59.19 | K |

| 59496 | TELEBRIX GASTRO | sol 1x100ml/30gm i | GUT | F |

| --- | --- | --- | --- | --- |

| 59497 | TELEBRIX GASTRO | sol 10x100ml/30gm i | GUT | F |

| 284.6 | V08AA05 | kyselina ioxitalamová (koncentrace 300 mg l/ml) | parent. | 10.00 | ML | 54.73 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32931 | TELEBRIX 30 MEGLUMINE | inj sol 1x50ml | GUT | F |

| --- | --- | --- | --- | --- |

| 32932 | TELEBRIX 30 MEGLUMINE | inj sol 1x100ml | GUT | F |

| 284.7 | V08AA05 | kyselina ioxitalamová (koncentrace 350 mg l/ml a více) | parent. | 10.00 | ML | 66.00 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32935 | TELEBRIX 35 | inj sol 1x50ml | GUT | F |

| --- | --- | --- | --- | --- |

| 32936 | TELEBRIX 35 | inj sol 1x100ml | GUT | F |

| 32937 | TELEBRIX 35 | inj sol 1x200ml | GUT | F |

| 284.1 | V08AA01 | kyselina diatrizoová | parent. | 10.00 | ML | 43,98 | K |

| | | | | | | | |

| 284.2 | V08AA03 | iodamid (koncentrace 300 mg l/ml) | parent. | 10.00 | ML | 40,13 | K |

| | | | | | | | |

| 284.3 | V08AA03 | iodamid (koncentrace 380 mg l/ml) | parent. | 10.00 | ML | 43,95 | K |

| | | | | | | | |

| 284.4 | V08AA03 | iodamid (koncentrace 410 mg l/ml) | parent. | 10.00 | ML | 85,42 | K |

| | | | | | | | |

| 284.5 | V08AA05 | kyselina ioxitalamová | p.o. | 10.00 | ML | 57,85 | K |

| 59496 | TELEBRIX GASTRO | sol 1×100ml/30gm i | GUT | F |

| --- | --- | --- | --- | --- |

| 59497 | TELEBRIX GASTRO | sol 10×100ml/30gm i | GUT | F |

| 284.6 | V08AA05 | kyselina ioxitalamová (koncentrace 300 mg l/ml) | parent. | 10.00 | ML | 53,49 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32931 | TELEBRIX 30 MEGLUMINE | inj sol 1×50ml | GUT | F |

| --- | --- | --- | --- | --- |

| 32932 | TELEBRIX 30 MEGLUMINE | inj sol 1×100ml | GUT | F |

| 284.7 | V08AA05 | kyselina ioxitalamová (koncentrace 350 mg l/ml a více) | parent. | 10.00 | ML | 64,50 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| 32935 | TELEBRIX 35 | inj sol 1×50ml | GUT | F |

| --- | --- | --- | --- | --- |

| 32936 | TELEBRIX 35 | inj sol 1×100ml | GUT | F |

| 32937 | TELEBRIX 35 | inj sol 1×200ml | GUT | F |

| 285 | vodorozpustné nefrotropní nízkoosmolání RTG kontrastní látky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.1 | V08AB02 | iohexol (koncentrace 180 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 184.90 | K |

| | | | | | | | |

| 285.2 | V08AB02 | iohexol (koncentrace 240 mg l/ml, do 15 ml v jedné ampuli včetně) | parent. | 10.00 | ML | 220.90 | K |

| | | | | | | | |

| 285.3 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 159.40 | K |

| | | | | | | | |

| 285.4 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 122.70 | K |

| 02955 | IOHEXOL 240 | inj sol 1x100ml | ITP | CZ |

| --- | --- | --- | --- | --- |

| 285.5 | V08AB02 | iohexol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 256.70 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.6 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 185.50 | K |

| 02938 | IOHEXOL 300 | inj sol 10x20ml | ITP | CZ |

| --- | --- | --- | --- | --- |

| 285.7 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 142.65 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.8 | V08AB02 | iohexol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 207.20 | K |

| | | | | | | | |

| 285.9 | V08AB02 | iohexol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 159.40 | K |

| | | | | | | | |

| 285.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 200.58 | K |

| 59544 | HEXABRIX 320 | inj sol 1x50ml | GUT | F |

| --- | --- | --- | --- | --- |

| 59545 | HEXABRIX 320 | inj sol 25x50ml | GUT | F |

| 285.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 186.90 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.12 | V08AB04 | iopamidol | p.o. | 10.00 | ML | 59.19 | K |

| | | | | | | | |

| 285.13 | V08AB04 | iopamidol (koncentrace 200 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 242.54 | K |

| | | | | | | | |

| 285.14 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 299.78 | K |

| | | | | | | | |

| 285.15 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 185.92 | K |

| | | | | | | | |

| 285.16 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 169.67 | K |

| | | | | | | | |

| 285.17 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 365.98 | K |

| | | | | | | | |

| 285.18 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 15 do 30 ml v jedné ampuli včetně) | parent. | 10.00 | ML | 224.93 | K |

| | | | | | | | |

| 285.19 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 181.10 | K |

| | | | | | | | |

| 285.20 | V08AB05 | iopromid (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 122.70 | K |

| | | | | | | | |

| 285.21 | V08AB05 | iopromid (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 185.40 | K |

| | | | | | | | |

| 285.22 | V08AB05 | iopromid (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 142.60 | K |

| | | | | | | | |

| 285.23 | V08AB05 | iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 165.80 | K |

| | | | | | | | |

| 285.24 | V08AB06 | iotrolan (koncentrace 240 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 429.71 | K/P |

| | | | | | | | |

| 285.25 | V08AB06 | iotrolan (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 534.28 | K/P |

| 285.1 | V08AB02 | iohexol (koncentrace 180 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 180,70 | K |

| | | | | | | | |

| 285.2 | V08AB02 | iohexol (koncentrace 240 mg l/ml, do 15 ml v jedné ampuli včetně) | parent. | 10.00 | ML | 215,89 | K |

| | | | | | | | |

| 285.3 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 155,78 | K |

| | | | | | | | |

| 285.4 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 119,91 | K |

| 02955 | IOHEXOL 240 | inj sol 1×100ml | ITP | CZ |

| --- | --- | --- | --- | --- |

| 285.5 | V08AB02 | iohexol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 250,87 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.6 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 181,29 | K |

| 02938 | IOHEXOL 300 | inj sol 10×20ml | ITP | CZ |

| --- | --- | --- | --- | --- |

| 285.7 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 139,41 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.8 | V08AB02 | iohexol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 202,50 | K |

| | | | | | | | |

| 285.9 | V08AB02 | iohexol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 155,78 | K |

| | | | | | | | |

| 285.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 196,03 | K |

| 59544 | HEXABRIX 320 | inj sol 1×50ml | GUT | F |

| --- | --- | --- | --- | --- |

| 59545 | HEXABRIX 320 | inj sol 25×50ml | GUT | F |

| 285.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 182,66 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.12 | V08AB04 | iopamidol | p.o. | 10.00 | ML | 57,85 | K |

| | | | | | | | |

| 285.13 | V08AB04 | iopamidol (koncentrace 200 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 237,03 | K |

| | | | | | | | |

| 285.14 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 292,97 | K |

| | | | | | | | |

| 285.15 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 181,70 | K |

| | | | | | | | |

| 285.16 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 165,82 | K |

| | | | | | | | |

| 285.17 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 357,67 | K |

| | | | | | | | |

| 285.18 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 15 do 30 ml v jedné ampuli včetně) | parent. | 10.00 | ML | 219,82 | K |

| | | | | | | | |

| 285.19 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 176,99 | K |

| | | | | | | | |

| 285.20 | V08AB05 | iopromid (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 119,91 | K |

| | | | | | | | |

| 285.21 | V08AB05 | iopromid (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 181,19 | K |

| | | | | | | | |

| 285.22 | V08AB05 | iopromid (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 139,36 | K |

| | | | | | | | |

| 285.23 | V08AB05 | iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 162,04 | K |

| | | | | | | | |

| 285.24 | V08AB06 | iotrolan (koncentrace 240 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 419,96 | K/P |

| | | | | | | | |

| 285.25 | V08AB06 | iotrolan (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 522,15 | K/P |

Iotrolan aplikuje rentgenolog při vyšetření s intrathekálním podáním.

| 285.26 | V08AB07 | ioversol (koncentrace 160 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 95.60 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.27 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 122.70 | K |

| | | | | | | | |

| 285.28 | V08AB07 | ioversol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 256.70 | K |

| | | | | | | | |

| 285.29 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 185.40 | K |

| | | | | | | | |

| 285.30 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 142.65 | K |

| | | | | | | | |

| 285.31 | V08AB07 | ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 149.50 | K |

| | | | | | | | |

| 285.32 | V08AB07 | ioversol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 207.20 | K |

| | | | | | | | |

| 285.33 | V08AB07 | ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 159.42 | K |

| | | | | | | | |

| 285.34 | V08AB09 | iodixanol (koncentrace 150 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10.00 | ML | 193.90 | K |

| 42398 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | ABH | N |

| --- | --- | --- | --- | --- |

| 42399 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | AHC | IRL |

| 42400 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | ABH | N |

| 42401 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | AHC | IRL |

| 42402 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | ABH | N |

| 42403 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | AHC | IRL |

| 45115 | VISIPAQUE 150 MG l/ML | inj sol 6x200ml-skl | AHC | IRL |

| 84340 | VISIPAQUE 150 MG l/ML | inj sol 6x200ml-skl | ABH | N |

| 285.35 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10.00 | ML | 302.90 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.36 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10.00 | ML | 253.90 | K |

| 42406 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-skl | ABH | N |

| --- | --- | --- | --- | --- |

| 42407 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-skl | AHC | IRL |

| 42410 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-pp | ABH | N |

| 42411 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-pp | AHC | IRL |

| 42412 | VISIPAQUE 270 MG l/ML | inj sol 10x150ml-pp | ABH | N |

| 42413 | VISIPAQUE 270 MG l/ML | inj sol 10x150ml-pp | AHC | IRL |

| 42414 | VISIPAQUE 270 MG l/ML | inj sol 10x175ml-pp | ABH | N |

| 42415 | VISIPAQUE 270 MG l/ML | inj sol 10x175ml-pp | AHC | IRL |

| 42416 | VISIPAQUE 270 MG l/ML | inj sol 10x200ml-pp | ABH | N |

| 42417 | VISIPAQUE 270 MG l/ML | inj sol 10x200ml-pp | AHC | IRL |

| 42418 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-pp | ABH | N |

| 42419 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-pp | AHC | IRL |

| 45120 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-sk | AHC | IRL |

| 45121 | VISIPAQUE 270 MG l/ML | inj sol 6x200ml-skl | AHC | IRL |

| 84343 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-sk | ABH | N |

| 84344 | VISIPAQUE 270 MG l/ML | inj sol 6x200ml-skl | ABH | N |

| 285.37 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10.00 | ML | 321.70 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.38 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10.00 | ML | 258.50 | K |

| 42428 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-skl | ABH | N |

| --- | --- | --- | --- | --- |

| 42429 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-skl | AHC | IRL |

| 42438 | VISIPAQUE 320 MG l/ML | inj sol 10x200ml-pp | ABH | N |

| 42439 | VISIPAQUE 320 MG l/ML | inj sol 10x200ml-pp | AHC | IRL |

| 42440 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-pp | ABH | N |

| 42441 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-pp | AHC | IRL |

| 45125 | VISIPAQUE 320 MG l/ML | inj sol 6x200ml-skl | AHC | IRL |

| 84348 | VISIPAQUE 320 MG l/ML | inj sol 6x200ml-skl | ABH | N |

| 285.39 | V08AB10 | iomeprol (koncentrace 150 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 92.70 | K |

| | | | | | | | |

| 285.40 | V08AB10 | iomeprol (koncentrace 200 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 109.70 | K |

| | | | | | | | |

| 285.41 | V08AB10 | iomeprol (koncentrace 250 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 126.00 | K |

| | | | | | | | |

| 285.42 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 185.50 | K |

| | | | | | | | |

| 285.43 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 142.65 | K |

| | | | | | | | |

| 285.44 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 207.20 | K |

| | | | | | | | |

| 285.45 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 159.40 | K |

| | | | | | | | |

| 285.46 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 228.70 | K |

| | | | | | | | |

| 285.47 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 175.90 | K |

| | | | | | | | |

| 285.48 | V08AB11 | lobitridol (koncentrace 300 mg nad 50 ml v ampuli) | parent. | 10.00 | ML | 142.65 | K |

| | | | | | | | |

| 285.49 | V08AB11 | lobitridol (koncentrace 350 mg nad 50 ml v ampuli) | parent. | 10.00 | ML | 159.40 | K |

| 285.26 | V08AB07 | ioversol (koncentrace 160 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 93,43 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.27 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 119,91 | K |

| | | | | | | | |

| 285.28 | V08AB07 | ioversol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10.00 | ML | 250,87 | K |

| | | | | | | | |

| 285.29 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 181,19 | K |

| | | | | | | | |

| 285.30 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 139,41 | K |

| | | | | | | | |

| 285.31 | V08AB07 | ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 146,11 | K |

| | | | | | | | |

| 285.32 | V08AB07 | ioversol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 202,50 | K |

| | | | | | | | |

| 285.33 | V08AB07 | ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 155,80 | K |

| | | | | | | | |

| 285.34 | V08AB09 | iodixanol (koncentrace 150 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10.00 | ML | 189,50 | K |

| 42398 | VISIPAQUE 150 MG l/ML | inj sol 6×500ml-skl | ABH | N |

| --- | --- | --- | --- | --- |

| 42399 | VISIPAQUE 150 MG l/ML | inj sol 6×500ml-skl | AHC | IRL |

| 42400 | VISIPAQUE 150 MG l/ML | inj sol 10×100ml-pp | ABH | N |

| 42401 | VISIPAQUE 150 MG l/ML | inj sol 10×100ml-pp | AHC | IRL |

| 42402 | VISIPAQUE 150 MG l/ML | inj sol 10×200ml-pp | ABH | N |

| 42403 | VISIPAQUE 150 MG l/ML | inj sol 10×200ml-pp | AHC | IRL |

| 45115 | VISIPAQUE 150 MG l/ML | inj sol 6×200ml-skl | AHC | IRL |

| 84340 | VISIPAQUE 150 MG l/ML | inj sol 6×200ml-skl | ABH | N |

| 285.35 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10.00 | ML | 296,02 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.36 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10.00 | ML | 248,14 | K |

| 42406 | VISIPAQUE 270 MG l/ML | inj sol 6×500ml-skl | ABH | N |

| --- | --- | --- | --- | --- |

| 42407 | VISIPAQUE 270 MG l/ML | inj sol 6×500ml-skl | AHC | IRL |

| 42410 | VISIPAQUE 270 MG l/ML | inj sol 10×100ml-pp | ABH | N |

| 42411 | VISIPAQUE 270 MG l/ML | inj sol 10×100ml-pp | AHC | IRL |

| 42412 | VISIPAQUE 270 MG l/ML | inj sol 10×150ml-pp | ABH | N |

| 42413 | VISIPAQUE 270 MG l/ML | inj sol 10×150ml-pp | AHC | IRL |

| 42414 | VISIPAQUE 270 MG l/ML | inj sol 10×175ml-pp | ABH | N |

| 42415 | VISIPAQUE 270 MG l/ML | inj sol 10×175ml-pp | AHC | IRL |

| 42416 | VISIPAQUE 270 MG l/ML | inj sol 10×200ml-pp | ABH | N |

| 42417 | VISIPAQUE 270 MG l/ML | inj sol 10×200ml-pp | AHC | IRL |

| 42418 | VISIPAQUE 270 MG l/ML | inj sol 6×500ml-pp | ABH | N |

| 42419 | VISIPAQUE 270 MG l/ML | inj sol 6×500ml-pp | AHC | IRL |

| 45120 | VISIPAQUE 270 MG l/ML | inj sol 10×100ml-sk | AHC | IRL |

| 45121 | VISIPAQUE 270 MG l/ML | inj sol 6×200ml-skl | AHC | IRL |

| 84343 | VISIPAQUE 270 MG l/ML | inj sol 10×100ml-sk | ABH | N |

| 84344 | VISIPAQUE 270 MG l/ML | inj sol 6×200ml-skl | ABH | N |

| 285.37 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10.00 | ML | 314,40 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 285.38 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10.00 | ML | 252,63 | K |

| 42428 | VISIPAQUE 320 MG l/ML | inj sol 6×500ml-skl | ABH | N |

| --- | --- | --- | --- | --- |

| 42429 | VISIPAQUE 320 MG l/ML | inj sol 6×500ml-skl | AHC | IRL |

| 42438 | VISIPAQUE 320 MG l/ML | inj sol 10×200ml-pp | ABH | N |

| 42439 | VISIPAQUE 320 MG l/ML | inj sol 10×200ml-pp | AHC | IRL |

| 42440 | VISIPAQUE 320 MG l/ML | inj sol 6×500ml-pp | ABH | N |

| 42441 | VISIPAQUE 320 MG l/ML | inj sol 6×500ml-pp | AHC | IRL |

| 45125 | VISIPAQUE 320 MG l/ML | inj sol 6×200ml-skl | AHC | IRL |

| 84348 | VISIPAQUE 320 MG l/ML | inj sol 6×200ml-skl | ABH | N |

| 285.39 | V08AB10 | iomeprol (koncentrace 150 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 90,60 | K |

| | | | | | | | |

| 285.40 | V08AB10 | iomeprol (koncentrace 200 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 107,21 | K |

| | | | | | | | |

| 285.41 | V08AB10 | iomeprol (koncentrace 250 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 123,14 | K |

| | | | | | | | |

| 285.42 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 181,29 | K |

| | | | | | | | |

| 285.43 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 139,41 | K |

| | | | | | | | |

| 285.44 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 202,50 | K |

| | | | | | | | |

| 285.45 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 155,78 | K |

| | | | | | | | |

| 285.46 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10.00 | ML | 223,51 | K |

| | | | | | | | |

| 285.47 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, nad 50 ml v ampuli) | parent. | 10.00 | ML | 171,91 | K |

| | | | | | | | |

| 285.48 | V08AB11 | lobitridol (koncentrace 300 mg nad 50 ml v ampuli) | parent. | 10.00 | ML | 139,41 | K |

| | | | | | | | |

| 285.49 | V08AB11 | lobitridol (koncentrace 350 mg nad 50 ml v ampuli) | parent. | 10.00 | ML | 155,78 | K |

| | | | | | | | |

| 286 | vodorozpustné hepatotropní a vodonerozpustné RTG kontrastní látky | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 286.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg l/ml) | parent. | 10.00 | ML | 74.25 | K |

| | | | | | | | |

| 286.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg l/ml) | parent. | 10.00 | ML | 37.39 | K |

| | | | | | | | |

| 286.3 | V08AC04 | adipiodon | parent. | 10.00 | ML | 39.35 | K |

| | | | | | | | |

| 286.4 | V08AD | iopydol + iopyron | parent. | 10.00 | ML | 300.70 | K |

| | | | | | | | |

| 286.5 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10.00 | ML | 476.14 | K |

| 59494 | LIPIODOL ULTRA-FLUIDE | inj sol 1x10ml | GUT | F |

| 286.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg l/ml) | parent. | 10.00 | ML | 72,56 | K |

| | | | | | | | |

| 286.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg l/ml) | parent. | 10.00 | ML | 36,54 | K |

| | | | | | | | |

| 286.3 | V08AC04 | adipiodon | parent. | 10.00 | ML | 38,46 | K |

| | | | | | | | |

| 286.4 | V08AD | iopydol + iopyron | parent. | 10.00 | ML | 293,87 | K |

| | | | | | | | |

| 286.5 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10.00 | ML | 465,33 | K |

| 59494 | LIPIODOL ULTRA-FLUIDE | inj sol 1×10ml | GUT | F |

| --- | --- | --- | --- | --- |

| 287 | RTG kontrastní přípravky obsahující síran barnatý | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 287.1 | V08BA01 | RTG kontrastní přípravky obsahující síran barnatý (lékové formy kolon) | p.rect. | 100.00 | GM | 45.00 | K |

| | | | | | | | |

| 287.2 | V08BA01 | síran barnatý | p.o. | 100.00 | GM | 32.15 | K |

| | | | | | | | |

| 287.3 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100.00 | GM | 36.73 | K |

| 62396 | E-Z-HD | plv sus 1x340gm | EZE | USA |

| --- | --- | --- | --- | --- |

| 78270 | E-Z-HD | plv sus 1x340gm | EZE | CND |

| 287.4 | V08BA01 | síran barnatý (lékové formy pasty) | p.o. | 100.00 | GM | 94.58 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 287.5 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.50 | GM | 147.52 | K |

| 62399 | E-Z-CAT | sus 1x225ml | EZE | USA |

| --- | --- | --- | --- | --- |

| 78269 | E-Z-CAT | sus 1x225ml | EZE | CND |

| 287.1 | V08BA01 | RTG kontrastní přípravky obsahující síran barnatý (lékové formy kolon) | p.rect. | 100.00 | GM | 43,98 | K |

| | | | | | | | |

| 287.2 | V08BA01 | síran barnatý | p.o. | 100.00 | GM | 31,42 | K |

| | | | | | | | |

| 287.3 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100.00 | GM | 35,90 | K |

| 62396 | E-Z-HD | plv sus 1×340gm | EZE | USA |

| --- | --- | --- | --- | --- |

| 78270 | E-Z-HD | plv sus 1×340gm | EZE | CND |

| 287.4 | V08BA01 | síran barnatý (lékové formy pasty) | p.o. | 100.00 | GM | 92,43 | K |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 287.5 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.50 | GM | 144,17 | K |

| 62399 | E-Z-CAT | sus 1×225ml | EZE | USA |

| --- | --- | --- | --- | --- |

| 78269 | E-Z-CAT | sus 1×225ml | EZE | CND |

| 288 | paramagnetické kontrastní látky a kontrastní látky pro ultrazvuk | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 288.1 | V08CA01 | dimeglumin gadopentetat | parent. | 10.00 | ML | 1 472.10 | K |

| | | | | | | | |

| 288.2 | V08CA02 | meglumin gadoterat | parent. | 10.00 | ML | 1 472.10 | K |

| | | | | | | | |

| 288.3 | V08CA03 | gadodiamid | parent. | 10.00 | ML | 1 472.10 | K |

| | | | | | | | |

| 288.4 | V08CA04 | gadoteridol | parent. | 10.00 | ML | 1 472.10 | K |

| | | | | | | | |

| 288.5 | V08CA05 | mangafodipir | parent. | 10.00 | ML | 916.70 | K |

| | | | | | | | |

| 288.6 | V08CA08 | dimeglumin gadobenat | parent. | 10.00 | ML | 1 472.10 | K |

| | | | | | | | |

| 288.7 | V08CA09 | gadobutrol | parent. | 10.00 | ML | 2 518.00 | K |

| | | | | | | | |

| 288.8 | V08CB03 | oxid železa, nanočástice, s obsahem do 0,9 ml včetně | parent. | 1.00 | DF | 5 945.93 | H |

| 02251 | RESOVIST | inj sol 1x0.9ml-stŘ | SAG | D |

| --- | --- | --- | --- | --- |

| 288.9 | V08CB03 | oxid železa, nanočástice, s obsahem nad 0,9 ml | parent. | 1.00 | DF | 6 700.00 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 288.10 | V08DA01 | mikročástice albuminu s oktafluoropanem | parent. | 1.00 | DF | 2 857.50 | H |

| | | | | | | | |

| 288.11 | V08DA02 | mikročástice galaktózy | parent. | 1.00 | GM | 914.00 | H |

| | | | | | | | |

| 288.12 | V08DA05 | sulfur hexafluorid | parent. | 5.00 | ML | 2 551.00 | H |

| | | | | | | | |

| 288.13 | V08CA | dinatrii gadoxetas | parent. | 1.00 | ML | 560.00 | K |

| 16173 | PRIMOVIST 0.25 MMOL/ML | inj sol 1x10ml | SAG | D |

| 288.1 | V08CA01 | dimeglumin gadopentetat | parent. | 10.00 | ML | 1 438,68 | K |

| | | | | | | | |

| 288.2 | V08CA02 | meglumin gadoterat | parent. | 10.00 | ML | 1 438,68 | K |

| | | | | | | | |

| 288.3 | V08CA03 | gadodiamid | parent. | 10.00 | ML | 1 438,68 | K |

| | | | | | | | |

| 288.4 | V08CA04 | gadodiamid | parent. | 10.00 | ML | 1 438,68 | K |

| | | | | | | | |

| 288.5 | V08CA05 | mangafodipir | parent. | 10.00 | ML | 895,89 | K |

| | | | | | | | |

| 288.6 | V08CA08 | dimeglumin gadobenat | parent. | 10.00 | ML | 1 438,68 | K |

| | | | | | | | |

| 288.7 | V08CA09 | gadobutrol | parent. | 10.00 | ML | 2 460,84 | K |

| | | | | | | | |

| 288.8 | V08CB03 | oxid železa, nanočástice, s obsahem do 0,9 ml včetně | parent. | 1.00 | DF | 5 810,96 | H |

| 02251 | RESOVIST | inj sol 1×0.9ml-stř | SAG | D |

| --- | --- | --- | --- | --- |

| 288.9 | V08CB03 | oxid železa, nanočástice, s obsahem nad 0,9 ml | parent. | 1.00 | DF | 6 547,91 | H |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 288.10 | V08DA01 | mikročástice albuminu s oktafluoropanem | parent. | 1.00 | DF | 2 792,63 | H |

| | | | | | | | |

| 288.11 | V08DA02 | mikročástice galaktózy | parent. | 1.00 | GM | 893,25 | H |

| | | | | | | | |

| 288.12 | V08DA05 | sulfur hexafluorid | parent. | 5.00 | ML | 2 493,09 | H |

| | | | | | | | |

| 288.13 | V08CA | dinatrii gadoxetas | parent. | 1.00 | ML | 547,29 | K |

| 16173 | PRIMOVIST 0.25 MMOL/ML | inj sol 1×10ml | SAG | D |

| --- | --- | --- | --- | --- |

| 289 | Individuálně připravovaná radiofarmaka pro diagnostiku |

@@ -10916,7 +10966,7 @@

| 294 | individuálně připravovaná léčiva ze skupiny gynekologik | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | |

| 294.1 | V20 | natrium tetraboricum v lékové formě vaginálních globulí | vag. | | | plně | |

| 294.1 | V20 | natrium tetraboricum v lékové formě vaginálních globuli | vag. | | | plně | |

| | | | | | | | |

| 295 | individuálně připravovaná léčiva ze skupiny léčiv trávícího ústrojí | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

@@ -11056,7 +11106,7 @@

1) Deleukotizované trombocyty jsou indikovány v případě:

- 1.1) Výskytu nehemolytických potransfúzních reakcí

- 1.1 Výskytu nehemolytických potransfúzních reakcí

- a) u pacientů s opakovanými febrilními nehemolytickými reakcemi po transfuzi,

@@ -11104,7 +11154,7 @@

Vysvětlivky:

- při úhradě všech druhů Trombocytů se za 1 terapeutickou dávku považuje počet trombocytů 200-299×10^^9. Při počtu nižším nebo vyšším se vykazuje násobek jednotky s povolenými hodnotami 0,5; 1,5; 2,0

- při úhradě všech druhů Trombocytů se za 1 terapeutickou dávku považuje počet trombocytů 200-299 x10^^9. Při počtu nižším nebo vyšším se vykazuje násobek jednotky s povolenými hodnotami 0,5; 1,5; 2,0

| 299 | přípravky z plazmy | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- |

2005-12-31

Vyhláška č. 532/2005 Sb.

původní verze Text k tomuto datu